PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bossuyt, PM; Reitsma, JB; Bruns, DE; Gatsonis, CA; Glasziou, PP; Irwig, LM; Lijmer, JG; Moher, D; Rennie, D; de Vet, HCW				Bossuyt, PM; Reitsma, JB; Bruns, DE; Gatsonis, CA; Glasziou, PP; Irwig, LM; Lijmer, JG; Moher, D; Rennie, D; de Vet, HCW		STARD Grp	Towards complete and accurate reporting of studies of diagnostic accuracy: The STARD initiative	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIALS; PERIPHERAL ARTERIAL-DISEASE; CONSORT STATEMENT; QUALITY; METAANALYSIS; PERFORMANCE; EFFICACY; TESTS; BIAS	Background: To comprehend the results of diagnostic accuracy studies, readers must understand the design, conduct, analysis, and results of such studies. That goal can be achieved only through complete transparency from authors. Objective: To improve the accuracy and completeness of reporting of studies of diagnostic accuracy in order to allow readers to assess the potential for bias in the study and to evaluate its generalizability. Methods: The Standards for Reporting of Diagnostic Accuracy (STARD) steering committee searched the literature to identify publications on the appropriate conduct and reporting of diagnostic studies and extracted potential items into an extensive list. Researchers, editors, methodologists and statisticians, and members of professional organizations shortened this list during a 2-day consensus meeting with the goal of developing a checklist and a generic flow diagram for studies of diagnostic accuracy. Results: The search for published guidelines on diagnostic research yielded 33 previously published checklists, from which we extracted a list of 75 potential items. The consensus meeting shortened the list to 25 items, using evidence on bias whenever available. A prototypical flow diagram provides information about the method of patient recruitment, the order of test execution, and the numbers of patients undergoing the test under evaluation, the reference standard, or both. Conclusions: Evaluation of research depends on complete and accurate reporting. If medical journals adopt the checklist and the flow diagram, the quality of reporting of studies of diagnostic accuracy should improve to the advantage of the clinicians, researchers, reviewers, journals, and the public.	Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; Brown Univ, Providence, RI 02912 USA; Univ Queensland, Sch Med, Herston, Qld, Australia; Univ Sydney, Sydney, NSW 2006, Australia; Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON K1H 8L1, Canada	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Brown University; University of Queensland; University of Sydney; University of Ottawa; Children's Hospital of Eastern Ontario	Bossuyt, PM (corresponding author), Amer Coll Physicians, Amer Soc Internal Med, 190 N Independence Mall W, Philadelphia, PA 19106 USA.		Bossuyt, Patrick M./B-4557-2016; Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M/AAR-1183-2021	Bossuyt, Patrick M./0000-0003-4427-0128; Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M/0000-0003-4427-0128; de Vet, Henrica/0000-0002-5454-2804; Moher, David/0000-0003-2434-4206				[Anonymous], 1997, JAMA, V277, P927; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; deVries SO, 1996, ACAD RADIOL, V3, P361, DOI 10.1016/S1076-6332(96)80257-1; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; GRINER PF, 1981, ANN INTERN MED, V94, P553, DOI 10.7326/0003-4819-94-4-571; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; KENT DL, 1992, INVEST RADIOL, V27, P245, DOI 10.1097/00004424-199203000-00014; KNOTTNERUS JA, 1987, MED DECIS MAKING, V7, P139, DOI 10.1177/0272989X8700700304; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; PANZER RJ, 1987, MED DECIS MAKING, V7, P115, DOI 10.1177/0272989X8700700209; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; SACKETT DL, 1991, CLIN EPIDEMIOLOGY, P47	19	1368	1392	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					40	44		10.7326/0003-4819-138-1-200301070-00010	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00010			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513043	Green Submitted			2022-12-28	WOS:000180996200006
J	Bartel, B; Matsuda, SPT				Bartel, B; Matsuda, SPT			Seeing red	SCIENCE			English	Editorial Material							FLAVONOID BIOSYNTHESIS; BANYULS		Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; Rice University	Bartel, B (corresponding author), Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA.	matsuda@rice.edu	Bartel, Bonnie/O-8119-2019; Bartel, Bonnie/D-3550-2011	Bartel, Bonnie/0000-0002-6367-346X; Bartel, Bonnie/0000-0002-6367-346X				Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; Albert S, 1997, PLANT J, V11, P289, DOI 10.1046/j.1365-313X.1997.11020289.x; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Ross JA, 2002, ANNU REV NUTR, V22, P19, DOI 10.1146/annurev.nutr.22.111401.144957; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540	6	18	24	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					352	353		10.1126/science.1081096	http://dx.doi.org/10.1126/science.1081096			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532002				2022-12-28	WOS:000180426800029
J	Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA				Baum, JK; Myers, RA; Kehler, DG; Worm, B; Harley, SJ; Doherty, PA			Collapse and conservation of shark populations in the Northwest Atlantic	SCIENCE			English	Article							EXTINCTION; MANAGEMENT	Overexploitation threatens the future of many large vertebrates. In the ocean, tunas and sea turtles are current conservation concerns because of this intense pressure. The status of most shark species, in contrast, remains uncertain. Using the largest data set in the Northwest Atlantic, we show rapid large declines in large coastal and oceanic shark populations. Scalloped hammerhead, white, and thresher sharks are each estimated to have declined by over 75% in the past 15 years. Closed-area models highlight priority areas for shark conservation, and the need to consider effort reallocation and site selection if marine reserves are to benefit multiple threatened species.	Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada	Dalhousie University	Baum, JK (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS B3H 4J1, Canada.		Baum, Julia K/A-4693-2008	Baum, Julia/0000-0002-9827-1612; Worm, Boris/0000-0002-5742-8716				Alroy J, 2001, SCIENCE, V292, P1893, DOI 10.1126/science.1059342; [Anonymous], 1996, OVERVIEW WORLD TRADE; AU D, 1985, SCRS8475 INT COMM CO; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R., 1994, 341 FAO; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Casey JM, 1998, SCIENCE, V281, P690, DOI 10.1126/science.281.5377.690; CASTRO JI, 1999, 380 FAO; Compagno L. J. V., 2001, FAO SPECIES CATALOGU, V2; COMPAGNO LJV, 1984, FISH SYNOP, V125; Essington TE, 2002, ECOL APPL, V12, P724; Fernandez de Oviedo Gonzalo, 1959, HIST GEN NATURAL IND; GROGGER JT, 1991, J APPL ECONOM, V6, P225, DOI 10.1002/jae.3950060302; Halpern BS, 2002, ECOL LETT, V5, P361, DOI 10.1046/j.1461-0248.2002.00326.x; IUCN, 2002, 2002 IUCN RED LIST T; Jackson JBC, 2001, P NATL ACAD SCI USA, V98, P5411, DOI 10.1073/pnas.091092898; Musick JA, 2000, FISHERIES, V25, P9, DOI 10.1577/1548-8446(2000)025<0009:MOSATR>2.0.CO;2; NAKANO H, 1993, SCRS92145 INT COMM C; National Marine Fisheries Service (NMFS), 1999, FIN FISH MAN PLAN AT; *NMFS, 2001, US NAT PLAN ACT CONS; *NMFS, 2002, STOCK ASS FISH EV AT; Safina C., 1998, SONG BLUE OCEAN; Smith SE, 1998, MAR FRESHWATER RES, V49, P663, DOI 10.1071/MF97135; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Worm B, 2002, NATURE, V417, P848, DOI 10.1038/nature00830; FED REG, V66, P36711; FED REG, V67, P5393	28	817	860	8	502	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					389	392		10.1126/science.1079777	http://dx.doi.org/10.1126/science.1079777			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532016				2022-12-28	WOS:000180426800044
J	Dial, KP				Dial, KP			Wing-assisted incline running and the evolution of flight	SCIENCE			English	Article							BIRDS	Flapping wings of galliform birds are routinely used to produce aerodynamic forces oriented toward the substrate to enhance hindlimb traction. Here, I document this behavior in natural and laboratory settings. Adult birds fully capable of aerial flight preferentially employ wing-assisted incline running (WAIR), rather than flying, to reach elevated refuges (such as cliffs, trees, and boulders). From the day of hatching and before attaining sustained aerial flight, developing ground birds use WAIR to enhance their locomotor performance through improved foot traction, ultimately permitting vertical running. WAIR provides insight from behaviors observable in living birds into the possible role of incipient wings in feathered theropod dinosaurs and offers a previously unstudied explanation for the evolution of avian flight.	Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA	University of Montana System; University of Montana	Dial, KP (corresponding author), Univ Montana, Div Biol Sci, Avian Studies Program, Flight Lab, Missoula, MT 59812 USA.	kdial@selway.umt.edu						BERGERS P, 2001, NATURE, V399, P60; BILO D, 1985, BIONA REPORT, V3, P87; Bock W.J., 1985, P199; CAPLE G, 1983, AM NAT, V121, P455, DOI 10.1086/284076; Chatterjee S., 1997, THE RISE OF BIRDS; Darwin C., 1877, ORIGIN SPECIES; Feduccia A., 1996, ORIGIN EVOLUTION BIR; Gall L.F., 2002, NEW PERSPECTIVES ORI; Garner JP, 1999, P ROY SOC B-BIOL SCI, V266, P1259, DOI 10.1098/rspb.1999.0772; Hecht M.K., 1985, BEGINNINGS BIRDS; JENKINS FA, 1993, AM J SCI, V293A, P253, DOI 10.2475/ajs.293.A.253; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Norell M, 2002, NATURE, V416, P36, DOI 10.1038/416036a; OSTROM JH, 1979, AM SCI, V67, P46; Padian K, 1998, SCI AM, V278, P38, DOI 10.1038/scientificamerican0298-38; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Starck J.M., 1998, AVIAN GROWTH DEV; Tobalske BW, 1996, J EXP BIOL, V199, P263	18	144	152	2	202	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					402	404		10.1126/science.1078237	http://dx.doi.org/10.1126/science.1078237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532020	Green Submitted			2022-12-28	WOS:000180426800048
J	Luo, C; Ibanescu, M; Johnson, SG; Joannopoulos, JD				Luo, C; Ibanescu, M; Johnson, SG; Joannopoulos, JD			Cerenkov radiation in photonic crystals	SCIENCE			English	Article							CHERENKOV RADIATION		MIT, Dept Phys, Cambridge, MA 02139 USA; MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Joannopoulos, JD (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.		Wang, Chi/G-9004-2011; Joannopoulos, John D/E-6401-2013	Johnson, Steven/0000-0001-7327-4967				Afanasiev GN, 1999, PHYSICA B, V269, P95, DOI 10.1016/S0921-4526(99)00078-2; Born M., 2000, PRINCIPLES OPTICS EL; Carusotto I, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.064801; CASEY KF, 1965, PHYS REV B, V140, P768; de Abajo FJG, 1999, PHYS REV LETT, V82, P2776, DOI 10.1103/PhysRevLett.82.2776; FRANK IM, 1986, NUCL INSTRUM METH A, V248, P7, DOI 10.1016/0168-9002(86)90489-4; Jelly J. V., 1958, CERENKOV RAD ITS APP; Joannopoulos J. D., 1995, PHOTONIC CRYSTALS MO; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Johnson SG, 2001, OPT EXPRESS, V8, P173, DOI 10.1364/OE.8.000173; Koshiba M, 2001, IEEE MICROW WIREL CO, V11, P152, DOI 10.1109/7260.916327; Landau LD., 1984, ELECTRODYNAMICS CONT; Lastdrager B, 2000, PHYS REV E, V61, P5767, DOI 10.1103/PhysRevE.61.5767; Luo C, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.201104; Luo CY, 2002, APPL PHYS LETT, V81, P2352, DOI 10.1063/1.1508807; Notomi M, 2000, PHYS REV B, V62, P10696, DOI 10.1103/PhysRevB.62.10696; Ohtaka K, 2002, OPT QUANT ELECTRON, V34, P235, DOI 10.1023/A:1013341901930; Pendry JB, 1996, PHYS REV LETT, V76, P4773, DOI 10.1103/PhysRevLett.76.4773; Pendry JB, 1999, IEEE T MICROW THEORY, V47, P2075, DOI 10.1109/22.798002; Shelby RA, 2001, SCIENCE, V292, P77, DOI 10.1126/science.1058847; Shelby RA, 2001, APPL PHYS LETT, V78, P489, DOI 10.1063/1.1343489; Smith DR, 2000, PHYS REV LETT, V84, P4184, DOI 10.1103/PhysRevLett.84.4184; SMITH SJ, 1953, PHYS REV, V92, P1069, DOI 10.1103/PhysRev.92.1069; Stevens TE, 2001, SCIENCE, V291, P627, DOI 10.1126/science.291.5504.627; VESELAGO VG, 1968, SOV PHYS USPEKHI, V10, P509, DOI 10.1070/PU1968v010n04ABEH003699; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; YARIV A, 1984, OPTICAL WAVES CRYSTA, pCH6	27	252	270	9	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					368	371		10.1126/science.1079549	http://dx.doi.org/10.1126/science.1079549			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532010	Green Submitted			2022-12-28	WOS:000180426800037
J	Wong, GC; Giugliano, RP; Antman, EM				Wong, GC; Giugliano, RP; Antman, EM			Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; FACTOR PATHWAY INHIBITOR; ST-SEGMENT ELEVATION; VON-WILLEBRAND-FACTOR; UNFRACTIONATED HEPARIN; UNSTABLE ANGINA; TISSUE FACTOR; PLATELET ACTIVATION; THERAPEUTIC CONCENTRATIONS; SUBCUTANEOUS ENOXAPARIN	Context Low-molecular-weight heparins (LMWHs) possess several potential pharmacological advantages over unfractionated heparin as an antithrombotic agent. Objective To systematically summarize the clinical data on the efficacy and safety of LMWHs compared with unfractionated heparin across the spectrum of acute coronary syndromes (ACSs), and as an adjunct to percutaneous coronary intervention (PCI). Data Sources We searched MEDLINE for articles from 1990 to 2002 using the index terms heparin, enoxaparin, dalteparin, nadroparin, tinzaparin, low molecular weight heparin, myocardial infarction, unstable angina, coronary angiography, coronary angioplasty, thrombolytic therapy, reperfusion, and drug therapy, combination. Additional data sources included bibliographies of articles identified on MEDLINE, inquiry of experts and pharmaceutical companies, and data presented at recent national and international cardiology conferences. Study Selection We selected for review randomized trials comparing LMWHs against either unfractionated heparin or placebo for treatment of ACS, as well as trials and registries examining clinical outcomes, pharmacokinetics, and/or phamacodynamics of LMWHs in the setting of PCI. Of 39 studies identified, 31 fulfilled criteria for analysis. Data Extraction Data quality was determined by publication in the peer-reviewed literature or presentation at an official cardiology society-sponsored meeting. Data Synthesis The LMWHs are recommended by the American Heart Association and the American College of Cardiology for treatment of unstable angina/non-ST-elevation myocardial infarction. Clinical trials have demonstrated similar safety with LMWHs compared with unfractionated heparin in the setting of PCI and in conjunction with glycoprotein IIb/IIIa inhibitors. Finally, LMWHs show promise as an. antithrombotic agent for the treatment of ST-elevation myocardial infarction. Conclusions The LMWHs could potentially replace unfractionated heparin as the antithrombotic agent of choice across the spectrum of ACSs. In addition, they show promise as a safe and efficacious antithrombotic agent for PCI. However, further study is warranted to define the benefit of LMWHs in certain high-risk subgroups before their use can be universally recommended.	Brigham & Womens Hosp, TIMI Study Grp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Giugliano, RP (corresponding author), TIMI Study Grp, 350 Longwood Ave,1st Floor Off, Boston, MA 02115 USA.	rgiugliano@partners.org	Giugliano, Robert/N-7233-2017	Giugliano, Robert/0000-0003-4110-7675				Abbate R, 1998, AM J CARDIOL, V82, p33L, DOI 10.1016/S0002-9149(98)00111-8; AMBROSE JA, 1992, J AM COLL CARDIOL, V19, P1653, DOI 10.1016/0735-1097(92)90632-W; Ambrose JA, 1996, ARCH INTERN MED, V156, P1382, DOI 10.1001/archinte.156.13.1382; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Antman EM, 1999, CIRCULATION, V100, P1602, DOI 10.1161/01.CIR.100.15.1602; Antman EM, 2002, EUR HEART J, V23, P308, DOI 10.1053/euhj.2001.2779; Antman EM, 2002, CIRCULATION, V105, P1642, DOI 10.1161/01.CIR.0000013402.34759.46; Antman EM, 2001, CIRCULATION, V103, P2310; Ardissino D, 2000, CLIN CHIM ACTA, V291, P235, DOI 10.1016/S0009-8981(99)00231-4; Baird SH, 2002, EUR HEART J, V23, P627, DOI 10.1053/euhj.2001.2940; BARA L, 1993, THROMB RES, V69, P443, DOI 10.1016/0049-3848(93)90233-E; BARA L, 1985, THROMB RES, V39, P631, DOI 10.1016/0049-3848(85)90244-0; BARZU T, 1985, BIOCHIM BIOPHYS ACTA, V845, P196, DOI 10.1016/0167-4889(85)90177-6; BASSAND JP, 2000, 22 C EUR SOC CARD AU; Bastani B, 2002, AM J NEPHROL, V22, P403, DOI 10.1159/000065238; Bertrand ME, 2000, EUR HEART J, V21, P1406, DOI 10.1053/euhj.2000.2301; BHATT DL, IN PRESS J AM COLL C; Blazing MA, 2001, AM HEART J, V142, P211, DOI 10.1067/mhj.2001.116959; Boersma E, 2002, LANCET, V359, P189, DOI 10.1016/S0140-6736(02)07442-1; BONEU B, 1994, THROMB HAEMOSTASIS, V72, P330; Braunwald E, 1997, J AM COLL CARDIOL, V29, P1474; BRAUNWALD E, AHA 2002 GUIDELINE U; Cairns JA, 2001, CHEST, V119, p228S, DOI 10.1378/chest.119.1_suppl.228S; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Casele HL, 1999, AM J OBSTET GYNECOL, V181, P1113, DOI 10.1016/S0002-9378(99)70091-8; Cella G, 1999, CIRCULATION, V99, P3323, DOI 10.1161/01.CIR.99.25.3323; Choussat R, 2002, J AM COLL CARDIOL, V40, P1943, DOI 10.1016/S0735-1097(02)02531-7; Cohen M, 1999, INT J CARDIOL, V71, P273, DOI 10.1016/S0167-5273(99)00171-0; Cohen M, 1997, NEW ENGL J MED, V337, P447, DOI 10.1056/NEJM199708143370702; Cohen M, 2002, AM HEART J, V144, P470, DOI 10.1067/mhj.2002.126115; COHEN M, 2002, AM HEART ASS 75 SCI; Collet JP, 2001, CIRCULATION, V103, P658; Coulter SA, 2000, CIRCULATION, V101, P2690, DOI 10.1161/01.CIR.101.23.2690; DAVIES MJ, 1986, CIRCULATION, V73, P418, DOI 10.1161/01.CIR.73.3.418; DAVIES MJ, 1985, BRIT HEART J, V53, P363; DEWOOD MA, 1980, NEW ENGL J MED, V303, P897, DOI 10.1056/NEJM198010163031601; Duplaga BA, 2001, PHARMACOTHERAPY, V21, P218, DOI 10.1592/phco.21.2.218.34112; Eikelboom JW, 2000, LANCET, V355, P1936, DOI 10.1016/S0140-6736(00)02324-2; EISENBERG PR, 1986, J AM COLL CARDIOL, V7, P1255, DOI 10.1016/S0735-1097(86)80144-9; EISENBERG PR, 1987, J AM COLL CARDIOL, V10, P527, DOI 10.1016/S0735-1097(87)80194-8; Ernofsson M, 1998, THROMB HAEMOSTASIS, V79, P491; Ferguson JJ, 2002, AM HEART J, V143, P952, DOI 10.1067/mhj.2002.122120; Ferguson JJ, 2001, J AM COLL CARDIOL, V37, p365A; FITZGERALD DJ, 1988, CIRCULATION, V77, P142, DOI 10.1161/01.CIR.77.1.142; Fox KAA, 2002, AM J CARDIOL, V90, P477, DOI 10.1016/S0002-9149(02)02517-1; Frostfeldt G, 1999, J AM COLL CARDIOL, V33, P627, DOI 10.1016/S0735-1097(98)00612-3; GOODMAN S, 2002, AM COLL CARD 51 ANN; Goodman SG, 2000, J AM COLL CARDIOL, V36, P693, DOI 10.1016/S0735-1097(00)00808-1; GRAM J, 1988, THROMB RES, V52, P353, DOI 10.1016/0049-3848(88)90019-9; Guerrero RAA, 1999, EUR HEART J, V20, P1553; Hansen JB, 1998, THROMB RES, V91, P177, DOI 10.1016/S0049-3848(98)00079-6; Hansen JB, 1998, BRIT J HAEMATOL, V101, P638, DOI 10.1046/j.1365-2141.1998.00770.x; Hansen JB, 2000, THROMB RES, V100, P413, DOI 10.1016/S0049-3848(00)00351-0; HARENBERG J, 1990, SEMIN THROMB HEMOST, V16, P12; James S, 2002, EUR HEART J, V23, P1538, DOI 10.1053/euhj.2002.3257; Karsch KR, 1996, J AM COLL CARDIOL, V28, P1437, DOI 10.1016/S0735-1097(96)00343-9; Kaul S, 2000, J AM COLL CARDIOL, V35, P1699, DOI 10.1016/S0735-1097(00)00648-3; Kereiakes D J, 2001, J Invasive Cardiol, V13, P272; Kereiakes DJ, 2002, AM HEART J, V144, P615, DOI 10.1067/mhj.2002.124405; Kereiakes DJ, 2001, AM HEART J, V141, P348, DOI 10.1067/mhj.2001.113217; KERINS DM, 1989, CIRCULATION, V80, P1718, DOI 10.1161/01.CIR.80.6.1718; Klein W, 1997, CIRCULATION, V96, P61; Kontny F, 1997, J AM COLL CARDIOL, V30, P962, DOI 10.1016/S0735-1097(97)00258-1; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; Lindahl B, 1997, J AM COLL CARDIOL, V29, P43, DOI 10.1016/S0735-1097(96)00447-0; Lindahl B, 2001, J AM COLL CARDIOL, V38, P979, DOI 10.1016/S0735-1097(01)01501-7; Martin JL, 2001, EUR HEART J, V22, P14; MELANDRI G, 1993, AM J CARDIOL, V71, P469, DOI 10.1016/0002-9149(93)90461-K; MERLINI PA, 1994, CIRCULATION, V90, P61, DOI 10.1161/01.CIR.90.1.61; Merlini PA, 2000, ARTERIOSCL THROM VAS, V20, P2162, DOI 10.1161/01.ATV.20.9.2162; MERLINI PA, 1995, J AM COLL CARDIOL, V25, P203, DOI 10.1016/0735-1097(94)00360-3; MICHALIS LK, IN PRESS AM HEART J; Montalescot G, 1998, CIRCULATION, V98, P294, DOI 10.1161/01.CIR.98.4.294; Morrow DA, 2002, EUR HEART J, V23, P506; Mukherjee D, 2002, AM HEART J, V144, P995, DOI 10.1067/mhj.2002.126118; Rabah MM, 1999, AM J CARDIOL, V84, P1391, DOI 10.1016/S0002-9149(99)00582-2; Ross AM, 2001, CIRCULATION, V104, P648, DOI 10.1161/hc3101.093866; Sandset PR, 2000, HAEMOSTASIS, V30, P48; SEITZ R, 1993, FIBRINOLYSIS, V7, P109, DOI 10.1016/0268-9499(93)90031-P; Serra A, 1997, THROMB RES, V87, P405, DOI 10.1016/S0049-3848(97)00144-8; Simoons ML, 2002, EUR HEART J, V23, P1282, DOI 10.1053/euhj.2001.3083; Smith SC, 2001, J AM COLL CARDIOL, V37, P2215, DOI 10.1016/S0735-1097(01)01344-4; Tatu-Chitoiu G, 2000, EUR HEART J, V21, P177; Van de Werf F, 2001, LANCET, V358, P605; Wallentin L, 1999, LANCET, V354, P708; Wallentin L, 1996, LANCET, V347, P561; Wallentin L, 1999, LANCET, V354, P701; Wallentin L, 2001, CLIN CARDIOL, V24, pI12; WALLENTIN L, 2002, AM HEART ASS 75 SCI; WEITZ JI, 1995, AM J CARDIOL, V75, pB18, DOI 10.1016/0002-9149(95)80005-D; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Xiao ZH, 1998, CIRCULATION, V97, P251, DOI 10.1161/01.CIR.97.3.251; YOUNG E, 1994, THROMB HAEMOSTASIS, V71, P300; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901	95	66	74	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					331	342		10.1001/jama.289.3.331	http://dx.doi.org/10.1001/jama.289.3.331			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525234	Bronze			2022-12-28	WOS:000180345100028
J	Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP				Ruggero, D; Grisendi, S; Piazza, F; Rego, E; Mari, F; Rao, PH; Cordon-Cardo, C; Pandolfi, PP			Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification	SCIENCE			English	Article							HOYERAAL-HREIDARSSON-SYNDROME; TELOMERASE; MUTATIONS; GENE; YEAST; IDENTIFICATION; PSEUDOURIDINE; COMPONENT; PROTEIN; DKC1	Mutations in DKC1 cause dyskeratosis congenita (DC), a disease characterized by premature aging and increased tumor susceptibility. The DKC1 protein binds to the box H + ACA small nucleolar RNAs and the RNA component of telomerase. Here we show that hypomorphic Dkc1 mutant (Dkc1(m)) mice recapitulate in the first and second generations (G1 and G2) the clinical features of DC. Dkc1(m) cells from G1 and G2 mice were impaired in ribosomal RNA pseudouridylation before the onset of disease. Reductions of telomere length in Dkc1(m) mice became evident only in later generations. These results suggest that deregulated ribosome function is important in the initiation of DC, whereas telomere shortening may modify and/or exacerbate DC.	Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Dept Pathol, New York, NY 10021 USA; Univ Sao Paulo, FUNDHERP, Ctr Cell Based Therapy, BR-14049900 Ribeirao Preto, SP, Brazil; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Universidade de Sao Paulo; Baylor College of Medicine	Pandolfi, PP (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Mol Biol, 1275 York Ave, New York, NY 10021 USA.		Piazza, Francesco/AAD-1600-2019; Rego, Eduardo M/A-1058-2012; Mari, Francesca/E-7737-2012; Rego, Eduardo M./Y-5572-2019; Piazza, Francesco/K-6695-2016; Rego, Eduardo/AFS-7973-2022	Piazza, Francesco/0000-0002-2831-623X; Rego, Eduardo M/0000-0003-1567-4086; Mari, Francesca/0000-0003-1992-1654; Rego, Eduardo M./0000-0003-1567-4086; Piazza, Francesco/0000-0002-2831-623X; Rego, Eduardo/0000-0003-1567-4086				Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Devriendt K, 1997, AM J HUM GENET, V60, P581; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Giordano E, 1999, J CELL BIOL, V144, P1123, DOI 10.1083/jcb.144.6.1123; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Knight SW, 2001, HUM GENET, V108, P299, DOI 10.1007/s004390100494; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; MASUREKAR M, 1981, J MOL BIOL, V147, P381, DOI 10.1016/0022-2836(81)90490-3; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Phillips B, 1998, MOL GEN GENET, V260, P20, DOI 10.1007/s004380050866; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Yaghmai R, 2000, J PEDIATR-US, V136, P390, DOI 10.1067/mpd.2000.104295; Yang YF, 2000, MOL BIOL CELL, V11, P567, DOI 10.1091/mbc.11.2.567; Zebarjadian Y, 1999, MOL CELL BIOL, V19, P7461	22	312	331	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					259	262		10.1126/science.1079447	http://dx.doi.org/10.1126/science.1079447			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522253				2022-12-28	WOS:000180284000042
J	Shi, SH; Jan, LY; Jan, YN				Shi, SH; Jan, LY; Jan, YN			Hippocampal neuronal polarity specified by spatially localized mPar3/mPar6 and PI 3-kinase activity	CELL			English	Article							PROTEIN-KINASE-C; EPITHELIAL TIGHT JUNCTION; ASYMMETRIC CELL-DIVISION; ANTERIOR-POSTERIOR AXIS; TUMOR-SUPPRESSOR PTEN; CAENORHABDITIS-ELEGANS; PHOSPHOINOSITIDE 3-KINASE; EMBRYONIC POLARITY; AXON FORMATION; RHO-GTPASES	How a neuron becomes polarized remains an outstanding question. Here, we report that selection of the future axon among neurites of a cultured hippocampal neuron requires the activity of growth factor receptor tyrosine kinase, phosphatidylinositol 3-kinase (PI 3-kinase), as well as atypical protein kinase C (aPKC). The PI 3-kinase activity, highly localized to the tip of the newly specified axon of stage 3 neurons, is essential for the proper subcellular localization of mPar3, the mammalian homolog of C. elegans polarity protein Par3. Polarized distribution of not only mPar3 but also mPar6 is important for axon formation; ectopic expression of mPar6 or mPar3, or just the N terminus of mPar3, leaves neurons with no axon specified. Thus, neuronal polarity is likely to be controlled by the mPar3/mPar6/aPKC complex and the PI 3-kinase signaling pathway, both serving evolutionarily conserved roles in specifying cell polarity.	Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Dept Physiol, Howard Hughes Med Inst, 533 Parnassus Ave, San Francisco, CA 94143 USA.			Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Blomberg N, 1999, TRENDS BIOCHEM SCI, V24, P441, DOI 10.1016/S0968-0004(99)01472-3; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chan TO, 2002, CANCER CELL, V1, P181, DOI 10.1016/S1535-6108(02)00033-8; CHANT J, 1994, TRENDS GENET, V10, P328, DOI 10.1016/0168-9525(94)90036-1; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gao L, 2002, CURR BIOL, V12, P221, DOI 10.1016/S0960-9822(01)00663-7; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GOSLIN K, 1989, J CELL BIOL, V108, P1506; Gotta M, 2001, CURR BIOL, V11, P482, DOI 10.1016/S0960-9822(01)00142-7; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; HAWKINS PT, 1992, NATURE, V358, P157, DOI 10.1038/358157a0; Hirose T, 2002, J CELL SCI, V115, P2485; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Izumi Y, 1998, J CELL BIOL, V143, P95, DOI 10.1083/jcb.143.1.95; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Johansson AS, 2000, J CELL SCI, V113, P3267; Kabir N, 2001, J CELL BIOL, V152, P1033, DOI 10.1083/jcb.152.5.1033; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kay AJ, 2001, CURR BIOL, V11, P474, DOI 10.1016/S0960-9822(01)00141-5; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; Kemphues K, 2000, CELL, V101, P345, DOI 10.1016/S0092-8674(00)80844-2; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Liliental J, 2000, CURR BIOL, V10, P401, DOI 10.1016/S0960-9822(00)00417-6; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; MILLER PJ, 1994, MOL CELL BIOL, V14, P1075, DOI 10.1128/MCB.14.2.1075; Namikawa K, 2000, J NEUROSCI, V20, P2875; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Qiu RG, 2000, CURR BIOL, V10, P697, DOI 10.1016/S0960-9822(00)00535-2; Rappleye CA, 1999, GENE DEV, V13, P2838, DOI 10.1101/gad.13.21.2838; Redmond L, 2001, CURR OPIN NEUROBIOL, V11, P111, DOI 10.1016/S0959-4388(00)00181-1; Rickert P, 2000, TRENDS CELL BIOL, V10, P466, DOI 10.1016/S0962-8924(00)01841-9; Rose LS, 1998, ANNU REV GENET, V32, P521, DOI 10.1146/annurev.genet.32.1.521; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; STEPHENS LR, 1991, NATURE, V351, P33, DOI 10.1038/351033a0; Tabuse Y, 1998, DEVELOPMENT, V125, P3607; Tamura M, 1998, SCIENCE, V280, P1614, DOI 10.1126/science.280.5369.1614; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; TEJERODIEZ P, 1995, FEBS LETT, V363, P293, DOI 10.1016/0014-5793(95)00303-Q; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; TURING A, 1952, PHILOS T R SOC B, V237, P32; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; Wang F, 2002, NAT CELL BIOL, V4, P513, DOI 10.1038/ncb810; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128	61	489	502	0	31	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					63	75		10.1016/S0092-8674(02)01249-7	http://dx.doi.org/10.1016/S0092-8674(02)01249-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526794	Bronze			2022-12-28	WOS:000181191500007
J	Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT				Keeling, MJ; Woolhouse, MEJ; May, RM; Davies, G; Grenfell, BT			Modelling vaccination strategies against foot-and-mouth disease	NATURE			English	Article							GREAT-BRITAIN; EPIDEMIC; TRANSMISSION; DYNAMICS; SPREAD; DESIGN; IMPACT; FMD	Vaccination has proved a powerful defence against a range of infectious diseases of humans and animals. However, its potential to control major epidemics of foot-and-mouth disease (FMD) in livestock is contentious. Using an individual farm-based model, we consider either national prophylactic vaccination campaigns in advance of an outbreak, or combinations of reactive vaccination and culling strategies during an epidemic. Consistent with standard epidemiological theory, mass prophylactic vaccination could reduce greatly the potential for a major epidemic, while the targeting of high-risk farms increases efficiency. Given sufficient resources and preparation, a combination of reactive vaccination and culling might control ongoing epidemics. We also explore a reactive strategy, 'predictive' vaccination, which targets key spatial transmission loci and can reduce markedly the long tail that characterizes many FMD epidemics. These analyses have broader implications for the control of human and livestock infectious diseases in heterogeneous spatial landscapes.	Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; Univ Edinburgh, Coll Med & Vet Med, Ctr Infect Dis, Roslin EH25 9RG, Midlothian, Scotland; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Zinnia, Woking GU21 4JJ, Surrey, England; Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Warwick; University of Warwick; University of Edinburgh; University of Oxford; University of Cambridge	Keeling, MJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	m.j.keeling@warwick.ac.uk	Keeling, Matt J/J-9280-2012	Keeling, Matt J/0000-0003-4639-4765				ANDERSON R M, 1991; Barnett PV, 2002, VACCINE, V20, P1505, DOI 10.1016/S0264-410X(01)00503-5; *COMM INQ FOOT MOU, 1968, REP COMM INQ FOOT MO; Donaldson AI, 2001, VET REC, V148, P602, DOI 10.1136/vr.148.19.602; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Ferguson NM, 2001, SCIENCE, V292, P1155, DOI 10.1126/science.1061020; Gibbens JC, 2001, VET REC, V149, P729, DOI 10.1136/vr.149.24.729; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; HAYDON DT, 2001, IN PRESS P R SOC L B; Howard SC, 2000, RES VET SCI, V69, P189, DOI 10.1053/rvsc.2000.0415; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Keeling MJ, 2001, PHYSICA D, V148, P317, DOI 10.1016/S0167-2789(00)00187-1; Keeling MJ, 1999, P ROY SOC B-BIOL SCI, V266, P859, DOI 10.1098/rspb.1999.0716; McLean AR, 1995, TRENDS MICROBIOL, V3, P458, DOI 10.1016/S0966-842X(00)89010-1; Morris RS, 2001, VET REC, V149, P137, DOI 10.1136/vr.149.5.137; Muller J, 2000, J MATH BIOL, V41, P143, DOI 10.1007/s002850070003; Rohani P, 1999, SCIENCE, V286, P968, DOI 10.1126/science.286.5441.968; Salt J. S., 1997, VET VACCINOLOGY, P641; *SCI COMM AN HLTH, EU STRAT EM VACC FOO; Verschueren, 1997, VET VACCINOLOGY; Williams JR, 1996, J EPIDEMIOL COMMUN H, V50, P667, DOI 10.1136/jech.50.6.667; Woolhouse M, 2001, NATURE, V411, P258, DOI 10.1038/35077149; Woolhouse M, 2001, NATURE, V410, P515, DOI 10.1038/35069250; Woolhouse M.E.J., 1997, VET VACCINOLOGY, P565; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 1997, VET J, V153, P41, DOI 10.1016/S1090-0233(97)80007-X; Woolhouse MEJ, 1996, EPIDEMIOL INFECT, V116, P363, DOI 10.1017/S0950268800052699; Yang PC, 1999, VET REC, V145, P731, DOI 10.1136/vr.145.25.731	28	321	326	2	74	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					136	142		10.1038/nature01343	http://dx.doi.org/10.1038/nature01343			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12508120	Bronze			2022-12-28	WOS:000180267200032
J	Haider, AW; Larson, MG; Franklin, SS; Levy, D				Haider, AW; Larson, MG; Franklin, SS; Levy, D			Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study	ANNALS OF INTERNAL MEDICINE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ARTERIAL DISTENSIBILITY; SUBENDOCARDIAL ISCHEMIA; MYOCARDIAL-INFARCTION; AORTIC COMPLIANCE; HYPERTENSION; DISEASE; DOGS; PROGRESSION; PREVENTION	Background: Although hypertension is a principal precursor of congestive heart failure (CHF), the separate relations of systolic, diastolic, and pulse pressure with risk for heart failure have not been fully elucidated. Objective: To examine the value of blood pressure predictors of heart failure. Design: Community-based inception cohort study. Setting: Framingham, Massachusetts. Patients: 2040 free-living Framingham Heart Study participants (mean age, 61 years [range, 50 to 79 years]). Measurements: The association of baseline systolic, diastolic, and pulse pressure with risk for incident CHF was examined in 894 men and 1146 women. Framingham Heart Study participants free of CHF at the baseline examination (performed from 1968 to 1973) were monitored for up to 24 years (mean, 17.4 years) for new-onset heart failure. Cox proportional hazards models were used to adjust for age, sex, smoking, left ventricular hypertrophy, body mass index, diabetes mellitus, high-density lipoprotein cholesterol level, and heart rate; hazard ratios and 95% Cis for blood pressure variables were estimated. Results: CHF developed in 234 participants (11.8%) during the follow-up period. All three blood pressure components were related to the risk for CHF, but the relation was strongest for systolic and pulse pressure. A 1-SD (20 mm Hg) increment in systolic pressure conferred a 56% increased risk for CHF (hazard ratio, 1.56 [95% Cl, 1.37 to 1.77]); similarly, a 1-SD (16 mm Hg) increment in pulse pressure conferred a 55% increased risk for CHF (hazard ratio, 1.55 [Cl, 1.37 to 1.75]). These associations were unrelated to age, duration of follow-up, and initiation of treatment for hypertension during follow-up; they were also observed in patients with systolic hypertension (systolic blood pressure greater than or equal to 140 mm Hg) at the baseline examination (hazard ratio, 1.41 [Cl, 1.18 to 1.69] for pulse pressure and 1.42 [Cl, 1.14 to 1.76] for systolic pressure). Conclusions: Although each component of blood pressure was associated with risk for CHF, pulse and systolic pressure conferred greater risk than diastolic pressure. Increased pulse pressure may help identify hypertensive patients at high risk for overt CHF who are candidates for aggressive blood pressure control.	NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; NHLBI, Bethesda, MD 20892 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Univ Calif Irvine, Irvine, CA 92717 USA; Vet Adm Med Ctr, W Roxbury, MA USA; MCP Hahnemann Univ Hosp, Philadelphia, PA USA	Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California Irvine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Drexel University	Levy, D (corresponding author), NHLBI, Framingham Heart Study, 73 Mt Wayte Ave,Suite 2, Framingham, MA 01702 USA.		Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC038038] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01-HC-38038] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNETHY J, 1986, American Journal of Preventive Medicine, V2, P123; [Anonymous], 1991, JAMA, V265, P3255; AVOLIO AP, 1983, CIRCULATION, V68, P50, DOI 10.1161/01.CIR.68.1.50; BAUMBACH GL, 1991, CIRC RES, V68, P338, DOI 10.1161/01.RES.68.2.338; BENETOS A, 1993, ARTERIOSCLER THROMB, V13, P90, DOI 10.1161/01.ATV.13.1.90; Benetos A, 1997, HYPERTENSION, V30, P1410, DOI 10.1161/01.HYP.30.6.1410; BOUTHIER JD, 1985, AM HEART J, V109, P1345, DOI 10.1016/0002-8703(85)90364-3; BUCKBERG GD, 1972, CIRC RES, V30, P67, DOI 10.1161/01.RES.30.1.67; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; CHRISTENSEN KL, 1991, HYPERTENSION, V18, P722, DOI 10.1161/01.HYP.18.6.722; CUPPLES LA, 1998, PUBLICATION; Cutler Jeffrey A., 1995, P253; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DARNE B, 1989, HYPERTENSION, V13, P392, DOI 10.1161/01.HYP.13.4.392; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Domanski MJ, 1999, J AM COLL CARDIOL, V33, P951, DOI 10.1016/S0735-1097(98)00679-2; Franklin SS, 1999, CIRCULATION, V100, P354, DOI 10.1161/01.CIR.100.4.354; Franklin SS, 1997, CIRCULATION, V96, P308; FRANKLIN SS, 1994, AM HEART J, V128, P793, DOI 10.1016/0002-8703(94)90278-X; FREIS ED, 1982, JAMA-J AM MED ASSOC, V248, P2004; GIRERD X, 1991, AM HEART J, V122, P1210, DOI 10.1016/0002-8703(91)90941-A; KANNEL WB, 1981, JAMA-J AM MED ASSOC, V245, P1225, DOI 10.1001/jama.245.12.1225; KANNEL WB, 1972, NEW ENGL J MED, V287, P782; Kass DA, 1996, CIRCULATION, V93, P1533, DOI 10.1161/01.CIR.93.8.1533; KELLY RP, 1992, CIRC RES, V71, P490, DOI 10.1161/01.RES.71.3.490; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee MLT, 1999, ANN EPIDEMIOL, V9, P101, DOI 10.1016/S1047-2797(98)00034-9; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; LYON RT, 1987, J VASC SURG, V5, P59, DOI 10.1067/mva.1987.avs0050059; MADHAVAN S, 1994, HYPERTENSION, V23, P395, DOI 10.1161/01.HYP.23.3.395; MATERSON BJ, 1982, JAMA-J AM MED ASSOC, V248, P1996; Mitchell GF, 1997, CIRCULATION, V96, P4254; Moser M, 1996, J AM COLL CARDIOL, V27, P1214, DOI 10.1016/0735-1097(95)00606-0; NICHOLS WW, 1990, MCDONALDS BLOOD FLOW, P216; OROURKE MF, 1989, AM J CARDIOL, V63, pI38, DOI 10.1016/0002-9149(89)90127-6; OROURKE MF, 1992, ARTERIAL PULSE, P201; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; *SAS I INC, 1996, SAS STAT SOFTW CHANG, P381; Smulyan H, 2000, ANN INTERN MED, V132, P233, DOI 10.7326/0003-4819-132-3-200002010-00010; Staessen JA, 2000, LANCET, V355, P865, DOI 10.1016/S0140-6736(99)07330-4; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Vasan RS, 1996, ARCH INTERN MED, V156, P1789, DOI 10.1001/archinte.156.16.1789; WATANABE H, 1993, J AM COLL CARDIOL, V21, P1497, DOI 10.1016/0735-1097(93)90330-4; WATANABE H, 1992, CARDIOVASC RES, V26, P1212, DOI 10.1093/cvr/26.12.1212	45	346	362	1	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					10	16		10.7326/0003-4819-138-1-200301070-00006	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513039				2022-12-28	WOS:000180996200002
J	Macilwain, C				Macilwain, C			Human cloning claim sparks fear of Senate backlash	NATURE			English	News Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					3	3		10.1038/421003b	http://dx.doi.org/10.1038/421003b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511919				2022-12-28	WOS:000180165500004
J	Gordon, S				Gordon, S			Pattern recognition receptors: Doubling up for the innate immune response	CELL			English	Review								Antigen presenting cells (macrophages and dendritic cells) express pattern recognition molecules that are thought to recognize foreign ligands during early phases of the immune response. The best known of these are probably the Toll-like receptors, but a number of other receptors are also involved. Several of these recognize endogenous as well as exogenous ligands, suggesting that they play a dual role in normal tissue function and host defense.	Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Gordon, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	christine.holt@path.ox.ac.uk						Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Geijtenbeek TBH, 2002, J LEUKOCYTE BIOL, V71, P921; GORDON S, 1999, FUNDAMENTAL IMMUNOLO, P533; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Krieger M, 2001, J CLIN INVEST, V108, P645, DOI 10.1172/JCI13932; Lee SJ, 2002, SCIENCE, V295, P1898, DOI 10.1126/science.1069540; MCKENZIE EJ, 2002, TRENDS GLYCOSCI GLYC, V14, P269; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Ross GD, 2000, CRIT REV IMMUNOL, V20, P197; Takeuchi O, 2002, MICROBES INFECT, V4, P887, DOI 10.1016/S1286-4579(02)01615-5; Tobias PS, 2003, INFEC DIS S, P255; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	13	855	934	0	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					927	930		10.1016/S0092-8674(02)01201-1	http://dx.doi.org/10.1016/S0092-8674(02)01201-1			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507420	Bronze			2022-12-28	WOS:000180086000003
J	Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR				Knoll, R; Hoshijima, M; Hoffman, HM; Person, V; Lorenzen-Schmidt, I; Bang, ML; Hayashi, T; Shiga, N; Yasukawa, H; Schaper, W; McKenna, W; Yokoyama, M; Schork, NJ; Omens, JH; McCulloch, AD; Kimura, A; Gregorio, CC; Poller, W; Schaper, J; Schultheiss, HP; Chien, KR			The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy	CELL			English	Article							CYSTEINE-RICH PROTEIN; HEART-FAILURE; BIOMECHANICAL STRESS; T-CAP; TITIN; HYPERTROPHY; DOMAIN; PATHWAYS; MYOCYTES; MUSCLE	Muscle cells respond to mechanical stretch stimuli by triggering downstream signals for myocyte growth and survival. The molecular components of the muscle stretch sensor are unknown, and their role in muscle disease is unclear. Here, we present biophysical/biochemical studies in muscle LIM protein (MLP) deficient cardiac muscle that support a selective role for this Z disc protein in mechanical stretch sensing. MLP interacts with and colocalizes with telethonin (T-cap), a titin interacting protein. Further, a human MLP mutation (W4R) associated with dilated cardiomyopathy (DCM) results in a marked defect in T-cap interaction/localization. We propose that a Z disc MLP/T-cap complex is a key component of the in vivo cardiomyocyte stretch sensor machinery, and that defects in the complex can lead to human DCM and associated heart failure.	Univ Calif San Diego, Inst Mol Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Max Planck Inst, D-61231 Bad Nauheim, Germany; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Pathogenesis, Tokyo 1010062, Japan; Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc & Resp Med, Kobe, Hyogo 6500017, Japan; Univ London St Georges Hosp, Sch Med, Dept Cardiol Sci, London SW17 0RE, England; Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85724 USA; Free Univ Berlin, Klinikum Benjamin Franklin, Med Klin 2, D-12200 Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society; Tokyo Medical & Dental University (TMDU); Kobe University; St Georges University London; University of Arizona; University of Arizona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Chien, KR (corresponding author), Univ Calif San Diego, Inst Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.		Ralph, Knoell/AAE-5990-2020; McKenna, William J/C-3243-2008; Bang, Marie-Louise/B-5683-2015; Knöll, Ralph/GOH-3587-2022; Kimura, Akinori/I-5989-2018; Poller, Wolfgang/AAB-2185-2021	Ralph, Knoell/0000-0001-8871-112X; McKenna, William J/0000-0001-7994-2460; Bang, Marie-Louise/0000-0001-8859-5034; Kimura, Akinori/0000-0002-4933-2132; Poller, Wolfgang/0000-0002-2805-6634; Schork, Nicholas/0000-0003-0920-5013				Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Chien KR, 1999, CELL, V98, P555, DOI 10.1016/S0092-8674(00)80043-4; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200; Frey N, 2000, P NATL ACAD SCI USA, V97, P14632, DOI 10.1073/pnas.260501097; Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Granzier H, 2002, J PHYSIOL-LONDON, V541, P335, DOI 10.1113/jphysiol.2001.014381; GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Harper BD, 2000, BIOCHEM J, V350, P269, DOI 10.1042/0264-6021:3500269; Helmes M, 1996, CIRC RES, V79, P619, DOI 10.1161/01.RES.79.3.619; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoffman HM, 2000, AM J HUM GENET, V66, P1693, DOI 10.1086/302874; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; HUNTER JJ, 1999, MOL BASIS CARDIOVASC, P211; Itoh-Satoh M, 2002, BIOCHEM BIOPH RES CO, V291, P385, DOI 10.1006/bbrc.2002.6448; Kuo HC, 2001, CELL, V107, P801, DOI 10.1016/S0092-8674(01)00588-8; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee AA, 1996, AM J PHYSIOL-CELL PH, V271, pC1400, DOI 10.1152/ajpcell.1996.271.4.C1400; Louis HA, 1997, J BIOL CHEM, V272, P27484, DOI 10.1074/jbc.272.43.27484; Maisel A, 2002, CIRCULATION, V105, P2328, DOI 10.1161/01.CIR.0000019121.91548.C2; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822; Nguyen-Tran VTB, 2000, CELL, V102, P671, DOI 10.1016/S0092-8674(00)00089-1; Olson TM, 1998, SCIENCE, V280, P750, DOI 10.1126/science.280.5364.750; Pashmforoush M, 2001, NAT MED, V7, P591, DOI 10.1038/87920; Rana BK, 1999, GENETICS, V151, P1547; Reid ME, 2000, TRANSFUSION, V40, P48, DOI 10.1046/j.1537-2995.2000.40010048.x; Sadoshima J, 1997, ANNU REV PHYSIOL, V59, P551, DOI 10.1146/annurev.physiol.59.1.551; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SHAM PC, 1995, ANN HUM GENET, V59, P323, DOI 10.1111/j.1469-1809.1995.tb00751.x; Trombitas K, 2000, ADV EXP MED BIOL, V481, P405; Wettschureck N, 2001, NAT MED, V7, P1236, DOI 10.1038/nm1101-1236; Wollert KC, 1996, J BIOL CHEM, V271, P9535, DOI 10.1074/jbc.271.16.9535; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Xu XL, 2002, NAT GENET, V30, P205, DOI 10.1038/ng816; Yamazaki T, 1998, CIRC RES, V82, P430, DOI 10.1161/01.RES.82.4.430; Yasukawa H, 2001, J CLIN INVEST, V108, P1459, DOI 10.1172/JCI13939; Zeng T, 2000, AM J PHYSIOL-HEART C, V278, pH548, DOI 10.1152/ajpheart.2000.278.2.H548; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zolk O, 2000, CIRCULATION, V101, P2674, DOI 10.1161/01.CIR.101.23.2674	46	583	600	0	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					943	955		10.1016/S0092-8674(02)01226-6	http://dx.doi.org/10.1016/S0092-8674(02)01226-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507422	Bronze			2022-12-28	WOS:000180086000005
J	Klobutcher, LA; Farabaugh, PJ				Klobutcher, LA; Farabaugh, PJ			Shifty ciliates: Frequent programmed translational frameshifting in Euplotids	CELL			English	Review							STOP CODON RECOGNITION; GENETIC-CODE; PROTEIN; OCTOCARINATUS; TELOMERASE; MECHANISM; SUBUNIT	Recent work suggests that there is a high frequency of programmed +1 translational frameshifting in ciliates of the Euplotes genus. Frequent frameshifting may have been potentiated by stop codon reassignment, which is also a feature of this group.	Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA; Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA	University of Connecticut; University System of Maryland; University of Maryland Baltimore County	Klobutcher, LA (corresponding author), Univ Connecticut, Ctr Hlth, Dept Biochem, Farmington, CT 06032 USA.			Farabaugh, Philip/0000-0002-5658-7141; Klobutcher, Lawrence/0000-0001-9485-3482				Aigner S, 2000, EMBO J, V19, P6230, DOI 10.1093/emboj/19.22.6230; Asakura T, 1998, ONCOGENE, V16, P121, DOI 10.1038/sj.onc.1201487; Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; DOAK TG, 2003, IN PRESS EUKARYOTIC; Farabaugh PJ, 2000, PROG NUCLEIC ACID RE, V64, P131, DOI 10.1016/S0079-6603(00)64004-7; Inagaki Y, 2001, NUCLEIC ACIDS RES, V29, P921, DOI 10.1093/nar/29.4.921; JAHN CL, 1993, GENE, V133, P71, DOI 10.1016/0378-1119(93)90226-S; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Lozupone CA, 2001, CURR BIOL, V11, P65, DOI 10.1016/S0960-9822(01)00028-8; Morris DK, 1997, CURR BIOL, V7, P969, DOI 10.1016/S0960-9822(06)00416-7; Muramatsu T, 2001, FEBS LETT, V488, P105, DOI 10.1016/S0014-5793(00)02391-7; OSAWA S, 1990, P ROY SOC B-BIOL SCI, V241, P19, DOI 10.1098/rspb.1990.0060; Seit-Nebi A, 2002, EMBO REP, V3, P881, DOI 10.1093/embo-reports/kvf178; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P575, DOI 10.1111/j.1550-7408.2001.tb00193.x; Tan M, 2001, J EUKARYOT MICROBIOL, V48, P80, DOI 10.1111/j.1550-7408.2001.tb00418.x; TOURANCHEAU AB, 1995, EMBO J, V14, P3262, DOI 10.1002/j.1460-2075.1995.tb07329.x; Wang LB, 2002, NUCLEIC ACIDS RES, V30, P4032, DOI 10.1093/nar/gkf513; WEISS RB, 1987, COLD SPRING HARB SYM, V52, P687, DOI 10.1101/SQB.1987.052.01.078	20	48	53	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					763	766		10.1016/S0092-8674(02)01138-8	http://dx.doi.org/10.1016/S0092-8674(02)01138-8			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526802	Bronze			2022-12-28	WOS:000179862600002
J	Connolly, MA; Heymann, DL				Connolly, MA; Heymann, DL			Deadly comrades: war and infectious diseases	LANCET			English	Article									WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland	World Health Organization	Connolly, MA (corresponding author), WHO, Programme Communicable Dis Complex Emergencies, CH-1211 Geneva 27, Switzerland.								0	35	35	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S23	S24		10.1016/S0140-6736(02)11807-1	http://dx.doi.org/10.1016/S0140-6736(02)11807-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504490				2022-12-28	WOS:000180064500011
J	Krause, SK; Otieno, M; Lee, C				Krause, SK; Otieno, M; Lee, C			Reproductive health for refugees	LANCET			English	Article									Womens Commiss Refugee Women & Children, Reprod Hlth Programme, New York, NY 10168 USA; Womens Commiss Refugee Women & Children, Int Rescue Comm, New York, NY 10168 USA		Krause, SK (corresponding author), Womens Commiss Refugee Women & Children, Reprod Hlth Programme, 122 E 42nd St, New York, NY 10168 USA.								0	6	6	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S15	S16		10.1016/S0140-6736(02)11803-4	http://dx.doi.org/10.1016/S0140-6736(02)11803-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504486				2022-12-28	WOS:000180064500007
J	Zwi, AB; Silove, D				Zwi, AB; Silove, D			Hearing the voices: mental health services in East Timor	LANCET			English	Article									Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; Univ New S Wales, Sch Psychiat, PRADET, Sydney, NSW 2052, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Zwi, AB (corresponding author), Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia.		Zwi, Anthony/AAP-7026-2021; Zwi, Anthony/AAP-8731-2020	Zwi, Anthony/0000-0001-6902-6602; 					0	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S45	S46		10.1016/S0140-6736(02)11818-6	http://dx.doi.org/10.1016/S0140-6736(02)11818-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	629TG	12504501				2022-12-28	WOS:000180064500022
J	Pasare, C; Medzhitov, R				Pasare, C; Medzhitov, R			Toll pathway-dependent blockade of CD4(+)CD25(+) T cell-mediated suppression by dendritic cells	SCIENCE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGICAL SELF-TOLERANCE; IL-6-DEFICIENT MICE; ACTIVATION; RECEPTOR; DISEASE; IMMUNITY; INTERLEUKIN-6; RESISTANT; INDUCTION	Toll-like receptors (TLRs) control activation of adaptive immune responses by antigen-presenting cells (APCs). However, initiation of adaptive immune responses is also controlled by regulatory T cells (T-R cells), which act to prevent activation of autoreactive T cells. Here we describe a second mechanism of immune induction by TLRs,which is independent of effects on costimulation. Microbial induction of the Toll pathway blocked the suppressive effect of CD4(+)CD25(+) T-R cells, allowing activation of pathogen-specific adaptive immune responses. This block of suppressor activity was dependent in part on interleukin-6, which was induced by TLRs upon recognition of microbial products.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.							Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kaisho T, 2001, J IMMUNOL, V166, P5688, DOI 10.4049/jimmunol.166.9.5688; KISHIMOTO T, 1992, J AUTOIMMUN, V5, P123, DOI 10.1016/0896-8411(92)90027-N; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Ohshima S, 1998, P NATL ACAD SCI USA, V95, P8222, DOI 10.1073/pnas.95.14.8222; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Onizuka S, 1999, CANCER RES, V59, P3128; PASARE C, UNPUB; Piccirillo CA, 2001, J IMMUNOL, V167, P1137, DOI 10.4049/jimmunol.167.3.1137; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rose NR, 1998, SEMIN IMMUNOL, V10, P5, DOI 10.1006/smim.1997.0100; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Samoilova EB, 1998, J IMMUNOL, V161, P6480; Schnare M, 2001, NAT IMMUNOL, V2, P947, DOI 10.1038/ni712; Shevach EM, 2000, ANNU REV IMMUNOL, V18, P423, DOI 10.1146/annurev.immunol.18.1.423; Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Taguchi O, 1996, EUR J IMMUNOL, V26, P1608, DOI 10.1002/eji.1830260730; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Yamamoto M, 2000, J IMMUNOL, V164, P4878, DOI 10.4049/jimmunol.164.9.4878	28	1688	1803	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1033	1036		10.1126/science.1078231	http://dx.doi.org/10.1126/science.1078231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12532024				2022-12-28	WOS:000180960000037
J	Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ				Wang, H; Yu, M; Ochani, M; Amella, CA; Tanovic, M; Susarla, S; Li, JH; Wang, HC; Yang, H; Ulloa, L; Al-Abed, Y; Czura, CJ; Tracey, KJ			Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation	NATURE			English	Article							TUMOR-NECROSIS-FACTOR; ENDOTOXIN LETHALITY; MICE; BUNGAROTOXIN; DEFICIENT; CACHECTIN; CLONING; CALCIUM; SHOCK	Excessive inflammation and tumour-necrosis factor (TNF) synthesis cause morbidity and mortality in diverse human diseases including endotoxaemia, sepsis, rheumatoid arthritis and inflammatory bowel disease(1-4). Highly conserved, endogenous mechanisms normally regulate the magnitude of innate immune responses and prevent excessive inflammation. The nervous system, through the vagus nerve, can inhibit significantly and rapidly the release of macrophage TNF, and attenuate systemic inflammatory responses(5-7). This physiological mechanism, termed the 'cholinergic anti- inflammatory pathway'(5) has major implications in immunology and in therapeutics; however, the identity of the essential macrophage acetylcholine-mediated (cholinergic) receptor that responds to vagus nerve signals was previously unknown. Here we report that the nicotinic acetylcholine receptor alpha7 subunit is required for acetylcholine inhibition of macrophage TNF release. Electrical stimulation of the vagus nerve inhibits TNF synthesis in wild-type mice, but fails to inhibit TNF synthesis in alpha7-deficient mice. Thus, the nicotinic acetylcholine receptor alpha7 subunit is essential for inhibiting cytokine synthesis by the cholinergic anti- inflammatory pathway.	N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, Manhasset, NY 11030 USA; N Shore Long Isl Jewish Res Inst, Med Chem Lab, Manhasset, NY 11030 USA	Northwell Health; Northwell Health	Tracey, KJ (corresponding author), N Shore Long Isl Jewish Res Inst, Lab Biomed Sci, 350 Community Dr, Manhasset, NY 11030 USA.		Wang, Haichao/K-6310-2012; Ulloa, Luis/AAE-8751-2019; Wang, Haichao/AAU-2237-2021; Susarla, Srinivas/P-1051-2019	Wang, Haichao/0000-0002-0211-9000; Ulloa, Luis/0000-0002-7702-7549; Wang, Haichao/0000-0002-0211-9000; Susarla, Srinivas/0000-0003-0155-8260; Tracey, Kevin J/0000-0003-1884-6314; Wang, Hong/0000-0003-4130-8741				Andersson L1992A, SCRIPTA BOT BELG, V1, P1; Bernik TR, 2002, J EXP MED, V195, P781, DOI 10.1084/jem.20011714; BIANCHI M, 1995, MOL MED, V1, P254, DOI 10.1007/BF03401550; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cohen PS, 1997, MOL MED, V3, P339, DOI 10.1007/BF03401812; Drisdel RC, 2000, J NEUROSCI, V20, P133, DOI 10.1523/JNEUROSCI.20-01-00133.2000; Feng GP, 1998, J NEUROSCI, V18, P4166; Franceschini D, 2000, BEHAV BRAIN RES, V113, P3, DOI 10.1016/S0166-4328(00)00195-9; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Kumins NH, 1996, SHOCK, V5, P385, DOI 10.1097/00024382-199605000-00012; LENOVERE N, 1995, J MOL EVOL, V40, P155, DOI 10.1007/BF00167110; Leonard S, 2001, Nicotine Tob Res, V3, P203; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; Lindstrom J.M., 1995, HDB RECEPTORS CHANNE, P153; Marubio LM, 2000, EUR J PHARMACOL, V393, P113, DOI 10.1016/S0014-2999(00)00007-8; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; PENG X, 1994, MOL PHARMACOL, V45, P546; SEGUELA P, 1993, J NEUROSCI, V13, P596; Shoop RD, 2000, J NEUROSCI, V20, P4021; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Steinlein O, 1998, BEHAV BRAIN RES, V95, P31, DOI 10.1016/S0166-4328(97)00207-6; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248	27	2251	2521	14	204	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 23	2003	421	6921					384	388		10.1038/nature01339	http://dx.doi.org/10.1038/nature01339			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637UW	12508119				2022-12-28	WOS:000180533000045
J	Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ				Genbacev, OD; Prakobphol, A; Foulk, RA; Krtolica, AR; Ilic, D; Singer, MS; Yang, ZQ; Kiessling, LL; Rosen, SD; Fisher, SJ			Trophoblast L-selectin-mediated adhesion at the maternal-fetal interface	SCIENCE			English	Article							HIGH-ENDOTHELIAL VENULES; HUMAN CYTOTROPHOBLASTS; LYMPHOCYTES; INVASION; RECEPTORS; LIGAND; CELLS	Trophoblast adhesion to the uterine wall is the requisite first step of implantation and, subsequently, placentation. At the maternal-fetal interface, we investigated the expression of selectin adhesion systems that enable leukocyte capture from the bloodstream. On the maternal side, human uterine epithelial cells up-regulated selectin oligosaccharide-based ligands during the window of receptivity. On the fetal side, human trophoblasts expressed L-selectin. This ligand-receptor system was functional, because beads coated with the selectin ligand 6-sulfo sLe(x) bound to trophoblasts, and trophoblasts bound to ligand-expressing uterine luminal epithelium in tissue sections. These results suggest that trophoblast L-selectin mediates interactions with the uterus and that this adhesion mechanism may be critical to establishing human pregnancy.	Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; Nevada Ctr Reprod Med, Reno, NV 89509 USA; Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Fisher, SJ (corresponding author), Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA.		Kiessling, Laura L/A-4074-2008	Rosen, Steven/0000-0002-6245-701X; Kiessling, Laura/0000-0001-6829-1500; ILIC, DUSKO/0000-0003-1647-0026	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD042283] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE007244, R01DE007244] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM023547] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 64597] Funding Source: Medline; NICHD NIH HHS [U01 HD 42283] Funding Source: Medline; NIDCR NIH HHS [DE 07244] Funding Source: Medline; NIGMS NIH HHS [R37GM23547] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Calatayud S, 1996, INT IMMUNOL, V8, P1637, DOI 10.1093/intimm/8.10.1637; Damsky CH, 1998, CURR OPIN CELL BIOL, V10, P660, DOI 10.1016/S0955-0674(98)80043-4; Drake PM, 2001, J EXP MED, V193, P1199, DOI 10.1084/jem.193.10.1199; Frenette PS, 1997, THROMB HAEMOSTASIS, V78, P60; GENBACEV O, 1992, PLACENTA, V13, P439, DOI 10.1016/0143-4004(92)90051-T; Giblin PA, 1997, J IMMUNOL, V159, P3498; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Isberg RR, 2002, CELL, V110, P1, DOI 10.1016/S0092-8674(02)00821-8; Kimber SJ, 2000, SEMIN CELL DEV BIOL, V11, P77, DOI 10.1006/scdb.2000.0154; LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Mitsuoka C, 1997, BIOCHEM BIOPH RES CO, V230, P546, DOI 10.1006/bbrc.1996.6012; NORWITZ ER, 1907, NEW ENGL J MED, V345, P1400; STAMPER HB, 1976, J EXP MED, V144, P828, DOI 10.1084/jem.144.3.828; Yeh JC, 2001, CELL, V105, P957, DOI 10.1016/S0092-8674(01)00394-4; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388	18	349	385	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					405	408		10.1126/science.1079546	http://dx.doi.org/10.1126/science.1079546			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532021				2022-12-28	WOS:000180426800049
J	Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD				Su, C; Evans, D; Cole, RH; Kissinger, JC; Ajioka, JW; Sibley, LD			Recent expansion of Toxoplasma through enhanced oral transmission	SCIENCE			English	Article							INTERNAL TRANSCRIBED SPACER; GONDII STRAINS; 2 ALLELES; SEQUENCE; PLASMODIUM; ANTIGEN; IDENTIFICATION; PHYLOGENY; VIRULENCE; CLONING	The global predominance of three clonal Toxoplasma gondii lineages suggests that they are endowed with an exceptional trait responsible for their current parasitism of nearly all warm-blooded vertebrates. Genetic polymorphism analyses indicate that these clonal lineages emerged within the last 10,000 years after a single genetic cross. Comparison with ancient strains (similar to1 million years) suggests that the success of the clonal lineages resulted from the concurrent acquisition of direct oral infectivity. This key adaptation circumvented sexual recombination, simultaneously promoting transmission through successive hosts, hence leading to clonal expansion. Thus, changes in complex life cycles can occur rapidly and can profoundly influence pathogenicity.	Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA; Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; Univ Georgia, Dept Genet, Athens, GA 30602 USA; Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA	Washington University (WUSTL); University of Cambridge; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Sibley, LD (corresponding author), Washington Univ, Dept Mol Microbiol, St Louis, MO 63110 USA.	sibley@borcim.wustl.edu	Kissinger, Jessica C/E-9610-2010; Kissinger, Jessica/M-9920-2019; Su, Chunlei/M-1892-2013; Sibley, L. David/C-4616-2008	Kissinger, Jessica C/0000-0002-6413-1101; Kissinger, Jessica/0000-0002-6413-1101; Su, Chunlei/0000-0001-8392-7108; 				BULOW R, 1991, J IMMUNOL, V147, P3496; CAI J, 1992, BIOCHIM BIOPHYS ACTA, V1131, P317, DOI 10.1016/0167-4781(92)90032-U; Darde ML, 1998, J CLIN MICROBIOL, V36, P324; DARDE ML, 1992, J PARASITOL, V78, P786, DOI 10.2307/3283305; Dubey J. P., 1977, PARASITIC PROTOZOA, V3, P101; DUBEY JP, 1980, AM J VET RES, V41, P427; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; Fazaeli A, 2000, INT J PARASITOL, V30, P637, DOI 10.1016/S0020-7519(00)00036-9; Fuentes I, 2001, J CLIN MICROBIOL, V39, P1566, DOI 10.1128/JCM.39.4.1566-1570.2001; GAGNON S, 1993, MOL BIOCHEM PARASIT, V60, P145, DOI 10.1016/0166-6851(93)90037-X; GAJADHAR AA, 1991, MOL BIOCHEM PARASIT, V45, P147, DOI 10.1016/0166-6851(91)90036-6; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hnida JA, 1999, J PARASITOL, V85, P873, DOI 10.2307/3285824; HOLE F, 1994, ORIGINS AGR, P373; Homan WL, 1997, PARASITOL RES, V83, P285, DOI 10.1007/s004360050248; HOWE DK, 1995, J INFECT DIS, V172, P1561, DOI 10.1093/infdis/172.6.1561; Hughes AL, 2001, P ROY SOC B-BIOL SCI, V268, P1855, DOI 10.1098/rspb.2001.1759; Israelski D M, 1993, Curr Clin Top Infect Dis, V13, P322; Lehmann T, 2000, J PARASITOL, V86, P960, DOI 10.1645/0022-3395(2000)086[0960:STOTGC]2.0.CO;2; LEVINE N. D., 1988, PROTOZOAN PHYLUM API, VI; Levine ND., 1988, PROTOZOAN PHYLUM API; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; Maynard-Smith J, 1974, GENET RES, V23, P23, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Meisel R, 1996, MOL BIOCHEM PARASIT, V81, P259, DOI 10.1016/0166-6851(96)02719-3; Mugridge NB, 1999, INT J PARASITOL, V29, P1545, DOI 10.1016/S0020-7519(99)00150-2; Olivier C, 2001, INT J PARASITOL, V31, P1475, DOI 10.1016/S0020-7519(01)00283-1; PARMLEY SF, 1994, J PARASITOL, V80, P293, DOI 10.2307/3283761; Remington JS, 2001, INFECT DIS FETUS NEW, P205; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; SERPELL J, 2000, DOMESTIC CAT; SIBLEY LD, 1992, GENETICS, V132, P1003; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; Su CL, 2002, P NATL ACAD SCI USA, V99, P10753, DOI 10.1073/pnas.172117099; Wray GA, 1996, SCIENCE, V274, P568, DOI 10.1126/science.274.5287.568	36	261	272	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					414	416		10.1126/science.1078035	http://dx.doi.org/10.1126/science.1078035			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532022	Green Published			2022-12-28	WOS:000180426800052
J	Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W				Kirschke, DL; Jones, TF; Craig, AS; Chu, PS; Mayernick, GG; Patel, JA; Schaffner, W			Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMISSION; INFECTION; OUTBREAK; STERILIZATION	Background: Several outbreaks and pseudo-outbreaks of Pseudomonas aeruginosa and Serratia marcescens infections associated with bronchoscopy have been reported. We conducted an investigation of P. aeruginosa and S. marcescens isolates related to bronchoscopy at a community hospital. Methods: We reviewed the records of all bronchoscopic procedures at the community hospital from July to October 2001. Environmental samples were obtained. Pulsed-field gel electrophoresis (PFGE) was performed on isolates of P. aeruginosa. Results: From July 1 to October 31, 2001, 66 bronchoscopic procedures were performed in 60 patients, and 43 specimens were obtained for bacterial culture; 20 of the specimens (47 percent) were positive for P. aeruginosa. Six (30 percent) of the specimens that were positive for P. aeruginosa also yielded S. marcescens. All 20 P. aeruginosa isolates were associated with procedures performed with three of four new bronchoscopes from the same manufacturer. Contrary to manufacturing specifications, the biopsy-port caps on all four bronchoscopes were easily removable, and P. aeruginosa was cultured from the biopsy ports of the three implicated bronchoscopes. The PFGE patterns of P. aeruginosa isolates from the bronchoscopes, patients, and two environmental samples were indistinguishable. One patient was hospitalized with P. aeruginosa pneumonia 11 days after bronchoscopy. The manufacturer reported a design change instituted in 1997, and production problems may have resulted in the distribution of bronchoscopes that did not meet specifications. Conclusions: We documented contamination of bronchoscopes with P. aeruginosa and S. marcescens and possible infection of patients at a community hospital as a result of the inadequate disinfection of bronchoscopes because of a manufacturing defect.	Vanderbilt Univ, Sch Med, Nashville, TN 37232 USA; Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; Tennessee Dept Hlth, Nashville, TN USA; Skyline Med Ctr, Nashville, TN USA	Vanderbilt University; Centers for Disease Control & Prevention - USA; Tennessee Department Health	Schaffner, W (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N,Rm A-1124, Nashville, TN 37232 USA.	william.schaffner@vanderbilt.edu						Alvarado CJ, 2000, AM J INFECT CONTROL, V28, P138; [Anonymous], MMWR MORB MORTAL WKL; *BIOR LAB, 1992, MOL AN SOFTW VERS 1; Blanc DS, 1997, INFECT CONT HOSP EP, V18, P134; BOND WW, 1998, DISINFECTION STERILI, P151; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; DEAN AG, 2001, INFO 2000 VERSION 1; Favero M., 1991, DISINFECTION STERILI, P617; FEIGAL DW, 1999, FDA CDC PUBLIC HLTH; KOLMOS HJ, 1994, SCAND J INFECT DIS, V26, P653, DOI 10.3109/00365549409008632; Kolter R, 1998, SCIENCE, V280, P226, DOI 10.1126/science.280.5361.226; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; Muscarella LF, 2000, INFECT CONT HOSP EP, V21, P628, DOI 10.1086/503241; Muscarella LF, 1996, INFECT CONT HOSP EP, V17, P183; Ostrowsky B., 2001, SEMIN INFECT CONTROL, V1, P267; OWINGS MF, 1996, VITAL HLTH STAT 13, V139; PRAKASH UBS, 1993, CHEST, V104, P552, DOI 10.1378/chest.104.2.552; Rutala WA, 1998, AM J INFECT CONTROL, V26, P393, DOI 10.1016/S0196-6553(98)70034-3; Rutala WA, 1999, INFECT CONT HOSP EP, V20, P302; Sammartino M T, 1982, J Hosp Infect, V3, P65, DOI 10.1016/0195-6701(82)90032-9; Seijo LM, 2001, NEW ENGL J MED, V344, P740, DOI 10.1056/NEJM200103083441007; SIEGMANIGRA Y, 1985, J HOSP INFECT, V6, P218; Sorin M, 2001, INFECT CONT HOSP EP, V22, P409, DOI 10.1086/501925; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Srinivasan A, 2003, NEW ENGL J MED, V348, P221, DOI 10.1056/NEJMoa021808; VANDENBROUCKEGRAULS CMJE, 1993, J HOSP INFECT, V23, P263, DOI 10.1016/0195-6701(93)90143-N; Weber DJ, 2001, INFECT CONT HOSP EP, V22, P403, DOI 10.1086/501924; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	28	94	101	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					214	220		10.1056/NEJMoa021791	http://dx.doi.org/10.1056/NEJMoa021791			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529461				2022-12-28	WOS:000180390600005
J	Friend, M; Vucenik, I; Miller, M				Friend, M; Vucenik, I; Miller, M			Platelet responsiveness to aspirin in patients with hyperlipidaemia	BRITISH MEDICAL JOURNAL			English	Article							RESISTANCE		Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA; Univ Maryland, Med Ctr, Dept Med & Res Technol & Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Miller, M (corresponding author), Univ Maryland, Med Ctr, Div Cardiol, Baltimore, MD 21201 USA.		Miller, Michael/AGX-6773-2022	Miller, Michael/0000-0002-1679-2095	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061369] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL061369, HL 61369] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CARVALHO AC, 1974, NEW ENGL J MED, V290, P434, DOI 10.1056/NEJM197402212900805; HELGASON CM, 1994, STROKE, V25, P2331, DOI 10.1161/01.STR.25.12.2331; Kawasaki T, 2000, STROKE, V31, P591, DOI 10.1161/01.STR.31.3.591; SATHIROPAS P, 1988, THROMB RES, V51, P55, DOI 10.1016/0049-3848(88)90282-4; Weber AA, 1999, LANCET, V353, P900, DOI 10.1016/S0140-6736(99)00498-5	5	117	129	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					82	83		10.1136/bmj.326.7380.82	http://dx.doi.org/10.1136/bmj.326.7380.82			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521973	Green Published, Bronze			2022-12-28	WOS:000180426900017
J	Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J				Voulhoux, R; Bos, MP; Geurtsen, J; Mols, M; Tommassen, J			Role of a highly conserved bacterial protein in outer membrane protein assembly	SCIENCE			English	Article							CHLOROPLASTIC ENVELOPE MEMBRANES; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; PHOSPHOLIPASE-A; GONORRHOEAE; ORIGIN	After transport across the cytoplasmic membrane, bacterial outer membrane proteins are assembled into the outer membrane. Meningococcal Omp85 is a highly conserved protein in Gram-negative bacteria, and its homolog Toc75 is a component of the chloroplast protein-import machinery. Omp85 appeared to be essential for viability, and unassembled forms of various outer membrane proteins accumulated upon Omp85 depletion. Immuno fluorescence microscopy revealed decreased surface exposure of outer membrane proteins, which was particularly apparent at the cell-division planes. Thus, Omp85 is likely to play a role in outer membrane protein assembly.	Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands	Utrecht University; Utrecht University	Tommassen, J (corresponding author), Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.		Tommassen, Jan/I-1690-2016; Voulhoux, Rome/AAT-5333-2021	Tommassen, Jan/0000-0001-7633-4945; 				Bolter B, 1998, P NATL ACAD SCI USA, V95, P15831, DOI 10.1073/pnas.95.26.15831; BROK RGPM, 1994, J BACTERIOL, V176, P861, DOI 10.1128/jb.176.3.861-870.1994; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; deCock H, 1996, EMBO J, V15, P5567, DOI 10.1002/j.1460-2075.1996.tb00941.x; Dekker N, 1997, J BIOL CHEM, V272, P3179, DOI 10.1074/jbc.272.6.3179; Eppens EF, 1997, EMBO J, V16, P4295, DOI 10.1093/emboj/16.14.4295; Fussenegger M, 1996, MOL MICROBIOL, V19, P1357, DOI 10.1111/j.1365-2958.1996.tb02479.x; Henderson IR, 1998, TRENDS MICROBIOL, V6, P370, DOI 10.1016/S0966-842X(98)01318-3; Jansen C, 2000, BBA-BIOMEMBRANES, V1464, P284, DOI 10.1016/S0005-2736(00)00155-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lazar SW, 1996, J BACTERIOL, V178, P1770, DOI 10.1128/jb.178.6.1770-1773.1996; Manning DS, 1998, MICROB PATHOGENESIS, V25, P11, DOI 10.1006/mpat.1998.0206; Manting EH, 2000, MOL MICROBIOL, V37, P226, DOI 10.1046/j.1365-2958.2000.01980.x; Martin D, 1997, J EXP MED, V185, P1173, DOI 10.1084/jem.185.7.1173; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; Prinz T, 2000, FEMS MICROBIOL LETT, V183, P49, DOI 10.1111/j.1574-6968.2000.tb08932.x; Reumann S, 1999, TRENDS PLANT SCI, V4, P302, DOI 10.1016/S1360-1385(99)01449-1; Reumann S, 1999, P NATL ACAD SCI USA, V96, P784, DOI 10.1073/pnas.96.2.784; Steeghs L, 2001, EMBO J, V20, P6937, DOI 10.1093/emboj/20.24.6937; Steeghs L, 1998, NATURE, V392, P449, DOI 10.1038/33046; Thomas KL, 2001, INFECT IMMUN, V69, P4438, DOI 10.1128/IAI.69.7.4438-4446.2001; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408	22	571	582	5	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					262	265		10.1126/science.1078973	http://dx.doi.org/10.1126/science.1078973			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522254				2022-12-28	WOS:000180284000043
J	Choudhry, NK; Choudhry, S; Singer, PA				Choudhry, NK; Choudhry, S; Singer, PA			CPR for patients labeled DNR: The role of the limited aggressive therapy order	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HOSPITAL CARDIAC-ARREST; NOT-RESUSCITATE ORDERS; CARDIOPULMONARY-RESUSCITATION; OPERATING-ROOM; ADVERSE EVENTS; SURVIVAL; SURGERY; ANESTHESIA; PREFERENCES; COMMUNITY	Patients who sustain a cardiac arrest have a less than 20% chance of surviving to hospital discharge. Patients may request do-not-resuscitate (DNR) orders if they believe that their chances for a meaningful recovery after cardiopulmonary arrest are low. However, in some identifiable circumstances, cardiopulmonary resuscitation (CPR) has a higher chance of success and lower likelihood of neurologic impairment. The probability of survival from a cardiac arrest influences patients' wishes regarding resuscitation; thus, when CPR has a higher likelihood of success, patients' expressed preferences for treatment as contained within a DNR order may not accurately reflect their intended goals. Patients should be offered the option of consenting to CPR for "higher-success" situations, including a witnessed cardiopulmonary arrest in which the initial cardiac rhythm is ventricular tachycardia or fibrillation, cardiac arrest in the operating room, and cardiac arrest resulting from a readily identifiable iatrogenic cause. This new level of resuscitation could be called a "limited aggressive therapy" order.	Univ Toronto, Toronto, ON M5G 1L4, Canada; Harvard Univ, Cambridge, MA 02138 USA	University of Toronto; Harvard University	Singer, PA (corresponding author), Univ Toronto, 88 Coll St, Toronto, ON M5G 1L4, Canada.			Choudhry, Sujit/0000-0002-6543-6644				BEDELL SE, 1991, JAMA-J AM MED ASSOC, V265, P2815, DOI 10.1001/jama.265.21.2815; BERNAT JL, 1993, SURG NEUROL, V40, P7, DOI 10.1016/0090-3019(93)90161-S; BEURET P, 1993, RESUSCITATION, V25, P171, DOI 10.1016/0300-9572(93)90093-6; BIALECKI L, 1995, CHEST, V108, P1009, DOI 10.1378/chest.108.4.1009; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; BURNS R, 1989, ARCH INTERN MED, V149, P1318, DOI 10.1001/archinte.149.6.1318; Casarett D, 1997, NEW ENGL J MED, V336, P1908, DOI 10.1056/NEJM199706263362611; Cobbe SM, 1996, BRIT MED J, V312, P1633, DOI 10.1136/bmj.312.7047.1633; COHEN CB, 1991, NEW ENGL J MED, V325, P1879, DOI 10.1056/NEJM199112263252611; de Vos R, 1999, ARCH INTERN MED, V159, P249, DOI 10.1001/archinte.159.3.249; de Vos R, 1999, ARCH INTERN MED, V159, P845, DOI 10.1001/archinte.159.8.845; DUBOIS RW, 1988, ANN INTERN MED, V109, P582, DOI 10.7326/0003-4819-109-7-582; EISENBERG MS, 1979, JAMA-J AM MED ASSOC, V241, P1905, DOI 10.1001/jama.241.18.1905; GASCHO JA, 1979, CIRCULATION, V60, P231, DOI 10.1161/01.CIR.60.2.231; Gueugniaud PY, 1998, NEW ENGL J MED, V339, P1595, DOI 10.1056/NEJM199811263392204; Hamel MB, 1999, ANN INTERN MED, V130, P116, DOI 10.7326/0003-4819-130-2-199901190-00005; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LONGSTRETH WT, 1990, JAMA-J AM MED ASSOC, V264, P2109, DOI 10.1001/jama.264.16.2109; MARGOLIS JO, 1995, ANESTH ANALG, V80, P806, DOI 10.1097/00000539-199504000-00027; MILES SH, 1982, ANN INTERN MED, V96, P660, DOI 10.7326/0003-4819-96-5-660; MURPHY DJ, 1994, NEW ENGL J MED, V330, P545, DOI 10.1056/NEJM199402243300807; MYERBURG RJ, 1980, AM J MED, V68, P568, DOI 10.1016/0002-9343(80)90307-1; OLSSON GL, 1988, ACTA ANAESTH SCAND, V32, P653, DOI 10.1111/j.1399-6576.1988.tb02804.x; OTOOLE EE, 1994, ARCH INTERN MED, V154, P425, DOI 10.1001/archinte.154.4.425; PEARLMAN RA, 1993, J CLIN ETHIC, V4, P33; Plaisance P, 1999, NEW ENGL J MED, V341, P569, DOI 10.1056/NEJM199908193410804; SCHONWETTER RS, 1993, J GEN INTERN MED, V8, P295, DOI 10.1007/BF02600139; SINGER PA, 1995, J AM SOC NEPHROL, V6, P1410; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; TRESCH DD, 1989, AM J MED, V86, P145, DOI 10.1016/0002-9343(89)90259-3; TRESCH DD, 1990, AM J CARDIOL, V65, P453, DOI 10.1016/0002-9149(90)90809-F; Truog RD, 1999, ANESTHESIOLOGY, V90, P289, DOI 10.1097/00000542-199901000-00034; TRUOG RD, 1991, ANESTHESIOLOGY, V74, P606, DOI 10.1097/00000542-199103000-00030; van Walraven C, 1999, ARCH INTERN MED, V159, P129, DOI 10.1001/archinte.159.2.129; WALKER RM, 1991, JAMA-J AM MED ASSOC, V266, P2407, DOI 10.1001/jama.266.17.2407; Wenger NS, 1997, J CLIN ETHIC, V8, P250; YOUNGNER SJ, 1991, JAMA-J AM MED ASSOC, V266, P2433, DOI 10.1001/jama.266.17.2433; 1999, AM J KIDNEY DIS, V33, P980; 1983, DECIDING FORGO LIFE	40	21	21	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					65	68		10.7326/0003-4819-138-1-200301070-00014	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00014			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513047				2022-12-28	WOS:000180996200009
J	Greenberger, NJ				Greenberger, NJ			Update in gastroenterology	ANNALS OF INTERNAL MEDICINE			English	Review									Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Greenberger, NJ (corresponding author), Brigham & Womens Hosp, Div Gastroenterol, 75 Francis St, Boston, MA 02115 USA.	ngreenberger@partners.org						ASAKA M, 1999, HELICOBACTER PYLORI, P116; Lau JYW, 2000, NEW ENGL J MED, V343, P310, DOI 10.1056/NEJM200008033430501	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					45	53		10.7326/0003-4819-138-1-200301070-00011	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00011			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513044				2022-12-28	WOS:000180996200007
J	Manfredi, M; Bozzao, L; Inghiller, M				Manfredi, M; Bozzao, L; Inghiller, M			Medial longitudinal fascicles	LANCET			English	Editorial Material									Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy	Sapienza University Rome	Manfredi, M (corresponding author), Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy.		Inghilleri, Maurizio/AAZ-6136-2020	Inghilleri, Maurizio/0000-0001-5365-3417					0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					20	20		10.1016/S0140-6736(03)12114-9	http://dx.doi.org/10.1016/S0140-6736(03)12114-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517461				2022-12-28	WOS:000180191600015
J	Heilbron, JL; Bynum, WF				Heilbron, JL; Bynum, WF			1903 and all that - Honours go to the first powered flight and the DNA double helix.	NATURE			English	Editorial Material									Univ Oxford Worcester Coll, Oxford OX1 2HB, England; UCL, Wellcome Trust Ctr Hist Med, London NW1 1AD, England	University of Oxford; University of London; University College London	Heilbron, JL (corresponding author), Univ Oxford Worcester Coll, Oxford OX1 2HB, England.								0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					15	18		10.1038/421015a	http://dx.doi.org/10.1038/421015a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511930				2022-12-28	WOS:000180165500014
J	Rossouw, JE				Rossouw, JE			Hormones for coronary disease - full circle	LANCET			English	Editorial Material							ESTROGEN-REPLACEMENT; TRIAL; ATHEROSCLEROSIS; PREVENTION		US Dept HHS, NHLBI, Bethesda, MD 20014 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Rossouw, JE (corresponding author), US Dept HHS, NHLBI, Bethesda, MD 20014 USA.							Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; HODIS HN, 2002, WELL HART AM HEART A; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; *MRC, 2002, MRC STOPS STUD LONG; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schulman SP, 2002, J AM COLL CARDIOL, V39, P231, DOI 10.1016/S0735-1097(01)01724-7; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432	9	14	14	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					1996	1997		10.1016/S0140-6736(02)12030-7	http://dx.doi.org/10.1016/S0140-6736(02)12030-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504389				2022-12-28	WOS:000179974200002
J	Nie, JB				Nie, JB			Japanese doctors' experimentation in wartime China	LANCET			English	Article									Univ Otago, Ctr Bioeth, Dundee, Scotland; Hunan Normal Univ, Inst Eth, Changsha, Peoples R China	Hunan Normal University	Nie, JB (corresponding author), Univ Otago, Ctr Bioeth, POB 913, Dundee, Scotland.							Gold Hal, 1996, UNIT 731 TESTIMONY; Harris Sheldon, 1994, FACTORIES DEATH JAPA; KEIICHI T, IN PRESS SECRETS UNI; Nie J. -B, 2001, EUBIOS J ASIAN INT B, V11, P3; Williams P, 1989, UNIT 731 JAPANESE AR	5	8	8	0	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S5	S6		10.1016/S0140-6736(02)11797-1	http://dx.doi.org/10.1016/S0140-6736(02)11797-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504481				2022-12-28	WOS:000180064500002
J	Tonelli, M; Moye, L; Sacks, FM; Kiberd, B; Curhan, G				Tonelli, M; Moye, L; Sacks, FM; Kiberd, B; Curhan, G		CARE Trial Investigators	Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency	ANNALS OF INTERNAL MEDICINE			English	Article							MYOCARDIAL-INFARCTION; RISK-FACTORS; DISEASE; EPIDEMIOLOGY; CHOLESTEROL; MANAGEMENT; IMPACT	Background: Cardiovascular disease is a common cause of morbidity and death in persons with renal insufficiency. Although 3-hydroxy-3methylglutaryl coenzyme A reductase inhibitors (statins) are effective for secondary prevention of cardiovascular events in the general population, they have not been specifically studied in chronic renal insufficiency. Objective: To determine whether pravastatin is effective and safe for secondary prevention of cardiovascular events in persons with chronic renal insufficiency. Design: Post hoc subgroup analysis of a randomized, double-blind, placebo-controlled trial. Setting: The Cholesterol and Recurrent Events (CARE) study, a randomized trial of pravastatin versus placebo in 4159 participants with previous myocardial infarction and total plasma cholesterol levels less than 6.21 mmol/L (<240 mg/dL). Participants: 1711 participants with chronic renal insufficiency defined by creatinine clearance less than or equal to 75 mL/min, using the Cockcroft-Gault equation. Measurements: The primary outcome was death from coronary disease or symptomatic nonfatal myocardial infarction. Results: After a median follow-up of 58.9 months, the incidence of the primary end point was lower in participants receiving pravastatin than in those receiving placebo (adjusted hazard ratio, 0.72 [95% Cl, 0.55 to 0.95]; P = 0.02). Pravastatin was associated with lower adjusted hazard ratios for major coronary events (0.72 [Cl, 0.59 to 0.88]; P = 0.001) and coronary revascularization (0.65 [Cl, 0.50 to 0.83]; P = 0.001), but not total mortality (0.81 [Cl, 0.61 to 1.08]; P = 0.14) or stroke (0.62 [Cl, 0.39 to 1.00]; P = 0.051). Tests for interaction suggested that the observed benefit was independent of the presence and severity of renal insufficiency. Incidence of side effects was similar in persons receiving pravastatin and those receiving placebo. Conclusions: These data suggest that pravastatin is effective and appears safe for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Since statins may be underused in this setting, physicians should consider prescribing them for patients with chronic renal insufficiency and known coronary disease.	Univ Alberta, Div Nephrol & Immunol, Edmonton, AB T6B 2B7, Canada; Univ Texas, Sch Publ Hlth, Houston, TX USA; Harvard Univ, Brigham & Womens Hosp, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Dalhousie Univ, Halifax, NS, Canada	University of Alberta; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Dalhousie University	Tonelli, M (corresponding author), Univ Alberta, Div Nephrol & Immunol, Clin Sci Bldg,Suite 11-108C,8440 112 St, Edmonton, AB T6B 2B7, Canada.		Tonelli, Marcello/B-3028-2009	Tonelli, Marcello/0000-0002-0846-3187				Baigent C, 2000, LANCET, V356, P147, DOI 10.1016/S0140-6736(00)02456-9; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Culleton BF, 1999, KIDNEY INT, V56, P2214, DOI 10.1046/j.1523-1755.1999.00773.x; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; HALSTENSON CE, 1992, J CLIN PHARMACOL, V32, P124, DOI 10.1002/j.1552-4604.1992.tb03816.x; Jones CA, 1998, AM J KIDNEY DIS, V32, P992, DOI 10.1016/S0272-6386(98)70074-5; Kitiyakara C, 2000, CURR OPIN NEPHROL HY, V9, P477, DOI 10.1097/00041552-200009000-00004; Levin A, 2000, AM J KIDNEY DIS, V36, pS24, DOI 10.1053/ajkd.2000.19928; Levin A, 1999, AM J KIDNEY DIS, V34, P125, DOI 10.1016/S0272-6386(99)70118-6; Lipscombe J, 2001, CLIN NEPHROL, V55, P39; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; *NKF K DOQI, 2002, AM J KIDNEY DIS S, V39, pS76; PEDERSEN TR, 1994, LANCET, V344, P1383; Rostand SC, 2000, J AM SOC NEPHROL, V11, P1948, DOI 10.1681/ASN.V11101948; Ruilope LM, 2001, J AM SOC NEPHROL, V12, P218, DOI 10.1681/ASN.V122218; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; SACKS FM, 1991, AM J CARDIOL, V68, P1436, DOI 10.1016/0002-9149(91)90276-Q; Sarnak MJ, 2000, AM J KIDNEY DIS, V35, pS117, DOI 10.1016/S0272-6386(00)70239-3; Sarnak MJ, 2000, J THROMB THROMBOLYS, V10, P169, DOI 10.1023/A:1018718727634; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; Tonelli M, 2001, AM J KIDNEY DIS, V37, P484, DOI 10.1053/ajkd.2001.22070; YUSUF S, 1991, JAMA-J AM MED ASSOC, V266, P93, DOI 10.1001/jama.266.1.93	22	227	239	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					98	104		10.7326/0003-4819-138-2-200301210-00010	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529091				2022-12-28	WOS:000181018300003
J	Nolan, B; Vidler, V; Vora, A; Makris, M				Nolan, B; Vidler, V; Vora, A; Makris, M			Lesson of the week - Unsuspected haemophilia in children with a single swollen joint	BRITISH MEDICAL JOURNAL			English	Review									Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England	Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital	Makris, M (corresponding author), Sheffield Childrens Hosp, Sheffield S10 2TH, S Yorkshire, England.		Nolan, Beatrice/AAV-4356-2021; Makris, Mike/A-2772-2011	Nolan, Beatrice/0000-0003-0145-4736; Makris, Mike/0000-0001-7622-7939				DUTHIE R, 1997, HAEMOPHILIA OTHER IN, P227; Eickhoff HH, 1998, HAEMOPHILIA, V4, P511, DOI 10.1046/j.1365-2516.1998.440511.x; FINK PC, 1992, PEDIAT EMERGENCY MED, P1025; Mannucci PM, 2001, NEW ENGL J MED, V344, P1773, DOI 10.1056/NEJM200106073442307	4	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					151	152		10.1136/bmj.326.7381.151	http://dx.doi.org/10.1136/bmj.326.7381.151			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531850	Green Published			2022-12-28	WOS:000180575900029
J	Charlebois, RL; Beiko, RG; Ragan, MA				Charlebois, RL; Beiko, RG; Ragan, MA			Branching out	NATURE			English	Editorial Material									Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada; Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	University of Ottawa; University of Queensland	Charlebois, RL (corresponding author), Univ Ottawa, Dept Biol, Ottawa, ON K1N 6N5, Canada.		Ragan, Mark A/A-9825-2014	Ragan, Mark A/0000-0003-1672-7020				Clarke GDP, 2002, J BACTERIOL, V184, P2072, DOI 10.1128/JB.184.8.2072-2080.2002; Doolittle WF, 1999, SCIENCE, V284, P2124, DOI 10.1126/science.284.5423.2124; Gogarten JP, 2002, MOL BIOL EVOL, V19, P2226, DOI 10.1093/oxfordjournals.molbev.a004046; Woese CR, 2002, P NATL ACAD SCI USA, V99, P8742, DOI 10.1073/pnas.132266999; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8	5	28	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					217	217		10.1038/421217a	http://dx.doi.org/10.1038/421217a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529621	Bronze			2022-12-28	WOS:000180397600026
J	Dembitzer, A; Lai, EJ				Dembitzer, A; Lai, EJ			Retained surgical instrument	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Dembitzer, A (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					228	228		10.1056/NEJMicm020710	http://dx.doi.org/10.1056/NEJMicm020710			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529463				2022-12-28	WOS:000180390600007
J	Grosshans, F; Van Assche, G; Wenger, J; Brouri, R; Cerf, NJ; Grangier, P				Grosshans, F; Van Assche, G; Wenger, J; Brouri, R; Cerf, NJ; Grangier, P			Quantum key distribution using gaussian-modulated coherent states	NATURE			English	Article							NONDEMOLITION MEASUREMENTS; CRYPTOGRAPHY; CLONING	Quantum continuous variables(1) are being explored(2-14) as an alternative means to implement quantum key distribution, which is usually based on single photon counting(15). The former approach is potentially advantageous because it should enable higher key distribution rates. Here we propose and experimentally demonstrate a quantum key distribution protocol based on the transmission of gaussian-modulated coherent states (consisting of laser pulses containing a few hundred photons) and shot-noise-limited homodyne detection; squeezed or entangled beams are not required(13). Complete secret key extraction is achieved using a reverse reconciliation(14) technique followed by privacy amplification. The reverse reconciliation technique is in principle secure for any value of the line transmission, against gaussian individual attacks based on entanglement and quantum memories. Our table-top experiment yields a net key transmission rate of about 1.7 megabits per second for a loss-free line, and 75 kilobits per second for a line with losses of 3.1 dB. We anticipate that the scheme should remain effective for lines with higher losses, particularly because the present limitations are essentially technical, so that significant margin for improvement is available on both the hardware and software.	Inst Opt, CNRS, UMR 8501, Lab Charles Fabry, F-91403 Orsay, France; Free Univ Brussels, Ecole Polytech, B-1050 Brussels, Belgium	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite Libre de Bruxelles; Vrije Universiteit Brussel	Grangier, P (corresponding author), Inst Opt, CNRS, UMR 8501, Lab Charles Fabry, F-91403 Orsay, France.	philippe.grangier@iota.u-psud.fr	Wenger, Jerome/A-5657-2008	Wenger, Jerome/0000-0002-2145-5341; Grosshans, Frederic/0000-0001-8170-9668				Bencheikh K, 2001, J MOD OPTIC, V48, P1903, DOI 10.1080/09500340110075122; Bennett CH, 1995, IEEE T INFORM THEORY, V41, P1915, DOI 10.1109/18.476316; BENNETT CH, 1992, PHYS REV LETT, V68, P3121, DOI 10.1103/PhysRevLett.68.3121; BRASSARD G, 1993, LECT NOTES COMPUTER, P411; BRAUNSTEIN SL, QUANTUM INFORMATION; BUTTLER WT, 2002, QUANTPH0203096; Cerf NJ, 2000, PHYS REV LETT, V85, P1754, DOI 10.1103/PhysRevLett.85.1754; Cerf NJ, 2002, EUR PHYS J D, V18, P211, DOI 10.1140/epjd/e20020025; Cerf NJ, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.052311; Cerf NJ, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.040301; CSISZAR I, 1978, IEEE T INFORM THEORY, V24, P339, DOI 10.1109/TIT.1978.1055892; Duan LM, 2000, PHYS REV LETT, V84, P4002, DOI 10.1103/PhysRevLett.84.4002; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; GOTTESMAN D, 1908, PHYS REV A, V63; Grangier, 2002, QUANTPH0204127; Grangier P, 1998, NATURE, V396, P537, DOI 10.1038/25059; GROSSHANS E, 2001, PHYS REV A, V64; Grosshans F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.057902; Hillery M, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.022309; LO HK, 2002, QUANTPH0201030; MAURER UM, 1993, IEEE T INFORM THEORY, V39, P733, DOI 10.1109/18.256484; NGUYEN K, 2002, THESIS U LIBRE BRUXE; POIZAT JP, 1994, ANN PHYS-PARIS, V19, P265, DOI 10.1051/anphys:01994001903026500; Ralph TC, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.010303; Ralph TC, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062306; Reid MD, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.062308; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Silberhorn C, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.167901; Silberhorn C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167902; VANASSCHE G, CSCR0107030	30	985	1016	13	162	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					238	241		10.1038/nature01289	http://dx.doi.org/10.1038/nature01289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529636	Green Submitted			2022-12-28	WOS:000180397600039
J	Hoffmeister, KM; Felbinger, TW; Falet, H; Denis, CV; Bergmeier, W; Mayadas, TN; von Andrian, UH; Wagner, DD; Stossel, TP; Hartwig, JH				Hoffmeister, KM; Felbinger, TW; Falet, H; Denis, CV; Bergmeier, W; Mayadas, TN; von Andrian, UH; Wagner, DD; Stossel, TP; Hartwig, JH			The clearance mechanism of chilled blood platelets	CELL			English	Article							VON-WILLEBRAND-FACTOR; P-SELECTIN; BACTERIAL-CONTAMINATION; GPIB-IX; INTEGRIN; ACTIVATION; MEMBRANE; ALPHA; CD11B/CD18; EXPRESSION	Platelet transfusion is a very common lifesaving medical procedure. Not widely known is the fact that platelets, unlike other blood cells, rapidly leave the circulation if refrigerated prior to transfusion. This peculiarity requires blood services to store platelets at room temperature, limiting platelet supplies for clinical needs. Here, we describe the mechanism of this clearance system, a longstanding mystery. Chilling platelets clusters their von Willebrand (vWf) receptors, eliciting recognition of mouse and human platelets by hepatic macrophage complement type 3 (CR3) receptors. CR3-expressing but not CR3-deficient mice exposed to cold rapidly decrease platelet counts. Cooling primes platelets for activation. We propose that platelets are thermosensors, primed at peripheral sites where most injuries occurred throughout evolution. Clearance prevents pathologic thrombosis by primed platelets. Chilled platelets bind vWf and function normally in vitro and ex vivo after transfusion into CR3-deficient mice. Therefore, GPIb modification might permit cold platelet storage.	Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School	Hoffmeister, KM (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	khoffmeister@rics.bwh.harvard.edu	Denis, Cecile/A-7649-2011; von Andrian, Ulrich H/A-5775-2008	Denis, Cecile/0000-0001-5152-9156; Falet, Herve/0000-0003-0788-9204	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019429, P01HL036028, R37HL019429, P01HL056949] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL56949, HL36028, HL19429, P01 HL056949] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AAS KA, 1958, J CLIN INVEST, V37, P1257, DOI 10.1172/JCI103713; Alugupalli KR, 2001, THROMB HAEMOSTASIS, V86, P668, DOI 10.1055/s-0037-1616102; Baker GR, 1997, AM J HEMATOL, V56, P17; BECKER GA, 1973, TRANSFUSION, V13, P61, DOI 10.1111/j.1537-2995.1973.tb05442.x; Berger G, 1998, BLOOD, V92, P4446, DOI 10.1182/blood.V92.11.4446; Bergmeier W, 2000, BLOOD, V95, P886, DOI 10.1182/blood.V95.3.886.003k45_886_893; Bergmeier W, 2001, J BIOL CHEM, V276, P25121, DOI 10.1074/jbc.M103892200; BERMAN CL, 1986, J CLIN INVEST, V78, P130, DOI 10.1172/JCI112542; BioulacSage P, 1996, HEPATO-GASTROENTEROL, V43, P4; Brown SB, 2000, J BIOL CHEM, V275, P5987, DOI 10.1074/jbc.275.8.5987; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Denis C, 1998, P NATL ACAD SCI USA, V95, P9524, DOI 10.1073/pnas.95.16.9524; Deveci D, 2001, J COMP PHYSIOL B, V171, P135, DOI 10.1007/s003600000156; Engelfriet CP, 2000, VOX SANG, V78, P59, DOI 10.1046/j.1423-0410.2000.78100591.x; Falet H, 2002, BLOOD, V100, P2113, DOI 10.1182/blood.V100.6.2113.h81802002113_2113_2122; Faraday N, 1998, ANESTHESIOLOGY, V88, P1579, DOI 10.1097/00000542-199806000-00022; GOTO S, 1995, J BIOL CHEM, V270, P23352, DOI 10.1074/jbc.270.40.23352; HARTWIG JH, 1991, J CELL BIOL, V112, P407, DOI 10.1083/jcb.112.3.407; HARTWIG JH, 1995, CELL, V82, P643, DOI 10.1016/0092-8674(95)90036-5; Hoffmeister KM, 2001, J BIOL CHEM, V276, P24751, DOI 10.1074/jbc.M011642200; Jacobs MR, 2001, TRANSFUSION, V41, P1331, DOI 10.1046/j.1537-2995.2001.41111331.x; JANMEY PA, 1989, J BIOL CHEM, V264, P4825; Kawakami Hayato, 2001, Journal of Smooth Muscle Research, V37, P113, DOI 10.1540/jsmr.37.113; KOTZE HF, 1985, THROMB HAEMOSTASIS, V53, P404; Kovacsovics TJ, 1996, BLOOD, V87, P618, DOI 10.1182/blood.V87.2.618.bloodjournal872618; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Maurer-Spurej E, 2001, LAB INVEST, V81, P581, DOI 10.1038/labinvest.3780267; MENGER MD, 1991, EUR SURG RES, V23, P158, DOI 10.1159/000129148; Michelson AD, 1996, P NATL ACAD SCI USA, V93, P11877, DOI 10.1073/pnas.93.21.11877; SELIGSOHN U, 1995, DISSEMINATED INTRAVA, P1289; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Simon DI, 2000, J EXP MED, V192, P193, DOI 10.1084/jem.192.2.193; SLICHTER SJ, 1976, BRIT J HAEMATOL, V34, P403, DOI 10.1111/j.1365-2141.1976.tb03587.x; SNYDER EL, 1989, TRANSFUSION, V29, P390, DOI 10.1046/j.1537-2995.1989.29589284136.x; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sungaran R, 2000, BLOOD, V95, P3094, DOI 10.1182/blood.V95.10.3094.009k05_3094_3101; Tablin F, 1996, J CELL PHYSIOL, V168, P305, DOI 10.1002/(SICI)1097-4652(199608)168:2<305::AID-JCP9>3.0.CO;2-T; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; WARD C, 1996, BIOCHEMISTRY-US, V28, P8326; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Yan J, 2000, IMMUNOPHARMACOLOGY, V46, P39, DOI 10.1016/S0162-3109(99)00157-5; Zucker M, 1954, BLOOD, V28, P524	43	307	328	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					87	97		10.1016/S0092-8674(02)01253-9	http://dx.doi.org/10.1016/S0092-8674(02)01253-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526796	Bronze			2022-12-28	WOS:000181191500009
J	Nicholson, DW; Thornberry, NA				Nicholson, DW; Thornberry, NA			Life and death decisions	SCIENCE			English	Editorial Material							CYTOCHROME-C; APOPTOSIS; DATP		Merck Res Labs, Merck Frosst Ctr Therapeut Res, Montreal, PQ HLH 3L1, Canada; Merck Res Labs, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Nicholson, DW (corresponding author), Merck Res Labs, Merck Frosst Ctr Therapeut Res, Montreal, PQ HLH 3L1, Canada.	nancy_thornberry@merck.com						Bratton SB, 2001, TRENDS PHARMACOL SCI, V22, P306, DOI 10.1016/S0165-6147(00)01718-1; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Gervais FG, 2002, NAT CELL BIOL, V4, P95, DOI 10.1038/ncb735; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Jiang XJ, 2003, SCIENCE, V299, P223, DOI 10.1126/science.1076807; Kaufmann SH, 2001, TRENDS CELL BIOL, V11, P526, DOI 10.1016/S0962-8924(01)02173-0; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Reed JC, 2002, NAT REV DRUG DISCOV, V1, P111, DOI 10.1038/nrd726; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Verhagen AM, 2002, APOPTOSIS, V7, P163, DOI 10.1023/A:1014318615955; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	18	176	229	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					214	215		10.1126/science.1081274	http://dx.doi.org/10.1126/science.1081274			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522239				2022-12-28	WOS:000180284000026
J	Reichhardt, T				Reichhardt, T			NSF urged to take multidisciplinary tack on environment	NATURE			English	News Item																			0	0	0	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102a	http://dx.doi.org/10.1038/421102a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520270	Bronze			2022-12-28	WOS:000180267200008
J	Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB				Fontaine, KR; Redden, DT; Wang, CX; Westfall, AO; Allison, DB			Years of life lost due to obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; WHITE; DISEASE; COHORT; HEALTH; MEN	Context Public health officials and organizations have disseminated health messages regarding the dangers of obesity, but these have not produced the desired effect. Objective To estimate the expected number of years of life lost (YLL) due to overweight and obesity across the life span of an adult. Design, Setting, and Subjects Data from the (1) US Life Tables (1999); (2) Third National Health and Nutrition Examination Survey (NHANES III; 1988-1994); and (3) First National Health and Nutrition Epidemiologic Follow-up Study (NHANES I and II; 1971-1992) and NHANES II, Mortality Study (1976-1992) were used to derive YLL estimates for adults aged 18 to 85 years. Body mass index (BMI) integer-defined categories were used (ie, <17; 17 to <18; 18 to <19; 20 to <21; 21 to 45; or greater than or equal to45). A BMI of 24 was used as the reference category. Main Outcome Measure The difference between the number of years of life expected if an individual were obese vs not obese, which was designated YLL. Results Marked race and sex differences were observed in estimated YLL. Among whites, a J- or U-shaped association was found between overweight or obesity and YLL. The optimal BMI (associated with the least YLL or greatest longevity) is approximately 23 to 25 for whites and -23 to 30 for blacks. For any given degree of overweight, younger adults generally had greater YLL than did older adults. The maximum YLL for white men aged 20 to 30 years with a severe level of obesity (BMI >45) is 13 and is 8 for white women. For men, this could represent a 22% reduction in expected remaining life span. Among black men and black women older than 60 years, overweight and moderate obesity were generally not associated with an increased YLL and only severe obesity resulted in YLL. However, blacks at younger ages with severe levels of obesity had a maximum YLL of 20 for men and 5 for women. Conclusion Obesity appears to lessen life expectancy markedly, especially among younger adults.	Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Clin Nutr Res Ctr, Sect Stat Genet, Birmingham, AL 35294 USA; Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Johns Hopkins University	Allison, DB (corresponding author), Univ Alabama Birmingham, Dept Biostat, 327 Ryals Publ Hlth Bldg,1665 Univ Blvd, Birmingham, AL 35294 USA.	dallison@ms.soph.uab.edu	Kohn, Geoffrey P/A-9056-2009	Allison, David/0000-0003-3566-9399; Westfall, Andrew/0000-0002-0468-4695	NIDDK NIH HHS [P30DK56336] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Allison D. B., 2001, International textbook of obesity, P31, DOI 10.1002/0470846739.ch3; Allison DB, 1999, INT J OBESITY, V23, P603, DOI 10.1038/sj.ijo.0800875; Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Allison DB, 1997, AM J EPIDEMIOL, V146, P672; Allison DB, 1997, AM J EPIDEMIOL, V146, P339, DOI 10.1093/oxfordjournals.aje.a009275; Allison DB, 1999, AM J PUBLIC HEALTH, V89, P1194, DOI 10.2105/AJPH.89.8.1194; Allison DB, 2002, INT J OBESITY, V26, P410, DOI 10.1038/sj.ijo.0801925; ANDRES R, 1985, PRINCIPLES GERIATRIC, P311; [Anonymous], 1994, VITAL HLTH STAT, V1, P1; Berman DM, 2001, J CLIN ENDOCR METAB, V86, P97, DOI 10.1210/jc.86.1.97; Billington CJ, 2000, ARCH INTERN MED, V160, P898, DOI 10.1001/archinte.160.7.898; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1988, MMWR-MORBID MORTAL W, V37, P543; CONWAY JM, 1995, AM J CLIN NUTR, V61, P765, DOI 10.1093/ajcn/61.4.765; Cox C S, 1997, Vital Health Stat 1, P1; David H., 1978, THEORY COMPETING RIS; DRENICK EJ, 1980, JAMA-J AM MED ASSOC, V243, P443, DOI 10.1001/jama.243.5.443; Durazo-Arvizu R, 1997, J AM STAT ASSOC, V92, P1312, DOI 10.2307/2965401; Ezzati T M, 1992, Vital Health Stat 2, P1; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; FLEGAL KM, 1997, OBES RES, V5, pS93; Fontaine K R, 2001, Eat Behav, V2, P87, DOI 10.1016/S1471-0153(01)00024-1; Fontaine K R, 2001, Obes Rev, V2, P173, DOI 10.1046/j.1467-789x.2001.00032.x; Green L. W., 1999, HLTH PROMOTION PLANN; HEO M, IN PRESS STAT MED; JOHNSON JL, 1986, AM J EPIDEMIOL, V123, P209, DOI 10.1093/oxfordjournals.aje.a114230; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24; Seidell JC, 1999, MED SCI SPORT EXER, V31, pS597, DOI 10.1097/00005768-199911001-00018; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Stevens J, 1999, AM J EPIDEMIOL, V150, P399, DOI 10.1093/oxfordjournals.aje.a010019; Stevens J, 2000, NUTR REV, V58, P346, DOI 10.1111/j.1753-4887.2000.tb01832.x; U.S. Department of Health and Human Services, 2001, SURG GEN CALL ACT PR; WIENPAHL J, 1990, J CLIN EPIDEMIOL, V43, P949, DOI 10.1016/0895-4356(90)90078-4	34	1534	1596	9	107	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					187	193		10.1001/jama.289.2.187	http://dx.doi.org/10.1001/jama.289.2.187			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517229				2022-12-28	WOS:000180226400029
J	Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Grady, D; Bittner, V; Cauley, JA; Barrett-Connor, E				Kanaya, AM; Herrington, D; Vittinghoff, E; Lin, F; Grady, D; Bittner, V; Cauley, JA; Barrett-Connor, E			Glycemic effects of postmenopausal hormone therapy: The heart and estrogen/progestin replacement study - A randomized, double-blind, placebo-controlled trial	ANNALS OF INTERNAL MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; DEPENDENT DIABETES-MELLITUS; TRANSDERMAL ESTROGEN REPLACEMENT; IMPAIRED FASTING GLUCOSE; INSULIN SENSITIVITY; CARBOHYDRATE-METABOLISM; GROWTH-HORMONE; PLASMA-LIPIDS; MEDROXYPROGESTERONE ACETATE; WOMEN	Background: Randomized trials of postmenopausal hormone therapy have found differing effects on fasting glucose levels. No trial has evaluated the effect of hormone therapy on diabetes incidence. Objective: To evaluate the effect of hormone therapy on fasting glucose level and incident diabetes. Design: Randomized, double-blind, placebo-controlled trial. Setting: 20 U.S. clinical centers. Participants: 2763 postmenopausal women with coronary heart disease who were followed for 4.1 years. At baseline, 734 women had diabetes, 218 women had impaired fasting glucose, and 1811 women were normoglycemic; the 2029 women without diabetes were followed for incident diabetes. Intervention: 0.625 mg of conjugated estrogen plus 2.5 ring of medroxyprogesterone acetate daily, or placebo. Measurements: Fasting glucose level was measured at baseline, at year 1, and at the end of the trial. incident diabetes was defined by self-report of diabetes or disease complication, fasting glucose level of 6.9 mmol/L or greater (greater than or equal to 126 mg/dL), or initiation of therapy with diabetes medication. Results: Fasting glucose levels increased significantly among women assigned to placebo but did not change among women receiving hormone therapy. The incidence of diabetes was 6.2% in the hormone therapy group and 9.5% in the placebo group (relative hazard, 0.65 [95% Cl, 0.48 to 0.89]; P = 0.006). The number needed to treat for benefit to prevent one case of diabetes was 30 (Cl, 18 to 103). Changes in weight and waist circumference did not mediate this effect. Conclusions: in women with coronary disease, hormone therapy reduced the incidence of diabetes by 35%. This observation provides important insights into the metabolic effects of postmenopausal hormones but is insufficient to recommend the use of hormones for secondary prevention of heart disease.	Univ Calif San Francisco, Div Gen Internal Med, San Francisco, CA 94143 USA; Univ Calif San Diego, La Jolla, CA 92093 USA; Wake Forest Univ, Bowman Gray Sch Med, Winston Salem, NC 27157 USA; Univ Alabama Birmingham, Birmingham, AL 35294 USA; Univ Pittsburgh, Pittsburgh, PA 15260 USA	University of California System; University of California San Francisco; University of California System; University of California San Diego; Wake Forest University; Wake Forest Baptist Medical Center; University of Alabama System; University of Alabama Birmingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kanaya, AM (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, 1701 Divisadero St,Suite 536, San Francisco, CA 94143 USA.	alkak@itsa.ucsf.edu	Cauley, Jane A/N-4836-2015	Cauley, Jane A/0000-0003-0752-4408; Bittner, Vera/0000-0001-9456-850X	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA [D15PE050109] Funding Source: NIH RePORTER; BHP HRSA HHS [1D08PE50109-01] Funding Source: Medline	DIVISION OF MEDICINE, BUREAU HEALTH PROFESSIONS, HRSA(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); BHP HRSA HHS		AJABOR LN, 1972, AM J OBSTET GYNECOL, V113, P383, DOI 10.1016/0002-9378(72)90689-8; Andersson B, 1997, J CLIN ENDOCR METAB, V82, P638, DOI 10.1210/jc.82.2.638; Ashley CD, 2000, SPORTS MED, V29, P221, DOI 10.2165/00007256-200029040-00001; Balkau B, 1999, DIABETES CARE, V22, P1667; BARRETTCONNOR E, 1990, ARTERIOSCLEROSIS, V10, P531, DOI 10.1161/01.ATV.10.4.531; BENGTSSON C, 1984, BMJ-BRIT MED J, V289, P1495, DOI 10.1136/bmj.289.6457.1495; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Brussaard HE, 1997, ARTERIOSCL THROM VAS, V17, P324, DOI 10.1161/01.ATV.17.2.324; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V74, P1396, DOI 10.1210/jc.74.6.1396; Colacurci N, 1998, PANMINERVA MED, V40, P18; Darko DA, 2001, DIABETES RES CLIN PR, V54, P157, DOI 10.1016/S0168-8227(01)00297-2; Davidson MH, 2000, ARCH INTERN MED, V160, P3315, DOI 10.1001/archinte.160.21.3315; de Valk-de Roo GW, 1999, ARTERIOSCL THROM VAS, V19, P2993, DOI 10.1161/01.ATV.19.12.2993; Espeland MA, 1998, DIABETES CARE, V21, P1589, DOI 10.2337/diacare.21.10.1589; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; Friday KE, 2001, J CLIN ENDOCR METAB, V86, P48, DOI 10.1210/jc.86.1.48; Friend KE, 1996, J CLIN ENDOCR METAB, V81, P2250, DOI 10.1210/jc.81.6.2250; Gabal LL, 1997, AM J PUBLIC HEALTH, V87, P443, DOI 10.2105/AJPH.87.3.443; Grady D, 2000, ANN INTERN MED, V132, P689, DOI 10.7326/0003-4819-132-9-200005020-00002; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; HAMMOND CB, 1979, AM J OBSTET GYNECOL, V133, P537, DOI 10.1016/0002-9378(79)90289-8; Hemminki E, 2000, LANCET, V355, P566, DOI 10.1016/S0140-6736(99)03432-7; HERITAGE AS, 1980, SCIENCE, V207, P1377, DOI 10.1126/science.7355296; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; KAHN CR, 1978, ENDOCRINOLOGY, V103, P1054; Karjalainen A, 2001, CLIN ENDOCRINOL, V54, P165, DOI 10.1046/j.1365-2265.2001.01208.x; Kimmerle R, 1999, MENOPAUSE, V6, P36; KUMAGAI S, 1993, ACTA PHYSIOL SCAND, V149, P91, DOI 10.1111/j.1748-1716.1993.tb09596.x; LARSSONCOHN U, 1977, ACTA ENDOCRINOL-COP, V86, P583, DOI 10.1530/acta.0.0860583; LINDHEIM SR, 1994, FERTIL STERIL, V62, P1176; Lobo RA, 2001, FERTIL STERIL, V76, P13, DOI 10.1016/S0015-0282(01)01829-5; LOBO RA, 1994, OBSTET GYNECOL, V84, P987; Manning PJ, 2001, ARCH INTERN MED, V161, P1772, DOI 10.1001/archinte.161.14.1772; Manson J E, 1992, Ann Epidemiol, V2, P665; MATUTE ML, 1973, ENDOCRINOLOGY, V92, P762, DOI 10.1210/endo-92-3-762; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; NABULSI AA, 1993, NEW ENGL J MED, V328, P1069, DOI 10.1056/NEJM199304153281501; NACHTIGALL LE, 1979, OBSTET GYNECOL, V54, P74, DOI 10.1097/00006250-197907000-00017; OSULLIVAN AJ, 1995, J CLIN ENDOCR METAB, V80, P1783, DOI 10.1210/jc.80.6.1783; Perera M, 2001, J CLIN ENDOCR METAB, V86, P1140, DOI 10.1210/jc.86.3.1140; Porte D, 1999, ANN NY ACAD SCI, V892, P73, DOI 10.1111/j.1749-6632.1999.tb07786.x; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Samaras K, 1999, DIABETES CARE, V22, P1401, DOI 10.2337/diacare.22.9.1401; Sargeant LA, 2000, DIABETES-METAB RES, V16, P20, DOI 10.1002/(SICI)1520-7560(200001/02)16:1<20::AID-DMRR76>3.3.CO;2-1; Seed M, 2000, FAM PRACT, V17, P497, DOI 10.1093/fampra/17.6.497; Shaw JA, 1999, DIABETES CARE, V22, P399, DOI 10.2337/diacare.22.3.399; SPELLACY WN, 1972, AM J OBSTET GYNECOL, V114, P378, DOI 10.1016/0002-9378(72)90615-1; STEVENSON JC, 1995, BRIT J CLIN PRACT, V49, P87; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; Troisi RJ, 2000, OBSTET GYNECOL, V96, P665, DOI 10.1097/00006250-200011000-00005; Vaccaro O, 1999, DIABETES CARE, V22, P1490, DOI 10.2337/diacare.22.9.1490; Vehkavaara S, 2000, J CLIN ENDOCR METAB, V85, P4663, DOI 10.1210/jc.85.12.4663; Zhang Y, 2002, DIABETES CARE, V25, P500, DOI 10.2337/diacare.25.3.500; 2002, DIABETES CARE S1, V25, pS21	57	430	446	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					1	9		10.7326/0003-4819-138-1-200301070-00005	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513038				2022-12-28	WOS:000180996200001
J	Dyer, O				Dyer, O			Family finds hospital willing to give experimental CJD treatment	BRITISH MEDICAL JOURNAL			English	News Item																			0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					8	8						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511437				2022-12-28	WOS:000180302000009
J	Laham, RJ; Oettgen, P				Laham, RJ; Oettgen, P			Bone marrow transplantation for the heart: fact or fiction?	LANCET			English	Editorial Material							GENE-TRANSFER; ISCHEMIC MYOCARDIUM; GROWTH-FACTOR; DOUBLE-BLIND; ANGIOGENESIS; ANGIOBLASTS; DISEASE; TRIAL; CELLS		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Angiogenesis Res Ctr,Cardiol Div, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Laham, RJ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Angiogenesis Res Ctr,Cardiol Div, Boston, MA 02215 USA.	rlaham@caregroup.harvard.edu	Oettgen, Peter/AAF-5026-2021					Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Grines CL, 2002, CIRCULATION, V105, P1291, DOI 10.1161/hc1102.105595; Henry TD, 2001, AM HEART J, V142, P872, DOI 10.1067/mhj.2001.118471; Isner JM, 1996, LANCET, V348, P370, DOI 10.1016/S0140-6736(96)03361-2; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laham RJ, 2000, J AM COLL CARDIOL, V36, P2132, DOI 10.1016/S0735-1097(00)00988-8; Laham RJ, 2001, ANNU REV MED, V52, P485, DOI 10.1146/annurev.med.52.1.485; Losordo DW, 2002, CIRCULATION, V105, P2012, DOI 10.1161/01.CIR.0000015982.70785.B7; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Min JY, 2002, ANN THORAC SURG, V74, P1568, DOI 10.1016/S0003-4975(02)03952-8; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407	12	17	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					11	12		10.1016/S0140-6736(03)12186-1	http://dx.doi.org/10.1016/S0140-6736(03)12186-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517456				2022-12-28	WOS:000180191600010
J	Espinel, CH				Espinel, CH			The portrait of breast cancer and Raphael's La Fornarina	LANCET			English	Editorial Material									Blood Pressure Ctr, Washington, DC USA; Georgetown Univ, Dept Med, Arlington, VA 22205 USA; Ctr Clin Bioeth, Arlington, VA 22205 USA	Georgetown University	Espinel, CH (corresponding author), Blood Pressure Ctr, Washington, DC USA.							Arasse D., 2001, RAPHAEL GRACE BEAUTY, P57; ARMELLINI M, 1882, STUDI ITALIA, V4, P62; DEAMUSCO JV, 1560, HIST COMPOSICION CUE; Espinel CH, 1999, LANCET, V354, P2149, DOI 10.1016/S0140-6736(99)09070-4; Espinel CH, 1998, LANCET, V352, P2007, DOI 10.1016/S0140-6736(98)10102-2; Espinel CH, 1997, LANCET, V350, P1835, DOI 10.1016/S0140-6736(97)08504-8; EWING J, 1940, NEOPLASTIC DISEASES, P535; FARABULINI D, 1875, RAFFAELLO URIBINO, P236; GALEN C, 1962, LATER BOOKS; Greco T, 1970, Osp Ital Chir, V22, P141; Haagensen CD, 1986, DIS BREAST, P516; Jones R, 1983, RAPHAEL, P1; ONORI LM, 2001, RAPHAEL GRACE BEAUTY, P69; RICHARDSON J, 1722, ACCOUNT STATUES BASR; Rosenzweig W, 1983, Paleopathol Newsl, V41, P8; VALERI A, 1997, VITA ITALIANA, V3, P353; VASARI G, 1976, VITE PIU ECCELLENTE, V4, P155; VASARI G, 1986, GREAT MASTERS, P127; Vesalius Andreas, 1543, HUMANI CORPORIFABR; WOLFF J, 1987, SCI CANC DIS EARLIES, P3	20	11	12	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2061	2063		10.1016/S0140-6736(02)11997-0	http://dx.doi.org/10.1016/S0140-6736(02)11997-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504417				2022-12-28	WOS:000179974200028
J	Nussbaum, A				Nussbaum, A			Democratic health care for a democratic Kosovo	LANCET			English	Article											Nussbaum, A (corresponding author), 157 Abbots Pk, London SW2 3QZ, England.								0	0	0	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S51	S52		10.1016/S0140-6736(02)11821-6	http://dx.doi.org/10.1016/S0140-6736(02)11821-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504504				2022-12-28	WOS:000180064500025
J	White, F				White, F			Water: life force or instrument of war?	LANCET			English	Article									Aga Khan Univ, Karachi 74800, Pakistan	Aga Khan University	White, F (corresponding author), Aga Khan Univ, Stadium Rd,Box 3500, Karachi 74800, Pakistan.								0	3	3	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S29	S30		10.1016/S0140-6736(02)11810-1	http://dx.doi.org/10.1016/S0140-6736(02)11810-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504493				2022-12-28	WOS:000180064500014
J	Meyer, M; O'Regan, A				Meyer, M; O'Regan, A			Broncholithiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Boston Univ, Sch Med, Boston, MA 02118 USA	Boston University	Meyer, M (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.								0	5	5	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					318	318		10.1056/NEJMicm010103	http://dx.doi.org/10.1056/NEJMicm010103			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540645				2022-12-28	WOS:000180507200007
J	Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S				Vittinghoff, E; Shlipak, MG; Varosy, PD; Furberg, CD; Ireland, CC; Khan, SS; Blumenthal, R; Barrett-Connor, E; Hulley, S		Heart Estrogen Progestin Replaceme	Risk factors and secondary prevention in women with heart disease: The heart and estrogen/progestin replacement study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; HEALTH-CARE PROFESSIONALS; ASSOCIATION TASK-FORCE; RENAL-INSUFFICIENCY; AMERICAN-COLLEGE; POTENTIAL IMPACT; ELDERLY-PATIENTS; SEX-DIFFERENCES; BETA-BLOCKERS; PREDICTORS	Background: Risk factors for coronary heart disease events have most commonly been evaluated in healthy men. Objective: To assess risk factors, event rates, and use of secondary prevention treatments in women with preexisting coronary disease. Design: A prospective cohort of clinical trial participants. Setting: 20 U.S. clinical centers. Participants: 2763 postmenopausal women with known coronary disease in the Heart and Estrogen/progestin Replacement Study (HERS). Measurements: Myocardial infarction or death from coronary heart disease. Results: On multivariable analysis, the researchers found 11 risk factors: 6 noted by history (nonwhite ethnicity, lack of exercise, treated diabetes, angina, congestive heart failure, and more than one previous myocardial infarction) and 5 that were measured (blood pressure, low-density lipoprotein cholesterol level, high-density lipoprotein cholesterol level, lipoprotein(a) level, and creatinine clearance). The annual rate of coronary events was 1.3% (95% Cl, 0.7% to 2.5%) in women with no risk factors and 8.7% (Cl, 7.1% to 10.8%) in women with five or more risk factors (a sixfold increase). At entry into HERS, 83% of participants were receiving aspirin or other antiplatelet agents, 33% were receiving beta-blockers, 18% were receiving angiotensin-converting enzyme inhibitors, and 53% were receiving lipid-lowering drugs. Women with more risk factors were less likely to be taking aspirin (P < 0.001) and lipid-lowering drugs (P = 0.006). Conclusions: Women with coronary disease are at high risk for myocardial infarction or death from coronary heart disease even in the absence of other risk factors, and their risk increases up to sixfold when many risk factors are present. Established drugs for secondary prevention, including. aspirin, beta-blockers, and lipid-lowering agents, are underused in these women, especially those at highest risk.	Univ Calif San Francisco, San Francisco, CA 94105 USA; Vet Affairs Med Ctr, San Francisco, CA 94121 USA; Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; Univ Calif Los Angeles, Los Angeles, CA USA; Johns Hopkins Univ, Baltimore, MD USA; Univ Calif San Diego, San Diego, CA 92103 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Wake Forest University; University of California System; University of California Los Angeles; Johns Hopkins University; University of California System; University of California San Diego	Vittinghoff, E (corresponding author), Univ Calif San Francisco, 74 New Montgomery,Suite 600, San Francisco, CA 94105 USA.		Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Alexander KP, 1998, J AM COLL CARDIOL, V32, P2023, DOI 10.1016/S0735-1097(98)00466-5; Allen JK, 2001, AM J CARDIOL, V87, P1203, DOI 10.1016/S0002-9149(01)01496-5; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; CLARKE KW, 1994, BMJ-BRIT MED J, V309, P563, DOI 10.1136/bmj.309.6954.563; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Denke Margo A., 1999, American Journal of Medicine, V107, p48S; Dries DL, 2000, J AM COLL CARDIOL, V35, P681, DOI 10.1016/S0735-1097(99)00608-7; EPSTEIN SE, 1982, NEW ENGL J MED, V307, P1487, DOI 10.1056/NEJM198212093072404; Fonarow GC, 2001, AM J CARDIOL, V87, P819, DOI 10.1016/S0002-9149(00)01519-8; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Giugliano RP, 1998, ARCH INTERN MED, V158, P1113, DOI 10.1001/archinte.158.10.1113; Gottdiener JS, 2000, J AM COLL CARDIOL, V35, P1628, DOI 10.1016/S0735-1097(00)00582-9; Gottlieb SS, 1998, NEW ENGL J MED, V339, P489, DOI 10.1056/NEJM199808203390801; Grady D, 1998, CONTROL CLIN TRIALS, V19, P314, DOI 10.1016/S0197-2456(98)00010-5; Grundy SM, 1998, CIRCULATION, V97, P1876, DOI 10.1161/01.CIR.97.18.1876; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; HENNING H, 1979, CIRCULATION, V59, P1124, DOI 10.1161/01.CIR.59.6.1124; Herrington DM, 1998, AM HEART J, V136, P115, DOI 10.1016/S0002-8703(98)70191-7; Hulley S, 1999, JAMA-J AM MED ASSOC, V281, P796; HULLEY S, 1998, JAMA-J AM MED ASSOC, V280, P608; KANNEL WB, 1990, J HYPERTENS, V8, pS3; KRONMAL RA, 1993, ARCH INTERN MED, V153, P1065, DOI 10.1001/archinte.153.9.1065; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manolio T A, 1992, Ann Epidemiol, V2, P161, DOI 10.1016/1047-2797(92)90051-Q; MANSON JE, 1996, PREVENTION MYOCARDIO; McCormick D, 1999, ARCH INTERN MED, V159, P561, DOI 10.1001/archinte.159.6.561; Mosca L, 1997, CIRCULATION, V96, P2468; MOSS AJ, 1977, AM J CARDIOL, V39, P635, DOI 10.1016/S0002-9149(77)80122-7; OROURKE RA, 1991, CIRCULATION, V84, pI177; Psaty BM, 1999, ARCH INTERN MED, V159, P1339, DOI 10.1001/archinte.159.12.1339; Ryan TJ, 1999, CIRCULATION, V100, P1016, DOI 10.1161/01.CIR.100.9.1016; SCHLANT RC, 1982, CIRCULATION, V66, P401, DOI 10.1161/01.CIR.66.2.401; Schrott HG, 1997, JAMA-J AM MED ASSOC, V277, P1281, DOI 10.1001/jama.277.16.1281; Schwartz LM, 1997, ARCH INTERN MED, V157, P1545, DOI 10.1001/archinte.157.14.1545; Shlipak MG, 2000, JAMA-J AM MED ASSOC, V283, P1845, DOI 10.1001/jama.283.14.1845; Shlipak MG, 2001, LANCET, V357, P717, DOI 10.1016/S0140-6736(05)71473-2; Shlipak MG, 2001, J AM COLL CARDIOL, V38, P705, DOI 10.1016/S0735-1097(01)01450-4; SHULMAN N B, 1989, Hypertension (Dallas), V13, pI80; SIEGEL D, 1988, ANN INTERN MED, V109, P213, DOI 10.7326/0003-4819-109-3-213; Vaccarino V, 2001, ANN INTERN MED, V134, P173, DOI 10.7326/0003-4819-134-3-200102060-00007; Wang TJ, 1998, ARCH INTERN MED, V158, P1901, DOI 10.1001/archinte.158.17.1901; WILLETT WC, 1987, NEW ENGL J MED, V317, P1303, DOI 10.1056/NEJM198711193172102; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; 1974, J CHRONIC DIS, V27, P267	46	74	80	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					81	89		10.7326/0003-4819-138-2-200301210-00007	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529088				2022-12-28	WOS:000181018300001
J	Irwin, ML; Yasui, Y; Ulrich, CM; Bowen, D; Rudolph, RE; Schwartz, RS; Yukawa, M; Aiello, E; Potter, JD; MeTiernan, A				Irwin, ML; Yasui, Y; Ulrich, CM; Bowen, D; Rudolph, RE; Schwartz, RS; Yukawa, M; Aiello, E; Potter, JD; MeTiernan, A			Effect of exercise on total and intra-abdominal body fat in postmenopausal women - A Randomized controlled trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ADIPOSE-TISSUE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; OVERWEIGHT; INSULIN; RISK; QUESTIONNAIRE; ADULTS	Context The increasing prevalence of obesity is a major public health concern. Physical activity may promote weight and body fat loss. Objective To examine the effects of exercise on total and intra-abdominal body fat overall and by level of exercise. Design Randomized controlled trial conducted from 1997 to 2001. Setting and Participants A total of 173 sedentary, overweight (body mass index greater than or equal to24.0 and >33% body fat), postmenopausal women aged 50 to 75 years who were living in the Seattle, Wash, area. Intervention Participants were randomly assigned to an intervention consisting of exercise facility and home-based moderate-intensity exercise (n = 87) or a stretching control group (n = 86). Main Outcome Measure Changes in body weight and waist and hip circumferences at 3 and 12 months; total body, intra-abdominal, and subcutaneous abdominal fat at 12 months. Results Twelve-month data were available for 168 women. Women in the exercise group participated in moderate-intensity sports/recreational activity for a mean (SD) of 3.5 (1.2) d/wk for 176 (91) min/wk. Walking was the most frequently reported activity. Exercisers showed statistically significant differences from controls in baseline to 12-month changes in body weight (-1.4 kg; 95% confidence interval [CI], -2.5 to -0.3 kg), total body fat (1.0%; 95% CI, -1.6% to -0.4%), intra-abdominal fat (-8.6 g/cm(2); 95% CI, -17.8 to 0.9 g/cm(2)), and subcutaneous abdominal fat (-28.8 g/cm(2); 95% CI, -47.5 to-10.0 g/cm(2)). A significant dose response for greater body fat loss was observed with increasing duration of exercise. Conclusions Regular exercise such as brisk walking results in reduced body weight and body fat among overweight and obese postmenopausal women.	Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, Seattle, WA 98109 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Internal Med, Seattle, WA 98195 USA; Univ Colorado, Hlth Sci Ctr, Dept Internal Med, Div Geriatr Med, Denver, CO USA	Fred Hutchinson Cancer Center; Yale University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	MeTiernan, A (corresponding author), Fred Hutchinson Canc Res Ctr, Canc Prevent Res Program, 1100 Fairview Ave N,MP-900, Seattle, WA 98109 USA.		Yasui, Yutaka/E-2564-2015	Yasui, Yutaka/0000-0002-7717-8638; Bowen, Deborah/0000-0002-5177-8520; Potter, John/0000-0001-5439-1500	NCI NIH HHS [T32 CA09661] Funding Source: Medline; NCRR NIH HHS [M01-RR-00037] Funding Source: Medline; NIA NIH HHS [AG1094] Funding Source: Medline; PHS HHS [R01-69334] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009661] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000037] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Asikainen TM, 2002, SCAND J MED SCI SPOR, V12, P99, DOI 10.1034/j.1600-0838.2002.120206.x; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; DATTILO AM, 1992, AM J CLIN NUTR, V56, P320, DOI 10.1093/ajcn/56.2.320; DiPietro L, 1998, J AM GERIATR SOC, V46, P875, DOI 10.1111/j.1532-5415.1998.tb02722.x; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; HARRIS M, 1979, DIABETES, V28, P1039; Huang ZP, 1997, JAMA-J AM MED ASSOC, V278, P1407, DOI 10.1001/jama.278.17.1407; Jakicic JM, 2001, MED SCI SPORT EXER, V33, P2145, DOI 10.1097/00005768-200112000-00026; KEIM NL, 1990, METABOLISM, V39, P651, DOI 10.1016/0026-0495(90)90035-B; KERN PA, 1989, DIABETES, V38, P710, DOI 10.2337/diabetes.38.6.710; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; MACMAHON S, 1987, EUR HEART J, V8, P57, DOI 10.1093/eurheartj/8.suppl_B.57; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; MATSUZAWA Y, 1995, OBES RES, V3, pS187, DOI 10.1002/j.1550-8528.1995.tb00462.x; McTiernan A, 1999, MED SCI SPORT EXER, V31, P1307, DOI 10.1097/00005768-199909000-00012; Mourier A, 1997, DIABETES CARE, V20, P385, DOI 10.2337/diacare.20.3.385; Pate R, 1991, GUIDELINES EXERCISE, P70; Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; PISUNYER FX, 1991, AM J CLIN NUTR, V53, pS1595; Pronk N P, 1994, Obes Res, V2, P587; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Rexrode KM, 1997, JAMA-J AM MED ASSOC, V277, P1539, DOI 10.1001/jama.277.19.1539; Ross R, 1996, DIABETES CARE, V19, P1404, DOI 10.2337/diacare.19.12.1404; Taniguchi A, 2002, METABOLISM, V51, P544, DOI 10.1053/meta.2002.31984; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tworoger SS, 2002, CANCER EPIDEM BIOMAR, V11, P73; U.S. Department of Health and Human Services, 1996, PHYS ACT HLTH REP SU; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	343	354	0	23	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					323	330		10.1001/jama.289.3.323	http://dx.doi.org/10.1001/jama.289.3.323			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525233	Bronze			2022-12-28	WOS:000180345100027
J	Dare, L				Dare, L			WHO and the challenges of the next decade	LANCET			English	Article									African Council Sustainable Hlth Dev, Ibadan, Oyo State, Nigeria		Dare, L (corresponding author), African Council Sustainable Hlth Dev, 29 Aare Ave,New Bodija Estate,UIPO Box 21633, Ibadan, Oyo State, Nigeria.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					170	171		10.1016/S0140-6736(03)12196-4	http://dx.doi.org/10.1016/S0140-6736(03)12196-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531596				2022-12-28	WOS:000180428000027
J	Murchie, P; Campbell, NC; Ritchie, LD; Simpson, JA; Thain, J				Murchie, P; Campbell, NC; Ritchie, LD; Simpson, JA; Thain, J			Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care	BRITISH MEDICAL JOURNAL			English	Article							HIGH CARDIOVASCULAR RISK; GENERAL-PRACTICE; HEALTH PROMOTION	Objectives To evaluate the effects of nurse led clinics in primary care on secondary prevention, total mortality, and coronary event rates after four years. Design Follow up of a randomised controlled trial by postal questionnaires and review of case notes and national datasets. Setting Stratified, random sample of 19 general practices in north east Scotland. Participants 1343 patients (673 intervention and 670 control) under 80 years with a working diagnosis of coronary heart disease but without terminal illness or dementia and not housebound. Intervention Nurse led secondary prevention clinics promoted medical and lifestyle components of secondary prevention and offered regular follow up for one year. Main outcome measures Components of secondary prevention (aspirin, blood pressure management, lipid management; healthy diet, exercise, non-smoking), total mortality, and coronary events (non-fatal myocardial infarctions and coronary deaths). Results Mean follow up was at 4.7 years. Significant improvements were shown in the intervention group in all components of secondary prevention except smoking at one year, and these were sustained after four years except for exercise. The control group, most of whom attended clinics after the initial year, caught up before final follow up, and differences between groups were no longer significant. At 4.7 years, 100 patients in the intervention group and 128 in the control group had died: cumulative death rates were 14.5% and 18.9%, respectively (P=0.038). 100 coronary events occurred in the intervention group and 125 in the control group: cumulative event rates were 14.2% and 18.2%, respectively (P=0.052). Adjusting for age, sex, general practice, and baseline secondary prevention, proportional hazard ratios, were 0.75 for all deaths (95% confidence intervals 0.58 to 0.98; P=0.036) and 0.76 for coronary events (0.58 to 1.00; P=0.049) Conclusions Nurse led secondary prevention improved medical and lifestyle components of secondary prevention and this seemed to lead to significantly fewer total deaths and probably fewer coronary events. Secondary prevention clinics should be started sooner rather than later.	Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland; Westburn Ctr, Aberdeen AB25 2XG, Scotland	University of Aberdeen; University of Aberdeen	Murchie, P (corresponding author), Univ Aberdeen, Dept Gen Practice & Primary Care, Foresterhill Hlth Ctr, Aberdeen AB25 2AY, Scotland.		Simpson, Julie A/P-7299-2014	Murchie, Peter/0000-0001-9968-5991; Simpson, Julie/0000-0002-2660-2013				Bain N S, 1997, Health Bull (Edinb), V55, P94; Berkman LF, 1983, HLTH WAYS LIVING ALA; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1430, DOI 10.1136/bmj.316.7142.1430; Campbell NC, 1998, HEART, V80, P447, DOI 10.1136/hrt.80.5.447; Campbell NC, 1998, BMJ-BRIT MED J, V316, P1434, DOI 10.1136/bmj.316.7142.1434; CAMPBELL NC, 2001, THESIS U CAMBRIDGE; CUPPLES ME, 1994, BRIT MED J, V309, P993, DOI 10.1136/bmj.309.6960.993; Cupples ME, 1999, BMJ-BRIT MED J, V319, P687, DOI 10.1136/bmj.319.7211.687; *DEP HLTH, 2000, NAT SERV FRAM COR HE; Jolly K, 1999, BMJ-BRIT MED J, V318, P706; Kotseva K, 2001, EUR HEART J, V22, P554, DOI 10.1053/euhj.2001.2610; McAlister FA, 2001, BRIT MED J, V323, P957, DOI 10.1136/bmj.323.7319.957; MILLS JK, 1999, ACP J CLUB       MAY; Moher M, 2001, BMJ-BRIT MED J, V322, P1338, DOI 10.1136/bmj.322.7298.1338; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; *SCOTT INT GUID NE, 2001, SIGN GUID NUMB 51 MA; SEVER P, 1993, BMJ-BRIT MED J, V306, P983, DOI 10.1136/bmj.306.6883.983; van der Weijden T, 1998, BMJ-BRIT MED J, V316, P1400, DOI 10.1136/bmj.316.7142.1400; WOODEND AK, 1999, EVIDENCE BASED NURS, V2, P21	19	166	167	1	10	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					84	+		10.1136/bmj.326.7380.84	http://dx.doi.org/10.1136/bmj.326.7380.84			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521974	Green Published, Bronze			2022-12-28	WOS:000180426900018
J	Caldecott, KW				Caldecott, KW			DNA single-strand break repair and spinocerebellar ataxia	CELL			English	Review							DAMAGE; GENE; PHOSPHODIESTERASE; SUPERFAMILY; PATHWAYS; MUTATION; TDP1	DNA single-strand break repair (SSBR) is critical for the survival and genetic stability of mammalian cells. Three papers have recently associated mutations in putative human SSBR genes with hereditary spinocerebellar ataxia. The emerging links between SSBR and neurodegenerative disorders are discussed.	Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England	University of Sussex	Caldecott, KW (corresponding author), Univ Sussex, Genome Damage & Stabil Ctr, Sci Pk Rd, Brighton BN1 9RQ, E Sussex, England.	k.w.caldecott@sussex.ac.uk	Caldecott, Keith/S-4245-2019	Caldecott, Keith/0000-0003-4255-9016	Medical Research Council [G0001259] Funding Source: Medline; MRC [G0001259] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barnes DE, 2002, CURR BIOL, V12, pR262, DOI 10.1016/S0960-9822(02)00788-1; Barrows LR, 1998, MUTAT RES-DNA REPAIR, V408, P103, DOI 10.1016/S0921-8777(98)00022-6; Brenner C, 2002, BIOCHEMISTRY-US, V41, P9003, DOI 10.1021/bi025942q; Caldecott KW, 2001, BIOESSAYS, V23, P447, DOI 10.1002/bies.1063; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Inamdar KV, 2002, J BIOL CHEM, V277, P27162, DOI 10.1074/jbc.M204688200; Karanjawala ZE, 2002, CURR BIOL, V12, P397, DOI 10.1016/S0960-9822(02)00684-X; LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031; Moore DJ, 2000, P NATL ACAD SCI USA, V97, P13649, DOI 10.1073/pnas.250477597; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Park SY, 2002, CANCER RES, V62, P459; Pouliot JJ, 1999, SCIENCE, V286, P552, DOI 10.1126/science.286.5439.552; Pouliot JJ, 2001, GENES CELLS, V6, P677, DOI 10.1046/j.1365-2443.2001.00452.x; Rolig RL, 2000, TRENDS NEUROSCI, V23, P417, DOI 10.1016/S0166-2236(00)01625-8; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Vance JR, 2002, P NATL ACAD SCI USA, V99, P13669, DOI 10.1073/pnas.202242599; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176	20	107	117	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					7	10		10.1016/S0092-8674(02)01247-3	http://dx.doi.org/10.1016/S0092-8674(02)01247-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526788	Bronze			2022-12-28	WOS:000181191500001
J	Gamwell, L				Gamwell, L			Perceptions of science - Beyond the visible - Microscopy, nature, and art	SCIENCE			English	Editorial Material									New York Acad, Gallery Art & Sci, New York, NY 10021 USA		Gamwell, L (corresponding author), New York Acad, Gallery Art & Sci, 2 E 63rd St, New York, NY 10021 USA.							Binet R, 1902, ESQUISSES DECORATIVE; Ehrenberg C. G., 1838, INFUSIONSTIERCHEN AL; Gamwell L, 2002, EXPLORING INVISIBLE; MELLERIO A, 1923, ODILON REDON PEINTRE, P155; REDON, 1922, SOIMEME, P19	5	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					49	50		10.1126/science.1077971	http://dx.doi.org/10.1126/science.1077971			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511631				2022-12-28	WOS:000180165800021
J	Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J				Hayflick, SJ; Westaway, SK; Levinson, B; Zhou, B; Johnson, MA; Ching, KHL; Gitschier, J			Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DISEASE	Background: Hallervorden-Spatz syndrome is an autosomal recessive disorder characterized by dystonia, parkinsonism, and iron accumulation in the brain. Many patients with this disease have mutations in the gene encoding pantothenate kinase 2 (PANK2); these patients are said to have pantothenate kinase-associated neurodegeneration. In this study, we compared the clinical and radiographic features of patients with Hallervorden-Spatz syndrome with and without mutations in PANK2. Methods: One hundred twenty-three patients from 98 families with a diagnosis of Hallervorden-Spatz syndrome were classified on the basis of clinical assessment as having classic disease (characterized by early onset with rapid progression) or atypical disease (later onset with slow progression). Their genomic DNA was sequenced for PANK2 mutations. Results: All patients with classic Hallervorden-Spatz syndrome and one third of those with atypical disease had PANK2 mutations. Whereas almost all mutations in patients with atypical disease led to amino acid changes, those in patients with classic disease more often resulted in predicted protein truncation. Patients with atypical disease who had PANK2 mutations were more likely to have prominent speech-related and psychiatric symptoms than patients with classic disease or mutation-negative patients with atypical disease. In all patients with pantothenate kinase-associated neurodegeneration, whether classic or atypical, T(sub 2)-weighted magnetic resonance imaging (MRI) of the brain showed a specific pattern of hyperintensity within the hypointense medial globus pallidus. This pattern was not seen in any patients without mutations. Conclusions: PANK2 mutations are associated with all cases of classic Hallervorden-Spatz syndrome and one third of cases of atypical disease. A specific MRI pattern distinguishes patients with PANK2 mutations. Predicted levels of pantothenate kinase 2 protein correlate with the severity of disease.	Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Pediat, Portland, OR 97201 USA; Oregon Hlth Sci Univ, Sch Med, Dept Neurol, Portland, OR 97201 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Hayflick, SJ (corresponding author), Oregon Hlth Sci Univ, Dept Mol & Med Genet, Sch Med, 3181 SW Sam Jackson Pk Rd,Mailcode L-103A, Portland, OR 97201 USA.				NEI NIH HHS [R01 EY012353] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ching KHL, 2002, NEUROLOGY, V58, P1673, DOI 10.1212/WNL.58.11.1673; COPPETO JR, 1990, NEUROLOGY, V40, P1359, DOI 10.1212/WNL.40.9.1359; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DOOLING EC, 1974, ARCH NEUROL-CHICAGO, V30, P70, DOI 10.1001/archneur.1974.00490310072012; Gitlin JD, 1998, PEDIATR RES, V44, P271, DOI 10.1203/00006450-199809000-00001; Guimaraes J, 1999, EUR J NEUROL, V6, P509, DOI 10.1046/j.1468-1331.1999.640509.x; Hallervorden J, 1922, Z GESAMTE NEUROL PSY, V79, P254, DOI 10.1007/BF02878455; HALLERVORDEN J, 1924, DTSCH Z NERVENHEILK, V81, P204; Halliday W, 1995, J NEUROL SCI, V134, P84, DOI 10.1016/0022-510X(95)00212-K; Hickman SJ, 2001, ACTA NEUROL SCAND, V103, P201, DOI 10.1034/j.1600-0404.2001.103003201.x; JANKOVIC J, 1985, NEUROLOGY, V35, P227, DOI 10.1212/WNL.35.2.227; LUCKENBACH MW, 1983, AM J OPHTHALMOL, V95, P369, DOI 10.1016/S0002-9394(14)78308-4; MORPHY MA, 1989, J CLIN PSYCHIAT, V50, P66; NARDOCCI N, 1994, MOVEMENT DISORD, V9, P369, DOI 10.1002/mds.870090322; ROTH AM, 1971, SURV OPHTHALMOL, V16, P24; SETHI KD, 1988, ANN NEUROL, V24, P692, DOI 10.1002/ana.410240519; SHEVELL M, 1992, NEUROLOGY, V42, P2214, DOI 10.1212/WNL.42.11.2214; SWAIMAN KF, 1991, ARCH NEUROL-CHICAGO, V48, P1285, DOI 10.1001/archneur.1991.00530240091029; SWISHER CN, 1972, T AM NEUROL ASSOC, V97, P212; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	20	464	491	0	10	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					33	40		10.1056/NEJMoa020817	http://dx.doi.org/10.1056/NEJMoa020817			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510040				2022-12-28	WOS:000180134400005
J	Miller, DH; Khan, OA; Sheremata, WA; Blumhardt, LD; Rice, GPA; Libonati, MA; Willmer-Hulme, AJ; Dalton, CM; Miszkiel, KA; O'Connor, PW				Miller, DH; Khan, OA; Sheremata, WA; Blumhardt, LD; Rice, GPA; Libonati, MA; Willmer-Hulme, AJ; Dalton, CM; Miszkiel, KA; O'Connor, PW		Int Natalizumab Multiple Sclerosis	A controlled trial of natalizumab for relapsing multiple sclerosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DOUBLE-BLIND; MONOCLONAL-ANTIBODY; ADHESION MOLECULES; CLINICAL COURSE; INTEGRIN; ENCEPHALOMYELITIS; MULTICENTER; DISABILITY; MRI	Background: In patients with multiple sclerosis, inflammatory brain lesions appear to arise from autoimmune responses involving activated lymphocytes and monocytes. The glycoprotein (alpha)(sub 4) integrin is expressed on the surface of these cells and plays a critical part in their adhesion to the vascular endothelium and migration into the parenchyma. Natalizumab is an (alpha)(sub 4) integrin antagonist that reduced the development of brain lesions in experimental models and in a preliminary study of patients with multiple sclerosis. Methods: In a randomized, double-blind trial, we randomly assigned a total of 213 patients with relapsing-remitting or relapsing secondary progressive multiple sclerosis to receive 3 mg of intravenous natalizumab per kilogram of body weight (68 patients), 6 mg per kilogram (74 patients), or placebo (71 patients) every 28 days for 6 months. The primary end point was the number of new brain lesions on monthly gadolinium-enhanced magnetic resonance imaging during the six-month treatment period. Clinical outcomes included relapses and self-reported well-being. Results: There were marked reductions in the mean number of new lesions in both natalizumab groups: 9.6 per patient in the placebo group, as compared with 0.7 in the group given 3 mg of natalizumab per kilogram (P<0.001) and 1.1 in the group given 6 mg of natalizumab per kilogram (P<0.001). Twenty-seven patients in the placebo group had relapses, as compared with 13 in the group given 3 mg of natalizumab per kilogram (P=0.02) and 14 in the group given 6 mg of natalizumab per kilogram (P=0.02). The placebo group reported a slight worsening in well-being (a mean decrease of 1.38 mm on a 100-mm visual-analogue scale), whereas the natalizumab groups reported an improvement (mean increase of 9.49 mm in the group given 3 mg of natalizumab per kilogram and 6.21 mm in the group given 6 mg of natalizumab per kilogram). Conclusions: In a placebo-controlled trial, treatment with natalizumab led to fewer inflammatory brain lesions and fewer relapses over a six-month period in patients with relapsing multiple sclerosis.	Inst Neurol, Dept Neuroinflammat, London WC1N 3BG, England; Wayne State Univ, Sch Med, Detroit, MI USA; Univ Miami, Sch Med, Miami, FL USA; Univ Hosp, Nottingham, England; London Multiple Sclerosis Clin, London, ON, Canada; Elan Pharmaceut, San Francisco, CA USA; Univ Toronto, St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of London; University College London; Wayne State University; University of Miami; Nottingham University Hospital NHS Trust; University of Nottingham; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Miller, DH (corresponding author), Inst Neurol, Dept Neuroinflammat, Queen Sq, London WC1N 3BG, England.		Calabrese, Massimiliano/I-6195-2012; Macedo, Ana/L-9912-2018	Macedo, Ana/0000-0002-6978-8989	Multiple Sclerosis Society [491] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		ADAMS C, 1989, COLOUR ATLAS MULTIPL; BARKHOF F, 1992, AM J NEURORADIOL, V13, P1257; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Comi G, 2001, ANN NEUROL, V49, P290, DOI 10.1002/ana.64.abs; COMPSTON DA, 1998, MCALPINES MULTIPLE S; DUQUETTE P, 1995, NEUROLOGY, V45, P1277; Ebers GC, 1998, LANCET, V352, P1498, DOI 10.1016/S0140-6736(98)03334-0; Frenette PS, 1996, NEW ENGL J MED, V335, P43, DOI 10.1056/NEJM199607043350108; Frenette PS, 1996, NEW ENGL J MED, V334, P1526, DOI 10.1056/NEJM199606063342308; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Grimaud J, 1996, MAGN RESON IMAGING, V14, P495, DOI 10.1016/0730-725X(96)00018-5; HARRIS JO, 1991, ANN NEUROL, V29, P548, DOI 10.1002/ana.410290515; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Jacobs LD, 1996, ANN NEUROL, V40, P480; JOHNSON KP, 1995, NEUROLOGY, V45, P1268, DOI 10.1212/WNL.45.7.1268; KENT SJ, 1995, J NEUROIMMUNOL, V58, P1, DOI 10.1016/0165-5728(94)00165-K; KENT SJ, 1994, P INT SOC MAGN RESON, V3, P1400; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Li DKB, 1999, ANN NEUROL, V46, P197, DOI 10.1002/1531-8249(199908)46:2<197::AID-ANA9>3.0.CO;2-P; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; NOETHER GE, 1987, J AM STAT ASSOC, V82, P645, DOI 10.2307/2289477; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; *PREV REL DIS INF, 1999, LANCET, V353, P678; THOMPSON AJ, 1992, NEUROLOGY, V42, P60, DOI 10.1212/WNL.42.1.60; THOMPSON AJ, 1991, ANN NEUROL, V29, P53, DOI 10.1002/ana.410290111; Tubridy N, 1999, NEUROLOGY, V53, P466, DOI 10.1212/WNL.53.3.466; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	27	951	1008	0	35	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					15	23		10.1056/NEJMoa020696	http://dx.doi.org/10.1056/NEJMoa020696			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510038	Green Published			2022-12-28	WOS:000180134400003
J	Kessler, MA; Werner, BT				Kessler, MA; Werner, BT			Self-organization of sorted patterned ground	SCIENCE			English	Article							FROZEN SOIL; MODEL	Striking circular, labyrinthine, polygonal, and striped patterns of stones and soil self-organize in many polar and high alpine environments. These forms emerge because freeze-thaw cycles drive an interplay between two feedback mechanisms. First, formation of ice lenses in freezing soil sorts stones and soil by displacing soil toward soil-rich domains and stones toward stone-rich domains. Second, stones are transported along the axis of elongate stone domains, which are squeezed and confined as freezing soil domains expand. In a numerical model implementing these feedbacks, circles, labyrinths, and islands form when sorting dominates; polygonal networks form when stone domain squeezing and confinement dominate; and stripes form as hillslope gradient is increased.	Univ Calif San Diego, Cecil & Ida Green Inst Geophys & Planetary Phys, Complex Syst Lab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Kessler, MA (corresponding author), Univ Calif Santa Cruz, Dept Earth Sci, Santa Cruz, CA 95064 USA.							Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; AHNERT F, 1981, T JAP GEOMORPH UN, V2, P301; ANDERSON SP, 1988, GEOL SOC AM BULL, V100, P609, DOI 10.1130/0016-7606(1988)100<0609:TUPEWA>2.3.CO;2; Cook F.A., 1955, ARCTIC, V8, P237, DOI [10.14430/arctic3822, DOI 10.14430/ARCTIC3822]; Corte A.E., 1966, B PERYGLAC, V15, P175; Elias F, 1997, PHYS REV E, V56, P3310, DOI 10.1103/PhysRevE.56.3310; FOWLER AC, 1994, SIAM J APPL MATH, V54, P1650, DOI 10.1137/S0036139993252554; GLEASON KJ, 1986, SCIENCE, V232, P216, DOI 10.1126/science.232.4747.216; GOLDTHWAIT RP, 1976, QUATERNARY RES, V6, P27, DOI 10.1016/0033-5894(76)90038-7; HALLET B, 1990, CAN J PHYS, V68, P842, DOI 10.1139/p90-122; Huxley JS, 1924, GEOGR J, V63, P207, DOI 10.2307/1780934; Kessler MA, 2001, J GEOPHYS RES-SOL EA, V106, P13287, DOI 10.1029/2001JB000279; Li N, 2000, COLD REG SCI TECHNOL, V31, P199, DOI 10.1016/S0165-232X(00)00013-6; Matsuoka N, 2001, EARTH-SCI REV, V55, P107, DOI 10.1016/S0012-8252(01)00057-5; MURRAY AB, 1994, NATURE, V371, P54, DOI 10.1038/371054a0; NICHOLSON FH, 1976, ARCTIC ALPINE RES, V8, P329, DOI 10.2307/1550437; Nicolis G, 1977, SELF ORG NONEQUILIBR; RAY RJ, 1983, J GLACIOL, V29, P317, DOI 10.3189/S0022143000008376; Rohani P, 1997, TRENDS ECOL EVOL, V12, P70, DOI 10.1016/S0169-5347(96)20103-X; Schmertmann J., 1965, QUANTITATIVE DATA PA; Stolum HH, 1996, SCIENCE, V271, P1710, DOI 10.1126/science.271.5256.1710; Taber S, 1929, J GEOL, V37, P428, DOI 10.1086/623637; WASHBURN AL, 1956, GEOL SOC AM BULL, V67, P823, DOI 10.1130/0016-7606(1956)67[823:COPGAR]2.0.CO;2; WASHBURN AL, 1997, PLUGS PLUG CIRCLES B; WEAIRE D, 1984, CONTEMP PHYS, V25, P59, DOI 10.1080/00107518408210979; WERNER BT, 1993, SCIENCE, V260, P968, DOI 10.1126/science.260.5110.968; WERNER BT, 1995, GEOLOGY, V23, P1107, DOI 10.1130/0091-7613(1995)023<1107:EDCSAA>2.3.CO;2; WERNER BT, 1993, NATURE, V361, P142, DOI 10.1038/361142a0	28	218	219	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					380	383		10.1126/science.1077309	http://dx.doi.org/10.1126/science.1077309			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532013				2022-12-28	WOS:000180426800041
J	Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL				Kash, TL; Jenkins, A; Kelley, JC; Trudell, JR; Harrison, NL			Coupling of agonist binding to channel gating in the GABA(A) receptor	NATURE			English	Article							ACETYLCHOLINE-RECEPTOR; MUTATIONS; SUBUNIT; AFFINITY; SITE; PORE; M2	Neurotransmitters such as acetylcholine and GABA (gamma-aminobutyric acid) mediate rapid synaptic transmission by activating receptors belonging to the gene superfamily of ligand-gated ion channels (LGICs)(1). These channels are pentameric proteins that function as signal transducers, converting chemical messages into electrical signals(2). Neurotransmitters activate LGICs by interacting with a ligand-binding site(3-7), triggering a conformational change in the protein that results in the opening of an ion channel(8). This process, which is known as 'gating', occurs rapidly and reversibly, but the molecular rearrangements involved are not well understood(9). Here we show that optimal gating in the GABA(A) receptor, a member of the LGIC superfamily, is dependent on electrostatic interactions between the negatively charged Asp 57 and Asp 149 residues in extracellular loops 2 and 7, and the positively charged Lys 279 residue in the transmembrane 2-3 linker region of the alpha(1)-subunit. During gating, Asp 149 and Lys 279 seem to move closer to one another, providing a potential mechanism for the coupling of ligand binding to opening of the ion channel.	Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Anesthesiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; Stanford Univ, Dept Anesthesia, Stanford, CA 94305 USA; Stanford Univ, Beckman Program Mol & Genet Med, Stanford, CA 94305 USA	Cornell University; Cornell University; Cornell University; Stanford University; Stanford University	Harrison, NL (corresponding author), Cornell Univ, Weill Grad Sch Biomed Sci, Grad Program Neurosci, New York, NY 10021 USA.	neh2001@med.cornell.edu	Jenkins, Andrew/E-1180-2011; Kash, Thomas/G-9625-2013					Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; Bera AK, 2002, J BIOL CHEM, V277, P43002, DOI 10.1074/jbc.M206321200; Bertaccini E, 2002, PROTEIN ENG, V15, P443, DOI 10.1093/protein/15.6.443; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; Boileau AJ, 1999, J NEUROSCI, V19, P4847; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Croxen R, 1997, HUM MOL GENET, V6, P767, DOI 10.1093/hmg/6.5.767; DIPAOLA M, 1989, J BIOL CHEM, V264, P15457; Dougherty DA, 2001, NATURE, V411, P252, DOI 10.1038/35077192; Ebert B, 1997, MOL PHARMACOL, V52, P1150, DOI 10.1124/mol.52.6.1150; Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Horenstein J, 2001, NAT NEUROSCI, V4, P477, DOI 10.1038/87425; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Nishikawa K, 2002, NEUROPHARMACOLOGY, V42, P337, DOI 10.1016/S0028-3908(01)00189-7; O'Shea SM, 2000, J BIOL CHEM, V275, P22764, DOI 10.1074/jbc.M001299200; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; SHIANG R, 1993, NAT GENET, V5, P351, DOI 10.1038/ng1293-351; Sigel E, 1999, J NEUROCHEM, V73, P1758, DOI 10.1046/j.1471-4159.1999.731758.x; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Steinbach JH, 2001, J PHYSIOL-LONDON, V537, P715; THORNTON JM, 1981, J MOL BIOL, V151, P261, DOI 10.1016/0022-2836(81)90515-5; Trudell JR, 2002, BBA-BIOMEMBRANES, V1565, P91, DOI 10.1016/S0005-2736(02)00512-6; Trudell JR, 2002, BRIT J ANAESTH, V89, P32, DOI 10.1093/bja/aef157; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9	28	266	271	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					272	275		10.1038/nature01280	http://dx.doi.org/10.1038/nature01280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529644				2022-12-28	WOS:000180397600048
J	Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F				Bischoff, FZ; Hahn, S; Johnson, KL; Simpson, JL; Bianchi, DW; Lewis, DE; Weber, WD; Klinger, K; Elias, S; Jackson, LG; Evans, MI; Holzgreve, W; de la Cruz, F			Intact fetal cells in maternal plasma: are they really there?	LANCET			English	Article							PRENATAL DETECTION; DOWNS-SYNDROME	Rare fetal cells can be recovered from maternal blood, which suggests that non-invasive prenatal diagnosis is possible. However, recovery and analysis of fetal cells from blood is complex, and sensitivity is low because of the rarity of these cells in the maternal circulation. An alternative strategy, which suggested that intact fetal cells can be found in maternal plasma by use of simple enrichment methods, has been reported. We aimed to replicate this technique. However, five independent laboratories were unable to identify any intact male cells from the plasma of 38 women known to be carrying male fetuses. Although apoptotic intact fetal cells could contribute to the detection of fetal DNA in maternal plasma, we believe that recovery of these cells is difficult and not clinically practical.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Basel, Dept Obstet & Gynecol, CH-4003 Basel, Switzerland; Tufts Univ, Sch Med, Dept Pediat Obstet & Gynecol, Div Genet, Boston, MA 02111 USA; Genzyme Genet, Framingham, MA USA; Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA; Med Coll Penn & Hahnemann Univ, Dept Obstet & Gynecol, Philadelphia, PA USA; NICHHD, Mental Retardat Res Branch, Bethesda, MD 20892 USA	Baylor College of Medicine; Baylor College of Medicine; University of Basel; Tufts University; Sanofi-Aventis; Genzyme Corporation; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Drexel University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Bischoff, FZ (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, 6550 Fannin St,Suite 885, Houston, TX 77030 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD043204, N01HD043201, N01HD043202, N01HD043203] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-4-3201, N01-HD-4-3202, N01-HD-4-3204, N01-HD-4-3203] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bianchi DW, 2002, PRENATAL DIAG, V22, P609, DOI 10.1002/pd.347; Choolani M, 2001, LANCET, V357, P958, DOI 10.1016/S0140-6736(05)71658-5; Pertl B, 1999, SEMIN PERINATOL, V23, P393, DOI 10.1016/S0146-0005(99)80005-6; Poon LLM, 2000, LANCET, V356, P1819, DOI 10.1016/S0140-6736(00)03237-2; van Wijk IJ, 2000, CLIN CHEM, V46, P729	5	29	44	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					139	140		10.1016/S0140-6736(03)12191-5	http://dx.doi.org/10.1016/S0140-6736(03)12191-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531583				2022-12-28	WOS:000180428000015
J	Boamfa, MI; Kim, MW; Maan, JC; Rasing, T				Boamfa, MI; Kim, MW; Maan, JC; Rasing, T			Observation of surface and bulk phase transitions in nematic liquid crystals	NATURE			English	Article							ISOTROPIC-PHASE; LAYER; DEPENDENCE; ORDER	The behaviour of liquid crystal (LC) molecules near a surface is of both fundamental and technological interest: it gives rise to various surface phase-transition and wetting phenomena(1-14), and surface-induced ordering of the LC molecules is integral to the operation of LC displays(15,16). Here we report the observation of a pure isotropic-nematic (IN) surface phase transition-clearly separated from the bulk IN transition-in a nematic LC on a substrate. Differences in phase behaviour between surface and bulk are expected(1-4,) but have hitherto proved difficult to distinguish, owing in part to the close proximity of their transition temperatures. We have overcome these difficulties by using a mixture of nematic LCs: small, surface-induced composition variations lead to complete separation of the surface and bulk transitions, which we then study independently as a function of substrate and applied magnetic field. We find the surface IN transition to be of first order on surfaces with a weak anchoring energy and continuous on surfaces with a strong anchoring. We show that the presence of high magnetic fields does not change the surface IN transition temperature, whereas the bulk IN transition temperature increases with field. We attribute this to the interaction energy between the surface and bulk phases, which is tuned by magnetic-field-induced order in the surface-wetting layer.	Univ Nijmegen, NSRIM Inst, NL-6525 ED Nijmegen, Netherlands; Univ Nijmegen, High Field Magnet Lab, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Boamfa, MI (corresponding author), Univ Nijmegen, NSRIM Inst, Toernooiveld 1, NL-6525 ED Nijmegen, Netherlands.	boamfa@sci.kun.nl	Maan, Jan Cornelis/D-4952-2012; Rasing, Theo/D-5207-2012	Rasing, Theo/0000-0002-6656-5528				Akiyama H, 1997, JPN J APPL PHYS 2, V36, pL1204, DOI 10.1143/JJAP.36.L1204; Bonn D, 2001, REP PROG PHYS, V64, P1085, DOI 10.1088/0034-4885/64/9/202; CAHN JW, 1977, J CHEM PHYS, V66, P3667, DOI 10.1063/1.434402; Chaudhari P, 2001, NATURE, V411, P56, DOI 10.1038/35075021; CHEN W, 1989, PHYS REV LETT, V62, P1860, DOI 10.1103/PhysRevLett.62.1860; CLARK NA, 1985, PHYS REV LETT, V55, P292, DOI 10.1103/PhysRevLett.55.292; CRAWFORD GP, 1991, PHYS REV LETT, V66, P723, DOI 10.1103/PhysRevLett.66.723; DEGENNES PG, 1993, PHYSICS LIQUID CRYST; DeSchrijver P, 1996, LIQ CRYST, V21, P745, DOI 10.1080/02678299608032886; HSIUNG H, 1986, PHYS REV LETT, V57, P3065, DOI 10.1103/PhysRevLett.57.3065; JAKLI A, 1991, MOL CRYST LIQ CRYST, V198, P331, DOI 10.1080/00268949108033409; JEROME B, 1991, REP PROG PHYS, V54, P391, DOI 10.1088/0034-4885/54/3/002; MARET G, 1985, TOP APPL PHYS, V57, P143; MIYANO K, 1979, PHYS REV LETT, V43, P51, DOI 10.1103/PhysRevLett.43.51; NAKANISHI H, 1982, PHYS REV LETT, V49, P1565, DOI 10.1103/PhysRevLett.49.1565; ROSENBLATT C, 1981, PHYS REV A, V24, P2236, DOI 10.1103/PhysRevA.24.2236; SHENG P, 1976, PHYS REV LETT, V37, P1059, DOI 10.1103/PhysRevLett.37.1059; SHENG P, 1992, PHYS REV A, V46, P946, DOI 10.1103/PhysRevA.46.946; Singh S, 2000, PHYS REP, V324, P108; SLUCKIN TJ, 1985, PHYS REV LETT, V55, P2907, DOI 10.1103/PhysRevLett.55.2907; van Haaren J, 2001, NATURE, V411, P29, DOI 10.1038/35075178; YOKOYAMA H, 1983, MOL CRYST LIQ CRYST, V99, P39, DOI 10.1080/00268948308072027	22	60	60	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					149	152		10.1038/nature01331	http://dx.doi.org/10.1038/nature01331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520297				2022-12-28	WOS:000180267200035
J	Kjaergard, LL; Liu, JP; Als-Nielsen, B; Gluud, C				Kjaergard, LL; Liu, JP; Als-Nielsen, B; Gluud, C			Artificial and bioartificial support systems for acute and acute-on-chronic liver failure - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FULMINANT HEPATIC-FAILURE; CHARCOAL HEMOPERFUSION; CLINICAL-TRIALS; RANDOMIZED-TRIALS; ALBUMIN DIALYSIS; THERAPY; QUALITY; SUSPENSION; MARS; BIAS	Context Artificial and bioartificial support systems may provide a "bridge" for patients with severe liver disease to recovery or transplantation. Objective To evaluate the effect of artificial and bioartificial support systems for acute and acute-on-chronic liver failure. Data Sources Randomized trials on any support system vs standard medical therapy were included irrespective of publication status or language. Nonrandomized studies were included in explorative analyses. Trials were identified through electronic searches (Cochrane Hepato-Biliary Group Controlled Trials Register, Cochrane Library, MEDLINE, EMBASE, and the Chinese Medical Database), bibliographies, and contact with experts. Searches were conducted of the entire databases through September 2002. Study Selection Of 528 references identified, 12 randomized trials with 483 patients were included. Eight nonrandomized studies were included in explorative analyses. Data Extraction Data were extracted and trial quality was assessed independently by 3 reviewers (L.L.K., J.L., B.A-N.). The primary outcome measure was all-cause mortality. Results were combined on the risk ratio (RR) scale. Random-effects models were used. Sources of heterogeneity were explored through meta-regression and stratified meta-analyses. Data Synthesis Of the 12 trials included, 10 assessed artificial systems for acute or acute-on-chronic liver failure and 2 assessed bioartificial systems for acute liver failure. Overall, support systems had no significant effect on mortality compared with standard medical therapy (RR, 0.86; 95% confidence interval [CI], 0.65-1.12). Meta- regression indicated that the effect of support systems depended on the type of liver failure (P=.03). In stratified meta-analyses, support systems appeared to reduce mortality by 33% in acute-on-chronic liver failure (RR, 0.67; 95% CI, 0.51-0.90), but not in acute liver failure (RR, 0.95; 95% CI, 0.71-1.29). Compared with randomized trials, nonrandomized studies produced significantly larger estimates of intervention effects (P=.01). Conclusion This review suggests that artificial support systems reduce mortality in acute-on-chronic liver failure compared with standard medical therapy. Artificial and bioartificial support systems did not appear to affect mortality in acute liver failure.	Univ Copenhagen Hosp, Rigshosp,Ctr Clin Intervent Res, Copenhagen Trial Unit, Cochrane Hepatobiliary Grp, DK-2100 Copenhagen, Denmark; Sichuan Univ, W China Hosp, Chengdu, Sichuan, Peoples R China	Rigshospitalet; University of Copenhagen; Sichuan University	Kjaergard, LL (corresponding author), Univ Copenhagen Hosp, Rigshosp,Ctr Clin Intervent Res, Copenhagen Trial Unit, Cochrane Hepatobiliary Grp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.	kjaergard@ctu.rh.dk	Gluud, Lise L/AAY-2120-2020; Gluud, Christian/AAY-1027-2021; Gluud, Christian/HGB-3191-2022	Gluud, Lise L/0000-0002-9462-4468; Gluud, Christian/0000-0002-8861-0799; 				Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; BION JF, 1993, INTENS CARE MED, V19, pS94, DOI 10.1007/BF01708809; Bonn D, 1996, LANCET, V348, P1372, DOI 10.1016/S0140-6736(05)65422-0; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; DENIS J, 1978, GUT, V19, P787, DOI 10.1136/gut.19.9.787; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ellis AJ, 1999, INT J ARTIF ORGANS, V22, P27, DOI 10.1177/039139889902200107; Ellis AJ, 1996, HEPATOLOGY, V24, P1446, DOI 10.1002/hep.510240625; GAZZARD BG, 1974, LANCET, V1, P1301; GIMSON AES, 1982, LANCET, V2, P681; He JQ, 2000, CHIN CRIT CARE MED, V12, P105; Heemann U, 2002, HEPATOLOGY, V36, P949, DOI 10.1053/jhep.2002.36130; HUGHES RD, 1994, INT J ARTIF ORGANS, V17, P657, DOI 10.1177/039139889401701207; *INT C HARM EXP WO, 1997, INT C HARM GUID PHIL; JIANG YS, 2000, CHINESE J INTERN MED, V39, P115; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kramer L, 1998, HEPATOLOGY, V28, p401A; KUNZ R, 2002, COCHRANE REV CD ROM, V4; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; LI LJ, 1997, CHIN J HEPATOL, V5, P202; Liu JP, 2002, LIVER, V22, P433, DOI 10.1034/j.1600-0676.2002.01554.x; LIU JP, 2002, COCHRANE REV CD ROM; MARGULIS MS, 1989, RESUSCITATION, V18, P85, DOI 10.1016/0300-9572(89)90115-9; Mazariegos GV., 1997, ARTIF ORGANS, V21, P529; Mitzner SR, 2000, LIVER TRANSPLANT, V6, P277, DOI 10.1053/lv.2000.6355; Mitzner SR, 2001, J AM SOC NEPHROL, V12, pS75; Moher D, 1998, LANCET, V352, P609, DOI 10.1016/S0140-6736(98)01085-X; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OGRADY JG, 1988, GASTROENTEROLOGY, V94, P1186, DOI 10.1016/0016-5085(88)90011-X; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; POCOCK SJ, 1993, STAT MED, V12, P1459, DOI 10.1002/sim.4780121512; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; Rahman TM, 1999, ALIMENT PHARM THERAP, V13, P1255; REDEKER AG, 1973, LANCET, V1, P3; Riordan SM, 1999, J GASTROEN HEPATOL, V14, P757, DOI 10.1046/j.1440-1746.1999.01945.x; Russell PS, 1999, JAMA-J AM MED ASSOC, V281, P1431, DOI 10.1001/jama.281.15.1431; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; SILK DBA, 1978, INT J ARTIF ORGANS, V1, P29; Sorkine P, 2001, CRIT CARE MED, V29, P1332, DOI 10.1097/00003246-200107000-00006; Stevens AC, 2001, HEPATOLOGY, V34, p299A; Tandon B, 1999, J GASTROEN HEPATOL, V14, P403; Wilkinson A H, 1998, J Transpl Coord, V8, P43	43	238	268	1	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					217	222		10.1001/jama.289.2.217	http://dx.doi.org/10.1001/jama.289.2.217			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517233				2022-12-28	WOS:000180226400033
J	Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P				Cowen, JP; Giovannoni, SJ; Kenig, F; Johnson, HP; Butterfield, D; Rappe, MS; Hutnak, M; Lam, P			Fluids from aging ocean crust that support microbial life	SCIENCE			English	Article							HYDROTHERMAL SYSTEMS; RIDGE; FLANK	Little is known about the potential for life in the vast, low-temperature (<100&DEG;C) reservoir of fluids within mid-ocean ridge flank and ocean basin crust. Recently, an overpressured 300-meter-deep borehole was fitted with an experimental seal (CORK) delivering crustal fluids to the sea floor for discrete and large-volume sampling and characterization. Results demonstrate that the 65&DEG;C fluids from 3.5-million-year-old ocean crust support microbial growth. Ribosomal RNA gene sequence data indicate the presence of diverse Bacteria and Archaea, including gene clones of varying degrees of relatedness to known nitrate reducers (with ammonia production), thermophilic sulfate reducers, and thermophilic fermentative heterotrophs, all consistent with fluid chemistry.	Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA; Oregon State Univ, Dept Microbiol, Corvallis, OR 97331 USA; Univ Illinois, Chicago, IL 60607 USA; Univ Washington, Joint Inst Study Atmosphere & Oceans, Seattle, WA 98195 USA; Univ Washington, Sch Oceanog, Seattle, WA 98195 USA	University of Hawaii System; Oregon State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Cowen, JP (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Dept Oceanog, Honolulu, HI 96822 USA.		Lam, Phyllis/D-9574-2011; Butterfield, David/H-3815-2016; Kenig, Fabien/A-4961-2008	Lam, Phyllis/0000-0003-2067-171X; Butterfield, David/0000-0002-1595-9279; Kenig, Fabien/0000-0003-4868-5232				Barns SM, 1996, P NATL ACAD SCI USA, V93, P9188, DOI 10.1073/pnas.93.17.9188; BECKER K, 1999, EOS, V80, pF931; Butterfield DA, 2001, GEOCHIM COSMOCHIM AC, V65, P4141, DOI 10.1016/S0016-7037(01)00712-8; COSTERTON JW, 1994, J BACTERIOL, V176, P2137, DOI 10.1128/JB.176.8.2137-2142.1994; Cowen JP, 1999, GEOPHYS RES LETT, V26, P3637, DOI 10.1029/1999GL002343; Davis E, 1999, EARTH PLANET SC LETT, V172, P141, DOI 10.1016/S0012-821X(99)00197-1; Davis E.E., 1997, P OCEAN DRILLING PRO, V168, P470; Davis EE, 1992, P OCEAN DRILL PROGRA, V139, P43, DOI DOI 10.2973/ODP.PROC.IR.139.103.1992; Elderfield H, 1999, EARTH PLANET SC LETT, V172, P151, DOI 10.1016/S0012-821X(99)00191-0; Ferdelman TG, 1997, GEOCHIM COSMOCHIM AC, V61, P3065, DOI 10.1016/S0016-7037(97)00158-0; Huber R, 1996, SYST APPL MICROBIOL, V19, P40, DOI 10.1016/S0723-2020(96)80007-5; KARL DM, 1980, SCIENCE, V207, P1345, DOI 10.1126/science.207.4437.1345; KENIG F, UNPUB; MARESCOTTI P, 2000, P OCEAN DRILL PROGRA, V168; Otte S, 1999, APPL ENVIRON MICROB, V65, P3148; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; RUETER P, 1994, NATURE, V372, P455, DOI 10.1038/372455a0; SHOCK EL, 1992, ORIGINS LIFE EVOL B, V22, P67, DOI 10.1007/BF01808019; WARWICK B, 1991, STUDIES PLANT SCI, V1, P162; Wheat CG, 2000, GEOCHIM COSMOCHIM AC, V64, P629, DOI 10.1016/S0016-7037(99)00347-6	20	189	200	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					120	123		10.1126/science.1075653	http://dx.doi.org/10.1126/science.1075653			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511653				2022-12-28	WOS:000180165800049
J	Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS				Wang, JD; Herman, C; Tipton, KA; Gross, CA; Weissman, JS			Directed evolution of substrate-optimized GroEL/S chaperonins	CELL			English	Article							GREEN FLUORESCENT PROTEIN; HEAT-SHOCK PROTEINS; FOLDING IN-VIVO; ESCHERICHIA-COLI; MOLECULAR CHAPERONES; CRYSTAL-STRUCTURE; TRIGGER FACTOR; CENTRAL CAVITY; BINDING; COMPLEX	GroEL/S chaperonin ring complexes fold many unrelated proteins. To understand the basis and extent of the chaperonin substrate spectrum, we used rounds of selection and DNA shuffling to obtain GroEL/S variants that dramatically enhanced folding of a single substrate-green fluorescent protein (GFP). Changes in the substrate-optimized chaperonins increase the polarity of the folding cavity and alter the ATPase cycle. These findings reveal a surprising plasticity of GroEL/S, which can be exploited to aid folding of recombinant proteins. Our studies also reveal a conflict between specialization and generalization of chaperonins as increased GFP folding comes at the expense of the ability of GroEL/S to fold its natural substrates. This conflict and the nature of the ring structure may help explain the evolution of cellular chaperone systems.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Stomatol & Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 513 Parnassus Ave, San Francisco, CA 94143 USA.		Wang, Jue/GVU-0480-2022	Wang, Jue/0000-0003-1503-170X; Weissman, Jonathan/0000-0003-2445-670X	NIGMS NIH HHS [GM36278, GM55595] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036278, R37GM036278, R01GM055595] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ang D, 2000, ANNU REV GENET, V34, P439, DOI 10.1146/annurev.genet.34.1.439; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chan HS, 1996, PROTEINS, V24, P345; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Coyle JE, 1999, NAT STRUCT BIOL, V6, P683; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; deLeon P, 1997, MICROBIOL-SGM, V143, P3563, DOI 10.1099/00221287-143-11-3563; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Farinas ET, 2001, CURR OPIN BIOTECH, V12, P545, DOI 10.1016/S0958-1669(01)00261-0; Farr GW, 2000, CELL, V100, P561, DOI 10.1016/S0092-8674(00)80692-3; Fewell SW, 2001, ANNU REV GENET, V35, P149, DOI 10.1146/annurev.genet.35.102401.090313; FISCHER HM, 1993, EMBO J, V12, P2901, DOI 10.1002/j.1460-2075.1993.tb05952.x; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GULUKOTA K, 1994, P NATL ACAD SCI USA, V91, P9292, DOI 10.1073/pnas.91.20.9292; Gutsche I, 1999, J MOL BIOL, V293, P295, DOI 10.1006/jmbi.1999.3008; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HERMAN C, 1995, MOL MICROBIOL, V18, P247, DOI 10.1111/j.1365-2958.1995.mmi_18020247.x; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Hunt JF, 1997, CELL, V90, P361, DOI 10.1016/S0092-8674(00)80343-8; James P, 1997, SCIENCE, V275, P387, DOI 10.1126/science.275.5298.387; KANEMORI M, 1994, J BACTERIOL, V176, P4235, DOI 10.1128/jb.176.14.4235-4242.1994; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; KHODURSKY A, 2002, IN PRESS METHODS MOL; Kubota H, 1997, FEBS LETT, V402, P53, DOI 10.1016/S0014-5793(96)01501-3; Leroux MR, 2000, CURR BIOL, V10, pR260, DOI 10.1016/S0960-9822(00)00432-2; Leroux MR, 2001, ADV APPL MICROBIOL, V50, P219, DOI 10.1016/S0065-2164(01)50007-6; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; LUO GX, 1993, J BIOL CHEM, V268, P10246; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; McLennan N, 1998, NATURE, V392, P139, DOI 10.1038/32317; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mogk A, 1997, EMBO J, V16, P4579, DOI 10.1093/emboj/16.15.4579; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; PERALTA D, 1994, FEBS LETT, V339, P45, DOI 10.1016/0014-5793(94)80381-1; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Richmond CS, 1999, NUCLEIC ACIDS RES, V27, P3821, DOI 10.1093/nar/27.19.3821; Ritco-Vonsovici M, 2000, J MOL BIOL, V304, P81, DOI 10.1006/jmbi.2000.4177; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, P NATL ACAD SCI USA, V94, P1096, DOI 10.1073/pnas.94.4.1096; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Teter SA, 1999, CELL, V97, P755, DOI 10.1016/S0092-8674(00)80787-4; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; TOBE T, 1984, MOL GEN GENET, V195, P10, DOI 10.1007/BF00332716; TODD MJ, 1994, SCIENCE, V265, P659, DOI 10.1126/science.7913555; Topell S, 1999, FEBS LETT, V457, P283, DOI 10.1016/S0014-5793(99)01044-3; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulrich HD, 2002, CURR TOP MICROBIOL, V268, P137; Wang JD, 1998, P NATL ACAD SCI USA, V95, P12163, DOI 10.1073/pnas.95.21.12163; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Wigley WC, 2001, NAT BIOTECHNOL, V19, P131, DOI 10.1038/84389; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yifrach O, 2000, P NATL ACAD SCI USA, V97, P1521, DOI 10.1073/pnas.040449997	62	110	116	5	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1027	1039		10.1016/S0092-8674(02)01198-4	http://dx.doi.org/10.1016/S0092-8674(02)01198-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507429	Bronze			2022-12-28	WOS:000180086000012
J	Dorsey, G; Njama, D; Kamya, MR; Cattamanchi, A; Kyabayinze, D; Staedke, SG; Gasasira, A; Rosenthal, PJ				Dorsey, G; Njama, D; Kamya, MR; Cattamanchi, A; Kyabayinze, D; Staedke, SG; Gasasira, A; Rosenthal, PJ			Sulfadoxine/pyrimethamine alone or with amodiaquine or artesunate for treatment of uncomplicated malaria: a longitudinal randomised trial	LANCET			English	Article							PLASMODIUM-FALCIPARUM MALARIA; COMBINATION THERAPY; CHLOROQUINE; RESISTANCE; EFFICACY; CHILDREN; KAMPALA; PYRIMETHAMINE; SULFADOXINE; AFRICA	Background New antimalarial treatments are urgently needed in sub-Saharan Africa. Improved therapies should decrease failure rates in the short term, but their effect on incidence of subsequent episodes of malaria is little studied. We aimed to compare the short-term and long-term effectiveness of three antimalarial regimens in children from Kampala, Uganda. Methods We randomly allocated healthy children aged 6 months to 5 years to receive 25 mg/kg sulfadoxine and 1.25 mg/kg pyrimethamine plus either placebo, 25 mg/kg amodiaquine, or 12 mg/kg artesunate. Participants were followed up for 1 year and received the same preassigned treatment for every new episode of uncomplicated malaria diagnosed during follow-up. Recrudescent and new infections were distinguished by comparison of polymorphisms in merozoite surface protein 2 (MSP2). Our primary endpoint was the total number of treatments for malaria per time at risk. Analyses were done per protocol.. Findings 183 (61%) of 316 participants were diagnosed with at least one episode of uncomplicated malaria. A total of 577 episodes of uncomplicated Plasmodium falciparum malaria were treated with study drugs;. all regimens were safe and well tolerated. Clinical treatment failure after 14 days was significantly more frequent in the sulfadoxine/ pyrimethamine group (38 of 215, 18%) compared with either the sulfadoxine/pyrimethamine plus amodiaquine group (two of 164, 1%; p<0.0001) or sulfadoxine/pyrimethamine plus artesunate group (one of 198, 1%; p<0.0001). After 28 and 42 days, patients in the sulfadoxine/pyrimethamine plus amodiaquine group were significantly less likely to develop malaria than were those in the other groups. Overall, sulfadoxine/pyrimethamine plus amodiaquine, reduced the rate of subsequent treatments for malaria by 54% (95% Cl 36-66, p<0.0001) compared with sulfadoxine/ pyrimethamine alone and by 37% (12-54, p=0.007) compared with sulfadoxine/pyrimethamine plus artesunate. Interpretation Sulfadoxine/pyrimethamine plus amodiaquine could be used as an inexpensive regimen to decrease the rate of subsequent episodes of malaria.	Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; Makerere Univ, Sch Med, Kampala, Uganda	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Makerere University	Dorsey, G (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, 1001 Potrero Ave,Bldg 30,Room 421, San Francisco, CA 94110 USA.	grantd@itsa.ucsf.edu		Kyabayinze, Daniel/0000-0002-0539-1341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI043301] Funding Source: NIH RePORTER; FIC NIH HHS [TW01506, TW00007] Funding Source: Medline; NIAID NIH HHS [AI43301] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; Basco LK, 2000, AM J TROP MED HYG, V63, P215, DOI 10.4269/ajtmh.2000.63.215; Bloland PB, 2000, B WORLD HEALTH ORGAN, V78, P1378; Breman JG, 2001, AM J TROP MED HYG, V64, P1; deVries PJ, 1996, DRUGS, V52, P818, DOI 10.2165/00003495-199652060-00004; Dorsey G, 2000, AM J TROP MED HYG, V62, P686, DOI 10.4269/ajtmh.2000.62.686; FENTON B, 1991, MOL CELL BIOL, V11, P963, DOI 10.1128/MCB.11.2.963; Kamya MR, 2001, T ROY SOC TROP MED H, V95, P50, DOI 10.1016/S0035-9203(01)90331-1; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marsh K, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P241; Mberu EK, 2000, AM J TROP MED HYG, V62, P396, DOI 10.4269/ajtmh.2000.62.396; NOSTEN F, 1994, J INFECT DIS, V170, P971, DOI 10.1093/infdis/170.4.971; Nosten F, 2000, LANCET, V356, P297, DOI 10.1016/S0140-6736(00)02505-8; Olliaro P, 1996, LANCET, V348, P1196, DOI 10.1016/S0140-6736(96)06217-4; Remme JHF, 2001, AM J TROP MED HYG, V64, P76, DOI 10.4269/ajtmh.2001.64.76; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Staedke SG, 2001, LANCET, V358, P368, DOI 10.1016/S0140-6736(01)05557-X; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; Watkins WM, 1997, PARASITOL TODAY, V13, P459, DOI 10.1016/S0169-4758(97)01124-1; Wendo C, 2002, LANCET, V359, P770, DOI 10.1016/S0140-6736(02)07912-6; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426; White NJ, 1999, LANCET, V353, P1965, DOI 10.1016/S0140-6736(98)07367-X; White NJ, 1996, LANCET, V348, P1184, DOI 10.1016/S0140-6736(05)65475-X; *WHO, 1996, ASS THER EFF ANT DRU; *WHO, 1994, ANT DRUG POL DAT REQ; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x; Zwetyenga J, 1998, AM J TROP MED HYG, V59, P726, DOI 10.4269/ajtmh.1998.59.726; [No title captured]	29	124	126	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2031	2038		10.1016/S0140-6736(02)12021-6	http://dx.doi.org/10.1016/S0140-6736(02)12021-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504399				2022-12-28	WOS:000179974200011
J	Bargmann, C; Hodgkin, J				Bargmann, C; Hodgkin, J			Accolade for elegans	CELL			English	Editorial Material									Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of California System; University of California San Francisco; University of Oxford	Bargmann, C (corresponding author), Univ Calif San Francisco, Dept Anat, Program Dev Biol, San Francisco, CA 94143 USA.			Bargmann, Cornelia/0000-0002-8484-0618					0	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					759	762		10.1016/S0092-8674(02)01195-9	http://dx.doi.org/10.1016/S0092-8674(02)01195-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526801	Bronze			2022-12-28	WOS:000179862600001
J	Park, SH; Zarrinpar, A; Lim, WA				Park, SH; Zarrinpar, A; Lim, WA			Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms	SCIENCE			English	Article							PDZ-DOMAIN PROTEIN; MUTATIONAL ANALYSIS; YEAST; STE5; ACTIVATION; ORGANIZATION; COMPLEXES; CASCADE; BINDING; SYSTEM	How scaffold proteins control information flow in signaling pathways is poorly understood: Do they simply tether components, or do they precisely orient and activate them? We found that the yeast mitogen-activated protein (MAP) kinase scaffold Ste5 is tolerant to major stereochemical perturbations; heterologous protein interactions could functionally replace native kinase recruitment interactions, indicating that simple tethering is largely sufficient for scaffold-mediated signaling. Moreover, by engineering a scaffold that tethers a unique kinase set, we could create a synthetic MAP kinase pathway with non-natural input-output properties. These findings demonstrate that scaffolds are highly flexible organizing factors that can facilitate pathway evolution and engineering.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lim, WA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.	wlim@itsa.ucsf.edu						Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; CHOI KY, 1994, CELL, V78, P499; Elion EA, 2001, J CELL SCI, V114, P3967; FERRELL JE, 2002, SCI STKE; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Harris BZ, 2001, J CELL SCI, V114, P3219; Harris BZ, 2001, BIOCHEMISTRY-US, V40, P5921, DOI 10.1021/bi010142l; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Inouye C, 1997, GENETICS, V147, P479; MAEDA T, 1994, NATURE, V369, P242, DOI 10.1038/369242a0; MAEDA T, 1995, SCIENCE, V269, P554, DOI 10.1126/science.7624781; Mahanty SK, 1999, CELL, V98, P501, DOI 10.1016/S0092-8674(00)81978-9; MARCUS S, 1994, P NATL ACAD SCI USA, V91, P7762, DOI 10.1073/pnas.91.16.7762; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Park S.C., UNPUB; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; PRINTEN JA, 1994, GENETICS, V138, P609; Ptashne M, 1998, CURR BIOL, V8, pR812, DOI 10.1016/S0960-9822(07)00508-8; Sette C, 2000, MOL BIOL CELL, V11, P4033, DOI 10.1091/mbc.11.11.4033; Struhl K, 1995, ANNU REV GENET, V29, P651, DOI 10.1146/annurev.ge.29.120195.003251; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7	27	267	289	0	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2003	299	5609					1061	1064		10.1126/science.1076979	http://dx.doi.org/10.1126/science.1076979			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12511654				2022-12-28	WOS:000180960000046
J	Metlay, JP; Fine, MJ				Metlay, JP; Fine, MJ			Testing strategies in the initial management of patients with community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Review							C-REACTIVE PROTEIN; ELDERLY-PATIENTS; PREDICTION RULE; PNEUMOCOCCAL PNEUMONIA; DIAGNOSING PNEUMONIA; LEGIONNAIRES-DISEASE; CLINICAL-PREDICTION; MEDICAL LITERATURE; PROGNOSTIC-FACTORS; LOBAR PNEUMONIA	The initial management of patients suspected of having community-acquired pneumonia is challenging because of the broad range of clinical presentations, potential life-threatening nature of the illness, and associated high costs of care. The initial testing strategies should accurately establish a diagnosis and prognosis in order to determine the optimal treatment strategy. The diagnosis is important in determining the need for antibiotic therapy, and the prognosis is important in determining the site of care. This paper reviews the test characteristics of the history, physical examination, and laboratory findings, individually and in combination, in diagnosing community-acquired pneumonia and predicting short-term risk for death from the infection. In addition, we consider the implications of these test characteristics from the perspective of decision thresholds. The history and physical examination cannot provide a high level of certainty in the diagnosis of community-acquired pneumonia, but the absence of vital sign abnormalities substantially reduces the probability of the infection. Chest radiography is considered the gold standard for pneumonia diagnosis; however, we do not know its sensitivity and specificity, and we have limited data on the costs of false-positive and false-negative results. In the absence of empirical evidence, the decision to order a chest radiograph needs to rely on expert opinion in seeking strategies to optimize the balance between harms and benefits. Once community-acquired pneumonia is diagnosed, a combination of history, physical examination, and laboratory items can help estimate the short-term risk for death and, along with the patient's psychosocial characteristics, determine the appropriate site of treatment.	Dept Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA USA; Univ Pittsburgh, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Metlay, JP (corresponding author), Dept Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, 9th Floor,Univ & Woodland Ave, Philadelphia, PA 19104 USA.				AHRQ HHS [R01 HS06468] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006468] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADERAYE G, 1994, TUBERCLE LUNG DIS, V75, P308, DOI 10.1016/0962-8479(94)90138-4; ALBAZZAZ MK, 1994, AGE AGEING, V23, P299, DOI 10.1093/ageing/23.4.299; ALLEN SC, 1984, THORAX, V39, P612, DOI 10.1136/thx.39.8.612; ALMIRALL J, 1995, CHEST, V107, P511, DOI 10.1378/chest.107.2.511; ANDREWS BE, 1987, Q J MED, V62, P195; Atlas SJ, 1998, ARCH INTERN MED, V158, P1350, DOI 10.1001/archinte.158.12.1350; Auble TE, 1998, INFECT DIS CLIN N AM, V12, P741, DOI 10.1016/S0891-5520(05)70208-7; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; BARTLETT JG, 1995, NEW ENGL J MED, V333, P1618, DOI 10.1056/NEJM199512143332408; Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; BASILIER.JL, 1968, AM J MED, V44, P580, DOI 10.1016/0002-9343(68)90058-2; BENEDETTI TJ, 1982, AM J OBSTET GYNECOL, V144, P413, DOI 10.1016/0002-9378(82)90246-0; BISNO AL, 1971, AM J MED SCI, V261, P251, DOI 10.1097/00000441-197105000-00004; BLACK ER, 1991, J GEN INTERN MED, V6, P394, DOI 10.1007/BF02598159; CARPENTER JL, 1991, SOUTHERN MED J, V84, P299, DOI 10.1097/00007611-199103000-00004; COHEN MA, 1989, MED J, V30, P141; COHEN ML, 1992, SCIENCE, V257, P1050, DOI 10.1126/science.257.5073.1050; Conte HA, 1999, AM J MED, V106, P20, DOI 10.1016/S0002-9343(98)00369-6; DALEY J, 1988, JAMA-J AM MED ASSOC, V260, P3617, DOI 10.1001/jama.260.24.3617; DIEHR P, 1984, J CHRON DIS, V37, P215, DOI 10.1016/0021-9681(84)90149-8; DOUGLAS RM, 1970, PAPUA NEW GUINEA MED, V13, P105; EL-AMIN A M, 1978, Medical Journal of Zambia, V12, P42; EMERMAN CL, 1991, ANN EMERG MED, V20, P1215, DOI 10.1016/S0196-0644(05)81474-X; Ewig S, 1999, CLIN CHEST MED, V20, P575, DOI 10.1016/S0272-5231(05)70237-9; EWIG S, 1995, EUR RESPIR J, V8, P392, DOI 10.1183/09031936.95.08030392; FARR BM, 1991, ANN INTERN MED, V115, P428, DOI 10.7326/0003-4819-115-6-428; FEDULLO AJ, 1985, J GERONTOL, V40, P29, DOI 10.1093/geronj/40.1.29; FINE MJ, 1990, AM J MED, V89, P713, DOI 10.1016/0002-9343(90)90211-U; Fine MJ, 1999, ARCH INTERN MED, V159, P970, DOI 10.1001/archinte.159.9.970; FINE MJ, 1990, AM J MED, V88, pN1; Fine MJ, 1996, JAMA-J AM MED ASSOC, V275, P134, DOI 10.1001/jama.275.2.134; FINE MJ, 1995, J GEN INTERN MED, V10, P359, DOI 10.1007/BF02599830; FINE MJ, 1993, AM J MED, V94, P153, DOI 10.1016/0002-9343(93)90177-Q; Fine MJ, 1997, NEW ENGL J MED, V336, P243, DOI 10.1056/NEJM199701233360402; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Gennis P, 1989, J Emerg Med, V7, P263, DOI 10.1016/0736-4679(89)90358-2; Hash RB, 2000, J FAM PRACTICE, V49, P833; HECKERLING PS, 1990, ANN INTERN MED, V113, P664, DOI 10.7326/0003-4819-113-9-664; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Janssens JP, 1996, J AM GERIATR SOC, V44, P539, DOI 10.1111/j.1532-5415.1996.tb01439.x; JONG GM, 1995, CHEST, V107, P214, DOI 10.1378/chest.107.1.214; Kamat S R, 1979, J Postgrad Med, V25, P15; KEELER EB, 1990, JAMA-J AM MED ASSOC, V264, P1962, DOI 10.1001/jama.264.15.1962; KIM TC, 1981, SOUTH MED J, V74, P1304, DOI 10.1097/00007611-198111000-00005; KURASHI NY, 1992, THORAX, V47, P115, DOI 10.1136/thx.47.2.115; Leroy O, 1999, CHEST, V116, P157, DOI 10.1378/chest.116.1.157; LIM I, 1989, MED J AUSTRALIA, V151, P87, DOI 10.5694/j.1326-5377.1989.tb101168.x; Luna CM, 2000, CHEST, V118, P1344, DOI 10.1378/chest.118.5.1344; Macfarlane J, 2001, THORAX, V56, P109, DOI 10.1136/thorax.56.2.109; MACFARLANE JT, 1982, LANCET, V2, P255; MANTEL N, 1959, J NATL CANCER I, V22, P719; MARRIE TJ, 1988, CLIN INVEST MED, V11, P10; MARRIE TJ, 1989, REV INFECT DIS, V11, P586; Marrie TJ, 2000, JAMA-J AM MED ASSOC, V283, P749, DOI 10.1001/jama.283.6.749; MCNABB WR, 1984, J ROY SOC MED, V77, P550, DOI 10.1177/014107688407700705; Meehan TP, 1997, JAMA-J AM MED ASSOC, V278, P2080, DOI 10.1001/jama.278.23.2080; MELBYE H, 1992, Scandinavian Journal of Primary Health Care, V10, P234, DOI 10.3109/02813439209014067; MERCAT A, 1991, CHEST, V99, P147, DOI 10.1378/chest.99.1.147; Metlay JP, 1998, ARCH INTERN MED, V158, P1813, DOI 10.1001/archinte.158.16.1813; Metlay JP, 1997, JAMA-J AM MED ASSOC, V278, P1440, DOI 10.1001/jama.278.17.1440; MEYERS JD, 1975, ANN INTERN MED, V82, P181, DOI 10.7326/0003-4819-82-2-181; MEYERS JD, 1982, REV INFECT DIS, V4, P1119; MOHAMED ARE, 1987, J INFECTION, V14, P31, DOI 10.1016/S0163-4453(87)90756-0; MOINE P, 1994, CHEST, V105, P1487, DOI 10.1378/chest.105.5.1487; MOORE MA, 1977, JOHNS HOPKINS MED J, V140, P9; MORLEY JJ, 1982, ANN NY ACAD SCI, V389, P406, DOI 10.1111/j.1749-6632.1982.tb22153.x; Munda R, 1976, Proc Clin Dial Transplant Forum, V6, P1; Niederman MS, 2001, AM J RESP CRIT CARE, V163, P1730, DOI 10.1164/ajrccm.163.7.at1010; NOONE P, 1978, J ANTIMICROB CHEMOTH, V4, P83, DOI 10.1093/jac/4.suppl_C.83; NORDSTROM K, 1983, SCAND J INFECT DIS, V15, P43, DOI 10.3109/inf.1983.15.issue-1.08; ORTQVIST A, 1990, EUR RESPIR J, V3, P1105; ORTQVIST A, 1985, SCAND J INFECT DIS, V17, P377; ORTQVIST A, 1988, SCAND J INFECT DIS, V20, P163, DOI 10.3109/00365548809032433; OSEASOHN R, 1978, AM REV RESPIR DIS, V117, P1003; PACHON J, 1990, AM REV RESPIR DIS, V142, P369, DOI 10.1164/ajrccm/142.2.369; PAUKER SG, 1980, NEW ENGL J MED, V302, P1109, DOI 10.1056/NEJM198005153022003; PETERS SG, 1987, AM J MED, V82, P73, DOI 10.1016/0002-9343(87)90380-9; POE RH, 1986, ARCH INTERN MED, V146, P1304, DOI 10.1001/archinte.146.7.1304; Porath A, 1996, ANN EMERG MED, V27, P176, DOI 10.1016/S0196-0644(96)70320-7; Potgieter PD, 1996, INTENS CARE MED, V22, P1301, DOI 10.1007/BF01709542; REE GH, 1982, PAPUA NEW GUINEA MED, V25, P223; RELLO J, 1993, CHEST, V103, P232, DOI 10.1378/chest.103.1.232; Rello J, 1996, CLIN INFECT DIS, V23, P723, DOI 10.1093/clinids/23.4.723; RICHEY SD, 1994, OBSTET GYNECOL, V84, P525; Riquelme R, 1996, AM J RESP CRIT CARE, V154, P1450, DOI 10.1164/ajrccm.154.5.8912763; Salkind AR, 2001, JAMA-J AM MED ASSOC, V285, P2498, DOI 10.1001/jama.285.19.2498; SINGAL BM, 1989, ANN EMERG MED, V18, P13, DOI 10.1016/S0196-0644(89)80304-X; SMITH RP, 1995, CHEST, V107, P1028, DOI 10.1378/chest.107.4.1028; SOBRADILLO V, 1989, EUR RESPIR J, V2, P263; SORENSEN J, 1989, SCAND J INFECT DIS, V21, P33, DOI 10.3109/00365548909035678; SORENSEN J, 1986, SCAND J INFECT DIS, V18, P329, DOI 10.3109/00365548609032344; STARCZEWSKI AR, 1988, AGE AGEING, V17, P181, DOI 10.1093/ageing/17.3.181; SULKAVA R, 1980, ANN CLIN RES, V12, P59; Syrjala H, 1998, CLIN INFECT DIS, V27, P358, DOI 10.1086/514675; TORRES A, 1991, AM REV RESPIR DIS, V144, P312, DOI 10.1164/ajrccm/144.2.312; VANEEDEN SF, 1988, S AFR MED J, V73, P77; VANEEDEN SF, 1990, CRIT CARE MED, V18, P1204, DOI 10.1097/00003246-199011000-00003; WANG MC, 1999, INTEGRATING RESULTS; WHITE RJ, 1981, THORAX, V36, P566, DOI 10.1136/thx.36.8.566; Wipf JE, 1999, ARCH INTERN MED, V159, P1082, DOI 10.1001/archinte.159.10.1082; WOODHEAD MA, 1987, Q J MED, V64, P783; WOODHEAD MA, 1985, J INFECTION, V10, P204, DOI 10.1016/S0163-4453(85)92463-6; ZWEIG S, 1990, J FAM PRACTICE, V30, P153	104	166	180	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					109	118		10.7326/0003-4819-138-2-200301210-00012	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00012			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529093				2022-12-28	WOS:000181018300005
J	Moellering, RC				Moellering, RC			Linezolid: The first oxazolidinone antimicrobial	ANNALS OF INTERNAL MEDICINE			English	Review							RESISTANT STAPHYLOCOCCUS-AUREUS; IN-VITRO ACTIVITIES; RIBOSOMAL-RNA; ANTIBACTERIAL AGENTS; PROTEIN-SYNTHESIS; VANCOMYCIN; INFECTIONS; MUTATIONS; THERAPY; QUINUPRISTIN/DALFOPRISTIN	Linezolid is the first of a new class of antimicrobial agents, the oxazolidinones, to be approved for clinical use in the United States and elsewhere. The drug is a totally synthetic compound, which lessens the likelihood of: naturally occurring resistance mechanisms. It has excellent activity against virtually all important gram-positive pathogens, including methicillin-resistant staphylococci, penicillin-resistant pneumococci, macrolide-resistant streptococci, and vancomycin-resistant enterococci. Development of resistance to the compound has been infrequent thus far. Linezolid is 100% bioavailable, so it can be given in equal doses orally or parenterally. Its elimination half-life allows dosing twice per day, and alteration of drug dosage is not required in patients with impaired renal or hepatic function. Linezolid has approved indications for skin and soft tissue infections; lower respiratory tract infections; and vancomycin-resistant Enterococcus faecium infections, including cases with concurrent bacteremia. The drug has an acceptable profile of adverse events, but reversible myelosuppression has occurred in patients receiving high doses for more than 2 weeks.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center	Moellering, RC (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, 110 Francis St,Suite 6A, Boston, MA 02215 USA.							Bassetti M, 2001, J INFECTION, V43, P148, DOI 10.1053/jinf.2001.0863; BASSETTI M, 2001, 41 INT C ANT AG CHEM; Brickner SJ, 1996, CURR PHARM DESIGN, V2, P175; BRIER ME, 1998, 38 INT C ANT AG CHEM; BROWN BA, 2000, 100 GEN M AM SOC MIC; BUYSSE JM, 1998, 36 INT C ANT AG CHEM; Cammarata SK, 2000, EUR C CLIN MICR INF; Cercenado E, 2001, J ANTIMICROB CHEMOTH, V47, P77, DOI 10.1093/jac/47.1.77; Cottagnoud P, 2000, J ANTIMICROB CHEMOTH, V46, P981, DOI 10.1093/jac/46.6.981; DALY JS, 1988, ANTIMICROB AGENTS CH, V32, P1341, DOI 10.1128/AAC.32.9.1341; Diekema DJ, 2000, DRUGS, V59, P7, DOI 10.2165/00003495-200059010-00002; Eliopoulos GM, 1996, ANTIMICROB AGENTS CH, V40, P1745, DOI 10.1128/AAC.40.7.1745; Ford C, 1999, INFECT MED, V16, P435; GEMMELL GC, 1999, 39 INT C ANT AG CHEM; Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907; Gonzales RD, 2001, LANCET, V357, P1179, DOI 10.1016/S0140-6736(00)04376-2; Green SL, 2001, JAMA-J AM MED ASSOC, V285, P1291, DOI 10.1001/jama.285.10.1291; Henwood CJ, 2000, J ANTIMICROB CHEMOTH, V46, P931, DOI 10.1093/jac/46.6.931; HYATT JM, 1998, 38 INT C ANT AG CHEM; Kloss P, 1999, J MOL BIOL, V294, P93, DOI 10.1006/jmbi.1999.3247; Li ZM, 2001, PHARMACOTHERAPY, V21, P263, DOI 10.1592/phco.21.3.263.34198; Lin AH, 1997, ANTIMICROB AGENTS CH, V41, P2127, DOI 10.1128/AAC.41.10.2127; *LIN ZYV, 2000, MED LETT DRUGS THER, V42, P45; Livermore DM, 2000, J ANTIMICROB CHEMOTH, V46, P347, DOI 10.1093/jac/46.3.347; Melzer M, 2000, CLIN INFECT DIS, V31, P208, DOI 10.1086/313897; Moellering RC, 1999, J ANTIMICROB CHEMOTH, V44, P25, DOI 10.1093/jac/44.suppl_1.25; Moellering RC, 1999, ANN INTERN MED, V130, P155, DOI 10.7326/0003-4819-130-2-199901190-00012; Moellering RC, 1995, AM J MED, V99, pS11, DOI 10.1016/S0002-9343(99)80279-4; Murray RW, 1998, ANTIMICROB AGENTS CH, V42, P947, DOI 10.1128/AAC.42.4.947; Oramas-Shirey MP, 2001, J ANTIMICROB CHEMOTH, V47, P349, DOI 10.1093/jac/47.3.349; Patel R, 2000, ANTIMICROB AGENTS CH, V44, P3438, DOI 10.1128/AAC.44.12.3438-3440.2000; Patel R, 2001, ANTIMICROB AGENTS CH, V45, P621, DOI 10.1128/AAC.45.2.621-623.2001; PETERS J, 1995, J ANTIMICROB CHEMOTH, V35, P675, DOI 10.1093/jac/35.5.675; Plouffe JF, 2000, CLIN INFECT DIS, V31, pS144, DOI 10.1086/314080; Prystowsky J, 2001, ANTIMICROB AGENTS CH, V45, P2154, DOI 10.1128/AAC.45.7.2154-2156.2001; Rubinstein E, 2001, CLIN INFECT DIS, V32, P402, DOI 10.1086/318486; SILVER L, 1990, EUR J CLIN MICROBIOL, V9, P455, DOI 10.1007/BF01964283; STALKER DJ, 1997, 37 INT C ANT AG CHEM; Stevens DL, 2000, ANTIMICROB AGENTS CH, V44, P3408, DOI 10.1128/AAC.44.12.3408-3413.2000; Swaney SM, 1998, ANTIMICROB AGENTS CH, V42, P3251, DOI 10.1128/AAC.42.12.3251; SWEENEY MT, 1999, 39 INT C ANT AG CHEM; Tsiodras S, 2001, LANCET, V358, P207, DOI 10.1016/S0140-6736(01)05410-1; Wallace RJ, 2001, ANTIMICROB AGENTS CH, V45, P764, DOI 10.1128/AAC.45.3.764-767.2001; Xiong LQ, 2000, J BACTERIOL, V182, P5325, DOI 10.1128/JB.182.19.5325-5331.2000; ZURENKO G, 1909, 39 INT C ANT AG CHEM; Zurenko GE, 1996, ANTIMICROB AGENTS CH, V40, P839, DOI 10.1128/AAC.40.4.839	46	344	375	2	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					135	142		10.7326/0003-4819-138-2-200301210-00015	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529096	Green Published			2022-12-28	WOS:000181018300008
J	Campbell, CT				Campbell, CT			Waltzing with O-2	SCIENCE			English	Editorial Material							TIO2(110) SURFACE; ADSORPTION; TITANIA; OXYGEN; GOLD		Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Campbell, CT (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	campbell@chem.washington.edu						Gamble L, 1996, SURF SCI, V348, P1, DOI 10.1016/0039-6028(95)00942-6; Gan S, 2001, SURF SCI, V475, P159, DOI 10.1016/S0039-6028(00)01107-9; Giordano L, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075417; Hebenstreit ELD, 2002, SURF SCI, V505, P336, DOI 10.1016/S0039-6028(02)01385-7; Henderson MA, 2002, SURF SCI REP, V46, P1, DOI 10.1016/S0167-5729(01)00020-6; Henderson MA, 1999, J PHYS CHEM B, V103, P5328, DOI 10.1021/jp990655q; Iwasawa Y, 1999, FARADAY DISCUSS, V114, P259, DOI 10.1039/a903106e; Kim YD, 2002, J PHYS CHEM B, V106, P6827, DOI 10.1021/jp0205766; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Liu G, 2002, J PHYS CHEM B, V106, P9883, DOI 10.1021/jp021155r; LU G, 1995, J PHYS CHEM-US, V99, P7626, DOI 10.1021/j100019a049; Over H, 2000, SCIENCE, V287, P1474, DOI 10.1126/science.287.5457.1474; Sanchez A, 1999, J PHYS CHEM A, V103, P9573, DOI 10.1021/jp9935992; Schaub R, 2003, SCIENCE, V299, P377, DOI 10.1126/science.1078962; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647	15	20	21	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					357	357		10.1126/science.1081090	http://dx.doi.org/10.1126/science.1081090			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532006				2022-12-28	WOS:000180426800033
J	Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M				Kawai, H; Kanegae, T; Christensen, S; Kiyosue, T; Sato, Y; Imaizumi, T; Kadota, A; Wada, M			Responses of ferns to red light are mediated by an unconventional photoreceptor	NATURE			English	Article							ADIANTUM-CAPILLUS-VENERIS; ORIENTED CHLOROPLAST MOVEMENT; BLUE-LIGHT; ARABIDOPSIS NPH1; PHYTOCHROME; PHOTOTROPISM; PROTONEMATA; RELOCATION; PLANTS; NPL1	Efficient photosynthesis is essential for plant survival. To optimize photosynthesis, plants have developed several photo-responses. Stems bend towards a light source (phototropism), chloroplasts move to a place of appropriate light intensity (chloroplast photorelocation) and stomata open to absorb carbon dioxide. These responses are mediated by the blue-light receptors phototropin 1 (phot1) and phototropin 2 (phot2) in Arabidopsis (refs 1-5). In some ferns, phototropism and chloroplast photorelocation are controlled by red light as well as blue light(6). However, until now, the photoreceptor mediating these red-light responses has not been identified. The fern Adiantum capillus-veneris has an unconventional photoreceptor, phytochrome 3 (phy3), which is a chimaera of the red/far-red light receptor phytochrome and phototropin(7). We identify here a function of phy3 for red-light-induced phototropism and for red-light-induced chloroplast photorelocation, by using mutational analysis and complementation. Because phy3 greatly enhances the sensitivity to white light in orienting leaves and chloroplasts, and PHY3 homologues exist among various fern species, this chimaeric photoreceptor may have had a central role in the divergence and proliferation of fern species under low-light canopy conditions.	Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan; Natl Inst Basic Biol, Div Biol Regulat & Photobiol, Aichi 4448585, Japan	Tokyo Metropolitan University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Wada, M (corresponding author), Tokyo Metropolitan Univ, Grad Sch Sci, Dept Biol Sci, Tokyo 1920397, Japan.		Sato, Yoshikatsu/I-6129-2014					Augustynowicz J, 1999, PLANT CELL ENVIRON, V22, P1239, DOI 10.1046/j.1365-3040.1999.00487.x; Bunning E., 1958, BER DEUT BOT GES, V71, P304; Christie JM, 1999, P NATL ACAD SCI USA, V96, P8779, DOI 10.1073/pnas.96.15.8779; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; DAVIS BD, 1975, PLANT CELL PHYSIOL, V16, P537; Davis SJ, 1998, PLANT MOL BIOL, V36, P521, DOI 10.1023/A:1005991617182; Hasebe M, 1995, AM FERN J, V85, P134, DOI 10.2307/1547807; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; KADOTA A, 1982, PHOTOCHEM PHOTOBIOL, V35, P533, DOI 10.1111/j.1751-1097.1982.tb02605.x; Kadota A, 1999, PLANT CELL PHYSIOL, V40, P238, DOI 10.1093/oxfordjournals.pcp.a029533; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kagawa T, 1996, PLANTA, V198, P488, DOI 10.1007/BF00620067; Kanegae T, 1998, MOL GEN GENET, V259, P345, DOI 10.1007/s004380050821; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; MILLER JH, 1974, AM J BOT, V61, P296, DOI 10.2307/2441609; Nozue K, 1998, P NATL ACAD SCI USA, V95, P15826, DOI 10.1073/pnas.95.26.15826; NOZUE K, 2000, PLANT PHYSIOL, V122, P1457; Pryer KM, 1995, AM FERN J, V85, P205, DOI 10.2307/1547810; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; TAYLOR TN, 1993, BIOL EVOLUTION FOSSI, P346; TIDWELL WD, 1994, J PLANT RES, V107, P417, DOI 10.1007/BF02344066; WADA M, 1994, J PLANT RES, V107, P181, DOI 10.1007/BF02346015; WADA M, 1989, ANNU REV PLANT PHYS, V40, P169; Willis K. J, 2002, EVOLUTION PLANTS, P130; YATSUHASHI H, 1990, PLANT SCI, V68, P87, DOI 10.1016/0168-9452(90)90156-I; YATSUHASHI H, 1993, J PHOTOCH PHOTOBIO B, V19, P25, DOI 10.1016/1011-1344(93)80089-R; YATSUHASHI H, 1985, PLANTA, V165, P43, DOI 10.1007/BF00392210	29	168	184	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					287	290		10.1038/nature01310	http://dx.doi.org/10.1038/nature01310			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529647				2022-12-28	WOS:000180397600052
J	Watzman, H				Watzman, H			German researchers set to receive Israeli stem-cell shipment	NATURE			English	News Item																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					199	199		10.1038/421199b	http://dx.doi.org/10.1038/421199b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529601	Bronze			2022-12-28	WOS:000180397600008
J	Smith, LK; Peake, MD; Botha, JL				Smith, LK; Peake, MD; Botha, JL			Recent changes in lung cancer incidence for south Asians: a population based register study	BRITISH MEDICAL JOURNAL			English	Article									Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England; Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England; Weston Pk Hosp, Trent Canc Registry, Sheffield S10 2SJ, S Yorkshire, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Weston Park Hospital	Smith, LK (corresponding author), Univ Leicester, Dept Epidemiol & Publ Hlth, Leicester LE1 6TP, Leics, England.		Smith, Lucy K/I-6300-2018; Smith, Lucy K/S-6593-2019	Smith, Lucy K/0000-0001-9470-0793; Smith, Lucy K/0000-0001-9470-0793				Bhopal RS, 1996, BRIT J CANCER, V74, pS22; Cummins C, 1999, J PUBLIC HEALTH MED, V21, P401, DOI 10.1093/pubmed/21.4.401; Johnson M, 1999, BLACK MINORITY ETHNI; Winter H, 1999, BRIT J CANCER, V79, P645, DOI 10.1038/sj.bjc.6690102	4	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					81	82		10.1136/bmj.326.7380.81	http://dx.doi.org/10.1136/bmj.326.7380.81			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521972	Green Published, Bronze			2022-12-28	WOS:000180426900016
J	Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML				Abtahian, F; Guerriero, A; Sebzda, E; Lu, MM; Zhou, R; Mocsai, A; Myers, EE; Huang, B; Jackson, DG; Ferrari, VA; Tybulewicz, V; Lowell, CA; Lepore, JJ; Koretzky, GA; Kahn, ML			Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk	SCIENCE			English	Article							B-CELL DEVELOPMENT; ENDOTHELIAL-CELLS; MICE LACKING; ANGIOGENESIS; EXPRESSION; VIABILITY; RECEPTORS; COLLAGEN	Lymphatic vessels develop from specialized endothelial cells in preexisting blood vessels, but the molecular signals that regulate this separation are unknown. Here we identify a failure to separate emerging lymphatic vessels from blood vessels in mice lacking the hematopoietic signaling protein SLP-76 or Syk. Blood-lymphatic connections lead to embryonic hemorrhage and arteriovenous shunting. Expression of slp-76 could not be detected in endothelial cells, and blood-filled lymphatics also arose in wild-type mice reconstituted with SLP-76 deficient bone marrow. These studies reveal a hematopoietic signaling pathway required for separation of the two major vascular networks in mammals.	Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Div Cardiol, Philadelphia, PA 19104 USA; Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; John Radcliffe Hosp, MRC, Inst Mol Med, Human Immunol Unit, Oxford OX3 9DS, England; Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of California System; University of California San Francisco; University of Oxford; MRC National Institute for Medical Research; University of Pennsylvania	Koretzky, GA (corresponding author), Univ Penn, Signal Transduct Program, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.		Mocsai, Attila/B-2792-2008; Koretzky, Gary/AAU-5381-2021	Tybulewicz, Victor/0000-0003-2439-0798; Ferrari, Victor/0000-0001-8696-3243; , david/0000-0002-4133-9364; Mocsai, Attila/0000-0002-0512-1157	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB002473] Funding Source: NIH RePORTER; NIBIB NIH HHS [R21 EB002473, R21 EB002473-02] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		ABTAHIAN F, UNPUB; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Braunwald E., 1997, HEART DIS; Carmeliet P, 2001, THROMB HAEMOSTASIS, V86, P289; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Clements JL, 1999, J CLIN INVEST, V103, P19, DOI 10.1172/JCI5317; Dumont DJ, 1998, SCIENCE, V282, P946, DOI 10.1126/science.282.5390.946; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Judd BA, 2000, P NATL ACAD SCI USA, V97, P12056, DOI 10.1073/pnas.97.22.12056; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kriehuber E, 2001, J EXP MED, V194, P797, DOI 10.1084/jem.194.6.797; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Prevo R, 2001, J BIOL CHEM, V276, P19420, DOI 10.1074/jbc.M011004200; SABIN F, 2001, AM J ANAT, V4, P367; Sauter B, 1998, J HISTOCHEM CYTOCHEM, V46, P165, DOI 10.1177/002215549804600205; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505	25	312	330	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					247	251		10.1126/science.1079477	http://dx.doi.org/10.1126/science.1079477			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522250	Green Accepted			2022-12-28	WOS:000180284000038
J	Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A				Strazzullo, P; Lacone, R; Lacoviello, L; Russo, O; Barba, G; Russo, P; D'Orazio, A; Barbato, A; Cappuccio, FP; Farinaro, E; Siani, A			Genetic variation in the renin-angiotensin system and abdominal adiposity in men: The olivetti prospective heart study	ANNALS OF INTERNAL MEDICINE			English	Article							CONVERTING-ENZYME GENE; HUMAN OBESITY GENES; INSERTION DELETION POLYMORPHISM; HUMAN ESSENTIAL-HYPERTENSION; CARDIOVASCULAR-RENAL RISK; BLOOD-PRESSURE; ACE GENE; INSULIN-RESISTANCE; TISSUE; ASSOCIATION	Background: The renin-angiotensin system is involved in adipocyte growth and differentiation and possibly in adipose tissue metabolism. Objective: To investigate the association of polymorphism in the angiotensin-converting enzyme (ACE) I/D gene, angiotensinogen M235T gene, and angiotensin II type 1 receptor A1166C gene with body mass index, body fat pattern, and obesity-associated hypertension. Design: Cross-sectional longitudinal study. Setting: The Olivetti factories in Marcianise and Pozzuoli, suburbs of Naples, Italy. Participants: 959 adult men, 25 to 75 years of age. Measurements: Renin-angiotensin system polymorphism, anthropometric indexes, blood pressure, and serum glucose and insulin levels. Results: No association was detected between angiotensinogen or angiotensin II type 1 receptor gene polymorphism and anthropometric indexes or blood pressure. For ACE I/D polymorphism, significant age-genotype interaction was detected on cross-sectional observation; the relation of body mass index, waist circumference, and diastolic blood pressure to age was significantly greater in persons with the DD genotype than in those with the ID or II genotype. Overweight and abdominal adiposity were more common in men with the DD genotype, particularly among older participants (51.1% vs. 36.5% and 33.1% vs. 22.0%, respectively). Odds ratios were 1.82 (95% Cl, 1.16 to 2.87) for overweight and 1.76 (Cl, 1.06 to 2.90) for abdominal adiposity. Among 314 untreated men first examined 20 years earlier, those with the DD genotype had greater age-adjusted weight gain (1.45 kg [Cl, 0.12 to 2.78 kg]) and change in diastolic blood pressure (2.83 mm Hg [Cl, 0.39 to 5.28 mm Hg]). The relative risk for overweight was 2.34 (Cl, 1.32 to 4.15) among participants with the DD genotype versus those with the ID or II genotype. Conclusions: The ACE I/D polymorphism was a significant predictor of overweight and abdominal adiposity in men. DD homozygosity was associated with larger increases in body weight and blood pressure in aging persons, as well as with higher incidence of overweight.	Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, I-80131 Naples, Italy; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy; CNR, Inst Food Sci, Avellino, Italy; Univ London St Georges Hosp, Sch Med, London SW17 0RE, England	University of Naples Federico II; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); St Georges University London	Strazzullo, P (corresponding author), Univ Naples Federico II, Sch Med, Dept Clin & Expt Med, Via S Pansini 5, I-80131 Naples, Italy.	strazzul@unina.it	Iacoviello, Licia/AGX-7071-2022; Barbato, Antonio/AAG-3313-2020; Siani, Alfonso/B-7925-2015; Russo, Paola/AAW-8308-2020; Cappuccio, Francesco Paolo/ABF-1094-2020; Iacoviello, Licia/K-4676-2016; Cappuccio, Francesco/D-3028-2009	Iacoviello, Licia/0000-0003-0514-5885; Cappuccio, Francesco Paolo/0000-0002-7842-5493; Iacoviello, Licia/0000-0003-0514-5885; IACONE, ROBERTO/0000-0003-3360-3855; Barbato, Antonio/0000-0002-4660-821X				Ailhaud G, 2000, INT J OBESITY, V24, pS33, DOI 10.1038/sj.ijo.0801501; Arner P, 2000, INT J OBESITY, V24, pS57, DOI 10.1038/sj.ijo.0801507; BLOEM LJ, 1995, J CLIN INVEST, V95, P948, DOI 10.1172/JCI117803; BONNARDEAUX A, 1994, HYPERTENSION, V24, P63, DOI 10.1161/01.HYP.24.1.63; BOUCHARD C, 1993, ANNU REV NUTR, V13, P337, DOI 10.1146/annurev.nu.13.070193.002005; CAMPBELL DJ, 1995, J CARDIOVASC PHARM, V26, P426, DOI 10.1097/00005344-199509000-00013; CAPPUCCIO FP, 1993, JAMA-J AM MED ASSOC, V270, P354, DOI 10.1001/jama.270.3.354; Comuzzie AG, 1997, NAT GENET, V15, P273, DOI 10.1038/ng0397-273; Comuzzie AG, 1998, SCIENCE, V280, P1374, DOI 10.1126/science.280.5368.1374; Cooper R, 1998, J HYPERTENS, V16, P571, DOI 10.1097/00004872-199816050-00003; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; CRANDALL DL, 1994, DRUG DEVELOP RES, V32, P117, DOI 10.1002/ddr.430320208; DARIMONT C, 1994, ENDOCRINOLOGY, V135, P2030, DOI 10.1210/en.135.5.2030; EGAN BM, 1994, AM J HYPERTENS, V7, P886, DOI 10.1093/ajh/7.10.886; Engeli S, 1999, J HYPERTENS, V17, P555, DOI 10.1097/00004872-199917040-00014; Engeli S, 2000, HYPERTENSION, V35, P1270, DOI 10.1161/01.HYP.35.6.1270; Giacchetti G, 1999, INT J OBES RELAT S5, V23, pS71; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hennes MMI, 1996, HYPERTENSION, V28, P120, DOI 10.1161/01.HYP.28.1.120; Inoue I, 1997, J CLIN INVEST, V99, P1786, DOI 10.1172/JCI119343; JEUNEMAITRE X, 1992, CELL, V71, P169, DOI 10.1016/0092-8674(92)90275-H; JEUNEMAITRE X, 1992, NAT GENET, V1, P72, DOI 10.1038/ng0492-72; Jones BH, 1997, AM J PHYSIOL-REG I, V273, pR236, DOI 10.1152/ajpregu.1997.273.1.R236; Jones BH, 1997, ENDOCRINOLOGY, V138, P1512, DOI 10.1210/en.138.4.1512; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; KATSUYA T, 1995, LANCET, V345, P1600, DOI 10.1016/S0140-6736(95)90115-9; Kunz R, 1997, HYPERTENSION, V30, P1331, DOI 10.1161/01.HYP.30.6.1331; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; Lee JH, 1999, AM J HUM GENET, V64, P196, DOI 10.1086/302195; LICATA G, 1994, AM J HYPERTENS, V7, P314, DOI 10.1093/ajh/7.4.314; LINDPAINTNER K, 1995, NEW ENGL J MED, V332, P706, DOI 10.1056/NEJM199503163321103; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Norman RA, 1998, AM J HUM GENET, V62, P659, DOI 10.1086/301758; RIGAT B, 1992, NUCLEIC ACIDS RES, V20, P1433, DOI 10.1093/nar/20.6.1433-a; RIGAT B, 1990, J CLIN INVEST, V86, P1343, DOI 10.1172/JCI114844; RUSS AP, 1993, HUM MOL GENET, V2, P609, DOI 10.1093/hmg/2.5.609; Ryan AS, 2001, DIABETES CARE, V24, P1646, DOI 10.2337/diacare.24.9.1646; Schling P, 1999, INT J OBESITY, V23, P336, DOI 10.1038/sj.ijo.0800821; Sharma P, 1998, J NEUROL NEUROSUR PS, V64, P227, DOI 10.1136/jnnp.64.2.227; Staessen JA, 1999, J HYPERTENS, V17, P9, DOI 10.1097/00004872-199917010-00003; Staessen JA, 1997, J HYPERTENS, V15, P1579, DOI 10.1097/00004872-199715120-00059; Strazzullo P, 2001, J HYPERTENS, V19, P399, DOI 10.1097/00004872-200103000-00007; Thomas GN, 2001, DIABETES CARE, V24, P356, DOI 10.2337/diacare.24.2.356; TIRET L, 1994, LANCET, V344, P910, DOI 10.1016/S0140-6736(94)92268-3; TIRET L, 1992, AM J HUM GENET, V51, P197; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Viitanen L, 2001, ATHEROSCLEROSIS, V157, P57, DOI 10.1016/S0021-9150(00)00705-X	47	140	143	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					17	23		10.7326/0003-4819-138-1-200301070-00007	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00007			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513040				2022-12-28	WOS:000180996200003
J	Carbajal, R; Veerapen, S; Couderc, S; Jugie, M; Ville, Y				Carbajal, R; Veerapen, S; Couderc, S; Jugie, M; Ville, Y			Analgesic effect of breast feeding in term neonates: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACUTE PAIN; SUCROSE	Objectives To investigate whether breast feeding is effective for pain relief during venepuncture in term neonates and compare any effect with that of oral glucose combined with a pacifier. Design Randomised controlled trial. Participants 180 term newborn infants undergoing venepuncture; 45 in each group. Interventions During venepuncture infants were either breast fed (group 1), held in their mother's arms without breast feeding (group 2), given 1 ml of sterile water as placebo (group 3), or given 1 ml of 30% glucose followed by pacifier (group 4). Video recordings of the procedure were assessed by two observers blinded to the purpose of the study. Main outcome measures Pain related behaviours evaluated with two acute pain rating scales: the Douleur Aigue Nouveau-ne scale (range 0 to 10) and the premature infant pain profile scale (range 0 to 18). Results Median pain scores (interquartile range) for breast feeding, held in mother's arms, placebo, and 30% glucose plus pacifier groups were 1 (0-3), 10 (8.5-10),10 (7.5-10), and 3 (0-5) with the Douleur Aigue Nouveau-ne scale and 4.5 (2.25-8),13 (10.5-15), 12 (9-13), and 4 (1-6) with die premature infant pain profile scale. Analysis of variance showed significantly different median pain scores (P < 0.0001) among the groups. There were significant reductions in both scores for the breast feeding and glucose plus pacifier groups compared with the other two groups (P < 0.0001, two tailed Mann-Whitney U tests between groups). The difference in Douleur Aigue Nouveau-ne scores between breast feeding and glucose plus pacifier groups was not significant (P=0.168). Conclusions Breast feeding effectively reduces response to pain during minor invasive procedure in term neonates.	Poissy St Germain Hosp, Dept Paediat, F-78300 Poissy, France; Poissy St Germain Hosp, Dept Obstet & Gynaecol, F-78300 Poissy, France		Carbajal, R (corresponding author), Poissy St Germain Hosp, Dept Paediat, F-78300 Poissy, France.	carbajal@club-internet.fr						Anand KJS, 1998, BIOL NEONATE, V73, P1, DOI 10.1159/000013953; Anand KJS, 2001, ARCH PEDIAT ADOL MED, V155, P173, DOI 10.1001/archpedi.155.2.173; Bellieni CV, 2002, PEDIATR RES, V51, P460, DOI 10.1203/00006450-200204000-00010; Bilgen H, 2001, J PAIN, V2, P301, DOI 10.1054/jpai.2001.23140; Blass EM, 1999, PAIN, V83, P611, DOI 10.1016/S0304-3959(99)00166-9; Carbajal R, 1999, BRIT MED J, V319, P1393, DOI 10.1136/bmj.319.7222.1393; Carbajal R, 1997, ARCH PEDIATRIE, V4, P623, DOI 10.1016/S0929-693X(97)83360-X; FRANCK L, 2000, PAIN NEONATES, P203; Gray L, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.1.e14; Gray L, 2002, PEDIATRICS, V109, P590, DOI 10.1542/peds.109.4.590; Prechtl HFR., 1977, NEUROLOGICAL EXAMINA, V2nd; Shah V, 1998, ARCH DIS CHILD-FETAL, V79, pF209, DOI 10.1136/fn.79.3.F209; Skogsdal Y, 1997, ACTA PAEDIATR, V86, P217, DOI 10.1111/j.1651-2227.1997.tb08872.x; Stevens B, 1996, CLIN J PAIN, V12, P13, DOI 10.1097/00002508-199603000-00004; STEVENS B, 2001, COCHRANE DB SYST REV; Taddio A, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.2.e1	16	132	144	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					13	15		10.1136/bmj.326.7379.13	http://dx.doi.org/10.1136/bmj.326.7379.13			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511452	Bronze, Green Published			2022-12-28	WOS:000180302000016
J	Kassabian, VS				Kassabian, VS			Sexual function in patients treated for benign prostatic hyperplasia	LANCET			English	Review							DOUBLE-BLIND; FINASTERIDE; MEN; DYSFUNCTION; DOXAZOSIN; RESECTION; ERECTILE	Context What is the effect of different treatment options for benign prostatic hyperplasia (BPH) on sexual function or dysfunction? With increasing age, sexual dysfunction and BPH become more prevalent. Some treatments for BPH can affect sexual function. Different surgical treatments have different effects on sexual function depending on how much the internal involuntary sphincter is affected. The same is true for medical therapies, each class of drug having a unique affect on sexual function. Starting point In the past, many articles suggested a causal relation between BPH and sexual dysfunction. But a recent report by H Leliefeld and colleagues (BJU International 2002; 89: 208-13) confirms the idea that the relation is coincidental. Prospectively, these investigators examined patients at baseline and 9 months after various treatments for BPH with questionnaires on voiding symptoms, related complications, and sexual function. 84% of patients reported no change in sexual function. All treatments showed both improvement and deterioration in 3-14% and 0-16% of patients, respectively. As expected, age was the most important determinant of sexual function. In addition, the effect of severe irritative symptoms or the, presence of urological comorbidity, such as bladder stones, increased the rate of sexual dysfunction. In this study, most patients underwent surgical therapy or watchful waiting while fewer had medical therapy. Too few patients'had minimally invasive procedures to comment on their effect on sexual function. Where next? Thus the relation between treatment of BPH (or watchful waiting) and sexual dysfunction is usually coincidental, unless symptoms become severe or complications (such as bladder stones or urinary retention) develop. More prospective studies are needed to assess the effect of BPH and its treatment on sexual function. Medical therapy is now more common than surgery in developed countries and treatment of BPH is commonly advocated for improvement in quality of life. Therefore any, effects-on sexual function become even more important. As minimally invasive surgical operations become more common, more data will be required for such interventions. The difficulty will be in keeping up with the rapidly evolving techniques of minimally invasive therapies.	Georgia Urol, Atlanta, GA 30342 USA		Kassabian, VS (corresponding author), Georgia Urol, Atlanta, GA 30342 USA.	kassvn@bellsouth.net						Andriole GL, 1998, UROLOGY, V52, P195, DOI 10.1016/S0090-4295(98)00184-8; Baniel J, 2000, EUR UROL, V38, P53, DOI 10.1159/000020252; BERRY SJ, 1984, J UROLOGY, V132, P474, DOI 10.1016/S0022-5347(17)49698-4; Blanker MH, 2001, J AM GERIATR SOC, V49, P436, DOI 10.1046/j.1532-5415.2001.49088.x; BRETSCHNEIDER JG, 1988, ARCH SEX BEHAV, V17, P109, DOI 10.1007/BF01542662; DIOKNO AC, 1990, ARCH INTERN MED, V150, P197, DOI 10.1001/archinte.150.1.197; Downs T M, 1999, Curr Opin Urol, V9, P9, DOI 10.1097/00042307-199901000-00003; FAWZY A, 1995, J UROLOGY, V154, P105, DOI 10.1016/S0022-5347(01)67240-9; Frankel SJ, 1998, J CLIN EPIDEMIOL, V51, P677, DOI 10.1016/S0895-4356(98)00044-4; GILLENWATER JY, 1995, J UROLOGY, V154, P110, DOI 10.1016/S0022-5347(01)67243-4; JANUS SS, 1993, JANUS REPORT SEXUAL, P25; KAISER FE, 1994, NEUROBIOL AGING, V15, P559, DOI 10.1016/0197-4580(94)90097-3; Kinn AC, 1998, SCAND J UROL NEPHROL, V32, P33; Leliefeld HHJ, 2002, BJU INT, V89, P208, DOI 10.1046/j.1464-4096.2001.01817.x; Lepor H, 1996, NEW ENGL J MED, V335, P533, DOI 10.1056/NEJM199608223350801; Lukacs B, 1998, EUR UROL, V33, P28, DOI 10.1159/000052231; Marberger MJ, 1998, UROLOGY, V51, P677, DOI 10.1016/S0090-4295(98)00094-6; MARSIGLIO W, 1991, J GERONTOL, V46, pS338, DOI 10.1093/geronj/46.6.S338; MEBUST WK, 1989, J UROLOGY, V141, P243, DOI 10.1016/S0022-5347(17)40731-2; MORLEY JE, 1989, MED CLIN N AM, V73, P1483, DOI 10.1016/S0025-7125(16)30611-3; NETTO NR, 1994, J ENDOUROL, V8, P217, DOI 10.1089/end.1994.8.217; PARSONS CI, 1990, COMMON PROBLEMS INFE, P352; Richard F, 2001, PROG UROL, V11, P250; Roehrborn CG, 1998, UROLOGY, V51, P415, DOI 10.1016/S0090-4295(97)00682-1; Tsai YS, 2001, EUR UROL, V39, P688, DOI 10.1159/000052528; TSCHOLL R, 1995, J UROLOGY, V153, P1491, DOI 10.1016/S0022-5347(01)67442-1; Tubaro A, 2001, EUR UROL, V40, P19, DOI 10.1159/000049873; Vale J, 2000, CURR MED RES OPIN, V16, pS63, DOI 10.1185/0300799009117042; VERMEULEN A, 1991, EUR UROL, V20, P82; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Zlotta AR, 1999, EUR UROL, V36, P107, DOI 10.1159/000052330	31	54	58	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					60	62		10.1016/S0140-6736(03)12164-2	http://dx.doi.org/10.1016/S0140-6736(03)12164-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517472				2022-12-28	WOS:000180191600026
J	Nishida, M; MacKinnon, R				Nishida, M; MacKinnon, R			Structural basis of inward rectification: Cytoplasmic pore of the G protein-gated inward rectifier GIRK1 at 1.8 angstrom resolution	CELL			English	Article							K+-CHANNEL; POTASSIUM CHANNEL; BETA-GAMMA; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; MECHANISM; SUBUNIT; ACTIVATION; CELLS; BLOCK	Inward rectifier K+ channels govern the resting membrane voltage in many cells. Regulation of these ion channels via G protein-coupled receptor signaling underlies the control of heart rate and the actions of neurotransmitters in the central nervous system. We have determined the protein structure formed by the intracellular N- and C termini of the G protein-gated inward rectifier K+ channel GIRK1 at 1.8 Angstrom resolution. A cytoplasmic pore, conserved among inward rectifier K+ channels, extends the ion pathway to 60 Angstrom, nearly twice the length of a canonical transmembrane K+ channel. The cytoplasmic pore is lined by acidic and hydrophobic amino acids, creating a favorable environment for polyamines, which block the pore. These results explain in structural and chemical terms the basis of inward rectification, and they also have implications for G protein regulation of GIRK channels.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Neurobiol & Biophys, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	mackinn@rockvax.rockefeller.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43949] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albsoul-Younes AM, 2001, J BIOL CHEM, V276, P12712, DOI 10.1074/jbc.M011231200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baukrowitz T, 1999, EMBO J, V18, P847, DOI 10.1093/emboj/18.4.847; BREITWIESER GE, 1985, NATURE, V317, P538, DOI 10.1038/317538a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BURGEN ASV, 1953, J PHYSIOL-LONDON, V120, P449, DOI 10.1113/jphysiol.1953.sp004910; CHEN JQ, 1995, SCIENCE, V268, P1166, DOI 10.1126/science.7761832; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; FICKER E, 1994, SCIENCE, V266, P1068, DOI 10.1126/science.7973666; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; HAGIWARA S, 1976, J GEN PHYSIOL, V67, P621, DOI 10.1085/jgp.67.6.621; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HO K, 1993, NATURE, V362, P31, DOI 10.1038/362031a0; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; KURACHI Y, 1986, PFLUG ARCH EUR J PHY, V407, P264, DOI 10.1007/BF00585301; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; LOPATIN AN, 1995, J GEN PHYSIOL, V106, P923, DOI 10.1085/jgp.106.5.923; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; PFAFFINGER PJ, 1985, NATURE, V317, P536, DOI 10.1038/317536a0; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; STANFIELD PR, 1994, J PHYSIOL-LONDON, V478, P1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAGLIALATELA M, 1994, SCIENCE, V264, P844, DOI 10.1126/science.8171340; TRAUTWEIN W, 1958, PFLUG ARCH GES PHYS, V266, P324, DOI 10.1007/BF00416781; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504; WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	60	301	319	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					957	965		10.1016/S0092-8674(02)01227-8	http://dx.doi.org/10.1016/S0092-8674(02)01227-8			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507423	Bronze			2022-12-28	WOS:000180086000006
J	Hartung, HP; Gonsette, R; Konig, N; Kwiecinski, H; Guseo, A; Morrissey, SP; Krapf, H; Zwingers, T				Hartung, HP; Gonsette, R; Konig, N; Kwiecinski, H; Guseo, A; Morrissey, SP; Krapf, H; Zwingers, T		MIMS	Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial	LANCET			English	Article							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; SUPPRESSION; DISEASE; CARDIOTOXICITY; AGENT; MRI	Background Treatment options for patients with secondary progressive multiple,sclerosis are few. Encouraging results in open-label studies prompted this randomised trial of mitoxantrone in such patients. Methods 194 patients with worsening relapsing-remitting or secondary progressive multiple sclerosis were assigned placebo or mitoxantrone (mg/m(2) [exploratory group] or 12 mg/m(2) intravenously) every 3 months for 24 months. Clinical assessments were made every 3 months for 24 months. The primary endpoint was a multivariate analysis of five clinical measures. Analyses of mitoxantrone 12 mg/m(2) versus placebo were based on patients who received at least one dose and returned for at least one assessment of efficacy. Findings Of 194 patients enrolled, 188 were able to be assessed at 24 months. There were no drug-related serious adverse events or evidence of clinically significant cardiac dysfunction. At 24 months, the mitoxantrone group experienced benefits compared with the placebo group for the primary outcome (difference 0.30 [95% Cl 0.17-0.44]; p<0.0001) and the preplanned univariate analyses of those measures: change in expanded disability status scale (0.24 [0.04-0.44]; p=0.0194), change in ambulation index (0.21 [0.02-0.40]; p=0.0306), adjusted total number of treated relapses (0.38 [0.18-0.59]; p=0.0002), time to first treated relapse (0.44 [0.20-0.69]; p=0.0004), and change in standardised neurological status (0.23 [0.03-0.43]; p=0.0268). Interpretation Mitoxantrone 12 mg/m(2) was generally well tolerated and reduced progression of disability and clinical exacerbations. Further studies are needed to identify the patients with these forms of multiple sclerosis who are most likely to respond to therapy, the best treatment protocols, and the frequency of long-term drug-related side-effects.	Univ Dusseldorf, Dept Neurol, D-40225 Dusseldorf, Germany; Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; Natl Ctr Multiple Sclerosis, Melsbroek, Belgium; Marianne Strauss Klin, Berg, Germany; Med Acad Warsaw, Dept Neurol, Warsaw, Poland; St Gyorgy Hosp, Dept Neurol, Szekesfehervar, Hungary; Univ Tubingen, Dept Neuroradiol, D-7400 Tubingen, Germany; Estimate GmbH, Augsburg, Germany	Heinrich Heine University Dusseldorf; University of Wurzburg; Eberhard Karls University of Tubingen	Hartung, HP (corresponding author), Univ Dusseldorf, Dept Neurol, Moorenstr 5, D-40225 Dusseldorf, Germany.		Macedo, Ana/L-9912-2018	Macedo, Ana/0000-0002-6978-8989				BAKER D, 1992, CLIN EXP IMMUNOL, V90, P124; Cohen JA, 2002, NEUROLOGY, V59, P679, DOI 10.1212/WNL.59.5.679; COMPSTON A, 1998, MCALPINES MULTIPLE S, P437; DECASTRO S, 1995, J CLIN PHARMACOL, V35, P627, DOI 10.1002/j.1552-4604.1995.tb05021.x; Dukart G, 1984, CANCER TREAT S, V3, P35; EBERS G, 1998, MCALPINES MULTIPLE S, P191; Edan G, 1997, J NEUROL NEUROSUR PS, V62, P112, DOI 10.1136/jnnp.62.2.112; Edan G, 2001, MULT SCLER, V7, pS14; GONSETTE R E, 1990, Neurology, V40, P261; Goodkin DE, 2000, NEUROLOGY, V54, P2352; Goodkin DE, 2001, MULT SCLER S1, V7, pS129; HARTUNG HP, 1999, MULTIPLE SCLEROSIS T, P335; HAUSER SL, 1983, NEW ENGL J MED, V308, P173, DOI 10.1056/NEJM198301273080401; Jacobs LD, 1996, ANN NEUROL, V39, P285, DOI 10.1002/ana.410390304; Kappos L, 1998, LANCET, V352, P1491, DOI 10.1016/S0140-6736(98)10039-9; KAPPOS L, 1990, Neurology, V40, P261; King J, 2001, NEUROLOGY, V56, P1496; KRAPF H, 1995, NEURORADIOLOGY, V37, P113; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lemez P, 1998, SEMIN ONCOL, V25, P61; Lublin FD, 1996, NEUROLOGY, V46, P907, DOI 10.1212/WNL.46.4.907; LUBLIN FD, 1987, CLIN IMMUNOL IMMUNOP, V45, P122, DOI 10.1016/0090-1229(87)90118-8; MATHER FJ, 1987, CANCER TREAT REP, V71, P609; Millefiorini E, 1997, J NEUROL, V244, P153, DOI 10.1007/s004150050066; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; NOSEWORTHY JH, 1993, NEUROLOGY, V43, P1401, DOI 10.1212/WNL.43.7.1401; Noseworthy JH, 2000, NEW ENGL J MED, V343, P938, DOI 10.1056/NEJM200009283431307; NOSEWORTHY JH, 1991, LANCET, V337, P441; Ramey D R, 1992, Arthritis Care Res, V5, P119, DOI 10.1002/art.1790050303; RIDGE SC, 1985, CLIN IMMUNOL IMMUNOP, V35, P35, DOI 10.1016/0090-1229(85)90075-3; SHENKENBERG TD, 1986, ANN INTERN MED, V105, P67, DOI 10.7326/0003-4819-105-1-67; WATSON CM, 1991, INT J IMMUNOPHARMACO, V13, P923, DOI 10.1016/0192-0561(91)90045-9; WEI LJ, 1984, J AM STAT ASSOC, V79, P653, DOI 10.2307/2288413; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	34	666	692	0	20	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2018	2025		10.1016/S0140-6736(02)12023-X	http://dx.doi.org/10.1016/S0140-6736(02)12023-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504397				2022-12-28	WOS:000179974200009
J	Dolev, E				Dolev, E			Reflections on military medicine	LANCET			English	Article									Tel Aviv Med Ctr & Sch Med, Dept Internal Med, Tel Aviv, Israel; Israel Def Forces Med Corps, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Dolev, E (corresponding author), Tel Aviv Med Ctr & Sch Med, Dept Internal Med E, Tel Aviv, Israel.							DOLEV E, 1984, ISRAEL J MED SCI, V20, P297; DOLEV E, 1985, MIL MED, V150, P471, DOI 10.1093/milmed/150.9.471; Dolev E, 1996, ISRAEL J MED SCI, V32, P785; MICHAELI D, 1979, J ROY SOC MED, V72, P370; NAYTHONS M, 1993, FACE MERCY PHOTOGRAP; ROZIN R, 1988, INJURY, V19, P193, DOI 10.1016/0020-1383(88)90014-9	6	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S9	S10		10.1016/S0140-6736(02)11799-5	http://dx.doi.org/10.1016/S0140-6736(02)11799-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504483				2022-12-28	WOS:000180064500004
J	Greenhalgh, T; Toon, P; Russell, J; Wong, G; Plumb, L; Macfarlane, F				Greenhalgh, T; Toon, P; Russell, J; Wong, G; Plumb, L; Macfarlane, F			Transferability of principles of evidence based medicine to improve educational quality: systematic review and case study of an online course in primary health care	BRITISH MEDICAL JOURNAL			English	Review							USERS GUIDES; KNOWLEDGE; XXIII		UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 5LW, England; UCL, Mkt Res & Evaluat Unit, London WC1, England; Univ Surrey, Sch Management, Surrey GU2 7XH, England	University of London; University College London; UCL Medical School; University of London; University College London; University of Surrey	Greenhalgh, T (corresponding author), UCL, Sch Med, Dept Primary Care & Populat Sci, London N19 5LW, England.	p.greenhaigh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Brigley S, 1997, MED EDUC, V31, P67, DOI 10.1111/j.1365-2923.1997.tb00046.x; Cluzeau FA, 1999, INT J QUAL HEALTH C, V11, P21, DOI 10.1093/intqhc/11.1.21; *CRIT APPR SKILLS, CRIT APPR CHECKL PUB; Cullen J., 2002, REV CURRENT PEDAGOGI; Desforges C., 1995, LEARN INSTR, V5, P385, DOI [https://doi.org/10.1016/0959-4752(95)00024-0, DOI 10.1016/0959-4752(95)00024-0]; Engestrom Y., 2001, J EDUC WORK, V14, P133, DOI [10.1080/13639080020028747, DOI 10.1080/13639080020028747]; Eriksson C, 2000, SCAND J PUBLIC HEALT, V28, P298, DOI 10.1177/14034948000280040101; Fraser SW, 2001, BRIT MED J, V323, P799, DOI 10.1136/bmj.323.7316.799; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P478, DOI 10.1001/jama.284.4.478; Giacomini MK, 2000, JAMA-J AM MED ASSOC, V284, P357, DOI 10.1001/jama.284.3.357; Greenhalgh T, 2001, BRIT MED J, V322, P40, DOI 10.1136/bmj.322.7277.40; GREENHALGH T, 2002, OXFORD TXB PRIMARY C; Hammersley M, 2001, BRIT EDUC RES J, V27, P543, DOI 10.1080/01411920120095726; HAMMERSLEY M, 2001, S EV BAS PRACT ED AN; Hesketh EA, 2001, MED EDUC, V35, P555, DOI 10.1046/j.1365-2923.2001.00920.x; Morris R, 2001, ANN MATH ARTIF INTEL, V33, P1, DOI 10.1023/A:1012361914091; Mulrow CD, 2001, J HEALTH POLIT POLIC, V26, P249, DOI 10.1215/03616878-26-2-249; Newman P, 2002, BMJ-BRIT MED J, V325, P200, DOI 10.1136/bmj.325.7357.200; Popay J, 1998, QUAL HEALTH RES, V8, P341, DOI 10.1177/104973239800800305; Prideaux D, 2002, MED EDUC, V36, P502, DOI 10.1046/j.1365-2923.2002.01247.x; Secretary of State for Health, 1998, 1 CLASS SERV QUAL NE; WEGENER E, 1996, COMMUNITIES PRACTICE	22	46	46	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					142	145		10.1136/bmj.326.7381.142	http://dx.doi.org/10.1136/bmj.326.7381.142			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531848	Green Submitted, Bronze, Green Published			2022-12-28	WOS:000180575900027
J	Fazleabas, AT; Kim, JJ				Fazleabas, AT; Kim, JJ			What makes an embryo stick?	SCIENCE			English	Editorial Material							ADHESION		Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fazleabas, AT (corresponding author), Univ Illinois, Dept Obstet & Gynecol, Chicago, IL 60612 USA.			Kim, J Julie/0000-0001-9834-8213				Alon R, 2002, SEMIN IMMUNOL, V14, P93, DOI 10.1006/smim.2001.0346; Genbacev O, 1997, SCIENCE, V277, P1669, DOI 10.1126/science.277.5332.1669; Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546; LESSEY BA, 1992, J CLIN INVEST, V90, P188, DOI 10.1172/JCI115835; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; Spandorfer SD, 2002, FERTIL STERIL, V77, P1209, DOI 10.1016/S0015-0282(02)03134-5	7	38	45	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					355	356		10.1126/science.1081277	http://dx.doi.org/10.1126/science.1081277			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532005				2022-12-28	WOS:000180426800032
J	Keiling, A; Wygant, JR; Cattell, CA; Mozer, FS; Russell, CT				Keiling, A; Wygant, JR; Cattell, CA; Mozer, FS; Russell, CT			The global morphology of wave Poynting flux: Powering the aurora	SCIENCE			English	Article							PLASMA SHEET; POLAR SPACECRAFT; ELECTRIC-FIELDS; SUBSTORM ONSETS; ASSOCIATION; BOUNDARY; DYNAMICS; REGION	Large-scale, electric currents owing along magnetic field lines into the polar regions of Earth are thought to be the main contributors of the energy that powers the ionospheric aurora. However, we have found evidence for global contributions from electromagnetic waves (Alfven waves). Data that were collected from the Polar spacecraft over the course of 1 year show that the flow of wave electromagnetic energy at altitudes of 25,000 to 38,000 kilometers delineates the statistical auroral oval. The Poynting flux of individual events distributed along the auroral oval was larger than 5 ergs per square centimeter per second, which is sufficient to power auroral acceleration processes. This evidence suggests that in addition to magnetic field-aligned currents, the dayside and nightside aurora is globally powered by the energy flow of these high-altitude Alfven waves.	Univ Minnesota, Dept Phys & Astron, St Paul, MN 55144 USA; Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90024 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Berkeley; University of California System; University of California Los Angeles	Keiling, A (corresponding author), Ctr Etud Spatiale Rayonnements, Toulouse, France.		Russell, Christopher T/E-7745-2012	Russell, Christopher T/0000-0003-1639-8298; Cattell, Cynthia/0000-0002-3805-320X				AKASOFU SI, 1966, PLANET SPACE SCI, V14, P587, DOI 10.1016/0032-0633(66)90043-2; Alfven H, 1942, NATURE, V150, P405, DOI 10.1038/150405d0; Baker DN, 1997, J GEOPHYS RES-SPACE, V102, P7159, DOI 10.1029/96JA03961; Chaston CC, 1999, GEOPHYS RES LETT, V26, P647, DOI 10.1029/1998GL900246; Cowley SWH, 2000, GEOPH MONOG SERIES, V118, P91; FRANK LA, 1995, GLOBAL GEOSPACE MISS, P297; HARVEY P, 1995, GLOBAL GEOSPACE MISS, P583; Keiling A, 2000, GEOPHYS RES LETT, V27, P3169, DOI 10.1029/2000GL000127; Keiling A, 2001, J GEOPHYS RES-SPACE, V106, P5779, DOI 10.1029/2000JA900130; KEILING A, 2002, J GEOPHYS RES, V107; Liou K, 1997, J GEOPHYS RES-SPACE, V102, P27197, DOI 10.1029/97JA02638; Lysak RL, 2001, PHYS CHEM EARTH PT C, V26, P3, DOI 10.1016/S1464-1917(00)00084-2; Maynard NC, 1996, J GEOPHYS RES-SPACE, V101, P7705, DOI 10.1029/95JA03856; MENG CI, 1986, J GEOPHYS RES, V91, P1572, DOI 10.1029/JA091iA02p01572; REIFF PH, 1993, GEOPH MONOG SERIES, V80, P143, DOI DOI 10.1029/GM080P0143; RUSSELL CT, 1995, GLOBAL GEOSPACE MISS, P563; SAMSON JC, 1991, J GEOPHYS RES-SPACE, V96, P15683, DOI 10.1029/91JA00796; Toivanen PK, 2001, J GEOPHYS RES-SPACE, V106, P19117, DOI 10.1029/2000JA003020; TORR MR, 1995, GLOBAL GEOSPACE MISS, P459; Wygant J. R., 2002, J GEOPHYS RES, V107; Wygant JR, 2000, J GEOPHYS RES-SPACE, V105, P18675, DOI 10.1029/1999JA900500	21	124	125	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					383	386		10.1126/science.1080073	http://dx.doi.org/10.1126/science.1080073			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532014				2022-12-28	WOS:000180426800042
J	Foley, SF; Buhre, S; Jacob, DE				Foley, SF; Buhre, S; Jacob, DE			Evolution of the Archaean crust by delamination and shallow subduction	NATURE			English	Article							DEPLETED MANTLE; ECLOGITE; STABILITY; BENEATH; ORIGIN; PHASES; SLABS; ARC	The Archaean oceanic crust was probably thicker than present-day oceanic crust owing to higher heat flow and thus higher degrees of melting at mid-ocean ridges(1). These conditions would also have led to a different bulk composition of oceanic crust in the early Archaean, that would probably have consisted of magnesium-rich picrite (with variably differentiated portions made up of basalt, gabbro, ultramafic cumulates and picrite). It is unclear whether these differences would have influenced crustal subduction and recycling processes, as experiments that have investigated the metamorphic reactions that take place during subduction have to date considered only modern mid-ocean-ridge basalts(2,3). Here we present data from high-pressure experiments that show that metamorphism of ultramafic cumulates and picrites produces pyroxenites, which we infer would have delaminated and melted to produce basaltic rocks, rather than continental crust as has previously been thought. Instead, the formation of continental crust requires subduction and melting of garnet-amphibolite(4)-formed only in the upper regions of oceanic crust-which is thought to have first occurred on a large scale during subduction in the late Archaean(5). We deduce from this that shallow subduction and recycling of oceanic crust took place in the early Archaean, and that this would have resulted in strong depletion of only a thin layer of the uppermost mantle. The misfit between geochemical depletion models and geophysical models for mantle convection (which include deep subduction) might therefore be explained by continuous deepening of this depleted layer through geological time(5,6).	Ernst Moritz Arndt Univ Greifswald, Inst Geol Wissensch, D-17487 Greifswald, Germany; Goethe Univ Frankfurt, Inst Mineral, D-60054 Frankfurt, Germany	Ernst Moritz Arndt Universitat Greifswald; Goethe University Frankfurt	Foley, SF (corresponding author), Ernst Moritz Arndt Univ Greifswald, Inst Geol Wissensch, FL Jahnstr 17A, D-17487 Greifswald, Germany.	sfoley@uni-greifswald.de	Jacob, Dorrit E/F-8617-2010; Foley, Stephen/I-1759-2013; Foley, Stephen/C-1923-2009	Jacob, Dorrit E/0000-0003-4744-6627; Foley, Stephen/0000-0001-7510-0223				ABBOTT D, 1995, REV GEOPHYS, V33, P231, DOI 10.1029/95RG00551; BENNETT VC, 1993, EARTH PLANET SC LETT, V119, P299, DOI 10.1016/0012-821X(93)90140-5; BICKLE MJ, 1994, J GEOL, V102, P121, DOI 10.1086/629658; Christensen UR, 1997, J GEOPHYS RES-SOL EA, V102, P22435, DOI 10.1029/97JB01342; Coogan LA, 2002, LITHOS, V63, P67, DOI 10.1016/S0024-4937(02)00114-7; Danyushevsky LV, 2000, J PETROL, V41, P1329, DOI 10.1093/petrology/41.8.1329; DEWIT MJ, 1996, GREENSTONE BELTS; Farnetani CG, 1996, EARTH PLANET SC LETT, V143, P81, DOI 10.1016/0012-821X(96)00138-0; Foley S, 2002, NATURE, V417, P837, DOI 10.1038/nature00799; Foley S. F., 1999, P 7 INT KIMB C CAP T, V1, P238; GREEN DH, 1967, GEOCHIM COSMOCHIM AC, V31, P767, DOI 10.1016/S0016-7037(67)80031-0; Holland TJB, 1998, J METAMORPH GEOL, V16, P309, DOI 10.1111/j.1525-1314.1998.00140.x; JACOB D, 1994, GEOCHIM COSMOCHIM AC, V58, P5191, DOI 10.1016/0016-7037(94)90304-2; Jacob DE, 1999, LITHOS, V48, P317, DOI 10.1016/S0024-4937(99)00034-1; Karsten JL, 1996, LITHOS, V37, P143, DOI 10.1016/0024-4937(95)00034-8; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Liu J, 1996, EARTH PLANET SC LETT, V143, P161, DOI 10.1016/0012-821X(96)00130-6; Martin H., 1994, ARCHEAN CRUSTAL EVOL, V11, P205, DOI DOI 10.1016/S0166-2635(08)70224-X; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P4717, DOI 10.1016/0016-7037(94)90203-8; Niu YL, 1997, EARTH PLANET SC LETT, V148, P471, DOI 10.1016/S0012-821X(97)00048-4; Nutman AP, 1996, PRECAMBRIAN RES, V78, P1, DOI 10.1016/0301-9268(95)00066-6; ONIONS RK, 1980, PHILOS T R SOC A, V297, P479, DOI 10.1098/rsta.1980.0226; Oxburgh E.R., 1977, J GEOL SOC LONDON, V133, P343, DOI [10.1144/gsjgs.133.4.0343, DOI 10.1144/GSJGS.133.4.0343]; RAPP RP, 1991, PRECAMBRIAN RES, V51, P1, DOI 10.1016/0301-9268(91)90092-O; Schmidt MW, 1998, EARTH PLANET SC LETT, V163, P361, DOI 10.1016/S0012-821X(98)00142-3; Shirey SB, 2001, GEOPHYS RES LETT, V28, P2509, DOI 10.1029/2000GL012589; WALLACE ME, 1991, MINER PETROL, V44, P1, DOI 10.1007/BF01167097; Widiyantoro S, 1996, SCIENCE, V271, P1566, DOI 10.1126/science.271.5255.1566; Winther KT, 1991, B GEOL SOC DENMARK, V39, P213; Zegers TE, 2001, GEOLOGY, V29, P1083, DOI 10.1130/0091-7613(2001)029<1083:MACFBC>2.0.CO;2	30	172	185	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					249	252		10.1038/nature01319	http://dx.doi.org/10.1038/nature01319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529633				2022-12-28	WOS:000180397600042
J	Rao, G; Fisch, L; Srinivasan, S; D'Amico, F; Okada, T; Eaton, C; Robbins, C				Rao, G; Fisch, L; Srinivasan, S; D'Amico, F; Okada, T; Eaton, C; Robbins, C			Does this patient have Parkinson disease?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-DIAGNOSIS; DIFFERENTIAL-DIAGNOSIS; ESSENTIAL TREMOR; FEATURES; ACCURACY; QUESTIONNAIRE; EPIDEMIOLOGY	Context Diagnosis of Parkinson disease (PD) remains challenging. An accurate diagnosis is important because effective symptomatic treatment for PD is available. Objective To systematically review the literature for information on the precision and accuracy of the clinical examination for diagnosing PD. Data Sources MEDLINE database was searched for all English-language articles related to the diagnosis of PD published from January 1966 through April 2001. The reference lists of all articles retrieved were searched for additional relevant sources. Study Selection Studies in which patients presented with 1 or more typical features of PD were included if the final diagnosis was confirmed by a suitable criterion standard and data could be extracted to determine the accuracy of 1 or more symptoms or signs. Variability in descriptions of symptoms and signs made it impossible to combine data across existing studies for most findings. Data Synthesis We identified 6 studies that met our criteria. The positive (presence) likelihood ratios (LRs) for tremor as a symptom of PD ranged from 1.3 to 17 (range of negative [absence] LRs, 0.24 to 0.60). Tremor as a sign of PD produced a range of positive LRs from 1.3 to 1.5 (negative LRs, 0.47 to 0.61). Clinical features useful in the diagnosis of PD include a history of the combination of symptoms of rigidity and bradykinesia (positive LR, 4.5; negative LR, 0.12); a history of loss of balance (range of positive LRs, 1.6 to 6.6; range of negative LRs, 0.29 to 0.35), symptoms of micrographia (range of positive LRs, 2.8 to 5.9; range of negative LRs, 0.30 to 0.44), and a history of shuffling gait (range of positive LRs, 3.3 to 15; range of negative LRs, 0.32 to 0.50). Trouble with certain tasks such as turning in bed (positive LR, 13; negative LR, 0.56), opening jars (positive LR, 6.1; negative LR, 0.26), and rising from a chair (range of positive LRs, 1.9 to 5.2; range of negative LRs, 0.39 to 0.58). Useful signs include the glabella tap test (positive LR, 4.5; negative LR, 0.13), difficulty walking heel-to-toe (positive LR, 2.9; negative LR, 0.32), and rigidity (range of positive LRs, 0.53 to 2.8; range of negative LRs, 0.38 to 1.6). Significant selection bias was detected in all studies included for review. Conclusions Symptoms of tremor, rigidity, bradykinesia, micrographia, shuffling gait, and difficulty with the tasks of turning in bed, opening jars, and rising from a chair should be carefully reviewed in all patients with suspected PD. The glabella tap and heel-to-toe tests also should be assessed.	Univ Pittsburgh, Dept Family Med, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Kaiser Permanente Colorado, Aurora, CO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Kaiser Permanente	Rao, G (corresponding author), Univ Pittsburgh, Dept Family Med, 3518 5th Ave, Pittsburgh, PA 15261 USA.		Okada, Tadao/ABF-7256-2021	Okada, Tadao/0000-0002-4002-3966				ALDER CH, 1999, MED CLIN N AM, V83, P349; Barbosa ER, 1997, PSYCHIAT CLIN N AM, V20, P769, DOI 10.1016/S0193-953X(05)70344-0; Ben-Shlomo Y, 1997, BAILLIERE CLIN NEUR, V6, P55; Bower JH, 2002, MOVEMENT DISORD, V17, P910, DOI 10.1002/mds.10202; CALNE DB, 1992, ANN NEUROL, V32, pS125, DOI 10.1002/ana.410320721; Clarke CE, 2000, J NEUROL NEUROSUR PS, V69, P590, DOI 10.1136/jnnp.69.5.590; Colcher A, 1999, MED CLIN N AM, V83, P327, DOI 10.1016/S0025-7125(05)70107-3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; DON C, 1996, W J MED, V165, P234; DUARTE J, 1995, MOVEMENT DISORD, V10, P643, DOI 10.1002/mds.870100518; FAHN S, 1972, MED CLIN N AM, V56, P1363, DOI 10.1016/S0025-7125(16)32326-4; Findley LJ, 1996, J CLIN NEUROPHYSIOL, V13, P122, DOI 10.1097/00004691-199603000-00003; GOETZ CG, 1999, TXB CLIN NEUROLOGY, P226; GREENLAND S, 1985, BIOMETRICS, V41, P55, DOI 10.2307/2530643; Habermann B, 2000, J ADV NURS, V31, P1409, DOI 10.1046/j.1365-2648.2000.01457.x; HAERER A, 1992, DEJONGS NEUROLOGIC E, P185; HOLLEMAN DR, 1995, JAMA-J AM MED ASSOC, V273, P313, DOI 10.1001/jama.273.4.313; Hughes AJ, 2002, BRAIN, V125, P861, DOI 10.1093/brain/awf080; Hughes AJ, 2001, NEUROLOGY, V57, P1497, DOI 10.1212/WNL.57.8.1497; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Jankovic J, 2000, ARCH NEUROL-CHICAGO, V57, P369, DOI 10.1001/archneur.57.3.369; JOBBAGY A, 1997, AN MOV PATT AIDS EAR, P1760; Koller WC, 2000, NEUROLOGY, V55, pS2; Kumar S, 2002, MOVEMENT DISORD, V17, P775, DOI 10.1002/mds.10167; Lee K. S., 1994, Singapore Medical Journal, V35, P265; LOU JS, 1991, NEUROLOGY, V41, P234, DOI 10.1212/WNL.41.2_Part_1.234; MARTINELLI P, 1987, ACTA NEUROL SCAND, V75, P106, DOI 10.1111/j.1600-0404.1987.tb07903.x; MENEGHINI F, 1992, J CLIN EPIDEMIOL, V45, P319, DOI 10.1016/0895-4356(92)90033-J; Mower WR, 1999, ANN EMERG MED, V33, P85, DOI 10.1016/S0196-0644(99)70422-1; MUTCH WJ, 1991, NEUROEPIDEMIOLOGY, V10, P150, DOI 10.1159/000110261; Olanow CW, 2001, NEUROLOGY, V56, pS1, DOI 10.1212/WNL.56.suppl_5.S1; Oppenheimer D.R., 1984, GREENFIELDS NEUROPAT, P699; PEARCE J, 1968, J NEUROL NEUROSUR PS, V31, P501, DOI 10.1136/jnnp.31.5.501; Playfer JR, 1997, POSTGRAD MED J, V73, P257, DOI 10.1136/pgmj.73.859.257; QUINN N, 1995, BRIT MED J, V310, P447, DOI 10.1136/bmj.310.6977.447; RAJPUT AH, 1991, CAN J NEUROL SCI, V18, P275, DOI 10.1017/S0317167100031814; Siderowf A, 2001, NEUROL CLIN, V19, P565, DOI 10.1016/S0733-8619(05)70035-9; Stoessl AJ, 1999, CAN J NEUROL SCI, V26, pS1, DOI 10.1017/S0317167100000020; Wenning GK, 2000, J NEUROL NEUROSUR PS, V68, P434, DOI 10.1136/jnnp.68.4.434	40	64	69	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					347	353		10.1001/jama.289.3.347	http://dx.doi.org/10.1001/jama.289.3.347			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525236				2022-12-28	WOS:000180345100030
J	Burkhart, CN				Burkhart, CN			Fomite transmission with head lice: a continuing controversy	LANCET			English	Editorial Material									Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA		Burkhart, CN (corresponding author), Med Coll Ohio, Dept Microbiol & Immunol, Sylvania, OH 43560 USA.							BACOT AW, 1915, PARASITOLOGY, V9, P228; Burgess Ian F., 1995, Advances in Parasitology, V36, P271, DOI 10.1016/S0065-308X(08)60493-5; BURGESS IF, 2001, PESTICIDE OUTLOOK, V10, P109; Burkhart CN., 1999, J CLIN DERMATOL, V2, P15; Canyon DV, 2002, J INVEST DERMATOL, V119, P629, DOI 10.1046/j.1523-1747.2002.00540.x; CARTER DG, 1992, THESIS U CAMBRIDGE U; MAUDER JW, 1993, HLTH VISITOR, V66, P317; MEINKING TL, 1999, CURRENT PROBLEMS DER, P77; NOBLE ER, 1982, PARASITOLOGY BIOL AN, P339; Taplin D, 1988, PEDIAT DERMATOLOGY, V2, P1465	10	18	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					99	100		10.1016/S0140-6736(03)12243-X	http://dx.doi.org/10.1016/S0140-6736(03)12243-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531574				2022-12-28	WOS:000180428000006
J	Palmer, ME; Haller, C; McKinney, PE; Klein-Schwartz, W; Tschirgi, A; Smolinske, SC; Woolf, A; Sprague, BM; Ko, R; Everson, G; Nelson, LS; Dodd-Butera, T; Bartlett, WD; Landzberg, BR				Palmer, ME; Haller, C; McKinney, PE; Klein-Schwartz, W; Tschirgi, A; Smolinske, SC; Woolf, A; Sprague, BM; Ko, R; Everson, G; Nelson, LS; Dodd-Butera, T; Bartlett, WD; Landzberg, BR			Adverse events associated with dietary supplements: an observational study	LANCET			English	Article							TRADITIONAL REMEDIES; HERBAL MEDICINES; FOOD SUPPLEMENTS; HEALTH	Background Adverse events associated with dietary supplements are difficult to monitor in the USA, because such products are not registered before sale, and there is little information about their content and safety. Methods In 1998, 11 poison control centres in the USA recorded details of 2332 telephone calls about 1466 ingestions of dietary supplements, in 784 of which patients had symptoms. We used a multitiered review process (kappa 0.42) to select 489 cases for whom we were at least 50% certain that their negative events were associated with dietary supplements. We aimed to assess the effects of multiple ingredients and long-term use, and collated data for patterns of use and information resources. Findings A third of events were of greater than mild severity. We noted both new and previously reported associations that included myocardial infarction, liver failure, bleeding, seizures, and death. Increased symptom severity was associated with use of several ingredients, long-term use, and age. Paediatric exposures were more often unintentional than were adult ingestions, and treatment of disease was the reason for supplement use in at least 28% of reports. Most products and ingredients were not identified in the information database (Poisindex) used by poison control centres, and specific adverse events were reported variably among five additional sources. Interpretation Dietary supplements are associated with adverse events that include all levels of severity, organ systems, and age groups. Associations between adverse events and ingredients are difficult to verify if a product has more than one ingredient, and because of incomplete information systems. Research into hazards and risks of dietary supplements should be a priority.	Landspitali Univ Hosp, Dept Emergency Med, IS-108 Reykjavik, Iceland; Calif Poison Control Syst, San Francisco Div, San Francisco, CA USA; Calif Poison Control Syst, Fresno Div, Fresno, CA USA; Calif Poison Control Syst, San Diego Div, San Diego, CA USA; Univ New Mexico, Hlth Sci Ctr, New Mexico Poison & Drug Informat Ctr, Albuquerque, NM 87131 USA; Univ Maryland, Sch Pharm, Maryland Poison Ctr, Baltimore, MD 21201 USA; Natl Capital Poison Ctr, Washington, DC USA; Wayne State Univ, Reg Poison Control Ctr, Detroit, MI USA; Boston Childrens Hosp, Massachusetts Poison Control Syst, Boston, MA USA; Childrens Natl Med Ctr, Ctr Hlth Serv & Clin Res, Washington, DC 20010 USA; Calif Dept Hlth Serv, Food & Drug Branch, Sacramento, CA USA; NYU, Med Ctr, New York City Poison Control Ctr, New York, NY 10016 USA; Poison Control Ctr, Philadelphia, PA USA; Cornell Univ, Weill Med Coll, Div Gastroenterol & Hepatol, New York, NY USA; New York Presbyterian Hosp, New York, NY USA	Landspitali National University Hospital; University of New Mexico; University of New Mexico's Health Sciences Center; University System of Maryland; University of Maryland Baltimore; Wayne State University; Harvard University; Boston Children's Hospital; Children's National Health System; California Department of Health Care Services; New York University; Cornell University; NewYork-Presbyterian Hospital	Palmer, ME (corresponding author), Landspitali Univ Hosp, Dept Emergency Med, IS-108 Reykjavik, Iceland.		Smolinske, Susan/AAE-7436-2021	Nelson, Lewis/0000-0001-9551-3922				Agresti A., 1990, CATEGORICAL DATA ANA, pXV; [Anonymous], 1998, PDR HERBAL MED; Blumenthal M, 1998, GERMAN COMMISSION E; Calman KC, 1996, BRIT MED J, V313, P799; Chyka P. A., 1999, Journal of Toxicology Clinical Toxicology, V37, P601; Deng JF, 1997, VET HUM TOXICOL, V39, P106; DerMarderosian A, 1999, REV NATURAL PRODUCTS; DESMET PAGM, 1995, DRUG SAFETY, V13, P81, DOI 10.2165/00002018-199513020-00003; DYER JE, 1991, AM J EMERG MED, V9, P321, DOI 10.1016/0735-6757(91)90050-T; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; Farah MH, 2000, PHARMACOEPIDEM DR S, V9, P105, DOI 10.1002/(SICI)1099-1557(200003/04)9:2<105::AID-PDS486>3.0.CO;2-2; Hamilton RJ, 1997, J TOXICOL-CLIN TOXIC, V35, P21, DOI 10.3109/15563659709001160; Hardman J. G., 1996, GOODMAN GILMANS PHAR; HOULDER AM, 1995, BRIT MED J, V310, P1473, DOI 10.1136/bmj.310.6992.1473; Hung OL, 1998, J TOXICOL-CLIN TOXIC, V36, P1; KESSLER JM, ADVERSE DRUG REACTIO; Ko RJ, 1998, NEW ENGL J MED, V339, P847, DOI 10.1056/NEJM199809173391214; Litovitz TL, 1999, AM J EMERG MED, V17, P435, DOI 10.1016/S0735-6757(99)90254-1; MCGUFFIN M, 1997, AM HERBAL PRODUCTS A; Mitka M, 1998, JAMA-J AM MED ASSOC, V280, P1554, DOI 10.1001/jama.280.18.1554; Palmer M., 2002, GOLDFRANKS TOXICOLOG, P1150; PALMER M, LANCET; Palmer ME, 1999, NEW ENGL J MED, V340, P568, DOI 10.1056/NEJM199902183400715; PALMER ME, 2001, CLIN TOXICOL, P316; PERHARIC L, 1994, DRUG SAFETY, V11, P284, DOI 10.2165/00002018-199411040-00006; PHILEN RM, 1992, JAMA-J AM MED ASSOC, V268, P1008, DOI 10.1001/jama.268.8.1008; PILLANS PI, 1995, NEW ZEAL MED J, V108, P469; Shaw D, 1997, DRUG SAFETY, V17, P342, DOI 10.2165/00002018-199717050-00006; TOLL LL, 1998, POISINDEX SYSTEM; Tyler VE, 1993, HONEST HERBAL SENSIB, V3rd; VENULET J, 1979, INT J CLIN PHARM BI, V17, P383; Zvosec DL, 2001, NEW ENGL J MED, V344, P87, DOI 10.1056/NEJM200101113440202; 2000, MICROMEDEX HEALTHCAR; 1999, PDR NONPRESCRIPTION; 2000, FED REG         0106, V65, P999	35	151	156	4	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					101	106		10.1016/S0140-6736(03)12227-1	http://dx.doi.org/10.1016/S0140-6736(03)12227-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531576				2022-12-28	WOS:000180428000008
J	Hotchkiss, RS; Karl, IE				Hotchkiss, RS; Karl, IE			Medical progress: The pathophysiology and treatment of sepsis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-C; INTERLEUKIN-1 RECEPTOR ANTAGONIST; SEPTIC SHOCK; IMPROVES SURVIVAL; CELL-DEATH; LYMPHOCYTE APOPTOSIS; MONOCLONAL-ANTIBODY; ORGAN FAILURE; DOUBLE-BLIND		Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, Campus Box 8054, St Louis, MO 63110 USA.	hotch@morpheus.wustl.edu			NIGMS NIH HHS [GM 44118, GM 55194] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118, R01GM055194, R37GM044118] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ABRAHAM E, 1995, JAMA-J AM MED ASSOC, V273, P934, DOI 10.1001/jama.273.12.934; Abraham E, 2002, JAMA-J AM MED ASSOC, V288, P886, DOI 10.1001/jama.288.7.886; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2001, CRIT CARE MED, V29, pS117, DOI 10.1097/00003246-200107001-00036; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; AYALA A, 1995, SHOCK, V3, P259, DOI 10.1097/00024382-199504000-00003; BELL RC, 1983, ANN INTERN MED, V99, P293, DOI 10.7326/0003-4819-99-3-293; Bernard GR, 1997, NEW ENGL J MED, V336, P912, DOI 10.1056/NEJM199703273361303; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Blosser SA, 1998, CRIT CARE MED, V26, P1332, DOI 10.1097/00003246-199808000-00015; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Calandra T, 2000, NAT MED, V6, P164, DOI 10.1038/72262; Chung CS, 1998, ARCH SURG-CHICAGO, V133, P1213, DOI 10.1001/archsurg.133.11.1213; Coopersmith CM, 2002, JAMA-J AM MED ASSOC, V287, P1716, DOI 10.1001/jama.287.13.1716; CRONIN L, 1995, CRIT CARE MED, V23, P1430, DOI 10.1097/00003246-199508000-00019; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; DEBETS JMH, 1989, CRIT CARE MED, V17, P489, DOI 10.1097/00003246-198906000-00001; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Docke WD, 1997, NAT MED, V3, P678, DOI 10.1038/nm0697-678; Echtenacher B, 2001, INFECT IMMUN, V69, P3550, DOI 10.1128/IAI.69.6.3550-3555.2001; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; ERTEL W, 1992, SURGERY, V111, P177; ESKANDARI MK, 1992, J IMMUNOL, V148, P2724; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FINK MP, 1990, J SURG RES, V49, P186, DOI 10.1016/0022-4804(90)90260-9; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; Freeman BD, 2000, CRIT CARE MED, V28, P3090, DOI 10.1097/00003246-200008000-00075; Fukuzuka K, 2000, AM J PHYSIOL-REG I, V278, pR1005, DOI 10.1152/ajpregu.2000.278.4.R1005; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; GLECKMAN R, 1982, JAMA-J AM MED ASSOC, V248, P1478, DOI 10.1001/jama.248.12.1478; Gogos CA, 2000, J INFECT DIS, V181, P176, DOI 10.1086/315214; Goldfarb RD, 2002, CRIT CARE MED, V30, P974, DOI 10.1097/00003246-200205000-00004; Green DR, 2000, NATURE, V405, P28, DOI 10.1038/35011175; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; HAGBERG L, 1985, J IMMUNOL, V134, P4118; Haslett C, 2001, BMJ-BRIT MED J, V322, P1499, DOI 10.1136/bmj.322.7301.1499; Hatherill M, 2000, CRIT CARE MED, V28, P2591, DOI 10.1097/00003246-200007000-00068; Heidecke CD, 1999, AM J SURG, V178, P288, DOI 10.1016/S0002-9610(99)00183-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2000, NAT IMMUNOL, V1, P496, DOI 10.1038/82741; Hotchkiss RS, 1999, J IMMUNOL, V162, P4148; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hotchkiss RS, 1997, CRIT CARE MED, V25, P1298, DOI 10.1097/00003246-199708000-00015; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Huber-Lang MS, 2001, FASEB J, V15, P568; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Khan AU, 2002, AM J PHYSIOL-LUNG C, V282, pL1082, DOI 10.1152/ajplung.00358.2001; KOLLEF MH, 1995, NEW ENGL J MED, V332, P27, DOI 10.1056/NEJM199501053320106; Lederer JA, 1999, SHOCK, V11, P153, DOI 10.1097/00024382-199903000-00001; Manjuck J, 2000, J LAB CLIN MED, V135, P153, DOI 10.1067/mlc.2000.104306; Manns BJ, 2002, NEW ENGL J MED, V347, P993, DOI 10.1056/NEJMsa020969; Matthay MA, 2001, NEW ENGL J MED, V344, P759, DOI 10.1056/NEJM200103083441009; MEAKINS JL, 1977, ANN SURG, V186, P241, DOI 10.1097/00000658-197709000-00002; Modlin RL, 1999, NEW ENGL J MED, V340, P1834, DOI 10.1056/NEJM199906103402312; Mort TC, 1999, CRIT CARE MED, V27, P299, DOI 10.1097/00003246-199902000-00035; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Murphy S., 2000, NATL VITAL STAT REPO, P48; NATANSON C, 1994, ANN INTERN MED, V120, P771, DOI 10.7326/0003-4819-120-9-199405010-00009; Nelson S, 1998, J INFECT DIS, V178, P1075, DOI 10.1086/515694; Nelson S, 1999, AM J RESP CRIT CARE, V159, P1365; O'Reilly M, 1999, SHOCK, V12, P411, DOI 10.1097/00024382-199912000-00001; Oberholzer A, 2001, SHOCK, V16, P83, DOI 10.1097/00024382-200116020-00001; Oberholzer A, 2000, CRIT CARE MED, V28, pN3, DOI 10.1097/00003246-200004001-00002; Oberholzer C, 2001, FASEB J, V15, P879, DOI 10.1096/fj.00-058rev; Oberholzer C, 2001, P NATL ACAD SCI USA, V98, P11503, DOI 10.1073/pnas.181338198; Opal SM, 1996, J INFECT DIS, V173, P1415, DOI 10.1093/infdis/173.6.1415; Opal SM, 2000, CHEST, V117, P1162, DOI 10.1378/chest.117.4.1162; OSuilleabhain C, 1996, SURGERY, V120, P290, DOI 10.1016/S0039-6060(96)80300-X; OSULLIVAN ST, 1995, ANN SURG, V222, P482; Parrillo J E, 1993, N Engl J Med, V328, P1471; Pellegrini JD, 2000, J SURG RES, V88, P200, DOI 10.1006/jsre.1999.5797; Pruitt JH, 1996, BLOOD, V87, P3282; Raff M, 1998, NATURE, V396, P119, DOI 10.1038/24055; Reinhart K, 2001, CRIT CARE MED, V29, pS121, DOI 10.1097/00003246-200107001-00037; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; ROGY MA, 1994, J AM COLL SURGEONS, V178, P132; ROOT RK, IN PRESS CRIT CARE M; Sawyer DB, 2002, CIRCULATION, V105, P1517, DOI 10.1161/01.CIR.0000014689.12415.89; Shenker Y, 2001, AM J RESP CRIT CARE, V163, P1520, DOI 10.1164/ajrccm.163.7.2012022; Siegel JP, 2002, NEW ENGL J MED, V347, P1030, DOI 10.1056/NEJMsb021512; SOLEZ K, 1979, MEDICINE, V58, P362, DOI 10.1097/00005792-197909000-00003; SORENSEN TIA, 1988, NEW ENGL J MED, V318, P727, DOI 10.1056/NEJM198803243181202; Soriano FG, 2002, SHOCK, V17, P286, DOI 10.1097/00024382-200204000-00008; STONE R, 1994, SCIENCE, V264, P365, DOI 10.1126/science.8153620; THOMAS L, 1972, NEW ENGL J MED, V287, P553, DOI 10.1056/NEJM197209142871109; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van der Pol WL, 2001, J INFECT DIS, V184, P1548, DOI 10.1086/324662; van Deventer SJH, 2000, INTENS CARE MED, V26, pS98, DOI 10.1007/s001340051125; Vasselon T, 2002, INFECT IMMUN, V70, P1033, DOI 10.1128/IAI.70.3.1033-1041.2002; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren BL, 2002, JAMA-J AM MED ASSOC, V287, P192; WARREN HS, 1993, J EXP MED, V177, P89, DOI 10.1084/jem.177.1.89; Warren HS, 1997, NEW ENGL J MED, V336, P952, DOI 10.1056/NEJM199703273361311; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574; Weighardt H, 2000, SURGERY, V127, P309, DOI 10.1067/msy.2000.104118; Weinberg JM, 2001, J CLIN INVEST, V108, P1279, DOI 10.1172/JCI14320; Wheeler AP, 1999, NEW ENGL J MED, V340, P207, DOI 10.1056/NEJM199901213400307; Zeni F, 1997, CRIT CARE MED, V25, P1095, DOI 10.1097/00003246-199707000-00001; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	111	2831	3124	6	326	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					138	150		10.1056/NEJMra021333	http://dx.doi.org/10.1056/NEJMra021333			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519925				2022-12-28	WOS:000180263900007
J	Doorenbos, CJ; Vermeij, CG				Doorenbos, CJ; Vermeij, CG			Lesson of the week - Danger of salt substitutes that contain potassium in patients with renal failure	BRITISH MEDICAL JOURNAL			English	Review							HYPERKALEMIA		Deventer Hosp, Dept Internal Med & Nephrol, NL-7400 GC Deventer, Netherlands	Deventer Hospital	Doorenbos, CJ (corresponding author), Deventer Hosp, Dept Internal Med & Nephrol, POB 5001, NL-7400 GC Deventer, Netherlands.							He FJ, 2001, BMJ-BRIT MED J, V323, P497, DOI 10.1136/bmj.323.7311.497; PAL B, 1995, BRIT MED J, V311, P1486, DOI 10.1136/bmj.311.7018.1486; Perazella MA, 2000, AM J MED, V109, P307, DOI 10.1016/S0002-9343(00)00496-4; ROSE BD, 2001, UPTODATE VERSION 9 2	4	19	20	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					35	36		10.1136/bmj.326.7379.35	http://dx.doi.org/10.1136/bmj.326.7379.35			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511461	Green Published			2022-12-28	WOS:000180302000026
J	Ellershaw, J; Ward, C				Ellershaw, J; Ward, C			Care of the dying patient: the last hours or days of life	BRITISH MEDICAL JOURNAL			English	Review									Marie Curie Ctr Liverpool, Liverpool L25 8QA, Merseyside, England; Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Dundee DD2 9SY, Scotland	University of Dundee	Ellershaw, J (corresponding author), Marie Curie Ctr Liverpool, Speke Rd, Liverpool L25 8QA, Merseyside, England.		Ram, Prem/K-4511-2012	Ellershaw, John/0000-0001-9789-3180				Anderson H, 2001, PALLIATIVE MED, V15, P279, DOI 10.1191/026921601678320269; *BRIT MED ASS, 1995, ADV STAT MED TREATM; Campbell H, 1998, BMJ-BRIT MED J, V316, P133; Clark D, 2002, BRIT MED J, V324, P905, DOI 10.1136/bmj.324.7342.905; *DEP HLTH, 2000, NAT SERV FRAM COR HE, pCH6; *DEP HLTH, 2000, NAT SERV FRAM COR HE, pCH7; DYER C, 1992, BRIT MED J, V305, P1311; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Ellershaw J., 1997, EUR J PALLIAT CARE, V4, P203; Fallowfield LJ, 2002, PALLIATIVE MED, V16, P297, DOI 10.1191/0269216302pm575oa; FIELD D, IN PRESS MED ED; *GEN MED COUNC, 2002, TOM DOCT REC UND MED; Hanks GW, 1996, BRIT MED J, V312, P823; Higgs R, 1999, J ROY COLL PHYS LOND, V33, P110; HINTON JM, 1963, Q J MED, V32, P1; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; McCarthy M, 1996, J ROY COLL PHYS LOND, V30, P325; *NAT COUNC HOSP SP, 1997, J EUR ASS PALLIATIVE, V4, P203; *NAT COUNC HOSP SP, 2002, ETH DEC MAK PALL CAR; NHS Beacon Programme, 2001, NHS BEAC LEARN HDB S, V4, P128; Office of National Statistics, 2000, ANN REV REG GEN DEAT; Thomas K., 2003, CARING DYING HOME CO; TWYCROSS R, 1998, OXFORD BOOK PALLIATI, pCH17; *WORK PART CLIN GU, 1997, CHANG GEAR GUID MAN	24	351	359	1	22	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					30	34		10.1136/bmj.326.7379.30	http://dx.doi.org/10.1136/bmj.326.7379.30			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511460				2022-12-28	WOS:000180302000024
J	Jilma, B; Kamath, S; Lip, GYH				Jilma, B; Kamath, S; Lip, GYH			ABC of antithrombotic therapy - Antithrombotic therapy in special circumstances. I-pregnancy and cancer	BRITISH MEDICAL JOURNAL			English	Review							PREVENTION		Univ Hosp Vienna, Dept Clin Pharmacol, Vienna, Austria; City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England	University Hospital Vienna; University of Birmingham	Jilma, B (corresponding author), Univ Hosp Vienna, Dept Clin Pharmacol, Vienna, Austria.			Jilma, Bernd/0000-0001-5652-7977				Barbour LA, 1997, OBSTET GYN CLIN N AM, V24, P499, DOI 10.1016/S0889-8545(05)70319-3; BEROYZ G, 1994, LANCET, V343, P619; Chan WS, 2002, THROMB RES, V107, P85, DOI 10.1016/S0049-3848(02)00105-6; Coomarasamy A, 2001, OBSTET GYNECOL, V98, P861, DOI 10.1016/S0029-7844(01)01569-1; Cotrufo M, 2002, OBSTET GYNECOL, V99, P35, DOI 10.1016/S0029-7844(01)01658-1; Cumming AM, 1999, CLIN LAB HAEMATOL, V21, P77, DOI 10.1046/j.1365-2257.1999.00210.x; Farquharson RG, 2002, OBSTET GYNECOL, V100, P408, DOI 10.1016/S0029-7844(02)02165-8; Ginsberg JS, 2001, CHEST, V119, p122S, DOI 10.1378/chest.119.1_suppl.122S; Letai A, 1999, Oncologist, V4, P443; LEVINE M, 1994, LANCET, V343, P886, DOI 10.1016/S0140-6736(94)90008-6; Lip GYH, 2002, LANCET ONCOL, V3, P27, DOI 10.1016/S1470-2045(01)00619-2; Nash GF, 2001, LANCET ONCOL, V2, P608, DOI 10.1016/S1470-2045(01)00518-6; Prandoni P, 1997, THROMB HAEMOSTASIS, V78, P141; Sanson BJ, 1999, THROMB HAEMOSTASIS, V81, P668, DOI 10.1055/s-0037-1614550	14	7	12	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					37	40		10.1136/bmj.326.7379.37	http://dx.doi.org/10.1136/bmj.326.7379.37			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511462	Bronze, Green Published			2022-12-28	WOS:000180302000027
J	Crespi, B; Springer, S				Crespi, B; Springer, S			Social slime molds meet their match	SCIENCE			English	Editorial Material									Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Crespi, B (corresponding author), Simon Fraser Univ, Dept Biosci, Behav Ecol Res Grp, Burnaby, BC V5A 1S6, Canada.	crespi@sfu.ca	Springer, Stevan/D-5143-2011					Dawkins Richard, 1976, SELFISH GENE; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAIG D, 1996, BEHAV ECOLOGY EVOLUT, P284; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore T, 2002, TRENDS ECOL EVOL, V17, P112, DOI 10.1016/S0169-5347(01)02425-9; Pignatelli M, 1998, J PATHOL, V186, P1, DOI 10.1002/(SICI)1096-9896(199809)186:1<1::AID-PATH135>3.0.CO;2-T; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742	10	4	4	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					56	57		10.1126/science.1080776	http://dx.doi.org/10.1126/science.1080776			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511635				2022-12-28	WOS:000180165800026
J	Palumbi, SR; Warner, RR				Palumbi, SR; Warner, RR			Why gobies are like hobbits	SCIENCE			English	Editorial Material									Stanford Univ, Dept Biol Sci, Pacific Grove, CA 93950 USA; Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA	Stanford University; University of California System; University of California Santa Barbara	Palumbi, SR (corresponding author), Stanford Univ, Dept Biol Sci, Pacific Grove, CA 93950 USA.		Warner, Robert R./M-5342-2013	Warner, Robert R./0000-0002-3299-5685				Avise J.C., 2000, PHYLOGEOGRAPHY; Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; MENGE B, AAAS M DENV CO OP BL; Mora C, 2002, TRENDS ECOL EVOL, V17, P422, DOI 10.1016/S0169-5347(02)02584-3; Planes S, 1998, CORAL REEFS, V17, P9, DOI 10.1007/s003380050086; QUESADA H, 1995, MAR ECOL PROG SER, V116, P99, DOI 10.3354/meps116099; Swearer SE, 2002, B MAR SCI, V70, P251; Taylor MS, 2003, SCIENCE, V299, P107, DOI 10.1126/science.1079365; TOLKIEN JRR, 1994, LORD RINGS FELLOWSHI, P72; ZACHERL D, 2002, THESIS U CALIFORNIA	10	37	40	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					51	52		10.1126/science.1080775	http://dx.doi.org/10.1126/science.1080775			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511632				2022-12-28	WOS:000180165800022
J	Paul, A; Bartels, RA; Tobey, R; Green, H; Weiman, S; Christov, IP; Murnane, MM; Kapteyn, HC; Backus, S				Paul, A; Bartels, RA; Tobey, R; Green, H; Weiman, S; Christov, IP; Murnane, MM; Kapteyn, HC; Backus, S			Quasi-phase-matched generation of coherent extreme-ultraviolet light	NATURE			English	Article							SOFT X-RAYS; ORDER HARMONIC-GENERATION; ATTOSECOND PULSES; WAVE-GUIDES; GASES	High-harmonic generation is a well-known method of producing coherent extreme-ultraviolet (EUV) light, with photon energies up to about 0.5 keV (refs 1, 2). This is achieved by focusing a femtosecond laser into a gas, and high harmonics of the fundamental laser frequency are radiated in the forward direction(3,4). However, although this process can generate high-energy photons, efficient high-harmonic generation has been demonstrated only for photon energies of the order 50-100 eV (ref. 5). Ionization of the gas prevents the laser and the EUV light from propagating at the same speed, which severely limits the conversion efficiency. Here we report a technique to overcome this problem, and demonstrate quasi-phase-matched frequency conversion of laser light into EUV. Using a modulated hollow-core waveguide to periodically vary the intensity of the laser light driving the conversion, we efficiently generate EUV light even in the presence of substantial ionization. The use of a modulated fibre shifts the energy spectrum of the high-harmonic light to significantly higher photon energies than would otherwise be possible. We expect that this technique could form the basis of coherent EUV sources for advanced lithography and high-resolution imaging applications. In future work, it might also be possible to generate isolated attosecond pulses.	Univ Colorado, Dept Phys, Boulder, CO 80309 USA; Univ Colorado, JILA, Boulder, CO 80309 USA; Univ Sofia, Dept Phys, Sofia 1164, Bulgaria	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Bulgarian Academy of Sciences; University of Sofia	Murnane, MM (corresponding author), Univ Colorado, Dept Phys, Boulder, CO 80309 USA.		Christov, Ivan P/D-4446-2014; Kapteyn, Henry C/H-6559-2011; Bartels, Randy/A-1217-2011; Backus, Sterling/C-2506-2008	Christov, Ivan P/0000-0002-9146-6708; Kapteyn, Henry C/0000-0001-8386-6317; Bartels, Randy/0000-0003-0530-0435; 				ARMSTRONG JA, 1962, PHYS REV, V127, P1918, DOI 10.1103/PhysRev.127.1918; Backus S, 2001, OPT LETT, V26, P465, DOI 10.1364/OL.26.000465; Bartels R, 2000, NATURE, V406, P164, DOI 10.1038/35018029; Bartels RA, 2002, SCIENCE, V297, P376, DOI 10.1126/science.1071718; Bloembergen N., 1996, NONLINEAR OPTICS; Chang ZH, 1997, PHYS REV LETT, V79, P2967, DOI 10.1103/PhysRevLett.79.2967; Christov IP, 2000, OPT EXPRESS, V7, P362, DOI 10.1364/OE.7.000362; Christov IP, 1997, PHYS REV LETT, V78, P1251, DOI 10.1103/PhysRevLett.78.1251; Durfee CG, 1999, PHYS REV LETT, V83, P2187, DOI 10.1103/PhysRevLett.83.2187; FEJER MM, 1992, IEEE J QUANTUM ELECT, V28, P2631, DOI 10.1109/3.161322; FERRAY M, 1988, J PHYS B-AT MOL OPT, V21, pL31, DOI 10.1088/0953-4075/21/3/001; FRANKEN PA, 1961, PHYS REV LETT, V7, P118, DOI 10.1103/PhysRevLett.7.118; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Lange HR, 1998, PHYS REV LETT, V81, P1611, DOI 10.1103/PhysRevLett.81.1611; MCPHERSON A, 1987, J OPT SOC AM B, V4, P595, DOI 10.1364/JOSAB.4.000595; Miller GD, 1997, OPT LETT, V22, P1834, DOI 10.1364/OL.22.001834; Misoguti L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.013601; Rundquist A, 1998, SCIENCE, V280, P1412, DOI 10.1126/science.280.5368.1412; SHKOLNIKOV PL, 1994, PHYS REV A, V50, pR4461, DOI 10.1103/PhysRevA.50.R4461; Somekh S., 1972, Optics Communications, V6, P301, DOI 10.1016/0030-4018(72)90200-3; Spielmann C, 1997, SCIENCE, V278, P661, DOI 10.1126/science.278.5338.661; Voronov SL, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.133902; Zhu S, 1997, SCIENCE, V278, P843, DOI 10.1126/science.278.5339.843	23	269	275	8	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					51	54		10.1038/nature01222	http://dx.doi.org/10.1038/nature01222			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511950	Green Published			2022-12-28	WOS:000180165500033
J	Gamulin, A; Oberholzer, J; Rubbia-Brandt, L; Mentha, G				Gamulin, A; Oberholzer, J; Rubbia-Brandt, L; Mentha, G			An unusual, presumably hepatic mass	LANCET			English	Editorial Material									Univ Hosp, Dept Surg, Cin Digest & Transplant Surg, CH-1211 Geneva, Switzerland; Univ Hosp, Dept Pathol, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva	Gamulin, A (corresponding author), Univ Hosp, Dept Surg, Cin Digest & Transplant Surg, CH-1211 Geneva, Switzerland.		Gamulin, Axel/AAZ-5342-2021						0	8	8	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2066	2066		10.1016/S0140-6736(02)11999-4	http://dx.doi.org/10.1016/S0140-6736(02)11999-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504419				2022-12-28	WOS:000179974200030
J	Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC				Ray, JG; Meier, C; Vermeulen, MJ; Boss, S; Wyatt, PR; Cole, DEC			Association of neural tube defects and folic acid food fortification in Canada	LANCET			English	Article							WOMEN	Many women do not receive folic acid supplements before conception. In response, most of Canada's cereal grain products were being fortified with folic acid by January, 1998, thereby providing an additional 0.1-0.2 mg per day of dietary folate to the Canadian population. We assessed the effect of supplementation on prevalence of open neural tube defects in the province of Ontario. Among 336 963 women who underwent maternal serum screening over 77 months, the prevalence of open neural tube defects declined from 1.13 per 1000 pregnancies before fortification to 0.58 per 1000 pregnancies thereafter (prevalence ratio 0.52, 95% Cl 0.40-0.67, p<0.0001). At a population level, folic acid food fortification is associated with a pronounced reduction in open neural tube defects.	Sunnybrook & Womens Coll, Hlth Sci Ctr, Dept Med, Toronto, ON, Canada; Sunnybrook & Womens Coll, Hlth Sci Ctr, Prehosp Care Programme, Toronto, ON, Canada; N York Gen Hosp, Genet Programme, Ontario Maternal Serum Screening Database Dept, Toronto, ON, Canada; MDS Serv, Toronto, ON, Canada; N York Gen Hosp, Dept Genet, Toronto, ON, Canada; Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med, Toronto, ON, Canada; Univ Toronto, Dept Paediat Genet, Toronto, ON, Canada	University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; University of Toronto; University of Toronto	Ray, JG (corresponding author), 235A Medland St, Toronto, ON M6P 2N6, Canada.	Jray515445@aol.com						Berry RJ, 1999, NEW ENGL J MED, V341, P1485, DOI 10.1056/NEJM199911113412001; Honein MA, 2001, JAMA-J AM MED ASSOC, V285, P2981, DOI 10.1001/jama.285.23.2981; LUMLEY J, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001056.pub2, 10.1002/14651858.CD001056, DOI 10.1002/14651858.CD001056]; Mathews F, 1998, BRIT J OBSTET GYNAEC, V105, P954, DOI 10.1111/j.1471-0528.1998.tb10257.x; Ray JG, 2002, EPIDEMIOLOGY, V13, P238, DOI 10.1097/00001648-200203000-00026	5	195	200	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2047	2048		10.1016/S0140-6736(02)11994-5	http://dx.doi.org/10.1016/S0140-6736(02)11994-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504403				2022-12-28	WOS:000179974200015
J	Hung, J; Beilby, JP; Knuiman, MW; Divitini, M				Hung, J; Beilby, JP; Knuiman, MW; Divitini, M			Folate and vitamin B-12 and risk of fatal cardiovascular disease: cohort study from Busselton, Western Australia	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; SERUM FOLATE; HOMOCYSTEINE; HEALTH; ATHEROSCLEROSIS; HOMOCYST(E)INE; DIET	Objective To test the hypothesis that the incidence of fatal coronary heart disease and cardiovascular disease in a general population is related to serum and red cell folate and vitamin B-12 concentrations. Design Cohort study with follow up of 29 years. Setting Busselton, Western Australia. Participants 1419 men and 1531 women aged 20 to 90 years, who were alive more than three years after their participation in the 1969 Busselton health survey. 2314 (78.4%) had no cardiovascular disease at the initial survey. Main outcome measures Hazard. ratios for fatal coronary heart disease and cardiovascular disease in men and women according to baseline concentrations of serum and red cell folate and serum vitamin B-12. Results 213 men and 159 women died from coronary heart disease, and 342 men and 302 women died from cardiovascular disease. Serum and red cell folate concentrations showed a moderate positive correlation (r=0.26, P<0.001) but other-wise serum and red cell folate and serum B-12 concentrations were not strongly correlated with each other or with other standard risk factors. After age and standard risk factors were adjusted for, there was no independent association between folate and B-12 concentrations and death from coronary heart disease or cardiovascular disease in the full cohort or the subcohort with no cardiovascular disease at baseline. The multivariate adjusted hazard ratio for death from cardiovascular disease in the lowest versus the highest category of red cell folate concentration was 1.05 (95% confidence interval 0.77 to 1.43) in men and 1.10 (0.81 to 1.51) in women. Conclusions These findings do not support the hypothesis that lower folate and B-12 concentrations increase the risk of fatal cardiovascular disease in a general population. The routine use of these vitamins for preventing cardiovascular disease should await evidence from clinical trials.	Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia; Univ Western Australia, Sir Charles Gairdner Hosp, Dept Med, Nedlands, WA 6009, Australia; QEII Med Ctr, PathCtr, Nedlands, WA 6009, Australia; Univ Western Australia, Dept Publ Hlth, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia	Hung, J (corresponding author), Univ Western Australia, Sir Charles Gairdner Hosp, Dept Cardiol, Nedlands, WA 6009, Australia.		Knuiman, Matthew W/I-5549-2013	Knuiman, Matthew/0000-0001-8874-2305; Beilby, John/0000-0002-4915-2254				BABIOR BM, 2001, WILLIAMS HEMATOLOGY, P425; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; ChasanTaber L, 1996, J AM COLL NUTR, V15, P136; Clarke R, 1998, J Cardiovasc Risk, V5, P249, DOI 10.1097/00043798-199808000-00007; CULLEN KJ, 1972, MED J AUSTRALIA, V2, P714, DOI 10.5694/j.1326-5377.1972.tb103506.x; Davis R. E., 1979, Proceedings of the Nutrition Society of Australia, V4, P45; Eikelboom JW, 1999, ANN INTERN MED, V131, P363, DOI 10.7326/0003-4819-131-5-199909070-00008; Folsom AR, 1998, CIRCULATION, V98, P204, DOI 10.1161/01.CIR.98.3.204; Ford ES, 1998, INT J EPIDEMIOL, V27, P592, DOI 10.1093/ije/27.4.592; Knuiman M W, 1996, J Cardiovasc Risk, V3, P447; KNUIMAN MW, 1995, AUST J PUBLIC HEALTH, V19, P375; Knuiman MW, 1998, AUST NZ J PUBL HEAL, V22, P747, DOI 10.1111/j.1467-842X.1998.tb01487.x; Knuiman MW, 1997, J EPIDEMIOL COMMUN H, V51, P515, DOI 10.1136/jech.51.5.515; Lonn E, 2001, J AM COLL CARDIOL, V38, P1795, DOI 10.1016/S0735-1097(01)01626-6; Malinow MR, 1999, CIRCULATION, V99, P178, DOI 10.1161/01.CIR.99.1.178; MILLBANK L, 1970, J CLIN PATHOL, V23, P54, DOI 10.1136/jcp.23.1.54; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; Rimm EB, 1998, JAMA-J AM MED ASSOC, V279, P359, DOI 10.1001/jama.279.5.359; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; UBBINK JB, 1994, NUTR REV, V52, P383, DOI 10.1111/j.1753-4887.1994.tb01369.x; Voutilainen S, 2001, CIRCULATION, V103, P2674, DOI 10.1161/01.CIR.103.22.2674; WELBORN TA, 1969, AM J EPIDEMIOL, V89, P521, DOI 10.1093/oxfordjournals.aje.a120965	23	39	40	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					131	134		10.1136/bmj.326.7381.131	http://dx.doi.org/10.1136/bmj.326.7381.131			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531843	Bronze, Green Published			2022-12-28	WOS:000180575900022
J	Reilly, SM; White, TD				Reilly, SM; White, TD			Hypaxial motor patterns and the function of epipubic bones in primitive mammals	SCIENCE			English	Article							LOCOMOTION; MUSCLES; WALKING	Since the first description of epipubic bones in 1698, their functions and those of the associated abdominal muscles of monotremes and marsupial mammals have remained unresolved. We show that each epipubic bone is part of a kinetic linkage extending from the femur, by way of the pectineus muscle, to the epipubic bone, through the pyramidalis and rectus abdominis muscles on one side of the abdomen, and through the contralateral external and internal oblique muscles to the vertebrae and ribs of the opposite side. This muscle series is activated synchronously as the femur and contralateral forelimb are retracted during the stance phase in locomotion. The epipubic bone acts as a lever that is retracted ( depressed) to stiffen the trunk between the diagonal limbs that support the body during each step. This cross-couplet kinetic linkage and the stiffening function of the epipubic bone appear to be the primitive conditions for mammals.	Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA; SUNY Coll Buffalo, Dept Biol, Buffalo, NY 14222 USA	University System of Ohio; Ohio University; State University of New York (SUNY) System; Buffalo State College	Reilly, SM (corresponding author), Ohio Univ, Dept Biol Sci, Athens, OH 45701 USA.	reilly@ohiou.edu						Bennett WO, 2001, J EXP BIOL, V204, P1979; CARRIER D, 1990, J EXP BIOL, V152, P453; CARRIER DR, 1993, J EXP BIOL, V180, P75; Fife MM, 2001, J EXP BIOL, V204, P2371; FOURIE S, 1963, NATURE, V198, P201, DOI 10.1038/198201a0; Gambaryan P.P., 1974, MAMMALS RUN ANATOMIC; HILDEBRAND M, 1977, J MAMMAL, V58, P131, DOI 10.2307/1379571; JENKINS FA, 1970, EVOLUTION, V24, P230, DOI 10.1111/j.1558-5646.1970.tb01756.x; Ji Q, 2002, NATURE, V416, P816, DOI 10.1038/416816a; Novacek MJ, 1997, NATURE, V389, P483, DOI 10.1038/39020; OWEN R, 1943, P ZOOL SOC LOND 1843, P148; Reilly SM, 1998, BRAIN BEHAV EVOLUT, V52, P126, DOI 10.1159/000006557; Ritter D, 1996, J EXP BIOL, V199, P2499; Tyson, 1698, PHIL T R SOC, V239, P105, DOI [10.1098/rstl.1698.0023, DOI 10.1098/RSTL.1698.0023]; VAUGHN PETER PAUL, 1956, JOUR ELISHA MITCHELL SCI SOC, V72, P243; WHITE TD, 1989, J THEOR BIOL, V139, P343, DOI 10.1016/S0022-5193(89)80213-9; WHITE TD, 1990, J MAMMAL, V71, P79, DOI 10.2307/1381321	17	25	27	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					400	402		10.1126/science.1074905	http://dx.doi.org/10.1126/science.1074905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532019				2022-12-28	WOS:000180426800047
J	Brumfiel, G				Brumfiel, G			Gravity experiment sparks spat between physicists	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					198	198		10.1038/421198a	http://dx.doi.org/10.1038/421198a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529598	Bronze			2022-12-28	WOS:000180397600004
J	Edmonds, HN; Michael, PJ; Baker, ET; Connelly, DP; Snow, JE; Langmuir, CH; Dick, HJB; Muhe, R; German, CR; Graham, DW				Edmonds, HN; Michael, PJ; Baker, ET; Connelly, DP; Snow, JE; Langmuir, CH; Dick, HJB; Muhe, R; German, CR; Graham, DW			Discovery of abundant hydrothermal venting on the ultraslow-spreading Gakkel ridge in the Arctic	NATURE			English	Article							MID-ATLANTIC RIDGE; VOLCANIC ACTIVITY; INDIAN RIDGE; PLUMES; FIELD; OCEAN	Submarine hydrothermal venting along mid-ocean ridges is an important contributor to ridge thermal structure(1), and the global distribution of such vents has implications for heat and mass fluxes(2) from the Earth's crust and mantle and for the biogeography of vent-endemic organisms.(3) Previous studies have predicted that the incidence of hydrothermal venting would be extremely low on ultraslow-spreading ridges (ridges with full spreading rates <2 cm yr(-1)-which make up 25 per cent of the global ridge length), and that such vent systems would be hosted in ultramafic in addition to volcanic rocks(4,5). Here we present evidence for active hydrothermal venting on the Gakkel ridge, which is the slowest spreading (0.6-1.3 cm yr(-1)) and least explored mid-ocean ridge. On the basis of water column profiles of light scattering, temperature and manganese concentration along 1,100 km of the rift valley, we identify hydrothermal plumes dispersing from at least nine to twelve discrete vent sites. Our discovery of such abundant venting, and its apparent localization near volcanic centres, requires a reassessment of the geologic conditions that control hydrothermal circulation on ultraslow-spreading ridges.	Univ Texas, Inst Marine Sci, Port Aransas, TX 78373 USA; Univ Tulsa, Tulsa, OK 74104 USA; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England; Max Planck Inst Chem, D-55020 Mainz, Germany; Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; Woods Hole Oceanog Inst, Dept Marine Geol & Geophys, Woods Hole, MA 02543 USA; Univ Kiel, Inst Geosci, D-24118 Kiel, Germany; Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA	University of Texas System; University of Tulsa; National Oceanic Atmospheric Admin (NOAA) - USA; NERC National Oceanography Centre; University of Southampton; Max Planck Society; Harvard University; Woods Hole Oceanographic Institution; University of Kiel; Oregon State University	Edmonds, HN (corresponding author), Univ Texas, Inst Marine Sci, 750 Channel View Dr, Port Aransas, TX 78373 USA.	edmonds@utmsi.utexas.edu	Graham, David/C-3612-2014; Baker, Edward/C-7688-2015; Snow, Jonathan/E-5591-2011	Graham, David/0000-0002-7411-1905; Baker, Edward/0000-0002-8794-4180; Michael, Peter/0000-0003-2829-9502				BACH W, 2002, GEOCHEM GEOPHYS GEOS, V3, DOI DOI 10.1029/2001GC000279; Baker E.T., 1997, RIDGE EVENTS, V8, P23; Baker ET, 2001, DEEP-SEA RES PT I, V48, P593, DOI 10.1016/S0967-0637(00)00011-X; Baker ET, 2001, GEOCHEM GEOPHY GEOSY, V2, DOI 10.1029/2000GC000165; Baker ET, 1996, EARTH PLANET SC LETT, V142, P137, DOI 10.1016/0012-821X(96)00097-0; BAKER ET, 1995, SEAFLOOR HYDROTHERMA, P47; BOWN JW, 1994, EARTH PLANET SC LETT, V121, P435, DOI 10.1016/0012-821X(94)90082-5; Charlou JL, 1998, GEOCHIM COSMOCHIM AC, V62, P2323, DOI 10.1016/S0016-7037(98)00138-0; CHARLOU JL, 1993, J GEOPHYS RES-SOL EA, V98, P9625, DOI 10.1029/92JB02047; Chen YJ, 2000, GEOL SOC AM SPEC PAP, P161; Coakley BJ, 1998, EARTH PLANET SC LETT, V162, P81, DOI 10.1016/S0012-821X(98)00158-7; Edwards MH, 2001, NATURE, V409, P808, DOI 10.1038/35057258; Fouquet Y., 1998, INTERRIDGE NEWS, V7, P24; GERMAN CR, 1994, EARTH PLANET SC LETT, V121, P647, DOI 10.1016/0012-821X(94)90098-1; German CR, 1998, EARTH PLANET SC LETT, V160, P327, DOI 10.1016/S0012-821X(98)00093-4; German CR, 1996, EARTH PLANET SC LETT, V138, P93, DOI 10.1016/0012-821X(95)00224-Z; German CR, 1998, NATURE, V395, P490, DOI 10.1038/26730; JOHNSON GL, 1994, POLAR OCEANS THEIR R, P285; Kelley DS, 2001, NATURE, V412, P145, DOI 10.1038/35084000; Kleinrock MC, 1996, NATURE, V382, P149, DOI 10.1038/382149a0; KLINKHAMMER G, 1985, NATURE, V314, P727, DOI 10.1038/314727a0; KURRAS GJ, 2001, EOS S, V82; LAWVER LA, 1990, NATO ADV SCI I C-MAT, V308, P29; LUPTON JE, 1985, NATURE, V316, P621, DOI 10.1038/316621a0; Muller C., 2000, EOS T AM GEOPHYS UN, V81, P265, DOI [10.1029/00EO00186, DOI 10.1029/00EO00186]; Scheirer DS, 1998, GEOPHYS RES LETT, V25, P97, DOI 10.1029/97GL03443; SPEER KG, 1989, J GEOPHYS RES-OCEANS, V94, P6213, DOI 10.1029/JC094iC05p06213; Tolstoy M, 2001, GEOLOGY, V29, P1139, DOI 10.1130/0091-7613(2001)029<1139:SCOVAA>2.0.CO;2; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; Van Dover CL, 2002, SCIENCE, V295, P1253, DOI 10.1126/science.1067361	30	167	182	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					252	256		10.1038/nature01351	http://dx.doi.org/10.1038/nature01351			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529639				2022-12-28	WOS:000180397600043
J	Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR				Mahadevia, PJ; Fleisher, LA; Fric, KD; Eng, J; Goodman, SN; Powe, NR			Lung, cancer screening with helical computed tomography in older adult smokers - A decision and cost-effectiveness analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SMOKING CESSATION; ACTION PROJECT; SURVIVAL; ASPIRATION; SURGERY; UTILITY; PROGRAM; SCANNER; STATES; BIOPSY	Context Encouraged by direct-to-consumer marketing, smokers and-their physicians are contemplating lung cancer screening with a promising but unproven imaging procedure, helical computed tomography (CT). Objective To estimate the potential benefits, harms, and cost-effectiveness of lung cancer screening with helical CT in various efficacy scenarios. Design, Setting, and Population Using a computer-simulated model, we compared annual helical CT screening to no screening for hypothetical cohorts of 100000 current, quitting, and former heavy smokers, aged 60 years, of whom 55% were men. We simulated efficacy by changing the clinical stage distribution of lung cancers so that the screened group would have fewer advanced-stage cancers and more localized-stage cancers than the nonscreened group (ie, a stage shift). Our model incorporated known biases in screening programs such as lead time, length, and overdiagnosis bias. Main Outcome Measures We measured the benefits of screening by comparing the absolute and relative difference in lung cancer-specific deaths. We measured harms by the number of false-positive invasive tests or surgeries per 100000 and incremental cost-effectiveness in US dollars per quality-adjusted life-year (QALY) gained. Results Over a 20-year period, assuming a 50% stage shift, the current heavy smoker cohort had 553 fewer lung cancer deaths (13% lung cancer-specific mortality reduction) and 1186 false-positive invasive procedures per 100000 persons. The incremental cost-effectiveness for current smokers was $116300 per QALY gained. For quitting and former smokers, the incremental cost-effectiveness was $558600 and $2322700 per QALY gained, respectively. Other than the degree of stage shift, the most influentia parameters were adherence to screening, degree of length or overdiagnosis bias in the first year of screening, quality of life of persons with screen-detected localized lung cancers, cost of helical CT, and anxiety about indeterminate nodule diagnoses. In 1-way sensitivity analyses, none of these parameters was sufficient to make screening highly cost-effective for any of the cohorts. In multiway sensitivity analyses, a program screening current smokers was $42 500 per QALY gained if extremely favorable estimates were used for all of the influential parameters simultaneously. Conclusion Even if efficacy is eventually proven, screening must overcome multiple additional barriers to be highly cost-effective. Given the current uncertainty of benefits, the harms from invasive testing, and the high costs associated with screening, direct-to-consumer marketing of helical CT is not advisable.	Johns Hopkins Sch Med, Robert Wood Johnson Clin Scholars Program, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Med, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; Johns Hopkins Sch Med, Dept Oncol, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; MEDTAP Int, Bethesda, MD 20814 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine	Mahadevia, PJ (corresponding author), MEDTAP Int, 7101 Wisconsin Ave, Bethesda, MD 20814 USA.		Lee A, Fleisher/Q-9894-2019	Goodman, Steven/0000-0002-3872-5723; Frick, Kevin/0000-0002-0178-5319				*AM MED ASS, 1998, 1998 NAT PHYS FREE S; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; BRICE J, 2000, DIAGN IMAGING SAN FR, V22, P44; Burns DM, 2000, CANCER, V89, P2506, DOI 10.1002/1097-0142(20001201)89:11+<2506::AID-CNCR33>3.3.CO;2-#; Celik M, 1998, EUR J CARDIO-THORAC, V14, P113, DOI 10.1016/S1010-7940(98)00167-5; DECAMP MM, 1995, J AM COLL SURGEONS, V181, P113; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Earle CC, 2000, J CLIN ONCOL, V18, P3302, DOI 10.1200/JCO.2000.18.18.3302; EDDY DM, 1990, ANN INTERN MED, V112, P73, DOI 10.7326/0003-4819-112-1-73; Fireman BH, 1997, HEALTH CARE FINANC R, V18, P51; FONTANA RS, 1986, J OCCUP ENVIRON MED, V28, P746, DOI 10.1097/00043764-198608000-00038; FONTANA RS, 1991, CANCER-AM CANCER SOC, V67, P1155, DOI 10.1002/1097-0142(19910215)67:4+<1155::AID-CNCR2820671509>3.0.CO;2-0; Fry WA, 1999, CANCER, V86, P1867, DOI 10.1002/(SICI)1097-0142(19991101)86:9<1867::AID-CNCR31>3.0.CO;2-9; Grannis FW, 2002, CHEST, V121, P1388, DOI 10.1378/chest.121.5.1388; Gurley MB, 1998, RADIOLOGY, V209, P717, DOI 10.1148/radiology.209.3.9844664; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Henschke CI, 2001, CANCER, V92, P153, DOI 10.1002/1097-0142(20010701)92:1<153::AID-CNCR1303>3.0.CO;2-S; Henschke CI, 2000, RADIOL CLIN N AM, V38, P487, DOI 10.1016/S0033-8389(05)70179-2; Henschke CI, 1999, LANCET, V354, P99, DOI 10.1016/S0140-6736(99)06093-6; Hillner BE, 1996, SEMIN ONCOL, V23, P25; HULKA BS, 1986, J OCCUP ENVIRON MED, V28, P687, DOI 10.1097/00043764-198608000-00030; Jaklitsch MT, 1996, CHEST, V110, P751, DOI 10.1378/chest.110.3.751; Kaneko M, 1996, RADIOLOGY, V201, P798, DOI 10.1148/radiology.201.3.8939234; KOLATA G, 2001, NY TIMES        0720, pA1; KUBIK A, 1990, INT J CANCER, V45, P26, DOI 10.1002/ijc.2910450107; Lee TH, 2002, NEW ENGL J MED, V346, P529, DOI 10.1056/NEJM200202143460715; LERNER BH, 2002, NY TIMES        0305, pD6; MELAMED MR, 1984, CHEST, V86, P44, DOI 10.1378/chest.86.1.44; MELAMED MR, 1987, SURG CLIN N AM, V67, P909; *NAT ALL CAR AM AS, 2001, CAR US FIND NAT SURV; *NAT CANC I, 2001, DEVC PROB DEV DYING; *NAT CANC I, 2001, SURV EP END RES SEER; *NAT CANC I AM CAN, 2001, EARL LUNG CANC SCREE; Palmisano WA, 2000, CANCER RES, V60, P5954; Patz EF, 2000, NEW ENGL J MED, V343, P1627, DOI 10.1056/NEJM200011303432208; Patz EF, 2000, CHEST, V117, P1568, DOI 10.1378/chest.117.6.1568; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; SAGEL SS, 1978, ANN THORAC SURG, V26, P399, DOI 10.1016/S0003-4975(10)62917-7; SHAH SS, 1992, RESPIRATION, V59, P243; Sobue T, 2002, J CLIN ONCOL, V20, P911, DOI 10.1200/JCO.2002.20.4.911; Sone S, 2001, BRIT J CANCER, V84, P25, DOI 10.1054/bjoc.2000.1531; Sone S, 1998, LANCET, V351, P1242, DOI 10.1016/S0140-6736(97)08229-9; Swensen SJ, 2002, AM J RESP CRIT CARE, V165, P508, DOI 10.1164/ajrccm.165.4.2107006; *THOMS HEALTHC, 2001, RED BOOK DRUG TOP 20; TOCKMAN MS, 1986, CHEST S, V89, P324; TRAVIS WD, 1995, CANCER-AM CANCER SOC, V75, P191, DOI 10.1002/1097-0142(19950101)75:1+<191::AID-CNCR2820751307>3.0.CO;2-Y; *TREEAG INC, 2002, DAT PRO COMP PROGR V; Trippoli S, 2001, PHARMACOECONOMICS, V19, P855, DOI 10.2165/00019053-200119080-00007; WALTER SD, 1992, CANCER CAUSE CONTROL, V3, P115, DOI 10.1007/BF00051651; 2000, ONCOL NEWS INT, V9, P1	50	248	252	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					313	322		10.1001/jama.289.3.313	http://dx.doi.org/10.1001/jama.289.3.313			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525232	Bronze			2022-12-28	WOS:000180345100026
J	Meyer, G; Warnke, A; Bender, R; Muhlhauser, I				Meyer, G; Warnke, A; Bender, R; Muhlhauser, I			Effect on hip fractures of increased use of hip protectors in nursing homes: cluster randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ACCEPTABILITY	Objective To assess the effects of an intervention programme designed to increase use of hip protectors in elderly people in nursing homes. Design Cluster randomised controlled trial with 18 months of follow up. Setting Nursing homes in Hamburg (25 clusters in intervention group; 24 in control group). Participants Residents with a high risk of falling (459 in intervention group; 483 in control group). Intervention Single education session for nursing staff, who then educated residents; provision of three hip protectors per resident in intervention group. Usual care optimised by brief information to nursing staff about hip protectors and provision of two hip protectors per cluster for demonstration purposes. Main outcome measure Incidence of hip fractures. Results Mean follow up was 15 months for the intervention group and 14 months for the control group. In total 167 residents in the intervention group and 207 in the control group died or moved away. There were 21 hip fractures in 21 (4.6%) residents in the intervention group and 42 hip fractures in 39 (8.1%) residents in the control group (relative risk 0.57, absolute risk difference -3.5%, 95% confidence interval -7.3% to 0.3%, P=0.072). After adjustment for the cluster randomisation the proportions of fallers who used a hip protector were 68% and 15% respectively (mean difference 53%, 38% to 67%, P=0.0001). There were 39 other fractures in the intervention group and 38 in the control group. Conclusion The introduction of a structured education programme and the provision of free hip protectors in nursing homes increases the use of protectors and may reduce the number of hip fractures.	Univ Hamburg, Unit Hlth Sci & Educ, D-20146 Hamburg, Germany; Univ Bielefeld, Sch Publ Hlth, Dept Epidemiol & Med Stat, D-33501 Bielefeld, Germany	University of Hamburg; University of Bielefeld	Muhlhauser, I (corresponding author), Univ Hamburg, Unit Hlth Sci & Educ, Martin Luther King Pl 6, D-20146 Hamburg, Germany.							Altman DG, 1998, BRIT MED J, V317, P1309, DOI 10.1136/bmj.317.7168.1309; Bandura A., 1977, SOCIAL LEARNING THEO, V1; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Cameron ID, 2002, BRIT MED J, V324, P375, DOI 10.1136/bmj.324.7334.375; Cameron ID, 2001, AGE AGEING, V30, P477, DOI 10.1093/ageing/30.6.477; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chan DK, 2000, ARCH GERONTOL GERIAT, V30, P25, DOI 10.1016/S0167-4943(99)00048-5; Clark NM, 1999, HEALTH EDUC BEHAV, V26, P72, DOI 10.1177/109019819902600107; Cumming RG, 1996, AM J EPIDEMIOL, V143, P1191; DALICHAU G, 2002, SGB 11 PFLEGEVERSICH; DONNER A, 1993, J CLIN EPIDEMIOL, V46, P123, DOI 10.1016/0895-4356(93)90050-B; DONNER A, 1994, AM J EPIDEMIOL, V140, P279, DOI 10.1093/oxfordjournals.aje.a117247; Ekman A, 1997, LANCET, V350, P563, DOI 10.1016/S0140-6736(05)63140-6; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; KEENE GS, 1993, BRIT MED J, V307, P1248, DOI 10.1136/bmj.307.6914.1248; KRONSBEIN P, 1988, LANCET, V2, P1407; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; MUHLHAUSER I, 1993, VERBESSERUNG BEHANDL; PARKER MJ, 2002, COCHRANE DATABASE SY, V4, DOI UNSP CD001255; Parkkari J, 1998, AGE AGEING, V27, P225, DOI 10.1093/ageing/27.2.225; Villar MTA, 1998, AGE AGEING, V27, P195, DOI 10.1093/ageing/27.2.195; WARNKE A, 2002, THESIS U HAMBURG HAM	22	88	89	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					76	78A		10.1136/bmj.326.7380.76	http://dx.doi.org/10.1136/bmj.326.7380.76			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521969	Green Published, Bronze			2022-12-28	WOS:000180426900013
J	Horiuchi, S; Okimoto, Y; Kumai, R; Tokura, Y				Horiuchi, S; Okimoto, Y; Kumai, R; Tokura, Y			Quantum phase transition in organic charge-transfer complexes	SCIENCE			English	Article							NEUTRAL-IONIC TRANSITION; CHLORANIL; CRYSTALS; DISCOVERY; DIAGRAM	A phase transition in an organic charge-transfer complex, which originates from the neutral-ionic valence instability, can be tuned toward zero kelvin with use of external pressure or chemical modi cation as a control parameter. The phase diagram and observed dielectric behaviors are typical of quantum paraelectricity, yet this zero-kelvin transition point namely, the quantum critical point, accompanies large quantum fluctuation of the molecular charge, as demonstrated by the molecular vibrational mode spectra. The result indicates that the pi-electron transfer between donor and acceptor molecules is coupled with the zero-point lattice dynamics around the quantum critical point.	Natl Inst Adv Ind Sci & Technol, Correlated Elect Res Ctr, Tsukuba, Ibaraki 3058562, Japan; Natl Inst Adv Ind Sci & Technol, ERATO, Japan Sci & Technol Corp, Spin Superstruct Project, Tsukuba, Ibaraki 3058562, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Horiuchi, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Correlated Elect Res Ctr, Tsukuba, Ibaraki 3058562, Japan.		Tokura, Yoshinori/C-7352-2009; Okimoto, Yoichi/K-6099-2012; Kumai, Reiji/R-2453-2017; Horiuchi, Sachio/R-2377-2017	Tokura, Yoshinori/0000-0002-2732-4983; Kumai, Reiji/0000-0002-5320-0028; Horiuchi, Sachio/0000-0002-7720-4605; Okimoto, Yoichi/0000-0003-0095-4579				AOKI S, 1993, PHYS REV B, V48, P626, DOI 10.1103/PhysRevB.48.626; AOKI S, 1995, SYNTHETIC MET, V70, P1243, DOI 10.1016/0379-6779(94)02838-P; BARRETT JH, 1952, PHYS REV, V86, P118, DOI 10.1103/PhysRev.86.118; Collet E, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054105; Coronado E., 1996, NATO ASI SERIES E; GIRLANDO A, 1978, J CHEM PHYS, V68, P22, DOI 10.1063/1.435487; GIRLANDO A, 1982, PHYS REV B, V26, P2306, DOI 10.1103/PhysRevB.26.2306; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; Horiuchi S, 2000, J PHYS SOC JPN, V69, P1302, DOI 10.1143/JPSJ.69.1302; Horiuchi S, 2001, J AM CHEM SOC, V123, P665, DOI 10.1021/ja0016654; Ishiguro T., 1998, ORGANIC SUPERCONDUCT, V2nd; LemeeCailleau MH, 1997, PHYS REV LETT, V79, P1690, DOI 10.1103/PhysRevLett.79.1690; Luty T, 2002, EUROPHYS LETT, V59, P619, DOI 10.1209/epl/i2002-00149-4; Mathur ND, 1998, NATURE, V394, P39, DOI 10.1038/27838; Miller J.S., 1982, EXTENDED LINEAR CHAI, V1-3; MITANI T, 1987, PHYS REV B, V35, P427, DOI 10.1103/PhysRevB.35.427; MULLER KA, 1979, PHYS REV B, V19, P3593, DOI 10.1103/PhysRevB.19.3593; NAGAOSA N, 1986, J PHYS SOC JPN, V55, P2754, DOI 10.1143/JPSJ.55.2754; Nasu K. K., 1997, SPRINGER SERIES SOLI, V124, DOI [10.1007/978-3-642-60702-8_1, DOI 10.1007/978-3-642-60702-8_1]; NOGAMI Y, 1995, SYNTHETIC MET, V70, P1219, DOI 10.1016/0379-6779(94)02826-K; Okimoto Y, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.187401; SAMARA GA, 1971, PHYS REV LETT, V27, P103, DOI 10.1103/PhysRevLett.27.103; SCHNEIDER T, 1976, PHYS REV B, V13, P1123, DOI 10.1103/PhysRevB.13.1123; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; TOKURA Y, 1989, PHYS REV LETT, V63, P2405, DOI 10.1103/PhysRevLett.63.2405; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253	26	142	144	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					229	232		10.1126/science.1076129	http://dx.doi.org/10.1126/science.1076129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522245				2022-12-28	WOS:000180284000032
J	Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W				Nikolaev, AY; Li, MY; Puskas, N; Qin, J; Gu, W			Parc: A cytoplasmic anchor for p53	CELL			English	Article							WILD-TYPE P53; NUCLEAR EXPORT SIGNAL; TUMOR-SUPPRESSOR P53; RING-FINGER DOMAIN; COLORECTAL ADENOCARCINOMA; MDM2-MEDIATED DEGRADATION; DNA-DAMAGE; PROTEIN; MDM2; UBIQUITINATION	Nuclear localization of p53 is essential for its tumor suppressor function. Here, we have identified Parc, a Parkin-like ubiquitin ligase, as a cytoplasmic anchor protein in p53-associated protein complexes. Parc directly interacts and forms a similar to1 MDa complex with p53 in the cytoplasm of unstressed cells. In the absence of stress, inactivation of Parc induces nuclear localization of endogenous p53 and activates p53-dependent apoptosis. Overexpression of Parc promotes cytoplasmic sequestration of ectopic p53. Furthermore, abnormal cytoplasmic localization of p53 was observed in a number of neuroblastoma cell lines; RNAi-mediated reduction of endogenous Parc significantly sensitizes these neuroblastoma cells in the DNA damage response. These results reveal that Parc is a critical regulator in controlling p53 subcellular localization and subsequent function.	Columbia Univ Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Baylor College of Medicine; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ Coll Phys & Surg, Inst Canc Genet, 1150 St Nicholas Ave, New York, NY 10032 USA.			Nikolaev, Anatoly/0000-0003-2818-5839				BOSARI S, 1995, AM J PATHOL, V147, P790; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Elela Sherif Abou, 1997, Cancer Letters, V117, P23; Fontoura BMA, 1997, MOL CELL BIOL, V17, P3146, DOI 10.1128/MCB.17.6.3146; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; GANNON JV, 1991, NATURE, V349, P802; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Giannakakou P, 2000, NAT CELL BIOL, V2, P709, DOI 10.1038/35036335; Gu JJ, 2001, MOL CELL BIOL, V21, P8533, DOI 10.1128/MCB.21.24.8533-8546.2001; Gu W, 1999, MOL CELL, V3, P97, DOI 10.1016/S1097-2765(00)80178-1; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Hollstein M, 1999, MUTAT RES-FUND MOL M, V431, P199, DOI 10.1016/S0027-5107(99)00162-1; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jimenez GS, 1999, ONCOGENE, V18, P7656, DOI 10.1038/sj.onc.1203013; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liang SH, 1998, J BIOL CHEM, V273, P19817, DOI 10.1074/jbc.273.31.19817; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Metcalfe S, 1999, ONCOGENE, V18, P2351, DOI 10.1038/sj.onc.1202559; Middeler G, 1997, ONCOGENE, V14, P1407, DOI 10.1038/sj.onc.1200949; MOLL UM, 1995, P NATL ACAD SCI USA, V92, P4407, DOI 10.1073/pnas.92.10.4407; Moll UM, 1996, MOL CELL BIOL, V16, P1126; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Schlamp CL, 1997, J NATL CANCER I, V89, P1530, DOI 10.1093/jnci/89.20.1530; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Sharpless NE, 2002, CELL, V110, P9, DOI 10.1016/S0092-8674(02)00818-8; SHAULSKY G, 1990, MOL CELL BIOL, V10, P6565, DOI 10.1128/MCB.10.12.6565; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; SUN XF, 1992, LANCET, V340, P1369, DOI 10.1016/0140-6736(92)92558-W; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; UEDA H, 1995, NAT GENET, V9, P41, DOI 10.1038/ng0195-41; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, BBA-REV CANCER, V1602, P47, DOI 10.1016/S0304-419X(02)00035-5; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314; Zaika A, 1999, J BIOL CHEM, V274, P27474, DOI 10.1074/jbc.274.39.27474; Zhang YP, 2001, SCIENCE, V292, P1910, DOI 10.1126/science.1058637	47	308	325	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					29	40		10.1016/S0092-8674(02)01255-2	http://dx.doi.org/10.1016/S0092-8674(02)01255-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526791	Bronze			2022-12-28	WOS:000181191500004
J	Check, E				Check, E			Biologists seek blueprint for international stem-cell effort	NATURE			English	News Item																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102b	http://dx.doi.org/10.1038/421102b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520271	Bronze			2022-12-28	WOS:000180267200009
J	Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB				Mukamal, KJ; Conigrave, KM; Mittleman, MA; Camargo, CAJ; Stampfer, MJ; Willett, WC; Rimm, EB			Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; REGULAR DRINKERS; CONTROLLED TRIAL; BRITISH MEN; CONSUMPTION; RISK; WINE; BEER; MORTALITY	BACKGROUND: Although moderate drinking confers a decreased risk of myocardial infarction, the roles of the drinking pattern and type of beverage remain unclear. METHODS: We studied the association of alcohol consumption with the risk of myocardial infarction among 38,077 male health professionals who were free of cardiovascular disease and cancer at base line. We assessed the consumption of beer, red wine, white wine, and liquor individually every four years using validated food-frequency questionnaires. We documented cases of nonfatal myocardial infarction and fatal coronary heart disease from 1986 to 1998. RESULTS: During 12 years of follow-up, there were 1418 cases of myocardial infarction. As compared with men who consumed alcohol less than once per week, men who consumed alcohol three to four or five to seven days per week had decreased risks of myocardial infarction (multivariate relative risk, 0.68 [95 percent confidence interval, 0.55 to 0.84] and 0.63 [95 percent confidence interval, 0.54 to 0.74], respectively). The risk was similar among men who consumed less than 10 g of alcohol per drinking day and those who consumed 30 g or more. No single type of beverage conferred additional benefit, nor did consumption with meals. A 12.5-g increase in daily alcohol consumption over a four-year follow-up period was associated with a relative risk of myocardial infarction of 0.78 (95 percent confidence interval, 0.62 to 0.99). CONCLUSIONS: Among men, consumption of alcohol at least three to four days per week was inversely associated with the risk of myocardial infarction. Neither the type of beverage nor the proportion consumed with meals substantially altered this association. Men who increased their alcohol consumption by a moderate amount during follow-up had a decreased risk of myocardial infarction.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Beth Israel Deaconess Med Ctr, Div Cardiol, Boston, MA 02215 USA; Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia; Univ Sydney, Dept Med, Sydney, NSW 2006, Australia; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; University of Sydney; University of Sydney; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital	Mukamal, KJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave,LY-303, Boston, MA 02215 USA.		Camargo, Carlos A./C-2145-2008; Mukamal, Kenneth/GVR-7978-2022	Camargo, Carlos A./0000-0002-5071-7654; Mittleman, Murray/0000-0001-9788-7274; Conigrave, Katherine/0000-0002-6428-1441	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL035464] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA011181] Funding Source: NIH RePORTER; NCI NIH HHS [CA55075] Funding Source: Medline; NHLBI NIH HHS [HL35464] Funding Source: Medline; NIAAA NIH HHS [AA00299, AA11181] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ABE H, 1994, CIRCULATION, V89, P2626, DOI 10.1161/01.CIR.89.6.2626; *AM CANC SOC, 2002, ALC CANC; Cleophas TJ, 1999, BIOMED PHARMACOTHER, V53, P417, DOI 10.1016/S0753-3322(99)80121-8; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; [Department of Agriculture US Department of Health and Human Services], 2000, HOM GARD B, V232; Di Castelnuovo A, 2002, CIRCULATION, V105, P2836, DOI 10.1161/01.CIR.0000018653.19696.01; Dimmitt SB, 1998, BLOOD COAGUL FIBRIN, V9, P39, DOI 10.1097/00001721-199801000-00005; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; GABH Rose, 1982, WHO MONOGRAPH SERIES; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GOLDBERG RJ, 1994, CIRCULATION, V89, P651, DOI 10.1161/01.CIR.89.2.651; GRUCHOW HW, 1982, ATHEROSCLEROSIS, V43, P393, DOI 10.1016/0021-9150(82)90038-7; JACKSON R, 1992, AM J EPIDEMIOL, V136, P819, DOI 10.1093/aje/136.7.819; Kauhanen J, 1997, BMJ-BRIT MED J, V315, P846, DOI 10.1136/bmj.315.7112.846; MACLURE M, 1993, EPIDEMIOL REV, V15, P328, DOI 10.1093/oxfordjournals.epirev.a036124; MARMOT MG, 1994, BRIT MED J, V308, P1263, DOI 10.1136/bmj.308.6939.1263; McElduff P, 1997, BRIT MED J, V314, P1159, DOI 10.1136/bmj.314.7088.1159; MIKHAILIDIS DP, 1990, ALCOHOL, V7, P171, DOI 10.1016/0741-8329(90)90080-V; Mortensen EL, 2001, ARCH INTERN MED, V161, P1844, DOI 10.1001/archinte.161.15.1844; *NUTR DAT LAB, 1999, USDA NUTR DAT STAND; Rakic V, 1998, ATHEROSCLEROSIS, V137, P243, DOI 10.1016/S0021-9150(97)00269-4; Rakic V, 1998, J HYPERTENS, V16, P165, DOI 10.1097/00004872-199816020-00006; Rehm J, 2001, AM J EPIDEMIOL, V153, P64, DOI 10.1093/aje/153.1.64; RENAUD SC, 1992, AM J CLIN NUTR, V55, P1012, DOI 10.1093/ajcn/55.5.1012; Rimm E, 2001, EPIDEMIOLOGY, V12, P380, DOI 10.1097/00001648-200107000-00006; Rimm EB, 1996, AM J EPIDEMIOL, V143, P1094; Rimm EB, 1996, BRIT MED J, V312, P731, DOI 10.1136/bmj.312.7033.731; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; Sesso HD, 2000, ARCH INTERN MED, V160, P2605, DOI 10.1001/archinte.160.17.2605; SHAPER AG, 1988, LANCET, V2, P1267; SHAPER AG, 1987, BMJ-BRIT MED J, V294, P733, DOI 10.1136/bmj.294.6574.733; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; TASKINEN MR, 1985, METABOLISM, V34, P112, DOI 10.1016/0026-0495(85)90118-0; Tjonneland A, 1999, AM J CLIN NUTR, V69, P49; WANNAMETHEE G, 1991, J HUM HYPERTENS, V5, P59; Wannamethee SG, 2002, HEART, V87, P32, DOI 10.1136/heart.87.1.32; Wouters S, 2000, AM J EPIDEMIOL, V151, P1189, DOI 10.1093/oxfordjournals.aje.a010169	37	566	590	0	52	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					109	118		10.1056/NEJMoa022095	http://dx.doi.org/10.1056/NEJMoa022095			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519921				2022-12-28	WOS:000180263900003
J	Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S				Nakano, H; Hibino, T; Oji, T; Hara, Y; Amemiya, S			Larval stages of a living sea lily (stalked crinoid echinoderm)	NATURE			English	Article							RADIATION	The embryos and larvae of stalked crinoids, which are considered the most basal group of extant echinoderms(1,2), have not previously been described. In contrast, much is known about the development of the more accessible stalkless crinoids (feather stars)(3), which are phylogenetically derived from stalked forms(4). Here we describe the development of a sea lily from fertilization to larval settlement. There are two successive larval stages: the first is a non-feeding auricularia stage with partly longitudinal ciliary bands (similar to the auricularia and bipinnaria larvae of holothurian and asteroid echinoderms, respectively); the second is a doliolaria larva with circumferential ciliary bands (similar to the earliest larval stage of stalkless crinoids). We suggest that a dipleurula-type larva is primitive for echinoderms and is the starting point for the evolution of additional larval forms within the phylum. From a wider evolutionary viewpoint, the demonstration that the most basal kind of echinoderm larva is a dipleurula is consistent with Garstang's auricularia theory(5) for the phylogenetic origin of the chordate neural tube.	Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Chiba 2778562, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Amemiya, S (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bldg FSB-501,5-1-5 Kashiwanoha, Chiba 2778562, Japan.		拓, 日比野/D-8115-2013; Oji, Tatsuo/A-1840-2009	拓, 日比野/0000-0002-4789-7375; Oji, Tatsuo/0000-0002-1034-1111				Foote M, 1999, PALEOBIOLOGY, V25, P1, DOI 10.1666/0094-8373(1999)25[1:MDITER]2.0.CO;2; GARSTANG W, 1894, ZOOL ANT, V17, P122; Gee C. H. R., COMMUNICATION; HENDLER G, 1991, REPRODUCTION MARINE, V6, P355; Holland N. D, 1991, REPROD MARINE INVERT, V4, P247; Hyman L. H., 1955, INVERTEBRATES; Janies D, 2001, CAN J ZOOL, V79, P1232, DOI 10.1139/cjz-79-7-1232; LACALLI TC, 1986, J EMBRYOL EXP MORPH, V96, P303; Metschnikoff E, 1881, ZOOL ANZ, V4, p[139, 153]; Nielsen C., 1995, ANIMAL EVOLUTION; PAUL CRC, 1984, BIOL REV, V59, P443, DOI 10.1111/j.1469-185X.1984.tb00411.x; Smiley S., 1991, P663; Strathmann R., 1974, Thalassia Jugosl, V10, P321	13	86	89	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					158	160		10.1038/nature01236	http://dx.doi.org/10.1038/nature01236			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520300				2022-12-28	WOS:000180267200038
J	Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S				Shingo, T; Gregg, C; Enwere, E; Fujikawa, H; Hassam, R; Geary, C; Cross, JC; Weiss, S			Pregnancy-stimulated neurogenesis in the adult female forebrain mediated by prolactin	SCIENCE			English	Article							NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MAMMALIAN FOREBRAIN; MATERNAL-BEHAVIOR; NULL MUTATION; INSECT BRAIN; RECEPTOR; MOUSE; MECHANISMS; RAT	Neurogenesis occurs in the olfactory system of the adult brain throughout life, in both invertebrates and vertebrates, but its physiological regulation is not understood. We show that the production of neuronal progenitors is stimulated in the forebrain subventricular zone of female mice during pregnancy and that this effect is mediated by the hormone prolactin. The progenitors then migrate to produce new olfactory interneurons, a process likely to be important for maternal behavior, because olfactory discrimination is critical for recognition and rearing of offspring. Neurogenesis occurs even in females that mate with sterile males. These findings imply that forebrain olfactory neurogenesis may contribute to adaptive behaviors in mating and pregnancy.	Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	University of Calgary; University of Calgary	Weiss, S (corresponding author), Univ Calgary, Fac Med, Dept Cell Biol & Anat, Genes & Dev Res Grp, Calgary, AB T2N 4N1, Canada.	weiss@ucalgary.ca	Cross, James/AAU-2973-2020; Cross, James/F-4814-2011	Cross, James/0000-0003-0956-9378; Cross, James/0000-0003-0956-9378				ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; BARKLEY MS, 1978, BIOL REPROD, V19, P291, DOI 10.1095/biolreprod19.2.291; Brennan PA, 1997, PROG NEUROBIOL, V51, P457, DOI 10.1016/S0301-0082(96)00069-X; Bridges RS, 2001, ENDOCRINOLOGY, V142, P730, DOI 10.1210/en.142.2.730; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; Cayre M, 2002, COMP BIOCHEM PHYS B, V132, P1, DOI 10.1016/S1096-4959(01)00525-5; DIAZRUIZ C, 1993, NEUROSCI LETT, V164, P44, DOI 10.1016/0304-3940(93)90853-D; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dorshkind K, 2001, BIOESSAYS, V23, P288, DOI 10.1002/1521-1878(200103)23:3<288::AID-BIES1039>3.0.CO;2-P; Exton MS, 2001, PSYCHONEUROENDOCRINO, V26, P287, DOI 10.1016/S0306-4530(00)00053-6; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Goffin V, 2002, ANNU REV PHYSIOL, V64, P47, DOI 10.1146/annurev.physiol.64.081501.131049; Harzsch S, 1999, J NEUROSCI, V19, P3472; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hull KL, 1998, COMP BIOCHEM PHYS C, V119, P389, DOI 10.1016/S0742-8413(98)00010-3; Kendrick KM, 1997, BRAIN RES BULL, V44, P383, DOI 10.1016/S0361-9230(97)00218-9; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Krieger J, 1999, SCIENCE, V286, P720, DOI 10.1126/science.286.5440.720; Kruger THC, 2002, NEUROSCI BIOBEHAV R, V26, P31, DOI 10.1016/S0149-7634(01)00036-7; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lucas BK, 1998, ENDOCRINOLOGY, V139, P4102, DOI 10.1210/en.139.10.4102; Melzig J, 1998, CURR BIOL, V8, P1223, DOI 10.1016/S0960-9822(07)00514-3; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Nielsen JH, 1999, J MOL MED-JMM, V77, P62; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Ormandy CJ, 1997, GENE DEV, V11, P167, DOI 10.1101/gad.11.2.167; OUHTIT A, 1993, ENDOCRINOLOGY, V133, P135, DOI 10.1210/en.133.1.135; Pi XJ, 1998, J COMP NEUROL, V394, P462, DOI 10.1002/(SICI)1096-9861(19980518)394:4<462::AID-CNE5>3.0.CO;2-#; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Roky R, 1996, NEUROENDOCRINOLOGY, V63, P422, DOI 10.1159/000127067; Schmidt M, 1997, BRAIN RES, V762, P131, DOI 10.1016/S0006-8993(97)00376-4; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001	43	524	545	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					117	120		10.1126/science.1076647	http://dx.doi.org/10.1126/science.1076647			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511652				2022-12-28	WOS:000180165800048
J	Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE				Shin, BS; Maag, D; Roll-Mecak, A; Arefin, MS; Burley, SK; Lorsch, JR; Dever, TE			Uncoupling of initiation factor eIF5B/IF2 GTPase and translational activities by mutations that lower ribosome affinity	CELL			English	Article							ELONGATION-FACTOR G; TRANSFER-RNA; LATE EVENTS; FACTOR IF2; BINDING; HYDROLYSIS; VISUALIZATION; MECHANISM; SUBUNITS; SWITCH	Translation initiation factor eIF5B/IF2 is a GTPase that promotes ribosomal subunit joining. We show that eIF5B mutations in Switch I, an element conserved in all GTP binding domains, impair GTP hydrolysis and general translation but not eIF5B subunit joining function. Intragenic suppressors of the Switch I mutation restore general translation, but not eIF5B GTPase activity. These suppressor mutations reduce the ribosome affinity of eIF5B and increase AUG skipping/leaky scanning. The uncoupling of translation and eIF5B GTPase activity suggests a regulatory rather than mechanical function for eIF5B GTP hydrolysis in translation initiation. The translational defect suggests eIF5B stabilizes Met-tRNAi(Met) binding and that GTP hydrolysis by eIF5B is a checkpoint monitoring 80S ribosome assembly in the final step of translation initiation.	NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Lab Mol Biophys, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Dever, TE (corresponding author), NICHHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA.	tdever@box-t.nih.gov	Dever, Thomas/GSE-0966-2022	Lorsch, Jon/0000-0002-4521-4999; Roll-Mecak, Antonina/0000-0003-2621-7307; Dever, Thomas/0000-0001-7120-9678; Burley, Stephen K./0000-0002-2487-9713	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001010] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061262, R01GM062128] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62128, GM61262] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Algire MA, 2002, RNA, V8, P382, DOI 10.1017/S1355838202029527; Asano K, 2000, GENE DEV, V14, P2534, DOI 10.1101/gad.831800; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Choi SK, 2000, MOL CELL BIOL, V20, P7183, DOI 10.1128/MCB.20.19.7183-7191.2000; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Gomez-Lorenzo MG, 2000, EMBO J, V19, P2710, DOI 10.1093/emboj/19.11.2710; GRANT CM, 1994, MOL CELL BIOL, V14, P2616, DOI 10.1128/MCB.14.4.2616; Hinnebusch A.G., 1996, TRANSLATIONAL CONTRO, P199; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Huang HK, 1997, GENE DEV, V11, P2396, DOI 10.1101/gad.11.18.2396; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; LaTeana A, 1996, J MOL BIOL, V256, P667; Luchin S, 1999, J BIOL CHEM, V274, P6074, DOI 10.1074/jbc.274.10.6074; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; MASISON DC, 1995, MOL CELL BIOL, V15, P2763; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Moreno JMP, 1998, BIOCHEM BIOPH RES CO, V252, P465, DOI 10.1006/bbrc.1998.9664; Peske F, 2000, MOL CELL, V6, P501, DOI 10.1016/S1097-2765(00)00049-6; Pestova TV, 2000, NATURE, V403, P332, DOI 10.1038/35002118; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Roll-Mecak A, 2001, TRENDS BIOCHEM SCI, V26, P705, DOI 10.1016/S0968-0004(01)02024-2; Roll-Mecak A, 2000, CELL, V103, P781, DOI 10.1016/S0092-8674(00)00181-1; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; Tomsic J, 2000, EMBO J, V19, P2127, DOI 10.1093/emboj/19.9.2127; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023	33	96	98	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1015	1025		10.1016/S0092-8674(02)01171-6	http://dx.doi.org/10.1016/S0092-8674(02)01171-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507428	Bronze			2022-12-28	WOS:000180086000011
J	Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC				Unhavaithaya, Y; Shin, TH; Miliaras, N; Lee, J; Oyama, T; Mello, CC			MEP-1 and a homolog of the NURD complex component Mi-2 act together to maintain germline-soma distinctions in C-elegans	CELL			English	Article							ZYGOTIC GENE-EXPRESSION; CAENORHABDITIS-ELEGANS; POLYCOMB GROUP; HISTONE DEACETYLASE; RNA INTERFERENCE; MATERNAL CONTROL; PROTEIN; LINE; PIE-1; MES-3	A rapid cascade of regulatory events defines the developmental fates of embryonic cells. However, once established, these developmental fates and the underlying transcriptional programs can be remarkably stable. Here, we describe two proteins, MEP-1 and LET-418/Mi-2, required for maintenance of somatic differentiation in C. elegans. In animals lacking MEP-1 and LET-418, germline-specific genes become derepressed in somatic cells, and Polycomb group (PcG) and SET domain-related proteins promote this ectopic expression. MEP-1 and LET-418 interact in vivo with the germline-protein PIE-1. Our findings support a model in which PIE-1 inhibits MEP-1 and associated factors to maintain the pluripotency of germ cells, while at later times MEP-1 and LET-418 remodel chromatin to establish new stage- or cell-type-specific differentiation potential.	Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA; Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Baylor College of Medicine	Mello, CC (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 373 Plantat St, Worcester, MA 01605 USA.	craig.mello@umassmed.edu		/0000-0001-7230-1767	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036247, R01HD033769] Funding Source: NIH RePORTER; NICHD NIH HHS [HD33769, HD36247] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Batchelder C, 1999, GENE DEV, V13, P202, DOI 10.1101/gad.13.2.202; Baulcombe D, 2002, CURR BIOL, V12, pR82, DOI 10.1016/S0960-9822(02)00665-6; Belfiore M, 2002, RNA, V8, P725, DOI 10.1017/S1355838202028595; BOWERMAN B, 1993, CELL, V74, P443, DOI 10.1016/0092-8674(93)80046-H; Brock HW, 2001, CURR OPIN GENET DEV, V11, P175, DOI 10.1016/S0959-437X(00)00176-3; CAPOWSKI EE, 1991, GENETICS, V129, P1061; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; DEMBURG AF, 2002, CELL, V111, P159; EPSTEIN RJ, 1988, CYTOMETRY, V9, P349, DOI 10.1002/cyto.990090412; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Francis NJ, 2001, NAT REV MOL CELL BIO, V2, P409, DOI 10.1038/35073039; FRANCIS R, 1991, J CELL BIOL, V114, P465, DOI 10.1083/jcb.114.3.465; Garvin C, 1998, GENETICS, V148, P167; Gruidl ME, 1996, P NATL ACAD SCI USA, V93, P13837, DOI 10.1073/pnas.93.24.13837; Holdeman R, 1998, DEVELOPMENT, V125, P2457; James P, 1996, GENETICS, V144, P1425; Kawasaki I, 1998, CELL, V94, P635, DOI 10.1016/S0092-8674(00)81605-0; Kelly WG, 2002, DEVELOPMENT, V129, P479; Korf I, 1998, DEVELOPMENT, V125, P2469; Kuznicki KA, 2000, DEVELOPMENT, V127, P2907; Lukacsovich T, 2001, GENETICS, V157, P727; MELLO CC, 1992, CELL, V70, P163, DOI 10.1016/0092-8674(92)90542-K; Mello CC, 1996, NATURE, V382, P710, DOI 10.1038/382710a0; Mohler WA, 1998, CURR BIOL, V8, P1087, DOI 10.1016/S0960-9822(98)70447-6; Ogas J, 1997, SCIENCE, V277, P91, DOI 10.1126/science.277.5322.91; PAULSEN JE, 1995, GENETICS, V141, P1383; Pirrotta V, 2002, CELL, V110, P661, DOI 10.1016/S0092-8674(02)00967-4; Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9; Rocheleau CE, 1999, CELL, V97, P717, DOI 10.1016/S0092-8674(00)80784-9; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Seydoux G, 1999, DEVELOPMENT, V126, P3275; Seydoux G, 1996, NATURE, V382, P713, DOI 10.1038/382713a0; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; Solari F, 2000, CURR BIOL, V10, P223, DOI 10.1016/S0960-9822(00)00343-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1996, NUCLEIC ACIDS RES, V24, P2119, DOI 10.1093/nar/24.11.2119; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Van Doren M, 1998, CURR BIOL, V8, P243; von Zelewsky T, 2000, DEVELOPMENT, V127, P5277; Wu-Scharf D, 2000, SCIENCE, V290, P1159, DOI 10.1126/science.290.5494.1159; Xu L, 2001, GENETICS, V159, P1019; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	44	148	178	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					991	1002		10.1016/S0092-8674(02)01202-3	http://dx.doi.org/10.1016/S0092-8674(02)01202-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507426	Bronze			2022-12-28	WOS:000180086000009
J	Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH				Zhu, J; Nathan, C; Jin, WW; Sim, D; Ashcroft, GS; Wahl, SM; Lacomis, L; Erdjument-Bromage, H; Tempst, P; Wright, CD; Ding, AH			Conversion of proepithelin to epithelins: Roles of SLPI and elastase in host defense and wound repair	CELL			English	Article							LEUKOCYTE PROTEASE INHIBITOR; SECRETORY LEUKOPROTEASE INHIBITOR; PROTEINASE-INHIBITOR; HUMAN-NEUTROPHILS; EPITHELIN/GRANULIN PRECURSOR; BACTERIAL LIPOPOLYSACCHARIDE; GRANULIN/EPITHELIN PRECURSOR; 2-HYBRID SYSTEM; GENE-EXPRESSION; GROWTH-FACTORS	Increased leukocyte elastase activity in mice lacking secretory leukocyte protease inhibitor (SLPI) leads to impaired wound healing due to enhanced activity of TGFbeta and perhaps additional mechanisms. Proepithelin (PEPI), an epithelial growth factor, can be converted to epithelins (EPIs) in vivo by unknown mechanisms with unknown consequences. We found that PEPI and EPIs exert opposing activities. EPIs inhibit the growth of epithelial cells but induce them to secrete the neutrophil attractant IL-8, while PEPI blocks neutrophil activation by tumor necrosis factor, preventing release of oxidants and proteases. SLPI and PEPI form complexes, preventing elastase from converting PEPI to EPIs. Supplying PEPI corrects the wound-healing defect in SLPI null mice. Thus, SLPI/elastase act via PEPI/EPIs to operate a switch at the interface between innate immunity and wound healing.	Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA; Cornell Univ, Program Pharmacol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Immunol, Weill Grad Sch Med Sci, New York, NY 10021 USA; Cornell Univ, Program Mol Biol, Weill Grad Sch Med Sci, New York, NY 10021 USA; NIDCR, Oral Infect & Immun Branch, NIH, Bethesda, MD 20892 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; Amgen Inc, Thousand Oaks, CA 91320 USA	Cornell University; Cornell University; Cornell University; Cornell University; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Memorial Sloan Kettering Cancer Center; Amgen	Ding, AH (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Weill Med Coll, New York, NY 10021 USA.			Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000691, Z01DE000046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061710] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA08748] Funding Source: Medline; NIAID NIH HHS [AI46382] Funding Source: Medline; NIGMS NIH HHS [GM61710] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE T, 1991, J CLIN INVEST, V87, P2207, DOI 10.1172/JCI115255; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; Ashcroft GS, 1999, NAT CELL BIOL, V1, P260, DOI 10.1038/12971; Avrova AO, 1999, MOL PLANT MICROBE IN, V12, P1114, DOI 10.1094/MPMI.1999.12.12.1114; BABA T, 1993, MOL REPROD DEV, V34, P233, DOI 10.1002/mrd.1080340302; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; BATEMAN A, 1990, BIOCHEM BIOPH RES CO, V173, P1161, DOI 10.1016/S0006-291X(05)80908-8; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; BELCOURT DR, 1993, J BIOL CHEM, V268, P9230; BHANDARI V, 1992, P NATL ACAD SCI USA, V89, P1715, DOI 10.1073/pnas.89.5.1715; CARP H, 1980, EXP LUNG RES, V1, P225, DOI 10.3109/01902148009065462; CAUGHEY GH, 1994, AM J RESP CRIT CARE, V150, P138; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; COUTO MA, 1992, INFECT IMMUN, V60, P3065, DOI 10.1128/IAI.60.8.3065-3071.1992; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diaz-Cueto L, 2000, DEV BIOL, V217, P406, DOI 10.1006/dbio.1999.9564; Drew AF, 2001, BLOOD, V97, P3691, DOI 10.1182/blood.V97.12.3691; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; FUORTES M, 1993, J CELL BIOL, V120, P777, DOI 10.1083/jcb.120.3.777; Fuortes M, 1999, J CLIN INVEST, V104, P327, DOI 10.1172/JCI6018; Grobmyer SR, 2000, CRIT CARE MED, V28, P1276, DOI 10.1097/00003246-200005000-00003; GRUTTER MG, 1988, EMBO J, V7, P345, DOI 10.1002/j.1460-2075.1988.tb02819.x; He ZH, 1999, CANCER RES, V59, P3222; HELMIG R, 1995, EUR J OBSTET GYN R B, V59, P95, DOI 10.1016/0028-2243(94)02023-8; Hong SJ, 1999, PROTEIN EXPRES PURIF, V16, P340; Hrabal R, 1996, NAT STRUCT BIOL, V3, P747, DOI 10.1038/nsb0996-747; HUNT TK, 1990, J TRAUMA, V30, P122; Hutchison D C, 1987, Eur J Respir Dis Suppl, V153, P78; Jin FY, 1998, INFECT IMMUN, V66, P2447, DOI 10.1128/IAI.66.6.2447-2452.1998; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; KRAMPS JA, 1983, SCAND J CLIN LAB INV, V43, P427; LEE CH, 1993, AM REV RESPIR DIS, V147, P710, DOI 10.1164/ajrccm/147.3.710; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mashimo H, 1996, SCIENCE, V274, P262, DOI 10.1126/science.274.5285.262; MCELVANEY NG, 1992, J CLIN INVEST, V90, P1296, DOI 10.1172/JCI115994; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; MELLET P, 1995, BIOCHEMISTRY-US, V34, P2645, DOI 10.1021/bi00008a031; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; NATHAN CF, 1987, J CLIN INVEST, V80, P1550, DOI 10.1172/JCI113241; OHLSSON K, 1995, J ANDROL, V16, P64; Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200; PLOWMAN GD, 1992, J BIOL CHEM, V267, P13073; RAPPOLEE DA, 1988, CURR OPIN IMMUNOL, V1, P47, DOI 10.1016/0952-7915(88)90050-7; Rehault S, 1999, J BIOL CHEM, V274, P13810, DOI 10.1074/jbc.274.20.13810; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Sallenave JM, 1997, J LEUKOCYTE BIOL, V61, P695, DOI 10.1002/jlb.61.6.695; SHOYAB M, 1990, P NATL ACAD SCI USA, V87, P7912, DOI 10.1073/pnas.87.20.7912; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; SOMORIN O, 1979, J BIOCHEM-TOKYO, V85, P157, DOI 10.1093/oxfordjournals.jbchem.a132305; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; Sparro G, 1997, PROTEIN EXPRES PURIF, V10, P169, DOI 10.1006/prep.1997.0726; Taggart AV, 2000, HEALTH SOC CARE COMM, V8, P1, DOI 10.1046/j.1365-2524.2000.00227.x; Tempst Paul, 1994, Methods (Orlando), V6, P248, DOI 10.1006/meth.1994.1027; THOMPSON RC, 1986, P NATL ACAD SCI USA, V83, P6692, DOI 10.1073/pnas.83.18.6692; Van Wetering S, 2000, AM J PHYSIOL-LUNG C, V278, pL51, DOI 10.1152/ajplung.2000.278.1.L51; Wahl SM, 1997, AM J PATHOL, V150, P1275; Weinzimer SA, 2001, J CLIN ENDOCR METAB, V86, P1806, DOI 10.1210/jc.86.4.1806; Witte MB, 1997, SURG CLIN N AM, V77, P509, DOI 10.1016/S0039-6109(05)70566-1; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108; Xu SQ, 1998, J BIOL CHEM, V273, P20078, DOI 10.1074/jbc.273.32.20078; YING QL, 1994, BIOCHEMISTRY-US, V33, P5445, DOI 10.1021/bi00184a013; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang HD, 1998, P NATL ACAD SCI USA, V95, P14202, DOI 10.1073/pnas.95.24.14202; Zhang YH, 1997, J CLIN INVEST, V99, P894, DOI 10.1172/JCI119254; ZHOU J, 1993, J BIOL CHEM, V268, P10863; Zhu J, 1999, BBA-MOL CELL RES, V1451, P219, DOI 10.1016/S0167-4889(99)00111-1; Zhu JW, 1997, P NATL ACAD SCI USA, V94, P13063, DOI 10.1073/pnas.94.24.13063; Zitnik RJ, 1997, BIOCHEM BIOPH RES CO, V232, P687, DOI 10.1006/bbrc.1997.6358	70	502	530	5	30	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					867	878		10.1016/S0092-8674(02)01141-8	http://dx.doi.org/10.1016/S0092-8674(02)01141-8			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526812	Bronze			2022-12-28	WOS:000179862600012
J	Schwalbe, N; Harrington, P				Schwalbe, N; Harrington, P			HIV and tuberculosis in the former Soviet Union	LANCET			English	Article									Open Soc Inst, New York, NY 10019 USA		Schwalbe, N (corresponding author), Open Soc Inst, 400 W 59th St, New York, NY 10019 USA.							*DEP SOC MED, 1999, PROGR SOC INF DIS SO; *INT HARM RED DEV, 2001, DRUGS AIDS HARM RED; RUHL C, 2002, EC CONSEQUENCES HIV; SHRESTHA L, 2002, HIV AIDS CENTRAL ASI; Stem V., 1998, SIN FUTURE IMPRISONM; VINOKUR A, 2001, 510 WORLD BANK; *WHO, 2002, GLOB PLAN STOP TB	7	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S19	S20		10.1016/S0140-6736(02)11805-8	http://dx.doi.org/10.1016/S0140-6736(02)11805-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504488				2022-12-28	WOS:000180064500009
J	Ghosh, S; Sood, AK; Kumar, N				Ghosh, S; Sood, AK; Kumar, N			Carbon nanotube flow sensors	SCIENCE			English	Article								We report that the flow of a liquid on single-waited carbon nanotube bundles induces a voltage in the sample along the direction of the flow. The voltage that was produced fit a logarithmic velocity dependence over nearly six decades of velocity. The magnitude of the voltage depended sensitively on the ionic conductivity and on the polar nature of the liquid. Our measurements suggest that the dominant mechanism responsible for this highly nonlinear response involves a direct forcing of the free charge carriers in the nanotubes by the fluctuating Coutombic field of the liquid flowing past the nanotubes. We propose an explanation based on pulsating asymmetric ratchets. Our work highlights the device potential for nanotubes as sensitive flow sensors and for energy conversion.	Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India; Raman Res Inst, Bangalore 560080, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Raman Research Institute (RRI)	Sood, AK (corresponding author), Indian Inst Sci, Dept Phys, Bangalore 560012, Karnataka, India.		Kumar, Narendra/B-6083-2009	Ghosh, Shankar/0000-0003-3617-5390				Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340; Collins PC, 2001, SCIENCE, V292, P706, DOI 10.1126/science.1058782; Curie P., 1894, J PHYS-PARIS, V3, P393, DOI DOI 10.1051/JPHYSTAP:018940030039300; Egger R, 1997, PHYS REV LETT, V79, P5082, DOI 10.1103/PhysRevLett.79.5082; Julicher F, 1997, REV MOD PHYS, V69, P1269, DOI 10.1103/RevModPhys.69.1269; Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622; Kral P, 2001, PHYS REV LETT, V86, P131, DOI 10.1103/PhysRevLett.86.131; Onsager L, 1932, J PHYS CHEM-US, V36, P2689, DOI 10.1021/j150341a001; Reimann P, 1997, PHYS REP, V290, P149, DOI 10.1016/S0370-1573(97)00064-1; Reimann P, 2002, PHYS REP, V361, P57, DOI 10.1016/S0370-1573(01)00081-3; Teredesai PV, 2000, CHEM PHYS LETT, V319, P296, DOI 10.1016/S0009-2614(00)00123-8	11	601	624	10	249	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1042	1044		10.1126/science.1079080	http://dx.doi.org/10.1126/science.1079080			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12532025	Green Accepted			2022-12-28	WOS:000180960000040
J	Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA				Currie, CR; Wong, B; Stuart, AE; Schultz, TR; Rehner, SA; Mueller, UG; Sung, GH; Spatafora, JW; Straus, NA			Ancient tripartite coevolution in the attine ant-microbe symbiosis	SCIENCE			English	Article							FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; HYMENOPTERA; AGRICULTURE; FORMICIDAE; MUTUALISM; PHYLOGENY; BACTERIA	The symbiosis between fungus-growing ants and the fungi they cultivate for food has been shaped by 50 million years of coevolution. Phylogenetic analyses indicate that this long coevolutionary history includes a third symbiont lineage: specialized microfungal parasites of the ants fungus gardens. At ancient levels, the phylogenies of the three symbionts are perfectly congruent, revealing that the ant-microbe symbiosis is the product of tripartite coevolution between the farming ants, their cultivars, and the garden parasites. At recent phylogenetic levels, coevolution has been punctuated by occasional host-switching by the parasite, thus intensifying continuous coadaptation between symbionts in a tripartite arms race.	Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA; Smithsonian Trop Res Inst, Balboa, Panama; Univ Toronto, Dept Bot, Toronto, ON M5S 3B2, Canada; Univ Texas, Austin, TX 78712 USA; Smithsonian Inst, Natl Museum Nat Hist, MRC 188, Washington, DC 20013 USA; ARS, Insect Biocontrol Lab, USDA, Beltsville, MD 20705 USA; Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	University of Kansas; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Toronto; University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; United States Department of Agriculture (USDA); Oregon State University	Currie, CR (corresponding author), Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA.							Ahmadjian V., 1987, SYMBIOSIS INTRO BIOL; BASS M, 1994, ECOL ENTOMOL, V19, P215, DOI 10.1111/j.1365-2311.1994.tb00412.x; Bot ANM, 2001, EVOLUTION, V55, P1980, DOI 10.1111/j.0014-3820.2001.tb01315.x; Boucher Douglas H., 1985, BIOL MUTUALISM ECOLO; Castle A, 1998, APPL ENVIRON MICROB, V64, P133; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Currie CR, 2001, OECOLOGIA, V128, P99, DOI 10.1007/s004420100630; Currie CR, 2001, P ROY SOC B-BIOL SCI, V268, P1033, DOI 10.1098/rspb.2001.1605; CURRIE CR, IN PRESS OIKOS; Futuyma D.J., 1983, COEVOLUTION; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; Margulis L., 1991, SYMBIOSISOURCE EVO; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; North RD, 1997, TRENDS ECOL EVOL, V12, P386, DOI 10.1016/S0169-5347(97)87381-8; QUINLAN RJ, 1977, ECOL ENTOMOL, V2, P161, DOI 10.1111/j.1365-2311.1977.tb00877.x; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Szathmary E, 1995, MAJOR TRANSITIONS EV; Wetterer JK, 1998, MOL PHYLOGENET EVOL, V9, P42, DOI 10.1006/mpev.1997.0466	23	273	291	3	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					386	388		10.1126/science.1078155	http://dx.doi.org/10.1126/science.1078155			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532015				2022-12-28	WOS:000180426800043
J	Doebeli, M; Dieckmann, U				Doebeli, M; Dieckmann, U			Speciation along environmental gradients	NATURE			English	Article							SYMPATRIC SPECIATION; DIVERGENCE; COMPETITION; RADIATION; ORIGIN; MORPHS	Traditional discussions of speciation are based on geographical patterns of species ranges(1,2). In allopatric speciation, long-term geographical isolation generates reproductively isolated and spatially segregated descendant species(1,3). In the absence of geographical barriers, diversification is hindered by gene flow(1,3,4). Yet a growing body of phylogenetic and experimental data suggests that closely related species often occur in sympatry or have adjacent ranges in regions over which environmental changes are gradual and do not prevent gene flow(5-14). Theory has identified a variety of evolutionary processes that can result in speciation under sympatric conditions(15-25), with some recent advances concentrating on the phenomenon of evolutionary branching(18,23-25). Here we establish a link between geographical patterns and ecological processes of speciation by studying evolutionary branching in spatially structured populations. We show that along an environmental gradient, evolutionary branching can occur much more easily than in non-spatial models. This facilitation is most pronounced for gradients of intermediate slope. Moreover, spatial evolutionary branching readily generates patterns of spatial segregation and abutment between the emerging species. Our results highlight the importance of local processes of adaptive divergence for geographical patterns of speciation, and caution against pitfalls of inferring past speciation processes from present biogeographical patterns.	Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z4, Canada; Int Inst Appl Syst Anal, Adapt Dynam Network, A-2361 Laxenburg, Austria	University of British Columbia; University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	Doebeli, M (corresponding author), Univ British Columbia, Dept Zool, 6270 Univ Blvd, Vancouver, BC V6T 1Z4, Canada.	doebeli@zoology.ubc.ca	Doebeli, Michael/D-5391-2012; Dieckmann, Ulf/E-1424-2011	Dieckmann, Ulf/0000-0001-7089-0393				Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Barton NH, 1999, GENET RES, V74, P223, DOI 10.1017/S001667239900422X; Case TJ, 2000, AM NAT, V155, P583, DOI 10.1086/303351; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; Dieckmann U., 2000, GEOMETRY ECOLOGICAL; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Endler J.A., 1977, Monographs in Population Biology, pi; Feder JL, 1998, ENDLESS FORMS, P130; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Gavrilets S, 2002, P NATL ACAD SCI USA, V99, P10533, DOI 10.1073/pnas.152011499; Geritz SAH, 1998, EVOL ECOL, V12, P35, DOI 10.1023/A:1006554906681; Gislason D, 1999, CAN J FISH AQUAT SCI, V56, P2229, DOI 10.1139/cjfas-56-12-2229; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI 10.1111/j.1558-5646.1997.tb05099.x; Kisdi E, 1999, J THEOR BIOL, V197, P149, DOI 10.1006/jtbi.1998.0864; KNOX EB, 1995, P NATL ACAD SCI USA, V92, P10349, DOI 10.1073/pnas.92.22.10349; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mayr E., 1963, ANIMAL SPECIES EVOLU; MIZERA F, IN PRESS EVOL ECOL R; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Schliewen U, 2001, MOL ECOL, V10, P1471, DOI 10.1046/j.1365-294X.2001.01276.x; SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0; SCHLUTER D, 1994, SCIENCE, V266, P798, DOI 10.1126/science.266.5186.798; SLATKIN M, 1978, J THEOR BIOL, V70, P213, DOI 10.1016/0022-5193(78)90348-X; Turelli M, 2001, TRENDS ECOL EVOL, V16, P330, DOI 10.1016/S0169-5347(01)02177-2; Van Doorn GS, 2001, P ROY SOC B-BIOL SCI, V268, P2155, DOI 10.1098/rspb.2001.1780; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	30	517	532	2	229	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					259	264		10.1038/nature01274	http://dx.doi.org/10.1038/nature01274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529641	Green Submitted			2022-12-28	WOS:000180397600045
J	Banker, G				Banker, G			Pars, PI 3-kinase, and the establishment of neuronal polarity	CELL			English	Editorial Material							CULTURED HIPPOCAMPAL-NEURONS; AXON SPECIFICATION	As reported in this issue of Cell (Shi et al., 2003), the protein complex consisting of mPar3, mPar6, and atypical protein kinase C is selectively localized to the axonal growth cone of cultured hippocampal neurons and is required for specification of the axon.	Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA	Oregon Health & Science University	Banker, G (corresponding author), Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.							Andersen SSL, 2000, BIOESSAYS, V22, P172, DOI 10.1002/(SICI)1521-1878(200002)22:2<172::AID-BIES8>3.0.CO;2-Q; Bradke F, 2000, CURR OPIN NEUROBIOL, V10, P574, DOI 10.1016/S0959-4388(00)00124-0; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch T, 1999, J NEUROSCI, V19, P6417; Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; SARGENT PB, 1989, TRENDS NEUROSCI, V12, P203, DOI 10.1016/0166-2236(89)90121-5; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Simonsen A, 2001, CURR OPIN CELL BIOL, V13, P485, DOI 10.1016/S0955-0674(00)00240-4; Wodarz A, 2002, NAT CELL BIOL, V4, pE39, DOI 10.1038/ncb0202-e39	10	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					4	5		10.1016/S0092-8674(02)01280-1	http://dx.doi.org/10.1016/S0092-8674(02)01280-1			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526787	Bronze			2022-12-28	WOS:000181191500016
J	Barends, S; Bink, HHJ; van den Worm, SHE; Pleij, CWA; Kraal, B				Barends, S; Bink, HHJ; van den Worm, SHE; Pleij, CWA; Kraal, B			Entrapping Ribosomes for viral translation: tRNA mimicry as a molecular Trojan horse	CELL			English	Article							YELLOW MOSAIC-VIRUS; DEPENDENT RNA-POLYMERASE; SYNTHESIS IN-VITRO; MESSENGER-RNA; TYMV-RNA; 3'-UNTRANSLATED REGIONS; ESCHERICHIA-COLI; CLEAVAGE SITE; ENTRY SITES; INITIATION	Turnip yellow mosaic virus (TYMV) has a genomic plus-strand RNA with a 5' cap followed by overlapping and different reading frames for the movement protein and polyprotein, while the distal coat protein cistron is translated from a subgenomic RNA. The 3'-untranslated region harbors a tRNA-like structure (TLS) to which a valine moiety can be added and it is indispensable for virus viability. Here, we report about a surprising interaction between TYMV-RNA-programmed ribosomes and 3'-valylated TLS that yields polyprotein with the valine N terminally incorporated by a translation mechanism resistant to regular initiation inhibitors. Disruption of the TLS exclusively abolishes polyprotein synthesis, which can be restored by adding excess TLS in trans. Our observations imply a novel eukaryotic mechanism for internal initiation of mRNA translation.	Leiden Univ, Leiden Inst Chem, Dept Biochem, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Kraal, B (corresponding author), Leiden Univ, Leiden Inst Chem, Dept Biochem, POB 9502, NL-2300 RA Leiden, Netherlands.		Worm, Steven D/I-3575-2012	Worm, Steven D/0000-0002-3865-4996				Barends S, 2000, BIOCHEMISTRY-US, V39, P2652, DOI 10.1021/bi992439d; BOZARTH CS, 1992, VIROLOGY, V187, P124, DOI 10.1016/0042-6822(92)90301-5; Bransom KL, 1996, VIROLOGY, V217, P404, DOI 10.1006/viro.1996.0131; Brosius J, 2001, TRENDS BIOCHEM SCI, V26, P653, DOI 10.1016/S0968-0004(01)01972-7; Carrasco L, 1974, Methods Enzymol, V30, P282; Choi YG, 2002, P NATL ACAD SCI USA, V99, P655, DOI 10.1073/pnas.022618199; Deiman BALM, 1998, J VIROL, V72, P3965, DOI 10.1128/JVI.72.5.3965-3972.1998; Dreher TW, 1999, ANNU REV PHYTOPATHOL, V37, P151, DOI 10.1146/annurev.phyto.37.1.151; Dreher TW, 1996, P NATL ACAD SCI USA, V93, P12212, DOI 10.1073/pnas.93.22.12212; DUNN DB, 1965, VIROLOGY, V25, P171, DOI 10.1016/0042-6822(65)90198-4; Fechter P, 2001, CELL MOL LIFE SCI, V58, P1547, DOI 10.1007/PL00000795; Goodwin JB, 1997, VIROLOGY, V230, P113, DOI 10.1006/viro.1997.8475; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; HAENNI AL, 1982, PROG NUCLEIC ACID RE, V27, P85, DOI 10.1016/S0079-6603(08)60598-X; HAENNI AL, 1973, NATURE-NEW BIOL, V241, P166, DOI 10.1038/newbio241166a0; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; JOSHI RL, 1986, EMBO J, V5, P1143, DOI 10.1002/j.1460-2075.1986.tb04339.x; KADARE G, 1995, J GEN VIROL, V76, P2853, DOI 10.1099/0022-1317-76-11-2853; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KOZAK M, 1978, J BIOL CHEM, V253, P6568; KOZAK M, 1986, CELL, V47, P481, DOI 10.1016/0092-8674(86)90609-4; KRAAL B, 1980, FEBS LETT, V121, P86, DOI 10.1016/0014-5793(80)81272-5; MANS RMW, 1991, EUR J BIOCHEM, V201, P303, DOI 10.1111/j.1432-1033.1991.tb16288.x; MATSUDA D, 2002, 21 ANN M; ODOM OW, 1978, J BIOL CHEM, V253, P1807; Olsthoorn RCL, 1999, EMBO J, V18, P4856, DOI 10.1093/emboj/18.17.4856; PINCK M, 1970, NATURE, V226, P954, DOI 10.1038/226954a0; PLEIJ CWA, 1976, P NATL ACAD SCI USA, V73, P4437, DOI 10.1073/pnas.73.12.4437; PROCHIANTZ A, 1973, NATURE-NEW BIOL, V241, P168, DOI 10.1038/newbio241168a0; RIETVELD K, 1983, EMBO J, V2, P1079, DOI 10.1002/j.1460-2075.1983.tb01549.x; ROZANOV MN, 1992, J GEN VIROL, V73, P2129, DOI 10.1099/0022-1317-73-8-2129; Sasaki J, 2000, P NATL ACAD SCI USA, V97, P1512, DOI 10.1073/pnas.010426997; Singh RN, 1997, VIROLOGY, V233, P430, DOI 10.1006/viro.1997.8621; SKOTNICKI ML, 1992, ARCH VIROL, V127, P25, DOI 10.1007/BF01309572; Skuzeski JM, 1996, J VIROL, V70, P2107, DOI 10.1128/JVI.70.4.2107-2115.1996; SZER W, 1970, Biochimica et Biophysica Acta, V224, P477, DOI 10.1016/0005-2787(70)90580-0; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WEILAND JJ, 1989, NUCLEIC ACIDS RES, V17, P4675, DOI 10.1093/nar/17.12.4675; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6	39	48	48	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					123	129		10.1016/S0092-8674(02)01256-4	http://dx.doi.org/10.1016/S0092-8674(02)01256-4			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526799	Bronze			2022-12-28	WOS:000181191500012
J	Adam, D; Butler, D				Adam, D; Butler, D			Comet mission hangs in the balance	NATURE			English	News Item																		2001, NATURE, V420, P723	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					102	102		10.1038/421102c	http://dx.doi.org/10.1038/421102c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520269	Bronze			2022-12-28	WOS:000180267200010
J	Stegman, DR; Jellinek, AM; Zatman, SA; Baumgardner, JR; Richards, MA				Stegman, DR; Jellinek, AM; Zatman, SA; Baumgardner, JR; Richards, MA			An early lunar core dynamo driven by thermochemical mantle convection	NATURE			English	Article							PROCELLARUM KREEP TERRANE; THERMAL EVOLUTION; MARE VOLCANISM; EARTHS CORE; MAGNETISM; HEAT; MOON	Although the Moon currently has no internally generated magnetic field, palaeomagnetic data, combined with radiometric ages of Apollo samples, provide evidence for such a magnetic field from similar to3.9 to 3.6 billion years (Gyr) ago(1), possibly owing to an ancient lunar dynamo(1,2). But the presence of a lunar dynamo during this time period is difficult to explain(1-4), because thermal evolution models for the Moon 5 yield insufficient core heat flux to power a dynamo after similar to4.2 Gyr ago. Here we show that a transient increase in core heat flux after an overturn of an initially stratified lunar mantle might explain the existence and timing of an early lunar dynamo. Using a three-dimensional spherical convection model(6), we show that a dense layer, enriched in radioactive elements (a 'thermal blanket'), at the base of the lunar mantle can initially prevent core cooling, thereby inhibiting core convection and magnetic field generation. Subsequent radioactive heating progressively increases the buoyancy of the thermal blanket, ultimately causing it to rise back into the mantle. The removal of the thermal blanket, proposed to explain the eruption of thorium- and titanium-rich lunar mare basalts(7), plausibly results in a core heat flux sufficient to power a short-lived lunar dynamo.	Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; Los Alamos Natl Lab, Div Theoret, Los Alamos, NM 87545 USA	University of California System; University of California Berkeley; University of Toronto; Washington University (WUSTL); United States Department of Energy (DOE); Los Alamos National Laboratory	Stegman, DR (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	dstegman@cps.berkeley.edu	Stegman, Dave/F-5794-2010	Stegman, Dave/0000-0001-8012-6145				Anderson OL, 1998, PHYS EARTH PLANET IN, V109, P179, DOI 10.1016/S0031-9201(98)00123-X; BAUMGARDNER JR, 1985, J STAT PHYS, V39, P501, DOI 10.1007/BF01008348; Buffett BA, 1996, J GEOPHYS RES-SOL EA, V101, P7989, DOI 10.1029/95JB03539; Bunge H.-P., 1995, Computers in Physics, V9, P207, DOI 10.1063/1.168525; CHRISTENSEN UR, 1984, PHYS EARTH PLANET IN, V35, P264, DOI 10.1016/0031-9201(84)90021-9; Cisowski S. M., 1983, Journal of Geophysical Research, V88, P691, DOI 10.1029/JB088iS02p0A691; COLLINSON DW, 1993, SURV GEOPHYS, V14, P89, DOI 10.1007/BF01044078; Davaille A, 1999, NATURE, V402, P756, DOI 10.1038/45461; DELANO JW, 1986, J GEOPHYS RES-SOLID, V91, pD201, DOI 10.1029/JB091iB04p0D201; Gonnermann HM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL014851; Haskin LA, 2000, J GEOPHYS RES-PLANET, V105, P20403, DOI 10.1029/1999JE001128; HESS PC, 1995, EARTH PLANET SC LETT, V134, P501, DOI 10.1016/0012-821X(95)00138-3; Hess PC, 2000, J GEOPHYS RES-PLANET, V105, P4347, DOI 10.1029/1999JE001067; Hood LL, 1999, GEOPHYS RES LETT, V26, P2327, DOI 10.1029/1999GL900487; Jellinek AM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014624; Jellinek AM, 1999, J GEOPHYS RES-SOL EA, V104, P7183, DOI 10.1029/1998JB900116; Jolliff BL, 2000, J GEOPHYS RES-PLANET, V105, P4197, DOI 10.1029/1999JE001103; Konrad W, 1997, ADV SPACE RES-SERIES, V19, P1511, DOI 10.1016/S0273-1177(97)00364-5; MORESI LN, 1995, PHYS FLUIDS, V7, P2154, DOI 10.1063/1.868465; ROBERTS PH, 1992, ANNU REV FLUID MECH, V24, P459, DOI 10.1146/annurev.fluid.24.1.459; Runcorn SK, 1996, GEOCHIM COSMOCHIM AC, V60, P1205, DOI 10.1016/0016-7037(96)00024-5; STACEY FD, 1984, PHYS EARTH PLANET IN, V36, P99, DOI 10.1016/0031-9201(84)90011-6; Stacey FD, 2001, PHYS EARTH PLANET IN, V124, P153, DOI 10.1016/S0031-9201(01)00186-8; Stegman DR, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000192; Stevenson DJ, 2001, NATURE, V412, P214, DOI 10.1038/35084155; STEVENSON DJ, 1983, ICARUS, V54, P466, DOI 10.1016/0019-1035(83)90241-5; STEVENSON DJ, 1983, REP PROG PHYS, V46, P555, DOI 10.1088/0034-4885/46/5/001; Tackley PJ, 1996, J GEOPHYS RES-SOL EA, V101, P3311, DOI 10.1029/95JB03211; WARREN PH, 1985, ANNU REV EARTH PL SC, V13, P201, DOI 10.1146/annurev.ea.13.050185.001221; Wieczorek MA, 2000, J GEOPHYS RES-PLANET, V105, P20417, DOI 10.1029/1999JE001092; Williams JG, 2001, J GEOPHYS RES-PLANET, V106, P27933, DOI 10.1029/2000JE001396; Yang WS, 2000, GEOPHYS ASTRO FLUID, V92, P151, DOI 10.1080/03091920008203715; Zhong SJ, 2000, EARTH PLANET SC LETT, V177, P131, DOI 10.1016/S0012-821X(00)00041-8	33	117	120	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					143	146		10.1038/nature01267	http://dx.doi.org/10.1038/nature01267			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520295				2022-12-28	WOS:000180267200033
J	Krauss, LM; Chaboyer, B				Krauss, LM; Chaboyer, B			Age estimates of globular clusters in the Milky Way: Constraints on cosmology	SCIENCE			English	Review							METAL-POOR STARS; HUBBLE-SPACE-TELESCOPE; ELEMENT DIFFUSION; HIGH-REDSHIFT; WHITE-DWARFS; MODELS; OXYGEN; MAGNITUDES; ABUNDANCES; HIPPARCOS	Recent observations of stellar globular clusters in the Milky Way Galaxy, combined with revised ranges of parameters in stellar evolution codes and new estimates of the earliest epoch of globular cluster formation, result in a 95% confidence level lower limit on the age of the Universe of 11.2 billion years. This age is inconsistent with the expansion age for a. at Universe for the currently allowed range of the Hubble constant, unless the cosmic equation of state is dominated by a component that violates the strong energy condition. This means that the three fundamental observables in cosmology-the age of the Universe, the distance-redshift relation, and the geometry of the Universe-now independently support the case for a dark energy dominated Universe.	Case Western Reserve Univ, Dept Phys & Astron, Cleveland, OH 44106 USA; Dartmouth Coll, Dept Phys & Astron, Wilder Lab 6127, Hanover, NH 03755 USA	Case Western Reserve University; Dartmouth College	Krauss, LM (corresponding author), Case Western Reserve Univ, Dept Phys & Astron, 10900 Euclid Ave, Cleveland, OH 44106 USA.	lmk9@po.cwru.edu; chaboyer@heather.dartmouth.edu		Chaboyer, Brian/0000-0003-3096-4161				BANKS TM, 2002, NATURE, V415, P54; Basu S, 2000, ASTROPHYS J, V529, P1084, DOI 10.1086/308302; Benedict GF, 2002, ASTRON J, V123, P473, DOI 10.1086/338087; Boesgaard AM, 1999, ASTRON J, V117, P492, DOI 10.1086/300691; Burgarella D, 2001, ASTRON J, V121, P2647, DOI 10.1086/320397; Burles S, 2001, ASTROPHYS J, V552, pL1, DOI 10.1086/320251; CAPUTO F, 1995, ASTRON ASTROPHYS, V298, P833; Carretta E, 2000, ASTRON ASTROPHYS, V356, P238; Catelan M, 1998, ASTROPHYS J, V495, pL81, DOI 10.1086/311227; Cayrel R, 2001, NATURE, V409, P691, DOI 10.1038/35055507; Chaboyer B, 1998, ASTROPHYS J, V494, P96, DOI 10.1086/305201; Chaboyer B, 2001, ASTROPHYS J, V562, P521, DOI 10.1086/323872; CHABOYER B, 1998, GLOBULAR CLUSTER DIS, P111; CHIEFFI A, 1989, ASTROPHYS J SUPPL S, V71, P47, DOI 10.1086/191364; CHRISTENSENDALSGAARD J, 1993, ASTROPHYS J, V403, pL75, DOI 10.1086/186725; Cowan JJ, 2002, ASTROPHYS J, V572, P861, DOI 10.1086/340347; de Bernardis P, 2002, ASTROPHYS J, V564, P559, DOI 10.1086/324298; Demarque P, 2000, ASTRON J, V119, P1398, DOI 10.1086/301261; DURRELL PR, 1993, ASTRON J, V105, P1420, DOI 10.1086/116521; FAHLMAN GG, 1985, ASTROPHYS J SUPPL S, V58, P225, DOI 10.1086/191039; Freedman WL, 2001, ASTROPHYS J, V553, P47, DOI 10.1086/320638; Garnavich PM, 1998, ASTROPHYS J, V509, P74, DOI 10.1086/306495; Gould A, 1998, ASTROPHYS J, V508, P844, DOI 10.1086/306448; Gratton RG, 1998, MON NOT R ASTRON SOC, V296, P739, DOI 10.1046/j.1365-8711.1998.01434.x; Gratton RG, 2001, ASTRON ASTROPHYS, V369, P87, DOI 10.1051/0004-6361:20010144; Green E.M., 1987, REVISED YALE ISOCHRO; Hansen BMS, 1999, ASTROPHYS J, V520, P680, DOI 10.1086/307476; HANSEN BMS, IN PRESS ASTROPHYS J; Hill V, 2002, ASTRON ASTROPHYS, V387, P560, DOI 10.1051/0004-6361:20020434; Israelian G, 2001, ASTROPHYS J, V551, P833, DOI 10.1086/320225; Kobulnicky HA, 2000, ASTROPHYS J, V545, P712, DOI 10.1086/317866; Krauss LM, 1998, ASTROPHYS J, V501, P461, DOI 10.1086/305846; KURUCZ RL, 1992, IAU SYMP, V149, P225; Melendez J, 2001, ASTROPHYS J, V556, P858, DOI 10.1086/321624; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pont F, 1998, ASTRON ASTROPHYS, V329, P87; Rees RF, 1996, ASTR SOC P, V92, P289; Renzini A, 1996, ASTROPHYS J, V465, pL23, DOI 10.1086/310128; Richer HB, 1997, ASTROPHYS J, V484, P741, DOI 10.1086/304379; THOUL AA, 1994, ASTROPHYS J, V421, P828, DOI 10.1086/173695; van den Bergh S, 2001, ASTROPHYS J, V559, pL113, DOI 10.1086/323754; [No title captured]	46	246	248	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					65	69		10.1126/science.1075631	http://dx.doi.org/10.1126/science.1075631			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511641				2022-12-28	WOS:000180165800032
J	Weiss, J; Marsan, D				Weiss, J; Marsan, D			Three-dimensional mapping of dislocation avalanches: Clustering and space/time coupling	SCIENCE			English	Article							VISCOPLASTIC DEFORMATION; ACOUSTIC-EMISSION; CRITICAL-DYNAMICS; SINGLE-CRYSTALS; SYSTEMS; FLOW; ICE	There is growing evidence for the complex, intermittent, and heterogeneous character of plastic flow. Here we report a three-dimensional mapping of dislocation avalanches during creep deformation of an ice crystal, from a multiple-transducers acoustic emission analysis. Correlation analysis shows that dislocation avalanches are spatially clustered according to a fractal pattern and that the closer in time two avalanches are, the larger the probability is that they will be closer in space. Such a space/time coupling may contribute to the self-organization of the avalanches into a clustered pattern.	CNRS, Lab Glaciol & Geophys Environm, F-38402 St Martin Dheres, France; Univ Savoie, Lab Geophys Interne & Tectonophys, F-73376 Le Bourget Du Lac, France	Centre National de la Recherche Scientifique (CNRS); Universite de Savoie	Weiss, J (corresponding author), CNRS, Lab Glaciol & Geophys Environm, 54 Rue Moliere,BP 96, F-38402 St Martin Dheres, France.		Marsan, David/E-1351-2011					Amitrano D, 1999, GEOPHYS RES LETT, V26, P2109, DOI 10.1029/1999GL900388; Ananthakrishna G, 1999, PHYS REV E, V60, P5455, DOI 10.1103/PhysRevE.60.5455; DUVAL P, 1995, J PHYS IV, V5, P197, DOI 10.1051/jp4:1995317; Hahner P, 1998, PHYS REV LETT, V81, P2470, DOI 10.1103/PhysRevLett.81.2470; HIRATA T, 1987, GEOPHYS J ROY ASTR S, V90, P369, DOI 10.1111/j.1365-246X.1987.tb00732.x; LOCKNER DA, 1991, NATURE, V350, P39, DOI 10.1038/350039a0; Marsan D, 2000, J GEOPHYS RES-SOL EA, V105, P28081, DOI 10.1029/2000JB900232; Miguel MC, 2001, NATURE, V410, P667, DOI 10.1038/35070524; Neuhauser H., 1983, Dislocations in solids. Vol.6. Applications and recent advances, P319; PETRI A, 1994, PHYS REV LETT, V73, P3423, DOI 10.1103/PhysRevLett.73.3423; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; SEVILLANO JG, 1991, SCRIPTA METALL MATER, V25, P355, DOI 10.1016/0956-716X(91)90192-4; Szekely F, 2001, MAT SCI ENG A-STRUCT, V309, P352, DOI 10.1016/S0921-5093(00)01629-4; Weiss J, 2001, MAT SCI ENG A-STRUCT, V309, P360, DOI 10.1016/S0921-5093(00)01633-6; Weiss J, 2000, J GEOPHYS RES-SOL EA, V105, P433, DOI 10.1029/1999JB900312; Weiss J, 1997, J PHYS CHEM B, V101, P6113, DOI 10.1021/jp963157f; Zaiser M, 2001, MAT SCI ENG A-STRUCT, V309, P304, DOI 10.1016/S0921-5093(00)01676-2; Zapperi S, 1999, PHYS REV E, V59, P5049, DOI 10.1103/PhysRevE.59.5049	18	160	161	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					89	92		10.1126/science.1079312	http://dx.doi.org/10.1126/science.1079312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511646				2022-12-28	WOS:000180165800038
J	Welter, S; Brunner, K; Hofstraat, JW; De Cola, L				Welter, S; Brunner, K; Hofstraat, JW; De Cola, L			Electroluminescent device with reversible switching between red and green emission	NATURE			English	Article							CHELATED RUTHENIUM(II) COMPLEX; ELECTRON-TRANSFER PROCESSES; MOLECULAR WIRES; CHEMILUMINESCENCE	Research on new materials for organic electroluminescence has recently focused strongly on phosphorescent emitters(1-3), with the aim of increasing the emission efficiency and stability. Here we report the fabrication of a simple electroluminescent device, based on a semiconducting polymer combined with a phosphorescent complex, that shows fully reversible voltage-dependent switching between green and red light emission. The active material is made of a polyphenylenevinylene (PPV) derivative molecularly doped with a homogeneously dispersed dinuclear ruthenium complex, which fulfils the dual roles of triplet emitter and electron transfer mediator. At forward bias (+4 V), the excited state of the ruthenium compound is populated, and the characteristic red emission of the complex is observed. On reversing the bias (-4 V), the lowest excited singlet state of the polymer host is populated, with subsequent emission of green light. The mechanism for the formation of the excited state of the PPV derivative involves the ruthenium dinuclear complex in a stepwise electron transfer process that finally leads to efficient charge recombination reaction on the polymer.	Univ Amsterdam, Mol Photon Grp, NL-1018 WV Amsterdam, Netherlands; Philips Natuurkundig Lab, NL-5656 AA Eindhoven, Netherlands	University of Amsterdam; Philips	De Cola, L (corresponding author), Univ Amsterdam, Mol Photon Grp, Nieuwe Achtergracht 166, NL-1018 WV Amsterdam, Netherlands.	klemens.brunner@philips.com; ldc@science.uva.nl	Hofstraat, Hans/ABI-3627-2020; De Cola, Luisa/AAO-1015-2021	De Cola, Luisa/0000-0002-2152-6517				Baldo MA, 1998, NATURE, V395, P151, DOI 10.1038/25954; BERGGREN M, 1994, NATURE, V372, P444, DOI 10.1038/372444a0; BREDAS JL, 1982, PHYS REV B, V26, P5843, DOI 10.1103/PhysRevB.26.5843; Buda M, 2002, J AM CHEM SOC, V124, P6090, DOI 10.1021/ja017834h; De Cola L, 1998, COORDIN CHEM REV, V177, P301, DOI 10.1016/S0010-8545(98)00198-2; DECOLA L, 2001, ELECT TRANSFER CHEM, V5, P97; deMello JC, 1998, PHYS REV B, V57, P12951, DOI 10.1103/PhysRevB.57.12951; Elliott CM, 1998, J AM CHEM SOC, V120, P6781, DOI 10.1021/ja974347m; Faulkner L. R., 1977, ELECTROANALYTICAL CH, P1; Hamaguchi M, 1996, APPL PHYS LETT, V69, P143, DOI 10.1063/1.116901; Handy ES, 1999, J AM CHEM SOC, V121, P3525, DOI 10.1021/ja984163n; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; LUTTMER JD, 1981, J PHYS CHEM-US, V85, P1155, DOI 10.1021/j150609a016; Maness KM, 1996, J AM CHEM SOC, V118, P10609, DOI 10.1021/ja953185w; PEI QB, 1995, SCIENCE, V269, P1086, DOI 10.1126/science.269.5227.1086; Pourtois G, 2002, J AM CHEM SOC, V124, P4436, DOI 10.1021/ja017150+; Rudmann H, 2002, J AM CHEM SOC, V124, P4918, DOI 10.1021/ja012721j; Tasch S, 1997, ADV MATER, V9, P33, DOI 10.1002/adma.19970090105; Wu A, 1999, J AM CHEM SOC, V121, P4883, DOI 10.1021/ja9833624; Yaliraki SN, 1999, J AM CHEM SOC, V121, P3428, DOI 10.1021/ja982918k; Yang Y, 1996, APPL PHYS LETT, V68, P2708, DOI 10.1063/1.116316	21	284	294	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					54	57		10.1038/nature01309	http://dx.doi.org/10.1038/nature01309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511951				2022-12-28	WOS:000180165500034
J	Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG				Hu, M; Li, PW; Li, MY; Li, WY; Yao, TT; Wu, JW; Gu, W; Cohen, RE; Shi, YG			Crystal structure of a UBP-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde	CELL			English	Article							ACTIVE-SITE; P53; PROTEASE; PATHWAY; ISOPEPTIDASE; DEGRADATION; SPECIFICITY; MECHANISMS; DIVERSITY; ALIGNMENT	The ubiquitin-specific processing protease (UBP) family of deubiquitinating enzymes plays an essential role in numerous cellular processes. HAUSP, a representative UBP, specifically deubiquitinates and hence stabilizes the tumor suppressor protein p53. Here, we report the crystal structures of the 40 kDa catalytic core domain of HAUSP in isolation and in complex with ubiquitin aldehyde. These studies reveal that the UBP deubiquitinating enzymes exhibit a conserved three-domain architecture, comprising Fingers, Palm, and Thumb. The leaving ubiquitin moiety is specifically coordinated by the Fingers, with its C terminus placed in the active site between the Palm and the Thumb. Binding by ubiquitin aldehyde induces a drastic conformational change in the active site that realigns the catalytic triad residues for catalysis.	Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA; Columbia Univ Coll Phys & Surg, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA	Princeton University; Columbia University; University of Iowa	Shi, YG (corresponding author), Princeton Univ, Dept Mol Biol, Lewis Thomas Lab, Princeton, NJ 08544 USA.	yshi@molbio.princeton.edu		Shi, Yigong/0000-0003-2030-168X				Baek KH, 2001, BLOOD, V98, P636, DOI 10.1182/blood.V98.3.636; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chai JJ, 2001, CELL, V104, P769, DOI 10.1016/S0092-8674(02)02034-2; CHEN ZJ, 1990, J BIOL CHEM, V265, P21835; Chung CH, 1999, BIOCHEM BIOPH RES CO, V266, P633, DOI 10.1006/bbrc.1999.1880; Chung JY, 2002, J CELL SCI, V115, P679; Chung KKK, 2001, TRENDS NEUROSCI, V24, pS7, DOI 10.1016/S0166-2236(00)01998-6; Conaway RC, 2002, SCIENCE, V296, P1254, DOI 10.1126/science.1067466; D'Andrea A, 1998, CRIT REV BIOCHEM MOL, V33, P337, DOI 10.1080/10409239891204251; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; DUNTEN RL, 1989, J BIOL CHEM, V264, P16739; Everett RD, 1997, EMBO J, V16, P566, DOI 10.1093/emboj/16.3.566; Gilchrist CA, 2000, BBA-PROTEIN STRUCT M, V1481, P297, DOI 10.1016/S0167-4838(00)00134-5; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HENIKOFF S, 1995, GENE-COMBIS, V163, pGC17, DOI 10.1016/0378-1119(95)00486-P; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; HERSHKO A, 1987, P NATL ACAD SCI USA, V84, P1829, DOI 10.1073/pnas.84.7.1829; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 1998, GENE DEV, V12, P901, DOI 10.1101/gad.12.7.901; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lai ZH, 2001, J BIOL CHEM, V276, P31357, DOI 10.1074/jbc.M011517200; Lam YA, 1997, J BIOL CHEM, V272, P28438, DOI 10.1074/jbc.272.45.28438; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Moldoveanu T, 2002, CELL, V108, P649, DOI 10.1016/S0092-8674(02)00659-1; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P461; Rodriguez MS, 2000, MOL CELL BIOL, V20, P8458, DOI 10.1128/MCB.20.22.8458-8467.2000; Schwartz AL, 1999, ANNU REV MED, V50, P57; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wu JW, 2001, J BIOL CHEM, V276, P20688, DOI 10.1074/jbc.M100174200; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zapata JM, 2001, J BIOL CHEM, V276, P24242, DOI 10.1074/jbc.M100354200	53	474	501	1	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					1041	1054		10.1016/S0092-8674(02)01199-6	http://dx.doi.org/10.1016/S0092-8674(02)01199-6			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507430	Bronze			2022-12-28	WOS:000180086000013
J	Jacks, T; Weinberg, RA				Jacks, T; Weinberg, RA			Taking the study of cancer cell survival to a new dimension	CELL			English	Review							APOPTOSIS; TUMOR; PROGRESSION; ONCOGENE; GROWTH	Apoptosis plays a key role in the development of cancer and the response of tumor cells to therapeutic intervention. Recent work using three-dimensional cell culture models underscores the importance of the interactions between epithelial cells-both normal and malignant-and the extracellular matrix that surrounds them in informing life and death decisions. Research in this area is beginning to define the oncogenic pathways that can interfere with this process and the biochemical pathways that transmit signals from proper cell-matrix interactions to promote cell survival.	MIT, Ctr Canc Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02142 USA.							BISSELL MJ, 2002, CELL, V111, P29; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARRIS J, 1999, ONCOGENE, V21, P5504; LOWE SW, 1994, P NATL ACAD SCI USA, V91, P2026, DOI 10.1073/pnas.91.6.2026; MacDougall JR, 1995, CANCER METAST REV, V14, P351, DOI 10.1007/BF00690603; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; SYMONDS H, 1994, CELL, V78, P703, DOI 10.1016/0092-8674(94)90534-7; Tagliabue E, 1998, CLIN CANCER RES, V4, P407; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; WEAVER VM, 1997, J CELL BIOL, V25, P14821	14	235	248	4	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					923	925		10.1016/S0092-8674(02)01229-1	http://dx.doi.org/10.1016/S0092-8674(02)01229-1			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507419	Bronze			2022-12-28	WOS:000180086000002
J	Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B				Moberg, L; Johansson, H; Lukinius, A; Berne, C; Foss, A; Kallen, R; Ostraat, O; Salmela, K; Tibell, A; Tufveson, G; Elgue, G; Ekdahl, KN; Korsgren, O; Nilsson, B			Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation	LANCET			English	Article							COMPLEMENT ACTIVATION; ENDOCRINE PANCREAS; HUMAN BLOOD; COAGULATION; BIOMATERIAL; EXPRESSION; INHIBITION; RECEPTOR; MODEL; RNA	Background Intraportal transplantation of pancreatic islets offers improved glycaemic control and insulin independence in type 1 diabetes mellitus, but intraportal thrombosis remains a possible complication. The thrombotic reaction may explain why graft loss occurs and islets from more than one donor are needed, since contact between human islets and ABO-compatible blood in vitro triggers a thrombotic reaction that damages the islets. We investigated the possible mechanism and treatment of such thrombotic reactions. Methods Coagulation activation and islet damage were monitored in four patients undergoing clinical islet transplantation according to a modified Edmonton protocol. Expression of tissue factor (TF) in the islet preparations was investigated by immunohistochemistry, immunoprecipitation, electron microscopy, and RT-PCR. To assess TF activity in purified islets, human islets were mixed with non-anticoagulated ABO-compatible blood in tubing loops coated with heparin. Findings Coagulation activation and subsequent release of insulin were found consistently after clinical islet transplantation, even in the absence of signs of intraportal thrombosis. The endocrine, but not the exocrine, cells of the pancreas were found to synthesise and secrete active TF. The clotting reaction triggered by pancreatic islets in vitro could be abrogated by blocking the active site of TF with specific antibodies or site-inactivated factor Vlla, a candidate drug for inhibition of TF activity in vivo. Interpretation Blockade of TF represents a new therapeutic approach that might increase the success of islet transplantation in patients with type 1 diabetes, in terms of both the risk of intraportal thrombosis and the need for islets from more than one donor.	Univ Uppsala Hosp, Rudbeck Lab, Dept Genet & Pathol, Div Pathol, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Div Med, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Surg Sci, Div Transplantat Surg, S-75185 Uppsala, Sweden; Dept Transplantat Surg, Oslo, Norway; Malmo Univ Hosp, Dept Nephrol & Transplantat, Malmo, Sweden; Skejby Hosp, Dept Urol, Aarhus, Denmark; Univ Helsinki, Surg Hosp, Div Transplantat, Helsinki, Finland; Dept Transplantat Surg, Stockholm, Sweden; Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Lund University; Skane University Hospital; Aarhus University; University of Helsinki; Linnaeus University; University of Kalmar	Nilsson, B (corresponding author), Univ Uppsala Hosp, Rudbeck Lab, Div Clin Immunol, Dept Radiol Oncol & Clin Immunol, S-75185 Uppsala, Sweden.		Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012	Nilsson, Bo/0000-0003-0057-2730; Korsgren, Olle/0000-0002-8524-9547				Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Brandhorst H, 1998, CELL TRANSPLANT, V7, P489, DOI 10.1016/S0963-6897(98)00028-1; Colman RW, 1996, BLOOD, V87, P2089; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Ekdahl KN, 1997, ARTHRITIS RHEUM, V40, P2178, DOI 10.1002/art.1780401212; EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x; Froberg MK, 1997, HUM PATHOL, V28, P1295, DOI 10.1016/S0046-8177(97)90204-5; Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228; GOUGH NM, 1988, ANAL BIOCHEM, V173, P93, DOI 10.1016/0003-2697(88)90164-9; Lakey JRT, 1999, CELL TRANSPLANT, V8, P285, DOI 10.1177/096368979900800309; Larsson R, 1997, IMMUNOPHARMACOLOGY, V38, P119, DOI 10.1016/S0162-3109(97)00064-7; LUKINIUS A, 1992, DEV BIOL, V153, P376, DOI 10.1016/0012-1606(92)90122-W; Lukinius A, 2001, DIABETES, V50, P962, DOI 10.2337/diabetes.50.5.962; Luther T, 1996, AM J PATHOL, V149, P101; Mavrommatis AC, 2000, CRIT CARE MED, V28, P451, DOI 10.1097/00003246-200002000-00027; MOLLNES TE, 1985, SCAND J IMMUNOL, V22, P183, DOI 10.1111/j.1365-3083.1985.tb01870.x; Morrissey JH, 2001, THROMB HAEMOSTASIS, V86, P66; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; PARKER RC, 1957, NY ACAD SCI, V5, P303; Pazzagli M, 1999, CLIN APPL THROMB-HEM, V5, P228, DOI 10.1177/107602969900500404; Peppelenbosch MP, 2001, TRENDS CARDIOVAS MED, V11, P335, DOI 10.1016/S1050-1738(01)00137-2; POTGENS AJG, 1994, THROMB HAEMOSTASIS, V71, P208; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; SHAPIRO AMJ, 1995, TRANSPLANTATION, V59, P1060, DOI 10.1097/00007890-199504150-00027; VANSUYLICHEM PTR, 1995, CELL TRANSPLANT, V4, P609, DOI 10.1016/0963-6897(95)00026-7; WILDGOOSE P, 1990, BIOCHEMISTRY-US, V29, P3413, DOI 10.1021/bi00465a039; ZHANG YM, 1994, J CLIN INVEST, V94, P1320, DOI 10.1172/JCI117451	30	434	444	1	23	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2039	2045		10.1016/S0140-6736(02)12020-4	http://dx.doi.org/10.1016/S0140-6736(02)12020-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504401				2022-12-28	WOS:000179974200013
J	Peppelenbosch, MP; Spek, CA				Peppelenbosch, MP; Spek, CA			Type I diabetes: a role for tissue factor in pancreatic islet transplantation?	LANCET			English	Editorial Material							COAGULATION; PATHWAY		Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Peppelenbosch, MP (corresponding author), Univ Amsterdam, Acad Med Ctr, Lab Expt Internal Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.		Spek, Arnold/AAC-5866-2019	Spek, Arnold/0000-0002-2149-4068; Peppelenbosch, Maikel/0000-0001-9112-6028				CREASEY AA, 1993, J CLIN INVEST, V91, P2850, DOI 10.1172/JCI116529; de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x; Esmon CT, 2001, THROMB HAEMOSTASIS, V86, P51; GATES RJ, 1972, LANCET, V2, P567; *IPITA, 1999, 7 WORLD C INT PANCR; Lawrence D, 2002, LANCET, V359, P2007, DOI 10.1016/S0140-6736(02)08853-0; Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Wiiger MT, 2000, TRENDS CARDIOVAS MED, V10, P360, DOI 10.1016/S1050-1738(01)00074-3; Yamaoka T, 2002, BIOCHEM BIOPH RES CO, V296, P1039, DOI 10.1016/S0006-291X(02)02000-4	10	4	4	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					1999	2000		10.1016/S0140-6736(02)12033-2	http://dx.doi.org/10.1016/S0140-6736(02)12033-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504392				2022-12-28	WOS:000179974200005
J	Boss, P				Boss, P			Ambiguous loss in families of the missing	LANCET			English	Article									Univ Minnesota, Dept Family Social Sci, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Boss, P (corresponding author), Univ Minnesota, Dept Family Social Sci, 290 Mcneal Hall, St Paul, MN 55108 USA.							[Anonymous], 1999, AMBIGUOUS LOSS; Boss P., 2016, FAMILY STRESS MANAGE; Boss PG, 2002, FAM PROCESS, V41, P14, DOI 10.1111/j.1545-5300.2002.40102000014.x	3	50	51	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S39	S40		10.1016/S0140-6736(02)11815-0	http://dx.doi.org/10.1016/S0140-6736(02)11815-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504498				2022-12-28	WOS:000180064500019
J	Ward, J; Vann, B				Ward, J; Vann, B			Gender-based violence in refugee settings	LANCET			English	Article									Int Rescue Comm, Reprod Hlth Refugees Consortium, New York, NY 10168 USA		Ward, J (corresponding author), Int Rescue Comm, Reprod Hlth Refugees Consortium, 122 E 42nd St, New York, NY 10168 USA.								0	32	32	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S13	S14		10.1016/S0140-6736(02)11802-2	http://dx.doi.org/10.1016/S0140-6736(02)11802-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504485	Bronze			2022-12-28	WOS:000180064500006
J	Hori, S; Nomura, T; Sakaguchi, S				Hori, S; Nomura, T; Sakaguchi, S			Control of regulatory T cell development by the transcription factor Foxp3	SCIENCE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; LYMPHOCYTE-ASSOCIATED ANTIGEN-4; AUTOIMMUNE-DISEASE; SCURFY MOUSE; ENTEROPATHY; HOMEOSTASIS; INDUCTION; CD25(+); MUTANT	Regulatory T cells engage in the maintenance of immunological self-tolerance by actively suppressing self-reactive lymphocytes. Little is known, however, about the molecular mechanism of their development. Here we show that Foxp3, which encodes a transcription factor that is genetically defective in an autoimmune and inflammatory syndrome in humans and mice, is specifically expressed in naturally arising CD4(+) regulatory T cells. Furthermore, retroviral gene transfer of Foxp3 converts naive T cells toward a regulatory T cell phenotype similar to that of naturally occurring CD4(+) regulatory T cells. Thus, Foxp3 is a key regulatory gene for the development of regulatory T cells.	Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	RIKEN; Kyoto University	Sakaguchi, S (corresponding author), Inst Phys & Chem Res, Res Ctr Allergy & Immunol, Immunopathol Lab, Yokohama, Kanagawa 2300045, Japan.		Hori, Shohei/O-6163-2019; Sakaguchi, Shimon/C-9535-2009	Hori, Shohei/0000-0001-8770-4593; 				Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Asano M, 1996, J EXP MED, V184, P387, DOI 10.1084/jem.184.2.387; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BLAIR PJ, 1994, J IMMUNOL, V153, P3764; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Clark LB, 1999, J IMMUNOL, V162, P2546; Coutinho A, 2001, IMMUNOL REV, V182, P89, DOI 10.1034/j.1600-065X.2001.1820107.x; de Lafaille MAC, 2001, J EXP MED, V194, P1349, DOI 10.1084/jem.194.9.1349; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Hori S., UNPUB; Itoh M, 1999, J IMMUNOL, V162, P5317; Lehmann J, 2002, P NATL ACAD SCI USA, V99, P13031, DOI 10.1073/pnas.192162899; Maloy KJ, 2001, NAT IMMUNOL, V2, P816, DOI 10.1038/ni0901-816; McHugh RS, 2002, IMMUNITY, V16, P311, DOI 10.1016/S1074-7613(02)00280-7; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shevach EM, 2002, NAT REV IMMUNOL, V2, P389, DOI 10.1038/nri821; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Stephens LA, 2000, J IMMUNOL, V165, P3105, DOI 10.4049/jimmunol.165.6.3105; Suri-Payer E, 2001, J AUTOIMMUN, V16, P115, DOI 10.1006/jaut.2000.0473; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Takahashi T, 1998, INT IMMUNOL, V10, P1969, DOI 10.1093/intimm/10.12.1969; Takahashi T, 2000, J EXP MED, V192, P303, DOI 10.1084/jem.192.2.303; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Van Parijs L, 1998, SCIENCE, V280, P243; Wildin RS, 2002, J MED GENET, V39, P537, DOI 10.1136/jmg.39.8.537; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Zahorsky-Reeves JL, 2001, EUR J IMMUNOL, V31, P196, DOI 10.1002/1521-4141(200101)31:1<196::AID-IMMU196>3.0.CO;2-9	31	6219	6850	6	578	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 14	2003	299	5609					1057	1061		10.1126/science.1079490	http://dx.doi.org/10.1126/science.1079490			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	645DB	12522256				2022-12-28	WOS:000180960000045
J	Aguayo, VM; Ross, JS; Kanon, S; Ouedraogo, AN				Aguayo, VM; Ross, JS; Kanon, S; Ouedraogo, AN			Monitoring compliance with the International Code of Marketing of Breastmilk Substitutes in West Africa: multisite cross sectional survey in Togo and Burkina Faso	BRITISH MEDICAL JOURNAL			English	Article							MILK SUBSTITUTES	Objectives To monitor compliance with the International Code of Marketing of Breastmilk Substitutes in health systems, sales outlets, distribution points, and the news media in Togo and Burkina Faso, west Africa. Design Multisite cross sectional survey. Participants Staff at 43 health facilities and 66 sales outlets and distribution points, 136 health providers, and 105 mothers of infants aged less than or equal to5 months in 16 cities. Results Six (14%) health facilities had received donations of breast milk substitutes. All donations were being given to mothers free of charge. Health providers in five (12%) health facilities had received free samples of breast milk substitutes for purposes other than professional research or evaluation. Health professionals in five (12%) health. facilities had received promotional gifts from manufacturers. Promotional materials of commercial breast milk substitutes were found in seven (16%) health facilities. Special displays to market commercial breast milk substitutes were found in 29 (44%) sales and distribution points. Forty commercial breast milk substitutes violated the labelling standards of the code: 21 were manufactured by Danone, 11 by Nestle, and eight by other national and international manufacturers. Most (148,90%) health providers had never heard of the code, and 66 mothers (63%) had never received any counselling on breast feeding by their health providers. Conclusion In west Africa manufacturers are violating the code of marketing of breast milk substitutes. Comparable levels of code violations are observed with (Burkina Faso) or without (Togo) regulating legislation. Legislation must be accompanied by effective information, training, and monitoring systems to ensure that healthcare providers and manufacturers comply with evidence based practice and the code.	Helen Keller Int Reg Off Africa, New York, NY 10010 USA; Acad Educ Dev, LINKAGES Project, Washington, DC 20009 USA; Int Baby Food Act Network, Reg Off W Africa, Ouagadougou, Burkina Faso; WHO, Reg Off Africa, Harare, Zimbabwe	World Health Organization	Aguayo, VM (corresponding author), Helen Keller Int Reg Off Africa, New York, NY 10010 USA.							Bellamy C, 2000, BRIT MED J, V321, P960, DOI 10.1136/bmj.321.7266.960; Costello A, 1998, BMJ-BRIT MED J, V316, P1103, DOI 10.1136/bmj.316.7138.1103; FRANK DA, 1987, PEDIATRICS, V80, P845; Haggerty P, 1999, DHS COMP STUDIES, V30; Jelliffe D B, 1972, Nutr Rev, V30, P199; Kean YJ, 2000, BRIT MED J, V321, P959; Lhotska L, 2000, ANN NY ACAD SCI, V918, P145; *LINKAGES, 1999, NUTR TOG INV AUJ HUI; *LINKAGES, 2000, NUTR CLE DEV HUM DUR; Mehdi T, 1998, FEEDING FIASCO PUSHI; Perera T, 1999, BRIT MED J, V318, P1140, DOI 10.1136/bmj.318.7191.1140; Pisacane A, 2000, BRIT MED J, V321, P960; Sinha S, 2000, BRIT MED J, V321, P959, DOI 10.1136/bmj.321.7266.959; SOKOL E, 2001, BREAKING RULES STRET; SOKOL E, 1998, COMPLYING CODE MANUF; SOKOL F, 1998, COMPLYING CODE MANUF; SOKOL F, 2001, BREAKING RULES STRET; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; *UNICEF, 2002, STAT WORLDS CHILDR; World Health Organization, 1981, INT COD MARK BREASTM; Yamey G, 2000, BRIT MED J, V321, P8, DOI 10.1136/bmj.321.7252.8/a; Yamey G, 2000, BRIT MED J, V320, P468	22	39	39	0	7	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					127	130B		10.1136/bmj.326.7381.127	http://dx.doi.org/10.1136/bmj.326.7381.127			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531842	Green Published, Bronze			2022-12-28	WOS:000180575900021
J	Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ				Gawande, AA; Studdert, DM; Orav, EJ; Brennan, TA; Zinner, MJ			Risk factors for retained instruments and sponges after surgery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAABDOMINAL SURGERY; SURGICAL SPONGE; CLAIMS	Background: Risk factors for medical errors remain poorly understood. We performed a case-control study of retained foreign bodies in surgical patients in order to identify risk factors for this type of error. Methods: We reviewed the medical records associated with all claims or incident reports of a retained surgical sponge or instrument filed between 1985 and 2001 with a large malpractice insurer representing one third of the physicians in Massachusetts. For each case, we identified an average of four randomly selected controls who underwent the same type of operation during the same six-month period. Results: Our study included 54 patients with a total of 61 retained foreign bodies (of which 69 percent were sponges and 31 percent instruments) and 235 control patients. Thirty-seven of the patients with retained foreign bodies (69 percent) required reoperation, and one died. Patients with retained foreign bodies were more likely than controls to have had emergency surgery (33 percent vs. 7 percent, P<0.001) or an unexpected change in surgical procedure (34 percent vs. 9 percent, P<0.001). Patients with retained foreign bodies also had a higher mean body-mass index and were less likely to have had counts of sponges and instruments performed. In multivariate analysis, factors associated with a significantly increased risk of retention of a foreign body were emergency surgery (risk ratio, 8.8 [95 percent confidence interval, 2.4 to 31.9]), unplanned change in the operation (risk ratio, 4.1 [95 percent confidence interval, 1.4 to 12.4]), and body-mass index (risk ratio for each one-unit increment, 1.1 [95 percent confidence interval, 1.0 to 1.2]). Conclusions: The risk of retention of a foreign body after surgery significantly increases in emergencies, with unplanned changes in procedure, and with higher body-mass index. Case -control analysis of medical-malpractice claims may identify and quantify risk factors for specific types of errors.	Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Gawande, AA (corresponding author), Brigham & Womens Hosp, Dept Surg, 75 Francis St, Boston, MA 02115 USA.		Studdert, David/AAF-3116-2021	Studdert, David/0000-0003-0585-5537; Gawande, Atul/0000-0002-1824-9176	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K02HS011285, U18HS011886] Funding Source: NIH RePORTER; AHRQ HHS [U18HS11886, KO2HS11285] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; CLARK C, 2002, SAN DIEGO UNION 0223, pB1; *DEP HHS, 1980, DHHS PUBL; Gibbs VC, 2001, MAKING HLTH CARE SAF, P255; Gonzalez-Ojeda A, 1999, HEPATO-GASTROENTEROL, V46, P808; HYSLOP JW, 1982, SOUTH MED J, V75, P657, DOI 10.1097/00007611-198206000-00006; Jason R S, 1979, J Natl Med Assoc, V71, P501; Kaiser CW, 1996, ANN SURG, V224, P79, DOI 10.1097/00000658-199607000-00012; KOHN LT, 1999, ERR HUMAN BUILDING S; LOCALIO AR, 1991, NEW ENGL J MED, V325, P245, DOI 10.1056/NEJM199107253250405; MALERNEE J, 2001, ST PETERSBURG T 0724, P3; Pierson MA., 1995, ALEXANDERS CARE PATI, P19; POPOVIC JR, 2001, ADV DATA VITAL HLTH, V319; RAPPAPORT W, 1990, ARCH SURG-CHICAGO, V125, P405; SMITH C, 2001, SEATTLE POSTINT 1208, pB1; Studdert DM, 2000, MED CARE, V38, P250, DOI 10.1097/00005650-200003000-00002	16	580	595	0	26	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					229	235		10.1056/NEJMsa021721	http://dx.doi.org/10.1056/NEJMsa021721			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529464	Bronze			2022-12-28	WOS:000180390600008
J	Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C				Knaut, H; Werz, C; Geisler, R; Nusslein-Volhard, C		Tubingen 2000 Screen Consortium	A zebrafish homologue of the chemokine receptor Cxcr4 is a germ-cell guidance receptor	NATURE			English	Article							HIV-1 ENTRY; PROTEIN; CHEMOTAXIS; ACTIVATION; AKT/PKB; RNA	Germ cells preserve an individual's genetic information and transmit it to the next generation. Early in development germ cells are set aside and undergo a specialized developmental programme, a hallmark of which is the migration from their site of origin to the future gonad(1). In Drosophila, several factors have been identified that control germ-cell migration to their target tissues(2-4); however, the germ-cell chemoattractant or its receptor have remained unknown. Here we apply genetics and in vivo imaging to show that odysseus, a zebrafish homologue of the G-protein-coupled chemokine receptor Cxcr4, is required specifically in germ cells for their chemotaxis. odysseus mutant germ cells are able to activate the migratory programme, but fail to undergo directed migration towards their target tissue, resulting in randomly dispersed germ cells. SDF-1, the presumptive cognate ligand for Cxcr4, shows a similar loss-of-function phenotype and can recruit germ cells to ectopic sites in the embryo, thus identifying a vertebrate ligand-receptor pair guiding migratory germ cells at all stages of migration towards their target.	Max Planck Inst Entwicklungsbiol, Abt Genet 3, D-72076 Tubingen, Germany	Max Planck Society	Knaut, H (corresponding author), Max Planck Inst Entwicklungsbiol, Abt Genet 3, Spemannstr 35, D-72076 Tubingen, Germany.		Geisler, Robert/K-6201-2013	Geisler, Robert/0000-0002-3909-8311; Knaut, Holger/0000-0002-8399-8720; Dahm, Ralf/0000-0001-5203-8578; Maderspacher, Florian/0000-0003-4324-8455				Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Chong SW, 2001, MECH DEVELOP, V109, P347, DOI 10.1016/S0925-4773(01)00520-2; Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Horuk R, 2001, CYTOKINE GROWTH F R, V12, P313, DOI 10.1016/S1359-6101(01)00014-4; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Meili R, 1999, EMBO J, V18, P2092, DOI 10.1093/emboj/18.8.2092; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; OBERLEY LW, 1982, SUPEROXIDE DISMUTASE, V1, P1; Olsen LC, 1997, MECH DEVELOP, V66, P95, DOI 10.1016/S0925-4773(97)00099-3; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; TACHMINTZIS J, 1994, BIOCONTROL SCI TECHN, V4, P591, DOI 10.1080/09583159409355372; Van Doren M, 1998, NATURE, V396, P466, DOI 10.1038/24871; Weidinger G, 2002, DEVELOPMENT, V129, P25; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Wylie C, 1999, CELL, V96, P165, DOI 10.1016/S0092-8674(00)80557-7; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	24	328	339	2	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					279	282		10.1038/nature01338	http://dx.doi.org/10.1038/nature01338			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12508118				2022-12-28	WOS:000180397600050
J	Kruse, J				Kruse, J			Convictions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					273	273		10.1001/jama.289.3.273	http://dx.doi.org/10.1001/jama.289.3.273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525211				2022-12-28	WOS:000180345100001
J	Benner, SA				Benner, SA			Act natural	NATURE			English	Editorial Material									Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Benner, SA (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.							BAIN JD, 1992, NATURE, V356, P537, DOI 10.1038/356537a0; Gee H, 2001, NATURE, V409, P1079; WOODWARD R B, 1968, Pure and Applied Chemistry, V17, P519, DOI 10.1351/pac196817030519	3	67	73	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					118	118		10.1038/421118a	http://dx.doi.org/10.1038/421118a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520282				2022-12-28	WOS:000180267200020
J	Bossuyt, PM; Reitsma, JB; Bruns, DE; Gatsonis, CA; Glasziou, PP; Irwig, LM; Lijmer, JG; Moher, D; Rennie, D; de Vet, HCE				Bossuyt, PM; Reitsma, JB; Bruns, DE; Gatsonis, CA; Glasziou, PP; Irwig, LM; Lijmer, JG; Moher, D; Rennie, D; de Vet, HCE		STARD Steering Grp	Towards complete and,accurate reporting of studies of diagnostic accuracy: the STARD initiative	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIALS; PERIPHERAL ARTERIAL-DISEASE; CONSORT STATEMENT; QUALITY; METAANALYSIS; PERFORMANCE; EFFICACY; TESTS; BIAS	Objective To improve the accuracy and completeness of reporting of studies of diagnostic accuracy, to allow readers to assess the potential for bias in a study, and to evaluate a study's generalisability. Methods The Standards for Reporting of Diagnostic Accuracy (STARD) steering committee searched the literature to identify publications on the appropriate conduct and reporting of diagnostic studies and extracted potential items into an extensive list. Researchers, editors, and members of professional organisations shortened this list during a two day consensus meeting, with the goal of developing a checklist and a generic flow diagram for studies of diagnostic accuracy. Results The search for published guidelines about diagnostic research yielded 33 previously published checklists, from which we extracted a list of 75 potential items. At the consensus meeting, participants shortened the list to a 25 item checklist, by using evidence, whenever available. A prototype of a flow diagram provides information about the method of patient recruitment, the order of test execution, and the numbers of patients undergoing the test under evaluation and the reference standard, or both. Conclusions Evaluation of research depends on complete and accurate reporting. If medical journals adopt the STARD checklist and flow diagram, the quality of reporting of studies of diagnostic accuracy should improve to the advantage of clinicians, researchers, reviewers, journals, and the public.	Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, NL-1100 DE Amsterdam, Netherlands; Univ Virginia, Charlottesville, VA 22903 USA; Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; Univ Queensland, Sch Populat Hlth, Brisbane, Qld 4006, Australia; Univ Sydney, Dept Publ Hlth & Community Med, Sydney, NSW 2006, Australia; Childrens Hosp Eastern Ontario, Thomas C Chalmers Ctr Systemat Reviews, Res Inst, Ottawa, ON K1H 8L1, Canada; JAMA, Chicago, IL 60610 USA; VU Univ Med Ctr, Inst Res Extramural Med, NL-1081 BT Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Virginia; Brown University; University of Queensland; University of Sydney; University of Ottawa; Children's Hospital of Eastern Ontario; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Bossuyt, PM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol & Biostat, POB 22700, NL-1100 DE Amsterdam, Netherlands.		Glasziou, Paul/A-7832-2008; Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Glasziou, Paul/0000-0001-7564-073X; Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128; de Vet, Henrica/0000-0002-5454-2804; Moher, David/0000-0003-2434-4206				Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; BEGG CB, 1987, STAT MED, V6, P411, DOI 10.1002/sim.4780060402; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Davidson F, 1997, JAMA-J AM MED ASSOC, V277, P927; deVries SO, 1996, ACAD RADIOL, V3, P361, DOI 10.1016/S1076-6332(96)80257-1; Egger M, 2001, JAMA-J AM MED ASSOC, V285, P1996, DOI 10.1001/jama.285.15.1996; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Griner P F, 1981, Ann Intern Med, V94, P557; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; KENT DL, 1992, INVEST RADIOL, V27, P245, DOI 10.1097/00004424-199203000-00014; KNOTTNERUS JA, 1987, MED DECIS MAKING, V7, P139, DOI 10.1177/0272989X8700700304; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1992, DOI 10.1001/jama.285.15.1992; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Nelemans PJ, 2000, RADIOLOGY, V217, P105, DOI 10.1148/radiology.217.1.r00oc11105; PANZER RJ, 1987, MED DECIS MAKING, V7, P115, DOI 10.1177/0272989X8700700209; REID MC, 1995, JAMA-J AM MED ASSOC, V274, P645, DOI 10.1001/jama.274.8.645; SACKETT DL, 1991, CLIN EPIDEMIOLOGY, P47	19	911	926	0	38	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					41	44		10.1136/bmj.326.7379.41	http://dx.doi.org/10.1136/bmj.326.7379.41			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511463	Green Published, Bronze			2022-12-28	WOS:000180302000028
J	Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A				Maas, R; Ventura, R; Kretzschmar, C; Aydin, A; Schuchert, A			Syncope, driving recommendations, and clinical reality: survey of patients	BRITISH MEDICAL JOURNAL			English	Article									Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, D-20246 Hamburg, Germany; Univ Hamburg, Hosp Eppendorf, Dept Cardiol, D-20246 Hamburg, Germany	University of Hamburg; University of Hamburg	Maas, R (corresponding author), Univ Hamburg, Hosp Eppendorf, Inst Expt & Clin Pharmacol & Toxicol, Dept Pharmacol,Clin Pharmacol Unit, Martinistr 52, D-20246 Hamburg, Germany.							Brignole M, 2001, EUR HEART J, V22, P1256, DOI 10.1053/euhj.2001.2739; Epstein AE, 1996, CIRCULATION, V94, P1147, DOI 10.1161/01.CIR.94.5.1147; Olshansky B., 1998, SYNCOPE MECH MANAGEM; Petch MC, 1998, EUR HEART J, V19, P1165; SHELDON R, 1995, AM J CARDIOL, V75, P955, DOI 10.1016/S0002-9149(99)80699-7	5	42	43	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					21	21		10.1136/bmj.326.7379.21	http://dx.doi.org/10.1136/bmj.326.7379.21			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511456	Green Published, Bronze			2022-12-28	WOS:000180302000020
J	McNamee, D				McNamee, D			Nestle's own goal	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		McNamee, D (corresponding author), Lancet, London NW1 7BY, England.								0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					12	12		10.1016/S0140-6736(03)12187-3	http://dx.doi.org/10.1016/S0140-6736(03)12187-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517457				2022-12-28	WOS:000180191600011
J	Reilly, BM; Clarke, P; Nikolinakos, P				Reilly, BM; Clarke, P; Nikolinakos, P			Easy to see but hard to find.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Cook Cty Hosp, Dept Med, Chicago, IL 60612 USA; Rush Med Coll, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; Rush University	Reilly, BM (corresponding author), Cook Cty Hosp, Dept Med, Rm 2129,1835 W Harrison St, Chicago, IL 60612 USA.							Blade J, 1999, HEMATOL ONCOL CLIN N, V13, P1259, DOI 10.1016/S0889-8588(05)70125-8; Gearin-Tosh M., 2002, LIVING PROOF MED MUT; GRECO FA, 2001, CANC PRINCIPLES PRAC, P2537; Katagiri H, 1999, CANCER, V86, P533, DOI 10.1002/(SICI)1097-0142(19990801)86:3<533::AID-CNCR24>3.0.CO;2-1; MUNSHI NC, 2001, CANC PRINCIPLES PRAC, P2465; Sackett D. L., 1997, EVIDENCE BASED MED P; Sox HC, 1988, MED DECISION MAKING	7	3	3	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					59	64		10.1056/NEJMcps022093	http://dx.doi.org/10.1056/NEJMcps022093			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510044				2022-12-28	WOS:000180134400009
J	Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW				Call, ME; Pyrdol, J; Wiedmann, M; Wucherpfennig, KW			The organizing principle in the formation of the T cell receptor-CD3 complex	CELL			English	Article							ANTIGEN RECEPTOR; SURFACE EXPRESSION; TCR/CD3 COMPLEX; MULTIVALENT STRUCTURE; TRANSMEMBRANE DOMAIN; MEMBRANE-PROTEIN; CD3-GAMMA CHAIN; CD3 COMPLEX; IN-VITRO; ASSOCIATION	The T cell receptor (TCR) serves a critical function in the immune system and represents one of the most complex receptor structures. A striking feature is the presence of nine highly conserved, potentially charged residues in the transmembrane helices. Previous models have attempted to explain assembly based on pairwise interactions of these residues. Using a novel method for the isolation of intact radiolabeled protein complexes, we demonstrate that one basic and two acidic transmembrane residues are required for the assembly of each of the three signaling dimers with the TCR. This remarkable three-helix arrangement applies to all three assembly steps and represents the organizing principle for the formation of this intricate receptor structure.	Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Program Immunol, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center	Wucherpfennig, KW (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.			Call, Matthew/0000-0001-5846-6469	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI045757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039096] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI045757, AI45757] Funding Source: Medline; NINDS NIH HHS [R01 NS039096, NS39096] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALCOVER A, 1990, J BIOL CHEM, V265, P4131; BIJLMAKERS MJE, 1993, EUR J IMMUNOL, V23, P1305, DOI 10.1002/eji.1830230618; BIJLMAKERS MJJE, 1994, EMBO J, V13, P2699, DOI 10.1002/j.1460-2075.1994.tb06560.x; BLUMBERG RS, 1990, J BIOL CHEM, V265, P14036; BLUMBERG RS, 1990, P NATL ACAD SCI USA, V87, P7220, DOI 10.1073/pnas.87.18.7220; BONIFACINO JS, 1990, CELL, V63, P503, DOI 10.1016/0092-8674(90)90447-M; BUFERNE M, 1992, J IMMUNOL, V148, P657; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Diethrich EB, 1996, J ENDOVASC SURG, V3, P132, DOI 10.1583/1074-6218(1996)003<0132:IFCASA>2.0.CO;2; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Exley M, 1991, Semin Immunol, V3, P283; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Garbe TR, 1996, MOL MED, V2, P134, DOI 10.1007/BF03402209; GEISLER C, 1992, J IMMUNOL, V148, P2437; Germain RN, 1999, ANNU REV IMMUNOL, V17, P467, DOI 10.1146/annurev.immunol.17.1.467; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; HALL C, 1991, INT IMMUNOL, V3, P359, DOI 10.1093/intimm/3.4.359; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Huppa JB, 1997, J EXP MED, V186, P393, DOI 10.1084/jem.186.3.393; JACOBS RR, 1997, INT J OCCUP ENV HL S, V3, P3; KEARSE KP, 1995, IMMUNITY, V2, P391; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PUNT JA, 1994, J EXP MED, V180, P587, DOI 10.1084/jem.180.2.587; RUTLEDGE T, 1992, EMBO J, V11, P3245, DOI 10.1002/j.1460-2075.1992.tb05402.x; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; SUSSMAN JJ, 1988, CELL, V52, P85, DOI 10.1016/0092-8674(88)90533-8; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; WEGENER AMK, 1995, J BIOL CHEM, V270, P4675, DOI 10.1074/jbc.270.9.4675; Wilson DS, 2001, P NATL ACAD SCI USA, V98, P3750, DOI 10.1073/pnas.061028198; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	34	307	324	0	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					967	979		10.1016/S0092-8674(02)01194-7	http://dx.doi.org/10.1016/S0092-8674(02)01194-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507424	Green Accepted, Bronze			2022-12-28	WOS:000180086000007
J	Aggarwal, A; Battle, RW				Aggarwal, A; Battle, RW			Congenital absence of the left pericardium	LANCET			English	Editorial Material									Cardiol Unit, Burlington, VT 05401 USA		Aggarwal, A (corresponding author), Cardiol Unit, Burlington, VT 05401 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2038	2038		10.1016/S0140-6736(02)12028-9	http://dx.doi.org/10.1016/S0140-6736(02)12028-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504400				2022-12-28	WOS:000179974200012
J	Parker, DL				Parker, DL			Street children and child labour around the world	LANCET			English	Editorial Material									Pk Nicollet Clin, Minneapolis, MN 55404 USA		Parker, DL (corresponding author), Pk Nicollet Clin, 2001 Blaisdell Ave S, Minneapolis, MN 55404 USA.							ELTON C, 2001, CHRISTIAN SCI M 0208; Forastieri V., 1997, CHILDREN WORK HLTH S; *HUM RIGHTS ACT NE, ILL DET STREET CHILD; *INT LAB ORG, 1996, CHILD LAB TOD FACTS; Irwanto, 2002, LANCET, V360, P1508; LIM JY, 2000, ILO IPEC WORK PAP 20; PARKER DL, 1994, AM J IND MED, V26, P529, DOI 10.1002/ajim.4700260410; PARKER DL, 1998, STOLEN DREAMS PORTRA; PARKER DL, 2002, HLTH HUMAN RICHTS IN, V5, P93; SAUFIAN A, 1999, CHILD WORKERS ASIA, V15; Sinha S.K., 1991, CHILD LABOUR CALCUTT; SOFIAN A, 1997, INSIDE INDONESIA, V52	12	10	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2067	2071		10.1016/S0140-6736(02)12027-7	http://dx.doi.org/10.1016/S0140-6736(02)12027-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504420				2022-12-28	WOS:000179974200031
J	Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW				Schubert, WD; Urbanke, C; Ziehm, T; Beier, V; Machner, MP; Domann, E; Wehland, J; Chakraborty, T; Heinz, DW			Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor E-cadherin	CELL			English	Article							LEUCINE-RICH REPEAT; CELL-ADHESION; SURFACE-PROTEINS; ENTRY; RECOGNITION; REFINEMENT; EXPRESSION; CATENINS; DOMAIN; SRTA	Listeria monocytogenes, a food-borne bacterial pathogen, enters mammalian cells by inducing its own phagocytosis. The listerial protein internalin (InIA) mediates bacterial adhesion and invasion of epithelial cells in the human intestine through specific interaction with its host cell receptor E-cadherin. We present the crystal structures of the functional domain of InIA alone and in a complex with the extracellular, N-terminal domain of human E-cadherin (hEC1). The leucine rich repeat (LRR) domain of InIA surrounds and specifically recognizes hEC1. Individual interactions were probed by mutagenesis and analytical ultracentrifugation. These include Pro16 of hEC1, a major determinant for human susceptibility to L. monocytogenes infection that is essential for intermolecular recognition. Our studies reveal the structural basis for host tropism of this bacterium and the molecular deception L. monocytogenes employs to exploit the E-cadherin system.	German Res Ctr Biotechnol, Dept Biol Struct, D-38124 Braunschweig, Germany; German Res Ctr Biotechnol, Dept Cell Biol, D-38124 Braunschweig, Germany; Hannover Med Sch, Inst Biophys Chem, D-30623 Hannover, Germany; Univ Giessen, Inst Med Microbiol, D-35385 Giessen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Justus Liebig University Giessen	Heinz, DW (corresponding author), German Res Ctr Biotechnol, Dept Biol Struct, Mascheroder Weg 1, D-38124 Braunschweig, Germany.	dih@gbf.de	Schubert, Wolf-Dieter/A-5617-2009; Machner, Matthias/G-2758-2015	Schubert, Wolf-Dieter/0000-0003-4998-519X; Machner, Matthias/0000-0002-6971-7451				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bierne H, 2002, MOL MICROBIOL, V43, P869, DOI 10.1046/j.1365-2958.2002.02798.x; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchanan SGS, 1996, PROG BIOPHYS MOL BIO, V65, P1, DOI 10.1016/S0079-6107(96)00003-X; Cabanes D, 2002, TRENDS MICROBIOL, V10, P238, DOI 10.1016/S0966-842X(02)02342-9; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Cossart P, 1998, EMBO J, V17, P3797, DOI 10.1093/emboj/17.14.3797; Daniels JJD, 2000, FEMS MICROBIOL LETT, V190, P323, DOI 10.1016/S0378-1097(00)00356-6; DRAMSI S, 1995, MOL MICROBIOL, V16, P251, DOI 10.1111/j.1365-2958.1995.tb02297.x; DRAMSI S, 1993, MOL MICROBIOL, V9, P931, DOI 10.1111/j.1365-2958.1993.tb01223.x; Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973; GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N; Galan JE, 2000, CELL, V103, P363, DOI 10.1016/S0092-8674(00)00127-6; Garandeau C, 2002, INFECT IMMUN, V70, P1382, DOI 10.1128/IAI.70.3.1382-1390.2002; Glaser P, 2001, SCIENCE, V294, P849; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gumbiner BM, 2000, J CELL BIOL, V148, P399, DOI 10.1083/jcb.148.3.399; HARTMAN AB, 1990, J BACTERIOL, V172, P1905, DOI 10.1128/jb.172.4.1905-1915.1990; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kahn RA, 2002, TRENDS BIOCHEM SCI, V27, P308, DOI 10.1016/S0968-0004(02)02108-4; KEMLER R, 1993, TRENDS GENET, V9, P317, DOI 10.1016/0168-9525(93)90250-L; KOBE B, 1995, NATURE, V374, P183, DOI 10.1038/374183a0; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 2000, J APPL CRYSTALLOGR, V33, P990; Leahy DJ, 1997, ANNU REV CELL DEV BI, V13, P363, DOI 10.1146/annurev.cellbio.13.1.363; Lebrun M, 1996, MOL MICROBIOL, V21, P579, DOI 10.1111/j.1365-2958.1996.tb02566.x; Lecuit M, 2000, P NATL ACAD SCI USA, V97, P10008, DOI 10.1073/pnas.97.18.10008; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lorber B, 1997, CLIN INFECT DIS, V24, P1, DOI 10.1093/clinids/24.1.1; Machner MP, 2001, J BIOL CHEM, V276, P40096, DOI 10.1074/jbc.M104279200; Marino M, 1999, MOL CELL, V4, P1063, DOI 10.1016/S1097-2765(00)80234-8; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5; Schlech WF, 2000, CLIN INFECT DIS, V31, P770, DOI 10.1086/314008; Schubert WD, 2001, J MOL BIOL, V312, P783, DOI 10.1006/jmbi.2001.4989; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7; Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X	57	222	246	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					825	836		10.1016/S0092-8674(02)01136-4	http://dx.doi.org/10.1016/S0092-8674(02)01136-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526809	Bronze			2022-12-28	WOS:000179862600009
J	Barbera, JA; Macintyre, AG				Barbera, JA; Macintyre, AG			The reality of the modern bioterrorism response	LANCET			English	Article									George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA	George Washington University	Barbera, JA (corresponding author), George Washington Univ, Inst Crisis Disaster & Risk Management, Washington, DC 20052 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S33	S34		10.1016/S0140-6736(02)11812-5	http://dx.doi.org/10.1016/S0140-6736(02)11812-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504495	Bronze			2022-12-28	WOS:000180064500016
J	Keller, AS				Keller, AS			Caring and advocating for victims of torture	LANCET			English	Article									NYU, Sch Med, New York, NY USA; Bellevue Hosp, Bellevue NYU Program Survivors Torture, New York, NY 10016 USA	New York University; Bellevue Hospital Center	Keller, AS (corresponding author), Bellevue Hosp, Bellevue NYU Program Survivors Torture, 462 1st Ave, New York, NY 10016 USA.								0	8	8	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S55	S56		10.1016/S0140-6736(02)11823-X	http://dx.doi.org/10.1016/S0140-6736(02)11823-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504506	Bronze			2022-12-28	WOS:000180064500027
J	Landon, BE; Reschovsky, J; Blumenthal, D				Landon, BE; Reschovsky, J; Blumenthal, D			Changes in career satisfaction among primary care and specialist physicians, 1997-2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MANAGED CARE; JOB-SATISFACTION; HEALTH-CARE; QUALITY; ORGANIZATIONS	Context A number of forces have changed the practice of medicine in the past decade. Evidence suggests that physicians are becoming less satisfied in this environment. Objectives To describe changes in career satisfaction in a large, nationally representative sample of physicians and to examine market and practice factors associated with changes in physician satisfaction. Design and Setting Data were collected from the first 3 rounds of the Community Tracking Study (CTS) Physician Survey, a series of nationally representative telephone surveys of physicians in 60 US sites conducted in 1996-1997 (round 1: 12385 respondents; 65% response rate), 1998-1999 (round 2: 12 280 respondents; 61% response rate), and 2000-2001 (round 3: 12 389 respondents; 59% response rate) for the Center for Studying Health System Change. The second and third rounds of the survey included physicians sampled in the previous round, as well as new physicians. Participants Primary care and specialist physicians who spent at least 20 hours per week in direct patient care activities. Main Outcome Measures Changes in physicians' overall satisfaction with their career and the proportion of dissatisfied physicians in particular sites. Results Physician satisfaction levels declined marginally between 1997 and 2001, with most of the decline occurring between 1997 and 1999. Among primary care physicians, 42.4% were very satisfied in 1997, as were 433% of specialists, compared with 38.5% and 41.4%, respectively, in 2001. There were nearly equal increases in those who reported that they were somewhat satisfied. Overall means mask significant differences across the 60 sites. Among 12 sites randomly selected for more intensive study, the proportion of respondents who were somewhat or very dissatisfied ranged from 8.8% of physicians in Lansing, Mich (1999), to 34.2% in Miami, Fla (1997). Between 1997 and 1999, 25.6% of primary care physicians reported decreased satisfaction and 18.1% reported improved satisfaction, while approximately equal percentages reported increased (19.8%) and decreased (20.4%) satisfaction between 1999-2001. Findings were similar for specialist physicians. In multivariable models, the strongest and most consistent predictors of change in satisfaction were changes in measures of clinical autonomy, including increases in hours worked and physicians' ability to obtain services for their patients. Changes in exposure to managed care were weakly related to changes in satisfaction. Conclusions Our findings demonstrate that overall physician satisfaction levels over this time period did not change dramatically. in addition, satisfaction and changes in satisfaction vary greatly among sites. Rather than declining income, threats to physicians autonomy, to their ability to manage their day-to-day patient interactions and their time, and to their ability to provide high-quality care are most strongly associated with changes in satisfaction.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Massachusetts Gen Hosp Partners Healthcare Syst, Inst Hlth Care Policy, Boston, MA USA; Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Ctr Studying Hlth Syst Change, Washington, DC USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Partners Healthcare System; Harvard University; Beth Israel Deaconess Medical Center	Landon, BE (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	landon@hcp.med.harvard.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [P01HS010803] Funding Source: NIH RePORTER; AHRQ HHS [P01-HS-10803] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Baker LC, 1999, JAMA-J AM MED ASSOC, V281, P432, DOI 10.1001/jama.281.5.432; BARNARD A, 2000, BOSTON GLOBE    0709, pA1; BARNARD A, 2000, BOSTON GLOBE    0709, pA18; BREWSTER L, 2000, INSOLVENCY CHALLENGE; Brook RH, 1996, NEW ENGL J MED, V335, P966, DOI 10.1056/NEJM199609263351311; Buchbinder SB, 1999, AM J MANAG CARE, V5, P1431; *BUR HLTH PROF OFF, 1998, AR RES FIL; DRAPER DA, 2001, 12 CTR STUD HLTH SYS; FENNELL ML, 1993, ANNU REV SOCIOL, V19, P89; Gross CG, 2000, INT J PSYCHOL, V35, P7; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Hadley J, 1997, HEALTH AFFAIR, V16, P99, DOI 10.1377/hlthaff.16.6.99; Hirshman A.O., 1970, EXIT VOICE LOYALTY; KATZ A, 2001, 05 CTR STUD HLTH SYS; KEIL L, 1998, CTR STUDYING HLTH SY, V1; KERR EA, 1995, ANN INTERN MED, V123, P500, DOI 10.7326/0003-4819-123-7-199510010-00004; Konrad TR, 1999, MED CARE, V37, P1174, DOI 10.1097/00005650-199911000-00010; Landon BE, 2001, MED CARE, V39, P889, DOI 10.1097/00005650-200108000-00014; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; LANDON BE, IN PRESS AM J MANAG; LINN LS, 1985, JAMA-J AM MED ASSOC, V254, P2775, DOI 10.1001/jama.254.19.2775; Linzer M, 2000, J GEN INTERN MED, V15, P441, DOI 10.1046/j.1525-1497.2000.05239.x; METCALF CE, 1996, CTR STUDYING HLTH SY, V1; Murray A, 2001, J GEN INTERN MED, V16, P451, DOI 10.1007/s11606-001-0040-z; Reschovsky J, 2001, MED CARE, V39, P254, DOI 10.1097/00005650-200103000-00006; RESCHOVSKY JD, 1998, CTR STUDYING HLTH SY, V10; Rosenthal MB, 2001, HEALTH AFFAIR, V20, P187, DOI 10.1377/hlthaff.20.5.187; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Scott W R, 1993, Med Care Rev, V50, P271, DOI 10.1177/002570879305000303; St Peter RF, 1999, NEW ENGL J MED, V341, P1980, DOI 10.1056/NEJM199912233412606; Stoddard JJ, 2001, J GEN INTERN MED, V16, P675, DOI 10.1111/j.1525-1497.2001.01206.x; Stoddard JJ, 2001, AM J MANAG CARE, V7, P1061; Williams ES, 1999, MED CARE, V37, P1140, DOI 10.1097/00005650-199911000-00006; 2000, INTERSTUDY COMPETITI	34	219	226	1	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					442	449		10.1001/jama.289.4.442	http://dx.doi.org/10.1001/jama.289.4.442			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533123	Bronze			2022-12-28	WOS:000180472300025
J	Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP				Eogan, MA; Geary, MP; O'Connell, MP; Keane, DP			Effect of fetal sex on labour and delivery: retrospective review	BRITISH MEDICAL JOURNAL			English	Article							GENDER		Natl Matern Hosp, Dublin 2, Ireland	National Maternity Hospital, Dublin	Eogan, MA (corresponding author), Natl Matern Hosp, Holles St, Dublin 2, Ireland.							Feinstein U, 2002, INT J GYNECOL OBSTET, V77, P7, DOI 10.1016/S0020-7292(02)00007-3; Hindmarsh PC, 2002, PEDIATR RES, V52, DOI 10.1023/01.PDR.0000020600.45753.78; Makhseed M, 1998, INT J GYNECOL OBSTET, V63, P55, DOI 10.1016/S0020-7292(98)00078-2; ODRISCOLL K, 1993, ACTIVE MANAGEMENT LA; SPINILLO A, 1994, AM J OBSTET GYNECOL, V171, P1273, DOI 10.1016/0002-9378(94)90146-5	5	40	42	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					137	137		10.1136/bmj.326.7381.137	http://dx.doi.org/10.1136/bmj.326.7381.137			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531846	Green Published, Bronze			2022-12-28	WOS:000180575900025
J	Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R				Crotty, S; Kersh, EN; Cannons, J; Schwartzberg, PL; Ahmed, R			SAP is required for generating long-term humoral immunity	NATURE			English	Article							LINKED LYMPHOPROLIFERATIVE-DISEASE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; T-CELLS; VIRAL-INFECTION; ENCODING GENE; PLASMA-CELLS; BONE-MARROW; B-CELLS; MUTATIONS; MEMORY	Long-lived plasma cells and memory B cells are the primary cellular components of long-term humoral immunity and as such are vitally important for the protection afforded by most vaccines. The SAP gene has been identified as the genetic locus responsible for X-linked lymphoproliferative disease, a fatal immunodeficiency(1-4). Mutations in SAP have also been identified in some cases of severe common variable immunodeficiency disease(5,6). The underlying cellular basis of this genetic disorder remains unclear. We have used a SAP knockout mouse model system to explore the role of SAP in immune responses. Here we report that mice lacking expression of SAP generate strong acute IgG antibody responses after viral infection, but show a near complete absence of virus-specific long-lived plasma cells and memory B cells, despite the presence of virus-specific memory CD4(+) T cells. Adoptive transfer experiments show that SAP-deficient B cells are normal and the defect is in CD4(+) T cells. Thus, SAP has a crucial role in CD4(+) T-cell function: it is essential for late B-cell help and the development of long-term humoral immunity but is not required for early B-cell help and class switching.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; NHGRI, NIH, Bethesda, MD 20892 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.		Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.iy.12.040194.004313; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Coffey AJ, 1998, NAT GENET, V20, P129, DOI 10.1038/2424; Czar MJ, 2001, P NATL ACAD SCI USA, V98, P7449, DOI 10.1073/pnas.131193098; Durandy A, 2001, CURR OPIN IMMUNOL, V13, P543, DOI 10.1016/S0952-7915(00)00256-9; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; GRIERSON HL, 1991, AM J MED GENET, V40, P294, DOI 10.1002/ajmg.1320400309; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Latour S, 2001, NAT IMMUNOL, V2, P681, DOI 10.1038/90615; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; Morra M, 2001, BLOOD, V98, P1321, DOI 10.1182/blood.V98.5.1321; Morra M, 2001, ANNU REV IMMUNOL, V19, P657, DOI 10.1146/annurev.immunol.19.1.657; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Nichols KE, 1998, P NATL ACAD SCI USA, V95, P13765, DOI 10.1073/pnas.95.23.13765; Nistala K, 2001, CLIN EXP IMMUNOL, V126, P126, DOI 10.1046/j.1365-2249.2001.01599.x; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Sayos J, 1998, NATURE, V395, P462, DOI 10.1038/26683; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; SLIFKA MK, 1995, J VIROL, V69, P1895, DOI 10.1128/JVI.69.3.1895-1902.1995; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Sumegi J, 2000, BLOOD, V96, P3118; Tangye SG, 2002, EUR J IMMUNOL, V32, P1640, DOI 10.1002/1521-4141(200206)32:6<1640::AID-IMMU1640>3.0.CO;2-S; VANESSEN D, 1995, NATURE, V378, P620, DOI 10.1038/378620a0; Whitmire JK, 1998, J VIROL, V72, P8281, DOI 10.1128/JVI.72.10.8281-8288.1998; Wu CB, 2001, NAT IMMUNOL, V2, P410, DOI 10.1038/87713	30	335	348	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					282	287		10.1038/nature01318	http://dx.doi.org/10.1038/nature01318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529646				2022-12-28	WOS:000180397600051
J	Paulson, EK; Kalady, MF; Pappas, TN				Paulson, EK; Kalady, MF; Pappas, TN			Suspected appendicitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							C-REACTIVE PROTEIN; COMPUTED-TOMOGRAPHY; HELICAL CT; DIAGNOSTIC LAPAROSCOPY; NEGATIVE APPENDECTOMY; LEUKOCYTE COUNT; ABDOMINAL-PAIN; ULTRASONOGRAPHY; ACCURACY; CONTRAST		Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Duke University; Duke University	Paulson, EK (corresponding author), Duke Univ, Med Ctr, Dept Radiol, Box 3808, Durham, NC 27710 USA.	pauls003@mc.duke.edu		Pappas, Theodore/0000-0001-9110-4849				ABUYOUSEF MM, 1987, AM J ROENTGENOL, V149, P53, DOI 10.2214/ajr.149.1.53; ANDERSSON RE, 1992, EUR J SURG, V158, P37; Andersson RE, 2000, WORLD J SURG, V24, P479, DOI 10.1007/s002689910076; BALTHAZAR EJ, 1994, RADIOLOGY, V190, P31, DOI 10.1148/radiology.190.1.8259423; BALTHAZAR EJ, 2000, TXB GASTROINTESTINAL, V1, P1123; Birnbaum BA, 2000, RADIOLOGY, V215, P337, DOI 10.1148/radiology.215.2.r00ma24337; Birnbaum BA, 1998, AM J ROENTGENOL, V170, P361, DOI 10.2214/ajr.170.2.9456947; Colson M, 1997, AM J SURG, V174, P723, DOI 10.1016/S0002-9610(97)00183-9; DUEHOLM S, 1989, DIS COLON RECTUM, V32, P855, DOI 10.1007/BF02554555; ERIKSSON S, 1994, SCAND J GASTROENTERO, V29, P1145, DOI 10.3109/00365529409094902; Graff L, 2000, ACAD EMERG MED, V7, P1244, DOI 10.1111/j.1553-2712.2000.tb00470.x; GRAFF L, 1991, ANN EMERG MED, V20, P503, DOI 10.1016/S0196-0644(05)81603-8; Hale DA, 1997, ANN SURG, V225, P252, DOI 10.1097/00000658-199703000-00003; Jacobs JE, 2001, RADIOLOGY, V220, P683, DOI 10.1148/radiol.2202001557; Jahn H, 1997, EUR J SURG, V163, P433; JEFFREY RB, 1987, RADIOLOGY, V163, P11, DOI 10.1148/radiology.163.1.3547490; JEFFREY RB, 1988, RADIOLOGY, V167, P327, DOI 10.1148/radiology.167.2.3282253; JOHN H, 1993, WORLD J SURG, V17, P243, DOI 10.1007/BF01658936; Jones PF, 2001, BRIT J SURG, V88, P1570, DOI 10.1046/j.0007-1323.2001.01910.x; Kamel IR, 2000, RADIOLOGY, V217, P159, DOI 10.1148/radiology.217.1.r00oc34159; Kirby CP, 2001, AUST NZ J SURG, V71, P412, DOI 10.1046/j.1440-1622.2001.02148.x; Lane MJ, 1999, RADIOLOGY, V213, P341, DOI 10.1148/radiology.213.2.r99nv44341; Lane MJ, 1997, AM J ROENTGENOL, V168, P405, DOI 10.2214/ajr.168.2.9016216; Lane MJ, 1999, SEMIN ULTRASOUND CT, V20, P77, DOI 10.1016/S0887-2171(99)90039-2; Lee SL, 2001, ARCH SURG-CHICAGO, V136, P556, DOI 10.1001/archsurg.136.5.556; LEWIS FR, 1975, ARCH SURG-CHICAGO, V110, P677; MCCRAIG LF, 2001, ADV DATA VITAL HLTH, V320, P24; Moberg AC, 1998, EUR J SURG, V164, P833; Mutter D, 1996, SURGERY, V120, P71, DOI 10.1016/S0039-6060(96)80243-1; OWINGS MF, 1998, VITAL HLTH STAT, V13, P26; Pickuth D, 2000, EUR J SURG, V166, P315; POWERS RD, 1995, AM J EMERG MED, V13, P301, DOI 10.1016/0735-6757(95)90204-X; PUSKAR D, 1995, UROLOGY, V45, P108, DOI 10.1016/S0090-4295(95)97134-3; PUYLAERT JBCM, 1987, NEW ENGL J MED, V317, P666, DOI 10.1056/NEJM198709103171103; PUYLAERT JBCM, 1986, RADIOLOGY, V158, P355, DOI 10.1148/radiology.158.2.2934762; Raman SS, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781319; Rao PM, 1999, ANN SURG, V229, P344, DOI 10.1097/00000658-199903000-00007; Rao PM, 1999, AM J EMERG MED, V17, P325, DOI 10.1016/S0735-6757(99)90077-3; Rao PM, 1997, RADIOLOGY, V202, P139, DOI 10.1148/radiology.202.1.8988203; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Rothrock Steven G., 1995, Journal of Emergency Medicine, V13, P1, DOI 10.1016/0736-4679(94)00104-9; RUSNAK RA, 1994, AM J EMERG MED, V12, P397, DOI 10.1016/0735-6757(94)90047-7; Sauerland S, 2002, COCHRANE DB SYST REV, V1; Stroman DL, 1999, AM J SURG, V178, P485, DOI 10.1016/S0002-9610(99)00223-8; THOMPSON MM, 1992, BRIT J SURG, V79, P822, DOI 10.1002/bjs.1800790839; Thorell A, 1999, EUR J SURG, V165, P751; vonTitte SN, 1996, AM J EMERG MED, V14, P620, DOI 10.1016/S0735-6757(96)90074-1; Wagner JM, 1996, JAMA-J AM MED ASSOC, V276, P1589, DOI 10.1001/jama.276.19.1589; Walker S, 2000, AM J SURG, V180, P450, DOI 10.1016/S0002-9610(00)00540-7; WEBSTER DP, 1993, AM J EMERG MED, V11, P569, DOI 10.1016/0735-6757(93)90002-S; Weltman DI, 2000, RADIOLOGY, V216, P172, DOI 10.1148/radiology.216.1.r00jl34172; Wilson EB, 2001, ARCH SURG-CHICAGO, V136, P670, DOI 10.1001/archsurg.136.6.670; 1999, ABDOMINAL PLAIN FILM, P1	53	161	180	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					236	242		10.1056/NEJMcp013351	http://dx.doi.org/10.1056/NEJMcp013351			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529465				2022-12-28	WOS:000180390600009
J	Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD				Jiang, XJ; Kim, HE; Shu, HJ; Zhao, YM; Zhang, HC; Kofron, J; Donnelly, J; Burns, D; Ng, SC; Rosenberg, S; Wang, XD			Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway	SCIENCE			English	Article							ACIDIC NUCLEAR-PROTEIN; CYTOCHROME-C; ACTIVATION; EXPRESSION; DIFFERENTIATION; IDENTIFICATION; BINDING; FAMILY; GENE; RICH	A small molecule, alpha-(trichloromethyl)-4-pyridineethanol (PETCM), was identified by high-throughput screening as an activator of caspase-3 in extracts of a panel of cancer cells. PETCM was used in combination with biochemical fractionation to identify a pathway that regulates mitochondria-initiated caspase activation. This pathway consists of tumor suppressor putative HLA-DR associated proteins (PHAP) and oncoprotein prothymosin-alpha (ProT). PHAP proteins promoted caspase-9 activation after apoptosome formation, whereas ProT negatively regulated caspase-9 activation by inhibiting apoptosome formation. PETCM relieved ProT inhibition and allowed apoptosome formation at a physiological concentration of deoxyadenosine triphosphate. Elimination of ProT expression by RNA interference sensitized cells to ultraviolet irradiation induced apoptosis and negated the requirement of PETCM for caspase activation. Thus, this chemical-biological combinatory approach has revealed the regulatory roles of oncoprotein ProT and tumor suppressor PHAP in apoptosis.	Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Abbott Labs, Abbott Pk, IL 60064 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Abbott Laboratories	Wang, XD (corresponding author), Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA.	xwang@biochem.swmed.edu	Kim, Hyun-Eui/GOV-5988-2022	Kim, Hyun-Eui/0000-0003-1495-1993; Wang, Xiaodong/0000-0001-9885-356X	NIGMS NIH HHS [GMRO1-57158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bai JN, 2001, ONCOGENE, V20, P2153, DOI 10.1038/sj.onc.1204294; Brody JR, 1999, J BIOL CHEM, V274, P20053, DOI 10.1074/jbc.274.29.20053; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen TH, 1996, MOL BIOL CELL, V7, P2045, DOI 10.1091/mbc.7.12.2045; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; DOSIL M, 1993, EXP CELL RES, V204, P94, DOI 10.1006/excr.1993.1013; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Li M, 1996, BIOCHEMISTRY-US, V35, P6998, DOI 10.1021/bi960581y; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Magdalena C, 2000, BRIT J CANCER, V82, P584, DOI 10.1054/bjoc.1999.0968; Matilla A, 1997, NATURE, V389, P974, DOI 10.1038/40159; MATSUOKA K, 1994, P NATL ACAD SCI USA, V91, P9670, DOI 10.1073/pnas.91.21.9670; Mencinger M, 1998, BBA-GENE STRUCT EXPR, V1395, P176, DOI 10.1016/S0167-4781(97)00165-6; Mesner PW, 1999, J BIOL CHEM, V274, P22635, DOI 10.1074/jbc.274.32.22635; Mutai H, 2000, BIOCHEM BIOPH RES CO, V274, P427, DOI 10.1006/bbrc.2000.3133; Orre RS, 2001, J BIOL CHEM, V276, P1794, DOI 10.1074/jbc.M008560200; Pineiro A, 2000, PEPTIDES, V21, P1433, DOI 10.1016/S0196-9781(00)00288-6; Radrizzani M, 2001, BRAIN RES, V907, P162, DOI 10.1016/S0006-8993(01)02351-4; Rodriguez J, 1999, GENE DEV, V13, P3179, DOI 10.1101/gad.13.24.3179; Rodriguez P, 1998, BIOCHEM J, V331, P753, DOI 10.1042/bj3310753; SBURLATI AR, 1991, P NATL ACAD SCI USA, V88, P253, DOI 10.1073/pnas.88.1.253; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; SMITH MR, 1993, BLOOD, V82, P1127; Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200; Wang XD, 2001, GENE DEV, V15, P2922; Wu CG, 1997, BRIT J CANCER, V76, P1199, DOI 10.1038/bjc.1997.533; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zhu LJ, 1997, BIOCHEM MOL BIOL INT, V42, P927; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	41	330	351	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					223	226		10.1126/science.1076807	http://dx.doi.org/10.1126/science.1076807			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522243				2022-12-28	WOS:000180284000030
J	Jayaraman, KS				Jayaraman, KS			Indian prime minister pledges to revamp science	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					101	101		10.1038/421101b	http://dx.doi.org/10.1038/421101b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520268	Bronze			2022-12-28	WOS:000180267200007
J	Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K				Keller, G; Zimmer, G; Mall, G; Ritz, E; Amann, K			Nephron number in patients with primary hypertension.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LOW-BIRTH-WEIGHT; BLOOD-PRESSURE; ADULT HYPERTENSION; SIZE; KIDNEY; TRANSPLANTATION; GLOMERULI	BACKGROUND: A diminished number of nephrons has been proposed as one of the factors contributing to the development of primary hypertension. METHODS: To test this hypothesis, we used a three-dimensional stereologic method to compare the number and volume of glomeruli in 10 middle-aged white patients (age range, 35 to 59 years) with a history of primary hypertension or left ventricular hypertrophy (or both) and renal arteriolar lesions with the number and volume in 10 normotensive subjects matched for sex, age, height, and weight. All 20 subjects had died in accidents. RESULTS: Patients with hypertension had significantly fewer glomeruli per kidney than matched normotensive controls (median, 702,379 vs. 1,429,200). Patients with hypertension also had a significantly greater glomerular volume than did the controls (median, 6.50x10(sup -3) mm(sup 3) vs. 2.79x10(sup -3) mm(sup 3); P<0.001) but very few obsolescent glomeruli. CONCLUSIONS: The data support the hypothesis that the number of nephrons is reduced in white patients with primary hypertension.	Univ Erlangen Nurnberg, Dept Pathol, D-91054 Erlangen, Germany; Heidelberg Univ, Dept Pathol, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Forens Med, D-6900 Heidelberg, Germany; Heidelberg Univ, Dept Internal Med, D-6900 Heidelberg, Germany; City Hosp Darmstadt, Dept Pathol, Darmstadt, Germany	University of Erlangen Nuremberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Klinikum Darmstadt	Amann, K (corresponding author), Univ Erlangen Nurnberg, Dept Pathol, Krankenhausstr 8-10, D-91054 Erlangen, Germany.	kerstin.amann@patho.imed.uni-erlangen.de						BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; Bertram J. F., 2001, Journal of the American Society of Nephrology, V12, p724A; BIANCHI G, 1974, CLIN SCI MOL MED, V47, P435, DOI 10.1042/cs0470435; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; CURTIS JJ, 1983, NEW ENGL J MED, V309, P1009, DOI 10.1056/NEJM198310273091702; DAHL LK, 1974, CIRC RES, V34, P94, DOI 10.1161/01.RES.34.1.94; Fassi A, 1998, J AM SOC NEPHROL, V9, P1399; GENNSER G, 1988, BMJ-BRIT MED J, V296, P1498, DOI 10.1136/bmj.296.6635.1498; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Gurnani Anuradha, 2000, Journal of the American Society of Nephrology, V11, p390A; HAKIM RM, 1984, KIDNEY INT, V25, P930, DOI 10.1038/ki.1984.112; MCLACHLAN MSF, 1977, J PATHOL, V121, P65, DOI 10.1002/path.1711210202; Merlet-Benichou C, 1999, LAB INVEST, V79, P515; MERLETBENICHOU C, 1993, M S-MED SCI, V9, P777, DOI 10.4267/10608/2991; Neugarten J, 2000, J AM SOC NEPHROL, V11, P319, DOI 10.1681/ASN.V112319; NYENGAARD JR, 1992, ANAT REC, V232, P194, DOI 10.1002/ar.1092320205; Pesce CM, 1994, J NEPHROL, P355; RETTIG R, 1990, AM J PHYSIOL, V258, pF606, DOI 10.1152/ajprenal.1990.258.3.F606; SCHMIDT K, 1992, J AM SOC NEPHROL, V3, P229; SKOV K, 1994, J HYPERTENS, V12, P1373; Spencer J, 2001, AM J KIDNEY DIS, V37, P915, DOI 10.1016/S0272-6386(05)80006-X; STRANDGAARD S, 1986, BRIT MED J, V292, P1041, DOI 10.1136/bmj.292.6527.1041; Vehaskari VM, 2001, KIDNEY INT, V59, P238, DOI 10.1046/j.1523-1755.2001.00484.x; Yiu V, 1999, AM J KIDNEY DIS, V33, P253, DOI 10.1016/S0272-6386(99)70297-0	26	763	790	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					101	108		10.1056/NEJMoa020549	http://dx.doi.org/10.1056/NEJMoa020549			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519920				2022-12-28	WOS:000180263900002
J	Mitnick, C; Bayona, J; Palacios, E; Shin, S; Furin, J; Alcantara, F; Sanchez, E; Sarria, M; Becerra, M; Fawzi, MCS; Kapiga, S; Neuberg, D; Maguire, JH; Kim, JY; Farmer, P				Mitnick, C; Bayona, J; Palacios, E; Shin, S; Furin, J; Alcantara, F; Sanchez, E; Sarria, M; Becerra, M; Fawzi, MCS; Kapiga, S; Neuberg, D; Maguire, JH; Kim, JY; Farmer, P			Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SHORT-COURSE CHEMOTHERAPY; MYCOBACTERIUM-TUBERCULOSIS; TREATMENT FAILURE; DRUG-RESISTANCE; OUTBREAK; OUTCOMES; EPIDEMIOLOGY; TRANSMISSION	BACKGROUND: Despite the prevalence of multidrug-resistant tuberculosis in nearly all low-income countries surveyed, effective therapy has been deemed too expensive and considered not to be feasible outside referral centers. We evaluated the results of community-based therapy for multidrug-resistant tuberculosis in a poor section of Lima, Peru. METHODS: We describe the first 75 patients to receive ambulatory treatment with individualized regimens for chronic multidrug-resistant tuberculosis in northern Lima. We conducted a retrospective review of the charts of all patients enrolled in the program between August 1, 1996, and February 1, 1999, and identified predictors of poor outcomes. RESULTS: The infecting strains of Mycobacterium tuberculosis were resistant to a median of six drugs. Among the 66 patients who completed four or more months of therapy, 83 percent (55) were probably cured at the completion of treatment. Five of these 66 patients (8 percent) died while receiving therapy. Only one patient continued to have positive cultures after six months of treatment. All patients in whom treatment failed or who died had extensive bilateral pulmonary disease. In a multiple Cox proportional-hazards regression model, the predictors of the time to treatment failure or death were a low hematocrit (hazard ratio, 4.09; 95 percent confidence interval, 1.35 to 12.36) and a low body-mass index (hazard ratio, 3.23; 95 percent confidence interval, 0.90 to 11.53). Inclusion of pyrazinamide and ethambutol in the regimen (when susceptibility was confirmed) was associated with a favorable outcome (hazard ratio for treatment failure or death, 0.30; 95 percent confidence interval, 0.11 to 0.83). CONCLUSIONS: Community-based outpatient treatment of multidrug-resistant tuberculosis can yield high cure rates even in resource-poor settings. Early initiation of appropriate therapy can preserve susceptibility to first-line drugs and improve treatment outcomes.	Harvard Univ, Sch Med, Dept Social Med, Program Infect Dis & Social Change, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Partners Hlth, Boston, MA USA; Socios Salud, Lima, Peru; Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; Hosp Sergio E Bernales, Lima, Peru; Serv Basicos Salud, Lima, Peru	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Partners Healthcare System; Harvard University; Brigham & Women's Hospital	Mitnick, C (corresponding author), Harvard Univ, Sch Med, Dept Social Med, Program Infect Dis & Social Change, 643 Huntington Ave,4th Fl, Boston, MA 02115 USA.	carole_mitnick@hms.harvard.edu	Mitnick, Carole/GRO-1991-2022	Mitnick, Carole/0000-0002-3455-658X; Kapiga, Saidi/0000-0003-1753-4060	NIAID NIH HHS [AI 03535] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agerton TB, 1999, CLIN INFECT DIS, V29, P85, DOI 10.1086/520187; [Anonymous], WORLD MENTAL HLTH CA; Avendano M, 2000, Can Respir J, V7, P383; Bastian I, 2000, B WORLD HEALTH ORGAN, V78, P238; Becerra MC, 2000, INT J TUBERC LUNG D, V4, P108; Bender D. A., 1997, NUTR REFERENCE HDB; Coninx R, 1999, LANCET, V353, P969, DOI 10.1016/S0140-6736(98)08341-X; Crofton J., 1997, GUIDELINES MANAGEMEN; *CTR PAN ZOON, 1985, 27 OPSOMS CTR PAN ZO; Davies GR, 1999, INT J TUBERC LUNG D, V3, P799; Dye C, 2002, SCIENCE, V295, P2042, DOI 10.1126/science.1063814; Espinal MA, 2000, JAMA-J AM MED ASSOC, V283, P2537, DOI 10.1001/jama.283.19.2537; Espinal MA, 2001, NEW ENGL J MED, V344, P1294, DOI 10.1056/NEJM200104263441706; Espinal MA, 1999, INT J TUBERC LUNG D, V3, P561; Farmer P, 1998, BRIT MED J, V317, P671, DOI 10.1136/bmj.317.7159.671; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Farmer P, 2001, NEW ENGL J MED, V345, P208, DOI 10.1056/NEJM200107193450310; FARMER PE, 2000, J RESP DIS, V21, P53; FARMER PE, 1997, P INT UN TUB LUNG DI, P88; FARMER PE, 2000, TUBERCULOSIS CURRENT, P475; FARMER PE, 2000, LUNG BIOL HEALTH DIS, V144, P447; Frieden TR, 1996, JAMA-J AM MED ASSOC, V276, P1229, DOI 10.1001/jama.276.15.1229; Furin JJ, 2001, INT J TUBERC LUNG D, V5, P648; Garcia-Garcia MD, 2000, ARCH INTERN MED, V160, P630, DOI 10.1001/archinte.160.5.630; GOBLE M, 1993, NEW ENGL J MED, V328, P527, DOI 10.1056/NEJM199302253280802; GROTH-PETERSEN E., 1959, BULL WORLD HEALTH ORGAN, V21, P5; Gupta R, 2001, SCIENCE, V293, P1049, DOI 10.1126/science.1061861; Hadiarto M, 1996, CHEMOTHERAPY, V42, P24, DOI 10.1159/000239511; Harris EK, 1991, SURVIVORSHIP ANAL CL; Heifets LB, 1996, CLIN LAB MED, V16, P641, DOI 10.1016/S0272-2712(18)30259-2; Hills, 1993, STAT MODELS EPIDEMIO; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; *INT UN TUB LUNG D, 2000, MAN TUB GUID LOW INC; ISSELBACHER KJ, 1994, HARRISONS PRINCIPLES, V1, P313; Kent PT, 1985, GUIDE LEVEL 3 LAB; Kenyon TA, 1997, ANN INTERN MED, V127, P32, DOI 10.7326/0003-4819-127-1-199707010-00006; Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129; Kimerling ME, 1999, INT J TUBERC LUNG D, V3, P451; Laserson KF, 2000, INT J TUBERC LUNG D, V4, P673; Laserson KF, 2000, CHEST, V117, P623, DOI 10.1378/chest.117.3.623; Maher D, 1997, TREATMENT TUBERCULOS; MAHMOUDI A, 1993, JAMA-J AM MED ASSOC, V270, P65, DOI 10.1001/jama.270.1.65; MITNICK CD, 2002, 4 WORLD C TB WASH DC; Narita M, 2001, CHEST, V120, P343, DOI 10.1378/chest.120.2.343; OLAKOWSKI T, 1973, ASSIGNMENT REPORT TU; Pablos-Mendez A, 1998, NEW ENGL J MED, V338, P1641, DOI 10.1056/NEJM199806043382301; PablosMendez A, 1998, NEW ENGL J MED, V339, P139; Park MM, 1996, AM J RESP CRIT CARE, V153, P317, DOI 10.1164/ajrccm.153.1.8542137; Park SK, 1998, INT J TUBERC LUNG D, V2, P877; Portaels F, 1999, INT J TUBERC LUNG D, V3, P582; Primary multidrug-resistant tuberculosis - Ivanovo Oblast Russia, 1999, MMWR MORB MORTAL WKL, V48, P661; Ridzon R, 1997, J PEDIATR-US, V131, P863, DOI 10.1016/S0022-3476(97)70034-9; Rullan JV, 1996, EMERG INFECT DIS, V2, P125, DOI 10.3201/eid0202.960208; Sacks LV, 1999, CLIN INFECT DIS, V29, P96, DOI 10.1086/520189; SALOMON N, 1995, CLIN INFECT DIS, V21, P1245, DOI 10.1093/clinids/21.5.1245; *SCI PAN WORK GROU, 2000, WHOCDSTB2000279 SCI; Suarez PG, 2002, LANCET, V359, P1980, DOI 10.1016/S0140-6736(02)08830-X; Suo J, 1996, CHEMOTHERAPY, V42, P20, DOI 10.1159/000239510; Tahaoglu K, 2001, NEW ENGL J MED, V345, P170, DOI 10.1056/NEJM200107193450303; TURETT GS, 1995, CLIN INFECT DIS, V21, P1238, DOI 10.1093/clinids/21.5.1238; WEINBERGER SE, 1992, PRINCIPLES PULMONARY; *WHO, 1996, WHOTB96200; Yew WW, 2000, CHEST, V117, P744, DOI 10.1378/chest.118.3.744; 1990, MMWR MORB MORTAL WKL, V39, P369	64	390	402	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					119	128		10.1056/NEJMoa022928	http://dx.doi.org/10.1056/NEJMoa022928			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519922	Bronze, Green Accepted			2022-12-28	WOS:000180263900004
J	Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T				Nakazaki, T; Okumoto, Y; Horibata, A; Yamahira, S; Teraishi, M; Nishida, H; Inoue, H; Tanisaka, T			Mobilization of a transposon in the rice genome	NATURE			English	Article							INVERTED-REPEAT ELEMENTS; ORYZA-SATIVA L.; RETROTRANSPOSONS; IDENTIFICATION; PROTEIN; GENES	Rice (Oryza sativa L.) is an important crop worldwide and, with the availability of the draft sequence(1,2), a useful model for analysing the genome structure of grasses(3),(4). To practice efficient rice breeding through genetic engineering techniques, it is important to identify the economically important genes in this crop. The use of mobile transposons as gene tags in intact plants is a powerful tool for functional analysis because transposon insertions often inactivate genes(5). Here we identify an active rice transposon named miniature Ping (mPing) through analysis of the mutability of a slender mutation of the glume(6)-the seed structure that encloses and determines the shape of the grain. The mPing transposon is inserted in the slender glume (slg) mutant allele but not in the wild-type allele. Search of the O. sativa variety Nipponbare genome identified 34 sequences with high nucleotide similarity to mPing, indicating that mPing constitutes a family of transposon elements. Excision of mPing from slg plants results in reversion to a wild-type phenotype. The mobility of the transposon mPing in intact rice plants represents a useful alternative tool for the functional analysis of rice genes.	Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan; Kinki Univ, Fac Biol Oriented Sci & Technol, Wakayama 6496433, Japan	Kyoto University; Kindai University (Kinki University)	Tanisaka, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Agron & Hort Sci, Sakyo Ku, Kyoto 6068502, Japan.		Teraishi, Masayoshi/D-8602-2018; Teraishi, Masayoshi/AAC-1055-2021	Teraishi, Masayoshi/0000-0002-6768-8052; Teraishi, Masayoshi/0000-0002-6768-8052				BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Cartinhour SW, 1997, PLANT MOL BIOL, V35, P241, DOI 10.1023/A:1005797203035; Delseny M, 2001, PLANT PHYSIOL BIOCH, V39, P323, DOI 10.1016/S0981-9428(01)01245-1; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Fukada-Tanaka S, 2000, NATURE, V407, P581, DOI 10.1038/35036683; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Hirochika H, 1999, MOLECULAR BIOLOGY OF RICE, P43; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jurka J, 2001, P NATL ACAD SCI USA, V98, P12315, DOI 10.1073/pnas.231490598; Kumar A, 2001, TRENDS PLANT SCI, V6, P127, DOI 10.1016/S1360-1385(00)01860-4; KUNZE R, 1997, ADV BOT RES, V27, P321; Maes T, 1999, TRENDS PLANT SCI, V4, P90, DOI 10.1016/S1360-1385(99)01375-8; Nakazaki T, 1998, BREEDING SCI, V48, P371; STEPHEN A, 2002, SCIENCE, V296, P92; Teraishi M, 1999, MOL GEN GENET, V261, P487, DOI 10.1007/s004380050992; Teraishi M, 2001, GENOME, V44, P1, DOI 10.1139/gen-44-1-1; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	21	183	211	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					170	172		10.1038/nature01219	http://dx.doi.org/10.1038/nature01219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520304				2022-12-28	WOS:000180267200042
J	Geurts, JWM; van Wijk, RMAW; Wynne, HJ; Hammink, E; Buskens, E; Lousberg, R; Knape, JTA; Groen, GJ				Geurts, JWM; van Wijk, RMAW; Wynne, HJ; Hammink, E; Buskens, E; Lousberg, R; Knape, JTA; Groen, GJ			Radiofrequency lesioning of dorsal root ganglia for chronic lumbosacral radicular pain: a randomised, double-blind, controlled trial	LANCET			English	Article							SPINAL PAIN; MPI-DLV; RHIZOTOMY; SCIATICA; EFFICACY; VALIDITY; RELIEF; BLOCKS	Background Results of observational studies have shown pain reduction with percutaneous radiofrequency lesioning of dorsal root ganglia for lumbosacral radicular pain, but there are few randomised controlled trials. We aimed to assess the efficacy of radiofrequency lesioning of dorsal root ganglia for lumbosacral radicular pain. Methods We screened 1001 patients, who were mostly referred by their family doctor, in four hospitals for a double-blind randomised trial. 83 patients met inclusion criteria and thus were randomly assigned to receive a radiofrequency lesion or control treatment of the involved dorsal root ganglion. Control treatment was done in the same way as radiofrequency lesioning, but without radiofrequency current. Preoperatively and during 3-month follow-up, patients reported visual analogue leg-pain and back-pain scores, physical impairment, and use of analgesics in a diary. Primary outcome was success or failure of treatment, defined by a multidimensional decision rule, which included median outcome variables from the diary. Post-hoc analysis for possible covariate interference with outcome variables was done. Primary outcome data were analysed on an intention-to-treat basis. Findings 45 patients were assigned radiofrequency lesioning and 38 control treatment. Three patients dropped out before 3 months. After 3 months, seven (16%) of 44 patients treated with radiofrequency lesioning and nine (25%) of 36 in the control group had successful treatment (difference -9.1% [95% CI -33.0 to 12.0], p=0.43). No differences between groups in side-effects were seen. Interpretation Lumbosacral radiofrequency lesioning of dorsal root ganglia failed to show advantage over control treatment with local anaesthetics. Thus, its use as routine treatment in lumbosacral radicular pain should not be advocated.	Rijnstate Hosp, Dept Anaesthesiol, NL-6800 TA Arnhem, Netherlands; Univ Med Ctr Utrecht, Div Perioperat Med Anaesthesiol & Pain Management, Utrecht, Netherlands; Onze Lieve Vrouw Hosp, Dept Anaesthesiol, Amsterdam, Netherlands; Univ Utrecht, Ctr Biostat, Utrecht, Netherlands; Univ Med Ctr Utrecht, Julius Ctr Gen Practice & Patient Oriented Res, Utrecht, Netherlands; Roessingh Rehabil Ctr, Roessingh Res & Dev, Enschede, Netherlands	Rijnstate Hospital; Utrecht University; Utrecht University Medical Center; Onze Lieve Vrouwe Gasthuis Hospital; Utrecht University; Utrecht University; Utrecht University Medical Center	Geurts, JWM (corresponding author), Rijnstate Hosp, Dept Anaesthesiol, POB 9555, NL-6800 TA Arnhem, Netherlands.			Van Wijk, Roelof/0000-0001-8498-9861				ARNER S, 1990, PAIN, V43, P287, DOI 10.1016/0304-3959(90)90026-A; *CENTR BUR STAT, 1983, WON VAL HFST 5 LICH; Deville WLJM, 2000, SPINE, V25, P1140, DOI 10.1097/00007632-200005010-00016; DIJKSTRA P, 1974, STEMMING ONTSTEMMING, P98; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; FRYMOYER JW, 1988, NEW ENGL J MED, V318, P291, DOI 10.1056/NEJM198802043180506; GERUTS JWM, 2001, THESIS UTRECHT U, P79; Geurts JW, 2001, REGION ANESTH PAIN M, V26, P394, DOI 10.1053/rapm.2001.23673; Hollmann MW, 2000, REGION ANESTH PAIN M, V25, P337, DOI 10.1053/rapm.2000.7606; JENSEN MP, 1993, PAIN, V55, P195, DOI 10.1016/0304-3959(93)90148-I; LOESER JD, 1972, J NEUROSURG, V36, P745, DOI 10.3171/jns.1972.36.6.0745; Lord SM, 1996, NEW ENGL J MED, V335, P1721, DOI 10.1056/NEJM199612053352302; Lousberg R, 1999, BEHAV RES THER, V37, P167, DOI 10.1016/S0005-7967(98)00137-5; Lousberg R, 1996, J CLIN PSYCHOL, V52, P161, DOI 10.1002/(SICI)1097-4679(199603)52:2<161::AID-JCLP6>3.0.CO;2-X; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; MCQUAY H, 1999, EVIDENCE BASED RESOU, P14; NASH TP, 1986, PAIN, V24, P67, DOI 10.1016/0304-3959(86)90027-8; North RB, 1996, PAIN, V65, P77, DOI 10.1016/0304-3959(95)00170-0; North RB, 1996, NEW ENGL J MED, V335, P1763, DOI 10.1056/NEJM199612053352310; NORTH RB, 1991, J NEUROSURG, V74, P236, DOI 10.3171/jns.1991.74.2.0236; PAGURA JR, 1983, APPL NEUROPHYSIOL, V46, P138; Slappendel R, 1997, PAIN, V73, P159, DOI 10.1016/S0304-3959(97)00094-8; SLUIJTER ME, 1981, PERSISTENT PAIN, V3, P141; TURK DC, 1988, J CONSULT CLIN PSYCH, V56, P233, DOI 10.1037/0022-006X.56.2.233; van Wijk RMAW, 2001, J NEUROSURG, V94, P227, DOI 10.3171/spi.2001.94.2.0227; vanKleef M, 1996, NEUROSURGERY, V38, P1127, DOI 10.1097/00006123-199606000-00013; Vroomen PCAJ, 2000, SPINE, V25, P91, DOI 10.1097/00007632-200001010-00016; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	28	86	90	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					21	26		10.1016/S0140-6736(03)12115-0	http://dx.doi.org/10.1016/S0140-6736(03)12115-0			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517462				2022-12-28	WOS:000180191600016
J	Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J				Strand, A; Asami, T; Alonso, J; Ecker, JR; Chory, J			Chloroplast to nucleus communication triggered by accumulation of Mg-protoporphyrinIX	NATURE			English	Article							TETRAPYRROLE BIOSYNTHESIS; CHLOROPHYLL PRECURSORS; SIGNAL-TRANSDUCTION; LIGHT INDUCTION; EXPRESSION; SEEDLINGS; BINDING; GENES; INVOLVEMENT; MUTANTS	Plant cells coordinately regulate the expression of nuclear and plastid genes that encode components of the photosynthetic apparatus. Nuclear genes that regulate chloroplast development and chloroplast gene expression provide part of this coordinate control. There is evidence that information also flows in the opposite direction, from chloroplasts to the nucleus(1),(2). Until now, at least three different signalling pathways have been identified that originate in the plastid and control nuclear gene expression(3,4) but the molecular nature of these signals has remained unknown. Here we show that the tetrapyrrole intermediate Mg-protoporphyrin (Mg-ProtoIX) acts as a signalling molecule in one of the signalling pathways between the chloroplast and nucleus. Accumulation of Mg-ProtoIX is both necessary and sufficient to regulate the expression of many nuclear genes encoding chloroplastic proteins associated with photosynthesis.	Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; RIKEN, Plant Funct Lab, Wako, Saitama 3510198, Japan	Salk Institute; Howard Hughes Medical Institute; Salk Institute; RIKEN	Chory, J (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	Chory@salk.edu	Ecker, Joseph R/B-9144-2008; Alonso, Jose M/K-6826-2014; Strand, Åsa/C-5093-2012	Ecker, Joseph R/0000-0001-5799-5895; Alonso, Jose M/0000-0001-7087-1571; 				ANDERSON SL, 1994, PLANT J, V6, P457, DOI 10.1046/j.1365-313X.1994.6040457.x; BURGESS DG, 1987, PLANTA, V170, P520, DOI 10.1007/BF00402986; CRAWFORD MS, 1983, PLANT PHYSIOL, V71, P303, DOI 10.1104/pp.71.2.303; DAMM B, 1991, PLANT TISSUE CULTURE; FORSBURG SL, 1989, ANNU REV CELL BIOL, V5, P153, DOI 10.1146/annurev.cb.05.110189.001101; Ghassemian M, 2001, TRENDS PLANT SCI, V6, P448, DOI 10.1016/S1360-1385(01)02092-1; Ishikawa A, 2001, PLANT J, V27, P89, DOI 10.1046/j.1365-313x.2001.01058.x; Jarvis P, 2001, CURR BIOL, V11, pR307, DOI 10.1016/S0960-9822(01)00171-3; JOHANNINGMEIER U, 1984, J BIOL CHEM, V259, P3541; KITTSTEINER U, 1991, PHYSIOL PLANTARUM, V81, P190, DOI 10.1111/j.1399-3054.1991.tb02128.x; Kropat J, 1997, P NATL ACAD SCI USA, V94, P14168, DOI 10.1073/pnas.94.25.14168; Kropat J, 2000, PLANT J, V24, P523, DOI 10.1046/j.1365-313x.2000.00898.x; La Rocca N, 2001, PLANTA, V213, P101, DOI 10.1007/s004250000477; Lee BH, 2002, PLANT CELL, V14, P1235, DOI 10.1105/tpc.010433; MAYFIELD SP, 1984, EUR J BIOCHEM, V144, P79, DOI 10.1111/j.1432-1033.1984.tb08433.x; MAYFIELD SP, 1986, PLANTA, V169, P23, DOI 10.1007/BF01369771; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; OELMULLER R, 1986, PLANTA, V168, P482, DOI 10.1007/BF00392267; Papenbrock J, 2001, PLANTA, V213, P667, DOI 10.1007/s004250100593; Rodermel S, 2001, TRENDS PLANT SCI, V6, P471, DOI 10.1016/S1360-1385(01)02085-4; SATO R, 1991, PLANT PHYSIOL, V96, P432, DOI 10.1104/pp.96.2.432; Surpin M, 2002, PLANT CELL, V14, pS327, DOI 10.1105/tpc.010446; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; Terry MJ, 1999, PLANT PHYSIOL, V119, P143, DOI 10.1104/pp.119.1.143; TERZAGI WB, 1995, ANNU REV PLANT PHYS, V40, P211	26	429	462	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					79	83		10.1038/nature01204	http://dx.doi.org/10.1038/nature01204			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511958				2022-12-28	WOS:000180165500041
J	Elbourne, D; Dezateux, C; Arthur, R; Clarke, NMP; Gray, A; King, A; Quinn, A; Gardner, F; Russell, G				Elbourne, D; Dezateux, C; Arthur, R; Clarke, NMP; Gray, A; King, A; Quinn, A; Gardner, F; Russell, G		UK Collaborat Hip Trial Grp	Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip Trial): clinical and economic results of a multicentre randomised controlled trial	LANCET			English	Article							CONGENITAL DISLOCATION; ULTRASOUND; SPLINTAGE	Background Clinical screening aims to identify and treat neonatal hip instability associated with increased risk of hip displacement, but risks failures of diagnosis and treatment (abduction splinting), iatrogenic effects, and costs to parents and health services. Our objectives were to assess clinical effectiveness and net cost of ultrasonography compared with clinical assessment alone, to provide guidance for management of infants with clinical hip instability. Methods Infants with clinical hip instability were recruited from 33 centres in UK and Ireland and randomised to either ultrasonographic hip examination (n=314) or clinical assessment alone (n=315). The primary outcome was appearance on hip radiographs by 2 years. Secondary outcomes included surgical treatment, abduction splinting, level of mobility, resource use, and costs. Analysis was by intention to treat. Findings Protocol compliance was high, and radiographic information was available for 91% of children by 12-14 months and 85% by 2 years. By age 2 years, subluxation, dislocation, or acetabular dysplasia were identified by radiography on one or both hips of 21 children in each of the groups (relative risk 1.00; 95% Cl 0.56-1.80). Fewer children in the ultrasonography group had abduction splinting in the first 2 years than did those in the no-ultrasonography group (0.78; 0.65-0.94; p=0.01). Surgical treatment was required by 21 infants in the ultrasonography group (6.7%) and 25 (7.9%) in the no-ultrasonography group (0.84; 0.48-1.47). One child from the ultrasonography group and four from the no-ultrasonography group were not walking by 2 years (0.25; 0.03-2.53; p=0.37). Infants in the ultrasonography group incurred significantly higher ultrasound costs over the first 2 years (pound42 vs pound23, mean difference pound19, 95% CI 11-27); total hospital costs were lower for those infants, but the difference was not significant. Interpretation The use of ultrasonography in infants with screen-detected clinical hip instability allows abduction splinting rates to be reduced, and is not associated with an increase in abnormal hip development, higher rates of surgical treatment by 2 years of age, or significantly higher health-service costs.	Univ London London Sch Hyg & Trop Med, Med Stat Unit, London WC1E 7HT, England; Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England; Gen Infirm, Xray Dept, Leeds LS1 3EX, W Yorkshire, England; Univ Southampton, Southampton Gen Hosp, Dept Orthopaed, Southampton, Hants, England; Univ Oxford, Inst Hlth Sci, Hlth Econ Res Ctr, Oxford, England; Univ Oxford, Inst Hlth Sci, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England; Univ Oxford, Dept Social Policy & Social Work, Oxford OX1 2JD, England; St Michaels Hosp, Dept Neonatol, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Leeds General Infirmary; University of Southampton; University of Oxford; University of Oxford; University of Oxford	Elbourne, D (corresponding author), Univ London London Sch Hyg & Trop Med, Med Stat Unit, Keppel St, London WC1E 7HT, England.		Dezateux, Carol/A-3416-2009	Dezateux, Carol/0000-0001-9787-6276				ARONSSON DD, 1994, PEDIATRICS, V94, P201; BRADLEY J, 1987, J BONE JOINT SURG BR, V69, P257, DOI 10.1302/0301-620X.69B2.3818757; Breslow NE., 1987, STAT METHODS CANC RE, P81; Cashman JP, 2002, J BONE JOINT SURG BR, V84B, P418, DOI 10.1302/0301-620X.84B3.12230; CATFORD JC, 1982, BMJ-BRIT MED J, V285, P1527, DOI 10.1136/bmj.285.6354.1527; Chan A, 1999, LANCET, V354, P1514, DOI 10.1016/S0140-6736(98)12469-8; Dezateux C, 1996, ARCH DIS CHILD, V74, P445, DOI 10.1136/adc.74.5.445; DEZATEUX C, 2000, ARCH DIS CHILD S, V82, pA2; DEZATEUX C, 1998, RECENT ADV PAEDIAT, P41; Elliman DAC, 2002, ARCH DIS CHILD, V87, P6, DOI 10.1136/adc.87.1.6; GARDINER HM, 1990, LANCET, V336, P1553, DOI 10.1016/0140-6736(90)93318-J; Godward S, 1998, LANCET, V351, P1149, DOI 10.1016/S0140-6736(97)10466-4; Graf R, 1987, GUIDE SONOGRAPHY INF; HARCKE HT, 1990, AM J ROENTGENOL, V155, P837, DOI 10.2214/ajr.155.4.2119119; Holen KJ, 1999, J BONE JOINT SURG BR, V81B, P846, DOI 10.1302/0301-620X.81B5.9502; Homer CJ, 2000, PEDIATRICS, V105, P896; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; LANGKAMER VG, 1991, ARCH DIS CHILD, V66, P1322, DOI 10.1136/adc.66.11.1322; LENNOX IAC, 1993, J BONE JOINT SURG BR, V75, P72, DOI 10.1302/0301-620X.75B1.8421040; Lewis K, 1999, J PEDIATR ORTHOPED, V19, P760, DOI 10.1097/00004694-199911000-00013; Patel H, 2001, CAN MED ASSOC J, V164, P1669; ROSENDAHL K, 1992, ACTA PAEDIATR, V81, P177, DOI 10.1111/j.1651-2227.1992.tb12198.x; ROSENDAHL K, 1994, PEDIATRICS, V94, P47; ROSENDAHL K, 1995, ARCH PEDIAT ADOL MED, V149, P643, DOI 10.1001/archpedi.1995.02170190053009; SOMERVILLE EW, 1978, J BONE JOINT SURG BR, V60, P25, DOI 10.1302/0301-620X.60B1.627575; *STAND MED ADV COM, 1966, SCREEN DET CONG DISL; Standing Medical Advisory Committee and the Standing Nursing and Midwifery Advisory Committee, 1986, SCREEN DET CONG DISL; WEINSTEIN SL, 1987, CLIN ORTHOP RELAT R, P62; WILKINSON J, 1960, J BONE JOINT SURG BR, V42, P669; Wood MK, 2000, J PEDIATR ORTHOPED, V20, P302, DOI 10.1097/00004694-200005000-00006	30	79	85	0	10	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2009	2017		10.1016/S0140-6736(02)12024-1	http://dx.doi.org/10.1016/S0140-6736(02)12024-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504396				2022-12-28	WOS:000179974200008
J	Inaba, S; Egashira, K; Komori, K				Inaba, S; Egashira, K; Komori, K			Peripheral-blood or bone-marrow mononuclear cells for therapeutic angiogenesis?	LANCET			English	Letter									Kyushu Univ, Sch Med, Blood Transfus Serv, Higashi Ku, Fukuoka 8128582, Japan; Nagoya Univ, Nagoya, Aichi, Japan	Kyushu University; Nagoya University	Inaba, S (corresponding author), Kyushu Univ, Sch Med, Blood Transfus Serv, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.		Minamino, Tohru/P-8145-2018; KOMORI, Kimihiro/M-8870-2014	Minamino, Tohru/0000-0003-1627-6151; 				Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8	1	35	36	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2083	2083		10.1016/S0140-6736(02)11976-3	http://dx.doi.org/10.1016/S0140-6736(02)11976-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504445				2022-12-28	WOS:000179974200057
J	Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B				Parisi, M; Nuttall, R; Naiman, D; Bouffard, G; Malley, J; Andrews, J; Eastman, S; Oliver, B			Paucity of genes on the Drosophila X chromosome showing male-biased expression	SCIENCE			English	Article							MELANOGASTER; SPERMATOGENESIS; EVOLUTION; SEX	Sex chromosomes are primary determinants of sexual dimorphism in many organisms. These chromosomes are thought to arise via the divergence of an ancestral autosome pair and are almost certainly influenced by differing selection in mates and females. Exploring how sex chromosomes differ from autosomes is highly amenable to genomic analysis. We examined global gene expression in Drosophila melanogaster and report a dramatic underrepresentation of X-chromosome genes showing high relative expression in mates. Using comparative genomics, we find that these same X-chromosome genes are exceptionally poorly conserved in the mosquito Anopheles gambiae. These data indicate that the X chromosome is a disfavored location for genes selectively expressed in males.	NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA; Incyte Genom, Palo Alto, CA 94304 USA; Johns Hopkins Univ, Dept Math Sci, Baltimore, MD 21218 USA; NHGRI, Natl Inst Hlth Intramural Sequencing Ctr, NIH, US Dept HHS, Gaithersburg, MD 20877 USA; NIH, Ctr Informat Technol, US Dept HHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Incyte; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Oliver, B (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, US Dept HHS, Bethesda, MD 20892 USA.		Naiman, Daniel Q/A-3304-2010	Naiman, Daniel Q/0000-0001-6504-9081	NIDDK NIH HHS [Z01 DK015600-10] Funding Source: Medline; CENTER FOR INFORMATION TECHNOLOGY [Z01CT000268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK015600] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; BAKER BS, 1994, ANNU REV GENET, V28, P491, DOI 10.1146/annurev.ge.28.120194.002423; Betran E, 2002, GENOME RES, V12, P1854, DOI 10.1101/gr.6049; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fong YY, 2002, SCIENCE, V296, P2235, DOI 10.1126/science.1070790; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kelly WG, 2002, DEVELOPMENT, V129, P479; LIFSCHYTZ E, 1972, P NATL ACAD SCI USA, V69, P182, DOI 10.1073/pnas.69.1.182; Oliver B, 2002, INT REV CYTOL, V219, P1; Rastelli L, 1998, MECH DEVELOP, V71, P107, DOI 10.1016/S0925-4773(98)00009-4; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061	20	403	412	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					697	700		10.1126/science.1079190	http://dx.doi.org/10.1126/science.1079190			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12511656	Green Accepted			2022-12-28	WOS:000180687700044
J	Mello, MM; Rosenthal, M; Neumann, PJ				Mello, MM; Rosenthal, M; Neumann, PJ			Direct-to-consumer advertising and shared liability for pharmaceutical manufacturers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMED DECISION-MAKING; PRESCRIPTION DRUG; LEARNED INTERMEDIARY; PHYSICIANS; EXPERIENCES; DOCTORS		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Mello, MM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184; Mello, Michelle/0000-0003-2877-4270				*AM LAW I, 1997, REST 3 TORTS PROD LI, P4; Ausness Richard C., 2002, WAKE FOREST LAW REV, V37, P97; Balkrishnan R, 2002, AM J MANAG CARE, V8, P332; Bell RA, 1999, J GEN INTERN MED, V14, P651, DOI 10.1046/j.1525-1497.1999.01049.x; Bell RA, 1999, J FAM PRACTICE, V48, P446; Braddock CH, 1997, J GEN INTERN MED, V12, P339, DOI 10.1046/j.1525-1497.1997.00057.x; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brodie M, 2000, HEALTH AFFAIR, V19, P255, DOI 10.1377/hlthaff.19.6.255; Calabresi G, 1970, COSTS ACCIDENTS LEGA; COHEN EP, 1988, NEW ENGL J MED, V318, P373, DOI 10.1056/NEJM198802113180608; Crawford LM, 2002, JAMA-J AM MED ASSOC, V288, P36, DOI 10.1001/jama.288.1.36; Davis TC, 2002, AMBUL PEDIATR, V2, P193, DOI 10.1367/1539-4409(2002)002<0193:IVRBCW>2.0.CO;2; DREIER WA, 2000, SETON HALL LAW REV, V30, P806; ELLIOTT VS, 2002, AM MED NEWS     0729; *FOOD DRUG ADM, 1997, DRAFT GUID IND CONS; Gemperli MP, 2000, JAMA-J AM MED ASSOC, V284, P2241, DOI 10.1001/jama.284.17.2241; HAMMACK L, 2001, ROANOKE TIMES W 0807, P81; *HJ KAIS FAM FDN, 2001, UND EFF DIR TO CONS; Holmer AF, 2002, NEW ENGL J MED, V346, P526, DOI 10.1056/NEJM200202143460714; HUBER P, 1985, COLUMBIA LAW REV, V85, P277, DOI 10.2307/1122439; KALET A, 1994, J GEN INTERN MED, V9, P402, DOI 10.1007/BF02629523; KARNS JE, 2000, DEPAUL J HLTH CARE L, V3, P273; Kravitz RL, 2000, JAMA-J AM MED ASSOC, V284, P2244, DOI 10.1001/jama.284.17.2244; LEHRER J, 2000, NATL SURVEY PRESCRIP; Lipsky MS, 1997, J FAM PRACTICE, V45, P495; LOTA L, 2002, ASSOCIATED PRES 0820; Manning RL, 1997, J LAW ECON, V40, P203, DOI 10.1086/467371; Mechanic D, 2001, NEW ENGL J MED, V344, P198, DOI 10.1056/NEJM200101183440307; Mello MM, 2002, TEX LAW REV, V80, P1595; Mintzes B, 2002, BRIT MED J, V324, P278, DOI 10.1136/bmj.324.7332.278; Morris LA, 1997, MED CARE, V35, P996, DOI 10.1097/00005650-199710000-00002; Morris Louis A., 1986, CURRENT ISSUES RES A, V1, P93; Murphy J, 2001, J FAM PRACTICE, V50, P123; NOAH L, 1997, GA L REV, V32, P141; Plant NK, 1996, IOWA LAW REV, V81, P1007; Rosok Mae Joanne, 2000, SEATTLE U L REV, V24, P629; Roth MS, 1996, J PUBLIC POLICY MARK, V15, P63, DOI 10.1177/074391569601500106; Schommer JC, 1998, CLIN THER, V20, P617, DOI 10.1016/S0149-2918(98)80070-2; SCHWARTZ GT, 1994, UCLA LAW REV, V42, P377; SCHWARTZ TM, 1991, FOOD DRUG LAW J, V46, P829; SHARP LA, 1997, AM LAW REP, V47, P433; Spurgeon D, 1999, BRIT MED J, V319, P1321, DOI 10.1136/bmj.319.7221.1321a; Wilkes MS, 2000, HEALTH AFFAIR, V19, P110, DOI 10.1377/hlthaff.19.2.110; 2001, PREVENTION MAGAZINE, V1; 2002, PRESCRIPTION DRUGS F	45	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					477	481		10.1001/jama.289.4.477	http://dx.doi.org/10.1001/jama.289.4.477			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533128				2022-12-28	WOS:000180472300030
J	Krol, MC; Lelieveld, J; Oram, DE; Sturrock, GA; Penkett, SA; Brenninkmeijer, CAM; Gros, V; Williams, J; Scheeren, HA				Krol, MC; Lelieveld, J; Oram, DE; Sturrock, GA; Penkett, SA; Brenninkmeijer, CAM; Gros, V; Williams, J; Scheeren, HA			Continuing emissions of methyl chloroform from Europe	NATURE			English	Article							TRACE GASES; OH; SIMULATION; HISTORY; OZONE	The consumption of methyl chloroform (1,1,1-trichloroethane), an industrial solvent, has been banned by the 1987 Montreal Protocol because of its ozone-depleting potential. During the 1990s, global emissions have decreased substantially and, since 1999, near-zero emissions have been estimated for Europe and the United States. Here we present measurements of methyl chloroform that are inconsistent with the assumption of small emissions. Using a tracer transport model, we estimate that European emissions were greater than 20 Gg in 2000. Although these emissions are not significant for stratospheric ozone depletion, they have important implications for estimates of global tropospheric hydroxyl radical (OH) concentrations, deduced from measurements of methyl chloroform. Ongoing emissions therefore cast doubt upon recent reports of a strong and unexpected negative trend in OH during the 1990s and a previously calculated higher OH abundance in the Southern Hemisphere compared to the Northern Hemisphere.	Inst Marine & Atmospher Res, NL-3584 CC Utrecht, Netherlands; Max Planck Inst Chem, D-55128 Mainz, Germany; Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England	Utrecht University; Max Planck Society; University of East Anglia	Krol, MC (corresponding author), Inst Marine & Atmospher Res, NL-3584 CC Utrecht, Netherlands.	krol@phys.uu.nl	Krol, Maarten/B-3597-2010; Williams, Jonathan/K-7686-2017; Krol, Maarten C./E-3414-2013; Lelieveld, Jos/A-1986-2013; Brenninkmeijer, Carl/B-6860-2013	Williams, Jonathan/0000-0001-9421-1703; Krol, Maarten C./0000-0002-3506-2477; Lelieveld, Jos/0000-0001-6307-3846; Scheeren, Bert/0000-0001-6333-8402				BERKVENS PJF, 1999, MASR9921 CWI; Brenninkmeijer CAM, 1999, J ATMOS OCEAN TECH, V16, P1373, DOI 10.1175/1520-0426(1999)016<1373:CCAFGM>2.0.CO;2; Butler JH, 1999, NATURE, V399, P749, DOI 10.1038/21586; DENTENER F, 2002, ATMOS CHEM PHYS DISC, V2, P249; Dziura EL, 1997, ENVIRON ENG SCI, V14, P33, DOI 10.1089/ees.1997.14.33; Gerbig C, 1999, J GEOPHYS RES-ATMOS, V104, P1699, DOI 10.1029/1998JD100031; Hauglustaine DA, 1998, J GEOPHYS RES-ATMOS, V103, P28291, DOI 10.1029/98JD02398; Houweling S, 1998, J GEOPHYS RES-ATMOS, V103, P10673, DOI 10.1029/97JD03582; Jeuken A, 2001, J GEOPHYS RES-ATMOS, V106, P28295, DOI 10.1029/2001JD900063; Krol M, 2002, AIR POLLUTION MODELLING AND SIMULATION, PROCEEDINGS, P225; Krol M, 1998, J GEOPHYS RES-ATMOS, V103, P10697, DOI 10.1029/98JD00459; Krol M, 2001, J GEOPHYS RES-ATMOS, V106, P23159, DOI 10.1029/2001JD900039; KROL M, IN PRESS J GEOPHYS R; Lelieveld J, 2000, J GEOPHYS RES-ATMOS, V105, P3531, DOI 10.1029/1999JD901011; Lelieveld J, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002272; Lelieveld J, 2002, SCIENCE, V298, P794, DOI 10.1126/science.1075457; McCulloch A, 2001, ATMOS ENVIRON, V35, P5311, DOI 10.1016/S1352-2310(01)00306-5; MIDGLEY PM, 1995, ATMOS ENVIRON, V29, P1601, DOI 10.1016/1352-2310(95)00078-D; Montzka SA, 2000, SCIENCE, V288, P500, DOI 10.1126/science.288.5465.500; Olivier J. G. J., 2001, CLIMATE SYSTEM, P33; ORAM DE, 1995, GEOPHYS RES LETT, V22, P2741, DOI 10.1029/95GL02849; Peters W, 2001, J GEOPHYS RES-ATMOS, V106, P10389, DOI 10.1029/2000JD900658; PRINN R, 1987, SCIENCE, V238, P945, DOI 10.1126/science.238.4829.945; Prinn RG, 2001, SCIENCE, V292, P1882, DOI 10.1126/science.1058673; PRINN RG, 1995, SCIENCE, V269, P187, DOI 10.1126/science.269.5221.187; Prinn RG, 2000, J GEOPHYS RES-ATMOS, V105, P17751, DOI 10.1029/2000JD900141; Ryall DB, 2001, ATMOS ENVIRON, V35, P2507, DOI 10.1016/S1352-2310(00)00433-7; SCHEEREN HA, 2002, J GEOPHYS RES, V107, DOI DOI 10.1029/2001JD01121; SINGH HB, 1977, GEOPHYS RES LETT, V4, P453, DOI 10.1029/GL004i010p00453; Spivakovsky CM, 2000, J GEOPHYS RES-ATMOS, V105, P8931, DOI 10.1029/1999JD901006; Sturges WT, 2001, J GEOPHYS RES-ATMOS, V106, P1595, DOI 10.1029/2000JD900511; UNEP ( United Nations Environment Programme), 2002, PROD CONS OZ DEPL SU; Wang YH, 1998, J GEOPHYS RES-ATMOS, V103, P31123, DOI 10.1029/1998JD100004	33	77	80	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					131	135		10.1038/nature01311	http://dx.doi.org/10.1038/nature01311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520294				2022-12-28	WOS:000180267200031
J	Lillo, F; Farmer, JD; Mantegna, RN				Lillo, F; Farmer, JD; Mantegna, RN			Econophysics - Master curve for price-impact function	NATURE			English	Article							TRADE; TIME		Univ Palermo, Ist Nazl Fis Mat, I-90128 Palermo, Italy; Univ Palermo, Dipartimento Fis & Tecnol Relat, I-90128 Palermo, Italy; Santa Fe Inst, Santa Fe, NM 87501 USA	Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Palermo; University of Palermo; The Santa Fe Institute	Lillo, F (corresponding author), Univ Palermo, Ist Nazl Fis Mat, I-90128 Palermo, Italy.		Mantegna, Rosario N/H-3652-2014; Lillo, Fabrizio/E-6793-2014	Mantegna, Rosario N/0000-0003-4177-171X; 				CHAN LKC, 1995, J FINANC, V50, P1147, DOI 10.2307/2329347; DANIELS M, 2001, CONDMAT0112422; Dufour A, 2000, J FINANC, V55, P2467, DOI 10.1111/0022-1082.00297; FARMER JD, 1996, SLIPPAGE 1996; Hasbrouck Joel, 1996, HANDB STAT, V14, P647; HAUSMAN JA, 1992, J FINANC ECON, V31, P319, DOI 10.1016/0304-405X(92)90038-Y; Kempf A., 1999, J FINANC MARK, V2, P29; LEE CMC, 1991, J FINANC, V46, P733, DOI 10.2307/2328845; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; Torre N., 1997, BARRA MARKET IMPACT	11	237	240	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					129	130		10.1038/421129a	http://dx.doi.org/10.1038/421129a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	633DR	12520292				2022-12-28	WOS:000180267200029
J	Fitzgerald, DW; Behets, FMT				Fitzgerald, DW; Behets, FMT			Women's health and human rights in HIV prevention research	LANCET			English	Editorial Material									Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA; Univ N Carolina, Sch Publ Hlth, Dept Med, Chapel Hill, NC USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA	Cornell University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fitzgerald, DW (corresponding author), Cornell Univ, Coll Med, Div Int Med & Infect Dis, New York, NY 10021 USA.							Benatar SR, 2002, SOC SCI MED, V54, P1131, DOI 10.1016/S0277-9536(01)00327-6; COELHO HLL, 1993, LANCET, V341, P1261, DOI 10.1016/0140-6736(93)91157-H; Jewkes R, 2002, LANCET, V359, P319, DOI 10.1016/S0140-6736(02)07530-X; PIOT P, PREFACE REPORT GLOBA; Sankaranarayanan R, 2001, B WORLD HEALTH ORGAN, V79, P954	5	6	7	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					68	69		10.1016/S0140-6736(03)12166-6	http://dx.doi.org/10.1016/S0140-6736(03)12166-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517474				2022-12-28	WOS:000180191600028
J	Heikkinen, T; Jarvinen, A				Heikkinen, T; Jarvinen, A			The common cold	LANCET			English	Review							ACUTE OTITIS-MEDIA; RESPIRATORY SYNCYTIAL VIRUS; RANDOMIZED CONTROLLED TRIAL; EXPERIMENTAL RHINOVIRUS INFECTION; INFLUENZA-A VIRUS; POLYMERASE-CHAIN-REACTION; INTRANASAL FLUTICASONE PROPIONATE; OBSTRUCTIVE PULMONARY-DISEASE; PLACEBO-CONTROLLED TRIAL; TRACT INFECTION	Despite great advances in medicine, the common cold continues to be a great burden on society in terms of human suffering and economic losses. Of the several viruses that cause the disease, the role of rhinoviruses is most prominent. About a quarter of all colds are still without proven cause, and the recent discovery of human metapneumovirus suggests that other viruses could remain undiscovered. Research into the inflammatory mechanisms of the common cold has elucidated the complexity of the virus-host relation. Increasing evidence is also available for the central role of viruses in predisposing to complications. New antivirals for the treatment of colds are being developed, but optimum use of these agents would require rapid detection of the specific virus causing the infection. Although vaccines against many respiratory viruses could also become available, the ultimate prevention of the common cold seems to remain a distant aim.	Turku Univ Hosp, Dept Paediat, FIN-20520 Turku, Finland; Univ Helsinki, Cent Hosp, Dept Med, Div Infect Dis, Helsinki, Finland	University of Turku; University of Helsinki; Helsinki University Central Hospital	Heikkinen, T (corresponding author), Turku Univ Hosp, Dept Paediat, FIN-20520 Turku, Finland.	terho.heikkinen@utu.fi		Heikkinen, Terho/0000-0001-6504-0116				ADAMS PF, 1999, VITAL HLTH STAT, V10, P1996; ALHO OP, 1990, INT J PEDIATR OTORHI, V19, P151, DOI 10.1016/0165-5876(90)90221-C; [Anonymous], [No title captured]; AROLA M, 1990, J PEDIATR-US, V116, P697, DOI 10.1016/S0022-3476(05)82650-2; ARROLL B, 2002, COCHRANE LIB; Arruda E, 1997, J CLIN MICROBIOL, V35, P2864, DOI 10.1128/JCM.35.11.2864-2868.1997; Ball TM, 2002, ARCH PEDIAT ADOL MED, V156, P121, DOI 10.1001/archpedi.156.2.121; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Blomqvist S, 2002, J MED VIROL, V66, P263, DOI 10.1002/jmv.2140; Carrat F, 1999, CLIN INFECT DIS, V28, P283, DOI 10.1086/515117; Casselbrant ML, 1999, JAMA-J AM MED ASSOC, V282, P2125, DOI 10.1001/jama.282.22.2125; CHERRY JD, 1998, TXB PEDIAT INFECT DI, P1666; CHONMAITREE T, 1990, J INFECT DIS, V162, P546, DOI 10.1093/infdis/162.2.546; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Covalciuc KA, 1999, J CLIN MICROBIOL, V37, P3971, DOI 10.1128/JCM.37.12.3971-3974.1999; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; Crowe JE, 2001, VACCINE, V20, pS32, DOI 10.1016/S0264-410X(01)00287-0; DICK EC, 1987, J INFECT DIS, V156, P442, DOI 10.1093/infdis/156.3.442; DICK EC, 1998, TXB PEDIAT INFECT DI, P1839; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; DOUGLAS RG, 1968, NEW ENGL J MED, V279, P742, DOI 10.1056/NEJM196810032791404; DOUGLAS RM, 1986, NEW ENGL J MED, V314, P65, DOI 10.1056/NEJM198601093140201; DOUGLAS RM, 2002, COCHRANE LIB; DOYLE WJ, 1994, ANN OTO RHINOL LARYN, V103, P59, DOI 10.1177/000348949410300111; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Fan J, 1998, CLIN INFECT DIS, V26, P1397, DOI 10.1086/516357; FARR BM, 1990, J INFECT DIS, V162, P1173, DOI 10.1093/infdis/162.5.1173; FOX JP, 1972, AM J EPIDEMIOL, V96, P270, DOI 10.1093/oxfordjournals.aje.a121458; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Ghosh S, 1999, CLIN INFECT DIS, V29, P528, DOI 10.1086/598627; Glueck R, 2001, VACCINE, V20, pS42, DOI 10.1016/S0264-410X(01)00292-4; Gonzales R, 2001, CLIN INFECT DIS, V33, P757, DOI 10.1086/322627; Greenberg SB, 2000, AM J RESP CRIT CARE, V162, P167, DOI 10.1164/ajrccm.162.1.9911019; Gustafson LM, 1996, J ALLERGY CLIN IMMUN, V97, P1009, DOI 10.1016/S0091-6749(96)80077-7; GWALTNEY JM, 1978, ANN INTERN MED, V88, P463, DOI 10.7326/0003-4819-88-4-463; GWALTNEY JM, 1992, J INFECT DIS, V166, P776, DOI 10.1093/infdis/166.4.776; GWALTNEY JM, 1966, NEW ENGL J MED, V275, P1261, DOI 10.1056/NEJM196612082752301; GWALTNEY JM, 1992, NEW ENGL J MED, V326, P644; Gwaltney JM, 2002, J INFECT DIS, V186, P147, DOI 10.1086/341455; GWALTNEY JM, 1994, NEW ENGL J MED, V330, P25, DOI 10.1056/NEJM199401063300105; Gwaltney JM, 1997, CLIN INFECT DIS, V25, P1188, DOI 10.1086/516105; Gwaltney JM, 2000, CLIN INFECT DIS, V30, P387, DOI 10.1086/313661; GWALTNEY JM, 1967, J AMER MED ASSOC, V202, P494, DOI 10.1001/jama.202.6.494; Gwaltney JM., 2000, PRINCIPLES PRACTICES, P651; HALL CB, 1975, J INFECT DIS, V131, P1, DOI 10.1093/infdis/131.1.1; HALPERIN SA, 1983, AM REV RESPIR DIS, V128, P806; Harris JM, 1996, CLIN INFECT DIS, V23, P1287, DOI 10.1093/clinids/23.6.1287; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 1996, ANN INTERN MED, V125, P89, DOI 10.7326/0003-4819-125-2-199607150-00002; Hayden FG, 1999, NEW ENGL J MED, V341, P1336, DOI 10.1056/NEJM199910283411802; Hayden FG, 2002, ANTIVIR THER, V7, P53; HAYDEN FG, 1988, ANTIMICROB AGENTS CH, V32, P224, DOI 10.1128/AAC.32.2.224; HAYDEN FG, 1989, NEW ENGL J MED, V321, P1696, DOI 10.1056/NEJM198912213212502; HAYDEN FG, 1984, J INFECT DIS, V150, P174, DOI 10.1093/infdis/150.2.174; HEIKKINEN T, 1995, J PEDIATR-US, V126, P313, DOI 10.1016/S0022-3476(95)70569-4; HEIKKINEN T, 1994, PEDIATR INFECT DIS J, V13, P659, DOI 10.1097/00006454-199407000-00016; Heikkinen T, 1998, PEDIATR INFECT DIS J, V17, P367, DOI 10.1097/00006454-199805000-00004; Heikkinen T, 1999, NEW ENGL J MED, V340, P260, DOI 10.1056/NEJM199901283400402; Heikkinen T, 2000, VACCINE, V19, pS51, DOI 10.1016/S0264-410X(00)00278-4; Heikkinen T, 2001, BMJ-BRIT MED J, V322, P138, DOI 10.1136/bmj.322.7279.138; Heiskanen-Kosma T, 1998, PEDIATR INFECT DIS J, V17, P986, DOI 10.1097/00006454-199811000-00004; HENDERSON FW, 1982, NEW ENGL J MED, V306, P1377, DOI 10.1056/NEJM198206103062301; HENDLEY JO, 1988, EPIDEMIOL REV, V10, P242, DOI 10.1093/oxfordjournals.epirev.a036024; Herbert AP, 1960, LOOK BACK LAUGH, P115; Hsyu PH, 2002, ANTIMICROB AGENTS CH, V46, P392, DOI 10.1128/AAC.46.2.392-397.2002; Hyypia T, 1998, J CLIN MICROBIOL, V36, P2081; IGARASHI Y, 1993, J ALLERGY CLIN IMMUN, V92, P722, DOI 10.1016/0091-6749(93)90016-9; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; JOHNSTON SL, 1993, J CLIN MICROBIOL, V31, P111, DOI 10.1128/JCM.31.1.111-117.1993; JOHNSTON SL, 1995, BRIT MED J, V310, P1225, DOI 10.1136/bmj.310.6989.1225; Juven T, 2000, PEDIATR INFECT DIS J, V19, P293, DOI 10.1097/00006454-200004000-00006; Kaiser L, 2000, ANTIVIR RES, V47, P215, DOI 10.1016/S0166-3542(00)00106-6; Kaiser L, 2000, ARCH INTERN MED, V160, P3234, DOI 10.1001/archinte.160.21.3234; KIM HW, 1983, J CLIN MICROBIOL, V18, P1399, DOI 10.1128/JCM.18.6.1399-1404.1983; Koivunen P, 1999, PEDIATR INFECT DIS J, V18, P303, DOI 10.1097/00006454-199903000-00023; KRILOV LR, 1994, PEDIATRICS, V93, P903; LARSON HE, 1980, J MED VIROL, V5, P221, DOI 10.1002/jmv.1890050306; Lee MS, 2001, J INFECT DIS, V184, P909, DOI 10.1086/323150; Lowenstein S R, 1987, Adv Intern Med, V32, P207; Makela MJ, 1998, J CLIN MICROBIOL, V36, P539; MARSHALL I, 2002, COCHRANE LIB; MCBRIDE TP, 1989, ARCH OTOLARYNGOL, V115, P1054; MCINTOSH K, 1993, CLIN INFECT DIS, V16, P151, DOI 10.1093/clinids/16.1.151; MELCHART D, 2002, COCHRANE LIB; MONTO A, 2001, 39 ANN M INF DIS SOC; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; MONTO AS, 1994, EPIDEMIOL REV, V16, P351, DOI 10.1093/oxfordjournals.epirev.a036158; MONTO AS, 1974, JAMA-J AM MED ASSOC, V227, P164, DOI 10.1001/jama.227.2.164; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MONTO AS, 1971, AM J EPIDEMIOL, V94, P280, DOI 10.1093/oxfordjournals.aje.a121321; MONTO AS, 1986, J INFECT DIS, V154, P128, DOI 10.1093/infdis/154.1.128; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; MONTO AS, 1987, J INFECT DIS, V156, P43, DOI 10.1093/infdis/156.1.43; NACLERIO RM, 1988, J INFECT DIS, V157, P133, DOI 10.1093/infdis/157.1.133; Nichol KL, 1999, JAMA-J AM MED ASSOC, V282, P137, DOI 10.1001/jama.282.2.137; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Nicholson KG, 1997, BRIT MED J, V315, P1060, DOI 10.1136/bmj.315.7115.1060; NIEMAN DC, 1994, MED SCI SPORT EXER, V26, P128, DOI 10.1249/00005768-199402000-00002; NIKKARI S, 1989, J VIROL METHODS, V23, P29, DOI 10.1016/0166-0934(89)90086-4; Nissen MD, 2002, MED J AUSTRALIA, V176, P188, DOI 10.5694/j.1326-5377.2002.tb04354.x; NOAH TL, 1995, J INFECT DIS, V171, P584, DOI 10.1093/infdis/171.3.584; Nokso-Koivisto J, 2002, J MED VIROL, V66, P417, DOI 10.1002/jmv.2161; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Patel JA, 1998, IMMUNOLOGY, V95, P501; Peret TCT, 2002, J INFECT DIS, V185, P1660, DOI 10.1086/340518; Pitkaranta A, 1997, J CLIN MICROBIOL, V35, P1791; Pitkaranta A, 1998, PEDIATRICS, V102, P291, DOI 10.1542/peds.102.2.291; Pitkaranta A, 1999, J CLIN VIROL, V14, P199, DOI 10.1016/S1386-6532(99)00056-6; Pitkaranta A, 2001, CLIN INFECT DIS, V33, P909, DOI 10.1086/322678; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V101, P726, DOI 10.1016/S0091-6749(98)70301-X; Puhakka T, 1998, J ALLERGY CLIN IMMUN, V102, P403, DOI 10.1016/S0091-6749(98)70127-7; PUTTO A, 1986, AM J DIS CHILD, V140, P1159, DOI 10.1001/archpedi.1986.02140250085040; PUTTO A, 1987, PEDIATRICS, V80, P6; Ruohola A, 2000, J ALLERGY CLIN IMMUN, V106, P467, DOI 10.1067/mai.2000.108912; RUUSKANEN O, 1989, PEDIATR INFECT DIS J, V8, P94; Saito T, 1997, J INFECT DIS, V175, P497, DOI 10.1093/infdis/175.3.497; SANYAL MA, 1980, J PEDIATR-US, V97, P11, DOI 10.1016/S0022-3476(80)80121-1; Schiff GM, 2000, J INFECT DIS, V181, P20, DOI 10.1086/315176; SCHROEDER K, 2002, COCHRANE LIB; Seemungal T, 2001, AM J RESP CRIT CARE, V164, P1618, DOI 10.1164/ajrccm.164.9.2105011; Silagy C, 1998, LANCET, V352, P1877, DOI 10.1016/S0140-6736(98)10190-3; Skiadopoulos MH, 2002, VACCINE, V20, P1846, DOI 10.1016/S0264-410X(02)00038-5; SMITH MBH, 1993, JAMA-J AM MED ASSOC, V269, P2258, DOI 10.1001/jama.269.17.2258; SPERBER SJ, 1992, ANN INTERN MED, V117, P37, DOI 10.7326/0003-4819-117-1-37; SPERBER SJ, 1989, B NEW YORK ACAD MED, V65, P145; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; Takkouche B, 2002, AM J EPIDEMIOL, V155, P853, DOI 10.1093/aje/155.9.853; Tapiainen T, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e19; Treanor JJ, 2000, PRINCIPLES PRACTICE, P1823; Turner RB, 1999, JAMA-J AM MED ASSOC, V281, P1797, DOI 10.1001/jama.281.19.1797; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Vesa S, 2001, PEDIATR INFECT DIS J, V20, P574, DOI 10.1097/00006454-200106000-00006; VOLOVITZ B, 1988, J PEDIATR-US, V112, P218, DOI 10.1016/S0022-3476(88)80058-1; WALD ER, 1988, J PEDIATR-US, V112, P540, DOI 10.1016/S0022-3476(88)80164-1; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; WARIS M, 1990, J CLIN MICROBIOL, V28, P1159, DOI 10.1128/JCM.28.6.1159-1162.1990; WARIS M, 1991, J INFECT DIS, V163, P464, DOI 10.1093/infdis/163.3.464; WARSHAUER DM, 1989, AM J EPIDEMIOL, V129, P319, DOI 10.1093/oxfordjournals.aje.a115136; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WELLIVER RC, 1981, NEW ENGL J MED, V305, P841, DOI 10.1056/NEJM198110083051501; Whitley RJ, 2001, PEDIATR INFECT DIS J, V20, P127, DOI 10.1097/00006454-200102000-00002; WINTHER B, 1986, JAMA-J AM MED ASSOC, V256, P1763, DOI 10.1001/jama.256.13.1763; Winther B, 2002, ARCH OTOLARYNGOL, V128, P131, DOI 10.1001/archotol.128.2.131; Winther B, 2002, PEDIATRICS, V109, P826, DOI 10.1542/peds.109.5.826; WINTHER B, 1984, ACTA OTO-LARYNGOL, V98, P315, DOI 10.3109/00016488409107569; Zhu Z, 1996, J CLIN INVEST, V97, P421, DOI 10.1172/JCI118431	148	603	655	0	104	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					51	59		10.1016/S0140-6736(03)12162-9	http://dx.doi.org/10.1016/S0140-6736(03)12162-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517470	Green Published, Bronze			2022-12-28	WOS:000180191600024
J	Mullan, Z				Mullan, Z			Lancet correspondence: old letters, new rules	LANCET			English	Editorial Material									Lancet, London NW1 7BY, England		Mullan, Z (corresponding author), Lancet, London NW1 7BY, England.								0	12	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					12	12		10.1016/S0140-6736(03)12188-5	http://dx.doi.org/10.1016/S0140-6736(03)12188-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517458				2022-12-28	WOS:000180191600012
J	Slap, GB; Lot, L; Huang, B; Daniyam, CA; Zink, TM; Succop, PA				Slap, GB; Lot, L; Huang, B; Daniyam, CA; Zink, TM; Succop, PA			Sexual behaviour of adolescents in Nigeria: cross sectional survey of secondary school students	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACADEMIC-ACHIEVEMENT; FAMILY; CHILDREN	Objectives To determine whether family structure (polygamous or monogamous) is associated with sexual activity among school students in Nigeria. Design Cross sectional school survey with a two stage, clustered sampling design. Participants 4218 students aged 12-21 years attending 39 schools in Plateau state, Nigeria. Responses from 2705 students were included in the analysis. Main outcome measure Report of ever having had sexual intercourse. Variables of interest included sexual history, age, sex, religion, family polygamy, educational level of parents, having a dead parent, and sense of connectedness to parents and school. Results Overall 909 students (34%) reported ever having had sexual intercourse, and 1119 (41%) reported a polygamous family structure. Sexual activity was more common among students from polygamous families (42% of students) than monogamous families (28%) (chi(2)=64.23; P < 0.0001). Variables independently associated with sexual activity were male sex (adjusted odds ratio 2.52 (95% confidence interval 2.05 to 3.12)), older age (1.62 (1.24 to 2.14)), lower sense of connectedness with parents (1.87 (1.48 to 2.38)), having a dead parent (1.59 (1.27 to 2.00)), family polygamy (1.58 (1.29 to 1.92)), lower sense of connectedness with school (1.25 (1.09 to 1.44)), and lower educational level of parents (1.14 (1.05 to 1.24)). Multistep logistic regression analysis showed that the effect of polygamy on sexual activity was reduced by 27% by whether students were married and 22% by a history of forced sex. Conclusions Secondary school students in Nigeria from a polygamous family structure are more likely to have engaged in sexual activity than students from a monogamous family structure. This effect is partly explained by a higher likelihood of marriage during adolescence and forced sex. Students' sense of connectedness to their parents and school, regardless of family structure, decreases the likelihood of sexual activity, and fostering this sense may help reduce risky sexual behaviour among Nigerian youth.	Univ Cincinnati, Childrens Hosp,Med Ctr, Coll Med, Div Adolescent Med, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Family Med, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45229 USA; Plateau State Specialist Hosp, Dept Med, Jos, Nigeria	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Slap, GB (corresponding author), Univ Cincinnati, Childrens Hosp,Med Ctr, Coll Med, Div Adolescent Med, ML-4000,3333 Burnet Ave, Cincinnati, OH 45229 USA.	gail.slap@cchmc.org	Huang, Bin/G-2468-2014					*A GUTTM I, 2001, CAN MOR PROGR BE MAD; ADELEKAN ML, 1993, DRUG ALCOHOL DEPEN, V33, P247, DOI 10.1016/0376-8716(93)90111-3; [Anonymous], 2000, MMWR Recomm Rep, V49, P1; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Barone C, 1996, FAM PLANN PERSPECT, V28, P69, DOI 10.2307/2136127; Blum RWM, 1998, J ADOLESCENT HEALTH, V22, P368, DOI 10.1016/S1054-139X(97)00261-9; Brieger WR, 2001, J ADOLESCENT HEALTH, V29, P436, DOI 10.1016/S1054-139X(01)00264-6; BROOKSGUNN J, 1989, AM PSYCHOL, V44, P249, DOI 10.1037/0003-066X.44.2.249; CHERIAN VI, 1990, J SOC PSYCHOL, V130, P117, DOI 10.1080/00224545.1990.9922942; CHERIAN VI, 1994, J SOC PSYCHOL, V134, P387, DOI 10.1080/00224545.1994.9711744; Dryfoos JG., 1990, ADOLESCENTS RISK PRE; FISHER TD, 1987, J YOUTH ADOLESCENCE, V16, P481, DOI 10.1007/BF02202942; HANDELSMAN CD, 1987, J ADOLESCENT RES, V2, P455; JOHNSON NE, 1989, J BIOSOC SCI, V21, P127, DOI 10.1017/S002193200001782X; *JOINT UN PROGR HI, 2000, NIG EP FACT SHEET HI; Kirby D., 2001, EMERGING ANSWERS RES; Orubuloye IO, 1997, SOC SCI MED, V44, P1195, DOI 10.1016/S0277-9536(96)00254-7; OWUAMANAM DO, 1984, INT J PSYCHOL, V19, P593, DOI 10.1080/00207598408247548; OYEFESO AO, 1992, J CHILD PSYCHOL PSYC, V33, P785, DOI 10.1111/j.1469-7610.1992.tb00914.x; Peterson SA, 1999, J BIOSOC SCI, V31, P93, DOI 10.1017/S0021932099000930; PICK S, 1995, ADOLESCENCE, V30, P667; *POP REF BUR, 1997, IMPR REPR HLTH DEV C; RESNICK MD, 1993, J PAEDIATR CHILD H, V29, pS3, DOI 10.1111/j.1440-1754.1993.tb02257.x; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Scales PC, 1997, CHILD WELFARE, V76, P611; VANCE PC, 1985, CHILDHOOD ED, V61, P272; *WHO, 2001, NIG COUNTR PROGR REP; Wold B, 1994, HLTH BEHAV SCH AGED	28	80	85	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					15	18B		10.1136/bmj.326.7379.15	http://dx.doi.org/10.1136/bmj.326.7379.15			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633UP	12511453	Green Submitted, Green Published, Bronze			2022-12-28	WOS:000180302000017
J	Ackert, RP				Ackert, RP			An ice sheet remembers	SCIENCE			English	Editorial Material							PLEISTOCENE-HOLOCENE RETREAT; ROSS-SEA; WEST ANTARCTICA; GLACIER; SYSTEM; PAST		Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	Woods Hole Oceanographic Institution	Ackert, RP (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.							Ackert RP, 1999, SCIENCE, V286, P276, DOI 10.1126/science.286.5438.276; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Domack EW, 1999, GEOL SOC AM BULL, V111, P1517, DOI 10.1130/0016-7606(1999)111<1517:LPHROT>2.3.CO;2; Licht KJ, 1996, GEOLOGY, V24, P223, DOI 10.1130/0091-7613(1996)024<0223:COLWIR>2.3.CO;2; Liu H., 2001, RADARSAT ANTARCTIC M; PARIZEK BR, 2002, GEOPHYS RES LETT, V29; RIGNOT E, IN PRESS ANN GLACIOL; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Shipp S, 1999, GEOL SOC AM BULL, V111, P1486, DOI 10.1130/0016-7606(1999)111<1486:LPHROT>2.3.CO;2; STEIG EJ, 1999, ANTARCT RES SER, V77, P75; Stone JO, 2003, SCIENCE, V299, P99, DOI 10.1126/science.1077998	12	2	2	3	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					57	58		10.1126/science.1079568	http://dx.doi.org/10.1126/science.1079568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511636				2022-12-28	WOS:000180165800027
J	Yantis, S				Yantis, S			To see is to attend	SCIENCE			English	Editorial Material							SELECTIVE VISUAL-ATTENTION; DIRECTED ATTENTION; PARIETAL CORTEX; MECHANISMS; SEARCH; MODEL; V4		Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA	Johns Hopkins University	Yantis, S (corresponding author), Johns Hopkins Univ, Dept Psychol & Brain Sci, Baltimore, MD 21218 USA.		Yantis, Steven/A-7488-2009					Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CORBETTA M, 1993, J NEUROSCI, V13, P1202; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOCH C, 1985, HUM NEUROBIOL, V4, P219; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MOTTER BC, 1994, J NEUROSCI, V14, P2190; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; OLSHAUSEN BA, 1993, J NEUROSCI, V13, P4700; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Vandenberghe R, 2001, NEUROIMAGE, V14, P661, DOI 10.1006/nimg.2001.0860; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601	25	8	10	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					54	56		10.1126/science.1080668	http://dx.doi.org/10.1126/science.1080668			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511634				2022-12-28	WOS:000180165800025
J	Cummins, P				Cummins, P			Access to health care in the Western Cape	LANCET			English	Article											Cummins, P (corresponding author), 15 Borough Lane, Saffron Walden CB11 2AS, Essex, England.							*DEP HLTH S AFR, 2001, ANN REP 2000 01; Health Systems Trust, S AFR HLTH REV; *PROV ADM W CAP, 2001, HLTH STAT REP HLTH S	3	10	12	0	3	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S49	S50		10.1016/S0140-6736(02)11820-4	http://dx.doi.org/10.1016/S0140-6736(02)11820-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504503				2022-12-28	WOS:000180064500024
J	Russell, P				Russell, P			Photonic crystal fibers	SCIENCE			English	Review							MICROSTRUCTURED OPTICAL FIBERS; ANOMALOUS-DISPERSION; CONTINUUM GENERATION; SILICA; GUIDANCE; LASER; AIR; PROPAGATION; PARTICLES; LIGHT		Univ Bath, Dept Phys, Bath BA2 7AY, Avon, England	University of Bath	Russell, P (corresponding author), Univ Bath, Dept Phys, Claverton Down, Bath BA2 7AY, Avon, England.	p.s.j.russell@bath.ac.uk	Russell, Philip St.J./G-5132-2012	Russell, Philip St.J./0000-0002-8972-2477				Allan DC, 2001, NATO SCI SER II-MATH, V563, P305; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Benabid F, 2002, SCIENCE, V298, P399, DOI 10.1126/science.1076408; Benabid F, 2002, OPT EXPRESS, V10, P1195, DOI 10.1364/OE.10.001195; Birks TA, 1997, OPT LETT, V22, P961, DOI 10.1364/OL.22.000961; BIRKS TA, 1995, ELECTRON LETT, V31, P1941, DOI 10.1049/el:19951306; Birks TA, 2001, IEICE T ELECTRON, VE84C, P585; BOWDEN CM, 1993, J OPT SOC AM B, V10, P279; Brabec T, 2000, REV MOD PHYS, V72, P545, DOI 10.1103/RevModPhys.72.545; Brechet F, 2000, ELECTRON LETT, V36, P514, DOI 10.1049/el:20000418; Cregan RF, 1999, SCIENCE, V285, P1537, DOI 10.1126/science.285.5433.1537; FARR L, 2002, P 28 EUR C OPT COMM; Ferrando A, 1999, OPT LETT, V24, P276, DOI 10.1364/OL.24.000276; Hartl I, 2001, OPT LETT, V26, P608, DOI 10.1364/OL.26.000608; Johnson SG, 2001, OPT EXPRESS, V9, P748, DOI 10.1364/OE.9.000748; KAISER P, 1974, AT&T TECH J, V53, P1021, DOI 10.1002/j.1538-7305.1974.tb02780.x; Kiang KM, 2002, ELECTRON LETT, V38, P546, DOI 10.1049/el:20020421; Knight JC, 2000, IEEE PHOTONIC TECH L, V12, P807, DOI 10.1109/68.853507; Knight JC, 1998, SCIENCE, V282, P1476, DOI 10.1126/science.282.5393.1476; Knight JC, 1999, OPT MATER, V11, P143, DOI 10.1016/S0925-3467(98)00040-8; Knight JC, 1998, ELECTRON LETT, V34, P1347, DOI 10.1049/el:19980965; Knight JC, 1997, OPT LETT, V22, P484, DOI 10.1364/OL.22.000484; KNIGHT JC, 2001, OPTICS NANOSTRUCTURE, P39; MacPherson WN, 2001, OPT COMMUN, V193, P97, DOI 10.1016/S0030-4018(01)01260-3; Mangan BJ, 2001, OPT LETT, V26, P1469, DOI 10.1364/OL.26.001469; Mogilevtsev D, 1999, J LIGHTWAVE TECHNOL, V17, P2078, DOI 10.1109/50.802997; Monro TM, 2001, MEAS SCI TECHNOL, V12, P854, DOI 10.1088/0957-0233/12/7/318; Ortigosa-Blanch A, 2000, OPT LETT, V25, P1325, DOI 10.1364/OL.25.001325; Price JHV, 2002, J OPT SOC AM B, V19, P1286, DOI 10.1364/JOSAB.19.001286; Ranka JK, 2000, OPT LETT, V25, P25, DOI 10.1364/OL.25.000025; Reeves WH, 2002, OPT EXPRESS, V10, P609, DOI 10.1364/OE.10.000609; Renn MJ, 1999, PHYS REV LETT, V82, P1574, DOI 10.1103/PhysRevLett.82.1574; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; RUSSELL PF, COMMUNICATION; SMITHGALL DH, 1986, IEEE J LIGHTWAVE TEC, V4, P1360; Sorensen T, 2001, ELECTRON LETT, V37, P287, DOI 10.1049/el:20010227; Steel MJ, 2001, OPT LETT, V26, P488, DOI 10.1364/OL.26.000488; TONUCCI RJ, 1992, SCIENCE, V258, P783, DOI 10.1126/science.258.5083.783; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; van Eijkelenborg MA, 2001, OPT EXPRESS, V9, P319, DOI 10.1364/OE.9.000319; Venkataraman N., 2002, P 28 EUR C OPT COMM; Wadsworth WJ, 2000, ELECTRON LETT, V36, P1452, DOI 10.1049/el:20000942; WADSWORTH WJ, IN PRESS J OPT SOC B; YEH P, 1976, OPT COMMUN, V19, P427, DOI 10.1016/0030-4018(76)90115-2	45	2870	3007	43	1104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					358	362		10.1126/science.1079280	http://dx.doi.org/10.1126/science.1079280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532007				2022-12-28	WOS:000180426800034
J	Palazzo, A; Ackerman, B; Gundersen, GG				Palazzo, A; Ackerman, B; Gundersen, GG			Cell biology - Tubulin acetylation and cell motility	NATURE			English	Article							INTERMEDIATE FILAMENTS; ALPHA-TUBULIN; MICROTUBULES; DETYROSINATION; STABILIZATION; KINESIN		Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA	Columbia University; Columbia University	Palazzo, A (corresponding author), Columbia Univ, Dept Anat & Cell Biol, New York, NY 10032 USA.		Palazzo, Alexander/B-1270-2013	Palazzo, Alexander/0000-0002-9700-1995				BULINSKI JC, 1991, BIOESSAYS, V13, P285, DOI 10.1002/bies.950130605; Cook TA, 1998, J CELL BIOL, V141, P175, DOI 10.1083/jcb.141.1.175; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Infante AS, 2000, J CELL SCI, V113, P3907; KHAWAJA S, 1988, J CELL BIOL, V106, P141, DOI 10.1083/jcb.106.1.141; Kreitzer G, 1999, MOL BIOL CELL, V10, P1105, DOI 10.1091/mbc.10.4.1105; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Lin SX, 2002, MOL BIOL CELL, V13, P96, DOI 10.1091/mbc.01-05-0224; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; WEBSTER DR, 1989, J CELL SCI, V92, P57; WEBSTER DR, 1990, J CELL BIOL, V111, P113, DOI 10.1083/jcb.111.1.113; WEBSTER DR, 1990, J CELL BIOL, V111, P1325	14	193	202	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					230	230		10.1038/421230a	http://dx.doi.org/10.1038/421230a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529632				2022-12-28	WOS:000180397600035
J	Levy, JA				Levy, JA			Is HIV superinfection worrisome?	LANCET			English	Editorial Material							HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; AIDS PATIENT; INFECTION; INDIVIDUALS; COINFECTION; TYPE-1; WOMEN		Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Levy, JA (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							Bale JF, 1996, J PEDIATR-US, V128, P347, DOI 10.1016/S0022-3476(96)70279-2; Barker E, 1996, J GEN VIROL, V77, P2953, DOI 10.1099/0022-1317-77-12-2953; Blackard JT, 2002, CLIN INFECT DIS, V34, P1108, DOI 10.1086/339547; EVANS LA, 1988, LANCET, V2, P1389; FULTZ PN, 1987, J VIROL, V61, P4026, DOI 10.1128/JVI.61.12.4026-4029.1987; Goulder PJR, 2002, NEW ENGL J MED, V347, P756, DOI 10.1056/NEJMe020091; Jost S, 2002, NEW ENGL J MED, V347, P731, DOI 10.1056/NEJMoa020263; Kampinga GA, 1997, VIROLOGY, V227, P63, DOI 10.1006/viro.1996.8318; Levy JA, 2001, LANCET, V357, P223, DOI 10.1016/S0140-6736(00)03601-1; Levy JA, 1998, HIV PATHOGENESIS AID; Markowitz M, 1999, J INFECT DIS, V179, P527, DOI 10.1086/314628; Palefsky JM, 2001, J INFECT DIS, V183, P383, DOI 10.1086/318071; Ramos A, 2002, J VIROL, V76, P7444, DOI 10.1128/JVI.76.15.7444-7452.2002; RAYFIELD M, 1988, J INFECT DIS, V158, P1170, DOI 10.1093/infdis/158.6.1170; Srivastava G, 2000, BLOOD, V95, P2443, DOI 10.1182/blood.V95.7.2443.007k18_2443_2445; Stranford SA, 2001, P NATL ACAD SCI USA, V98, P597, DOI 10.1073/pnas.021550598; Takehisa J, 1997, J ACQ IMMUN DEF SYND, V14, P81, DOI 10.1097/00042560-199701010-00015; 2002, REUTERS         0904	18	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					98	99		10.1016/S0140-6736(03)12242-8	http://dx.doi.org/10.1016/S0140-6736(03)12242-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531573				2022-12-28	WOS:000180428000005
J	Freiman, RN; Tjian, R				Freiman, RN; Tjian, R			Regulating the regulators: Lysine modifications make their mark	CELL			English	Review							TRANSCRIPTION FACTOR SP3; RNA-POLYMERASE-II; SUMO-1 MODIFICATION; GENE-EXPRESSION; DNA-DAMAGE; ACETYLATION; ACTIVATION; UBIQUITIN; RECRUITMENT; PROTEOLYSIS	Decades of research have uncovered much of the molecular machinery responsible for establishing and maintaining proper gene transcription patterns in eukaryotes. Although the composition of this machinery is largely known, mechanisms regulating its activity by covalent modification are just coming into focus. Here, we review several cases of ubiquitination, sumoylation, and acetylation that link specific covalent modification of the transcriptional apparatus to their regulatory function. We propose that potential cascades of modifications serve as molecular rheostats that fine-tune the control of transcription in diverse organisms.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.							Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Best JL, 2002, MOL CELL, V10, P843, DOI 10.1016/S1097-2765(02)00699-8; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Bhaskar V, 2002, MOL CELL BIOL, V22, P492, DOI 10.1128/MCB.22.2.492-504.2002; Braun H, 2001, NUCLEIC ACIDS RES, V29, P4994, DOI 10.1093/nar/29.24.4994; Brivanlou AH, 2002, SCIENCE, V295, P813, DOI 10.1126/science.1066355; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Ferdous A, 2001, MOL CELL, V7, P981, DOI 10.1016/S1097-2765(01)00250-7; Gonzalez F, 2002, SCIENCE, V296, P548, DOI 10.1126/science.1069490; Gronroos E, 2002, MOL CELL, V10, P483, DOI 10.1016/S1097-2765(02)00639-1; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2; Kim KI, 2002, J CELL PHYSIOL, V191, P257, DOI 10.1002/jcp.10100; Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Molinari E, 1999, EMBO J, V18, P6439, DOI 10.1093/emboj/18.22.6439; Munshi N, 2001, SCIENCE, V293, P1133, DOI 10.1126/science.293.5532.1133; Pham AD, 2000, SCIENCE, V289, P2357, DOI 10.1126/science.289.5488.2357; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rouillon A, 2000, EMBO J, V19, P282, DOI 10.1093/emboj/19.2.282; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sapetschnig A, 2002, EMBO J, V21, P5206, DOI 10.1093/emboj/cdf510; Woudstra EC, 2002, NATURE, V415, P929, DOI 10.1038/415929a; Xu W, 2001, SCIENCE, V294, P2507, DOI 10.1126/science.1065961	33	190	194	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					11	17		10.1016/S0092-8674(02)01278-3	http://dx.doi.org/10.1016/S0092-8674(02)01278-3			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526789	Bronze			2022-12-28	WOS:000181191500002
J	Shimaoka, M; Xiao, T; Liu, JH; Yang, YT; Dong, YC; Jun, CD; McCormack, A; Zhang, RG; Joachimiak, A; Takagi, J; Wang, JH; Springer, TA				Shimaoka, M; Xiao, T; Liu, JH; Yang, YT; Dong, YC; Jun, CD; McCormack, A; Zhang, RG; Joachimiak, A; Takagi, J; Wang, JH; Springer, TA			Structures of the alpha L I domain and its complex with ICAM-1 reveal a shape-shifting pathway for integrin regulation	CELL			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; FUNCTION-ASSOCIATED ANTIGEN-1; CRYSTAL-STRUCTURE; LIGAND-BINDING; A-DOMAIN; CONFORMATIONAL-CHANGES; MONOCLONAL-ANTIBODY; INSERTED DOMAIN; T-CELLS; LFA-1	The structure of the I domain of integrin alphaLbeta2 bound to the Ig superfamily ligand ICAM-1 reveals the open ligand binding conformation and the first example of an integrin-IgSF interface. The I domain Mg2+ directly coordinates Glu-34 of ICAM-1, and a dramatic swing of I domain residue Glu-241 enables a critical salt bridge. Liganded and unliganded structures for both high- and intermediate-affinity mutant I domains reveal that ligand binding can induce conformational change in the alphaL I domain and that allosteric signals can convert the closed conformation to intermediate or open conformations without ligand binding. Pulling down on the C-terminal alpha7 helix with introduced disulfide bonds ratchets the beta6-alpha7 loop into three different positions in the closed, intermediate, and open conformations, with a progressive increase in affinity.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Anesthesia, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Mol Pharmacol, Boston, MA 02115 USA; Argonne Natl Lab, Biosci Div, Argonne, IL 60439 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory	Wang, JH (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	jwang@red.dfci.harvard.edu; springer@cbr.med.harvard.edu	Xiao, Tsan Sam/A-8590-2010; Xiao, Tsan/I-7616-2013	Xiao, Tsan Sam/0000-0001-9688-475X; Xiao, Tsan/0000-0001-9688-475X	NCI NIH HHS [CA31798, R37 CA031798, R01 CA031798] Funding Source: Medline; NHLBI NIH HHS [P01 HL048675, HL48675] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA031798, R37CA031798] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL048675] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alonso JL, 2002, CURR BIOL, V12, pR340, DOI 10.1016/S0960-9822(02)00852-7; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casasnovas JM, 1997, NATURE, V387, P312, DOI 10.1038/387312a0; Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134; Chigaev A, 2001, J BIOL CHEM, V276, P48670, DOI 10.1074/jbc.M103194200; Constantin G, 2000, IMMUNITY, V13, P759, DOI 10.1016/S1074-7613(00)00074-1; DIAMOND MS, 1993, J CELL BIOL, V120, P545, DOI 10.1083/jcb.120.2.545; DUSTIN ML, 1992, J IMMUNOL, V148, P2654; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; DUSTIN ML, 1999, GUIDEBOOK EXTRACELLU; Edwards CP, 1998, J BIOL CHEM, V273, P28937, DOI 10.1074/jbc.273.44.28937; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fisher KL, 1997, MOL BIOL CELL, V8, P501, DOI 10.1091/mbc.8.3.501; Gahmberg CG, 1997, EUR J BIOCHEM, V245, P215, DOI 10.1111/j.1432-1033.1997.00215.x; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giblin PA, 2001, ANNU REP MED CHEM, V36, P181, DOI 10.1016/S0065-7743(01)36058-X; Gottlieb A, 2000, J AM ACAD DERMATOL, V42, P428, DOI 10.1016/S0190-9622(00)90214-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; Huth JR, 2000, P NATL ACAD SCI USA, V97, P5231, DOI 10.1073/pnas.97.10.5231; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; KAMATA T, 1995, J BIOL CHEM, V270, P12531, DOI 10.1074/jbc.270.21.12531; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LARSON RS, 1990, IMMUNOL REV, V114, P181, DOI 10.1111/j.1600-065X.1990.tb00565.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Legge GB, 2000, J MOL BIOL, V295, P1251, DOI 10.1006/jmbi.1999.3409; Li R, 2002, J IMMUNOL, V168, P1219, DOI 10.4049/jimmunol.168.3.1219; Lo Conte L, 1999, J MOL BIOL, V285, P2177; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Lupher ML, 2001, J IMMUNOL, V167, P1431, DOI 10.4049/jimmunol.167.3.1431; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; QU AD, 1995, P NATL ACAD SCI USA, V92, P10277, DOI 10.1073/pnas.92.22.10277; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; STAUNTON DE, 1990, CELL, V61, P243, DOI 10.1016/0092-8674(90)90805-O; Stewart MP, 1996, J IMMUNOL, V156, P1810; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; VANSEVENTER GA, 1990, J IMMUNOL, V144, P4579; Wang JH, 1998, IMMUNOL REV, V163, P197, DOI 10.1111/j.1600-065X.1998.tb01198.x	58	406	428	2	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					99	111		10.1016/S0092-8674(02)01257-6	http://dx.doi.org/10.1016/S0092-8674(02)01257-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526797	Green Accepted, Bronze			2022-12-28	WOS:000181191500010
J	Tuomisto, H; Ruokolainen, K; Yli-Halla, M				Tuomisto, H; Ruokolainen, K; Yli-Halla, M			Dispersal, environment, and floristic variation of western Amazonian forests	SCIENCE			English	Article							RAIN-FOREST; PATTERNS; BASIN; DIVERSITY; ECOLOGY; HISTORY	The distribution of plant species, the species compositions of different sites, and the factors that affect them in tropical rain forests are not well understood. The main hypotheses are that species composition is either (i) uniform over large areas, (ii) random but spatially autocorrelated because of dispersal limitation, or (iii) patchy and environmentally determined. Here we test these hypotheses, using a large data set from western Amazonia. The uniformity hypothesis gains no support, but the other hypotheses do. Environmental determinism explains a larger proportion of the variation in floristic differences between sites than does dispersal limitation; together, these processes explain 70 to 75% of the variation. Consequently, it is important that management planning for conservation and resource use take into account both habitat heterogeneity and biogeographic differences.	Univ Turku, Dept Biol, FIN-20014 Turku, Finland; MTT Agrifood Res Finland, FIN-31600 Jokioinen, Finland	University of Turku; Natural Resources Institute Finland (Luke)	Tuomisto, H (corresponding author), Univ Turku, Dept Biol, FIN-20014 Turku, Finland.	hantuo@utu.fi	Yli-Halla, Markku/B-5567-2015; Ruokolainen, Kalle/G-3141-2013; Tuomisto, Hanna/G-6483-2012	Ruokolainen, Kalle/0000-0002-7494-9417; Tuomisto, Hanna/0000-0003-1640-490X				BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Botschek J, 1996, GEODERMA, V72, P119, DOI 10.1016/0016-7061(96)00026-2; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Condit R, 1996, TRENDS ECOL EVOL, V11, P4, DOI 10.1016/0169-5347(96)81054-8; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; DUIVENVOORDEN JF, 1995, VEGETATIO, V120, P91, DOI 10.1007/BF00034341; GENTRY AH, 1988, ANN MO BOT GARD, V75, P1, DOI 10.2307/2399464; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; Hubbell S.P., 1986, COMMUNITY ECOLOGY, P314; Hubbell Stephen P., 2001, V32, pi; HURTT GC, 1995, J THEOR BIOL, V176, P1, DOI 10.1006/jtbi.1995.0170; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 1999, ECOLOGY, V80, P2651, DOI 10.1890/0012-9658(1999)080[2651:TSDIAU]2.0.CO;2; RASANEN M, 1992, GEOL MAG, V129, P293, DOI 10.1017/S0016756800019233; RASANEN ME, 1995, SCIENCE, V269, P386, DOI 10.1126/science.269.5222.386; RASANEN ME, 1987, SCIENCE, V238, P1398, DOI 10.1126/science.238.4832.1398; Ruokolainen K, 1997, J TROP ECOL, V13, P243, DOI 10.1017/S0266467400010439; Ruokolainen K, 2002, SCIENCE, V297; SANCHEZ PA, 1974, SOIL SCI SOC AM J, V38, P117, DOI 10.2136/sssaj1974.03615995003800010036x; Terborgh J, 1998, J TROP ECOL, V14, P645, DOI 10.1017/S0266467498000455; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tuomisto H, 1996, J BIOGEOGR, V23, P283, DOI 10.1046/j.1365-2699.1996.00044.x; TUOMISTO H, 1995, SCIENCE, V269, P63, DOI 10.1126/science.269.5220.63; TUOMISTO H, IN PRESS ECOL APPL; Vormisto J, 2000, ECOGRAPHY, V23, P349, DOI 10.1034/j.1600-0587.2000.d01-1644.x; Whitfield J, 2002, NATURE, V417, P480, DOI 10.1038/417480a; WHITTAKER RH, 1977, THEOR POPUL BIOL, V12, P117, DOI 10.1016/0040-5809(77)90039-9	29	724	783	10	198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					241	244		10.1126/science.1078037	http://dx.doi.org/10.1126/science.1078037			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522248				2022-12-28	WOS:000180284000036
J	Ingelfinger, JR				Ingelfinger, JR			Perspective: Is microanatomy destiny.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BLOOD-PRESSURE											BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335	2	44	44	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					99	100		10.1056/NEJMp020168	http://dx.doi.org/10.1056/NEJMp020168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519919				2022-12-28	WOS:000180263900001
J	Stone, JO; Balco, GA; Sugden, DE; Caffee, MW; Sass, LC; Cowdery, SG; Siddoway, C				Stone, JO; Balco, GA; Sugden, DE; Caffee, MW; Sass, LC; Cowdery, SG; Siddoway, C			Holocene deglaciation of Marie Byrd Land, West Antarctica	SCIENCE			English	Article							LAST GLACIAL MAXIMUM; SEA-LEVEL CHANGE; ICE-SHEET; PAST; EARTH	Surface exposure ages of glacial deposits in the Ford Ranges of western Marie Byrd Land indicate continuous thinning of the West Antarctic Ice Sheet by more than 700 meters near the coast throughout the past 10,000 years. Deglaciation lagged the disappearance of ice sheets in the Northern Hemisphere by thousands of years and may still be under way. These results provide further evidence that parts of the West Antarctic Ice Sheet are on a long-term trajectory of decline. West Antarctic melting contributed water to the oceans in the late Holocene and may continue to do so in the future.	Univ Washington, Quaternary Res Ctr, Seattle, WA 98195 USA; Univ Washington, Dept Earth & Space Sci, Seattle, WA 98195 USA; Univ Edinburgh, Dept Geog, Edinburgh EH8 9XP, Midlothian, Scotland; L397 Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; Colorado Coll, Dept Geol, Colorado Springs, CO 80903 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Edinburgh; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Colorado College	Stone, JO (corresponding author), Univ Washington, Quaternary Res Ctr, Box 351360, Seattle, WA 98195 USA.			Cowdery, Seth/0000-0002-7068-6998; Sass, Louis/0000-0003-4677-029X; Siddoway, Christine Smith/0000-0003-0478-6138				Ackert RP, 1999, SCIENCE, V286, P276, DOI 10.1126/science.286.5438.276; ALLEY RB, 1984, J GEOPHYS RES-OCEANS, V89, P6487, DOI 10.1029/JC089iC04p06487; Alley RB, 2001, ANTARCT RES SER, V77; Anderson JB, 2002, QUATERNARY SCI REV, V21, P49, DOI 10.1016/S0277-3791(01)00083-X; Bindschadler R, 1998, SCIENCE, V279, P689, DOI 10.1126/science.279.5351.689; BORNS HW, 2001, ANTARCT RES SER, V77, P59; Church JA, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P639; Clark PU, 2002, SCIENCE, V295, P2438; Clark PU, 1996, PALEOCEANOGRAPHY, V11, P563, DOI 10.1029/96PA01419; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Denton GH, 2002, QUATERNARY SCI REV, V21, P193, DOI 10.1016/S0277-3791(01)00090-7; FAHENSTOCK MA, 2000, J GLACIOL, V46, P155; Fleming K, 1998, EARTH PLANET SC LETT, V163, P327, DOI 10.1016/S0012-821X(98)00198-8; Goodwin ID, 1998, QUATERNARY SCI REV, V17, P319, DOI 10.1016/S0277-3791(97)00051-6; Hughes TJ, 1981, LAST GREAT ICE SHEET, P263; HULTON NRJ, UNPUB; Ingolfsson O, 1998, ANTARCT SCI, V10, P326, DOI 10.1017/S095410209800039X; JOHNSTON P, 1993, GEOPHYS J INT, V114, P615, DOI 10.1111/j.1365-246X.1993.tb06992.x; Joughin I, 2002, SCIENCE, V295, P476, DOI 10.1126/science.1066875; Liu H., 2001, RADARSAT ANTARCTIC M; MERCER JH, 1978, NATURE, V271, P321, DOI 10.1038/271321a0; Milne GA, 1996, GEOPHYS J INT, V126, pF13, DOI 10.1111/j.1365-246X.1996.tb04691.x; NAKADA M, 1988, NATURE, V333, P36, DOI 10.1038/333036a0; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Peltier WR, 1998, REV GEOPHYS, V36, P603, DOI 10.1029/98RG02638; Rignot EJ, 1998, SCIENCE, V281, P549, DOI 10.1126/science.281.5376.549; Scherer RP, 1998, SCIENCE, V281, P82, DOI 10.1126/science.281.5373.82; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Steig EJ, 1997, ANN GLACIOL, V25, P418, DOI 10.3189/S0260305500014385; STEIG EJ, 2001, ANTARCT RES SER, V77, P75, DOI DOI 10.1029/AR077; Wellner JS, 2001, J GLACIOL, V47, P397, DOI 10.3189/172756501781832043; Wilch TI, 1999, GEOL SOC AM BULL, V111, P1563, DOI 10.1130/0016-7606(1999)111<1563:LQVAIM>2.3.CO;2; Yokoyama Y, 2000, NATURE, V406, P713, DOI 10.1038/35021035	33	179	183	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					99	102		10.1126/science.1077998	http://dx.doi.org/10.1126/science.1077998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511648	Green Submitted			2022-12-28	WOS:000180165800041
J	Taylor, MS; Hellberg, ME				Taylor, MS; Hellberg, ME			Genetic evidence for local retention of pelagic larvae in a Caribbean reef fish	SCIENCE			English	Article							SEXUAL SELECTION; POPULATION; CONNECTIVITY; RECRUITMENT; VARIANCE	The pelagic larvae of many marine organisms can potentially disperse across hundreds of kilometers, but whether oceanographic or behavioral mechanisms can constrain dispersal over periods sufficient for the evolution of genetic differentiation remains unclear. Here, we concurrently examine larval duration and genetic population differentiation in a cleaner goby, Elacatinus evelynae, a member of the most species-rich genus of Caribbean reef fishes. Despite evidence for extended pelagic duration (21 days), populations of E. evelynae show strong genetic differentiation: among color forms (1.36 to 3.04% divergent at mitochondrial cytochrome b) and among island populations within color forms (Phi(ST) up to 70%). These results suggest that marine populations can remain demographically closed for thousands of generations despite extended larval duration, and that recognition cues such as color may promote speciation when geographic barriers are transient or weak.	Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Taylor, MS (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.		Gilbert, Marcus TP/A-8936-2013; 平山, 幸恵 Ｓ/G-9307-2012	Gilbert, Marcus TP/0000-0002-5805-7195; 				Barber PH, 2000, NATURE, V406, P692, DOI 10.1038/35021135; BOHLKE JE, 1968, P ACAD NAT SCI PHILA, V120, P45; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; BURTON RS, 1982, ESTUARINE COMP, P537, DOI DOI 10.1016/B978-0-12-404070-0.50038-7; Colin P., 1975, COLIN; Cowen RK, 2000, SCIENCE, V287, P857, DOI 10.1126/science.287.5454.857; EXCOFFIER L, 1992, GENETICS, V131, P479; Flowers JM, 2002, EVOLUTION, V56, P1445, DOI 10.1111/j.0014-3820.2002.tb01456.x; Jones GP, 1999, NATURE, V402, P802, DOI 10.1038/45538; Leis J.M., 1991, P183; Lessios HA, 2001, EVOLUTION, V55, P955, DOI 10.1554/0014-3820(2001)055[0955:PSASIT]2.0.CO;2; Li G, 1998, CAN J FISH AQUAT SCI, V55, P1025, DOI 10.1139/cjfas-55-4-1025; Nelson JS., 2016, FISHES WORLD, DOI DOI 10.1002/9781119174844.FMATTER; Palumbi SR, 2001, EVOLUTION, V55, P859, DOI 10.1554/0014-3820(2001)055[0859:PNGCFM]2.0.CO;2; Palumbi SR, 1998, ENDLESS FORMS, P271; Riginos C, 2001, P ROY SOC B-BIOL SCI, V268, P1931, DOI 10.1098/rspb.2001.1748; Roberts CM, 1997, SCIENCE, V278, P1454, DOI 10.1126/science.278.5342.1454; Rocha LA, 2002, MOL ECOL, V11, P243, DOI 10.1046/j.0962-1083.2001.01431.x; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; SHULMAN MJ, 1995, EVOLUTION, V49, P897, DOI 10.1111/j.1558-5646.1995.tb02325.x; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Swearer SE, 1999, NATURE, V402, P799, DOI 10.1038/45533; Warner RR, 1997, CORAL REEFS, V16, pS115, DOI 10.1007/s003380050247	23	433	441	0	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					107	109		10.1126/science.1079365	http://dx.doi.org/10.1126/science.1079365			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511651				2022-12-28	WOS:000180165800044
J	Lellouch, E; Paubert, G; Moses, JI; Schneider, NM; Strobel, DF				Lellouch, E; Paubert, G; Moses, JI; Schneider, NM; Strobel, DF			Volcanically emitted sodium chloride as a source for Io's neutral clouds and plasma torus	NATURE			English	Article							ATMOSPHERE; POTASSIUM; IONS	The atmosphere of Jupiter's satellite Io is extremely tenuous, time variable and spatially heterogeneous. Only a few molecules-SO2, SO and S-2-have previously been identified as constituents of this atmosphere, and possible sources(1-4) include frost sublimation, surface sputtering and active volcanism. Io has been known(5,6) for almost 30 years to be surrounded by a cloud of Na, which requires an as yet unidentified atmospheric source of sodium. Sodium chloride has been recently proposed as an important atmospheric constituent, based on the detection of chlorine in Io's plasma torus(7,8) and models of Io's volcanic gases(9). Here we report the detection of NaCl in Io's atmosphere; it constitutes only similar to0.3% when averaged over the entire disk, but is probably restricted to smaller regions than SO2 because of its rapid photolysis and surface condensation(10). Although the inferred abundance of NaCl in volcanic gases is lower than predicted(9), those volcanic emissions provide an important source of Na and Cl in Io's neutral clouds and plasma torus.	Observ Paris, F-92195 Meudon, France; Inst Radioastron Millimetr, E-18012 Granada, Spain; Lunar & Planetary Inst, Houston, TX 77058 USA; Univ Colorado, LASP, Boulder, CO 80309 USA; Johns Hopkins Univ, Baltimore, MD 21218 USA	UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; University of Colorado System; University of Colorado Boulder; Johns Hopkins University	Lellouch, E (corresponding author), Observ Paris, F-92195 Meudon, France.	emmanuel.lellouch@obspm.fr	Strobel, Darrell5/AAO-6643-2021; Moses, Julianne/I-2151-2013	Strobel, Darrell5/0000-0002-0944-8675; Moses, Julianne/0000-0002-8837-0035; SCHNEIDER, NICHOLAS/0000-0001-6720-5519				ALTENHOFF WJ, 1988, ASTRON ASTROPHYS, V190, pL15; BAGENAL F, 1981, J GEOPHYS RES-SPACE, V86, P8447, DOI 10.1029/JA086iA10p08447; Brown ME, 2001, ICARUS, V151, P190, DOI 10.1006/icar.2001.6612; BROWN RA, 1974, EXPLORATION SOLAR SY, P531; EWING CT, 1974, J PHYS CHEM-US, V78, P1998, DOI 10.1021/j100613a005; Fegley B, 2000, ICARUS, V148, P193, DOI 10.1006/icar.2000.6490; Feldman PD, 2001, ASTROPHYS J, V554, pL123, DOI 10.1086/320920; INGERSOLL AP, 1985, ICARUS, V64, P375, DOI 10.1016/0019-1035(85)90062-4; JOHNSON RE, 1994, ICARUS, V111, P65, DOI 10.1006/icar.1994.1133; Kuppers M, 2000, GEOPHYS RES LETT, V27, P513, DOI 10.1029/1999GL010718; Kuskov OL, 2001, ICARUS, V151, P204, DOI 10.1006/icar.2001.6611; LANZEROTTI LJ, 1982, ASTROPHYS J, V259, P920, DOI 10.1086/160225; LELLOUCH E, 1992, ICARUS, V98, P271, DOI 10.1016/0019-1035(92)90095-O; Lellouch E, 1996, ASTROPHYS J, V459, pL107, DOI 10.1086/309956; Lellouch E, 1996, ICARUS, V124, P1, DOI 10.1006/icar.1996.0186; McGrath MA, 2000, ICARUS, V146, P476, DOI 10.1006/icar.2000.6412; Moses JI, 2002, ICARUS, V156, P107, DOI 10.1006/icar.2001.6759; Moses JI, 2002, ICARUS, V156, P76, DOI 10.1006/icar.2001.6758; Pickett HM, 1998, J QUANT SPECTROSC RA, V60, P883, DOI 10.1016/S0022-4073(98)00091-0; SCHNEIDER NM, 1991, SCIENCE, V253, P1394, DOI 10.1126/science.253.5026.1394; SCHNEIDER NM, 2000, B ANN ASTRON SOC, V32; Spencer JR, 1996, ANNU REV EARTH PL SC, V24, P125, DOI 10.1146/annurev.earth.24.1.125; Spencer JR, 2000, SCIENCE, V288, P1208, DOI 10.1126/science.288.5469.1208; Strobel DF, 2001, ASTROPHYS SPACE SCI, V277, P271, DOI 10.1023/A:1012261209678; Summers ME, 1996, ICARUS, V120, P290, DOI 10.1006/icar.1996.0051; THOMAS N, 1992, SURV GEOPHYS, V13, P91, DOI 10.1007/BF01903525; TRAFTON L, 1974, ASTROPHYS J, V190, pL85, DOI 10.1086/181512; WILSON JK, 1994, ICARUS, V111, P31, DOI 10.1006/icar.1994.1131	28	70	70	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					45	47		10.1038/nature01292	http://dx.doi.org/10.1038/nature01292			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511948				2022-12-28	WOS:000180165500031
J	Tinetti, ME				Tinetti, ME			Preventing falls in elderly persons.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED CONTROLLED TRIAL; ADVERSE DRUG EVENTS; NURSING-HOME RESIDENTS; DWELLING OLDER PERSONS; RISK-FACTORS; EXERCISE PROGRAM; ENVIRONMENTAL HAZARDS; HOSPITAL DISCHARGE; COMMUNITY; PEOPLE		Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University	Tinetti, ME (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.							Adams M E, 1993, Int J Technol Assess Health Care, V9, P97; Buchner DM, 1997, J GERONTOL A-BIOL, V52, pM218, DOI 10.1093/gerona/52A.4.M218; Campbell AJ, 1999, J AM GERIATR SOC, V47, P850, DOI 10.1111/j.1532-5415.1999.tb03843.x; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; CARPENTER GI, 1990, BMJ-BRIT MED J, V300, P1253, DOI 10.1136/bmj.300.6734.1253; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Coleman EA, 1999, J AM GERIATR SOC, V47, P775, DOI 10.1111/j.1532-5415.1999.tb03832.x; Cumming RG, 1999, J AM GERIATR SOC, V47, P1397, DOI 10.1111/j.1532-5415.1999.tb01556.x; Ebrahim S, 1997, AGE AGEING, V26, P253, DOI 10.1093/ageing/26.4.253; FABACHER D, 1994, J AM GERIATR SOC, V42, P630, DOI 10.1111/j.1532-5415.1994.tb06862.x; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Gallagher EM, 1996, CAN J AGING, V15, P84, DOI 10.1017/S0714980800013301; GILLESPIE LD, 2001, COCHRANE DB SYST REV, V3; Gray SL, 1999, ANN PHARMACOTHER, V33, P1147, DOI 10.1345/aph.19036; Hanlon JT, 1997, J AM GERIATR SOC, V45, P945, DOI 10.1111/j.1532-5415.1997.tb02964.x; HORNBROOK MC, 1994, GERONTOLOGIST, V34, P16, DOI 10.1093/geront/34.1.16; Jitapunkul Sutthichai, 1998, Journal of the Medical Association of Thailand, V81, P352; KOSOROK MR, 1992, AM J PUBLIC HEALTH, V82, P1263, DOI 10.2105/AJPH.82.9.1263; Leipzig RM, 1999, J AM GERIATR SOC, V47, P40, DOI 10.1111/j.1532-5415.1999.tb01899.x; Leipzig RM, 1999, J AM GERIATR SOC, V47, P30, DOI 10.1111/j.1532-5415.1999.tb01898.x; LORD SR, 1995, J AM GERIATR SOC, V43, P1198, DOI 10.1111/j.1532-5415.1995.tb07394.x; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Luukinen H, 1999, ARCH INTERN MED, V159, P273, DOI 10.1001/archinte.159.3.273; MacRae PG, 1994, J AGING PHYS ACTIV, V2, P127, DOI DOI 10.1123/JAPA.2.2.127; MAHONEY J, 1994, J AM GERIATR SOC, V42, P269, DOI 10.1111/j.1532-5415.1994.tb01750.x; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; MCINTOSH S, 1993, AGE AGEING, V22, P53, DOI 10.1093/ageing/22.1.53; McMurdo MET, 1997, BRIT MED J, V314, P569, DOI 10.1136/bmj.314.7080.569; Means KM, 1996, ARCH PHYS MED REHAB, V77, P1030, DOI 10.1016/S0003-9993(96)90064-7; Muir AJ, 2001, J GEN INTERN MED, V16, P77, DOI 10.1046/j.1525-1497.2001.016002077.x; *NAT OST FDN, 2002, OST CLIN PRACT GUID; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; NEVITT MC, 1991, J GERONTOL, V46, P164; PARKER MJ, 2001, COCHRANE DB SYST REV, V2, P1255; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; *PREV SERV TASK FO, 1996, GUID CLIN PREV SERV, P659; REINSCH S, 1992, GERONTOLOGIST, V32, P450, DOI 10.1093/geront/32.4.450; Robertson MC, 2001, BRIT MED J, V322, P697, DOI 10.1136/bmj.322.7288.697; Runge J W, 1993, Emerg Med Clin North Am, V11, P241; SATTIN RW, 1992, ANNU REV PUBL HEALTH, V13, P489, DOI 10.1146/annurev.pu.13.050192.002421; Shannon JR, 2002, AM J MED, V112, P355, DOI 10.1016/S0002-9343(02)01025-2; Steinberg M, 2000, J EPIDEMIOL COMMUN H, V54, P227, DOI 10.1136/jech.54.3.227; Stevens M, 2001, J AM GERIATR SOC, V49, P1442, DOI 10.1046/j.1532-5415.2001.4911235.x; Thapa PB, 1998, NEW ENGL J MED, V339, P875, DOI 10.1056/NEJM199809243391303; Tilvis RS, 1996, J AM GERIATR SOC, V44, P809, DOI 10.1111/j.1532-5415.1996.tb03738.x; Tinetti ME, 1998, J GERONTOL A-BIOL, V53, pM112, DOI 10.1093/gerona/53A.2.M112; Tinetti ME, 1996, AM J EPIDEMIOL, V144, P389; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1995, J AM GERIATR SOC, V43, P1214, DOI 10.1111/j.1532-5415.1995.tb07396.x; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; Tinetti ME, 1997, NEW ENGL J MED, V337, P1279, DOI 10.1056/NEJM199710303371806; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; van Haastregt JCM, 2000, BMJ-BRIT MED J, V321, P994, DOI 10.1136/bmj.321.7267.994; VANROSSUM E, 1993, BMJ-BRIT MED J, V307, P27, DOI 10.1136/bmj.307.6895.27; VETTER NJ, 1992, BMJ-BRIT MED J, V304, P888, DOI 10.1136/bmj.304.6831.888; WAGNER EH, 1994, AM J PUBLIC HEALTH, V84, P1800, DOI 10.2105/AJPH.84.11.1800; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x	57	1094	1130	4	114	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					42	49		10.1056/NEJMcp020719	http://dx.doi.org/10.1056/NEJMcp020719			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630WY	12510042				2022-12-28	WOS:000180134400007
J	Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M				Imamura, H; Takayama, T; Sugawara, Y; Kokudo, N; Aoki, T; Kaneko, J; Matsuyama, Y; Sano, K; Maema, A; Makuuchi, M			Pringle's manoeuvre in living donors	LANCET			English	Article							TRANSPLANTATION	The safety of the donor is paramount in living donor liver transplantation. The most important risk to the donor during hepatectomy is bleeding, and the inflow occlusion technique (Pringle's manoeuvre) has been reported to decrease bleeding without inducing liver injury in liver surgery. However, most transplant centres are doing donor hepatectomies without this technique for fear that it would result in ischaemic injury to the graft. We have done 46 living donor hepatectomies with Pringle's manoeuvre without any negative outcome on the quality of the graft. Surgeons should not hesitate to apply this technique in living donor hepatectomy.	Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Sch Publ Hlth, Dept Biostat, Kyoto, Japan	University of Tokyo; Kyoto University	Makuuchi, M (corresponding author), Univ Tokyo, Grad Sch Med, Div Hepatobillary Pancreat Surg & Artificial Orga, Dept Surg,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	makuuchi-tky@umin.ac.jp	Sano, Keiji/ABI-6150-2020; 幕内, 雅敏 m/A-2140-2012					Arai M, 2000, HEPATOLOGY, V32, P297, DOI 10.1053/jhep.2000.8896; Clavien PA, 2000, ANN SURG, V232, P155, DOI 10.1097/00000658-200008000-00001; Strong RW, 2000, LIVER TRANSPLANT, V6, P250, DOI 10.1016/S1527-6465(00)80024-6; Surman OS, 2002, NEW ENGL J MED, V346, P1038, DOI 10.1056/NEJM200204043461402; Trotter JF, 2002, NEW ENGL J MED, V346, P1074, DOI 10.1056/NEJMra011629	5	82	83	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2049	2050		10.1016/S0140-6736(02)11995-7	http://dx.doi.org/10.1016/S0140-6736(02)11995-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504404				2022-12-28	WOS:000179974200016
J	Bhan, MK; Bhandari, N; Bahl, R				Bhan, MK; Bhandari, N; Bahl, R			Management of the severely malnourished child: perspective from developing countries	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SEVERE MALNUTRITION; CONTROLLED-TRIAL; SUPPLEMENTATION; MAGNESIUM; DIARRHEA; POTASSIUM; MORTALITY; ZINC		All India Inst Med Sci, Dept Paediat, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Bhan, MK (corresponding author), All India Inst Med Sci, Dept Paediat, New Delhi 110029, India.	community.research@cih.uib.no						Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ashraf H, 1996, B WORLD HEALTH ORGAN, V74, P479; AUKETT MA, 1986, ARCH DIS CHILD, V61, P849, DOI 10.1136/adc.61.9.849; Beaton G., 1993, 13 ACCSCN; BENNISH ML, 1990, NEW ENGL J MED, V322, P1357, DOI 10.1056/NEJM199005103221905; BERKOWITZ FE, 1992, PEDIATR INFECT DIS J, V11, P750, DOI 10.1097/00006454-199209000-00015; Bern C, 1997, B WORLD HEALTH ORGAN, V75, P87; Bhan MK, 1998, J PEDIATR GASTR NUTR, V26, P446, DOI 10.1097/00005176-199804000-00016; Brewster DR, 1997, EUR J CLIN NUTR, V51, P139, DOI 10.1038/sj.ejcn.1600367; BRIEND A, 1993, EUR J CLIN NUTR, V47, P750; CADDELL JL, 1967, NEW ENGL J MED, V276, P535, DOI 10.1056/NEJM196703092761002; CASTILLODURAN C, 1988, AM J CLIN NUTR, V47, P710, DOI 10.1093/ajcn/47.4.710; CASTILLODURAN C, 1983, AM J CLIN NUTR, V37, P898, DOI 10.1093/ajcn/37.6.898; Cavalcante AAM, 1998, TROP DOCT, V28, P95, DOI 10.1177/004947559802800213; CORDANO A, 1964, PEDIATRICS, V34, P324; deOnis M, 1996, AM J CLIN NUTR, V64, P650, DOI 10.1093/ajcn/64.4.650; Elizabeth K E, 1997, Indian Pediatr, V34, P681; Fontaine O, 2001, J HEALTH POPUL NUTR, V19, P339; Fruchwald-Schultes B, 2000, METABOLISM, V49, P794; *INT I POP SCI, 1995, NAT FAM HLTH SURV MC; International Institute for Population Sciences and ORC Macro, 2000, NAT FAM HLTH SURV NF; Kessler L, 2000, ANN TROP PAEDIATR, V20, P50, DOI 10.1080/02724930092075; KHANUM S, 1994, LANCET, V344, P1728; Lee, 1988, NUTR CLIN MANAGEMENT, P88; Manary MJ, 1997, J PEDIATR GASTR NUTR, V24, P194, DOI 10.1097/00005176-199702000-00014; MICHAELSEN KF, 1987, LANCET, V1, P1421; Rice AL, 2000, B WORLD HEALTH ORGAN, V78, P1207; ROSEN EU, 1970, J PEDIATR-US, V77, P709, DOI 10.1016/S0022-3476(70)80220-7; Schofield C, 1996, B WORLD HEALTH ORGAN, V74, P223; SCHOFIELD WN, 1995, LANCET, V345, P1303, DOI 10.1016/S0140-6736(95)90947-8; STEGEN G, 1969, PEDIATRICS, V43, P260; Stoltzfus RJ, 1998, GUIDELINES USE IRON; TROWBRIDGE FL, 1979, AM J CLIN NUTR, V32, P758, DOI 10.1093/ajcn/32.4.758; *UNICEF, 2002, STAT WORLDS CHILDR 2; WHARTON BA, 1967, LANCET, V2, P384; *WHO, 2002, GLOB FOR HLTH RES CH; World Health Organization, 2000, MAN CHILD SER INF SE; *ZINC INV COLL GRO, 1999, J PEDIATR, V155, P689	38	53	57	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2003	326	7381					146	151		10.1136/bmj.326.7381.146	http://dx.doi.org/10.1136/bmj.326.7381.146			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531849	Green Published			2022-12-28	WOS:000180575900028
J	Kumar, S; Little, P; Britten, N				Kumar, S; Little, P; Britten, N			Why do general practitioners prescribe antibiotics for sore throat? Grounded theory interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objectives To understand why general practitioners prescribe antibiotics for some cases of sore throat and to explore the factors that influence their prescribing. Design Grounded theory interview study. Setting General practice. Participants 40 general practitioners: 25 in the maximum variety sample and 15 in the theoretical sample. Results General practitioners are uncertain which patients will benefit from antibiotics but prescribe for sicker patients and for patients from socioeconomically deprived backgrounds because of concerns about complications. They are also more likely to prescribe in pressured clinical contexts. Doctors are mostly comfortable with their prescribing decisions and are not prescribing to maintain the doctor-patient relationship. Conclusions General practitioners have reduced prescribing for sore throat in response to research and policy initiatives. Further interventions to reduce prescribing would need to improve identification of patients at risk of complications and be workable in busy clinical situations.	Univ Southampton, Dept Primary Med Care, Southampton SO17 3RT, Hants, England; Guys Kings & St Thomass Univ London, Dept Primary Care & Gen Practice, Concordance Unit, London SE11 6SP, England	University of Southampton; University of London; King's College London	Kumar, S (corresponding author), Univ Southampton, Dept Primary Med Care, Southampton SO17 3RT, Hants, England.	skk@soton.ac.uk		Little, Paul/0000-0003-3664-1873				Adler PA., 1998, COLLECTING INTERPRET, P79; BRADLEY CP, 1992, BRIT MED J, V304, P294, DOI 10.1136/bmj.304.6822.294; Butler CC, 1998, BMJ-BRIT MED J, V317, P637, DOI 10.1136/bmj.317.7159.637; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; DELMAR CB, 2000, COCHRANE DATABASE SY; DESANTIS G, 1994, MED J AUSTRALIA, V160, P502; Glaser Barney G., 1967, DISCOV GROUNDED THEO; Glaser BG, 1978, THEORETICAL SENSITIV; *HL SEL COMM SCI T, 1998, 7 HOUS LORDS SEL COM; Howie J G, 1971, J R Coll Gen Pract, V21, P657; Little P, 1996, FAM PRACT, V13, P317, DOI 10.1093/fampra/13.3.317; Mainous AG, 1997, J FAM PRACTICE, V45, P75; *PRESCR PRIC AUTH, 2002, PRESCR AN COST DAT	13	202	203	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2003	326	7381					138	141		10.1136/bmj.326.7381.138	http://dx.doi.org/10.1136/bmj.326.7381.138			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531847	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000180575900026
J	Coldicott, Y; Pope, C; Roberts, C				Coldicott, Y; Pope, C; Roberts, C			The ethics of intimate examinations - teaching tomorrow's doctors	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Sch Med, Ctr Med Educ, Bristol BS8 8DZ, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England	University of Bristol; University of Bristol	Roberts, C (corresponding author), Univ Bristol, Sch Med, Ctr Med Educ, Bristol BS8 8DZ, Avon, England.			Pope, Catherine/0000-0002-8935-6702				Dyer CE, 1998, BRIT MED J, V316, P1924, DOI 10.1136/bmj.316.7149.1924a; HENNIGAN TW, 1991, BRIT MED J, V302, P829, DOI 10.1136/bmj.302.6780.829; Hicks LK, 2001, BRIT MED J, V322, P709, DOI 10.1136/bmj.322.7288.709; Hunter M, 2001, BRIT MED J, V322, P255, DOI 10.1136/bmj.322.7281.255; KORSGAARD CM, 1997, INTRO GROUNDWORK MET; *ROYAL COLL OBST G, 1997, INT EX REP WORK PART; West A, 2001, BRIT MED J, V322, P743, DOI 10.1136/bmj.322.7288.743	7	103	107	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					97	99		10.1136/bmj.326.7380.97	http://dx.doi.org/10.1136/bmj.326.7380.97			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521977	Green Published			2022-12-28	WOS:000180426900021
J	Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH				Schifano, F; Oyefeso, A; Webb, L; Pollard, M; Corkery, J; Ghodse, AH			Review of deaths related to taking ecstasy, England and Wales, 1997-2000	BRITISH MEDICAL JOURNAL			English	Article									St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England	St Georges University London	Schifano, F (corresponding author), St George Hosp, Sch Med, Dept Addict Behav & Psychol Med, Natl Programme Subst Abuse Deaths, London SW17 0RE, England.		Webb, Lucy/AAA-3078-2022	Webb, Lucy/0000-0003-2580-3654; Corkery, John Martin/0000-0002-3849-817X				*EUR MON CTR DRUG, 2001, ANN REP STAT DRUGS P; GHODSE AH, 2002, 9 NPSAD EUR CTR ADD; Giroud C, 1997, Praxis (Bern 1994), V86, P510; Gore SM, 1999, LANCET, V354, P1265, DOI 10.1016/S0140-6736(99)02729-4; Schifano F, 2000, NEUROPSYCHOBIOLOGY, V42, P25, DOI 10.1159/000026667	5	41	42	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					80	81		10.1136/bmj.326.7380.80	http://dx.doi.org/10.1136/bmj.326.7380.80			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521971	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000180426900015
J	Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A				Levin-Zaidman, S; Englander, J; Shimoni, E; Sharma, AK; Minton, KW; Minsky, A			Ringlike structure of the Deinococcus radiodurans genome: A key to radioresistance?	SCIENCE			English	Article							IONIZING-RADIATION; CELL-DIVISION; DNA; RESISTANT; REPAIR; RECOMBINATION; FRAGMENTS; MODEL	The bacterium Deinococcus radiodurans survives ionizing irradiation and other DNA-damaging assaults at doses that are lethal to all other organisms. How D. radiodurans accurately reconstructs its genome from hundreds of radiation-generated fragments in the absence of an intact template is unknown. Here we show that the D. radiodurans genome assumes an unusual toroidal morphology that may contribute to its radioresistance. We propose that, because of restricted diffusion within the tightly packed and laterally ordered DNA toroids, radiation-generated free DNA ends are held together, which may facilitate template-independent yet error-free joining of DNA breaks.	Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; NCI, Mol Pharmacol Lab, NIH, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA	Weizmann Institute of Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA	Minsky, A (corresponding author), Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel.							Battista JR, 2000, CURR BIOL, V10, pR204, DOI 10.1016/S0960-9822(00)00353-5; Battista JR, 1999, TRENDS MICROBIOL, V7, P362, DOI 10.1016/S0966-842X(99)01566-8; Battista JR, 1997, ANNU REV MICROBIOL, V51, P203, DOI 10.1146/annurev.micro.51.1.203; CHOU FI, 1990, J BACTERIOL, V172, P2029, DOI 10.1128/jb.172.4.2029-2035.1990; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; DALY MJ, 1995, SCIENCE, V270, P1318, DOI 10.1126/science.270.5240.1318; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Hud NV, 2001, P NATL ACAD SCI USA, V98, P14925, DOI 10.1073/pnas.261560398; Jary D, 1999, BIOCHEMISTRY-US, V38, P3223, DOI 10.1021/bi982770h; LEIBOWITZ PJ, 1976, PHOTOCHEM PHOTOBIOL, V23, P45; Lin JY, 1999, SCIENCE, V285, P1558, DOI 10.1126/science.285.5433.1558; MA CL, 1994, BIOPHYS J, V67, P1678, DOI 10.1016/S0006-3495(94)80641-1; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; MINTON KW, 1994, MOL MICROBIOL, V13, P9, DOI 10.1111/j.1365-2958.1994.tb00397.x; Minton KW, 1996, MUTAT RES-DNA REPAIR, V363, P1, DOI 10.1016/0921-8777(95)00014-3; MINTON KW, 1995, BIOESSAYS, V17, P457, DOI 10.1002/bies.950170514; MURRAY RGE, 1983, CAN J MICROBIOL, V29, P1412, DOI 10.1139/m83-217; NORRIS V, 1995, J MOL BIOL, V253, P739, DOI 10.1006/jmbi.1995.0587; RAU DC, 1992, BIOPHYS J, V61, P260, DOI 10.1016/S0006-3495(92)81832-5; ROBINOW C, 1994, MICROBIOL REV, V58, P211, DOI 10.1128/MMBR.58.2.211-232.1994; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; ZIMMERMAN SB, 1993, BIOCHIM BIOPHYS ACTA, V1216, P175, DOI 10.1016/0167-4781(93)90142-Z	22	186	210	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					254	256		10.1126/science.1077865	http://dx.doi.org/10.1126/science.1077865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522252				2022-12-28	WOS:000180284000040
J	Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L				Peeters, A; Barendregt, JJ; Willekens, F; Mackenbach, JP; Al Mamun, A; Bonneux, L		Netherlands Epidemiology Demograph	Obesity in adulthood and its consequences for, life expectancy: A life-table analysis	ANNALS OF INTERNAL MEDICINE			English	Article							BODY-MASS INDEX; CORONARY-HEART-DISEASE; WEIGHT CHANGE; DIABETES-MELLITUS; RISK-FACTORS; FOLLOW-UP; MORTALITY; HEALTH; ASSOCIATION; OVERWEIGHT	Background: Overweight and obesity in adulthood are linked to an increased risk for death and disease. Their potential effect on life expectancy and premature death has not yet been described. Objective: To analyze reductions in life expectancy and increases in premature death associated with overweight and obesity at 40 years of age. Design: Prospective cohort study. Setting: The Framingham Heart Study with follow-up from 1948 to 1990. Participants: 3457 Framingham Heart Study participants who were 30 to 49 years of age at baseline. Measurements: Mortality rates specific for age and body mass index group (normal weight, overweight, or obese at baseline) were derived within sex and smoking status strata. Life expectancy and the probability of death before 70 years of age were analyzed by using life tables. Results: Large decreases in life expectancy were associated with overweight and obesity. Forty-year-old female nonsmokers lost 3.3 years and 40-year-old male nonsmokers lost 3.1 years of life expectancy because of overweight. Forty-year-old female nonsmokers lost 7.1 years and 40-year-old male nonsmokers lost 5.8 years because of obesity. Obese female smokers lost 7.2 years and obese male smokers lost 6.7 years of life expectancy compared with normal-weight, smokers. Obese female smokers lost 13.3 years and obese male smokers lost 13.7 years compared with normal-weight nonsmokers. Body mass index at ages 30 to 49 years predicted mortality after ages 50 to 69 years, even after adjustment for body mass index at age 50 to 69 years. Conclusions: Obesity and overweight in adulthood are associated with large decreases in life expectancy and increases in early mortality. These decreases are similar to those seen with smoking. Obesity in adulthood is. a powerful predictor of death at older ages. Because of the increasing prevalence of obesity, more efficient prevention and treatment should become high priorities in public health.	Erasmus MC, Dept Publ Hlth, NL-3000 DR Rotterdam, Netherlands; Univ Groningen, Groningen, Netherlands	Erasmus University Rotterdam; Erasmus MC; University of Groningen	Peeters, A (corresponding author), Erasmus MC, Dept Publ Hlth, POB 1738, NL-3000 DR Rotterdam, Netherlands.	peeters@mgz.fgg.eur.nl	Peeters, Anna/M-8284-2019; Mamun, Abdullah A/A-4673-2011; PEETERS, ANNA/B-3663-2013; Barendregt, Jan J/F-6895-2010; Mamun, Abdullah/HHM-9898-2022	Peeters, Anna/0000-0003-4340-9132; Mamun, Abdullah A/0000-0002-1535-8086; PEETERS, ANNA/0000-0003-4340-9132; Kunst, Anton/0000-0002-3313-5273				ANDRES R, 1985, ANN INTERN MED, V103, P1030, DOI 10.7326/0003-4819-103-6-1030; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1989, US DEC LIF TABL 1989, V2; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dey DK, 2001, EUR J CLIN NUTR, V55, P482, DOI 10.1038/sj.ejcn.1601208; EFRON B, 1993, INTRO BOOTSTRAP, P184; Garrison RJ, 1996, CURR OPIN LIPIDOL, V7, P199, DOI 10.1097/00041433-199608000-00005; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HARRIS T, 1988, JAMA-J AM MED ASSOC, V259, P1520; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; LEE IM, 1993, JAMA-J AM MED ASSOC, V270, P2823, DOI 10.1001/jama.270.23.2823; LISSNER L, 1991, NEW ENGL J MED, V324, P1839, DOI 10.1056/NEJM199106273242602; Magarey AM, 2001, MED J AUSTRALIA, V174, P561, DOI 10.5694/j.1326-5377.2001.tb143435.x; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195; Peeters A, 2002, EUR HEART J, V23, P458, DOI 10.1053/euhj.2001.2838; PEKKANEN J, 1993, CARDIOLOGY, V82, P181, DOI 10.1159/000175867; PETERS ETJ, 1995, INT J OBESITY, V19, P862; Rexrode KM, 1996, CURR OPIN CARDIOL, V11, P490, DOI 10.1097/00001573-199609000-00007; ROGERS RG, 1991, SOC SCI MED, V32, P1151, DOI 10.1016/0277-9536(91)90092-Q; ROTHMAN K, 1998, MODERN EPIDEMIOLOGY, P422; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Seidell JC, 2000, EUR J CLIN NUTR, V54, pS33, DOI 10.1038/sj.ejcn.1601023; Sempos CT, 1998, ANN EPIDEMIOL, V8, P289, DOI 10.1016/S1047-2797(97)00233-0; Shaper AG, 1997, BRIT MED J, V314, P1311, DOI 10.1136/bmj.314.7090.1311; SHURTLEFF D, 1971, FRAMINGHAM STUDY EPI; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Thompson D, 1999, ARCH INTERN MED, V159, P2177, DOI 10.1001/archinte.159.18.2177; Visscher TLS, 2000, AM J EPIDEMIOL, V151, P660, DOI 10.1093/oxfordjournals.aje.a010260; Wannamethee SG, 1999, HEART, V81, P374, DOI 10.1136/hrt.81.4.374; Wannamethee SG, 2001, INT J EPIDEMIOL, V30, P777, DOI 10.1093/ije/30.4.777; *WHO, 1998, REP WHO CONS OB 3 5	35	894	924	3	79	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					24	32		10.7326/0003-4819-138-1-200301070-00008	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00008			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513041	Green Published			2022-12-28	WOS:000180996200004
J	Sneden, C; Cowan, JJ				Sneden, C; Cowan, JJ			Genesis of the heaviest elements in the Milky Way Galaxy	SCIENCE			English	Review							METAL-POOR STARS; S-PROCESS NUCLEOSYNTHESIS; GIANT BRANCH STARS; NEUTRON-CAPTURE; CHEMICAL-COMPOSITION; CS 31082-001; 1ST STARS; ABUNDANCES; SUPERNOVAE; RICH	We review the origin and evolution of the heavy elements, those with atomic numbers greater than 30, in the early history of the Milky Way. There is a large star-to-star bulk scatter in the concentrations of heavy elements with respect to the lighter metals, which suggests an early chemically unmixed and inhomogeneous Galaxy. The relative abundance patterns among the heavy elements are often very different from the solar system mix, revealing the characteristics of the first element donors in the Galaxy. Abundance comparisons among several halo stars show that the heaviest neutron-capture elements (including barium and heavier) are consistent with a scaled solar system rapid neutron-capture abundance distribution, whereas the lighter such elements do not conform to the solar pattern. The stellar abundances indicate an increasing contribution from the slow neutron-capture process (s-process) at higher metallicities in the Galaxy. The detection of thorium in halo and globular cluster stars offers a promising, independent age-dating technique that can put lower limits on the age of the Galaxy.	Univ Texas, Dept Astron, Austin, TX 78712 USA; Univ Texas, McDonald Observ, Austin, TX 78712 USA; Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Oklahoma System; University of Oklahoma - Norman	Sneden, C (corresponding author), Univ Texas, Dept Astron, RLM 15308, Austin, TX 78712 USA.	chris@verdi.as.utexas.edu						Aoki W, 2002, ASTROPHYS J, V576, pL141, DOI 10.1086/343761; Aoki W, 2000, ASTROPHYS J, V536, pL97, DOI 10.1086/312740; Arlandini C, 1999, ASTROPHYS J, V525, P886, DOI 10.1086/307938; BEERS TC, 1992, ASTRON J, V103, P1987, DOI 10.1086/116207; BOND HE, 1980, ASTROPHYS J SUPPL S, V44, P517, DOI 10.1086/190703; BURBIDGE EM, 1957, REV MOD PHYS, V29, P547, DOI 10.1103/RevModPhys.29.547; Burris DL, 2000, ASTROPHYS J, V544, P302, DOI 10.1086/317172; Busso M, 1999, ANNU REV ASTRON ASTR, V37, P239, DOI 10.1146/annurev.astro.37.1.239; Cameron A., 1982, ESSAYS NUCL ASTROPHY, P23; Cameron AGW, 1957, CRL41; Cayrel R, 2001, NATURE, V409, P691, DOI 10.1038/35055507; Cowan JJ, 2002, ASTROPHYS J, V572, P861, DOI 10.1086/340347; Depagne E, 2002, ASTRON ASTROPHYS, V390, P187, DOI 10.1051/0004-6361:20020687; Grevesse N, 1998, SPACE SCI REV, V85, P161, DOI 10.1023/A:1005161325181; Hill V, 2002, ASTRON ASTROPHYS, V387, P560, DOI 10.1051/0004-6361:20020434; KAPPELER F, 1989, REP PROG PHYS, V52, P945, DOI 10.1088/0034-4885/52/8/002; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; Moller P, 1997, ATOM DATA NUCL DATA, V66, P131, DOI 10.1006/adnd.1997.0746; Norris JE, 2001, ASTROPHYS J, V561, P1034, DOI 10.1086/323429; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Pont F, 1998, ASTRON ASTROPHYS, V329, P87; Qian YZ, 2001, ASTROPHYS J, V559, P925, DOI 10.1086/322367; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Schatz H, 2002, ASTROPHYS J, V579, P626, DOI 10.1086/342939; SIMMERER J, UNPUB; Sneden C, 1996, ASTROPHYS J, V467, P819, DOI 10.1086/177656; Sneden C, 2000, ASTROPHYS J, V536, pL85, DOI 10.1086/312742; SNEDEN C, 2000, APJ, V533, P139; SNEDEN C, UNPUB; SPITE M, 1978, ASTRON ASTROPHYS, V67, P23; Truran JW, 2002, PUBL ASTRON SOC PAC, V114, P1293, DOI 10.1086/344585	32	67	68	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					70	75		10.1126/science.1077506	http://dx.doi.org/10.1126/science.1077506			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511642	Green Submitted			2022-12-28	WOS:000180165800033
J	Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M				Klaholz, BP; Pape, T; Zavialov, AV; Myasnikov, AG; Orlova, EV; Vestergaard, B; Ehrenberg, M; van Heel, M			Structure of the Escherichia coli ribosomal termination complex with release factor 2	NATURE			English	Article							TRANSFER-RNA HYDROLYSIS; CRYSTAL-STRUCTURE; MESSENGER-RNA; FACTOR RF3; TRANSLATION; ERF1; RESOLUTION; BINDING; ERRORS; SITE	Termination of protein synthesis(1) occurs when the messenger RNA presents a stop codon in the ribosomal aminoacyl (A) site. Class I release factor proteins (RF1 or RF2) are believed to recognize stop codons via tripeptide motifs(2), leading to release of the completed polypeptide chain from its covalent attachment to transfer RNA in the ribosomal peptidyl (P) site. Class I RFs possess a conserved GGQ amino-acid motif that is thought to be involved directly in protein-transfer-RNA bond hydrolysis(3,4). Crystal structures of bacterial and eukaryotic class I RFs have been determined(5,6), but the mechanism of stop codon recognition and peptidyl-tRNA hydrolysis remains unclear. Here we present the structure of the Escherichia coli ribosome in a post-termination complex with RF2, obtained by single-particle cryo-electron microscopy (cryo-EM). Fitting the known 70S and RF2 structures into the electron density map reveals that RF2 adopts a different conformation on the ribosome when compared with the crystal structure of the isolated protein. The amino-terminal helical domain of RF2 contacts the factor-binding site of the ribosome, the 'SPF' loop of the protein is situated close to the mRNA, and the GGQ-containing domain of RF2 interacts with the peptidyl-transferase centre (PTC). By connecting the ribosomal decoding centre with the PTC, RF2 functionally mimics a tRNA molecule in the A site. Translational termination in eukaryotes is likely to be based on a similar mechanism.	Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark	Imperial College London; Uppsala University; Aarhus University	van Heel, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol Sci, London SW7 2AY, England.		Orlova, Elena/CAF-8290-2022; Myasnikov, Alexander/T-4654-2018	Orlova, Elena/0000-0003-3371-415X; Vestergaard, Bente/0000-0001-8011-6414; Pape, Tillmann/0000-0002-0612-3568; Zavialov, Andrey/0000-0001-6420-0368				Bertram G, 2000, RNA, V6, P1236, DOI 10.1017/S1355838200000777; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Frolova L, 2002, RNA, V8, P129, DOI 10.1017/S1355838202013262; Frolova LY, 1999, RNA, V5, P1014, DOI 10.1017/S135583829999043X; HARAUZ G, 1986, OPTIK, V73, P146; Inagaki Y, 2002, NUCLEIC ACIDS RES, V30, P532, DOI 10.1093/nar/30.2.532; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KASTNER B, 1990, J MOL BIOL, V212, P241, DOI 10.1016/0022-2836(90)90120-B; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Merkulova TI, 1999, FEBS LETT, V443, P41, DOI 10.1016/S0014-5793(98)01669-X; MOFFAT JG, 1994, J BIOL CHEM, V269, P18899; NISSEN P, 1995, SCIENCE, V270, P1464, DOI 10.1126/science.270.5241.1464; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; Tin OF, 2000, BIOCHIMIE, V82, P765, DOI 10.1016/S0300-9084(00)01149-4; Uno M, 2002, P NATL ACAD SCI USA, V99, P1819, DOI 10.1073/pnas.032457599; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Xu WB, 2002, J BACTERIOL, V184, P1200, DOI 10.1128/jb.184.4.1200-1203.2002; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6; ZAVIALOV AV, IN PRESS MOL CELL	29	166	170	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					90	94		10.1038/nature01225	http://dx.doi.org/10.1038/nature01225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511961				2022-12-28	WOS:000180165500044
J	Taylor, WR; Lin, K				Taylor, WR; Lin, K			Protein knots - A tangled problem	NATURE			English	Editorial Material									Natl Inst Med Res, Div Math Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Taylor, WR (corresponding author), Natl Inst Med Res, Div Math Biol, Mill Hill, London NW7 1AA, England.							MANSFIELD ML, 1994, NAT STRUCT BIOL, V1, P213, DOI 10.1038/nsb0494-213; Taylor WR, 2000, NATURE, V406, P916, DOI 10.1038/35022623; Taylor WR, 2001, REP PROG PHYS, V64, P517, DOI 10.1088/0034-4885/64/4/203; TAYLOR WR, IN PRESS COMP BIOL C	4	87	88	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					25	25		10.1038/421025a	http://dx.doi.org/10.1038/421025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511935	Bronze			2022-12-28	WOS:000180165500019
J	Sharp, D				Sharp, D			Two Ps better than one?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Sharp, D (corresponding author), The Lancet, London NW1 7BY, England.							BAKER N, 2002, DOUBLE FOLD LIB ASS; LAPORTE RE, 1995, BRIT MED J, V310, P1387, DOI 10.1136/bmj.310.6991.1387; LaPorte RE, 2002, BRIT MED J, V325, P1478, DOI 10.1136/bmj.325.7378.1478; SMITH RJ, 1991, FORTUNE TELLERS PHIL, P205; TENOPIR C, 2002, LIB J           1102	5	0	0	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2000	2000		10.1016/S0140-6736(02)12034-4	http://dx.doi.org/10.1016/S0140-6736(02)12034-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504393				2022-12-28	WOS:000179974200006
J	Varmus, H				Varmus, H			Building a global culture of science	LANCET			English	Article									Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Varmus, H (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.								0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S1	S4		10.1016/S0140-6736(02)11796-X	http://dx.doi.org/10.1016/S0140-6736(02)11796-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504480				2022-12-28	WOS:000180064500001
J	Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA				Heinrich, MC; Corless, CL; Duensing, A; McGreevey, L; Chen, CJ; Joseph, N; Singer, S; Griffith, DJ; Haley, A; Town, A; Demetri, GD; Fletcher, CDM; Fletcher, JA			PDGFRA activating mutations in gastrointestinal stromal tumors	SCIENCE			English	Article							C-KIT; CELLS; GENE; IDENTIFICATION; FLT3	Most gastrointestinal stromal tumors (GISTS) have activating mutations in the KIT receptor tyrosine kinase, and most patients with GISTS respond well to Gleevec, which inhibits KIT kinase activity. Here we show that similar to35% (14 of 40) of GISTS lacking KIT mutations have intragenic activation mutations in the related receptor tyrosine kinase, plate let-derived growth factor receptor alpha (PDGFRA). Tumors expressing KIT or PDGFRA oncoproteins were indistinguishable with respect to activation of downstream signaling intermediates and cytogenetic changes associated with tumor progression. Thus, KIT and PDGFRA mutations appear to be alternative and mutually exclusive oncogenic mechanisms in GISTs.	Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Med, Portland, OR 97201 USA; Oregon Hlth & Sci Univ, Inst Canc, Dept Pathol, Portland, OR 97201 USA; Portland VA Med Ctr, Portland, OR 97201 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Oregon Health & Science University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute	Heinrich, MC (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	heinrich@ohsu.edu; jfletcher@partners.org	ravegnini, gloria/K-1330-2016; Heinrich, Michael/AAC-6745-2019	ravegnini, gloria/0000-0002-7774-402X; Heinrich, Michael/0000-0003-3790-0478; Singer, Samuel/0000-0001-9713-8230; Duensing, Anette/0000-0002-0168-4067				Baxter EJ, 2002, HUM MOL GENET, V11, P1391, DOI 10.1093/hmg/11.12.1391; Buchdunger E, 2000, J PHARMACOL EXP THER, V295, P139; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; HUIZINGA JD, 1995, NATURE, V373, P347, DOI 10.1038/373347a0; Lokker NA, 2002, CANCER RES, V62, P3729; Longley BJ, 2001, LEUKEMIA RES, V25, P571, DOI 10.1016/S0145-2126(01)00028-5; Miettinen M, 2001, VIRCHOWS ARCH, V438, P1, DOI 10.1007/s004280000338; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Rubin BP, 2001, CANCER RES, V61, P8118; Spiekermann K, 2002, BLOOD, V100, P3423, DOI 10.1182/blood-2002-03-0953; Sun L, 2000, J MED CHEM, V43, P2655, DOI 10.1021/jm9906116; Taniguchi M, 1999, CANCER RES, V59, P4297; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Tuveson DA, 2001, ONCOGENE, V20, P5054, DOI 10.1038/sj.onc.1204704; van Oosterom AT, 2001, LANCET, V358, P1421, DOI 10.1016/S0140-6736(01)06535-7; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434	17	1756	1949	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 31	2003	299	5607					708	710		10.1126/science.1079666	http://dx.doi.org/10.1126/science.1079666			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522257				2022-12-28	WOS:000180687700047
J	Hirshberg, B; Conn, PM; Uwaifo, GI; Blauer, KL; Clark, BD; Nieman, LK				Hirshberg, B; Conn, PM; Uwaifo, GI; Blauer, KL; Clark, BD; Nieman, LK			Ectopic luteinizing hormone secretion and anovulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CARCINOMA; CHILDHOOD; CANCER; HCG		NIDDKD, Transplantat & Autoimmun Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NICHHD, Pediat & Reprod Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NCI, Pathol Lab, NIH, Bethesda, MD 20892 USA; Oregon Hlth & Sci Univ, Beaverton, OR USA; Genet & IVF Inst, Fairfax, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Oregon Health & Science University	Nieman, LK (corresponding author), Bldg 10,Rm 9D42,10 Ctr Dr,MSC 1583, Bethesda, MD 20892 USA.		Uwaifo, Gabriel I/M-2361-2016	Uwaifo, Gabriel I/0000-0002-6962-9304	NCRR NIH HHS [RR-00163] Funding Source: Medline; NICHD NIH HHS [HD-19899] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000637] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000637, R37HD019899, R01HD019899] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Barnes RB, 2002, HUM REPROD, V17, P88, DOI 10.1093/humrep/17.1.88; BOSCATO LM, 1988, CLIN CHEM, V34, P27; Byrd R P, 1993, J Ky Med Assoc, V91, P501; DANESHDOOST L, 1991, NEW ENGL J MED, V324, P589, DOI 10.1056/NEJM199102283240904; EHRMANN DA, 1995, ENDOCR REV, V16, P322, DOI 10.1210/er.16.3.322; ELLINWOOD WE, 1980, BIOL REPROD, V22, P955, DOI 10.1095/biolreprod22.4.955; FAIMAN C, 1967, NEW ENGL J MED, V277, P1395, DOI 10.1056/NEJM196712282772604; GADNER H, 1974, Z KINDERHEILKD, V118, P63, DOI 10.1007/BF00506054; GAILANI S, 1976, CANCER-AM CANCER SOC, V38, P1684, DOI 10.1002/1097-0142(197610)38:4<1684::AID-CNCR2820380440>3.0.CO;2-T; KAPLAN SL, 1976, J CLIN ENDOCR METAB, V42, P995, DOI 10.1210/jcem-42-5-995; KEW MC, 1977, NEW ENGL J MED, V296, P1084, DOI 10.1056/NEJM197705122961903; Latronico AC, 1996, NEW ENGL J MED, V334, P507, DOI 10.1056/NEJM199602223340805; MANZI D, 1995, CHEST, V107, P567, DOI 10.1378/chest.107.2.567; Mi YL, 2002, J CLIN INVEST, V109, P269, DOI 10.1172/JCI13997; MIYAKE A, 1981, OBSTET GYNECOL, V58, P566; NAKANUMA Y, 1986, VIRCHOWS ARCH A, V409, P365, DOI 10.1007/BF00708253; OMENN GS, 1971, PEDIATRICS, V47, P613; PADOVA G, 1991, FERTIL STERIL, V55, P637; RICHARDS.GS, 1972, NEW ENGL J MED, V286, P594; ROJAS FJ, 1988, HUM REPROD, V3, P207, DOI 10.1093/oxfordjournals.humrep.a136678; Romer TE, 1998, CLIN ENDOCRINOL, V48, P367, DOI 10.1046/j.1365-2265.1998.00294.x; Schneider DT, 2001, PEDIATR HEMAT ONCOL, V18, P11, DOI 10.1080/088800101750059828; TAMADA T, 1969, FERTIL STERIL, V20, P840; TSENG A, 1985, CANCER-AM CANCER SOC, V56, P2534, DOI 10.1002/1097-0142(19851115)56:10<2534::AID-CNCR2820561036>3.0.CO;2-Q; VAITUKAITIS JL, 1974, ANN CLIN LAB SCI, V4, P276; WEINTRAU.BD, 1972, NEW ENGL J MED, V286, P713	27	10	11	0	6	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					312	317		10.1056/NEJMoa022384	http://dx.doi.org/10.1056/NEJMoa022384			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540644				2022-12-28	WOS:000180507200006
J	Hartman, EE; Delbanco, T				Hartman, EE; Delbanco, T			A 52-year-old man with a positive PPD, 1 year later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		Iseman M, 2001, JAMA-J AM MED ASSOC, V286, P2015, DOI 10.1001/jama.286.16.2015	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					476	476		10.1001/jama.289.4.476	http://dx.doi.org/10.1001/jama.289.4.476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TD	12533127				2022-12-28	WOS:000180472300029
J	Kaaret, P; Corbel, S; Prestwich, AH; Zezas, A				Kaaret, P; Corbel, S; Prestwich, AH; Zezas, A			Radio emission from an ultraluminous x-ray source	SCIENCE			English	Article							HIGH-RESOLUTION IMAGER; SUPER STAR-CLUSTERS; BLACK-HOLES; OPTICAL COUNTERPART; RELATIVISTIC JETS; GALAXIES; POPULATION; IDENTIFICATIONS; REGION; STATES	The physical nature of ultraluminous x-ray sources is uncertain. Stellar-mass black holes with beamed radiation and intermediate black holes with isotropic radiation are two plausible explanations. We discovered radio emission from an ultraluminous x-ray source in the dwarf irregular galaxy NGC 5408. The x-ray, radio, and optical fluxes as well as the x-ray spectral shape are consistent with beamed relativistic jet emission from an accreting stellar black hole. If confirmed, this would suggest that the ultraluminous x-ray sources may be stellar-mass rather than intermediate-mass black holes. However, interpretation of the source as a jet-producing intermediate-mass black hole cannot be ruled out at this time.	Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; Ctr Etud Saclay, CEA Saclay Federat APC, F-91191 Gif Sur Yvette, France; Univ Paris 07, F-91191 Gif Sur Yvette, France	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Cite	Kaaret, P (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	pkaaret@cfa.harvard.edu	Zezas, Andreas/C-7543-2011	Zezas, Andreas/0000-0001-8952-676X				Angelini L, 2001, ASTROPHYS J, V557, pL35, DOI 10.1086/323026; BLAIR WP, 1983, ASTROPHYS J, V272, P84, DOI 10.1086/161263; Chu YH, 2001, SPACE TEL S, V13, P131; Colbert EJM, 1999, ASTROPHYS J, V519, P89, DOI 10.1086/307356; Corbel S, 2001, ASTROPHYS J, V554, P43, DOI 10.1086/321364; EBISAWA K, 1994, PUBL ASTRON SOC JPN, V46, P375; Ebisuzaki T, 2001, ASTROPHYS J, V562, pL19, DOI 10.1086/338118; FABBIANO G, 1989, ANNU REV ASTRON ASTR, V27, P87; FABIAN AC, 1993, MON NOT R ASTRON SOC, V263, pL51, DOI 10.1093/mnras/263.1.L51; Fabian AC, 1996, MON NOT R ASTRON SOC, V280, pL5, DOI 10.1093/mnras/280.1.L5; Fender RP, 2001, MON NOT R ASTRON SOC, V322, P31, DOI 10.1046/j.1365-8711.2001.04080.x; FENFER RP, 1999, MON NOT R ASTRON SOC, V304, P865; Foschini L, 2002, ASTRON ASTROPHYS, V396, P787, DOI 10.1051/0004-6361:20021391; Georganopoulos M, 2002, ASTRON ASTROPHYS, V388, pL25, DOI 10.1051/0004-6361:20020567; Greve A, 2002, ASTRON ASTROPHYS, V381, P825, DOI 10.1051/0004-6361:20011467; HARRIS DE, 1993, EINSTEIN OBSERVATORY; Kaaret P, 2001, MON NOT R ASTRON SOC, V321, pL29, DOI 10.1046/j.1365-8711.2001.04064.x; King AR, 2001, ASTROPHYS J, V552, pL109, DOI 10.1086/320343; Kording E, 2002, ASTRON ASTROPHYS, V382, pL13, DOI 10.1051/0004-6361:20011776; Landt H, 2001, MON NOT R ASTRON SOC, V323, P757, DOI 10.1046/j.1365-8711.2001.04269.x; Liu JF, 2002, ASTROPHYS J, V580, pL31, DOI 10.1086/345420; MACCACARO T, 1982, ASTROPHYS J, V253, P504, DOI 10.1086/159652; Makishima K, 2000, ASTROPHYS J, V535, P632, DOI 10.1086/308868; Mirabel IF, 1999, ANNU REV ASTRON ASTR, V37, P409, DOI 10.1146/annurev.astro.37.1.409; MOTCH C, 1994, VIOLENT STAR FORMATION, P208, DOI 10.1017/CBO9780511600159.036; PAKULL MW, 2002, NEW VISIONS XRAY UNI; PARTRIDGE RB, 1986, ASTROPHYS J, V308, P46, DOI 10.1086/164477; REYNOLDS JE, 1995, ASTRON ASTROPHYS, V304, P116; Roberts TP, 2000, MON NOT R ASTRON SOC, V315, P98, DOI 10.1046/j.1365-8711.2000.03384.x; Roberts TP, 2002, MON NOT R ASTRON SOC, V337, P677, DOI 10.1046/j.1365-8711.2002.05950.x; Roberts TP, 2001, MON NOT R ASTRON SOC, V325, pL7, DOI 10.1046/j.1365-8711.2001.04659.x; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Stevens IR, 2002, MON NOT R ASTRON SOC, V335, P1079, DOI 10.1046/j.1365-8711.2002.05696.x; STEWART GC, 1982, MON NOT R ASTRON SOC, V200, pP61, DOI 10.1093/mnras/200.1.61P; STOCKE JT, 1991, ASTROPHYS J SUPPL S, V76, P813, DOI 10.1086/191582; Tanaka Y, 1996, ANNU REV ASTRON ASTR, V34, P607, DOI 10.1146/annurev.astro.34.1.607; TANANBAUM H, 1979, ASTROPHYS J, V234, pL9, DOI 10.1086/183100; Wang QD, 1999, ASTROPHYS J, V523, P121, DOI 10.1086/307730; Weisskopf MC, 2002, PUBL ASTRON SOC PAC, V114, P1, DOI 10.1086/338108; Wu H, 2002, ASTROPHYS J, V576, P738, DOI 10.1086/341862	42	138	139	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					365	367		10.1126/science.1079610	http://dx.doi.org/10.1126/science.1079610			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532009	Green Submitted			2022-12-28	WOS:000180426800036
J	DeConto, RM; Pollard, D				DeConto, RM; Pollard, D			Rapid Cenozoic glaciation of Antarctica induced by declining atmospheric CO2	NATURE			English	Article							ICE-SHEET; SEDIMENTOLOGICAL EVIDENCE; STABLE-ISOTOPE; CLIMATE; OCEAN; TRANSITION; EVOLUTION; MARGIN	The sudden, widespread glaciation of Antarctica and the associated shift towards colder temperatures at the Eocene/Oligocene boundary (similar to34 million years ago) (refs 1-4) is one of the most fundamental reorganizations of global climate known in the geologic record. The glaciation of Antarctica has hitherto been thought to result from the tectonic opening of Southern Ocean gateways, which enabled the formation of the Antarctic Circumpolar Current and the subsequent thermal isolation of the Antarctic continent(5). Here we simulate the glacial inception and early growth of the East Antarctic Ice Sheet using a general circulation model with coupled components for atmosphere, ocean, ice sheet and sediment, and which incorporates palaeogeography, greenhouse gas, changing orbital parameters, and varying ocean heat transport. In our model, declining Cenozoic CO2 first leads to the formation of small, highly dynamic ice caps on high Antarctic plateaux. At a later time, a CO2 threshold is crossed, initiating ice-sheet height/mass-balance feedbacks that cause the ice caps to expand rapidly with large orbital variations, eventually coalescing into a continental-scale East Antarctic Ice Sheet. According to our simulation the opening of Southern Ocean gateways plays a secondary role in this transition, relative to CO2 concentration.	Penn State Univ, EMS Environm Inst, University Pk, PA 16802 USA; Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Massachusetts System; University of Massachusetts Amherst	DeConto, RM (corresponding author), Penn State Univ, EMS Environm Inst, University Pk, PA 16802 USA.	deconto@geo.umass.edu						ABE-OUCHI A, 1993, ANN GLACIOL-SER, V18, P203, DOI 10.1017/S0260305500011514; Bamber JL, 1997, ANN GLACIOL, V25, P439, DOI 10.3189/S0260305500014427; BARKER PF, 1977, MAR GEOL, V25, P15, DOI 10.1016/0025-3227(77)90045-7; Barrett P.J, 1996, TERRA ANTARCTICA, V3, P103; BARRETT PJ, 1987, GEOLOGY, V15, P634, DOI 10.1130/0091-7613(1987)15<634:MROGAS>2.0.CO;2; BIRCHFIELD GE, 1982, J ATMOS SCI, V39, P71, DOI 10.1175/1520-0469(1982)039<0071:AMSOTR>2.0.CO;2; BROTCHIE JF, 1969, J GEOPHYS RES, V74, P5240, DOI 10.1029/JB074i022p05240; Clark PU, 1998, PALEOCEANOGRAPHY, V13, P1, DOI 10.1029/97PA02660; EHRMANN WU, 1992, PALAEOGEOGR PALAEOCL, V93, P85, DOI 10.1016/0031-0182(92)90185-8; Exon N., 2000, JOIDES J, V26, P11; FRANCIS JE, 1999, TERRA ANTARCTICA REP, V3, P43; HAMBREY MJ, 1991, P OCEAN DRILLING PRO, V0119; Huybrechts P., 1993, GEOGR ANN A, V75, P221, DOI [10.2307/521202, DOI 10.1080/04353676.1993.11880395, DOI 10.2307/521202]; Kamb B., 2001, ANTARCT RES SER, V77, DOI DOI 10.1029/AR077P0157; KENNETT JP, 1977, J GEOPHYS RES-OC ATM, V82, P3843, DOI 10.1029/JC082i027p03843; Lawver L.A., 1992, ANTARCTIC PALEOENVIR, P7; Lawver L. A., 1998, TECTONIC BOUNDARY CO, P212; Lear CH, 2000, SCIENCE, V287, P269, DOI 10.1126/science.287.5451.269; Maqueda MAM, 1998, CLIM DYNAM, V14, P329, DOI 10.1007/s003820050227; Naish TR, 2001, NATURE, V413, P719, DOI 10.1038/35099534; Nong GT, 2000, GEOPHYS RES LETT, V27, P2689, DOI 10.1029/1999GL011072; Pagani M, 1999, PALEOCEANOGRAPHY, V14, P273, DOI 10.1029/1999PA900006; Pearson PN, 2000, NATURE, V406, P695, DOI 10.1038/35021000; Ritz C, 1996, CLIM DYNAM, V13, P11, DOI 10.1007/s003820050149; Thompson SL, 1997, J CLIMATE, V10, P871, DOI 10.1175/1520-0442(1997)010<0871:GAAMBF>2.0.CO;2; Toggweiler JR, 2000, J QUATERNARY SCI, V15, P319, DOI 10.1002/1099-1417(200005)15:4<319::AID-JQS545>3.0.CO;2-C; Wilson GS, 1998, GEOL SOC AM BULL, V110, P35, DOI 10.1130/0016-7606(1998)110<0035:MCOTEO>2.3.CO;2; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; ZACHOS JC, 1992, GEOLOGY, V20, P569, DOI 10.1130/0091-7613(1992)020<0569:EOISEO>2.3.CO;2; Zachos JC, 1996, PALEOCEANOGRAPHY, V11, P251, DOI 10.1029/96PA00571	30	724	762	3	318	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					245	249		10.1038/nature01290	http://dx.doi.org/10.1038/nature01290			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529638				2022-12-28	WOS:000180397600041
J	Feigal, DW; Gardner, SN; McClellan, M				Feigal, DW; Gardner, SN; McClellan, M			Ensuring safe and effective medical devices	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA; US FDA, Off Commissioner, Rockville, MD 20857 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Feigal, DW (corresponding author), US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20857 USA.								0	58	60	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					191	192		10.1056/NEJMp020170	http://dx.doi.org/10.1056/NEJMp020170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529457				2022-12-28	WOS:000180390600001
J	Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S				Davis, P; Lay-Yee, R; Scott, A; Briant, R; Schug, S			Acknowledgement of "no fault" medical injury: review of patients' hospital records in New Zealand	BRITISH MEDICAL JOURNAL			English	Article									Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, Christchurch, New Zealand; Univ Auckland, Fac Med & Hlth Sci, Div Community Hlth, Auckland 1, New Zealand; Univ Auckland, Dept Stat, Auckland 1, New Zealand; Univ Western Australia, Dept Anaesthesia, Perth, WA 6009, Australia	University of Otago; University of Auckland; University of Auckland; University of Western Australia	Davis, P (corresponding author), Univ Otago, Christchurch Sch Med & Hlth Sci, Dept Publ Hlth & Gen Practice, POB 4345, Christchurch, New Zealand.		Schug, Stephan/G-1432-2010	Schug, Stephan/0000-0002-0302-2315				Blendon RJ, 2001, HEALTH AFFAIR, V20, P233, DOI 10.1377/hlthaff.20.3.233; Davis P, 2001, 3 MIN HLTH; Gostin L, 2000, JAMA-J AM MED ASSOC, V283, P1742, DOI 10.1001/jama.283.13.1742; Miller R, 1993, MARYLAND LAW REV, V52, P1070; National Audit Office, 2001, HANDL CLIN NEGL CLAI	5	17	19	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					79	80		10.1136/bmj.326.7380.79	http://dx.doi.org/10.1136/bmj.326.7380.79			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521970	Green Published, Bronze			2022-12-28	WOS:000180426900014
J	Lin, Y; Skaff, H; Emrick, T; Dinsmore, AD; Russell, TP				Lin, Y; Skaff, H; Emrick, T; Dinsmore, AD; Russell, TP			Nanoparticle assembly and transport at liquid-liquid interfaces	SCIENCE			English	Article							FLUORESCENCE PHOTOBLEACHING RECOVERY; NANOCRYSTALS; ORIENTATION; MICROSCOPY	The self-assembly of particles at fluid interfaces, driven by the reduction in interfacial energy, is well established. However, for nanoscopic particles, thermal fluctuations compete with interfacial energy and give rise to a particle-size dependent self-assembly. Ligand-stabilized nanoparticles assembled into three-dimensional constructs at fluid-fluid interfaces, where the properties unique to the nanoparticles were preserved. The small size of the nanoparticles led to a weak confinement of the nanoparticles at the fluid interface that opens avenues to size-selective particle assembly, two-dimensional phase behavior, and functionalization. Fluid interfaces afford a rapid approach to equilibrium and easy access to nanoparticles for subsequent modi cation. A photoinduced transformation is described in which nanoparticles, initially soluble only in toluene, were transported across an interface into water and were dispersed in the water phase. The characteristic fluorescence emission of the nanoparticles provided a direct probe of their spatial distribution.	Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA; Univ Massachusetts, Dept Phys, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Emrick, T (corresponding author), Univ Massachusetts, Dept Polymer Sci & Engn, Amherst, MA 01003 USA.		Lin, Yao/E-5527-2011; Russell, Thomas Paul/ADL-3689-2022	Lin, Yao/0000-0001-5227-2663; Russell, Thomas Paul/0000-0001-6384-5826				Alivisatos AP, 1998, ADV MATER, V10, P1297; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Binks BP, 2002, LANGMUIR, V18, P1270, DOI 10.1021/la011420k; Birdi K.S., 1997, HDB SURFACE COLLOID; BLONK JCG, 1993, J MICROSC-OXFORD, V169, P363, DOI 10.1111/j.1365-2818.1993.tb03312.x; BRUS L, 1991, APPL PHYS A-MATER, V53, P465, DOI 10.1007/BF00331535; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Empedocles SA, 1999, NATURE, V399, P126, DOI 10.1038/20138; Gaudin A.M., 1957, FLOTATION, V2nd; Lenglet J, 1996, PHYS REV B, V53, P14941, DOI 10.1103/PhysRevB.53.14941; Liu GM, 2000, ENVIRON SCI TECHNOL, V34, P3982, DOI 10.1021/es001064c; Peng ZA, 2001, J AM CHEM SOC, V123, P183, DOI 10.1021/ja003633m; PIERANSKI P, 1980, PHYS REV LETT, V45, P569, DOI 10.1103/PhysRevLett.45.569; Qu LH, 2001, NANO LETT, V1, P333, DOI 10.1021/nl0155532; RADLER J, 1993, J PHYS II, V3, P727; Skaff H, 2002, J AM CHEM SOC, V124, P5729, DOI 10.1021/ja012576+; Velev OD, 1996, LANGMUIR, V12, P2374, DOI 10.1021/la9506786; WATANABE T, 1977, J PHYS CHEM-US, V81, P1845, DOI 10.1021/j100534a012; Wiegand G, 1998, APPL OPTICS, V37, P6892, DOI 10.1364/AO.37.006892	20	878	896	21	689	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					226	229		10.1126/science.1078616	http://dx.doi.org/10.1126/science.1078616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522244				2022-12-28	WOS:000180284000031
J	Lundstrom, M				Lundstrom, M			Moore's law forever?	SCIENCE			English	Editorial Material							LIMITS		Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Lundstrom, M (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.							Avouris P, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P281, DOI 10.1109/IEDM.2002.1175833; Chui CO, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P437, DOI 10.1109/IEDM.2002.1175872; DAMLE P, IN PRESS IEEE T NANO; Doris B, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P267, DOI 10.1109/IEDM.2002.1175829; Frank DJ, 2001, P IEEE, V89, P259, DOI 10.1109/5.915374; Goebel B, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P275, DOI 10.1109/IEDM.2002.1175831; Guarini KW, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P943, DOI 10.1109/IEDM.2002.1175992; Guo J, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P711, DOI 10.1109/IEDM.2002.1175937; Gusev E. P., 2001, TECHNICAL DIGEST INT, P451, DOI DOI 10.1109/IEDM.2001.979537; Hokazono A, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P639, DOI 10.1109/IEDM.2002.1175920; Hoyt JL, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P23, DOI 10.1109/IEDM.2002.1175770; Huang XJ, 2001, IEEE T ELECTRON DEV, V48, P880, DOI 10.1109/16.918235; *IEEE, 2002, INT EL DEV M IEDM SA; JAVEY A, IN PRESS NATURE MAT; Meindl JD, 2001, SCIENCE, V293, P2044, DOI 10.1126/science.293.5537.2044; Mizuno T, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P31, DOI 10.1109/IEDM.2002.1175772; Murata K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P937, DOI 10.1109/IEDM.2002.1175990; Ota K, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P27, DOI 10.1109/IEDM.2002.1175771; Packan PA, 1999, SCIENCE, V285, P2079, DOI 10.1126/science.285.5436.2079; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; Reed MA, 2001, APPL PHYS LETT, V78, P3735, DOI 10.1063/1.1377042; Shang HL, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P441, DOI 10.1109/IEDM.2002.1175873; Thompson S, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P61, DOI 10.1109/IEDM.2002.1175779; Yu B, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P251, DOI 10.1109/IEDM.2002.1175825	24	293	298	13	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					210	211		10.1126/science.1079567	http://dx.doi.org/10.1126/science.1079567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522237				2022-12-28	WOS:000180284000024
J	Hemmi, JM; Zeil, J				Hemmi, JM; Zeil, J			Robust judgement of inter-object distance by an arthropod	NATURE			English	Article							UCA LACTEA ANNULIPES; FIDDLER-CRABS; RESOLUTION; OCYPODIDAE; HORIZON; MODELS; WORLD; EYES	Animals use several strategies for depth vision, reflecting the constraints imposed by body size, the structure of the visual system and the visual geometry of the environment(1). Arthropods in particular have restricted depth perception, because they are small and possess closely set, low-resolution compound eyes. Yet, here we show that fiddler crabs defending their burrows from conspecifics can judge how close other crabs are to their burrow. When confronted with small dummy crabs, the burrow owners assess the dummy's position and motion relative to their burrow and not relative to themselves-in other words, by using an allocentric rather than an egocentric frame of reference. Irrespective of their own distance from the dummy, the likelihood that the crabs rush back to defend their burrow increases strongly as the dummy approaches the burrow. In addition, the mean dummy-burrow distance at which the crabs respond is constant and independent of the dummy's direction of approach. We propose that to solve this sophisticated task of relative distance judgement, the crabs combine visual information on dummy position and direction with information on burrow location acquired during path integration(2). In doing so, the crabs, like humans(3), make clever use of the visual geometry of their environment.	Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, Canberra, ACT 2601, Australia	Australian National University	Hemmi, JM (corresponding author), Australian Natl Univ, Res Sch Biol Sci, Ctr Visual Sci, POB 475, Canberra, ACT 2601, Australia.		Hemmi, Jan M/B-6458-2008; Zeil, Jochen/C-9223-2009	Hemmi, Jan M/0000-0003-4629-9362; 				Collett T.S., 1982, P111; Crane J., 1975, FIDDLER CRABS WORLD, V1st, DOI [10.1515/9781400867936, DOI 10.1515/9781400867936]; HYATT GW, 1978, BEHAVIOUR, V65, P182, DOI 10.1163/156853978X00602; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Krapp HG, 1998, J NEUROPHYSIOL, V79, P1902, DOI 10.1152/jn.1998.79.4.1902; LAND M, 1995, J COMP PHYSIOL A, V177, P81, DOI 10.1007/BF00243400; MONTAGUE CL, 1980, CONTRIB MAR SCI, V23, P25; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; SCHALL R, 1991, BIOMETRIKA, V78, P719; WEHNER R, 1987, J COMP PHYSIOL A, V161, P511, DOI 10.1007/BF00603659; Zeil J, 2002, CRUSTACEAN EXPERIMENTAL SYSTEMS IN NEUROBIOLOGY, P227; Zeil J, 1998, J COMP PHYSIOL A, V183, P367, DOI 10.1007/s003590050263; ZEIL J, 1986, J COMP PHYSIOL A, V159, P801, DOI 10.1007/BF00603733; Zeil J, 1996, J EXP BIOL, V199, P1569	14	43	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					160	163		10.1038/nature01247	http://dx.doi.org/10.1038/nature01247			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520301				2022-12-28	WOS:000180267200039
J	Oliveria, GHM; Schirger, A				Oliveria, GHM; Schirger, A			Page kidney.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Oliveria, GHM (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.								0	8	9	0	2	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					129	129		10.1056/NEJMicm020037	http://dx.doi.org/10.1056/NEJMicm020037			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519923				2022-12-28	WOS:000180263900005
J	Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ				Redfield, MM; Jacobsen, SJ; Burnett, JC; Mahoney, DW; Bailey, KR; Rodeheffer, RJ			Burden of systolic and diastolic ventricular dysfunction in the community - Appreciating the scope of the heart failure epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CORONARY-ARTERY DISEASE; DOPPLER-ECHOCARDIOGRAPHY; EJECTION FRACTION; NATRIURETIC PEPTIDE; FILLING PRESSURE; POPULATION; AGE; PREVALENCE; UTILITY	Context Approximately half of patients with overt congestive heart failure (CHF) have diastolic dysfunction without reduced ejection fraction (EF). Yet, the prevalence of diastolic dysfunction and its relation to systolic dysfunction and CHF in the community remain undefined. Objectives To determine the prevalence of CHF and preclinical diastolic dysfunction and systolic dysfunction in the community and determine if diastolic dysfunction is predictive of all-cause mortality. Design, Setting, Participants Cross-sectional survey of 2042 randomly selected residents of Olmsted County, Minnesota, aged 45 years or older from June 1997 through September 2000. Main Outcome Measures Doppler echocardiographic assessment of systolic and diastolic function. Presence of CHF diagnosis by review of medical records with designation as validated CHF if Framingham criteria are satisfied. Subjects without a CHF diagnosis but with diastolic or systolic dysfunction were considered as having either preclinical diastolic or preclinical systolic dysfunction. Results The prevalence of validated, CHF was 2.2% (95% confidence interval [CI], 1.6%-2.8%) with 44% having an EF higher than 50%. Overall, 20.8% (95% CI, 19.0%-22.7%) of the population had mild diastolic dysfunction, 6.6% (95% CI, 5.5%7.8%) had moderate diastolic dysfunction, and 0.7% (95% CI, 0.3%-1.1%) had severe diastolic dysfunction with 5.6% (95% CI, 4.5%-6.7%) of the population having moderate or severe diastolic dysfunction with normal EF. The prevalence of any systolic dysfunction (EF less than or equal to50%) was 6.0% (95% CI, 5.0%-7.1%) with moderate or severe systolic dysfunction (EF less than or equal to40.%) being present in 2.0% (95% CI, 1.4%-2.5%). CHF was much more common among those with systolic or diastolic dysfunction than in those with normal ventricular function. However, even among those with moderate or severe diastolic or systolic dysfunction, less than half had recognized CHF. In multivariate analysis, controlling for age, sex, and EF, mild diastolic dysfunction (hazard ratio, 8.31 [95% CI, 3.00-23.1], P<.001) and moderate or severe diastolic dysfunction (hazard ratio, 10.17 [95% CI, 3.28-31.0], P<.001) were predictive of all-cause mortality. Conclusions In the community, systolic dysfunction is frequently present in individuals without recognized CHF. Furthermore, diastolic dysfunction as rigorously defined by comprehensive Doppler techniques is common, often not accompanied by recognized CHF, and associated with marked increases in all-cause mortality.	Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Clin Epidemiol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Div Biostat, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Redfield, MM (corresponding author), Mayo Clin & Mayo Fdn, Dept Internal Med, Div Cardiovasc Dis, Guggenheim 9,200 1st St SW, Rochester, MN 55905 USA.		omidvari, elham/Q-6686-2016	Jacobsen, Steven/0000-0002-8174-8533	NHLBI NIH HHS [HL 55502] Funding Source: Medline; NIAMS NIH HHS [AR 30582] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Aurigemma GP, 2001, J AM COLL CARDIOL, V37, P1042, DOI 10.1016/S0735-1097(01)01110-X; Bella JN, 2002, CIRCULATION, V105, P1928, DOI 10.1161/01.CIR.0000015076.37047.D9; Black HR, 1998, ARCH INTERN MED, V158, P573; Black HR, 1997, ARCH INTERN MED, V157, P2413; Davies MK, 2001, LANCET, V358, P439, DOI 10.1016/S0140-6736(01)05620-3; Devereux RB, 2001, AM HEART J, V141, P439, DOI 10.1067/mhj.2001.113223; Devereux RB, 2000, AM J CARDIOL, V86, P1090, DOI 10.1016/S0002-9149(00)01165-6; Gandhi SK, 2000, PHYSIOL REV, V344, P17; GILLUM RF, 1984, AM HEART J, V108, P150, DOI 10.1016/0002-8703(84)90558-1; Gottdiener JS, 2002, ANN INTERN MED, V137, P631, DOI 10.7326/0003-4819-137-8-200210150-00006; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hart CYT, 2001, CIRCULATION, V104, P215, DOI 10.1161/01.CIR.104.2.215; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Hurrell DG, 1997, J AM COLL CARDIOL, V30, P459, DOI 10.1016/S0735-1097(97)00184-8; Jensen-Urstad K, 1998, AM J CARDIOL, V81, P538, DOI 10.1016/S0002-9149(97)00964-8; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; KLEIN AL, 1994, MAYO CLIN PROC, V69, P212, DOI 10.1016/S0025-6196(12)61059-3; LAKATTA EG, 1993, PHYSIOL REV, V73, P413, DOI 10.1152/physrev.1993.73.2.413; Lloyd-Jones D M, 2001, Curr Cardiol Rep, V3, P184, DOI 10.1007/s11886-001-0021-1; Lubien E, 2002, CIRCULATION, V105, P595, DOI 10.1161/hc0502.103010; Maisel AS, 2001, AM HEART J, V141, P367, DOI 10.1067/mhj.2001.113215; McDonagh TA, 1997, LANCET, V350, P829, DOI 10.1016/S0140-6736(97)03033-X; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mosterd A, 1999, EUR HEART J, V20, P447, DOI 10.1053/euhj.1998.1239; MURRAY JA, 1968, CIRCULATION, V37, P800, DOI 10.1161/01.CIR.37.5.800; Nishimura RA, 1997, J AM COLL CARDIOL, V30, P8, DOI 10.1016/S0735-1097(97)00144-7; Ommen SR, 2000, CIRCULATION, V102, P1788; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Redfield MM, 2002, J AM COLL CARDIOL, V40, P976, DOI 10.1016/S0735-1097(02)02059-4; Senni M, 1998, CIRCULATION, V98, P2282, DOI 10.1161/01.CIR.98.21.2282; SHUB C, 1994, MAYO CLIN PROC, V69, P205, DOI 10.1016/S0025-6196(12)61058-1; SOBUE T, 1995, J AM COLL CARDIOL, V25, P91, DOI 10.1016/0735-1097(94)00347-S; STARLING MR, 1981, CIRCULATION, V63, P1075, DOI 10.1161/01.CIR.63.5.1075; Vasan RS, 1999, J AM COLL CARDIOL, V33, P1948, DOI 10.1016/S0735-1097(99)00118-7; Vasan RS, 2002, JAMA-J AM MED ASSOC, V288, P1252, DOI 10.1001/jama.288.10.1252; Yamamoto K, 1996, HYPERTENSION, V28, P988, DOI 10.1161/01.HYP.28.6.988; Yamamoto K, 1997, J AM COLL CARDIOL, V30, P1819, DOI 10.1016/S0735-1097(97)00390-2; Yamamoto K, 2000, J CARD FAIL, V6, P194, DOI 10.1054/jcaf.2000.9676; Zile MR, 2001, CIRCULATION, V104, P779, DOI 10.1161/hc3201.094226	41	2234	2328	1	43	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					194	202		10.1001/jama.289.2.194	http://dx.doi.org/10.1001/jama.289.2.194			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517230	Bronze			2022-12-28	WOS:000180226400030
J	Ford, N; Piedagnel, JM				Ford, N; Piedagnel, JM			WHO must continue its work on access to medicines in developing countries	LANCET			English	Article									Med Sans Frontieres, Paris, France	Doctors Without Borders	Ford, N (corresponding author), Med Sans Frontieres, Paris, France.								0	4	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					3	3		10.1016/S0140-6736(03)12173-3	http://dx.doi.org/10.1016/S0140-6736(03)12173-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521032				2022-12-28	WOS:000180191600003
J	Lundin, J; Lundin, M; Isola, J; Joensuu, H				Lundin, J; Lundin, M; Isola, J; Joensuu, H			A web-based system for individualised survival estimation in breast cancer	BRITISH MEDICAL JOURNAL			English	Article									Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland; Univ Tampere, Inst Med Technol, FIN-33014 Tampere, Finland; Tampere Univ Hosp, FIN-33014 Tampere, Finland; Univ Helsinki, Mol Canc Biol Res Programme, FIN-00290 Helsinki, Finland	University of Helsinki; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki	Lundin, J (corresponding author), Univ Helsinki, Dept Oncol, FIN-00290 Helsinki, Finland.		Lundin, Johan/I-1843-2018; Lundin, Johan/AAC-8510-2020	Lundin, Johan/0000-0002-2681-4139; Lundin, Johan/0000-0002-2681-4139; Joensuu, Heikki/0000-0003-0281-2507				Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; *IH, 2000, J NATL CANC I MONOGR, V30, P5; Kattan M, 2002, J CLIN ONCOL, V20, P885, DOI 10.1200/JCO.2002.20.4.885; Lundin J, 2001, J CLIN ONCOL, V19, P28, DOI 10.1200/JCO.2001.19.1.28	4	26	26	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					29	29		10.1136/bmj.326.7379.29	http://dx.doi.org/10.1136/bmj.326.7379.29			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511459	Green Published, Bronze			2022-12-28	WOS:000180302000023
J	Neuberger, J				Neuberger, J			Commentary: a "good death" is possible in the NHS	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1M 0AN, England		Neuberger, J (corresponding author), Kings Fund, London W1M 0AN, England.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					34	34						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12516617				2022-12-28	WOS:000180302000025
J	Buck, SW; Sandmeier, JJ; Smith, JS				Buck, SW; Sandmeier, JJ; Smith, JS			RNA polymerase I propagates unidirectional spreading of rDNA silent chromatin	CELL			English	Article							TRANSCRIPTION FACTOR UAF; SACCHAROMYCES-CEREVISIAE; RIBOSOMAL DNA; PROTEIN SIR2; YEAST RDNA; LIFE-SPAN; SWITCH; GENE; HETEROCHROMATIN; DEACETYLASE	The ribosomal DNA (rDNA) tandem array in Saccharomyces cerevisiae induces transcriptional silencing of RNA polymerase II-transcribed genes. This SIR2-dependent form of repression (rDNA silencing) also functions to limit rDNA recombination and is involved in life span control. In this report, we demonstrate that rDNA silencing spreads into the centromere-proximal unique sequence located downstream of RNA polymerase I (Pol I) transcription, but fails to enter the upstream telomere-proximal sequences. The spreading of silencing correlates with SIR2-dependent histone H3 and H4 deacetylation and can be extended by SIR2 overexpression. Surprisingly, rDNA silencing required transcription by RNA polymerase I and the direction of spreading was controlled by the direction of Pol I transcription.	Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA	University of Virginia	Smith, JS (corresponding author), Univ Virginia Hlth Syst, Dept Biochem & Mol Genet, Box 80073,Jordan Hall, Charlottesville, VA 22908 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061692] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; Brachmann CB, 1998, YEAST, V14, P115; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Cioci F, 2002, J MOL BIOL, V322, P41, DOI 10.1016/S0022-2836(02)00749-0; CONRADWEBB H, 1995, MOL CELL BIOL, V15, P2420; Cuperus G, 2000, EMBO J, V19, P2641, DOI 10.1093/emboj/19.11.2641; Donze D, 1999, GENE DEV, V13, P698, DOI 10.1101/gad.13.6.698; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; Guarente L, 2000, GENE DEV, V14, P1021; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465; HULL MW, 1994, MOL CELL BIOL, V14, P1266, DOI 10.1128/MCB.14.2.1266; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kennedy BK, 1997, CELL, V89, P381, DOI 10.1016/S0092-8674(00)80219-6; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; MUSTERS W, 1989, NUCLEIC ACIDS RES, V17, P9661, DOI 10.1093/nar/17.23.9661; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P7026, DOI 10.1073/pnas.88.16.7026; NOGI Y, 1991, P NATL ACAD SCI USA, V88, P3962, DOI 10.1073/pnas.88.9.3962; Oakes M, 1999, MOL CELL BIOL, V19, P8559; Reeder RH, 1999, MOL CELL BIOL, V19, P7369; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; Sandmeier JJ, 2002, EMBO J, V21, P4959, DOI 10.1093/emboj/cdf498; Shou WY, 1999, CELL, V97, P233, DOI 10.1016/S0092-8674(00)80733-3; Shou WY, 2001, MOL CELL, V8, P45, DOI 10.1016/S1097-2765(01)00291-X; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Straight AF, 1999, CELL, V97, P245, DOI 10.1016/S0092-8674(00)80734-5; Thon G, 2000, GENETICS, V155, P551; VANDENBERG MA, 1995, EUR J BIOCHEM, V231, P704; Vu L, 1999, P NATL ACAD SCI USA, V96, P4390, DOI 10.1073/pnas.96.8.4390; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7	41	70	71	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					1003	1014		10.1016/S0092-8674(02)01193-5	http://dx.doi.org/10.1016/S0092-8674(02)01193-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507427	Bronze			2022-12-28	WOS:000180086000010
J	Kaech, SM; Hemby, S; Kersh, E; Ahmed, R				Kaech, SM; Hemby, S; Kersh, E; Ahmed, R			Molecular and functional profiling of memory CD8 T cell differentiation	CELL			English	Article							VIRAL-INFECTION; CYTOKINE PRODUCTION; EFFECTOR FUNCTION; GENE-EXPRESSION; IN-VIVO; ACTIVATION; NAIVE; LYMPHOCYTES; GENERATION; IMMUNITY	How and when memory T cells form during an immune response are long-standing questions. To better understand memory CD8 T cell development, a time course of gene expression and functional changes in antigen-specific T cells during viral infection was evaluated. The expression of many genes continued to change after viral clearance in accordance with changes in CD8 T cell functional properties. Even though memory cell precursors were present at the peak of the immune response, these cells did not display hallmark functional traits of memory T cells. However, these cells gradually acquired the memory cell qualities of self-renewal and rapid recall to antigen suggesting the model that antigen-specific CD8 T cells progressively differentiate into memory cells following viral infection.	Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Yerkes Natl Primate Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, 1510 Clifton Rd, Atlanta, GA 30322 USA.			Hemby, Scott/0000-0002-6987-1133	NIAID NIH HHS [AI30048] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI030048, R01AI030048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AHMED R, 1987, J VIROL, V61, P3920, DOI 10.1128/JVI.61.12.3920-3929.1987; Bachmann MF, 1999, EUR J IMMUNOL, V29, P291, DOI 10.1002/(SICI)1521-4141(199901)29:01<291::AID-IMMU291>3.0.CO;2-K; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; Chao CC, 1997, J IMMUNOL, V159, P1686; Chow S, 2001, CYTOMETRY, V46, P72, DOI 10.1002/cyto.1067; Deeths MJ, 1999, J IMMUNOL, V163, P102; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Goldrath AW, 2002, J EXP MED, V195, P1515, DOI 10.1084/jem.20020033; Grayson JM, 2000, J IMMUNOL, V164, P3950, DOI 10.4049/jimmunol.164.8.3950; Grayson JM, 2001, J IMMUNOL, V166, P795, DOI 10.4049/jimmunol.166.2.795; HATHCOCK K, 2003, IN PRESS J IMMUNOL; Homann D, 2001, NAT MED, V7, P913, DOI 10.1038/90950; Hu H, 2001, NAT IMMUNOL, V2, P705, DOI 10.1038/90643; Jacob J, 1999, NATURE, V399, P593, DOI 10.1038/21208; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; JOHNSON ED, 1975, J EXP MED, V141, P866; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kaech SM, 2002, NAT REV IMMUNOL, V2, P251, DOI 10.1038/nri778; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Liu K, 2001, J IMMUNOL, V166, P7335, DOI 10.4049/jimmunol.166.12.7335; Manjunath N, 2001, J CLIN INVEST, V108, P871, DOI 10.1172/JCI13296; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Moser B, 2001, NAT IMMUNOL, V2, P123, DOI 10.1038/84219; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Oehen S, 1998, J IMMUNOL, V161, P5338; Opferman JT, 1999, SCIENCE, V283, P1745, DOI 10.1126/science.283.5408.1745; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Tuosto L, 2001, EUR J IMMUNOL, V31, P345, DOI 10.1002/1521-4141(200102)31:2<345::AID-IMMU345>3.3.CO;2-C; Veiga-Fernandes H, 2000, NAT IMMUNOL, V1, P47, DOI 10.1038/76907; Voehringer D, 2001, J IMMUNOL, V167, P4838, DOI 10.4049/jimmunol.167.9.4838; VOLKERT M, 1974, J EXP MED, V139, P1329, DOI 10.1084/jem.139.5.1329; Yue HB, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.8.e41; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	42	738	752	2	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					837	851		10.1016/S0092-8674(02)01139-X	http://dx.doi.org/10.1016/S0092-8674(02)01139-X			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526810	Bronze			2022-12-28	WOS:000179862600010
J	Bhatia, R; Thorne-Lyman, AL				Bhatia, R; Thorne-Lyman, AL			Food shortages and nutrition in North Korea	LANCET			English	Article							FAMINE		World Food Programme, I-00148 Rome, Italy		Bhatia, R (corresponding author), World Food Programme, Via CG Viola 68,Parco Medici, I-00148 Rome, Italy.							Natsios A., 2001, GREAT N KOREAN FAMIN; Noland M, 2001, ECON DEV CULT CHANGE, V49, P741, DOI 10.1086/452523; YOUNG H, 1995, DISASTERS, V19, P94, DOI 10.1111/j.1467-7717.1995.tb00361.x	3	13	13	0	5	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S27	S28		10.1016/S0140-6736(02)11809-5	http://dx.doi.org/10.1016/S0140-6736(02)11809-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504492				2022-12-28	WOS:000180064500013
J	Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G				Zhang, L; Conejo-Garcia, JR; Katsaros, D; Gimotty, PA; Massobrio, M; Regnani, G; Makrigiannakis, A; Gray, H; Schlienger, K; Liebman, MN; Rubin, SC; Coukos, G			Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; ENDOTHELIAL GROWTH-FACTOR; CHEMOKINE RECEPTOR EXPRESSION; RECOMBINANT INTERLEUKIN-2; PROGNOSTIC-SIGNIFICANCE; PATIENT SURVIVAL; INTERFERON-GAMMA; CARCINOMA CELLS; DENDRITIC CELLS; INHIBITION	Background: Although tumor-infiltrating T cells have been documented in ovarian carcinoma, a clear association with clinical outcome has not been established. Methods: We performed immunohistochemical analysis of 186 frozen specimens from advanced-stage ovarian carcinomas to assess the distribution of tumor-infiltrating T cells and conducted outcome analyses. Molecular analyses were performed in some tumors by real-time polymerase chain reaction. Results: CD3+ tumor-infiltrating T cells were detected within tumor-cell islets (intratumoral T cells) in 102 of the 186 tumors (54.8 percent); they were undetectable in 72 tumors (38.7 percent); the remaining 12 tumors (6.5 percent) could not be evaluated. There were significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons). The five-year overall survival rate was 38.0 percent among patients whose tumors contained T cells and 4.5 percent among patients whose tumors contained no T cells in islets. Significant differences in the distributions of progression-free survival and overall survival according to the presence or absence of intratumoral T cells (P<0.001 for both comparisons) were also seen among 74 patients with a complete clinical response after debulking and platinum-based chemotherapy: the five-year overall survival rate was 73.9 percent among patients whose tumors contained T cells and 11.9 percent among patients whose tumors contained no T cells in islets. The presence of intratumoral T cells independently correlated with delayed recurrence or delayed death in multivariate analysis and was associated with increased expression of interferon-(gamma), interleukin-2, and lymphocyte-attracting chemokines within the tumor. The absence of intratumoral T cells was associated with increased levels of vascular endothelial growth factor. Conclusions: The presence of intratumoral T cells correlates with improved clinical outcome in advanced ovarian carcinoma.	Univ Penn, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Dept Obstet & Gynecol, Div Gynecol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; Univ Turin, Dept Obstet & Gynecol, Turin, Italy; Univ Heraklion, Dept Obstet & Gynecol, Iraklion, Greece	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Turin	Coukos, G (corresponding author), Univ Penn, Ctr Res Reprod & Womens Hlth, 1355 Biomed Res Bldg 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.		Liebman, Michael/A-8556-2009; Rubin, Stephen/U-8535-2019; Zhang, Lin/K-8478-2012; Coukos, George/ABG-7389-2020; Gimotty, Phyllis/GWZ-4136-2022; Conejo-Garcia, Jose R/V-1897-2019	Liebman, Michael/0000-0002-8626-8432; Rubin, Stephen/0000-0003-3688-5333; Gimotty, Phyllis/0000-0002-3850-9799; Conejo-Garcia, Jose R/0000-0001-6431-4074; Makrigiannakis, Antonis/0000-0002-8475-1500; Coukos, George/0000-0001-8813-7367	NATIONAL CANCER INSTITUTE [P50CA083638] Funding Source: NIH RePORTER; NCI NIH HHS [CA-83638] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berek JS, 1999, GYNECOL ONCOL, V75, P10, DOI 10.1006/gyno.1999.5532; Chen CA, 1999, GYNECOL ONCOL, V74, P235, DOI 10.1006/gyno.1999.5418; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dadmarz R D, 1996, Cancer J Sci Am, V2, P263; Favero J, 1998, BIOCHEM PHARMACOL, V56, P1539, DOI 10.1016/S0006-2952(98)00213-5; Freedman R S, 1996, Cancer Treat Res, V82, P115; Freedman RS, 2000, CLIN CANCER RES, V6, P2268; Fujita K, 1995, CLIN CANCER RES, V1, P501; HALAPI E, 1993, CANCER IMMUNOL IMMUN, V36, P191, DOI 10.1007/BF01741091; Halpern AC, 1997, SEMIN ONCOL, V24, pS2; Hartenbach EM, 1997, CANCER LETT, V121, P169, DOI 10.1016/S0304-3835(97)00350-9; Hayashi K, 1999, GYNECOL ONCOL, V74, P86, DOI 10.1006/gyno.1999.5430; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Jemal A, 2002, CA-CANCER J CLIN, V52, P119; Jemal A, 2002, CA-CANCER J CLIN, V52, P181; Jemal A, 2002, CA-CANCER J CLIN, V52, P23, DOI 10.3322/canjclin.52.1.23; Katsaros D, 2001, EUR J CANCER, V37, P478, DOI 10.1016/S0959-8049(00)00423-8; Kooi S, 1996, CELL IMMUNOL, V174, P116, DOI 10.1006/cimm.1996.0301; KOOI S, 1993, LYMPHOKINE CYTOK RES, V12, P429; Loercher AE, 1999, J IMMUNOL, V163, P6251; Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963; Luo LY, 2001, CLIN CANCER RES, V7, P2372; Markman M, 2000, Oncologist, V5, P26, DOI 10.1634/theoncologist.5-1-26; Marrogi AJ, 1997, INT J CANCER, V74, P492, DOI 10.1002/(SICI)1097-0215(19971021)74:5<492::AID-IJC3>3.0.CO;2-Z; Naito Y, 1998, CANCER RES, V58, P3491; Nakano O, 2001, CANCER RES, V61, P5132; Nakashima M, 1999, NAT MED, V5, P938, DOI 10.1038/11383; Negus RPM, 1997, AM J PATHOL, V150, P1723; Ohm JE, 2001, IMMUNOL RES, V23, P263, DOI 10.1385/IR:23:2-3:263; Ozols RF, 2000, SEMIN ONCOL, V27, P47; PEOPLES GE, 1995, P NATL ACAD SCI USA, V92, P432, DOI 10.1073/pnas.92.2.432; Pertl U, 2001, J IMMUNOL, V166, P6944, DOI 10.4049/jimmunol.166.11.6944; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Rubin SC, 1999, OBSTET GYNECOL, V93, P21, DOI 10.1016/S0029-7844(98)00334-2; Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Santin AD, 2000, OBSTET GYNECOL, V96, P422, DOI 10.1016/S0029-7844(00)00916-9; Santin AD, 2001, GYNECOL OBSTET INVES, V51, P254, DOI 10.1159/000058060; SAS INSTITUTE, 2000, SAS STAT US GUID VER; SCHLIENGER K, IN PRESS CLIN CANC R; Schumacher K, 2001, CANCER RES, V61, P3932; Shen GH, 2000, BRIT J CANCER, V83, P196; *SPSS, 1997, SPSS ADV STAT VERS 7; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; Sun H, 2001, J IMMUNOTHER, V24, P138, DOI 10.1097/00002371-200103000-00008; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; VESALAINEN S, 1994, EUR J CANCER, V30A, P1797, DOI 10.1016/0959-8049(94)E0159-2; Windbichler GH, 2000, BRIT J CANCER, V82, P1138; Woo EY, 2001, CANCER RES, V61, P4766	50	2433	2521	5	112	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					203	213		10.1056/NEJMoa020177	http://dx.doi.org/10.1056/NEJMoa020177			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529460	Bronze			2022-12-28	WOS:000180390600004
J	Jilma, B; Kamath, S; Lip, GYH				Jilma, B; Kamath, S; Lip, GYH			ABC of antithrombotic therapy - Antithrombotic therapy in special circumstances. II - In children, thrombophilia, and miscellaneous conditions	BRITISH MEDICAL JOURNAL			English	Review									Univ Hosp Vienna, Dept Clin Pharmacol, Vienna, Austria; Univ Birmingham, City Hosp, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham B15 2TT, W Midlands, England	University Hospital Vienna; University of Birmingham	Jilma, B (corresponding author), Univ Hosp Vienna, Dept Clin Pharmacol, Vienna, Austria.			Jilma, Bernd/0000-0001-5652-7977				Cumming AM, 1999, CLIN LAB HAEMATOL, V21, P77, DOI 10.1046/j.1365-2257.1999.00210.x; Monagle P, 2001, CHEST, V119, p344S, DOI 10.1378/chest.119.1_suppl.344S; Streif Werner, 1999, Current Opinion in Pediatrics, V11, P56, DOI 10.1097/00008480-199902000-00011; Walker ID, 2001, BRIT J HAEMATOL, V114, P512, DOI 10.1046/j.1365-2141.2001.02981.x	4	13	17	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					93	96		10.1136/bmj.326.7380.93	http://dx.doi.org/10.1136/bmj.326.7380.93			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521976	Green Published			2022-12-28	WOS:000180426900020
J	Shaw, FE; Bond, J; Richardson, DA; Dawson, P; Steen, IN; McKeith, IG; Kenny, RA				Shaw, FE; Bond, J; Richardson, DA; Dawson, P; Steen, IN; McKeith, IG; Kenny, RA			Multifactorial intervention after a fall in older people with cognitive impairment and dementia presenting to the accident and emergency department: randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							ELDERLY PATIENTS; COMMUNITY; RISK; ALZHEIMERS; DISEASE; BALANCE; SYNCOPE; REDUCE	Objective To determine the effectiveness of multifactorial intervention after a fall in older patients with cognitive impairment and dementia attending the accident and emergency department. Design Randomised controlled trial. Participants 274 cognitively impaired older people (aged 65 or over) presenting to accident and emergency department after a fall: 130 were randomised to assessment and intervention and 144 were randomised to assessment followed by conventional care (control group). Setting Two accident and emergency departments, Newcastle upon Tyne. Main outcome measures Primary outcome was number of participants who fell in year after intervention. Secondary outcomes were number of falls (corrected for diary returns), time to first fall, injury rates, fall related attendances at the accident and emergency department, fall related hospital admissions, and mortality. Results Intention to treat analysis showed no significant difference between intervention and control groups in proportion of patients who fell during 1 year's follow up (74% (96/130) and 80% (115/144), relative risk ratio 0.92, 95% confidence interval 0.81 to 1.05). No significant differences were found between groups for secondary outcome measures. Conclusions Multifactorial intervention was not effective in preventing falls in older people with cognitive impairment and dementia presenting to the accident and emergency department after a fall.	Newcastle Gen Hosp, Dept Old Age Psychiat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Royal Victoria Infirm, Cardiovasc Invest Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Newcastle Upon Tyne, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4AA, Tyne & Wear, England; Northumbria Univ, Div Physiotherapy & Appl Life Sci, Newcastle Upon Tyne NE7 7XA, Tyne & Wear, England	Newcastle General Hospital; Newcastle University - UK; Newcastle University - UK; Northumbria University	Shaw, FE (corresponding author), Newcastle Gen Hosp, Dept Old Age Psychiat, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.		McKeith, Ian/AAH-3382-2021	Kenny, Rose Anne/0000-0002-9336-8124; McKeith, Ian/0000-0002-9250-0568				Ballard C, 1998, NEUROLOGY, V51, P1760, DOI 10.1212/WNL.51.6.1760; BERGHMANS RLP, 1995, INT J GERIATR PSYCH, V10, P647, DOI 10.1002/gps.930100803; BURKE WJ, 1994, J AUTONOM NERV SYST, V48, P65, DOI 10.1016/0165-1838(94)90160-0; Campbell AJ, 1997, BMJ-BRIT MED J, V315, P1065, DOI 10.1136/bmj.315.7115.1065; Chong RKY, 1999, J GERONTOL A-BIOL, V54, pM122, DOI 10.1093/gerona/54.3.M122; Close J, 1999, LANCET, V353, P93, DOI 10.1016/S0140-6736(98)06119-4; Davies AJ, 1996, AGE AGEING, V25, P362, DOI 10.1093/ageing/25.5.362; *DEP HLTH, 2001, NAT SERV FRAM OLD PE, P76; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; KOCH M, 1994, PHYS THER, V74, P286, DOI 10.1093/ptj/74.4.286; LAURITZEN JB, 1993, LANCET, V341, P11, DOI 10.1016/0140-6736(93)92480-H; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; MCINTOSH S, 1993, AGE AGEING, V22, P53, DOI 10.1093/ageing/22.1.53; MULROW CD, 1994, JAMA-J AM MED ASSOC, V271, P519, DOI 10.1001/jama.271.7.519; Ray WA, 1997, JAMA-J AM MED ASSOC, V278, P557, DOI 10.1001/jama.278.7.557; RUBENSTEIN LZ, 1990, ANN INTERN MED, V113, P308, DOI 10.7326/0003-4819-113-4-308; TIDEIKSAAR R, 1986, GERIATRICS, V41, P26; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; TINETTI ME, 1994, NEW ENGL J MED, V331, P821, DOI 10.1056/NEJM199409293311301; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; VANDIJK PTM, 1993, GERONTOLOGIST, V33, P200, DOI 10.1093/geront/33.2.200; Ward CR, 1998, HEART, V79, P45, DOI 10.1136/hrt.79.1.45; Wolf SL, 1996, J AM GERIATR SOC, V44, P489, DOI 10.1111/j.1532-5415.1996.tb01432.x; World Health Organization, 1993, ICD 10 CLASS MENT BE, P29	24	263	262	0	21	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					73	+		10.1136/bmj.326.7380.73	http://dx.doi.org/10.1136/bmj.326.7380.73			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YC	12521968	Green Published			2022-12-28	WOS:000180426900012
J	Li, ZY; Xi, XD; Gu, MY; Feil, R; Ye, RD; Eigenthaler, M; Hofmann, F; Du, XP				Li, ZY; Xi, XD; Gu, MY; Feil, R; Ye, RD; Eigenthaler, M; Hofmann, F; Du, XP			A stimulatory role for cGMP-dependent protein kinase in platelet activation	CELL			English	Article							VON-WILLEBRAND-FACTOR; ACUTE MYOCARDIAL-INFARCTION; ASIALO-VONWILLEBRAND-FACTOR; BERNARD-SOULIER-SYNDROME; GLYCOPROTEIN-IB; MONOCLONAL-ANTIBODY; NITRIC-OXIDE; CYCLIC-GMP; GUANOSINE 3',5'-MONOPHOSPHATE; INTEGRIN ALPHA(IIB)BETA(3)	It is currently accepted that cGMP-dependent protein kinase (PKG) inhibits platelet activation. Here, we show that PKG plays an important stimulatory role in platelet activation. Expression of recombinant PKG in a reconstituted cell model enhanced von Willebrand factor (vWF)-induced activation of the platelet integrin alpha(IIb)beta(3). PKG knockout mice showed impaired platelet responses to vWF or low doses of thrombin and prolonged bleeding time. Human platelet aggregation induced by vWF or low-dose thrombin was inhibited by PKG inhibitors but enhanced by cGMP. Furthermore, a cGMP-enhancing agent, sildenafil, promoted vWF- or thrombin-induced platelet aggregation. The cGMP-stimulated platelet responses are biphasic, consisting of an initial transient stimulatory response that promotes platelet aggregation and a subsequent inhibitory response that limits the size of thrombi.	Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA; Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; Med Uniklin Bau 4 Klin Biochem, D-97080 Wurzburg, Germany	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Technical University of Munich; University of Wurzburg	Du, XP (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave, Chicago, IL 60612 USA.		Feil, Robert/B-8918-2014; Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020	Feil, Robert/0000-0002-7335-4841; Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL052547, R01HL068819, R01HL062350] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL062350, R01 HL068819, HL68819, HL62350] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Arora RR, 1999, NEW ENGL J MED, V341, P700, DOI 10.1056/NEJM199908263410915; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Azula FJ, 1996, MOL PHARMACOL, V50, P367; Browning DD, 2000, J BIOL CHEM, V275, P2811, DOI 10.1074/jbc.275.4.2811; Canobbio I, 2001, J BIOL CHEM, V276, P26022, DOI 10.1074/jbc.M102639200; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DEMARCO L, 1985, J CLIN INVEST, V75, P1198, DOI 10.1172/JCI111816; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; DU XP, 1999, ADV MOL CEL, V28, P269; Feenstra J, 1998, LANCET, V352, P957, DOI 10.1016/S0140-6736(98)00015-4; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Ginsberg Mark H., 1992, Current Opinion in Cell Biology, V4, P766, DOI 10.1016/0955-0674(92)90099-X; GRALNICK HR, 1985, J CLIN INVEST, V75, P19; Greco NJ, 1996, BIOCHEMISTRY-US, V35, P906, DOI 10.1021/bi951503y; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; HALBRUGGE M, 1990, J BIOL CHEM, V265, P3088; Haslam RJ, 1999, THROMB HAEMOSTASIS, V82, P412; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Hood J, 1998, J BIOL CHEM, V273, P23504, DOI 10.1074/jbc.273.36.23504; JAMIESON GA, 1978, J CLIN INVEST, V61, P861, DOI 10.1172/JCI109000; Li ZY, 2001, J BIOL CHEM, V276, P42226, DOI 10.1074/jbc.M106129200; Lopez JA, 1998, BLOOD, V91, P4397, DOI 10.1182/blood.V91.12.4397.412k42_4397_4418; Massberg S, 1999, J EXP MED, V189, P1255, DOI 10.1084/jem.189.8.1255; MAURICE DH, 1990, MOL PHARMACOL, V37, P671; MELLION BT, 1981, BLOOD, V57, P946; Mitka M, 2000, JAMA-J AM MED ASSOC, V283, P590, DOI 10.1001/jama.283.5.590; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Porter A, 1999, CLIN CARDIOL, V22, P762, DOI 10.1002/clc.4960221122; Ramakrishnan V, 2001, P NATL ACAD SCI USA, V98, P1823, DOI 10.1073/pnas.98.4.1823; RUAN CG, 1987, BLOOD, V69, P570; SAKARIASSEN KS, 1979, NATURE, V279, P636, DOI 10.1038/279636a0; SANDBERG M, 1989, FEBS LETT, V255, P321, DOI 10.1016/0014-5793(89)81114-7; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SAVAGE B, 1992, J BIOL CHEM, V267, P11300; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Sullam PM, 1998, J BIOL CHEM, V273, P5331, DOI 10.1074/jbc.273.9.5331; Wallis RM, 1999, AM J CARDIOL, V83, p3C; Ward CM, 1996, BIOCHEMISTRY-US, V35, P4929, DOI 10.1021/bi952456c; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; WEISS HJ, 1978, J LAB CLIN MED, V92, P750; Wu Y, 2001, BLOOD, V97, P3836, DOI 10.1182/blood.V97.12.3836; YAMAMOTO N, 1985, THROMB RES, V39, P751, DOI 10.1016/0049-3848(85)90259-2; Yan BX, 2000, J BIOL CHEM, V275, P39964, DOI 10.1074/jbc.M007041200	47	213	225	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					77	86		10.1016/S0092-8674(02)01254-0	http://dx.doi.org/10.1016/S0092-8674(02)01254-0			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526795	Bronze			2022-12-28	WOS:000181191500008
J	Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW				Lucas, RJ; Hattar, S; Takao, M; Berson, DM; Foster, RG; Yau, KW			Diminished pupillary light reflex at high irradiances in melanopsin-knockout mice	SCIENCE			English	Article							GANGLION-CELLS; OLIVARY	In the mammalian retina, a small subset of retinal ganglion cells (RGCs) are intrinsically photosensitive, express the opsin-like protein melanopsin, and project to brain nuclei involved in non image-forming visual functions such as pupillary light re ex and circadian photoentrainment. We report that in mice with the melanopsin gene ablated, RGCs retrograde-labeled from the suprachiasmatic nuclei were no longer intrinsically photosensitive, although their number, morphology, and projections were unchanged. These animals showed a pupillary light re ex indistinguishable from that of the wild type at low irradiances, but at high irradiances the re ex was incomplete, a pattern that suggests that the melanopsin-associated system and the classical rod/cone system are complementary in function.	Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, London W6 8RF, England; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Imperial College London; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Brown University	Lucas, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fac Med, Charing Cross Campus,St Dunstans Rd, London W6 8RF, England.	r.j.lucas@ic.ac.uk; kwyau@mail.jhmi.edu	Hattar, Samer/W-6927-2019	FOSTER, RUSSELL/0000-0001-6055-2067; Lucas, Robert/0000-0002-1088-8029	NATIONAL EYE INSTITUTE [R37EY006837, R01EY006837, R01EY014596] Funding Source: NIH RePORTER; NEI NIH HHS [R37 EY006837, R01 EY006837-16A1, R01 EY014596-01, R37 EY006837-15S1, R01 EY006837, R37 EY006837-13, R01 EY014596, R37 EY006837-15, R37 EY006837-14] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; TREJO LJ, 1984, BRAIN RES, V300, P49, DOI 10.1016/0006-8993(84)91340-4	12	615	634	3	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					245	247		10.1126/science.1077293	http://dx.doi.org/10.1126/science.1077293			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522249				2022-12-28	WOS:000180284000037
J	Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE				Queller, DC; Ponte, E; Bozzaro, S; Strassmann, JE			Single-gene greenbeard effects in the social amoeba Dictyostelium discoideum	SCIENCE			English	Article							CELL-ADHESION	Selection can favor reproductive altruism if an altruism allele aids copies of itself by helping relatives. The alternative "greenbeard" mechanism, in which an allele directly recognizes and aids copies of itself in others, is generally thought to be too complex for a single gene to carry out. The csA gene in Dictyostelium discoideum acts as a single-gene greenbeard. When wild-type cells are mixed with csA-knockout cells, the wild type is more altruistic, but is also able preferentially to direct the benefits to other wild-type cells. Both properties derive directly from homophilic cell adhesion of the protein encoded by csA.	Rice Univ, Dept Ecol & Evolut, Houston, TX 77251 USA; Univ Turin, Osped S Luigi, Dept Clin & Biol Sci, I-10043 Orbassano, Italy	Rice University; University of Turin	Queller, DC (corresponding author), Rice Univ, Dept Ecol & Evolut, POB 1892, Houston, TX 77251 USA.			bozzaro, salvatore/0000-0001-6323-6190; Strassmann, Joan/0000-0003-0638-8440				Alexander R. D., 1979, DARWINISM HUMAN AFFA; Bozzaro S, 1995, EXPERIENTIA, V51, P1175, DOI 10.1007/BF01944735; Dawkins Richard, 1976, SELFISH GENE; FORTUNATO A, IN PRESS MOL ECOL; Haig D, 1996, P NATL ACAD SCI USA, V93, P6547, DOI 10.1073/pnas.93.13.6547; HAIG D, 1996, BEHAV ECOLOGY EVOLUT, P284; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HARLOFF C, 1989, GENE DEV, V3, P2011, DOI 10.1101/gad.3.12a.2011; Keller L, 1998, NATURE, V394, P573, DOI 10.1038/29064; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Krieger MJB, 2002, SCIENCE, V295, P328, DOI 10.1126/science.1065247; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Maree AFM, 1999, J THEOR BIOL, V199, P297, DOI 10.1006/jtbi.1999.0958; Ponte E, 1998, P NATL ACAD SCI USA, V95, P9360, DOI 10.1073/pnas.95.16.9360; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087	18	202	207	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					105	106		10.1126/science.1077742	http://dx.doi.org/10.1126/science.1077742			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511650				2022-12-28	WOS:000180165800043
J	Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW				Sutton, MA; Schmidt, EF; Choi, KH; Schad, CA; Whisler, K; Simmons, D; Karanian, DA; Monteggia, LM; Neve, RL; Self, DW			Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour	NATURE			English	Article							AMPHETAMINE ADMINISTRATION ALTERS; RAT NUCLEUS-ACCUMBENS; IN-VIVO; GLUTAMATE TRANSMISSION; PREFRONTAL CORTEX; EXPRESSION; NEURONS; SENSITIZATION; SENSITIVITY; RESPONSES	Cocaine addiction is thought to involve persistent neurobiological changes that facilitate relapse to drug use despite efforts to abstain. But the propensity for relapse may be reduced by extinction training-a form of inhibitory learning that progressively reduces cocaine-seeking behaviour in the absence of cocaine reward(1). Here we show that extinction training during withdrawal from chronic cocaine self-administration induces experience-dependent increases in the GluR1 and GluR2/3 subunits of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate) glutamate receptors in the nucleus accumbens shell, a brain region that is critically involved in cocaine reward(2-5). Increases in the GluR1 subunit are positively associated with the level of extinction achieved during training, suggesting that GluR1 may promote extinction of cocaine seeking. Indeed, viral-mediated overexpression of both GluR1 and GluR2 in nucleus accumbens shell neurons facilitates extinction of cocaine- but not sucrose-seeking responses. A single extinction training session, when conducted during GluR subunit overexpression, attenuates stress-induced relapse to cocaine seeking even after GluR overexpression declines. Our findings indicate that extinction-induced plasticity in AMPA receptors may facilitate control over cocaine seeking by restoring glutamatergic tone in the nucleus accumbens, and may reduce the propensity for relapse under stressful situations in prolonged abstinence.	Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA; Yale Univ, Sch Med, Div Mol Psychiat, New Haven, CT 06520 USA; Yale Univ, Sch Med, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Yale University; Harvard University	Self, DW (corresponding author), Univ Texas, SW Med Ctr, Seay Ctr Basic & Appl Res Psychiat Illness, Dept Psychiat, Dallas, TX 75390 USA.		Schmidt, Eric F./AAE-8723-2019; Jansen, Heiko T./A-5770-2008; Sutton, Michael/C-6264-2011	Schmidt, Eric F./0000-0002-7869-0270; Jansen, Heiko T./0000-0003-0178-396X; Sutton, Michael/0000-0002-0692-6459				Bell K, 2000, NEUROPSYCHOPHARMACOL, V23, P335, DOI 10.1016/S0893-133X(00)00100-7; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; Cornish JL, 1999, NEUROSCIENCE, V93, P1359, DOI 10.1016/S0306-4522(99)00214-6; Cornish JL, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-15-j0006.2000; Fabbricatore A. T., 1998, Society for Neuroscience Abstracts, V24, P1736; Guitart X, 2000, NEUROPSYCHOPHARMACOL, V23, P539, DOI 10.1016/S0893-133X(00)00142-1; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; JAFFE JH, 1989, PSYCHOPHARMACOLOGY, V97, P59, DOI 10.1007/BF00443414; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Keys AS, 1998, SYNAPSE, V30, P393, DOI 10.1002/(SICI)1098-2396(199812)30:4<393::AID-SYN6>3.0.CO;2-H; London ED, 1999, CRIT REV NEUROBIOL, V13, P227, DOI 10.1615/CritRevNeurobiol.v13.i3.10; Lu WX, 1997, SYNAPSE, V26, P269, DOI 10.1002/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5; Lu WX, 1999, SYNAPSE, V32, P119, DOI 10.1002/(SICI)1098-2396(199905)32:2<119::AID-SYN5>3.0.CO;2-F; MCLENNAN H, 1980, NEUROSCI LETT, V18, P313, DOI 10.1016/0304-3940(80)90303-1; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; PETTIT HO, 1984, PSYCHOPHARMACOLOGY, V84, P167, DOI 10.1007/BF00427441; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Robbins SJ, 1997, ADDICT BEHAV, V22, P157, DOI 10.1016/S0306-4603(96)00007-X; ROBERTS DCS, 1980, PHARMACOL BIOCHEM BE, V12, P781, DOI 10.1016/0091-3057(80)90166-5; Schmidt EF, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-07-j0003.2001; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Sinha R, 1999, PSYCHOPHARMACOLOGY, V142, P343, DOI 10.1007/s002130050898; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Volkow ND, 2000, CEREB CORTEX, V10, P318, DOI 10.1093/cercor/10.3.318; VOLKOW ND, 1992, SYNAPSE, V11, P184, DOI 10.1002/syn.890110303; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; ZITO KA, 1985, PHARMACOL BIOCHEM BE, V23, P1029, DOI 10.1016/0091-3057(85)90110-8	30	266	272	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					70	75		10.1038/nature01249	http://dx.doi.org/10.1038/nature01249			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511956				2022-12-28	WOS:000180165500039
J	Hahn, ME				Hahn, ME			Advance directives and patient-physician communication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; END; LIFE; DEATH		Cornell Univ, Weill Med Coll, New York, NY 10021 USA; Rockefeller Univ, New York, NY 10021 USA	Cornell University; Rockefeller University	Hahn, ME (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.				NIGMS NIH HHS [GM07739] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Dales RE, 1999, CHEST, V116, P792, DOI 10.1378/chest.116.3.792; Dexter PR, 1998, ANN INTERN MED, V128, P102, DOI 10.7326/0003-4819-128-2-199801150-00005; Emanuel LL, 2000, ARCH FAM MED, V9, P1181, DOI 10.1001/archfami.9.10.1181; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; Goldblatt D, 2001, NEUROLOGY, V56, P148, DOI 10.1212/WNL.56.2.148; Gordon NP, 1999, ARCH INTERN MED, V159, P701, DOI 10.1001/archinte.159.7.701; Hammes BJ, 1998, ARCH INTERN MED, V158, P383, DOI 10.1001/archinte.158.4.383; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; Silveira MJ, 2000, JAMA-J AM MED ASSOC, V284, P2483, DOI 10.1001/jama.284.19.2483; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Sulmasy DP, 1998, ANN INTERN MED, V128, P621, DOI 10.7326/0003-4819-128-8-199804150-00002	11	21	21	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					96	96		10.1001/jama.289.1.96	http://dx.doi.org/10.1001/jama.289.1.96			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503989	Bronze			2022-12-28	WOS:000180136600037
J	Agrawal, M; Emanuel, EJ				Agrawal, M; Emanuel, EJ			Death and dignity: dogma disputed	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED TRIAL; OF-LIFE; ILL PATIENTS; CARE; QUALITY; END		NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Agrawal, M (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA.							ABIVEN M, 1991, World Health Forum, V12, P375; ADDINGTONHALL JM, 1992, BRIT MED J, V305, P1317, DOI 10.1136/bmj.305.6865.1317; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 2002, ARCH INTERN MED, V162, P142, DOI 10.1001/archinte.162.2.142; *I MED, 1997, APPR DEATH IMPR CARE; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884, DOI 10.1200/JCO.2001.19.18.3884; KANE RL, 1984, LANCET, V1, P890; Lynn J, 1997, J AM GERIATR SOC, V45, P526; MADAN TN, 1992, SOC SCI MED, V35, P425, DOI 10.1016/0277-9536(92)90335-N; Payne SA, 1996, PALLIATIVE MED, V10, P307, DOI 10.1177/026921639601000406; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Steinhauser Karen E, 2002, J Palliat Med, V5, P407, DOI 10.1089/109662102320135298; Weiss SC, 2001, LANCET, V357, P1311, DOI 10.1016/S0140-6736(00)04515-3	18	6	6	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					1997	1998		10.1016/S0140-6736(02)12031-9	http://dx.doi.org/10.1016/S0140-6736(02)12031-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504390				2022-12-28	WOS:000179974200003
J	Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M				Chochinov, HM; Hack, T; Hassard, T; Kristjanson, LJ; McClement, S; Harlos, M			Dignity in the terminally ill: a cross-sectional, cohort study	LANCET			English	Article							PHYSICIAN-ASSISTED SUICIDE; CANCER-PATIENTS; EUTHANASIA; EXPERIENCES; DEPRESSION; ATTITUDES; ILLNESS; OREGON; DEATH; LIFE	Background Considerations of dignity are often raised in reference to the care of dying patients. However, little research that addresses this issue has been done. Our aim was to identify the extent to which dying patients perceive they are able to maintain a sense of dignity, and to ascertain how demographic and disease-specific variables relate to the issue of dignity in these individuals. Methods We did a cross-sectional study of a cohort of terminally ill patients with cancer, who had a life expectancy of less than 6 months. We enrolled 213 patients from two palliative care units in Winnipeg, Canada, and asked them to rate their sense of dignity. Our main outcome measures included: a 7-point sense of dignity item; the symptom distress scale; the McGill pain questionnaire; the index of independence in activities of daily living (IADL); a quality of life scale; a brief battery of self-report measures, including screening for desire for death, anxiety, hopelessness, and will to live; burden to others; and requirement for social support. Findings 16 of 213 patients (7.5%; 95% Cl 4-11) indicated that loss of dignity was a great concern. These patients were far more than likely than the rest of the cohort to report psychological distress and symptom distress, heightened dependency needs, and loss of will to live. Interpretation Loss of dignity is closely associated with certain types of distress often seen among the terminally ill. Preservation of dignity should be an overall aim of treatment and care in patients who are nearing death.	Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada; Univ Manitoba, Fac Nursing, Winnipeg, MB R3E 3N4, Canada; CancerCare Manitoba, Winnipeg, MB, Canada; St Boniface Gen Hosp, Winnipeg, MB R2H 2A6, Canada; Edith Cowan Univ, Perth, WA, Australia	University of Manitoba; University of Manitoba; CancerCare Manitoba Foundation; University of Manitoba; Children's Hospital Research Institute of Manitoba; Edith Cowan University	Chochinov, HM (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB R3E 3N4, Canada.	chochin@cc.UManitoba.CA	Hack, Thomas/C-5174-2012; McClement, Susan E/H-7031-2016	Hack, Thomas/0000-0002-6913-8732; McClement, Susan E/0000-0002-9537-9900; Chochinov, Harvey/0000-0003-2656-4704				Allen JP, 1996, JAMA-J AM MED ASSOC, V275, P474; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BRORSSON B, 1984, SCAND J REHABIL MED, V16, P125; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; Chochinov HM, 2000, PSYCHOSOMATICS, V41, P500, DOI 10.1176/appi.psy.41.6.500; Chochinov HM, 2002, JAMA-J AM MED ASSOC, V287, P2253, DOI 10.1001/jama.287.17.2253; Chochinov HM, 1998, PSYCHOSOMATICS, V39, P366, DOI 10.1016/S0033-3182(98)71325-8; Chochinov HM, 1999, LANCET, V354, P816, DOI 10.1016/S0140-6736(99)80011-7; Chochinov HM, 2002, SOC SCI MED, V54, P433, DOI 10.1016/S0277-9536(01)00084-3; CHOCHINOV HM, 1995, AM J PSYCHIAT, V152, P1185; CRAIG TJ, 1974, AM J PSYCHIAT, V131, P1323; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; GRAHAM KY, 1987, CANCER NURS, V10, P338; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; LEVINE PM, 1978, CANCER, V42, P1385, DOI 10.1002/1097-0142(197809)42:3<1385::AID-CNCR2820420349>3.0.CO;2-0; MADAN TN, 1992, SOC SCI MED, V35, P425, DOI 10.1016/0277-9536(92)90335-N; McCorkle R, 1978, Cancer Nurs, V1, P373; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MELZACK R, 1975, PAIN, V1, P277, DOI 10.1016/0304-3959(75)90044-5; NOYES R, 1990, PSYCHOSOMATICS, V31, P321, DOI 10.1016/S0033-3182(90)72170-6; Pannuti F, 1993, World Health Forum, V14, P172; Pullman D, 1996, Health Law J, V4, P197; Quill TE, 2000, ANN INTERN MED, V132, P488, DOI 10.7326/0003-4819-132-6-200003210-00011; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Sullivan AD, 2000, NEW ENGL J MED, V342, P598, DOI 10.1056/NEJM200002243420822; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wilson KG, 2000, ARCH INTERN MED, V160, P2454, DOI 10.1001/archinte.160.16.2454	29	246	257	3	40	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2026	2030		10.1016/S0140-6736(02)12022-8	http://dx.doi.org/10.1016/S0140-6736(02)12022-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504398				2022-12-28	WOS:000179974200010
J	Hopkins, DR; Withers, PC				Hopkins, DR; Withers, PC			Sudan's war and eradication of dracunculiasis	LANCET			English	Article									Carter Ctr, Programme Support Hlth Programmes, Atlanta, GA 30307 USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Hopkins, DR (corresponding author), Carter Ctr, Programme Support Hlth Programmes, 1 Copenhill,453 Freedom Pkwy, Atlanta, GA 30307 USA.							FISCHER I, 2000, NY TIMES        0211; HOPKINS DR, IN PRESS AM J TROP M; *US CDC, 2001, MMWR-MORBID MORTAL W, V50, P269	3	14	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S21	S22		10.1016/S0140-6736(02)11806-X	http://dx.doi.org/10.1016/S0140-6736(02)11806-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504489				2022-12-28	WOS:000180064500010
J	Bekelman, JE; Li, Y; Gross, CP				Bekelman, JE; Li, Y; Gross, CP			Scope and impact of financial conflicts of interest in biomedical research - A systematic review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INDUSTRY RESEARCH RELATIONSHIPS; RANDOMIZED CLINICAL-TRIALS; NATIONAL-SURVEY; COMPETING INTERESTS; INTEREST POLICIES; ECONOMIC-ANALYSES; LIFE SCIENCES; PART 1; QUALITY; FACULTY	Context Despite increasing awareness about the potential impact of financial conflicts of interest on biomedical research, no comprehensive synthesis of the body of evidence relating to financial conflicts of interest has been performed. Objective To review original, quantitative studies on the extent, impact, and management of financial conflicts of interest in biomedical research. Data Sources Studies were identified by searching MEDLINE (January 1980-October 2002), the Web of Science citation database, references of articles, letters, commentaries, editorials, and books and by contacting experts. Study Selection All English-language studies containing original, quantitative data on financial relationships among industry, scientific investigators, and academic institutions were included. A total of 1664 citations were screened, 144 potentially eligible full articles were retrieved, and 37 studies met our inclusion criteria. Data Extraction One investigator (J.E.B.) extracted data from each of the 37 studies. The main outcomes were the prevalence of specific types of industry relationships, the relation between industry sponsorship and study outcome or investigator behavior, and the process for disclosure, review, and management of financial conflicts of interest. Data Synthesis Approximately one fourth of investigators have industry affiliations, and roughly two thirds of academic institutions hold equity in start-ups that sponsor research performed at the same institutions. Eight articles, which together evaluated 1140 original studies, assessed the relation between industry sponsorship and outcome in original research. Aggregating the results of these articles showed a statistically significant association between industry sponsorship and pro-industry conclusions (pooled Mantel-Haenszel odds ratio, 3.60; 95% confidence interval, 2.63-4.91). Industry sponsorship was also associated with restrictions on publication and data sharing, The approach to managing financial conflicts varied substantially across academic institutions and peer-reviewed journals. Conclusions Financial relationships among industry, scientific investigators, and academic institutions are widespread. Conflicts of interest arising from these ties can influence biomedical research in important ways.	Yale Univ, Sch Med, Primary Care Ctr, Dept Med, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Biostat, New Haven, CT 06520 USA	Yale University; Yale University	Gross, CP (corresponding author), Yale Univ, Sch Med, Primary Care Ctr, Dept Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	cary.gross@yale.edu						*AM ASS U, 2001, REP IND I FIN CONFL; *AM SOC GEN THER, 2000, POL AM SOC GEN THER; ANDERSON JJ, 1991, ARTHRITIS RHEUM-US, V34, P1304, DOI 10.1002/art.1780341015; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Berk PD, 1999, HEPATOLOGY, V30, P1332, DOI 10.1002/hep.510300532; Bero LA, 1997, ANN INTERN MED, V127, P37, DOI 10.7326/0003-4819-127-1-199707010-00007; Bero LA, 1996, INT J TECHNOL ASSESS, V12, P209, DOI 10.1017/S0266462300009582; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; BLUMENSTYK G, 2001, CHRONICLE HIGHE 1218; Blumenthal D, 1996, NEW ENGL J MED, V334, P368, DOI 10.1056/NEJM199602083340606; Blumenthal D, 1996, NEW ENGL J MED, V335, P1734, DOI 10.1056/NEJM199612053352305; BLUMENTHAL D, 1994, HEALTH AFFAIR, V13, P176, DOI 10.1377/hlthaff.13.3.176; Blumenthal D, 1997, JAMA-J AM MED ASSOC, V277, P1224, DOI 10.1001/jama.277.15.1224; Blumenthal D, 1997, NAT GENET, V16, P104, DOI 10.1038/ng0597-104; BLUMENTHAL D, 1986, SCIENCE, V232, P1361, DOI 10.1126/science.3715452; BLUMENTHAL D, 1986, SCIENCE, V231, P242, DOI 10.1126/science.3941897; Bodenheimer T, 2000, NEW ENGL J MED, V342, P1539, DOI 10.1056/NEJM200005183422024; Boyd EA, 2000, JAMA-J AM MED ASSOC, V284, P2209, DOI 10.1001/jama.284.17.2209; Breslow NE, 1987, STAT METHODS CANC RE; Campbell EG, 1998, JAMA-J AM MED ASSOC, V279, P995, DOI 10.1001/jama.279.13.995; Campbell EG, 2000, RES POLICY, V29, P303, DOI 10.1016/S0048-7333(99)00068-2; Campbell EG, 2002, JAMA-J AM MED ASSOC, V287, P473, DOI 10.1001/jama.287.4.473; Cho MK, 2000, JAMA-J AM MED ASSOC, V284, P2203, DOI 10.1001/jama.284.17.2203; Cho MK, 1996, ANN INTERN MED, V124, P485, DOI 10.7326/0003-4819-124-5-199603010-00004; Cohen JJ, 2001, ACAD MED, V76, P209, DOI 10.1097/00001888-200102000-00028; Cook DJ, 1997, ANN INTERN MED, V126, P376, DOI 10.7326/0003-4819-126-5-199703010-00006; Coyle SL, 2002, ANN INTERN MED, V136, P396, DOI 10.7326/0003-4819-136-5-200203050-00014; Coyle SL, 2002, ANN INTERN MED, V136, P403, DOI 10.7326/0003-4819-136-5-200203050-00015; Davidoff F, 2001, JAMA-J AM MED ASSOC, V286, P1232, DOI 10.1001/jama.286.10.1232; DAVIDSON RA, 1986, J GEN INTERN MED, V1, P155, DOI 10.1007/BF02602327; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V286, P89, DOI 10.1001/jama.286.1.89; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Dorman PJ, 1999, STROKE, V30, P1995, DOI 10.1161/01.STR.30.10.1995; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; Edwards SJ., 1998, HEALTH TECHNOL ASSES, V2, P1; EMANUEL EJ, 1995, NEW ENGL J MED, V332, P262, DOI 10.1056/NEJM199501263320412; *FOOD DRUG ADM, 2001, GUID IND CHOIC CONTR; Friedberg M, 1999, JAMA-J AM MED ASSOC, V282, P1453, DOI 10.1001/jama.282.15.1453; GART JJ, 1971, REV INST INT STAT, V39, P148, DOI 10.2307/1402171; Gelijns AC, 2002, JAMA-J AM MED ASSOC, V287, P72, DOI 10.1001/jama.287.1.72; Gillis J, 1999, WASHINGTON POST 0627, pA1; Gillis Justin, 2002, Washington Post, pA14; HEALY B, 1989, NEW ENGL J MED, V320, P949, DOI 10.1056/NEJM198904063201432; HILTS PJ, 2000, NY TIMES        0901, P26; Horton R, 1999, LANCET, V354, P1138, DOI 10.1016/S0140-6736(99)00328-1; Hussain A, 2001, BRIT MED J, V323, P263, DOI 10.1136/bmj.323.7307.263; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; KASSIRER JP, 1993, NEW ENGL J MED, V329, P570, DOI 10.1056/NEJM199308193290810; Kassirer JP, 2001, ANN INTERN MED, V134, P587, DOI 10.7326/0003-4819-134-7-200104030-00012; Kjaergard LL, 1999, HEPATOLOGY, V30, P1134, DOI 10.1002/hep.510300510; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; Knox KS, 2000, ANN ONCOL, V11, P1591, DOI 10.1023/A:1008309817708; Korn D, 2000, JAMA-J AM MED ASSOC, V284, P2234, DOI 10.1001/jama.284.17.2234; Krimsky S, 2001, SCI ENG ETHICS, V7, P205, DOI 10.1007/s11948-001-0041-7; Krimsky S, 1998, PSYCHOTHER PSYCHOSOM, V67, P194, DOI 10.1159/000012281; KRIMSKY S, 1991, SCI TECHNOL HUM VAL, V16, P275, DOI 10.1177/016224399101600301; Levinsky NG, 2002, NEW ENGL J MED, V347, P759, DOI 10.1056/NEJMsb020853; Lo B, 2000, NEW ENGL J MED, V343, P1616, DOI 10.1056/NEJM200011303432206; MANTEL N, 1959, J NATL CANCER I, V22, P719; McCrary SV, 2000, NEW ENGL J MED, V343, P1621, DOI 10.1056/NEJM200011303432207; McCray AT, 2000, ANN INTERN MED, V133, P609, DOI 10.7326/0003-4819-133-8-200010170-00013; Morin K, 2002, JAMA-J AM MED ASSOC, V287, P78, DOI 10.1001/jama.287.1.78; Moses H, 2001, JAMA-J AM MED ASSOC, V285, P933, DOI 10.1001/jama.285.7.933; Mulrow C, 1997, ANN INTERN MED, V127, P989, DOI 10.7326/0003-4819-127-11-199712010-00008; *NIH, 2000, NIH EXTR DAT TRENDS; PRESS E, 2000, ATLANTIC MONTHLY, V285, P39; PRESSMAN L, 2000, AUTM LICENSING SURVE; Rabino I, 1998, NATURWISSENSCHAFTEN, V85, P109, DOI 10.1007/s001140050464; Rennie D, 1997, JAMA-J AM MED ASSOC, V277, P1238, DOI 10.1001/jama.277.15.1238; Rennie D, 1999, JAMA-J AM MED ASSOC, V282, P1766, DOI 10.1001/jama.282.18.1766; Rettig RA, 2000, HEALTH AFFAIR, V19, P129, DOI 10.1377/hlthaff.19.2.129; ROBINS J, 1986, BIOMETRICS, V42, P311, DOI 10.2307/2531052; ROCHON PA, 1994, JAMA-J AM MED ASSOC, V272, P108, DOI 10.1001/jama.272.2.108; ROCHON PA, 1994, ARCH INTERN MED, V154, P157, DOI 10.1001/archinte.154.2.157; ROTHMAN KJ, 1994, NEW ENGL J MED, V331, P394, DOI 10.1056/NEJM199408113310611; Schulman KA, 2002, NEW ENGL J MED, V347, P1335, DOI 10.1056/NEJMsa020349; Shalala D, 2000, NEW ENGL J MED, V343, P808, DOI 10.1056/NEJM200009143431112; SLAVIN RE, 1995, J CLIN EPIDEMIOL, V48, P9, DOI 10.1016/0895-4356(94)00097-A; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; SWAEN GMH, 1988, BRIT J IND MED, V45, P624; *TASK FORC FIN CON, 2001, PROT SUBJ PRES TRUST; *TASK FORCE FIN CO, 2002, PROT SUBJ PRES TRUST, V2; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; TOPOL EJ, 1992, J AM COLL CARDIOL, V19, P1123, DOI 10.1016/0735-1097(92)90312-B; Turner C, 1997, ADDICTION, V92, P1423; WILSON D, 2001, SEATTLE TIMES   0311, P1; Yaphe J, 2001, FAM PRACT, V18, P565, DOI 10.1093/fampra/18.6.565	90	1290	1329	3	146	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					454	465		10.1001/jama.289.4.454	http://dx.doi.org/10.1001/jama.289.4.454			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533125				2022-12-28	WOS:000180472300027
J	Miklius, A; Cervelli, P				Miklius, A; Cervelli, P			Vulcanology: Interaction between Kilauea and Mauna Loa - Last year witnessed an unexpected communication between this pair of volcanoes.	NATURE			English	Article							HAWAIIAN VOLCANOS; MAGMA		US Geol Survey, Hawaiian Volcano Observ, Hawaii Natl Pk, HI 96718 USA	United States Department of the Interior; United States Geological Survey	Miklius, A (corresponding author), US Geol Survey, Hawaiian Volcano Observ, Hawaii Natl Pk, HI 96718 USA.			Cervelli, Peter/0000-0001-6765-1009				DANA JD, 1950, AM J SCI, V60, P235; FREY FA, 1993, PHILOS T R SOC A, V342, P121, DOI 10.1098/rsta.1993.0009; JAGGER TA, 1917, AM J SCI, V193, P255; KLEIN FW, 1982, J VOLCANOL GEOTH RES, V12, P1, DOI 10.1016/0377-0273(82)90002-6; Lockwood J. P., 1987, US GEOL SURV PROF PA, P537; RHODES JM, 1989, NATURE, V337, P257, DOI 10.1038/337257a0	6	36	36	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					229	229		10.1038/421229a	http://dx.doi.org/10.1038/421229a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529631	Bronze, Green Published			2022-12-28	WOS:000180397600034
J	Germain, A				Germain, A			Addressing inequalities: the role for the new WHO Director General	LANCET			English	Article									Int Womens Hlth Coalit, New York, NY 10010 USA		Germain, A (corresponding author), Int Womens Hlth Coalit, 24 E 21st St, New York, NY 10010 USA.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					171	172		10.1016/S0140-6736(03)12197-6	http://dx.doi.org/10.1016/S0140-6736(03)12197-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531597				2022-12-28	WOS:000180428000028
J	Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M				Manfrini, M; Innocenti, M; Ceruso, M; Mercuri, M			Original biological reconstruction of the hip in a 4-year-old girl	LANCET			English	Article							BONE	We resected the proximal femur in a 4-year-old child who had Ewing's sarcoma. We reconstructed her hip by an autotransplant of the ipsilateral proximal fibula with its vascular supply, inserted inside a massive bone allograft, and fixed to the residual femur by a plate. Serial postoperative imaging showed the progressive hypertrophy of the transplanted fibula, whose head displayed impressive tridimensional growth inside the acetabulum. 4 years after surgery, hip motility is 100degrees in flexion, 10degrees in extension, and 30degrees in abduction, and the patient's limb is weight bearing.	Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, I-40136 Bologna, Italy; Ctr Traumatol Ortoped, Unit REconstruct Microsurg, Florence, Italy	IRCCS Istituto Ortopedico Rizzoli	Manfrini, M (corresponding author), Ist Ortoped Rizzoli, Dept Musculo Skeletal Oncol, Via Pupulli 1, I-40136 Bologna, Italy.			MANFRINI, MARCO/0000-0003-2961-0171				Bacci G, 2000, J CLIN ONCOL, V18, P4, DOI 10.1200/JCO.2000.18.1.4; Innocenti M, 1998, J RECONSTR MICROSURG, V14, P137, DOI 10.1055/s-2007-1000157; Manfrini M, 1999, CLIN ORTHOP RELAT R, P111; MERCURI M, 1991, CLIN ORTHOP RELAT R, P156; Restrepo J., 1980, INT J MICROSUG, V2, P49	5	53	55	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					140	142		10.1016/S0140-6736(03)12192-7	http://dx.doi.org/10.1016/S0140-6736(03)12192-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531584				2022-12-28	WOS:000180428000016
J	Bearez, P; DeVries, TJ; Ortlieb, L				Bearez, P; DeVries, TJ; Ortlieb, L			Comment on "Otolith delta O-18 record of mid-Holocene sea surface temperatures in Peru"	SCIENCE			English	Editorial Material							BEACH RIDGE COMPLEX; EL-NINO; HISTORY; BP		Museum Natl Hist Nat, Ichtyol Gen & Appl Lab, F-75231 Paris 05, France; Inst Rech dev, Ur Paleotrop, F-93143 Bondy, France	Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD)	Bearez, P (corresponding author), Museum Natl Hist Nat, Ichtyol Gen & Appl Lab, 43 Rue Cuvier, F-75231 Paris 05, France.		ORTLIEB, Luc/A-8801-2011; Béarez, Philippe/D-2383-2012	Béarez, Philippe/0000-0003-0397-2393				ACERO AA, COMMUNICATION; Alamo V, 1987, B I MAR PERU CALLAO, VExtraordinario, P205; Allen G. R., 1994, FISHES TROPICAL E PA; Andrus CFT, 2002, SCIENCE, V295, P1508, DOI 10.1126/science.1062004; [Anonymous], COMMUNICATION, P31; Bearez P, 1996, REV BIOL TROP, V44, P731; Bearez Philippe, 2000, Archaeofauna, V9, P29; BORGO JL, 1966, INFORME I MAR PERU, V19; Bussing W.A., 1995, GUIA FAO IDENTIFICAC, VIII, P1629; CASTILLO PR, 2001, INF I MAR PERU, V159, P7; DEBUEN F, 1961, ZONARIDA B DEP INVES, V4, P2; DeVries TJ, 1997, SCIENCE, V276, P965, DOI 10.1126/science.276.5314.965; DEVRIES TJ, 1990, PALAEOGEOGR PALAEOCL, V81, P11, DOI 10.1016/0031-0182(90)90037-8; DEVRIES TJ, 1986, THESIS OHIO STATE U; DIAZ A, 1992, THESIS U R PALMA LIM; DIAZ A, 1991, 7 C PER GEOL LIM PER, P407; FROESE R, 2000, FISHBASE 2000 CONCEP; Kailola P.J., 1995, GUIA FAO IDENTIFICAC, V3, P860; KONG I, 1999, VOL RESUMENES, V34; PERRIER C, 1994, GEOGR PHYS QUATERN, V48, P23, DOI 10.7202/032970ar; Reitz EJ, 2001, INT J OSTEOARCHAEOL, V11, P163, DOI 10.1002/oa.554; Reitz EJ, 2001, J ARCHAEOL SCI, V28, P1085, DOI 10.1006/jasc.2000.0639; SAMARNE M, COMMUNICATION; Sandweiss DH, 1996, SCIENCE, V273, P1531, DOI 10.1126/science.273.5281.1531; Sandweiss DH, 1998, J COASTAL RES, V14, P367; SANDWEISS DH, 1997, SCIENCE, V276, P967; Sierra LM, 1994, ECOLOGIA PECES MARIN, P263; Wells LE, 1996, J COASTAL RES, V12, P1; WHITEHEAD PJP, 1995, GUIA FAO IDENTIFICAC, V2, P851; ZEVALLOS J, 2001, MERIUZA PERUANA MERI, P42	30	11	11	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604												2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522233				2022-12-28	WOS:000180284000045
J	Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH				Cai, Y; Yu, FW; Lin, SP; Chia, W; Yang, XH			Apical complex genes control mitotic spindle geometry and relative size of daughter cells in Drosophila neuroblast and pl asymmetric divisions	CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; ZINC-FINGER PROTEINS; C-ELEGANS EMBRYOS; PROSPERO GENE; 2 DISTINCT; G-ALPHA; LOCALIZATION; POLARITY; BAZOOKA; ORIENTATION	Drosophila neuroblast asymmetric divisions generate two daughters of unequal size and fate. A complex of apically localized molecules mediates basal localization of cell fate determinants and apicobasal orientation of the mitotic spindle, but how daughter cell size is controlled remains unclear. Here we show that mitotic spindle geometry and unequal daughter cell size are controlled by two parallel pathways (Bazooka/DaPKC and Pins/Galphai) within the apical complex. While the localized activity of either pathway alone is sufficient to mediate the generation of an asymmetric mitotic spindle and unequal size neuroblast daughters, loss of both pathways results in symmetric divisions. In sensory organ precursors, Bazooka/DaPKC and Pins/Galphai localize to opposite sides of the cortex and function in opposition to generate a symmetric spindle.	Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England; Inst Mol & Cell Biol, Singapore 117609, Singapore	University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Chia, W (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, Guys Hosp Campus,4th Floor New Hunts House, London SE1 1UL, England.	william.chia@kcl.ac.uk; mcbyangn@imcb.nus.edu.sg	Cai, Yu/R-7737-2019	Cai, Yu/0000-0003-2044-3290; Yu, Fengwei/0000-0003-0268-199X				ALBERTSON DG, 1984, DEV BIOL, V101, P61, DOI 10.1016/0012-1606(84)90117-9; Ashraf SI, 1999, EMBO J, V18, P6426, DOI 10.1093/emboj/18.22.6426; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Boyd L, 1996, DEVELOPMENT, V122, P3075; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cai Y, 2001, EMBO J, V20, P1704, DOI 10.1093/emboj/20.7.1704; CHULAGRAFF Q, 1991, DEVELOPMENT, P79; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ETEMADMOGHADAM B, 1995, CELL, V83, P743, DOI 10.1016/0092-8674(95)90187-6; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Giansanti MG, 2001, DEVELOPMENT, V128, P1137; Gotta M, 2001, NAT CELL BIOL, V3, P297, DOI 10.1038/35060092; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; HEUER JG, 1995, DEVELOPMENT, V121, P3861; IkeshimaKataoka H, 1997, NATURE, V390, P625, DOI 10.1038/37641; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Kraut R, 1996, NATURE, V383, P50, DOI 10.1038/383050a0; Kraut R, 1996, DEV BIOL, V174, P65, DOI 10.1006/dbio.1996.0052; Kuchinke U, 1998, CURR BIOL, V8, P1357, DOI 10.1016/S0960-9822(98)00016-5; Lu BW, 1999, MOL CELL, V4, P883, DOI 10.1016/S1097-2765(00)80218-X; MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; Roegiers F, 2001, NAT CELL BIOL, V3, P58, DOI 10.1038/35050568; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schmid A, 1999, DEVELOPMENT, V126, P4653; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X; Siderovski DP, 1999, TRENDS BIOCHEM SCI, V24, P340, DOI 10.1016/S0968-0004(99)01441-3; SPANA EP, 1995, DEVELOPMENT, V121, P3187; UEMURA T, 1989, CELL, V58, P349, DOI 10.1016/0092-8674(89)90849-0; VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8; Wang SW, 1997, DEVELOPMENT, V124, P4435; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2002, MOL CELL BIOL, V22, P4230, DOI 10.1128/MCB.22.12.4230-4240.2002	41	113	116	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					51	62		10.1016/S0092-8674(02)01170-4	http://dx.doi.org/10.1016/S0092-8674(02)01170-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526793	Bronze			2022-12-28	WOS:000181191500006
J	Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K				Fotiadis, D; Liang, Y; Filipek, S; Saperstein, DA; Engel, A; Palczewski, K			Atomic-force microscopy: Rhodopsin dimers in native disc membranes	NATURE			English	Article									Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Chem, Seattle, WA 98195 USA	University of Basel; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.	palczews@u.washington.edu	Filipek, Slawomir/A-2985-2008	Filipek, Slawomir/0000-0003-3147-3858				Dean MK, 2001, J MED CHEM, V44, P4595, DOI 10.1021/jm010290+; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Papermaster DS, 2002, INVEST OPHTH VIS SCI, V43, P1300; Rios CD, 2001, PHARMACOL THERAPEUT, V92, P71, DOI 10.1016/S0163-7258(01)00160-7	6	620	637	1	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					127	128		10.1038/421127a	http://dx.doi.org/10.1038/421127a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520290				2022-12-28	WOS:000180267200027
J	Plerou, V; Gopikrishnan, P; Stanley, HE				Plerou, V; Gopikrishnan, P; Stanley, HE			Econophysics - Two-phase behaviour of financial markets	NATURE			English	Article									Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA; Boston Univ, Dept Phys, Boston, MA 02215 USA	Boston University; Boston University	Gopikrishnan, P (corresponding author), Boston Univ, Ctr Polymer Studies, Boston, MA 02215 USA.			Stanley, H./0000-0003-2800-4495				[Anonymous], 1995, MARKET MICROSTRUCTUR; BLACK F, 1986, J FINANC, V41, P529, DOI 10.2307/2328481; Holy TE, 1997, PHYS REV LETT, V79, P3545, DOI 10.1103/PhysRevLett.79.3545; LEE CMC, 1991, J FINANC, V46, P733, DOI 10.2307/2328845; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; Plerou V, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.027104; SHLEIFER A., 2001, INEFFICIENT MARKETS; Takayasu H, 1999, PHYSICA A, V269, P24, DOI 10.1016/S0378-4371(99)00076-X	8	96	102	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					130	130		10.1038/421130a	http://dx.doi.org/10.1038/421130a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520293	Bronze			2022-12-28	WOS:000180267200030
J	Brown, ZA; Wald, A; Morrow, RA; Selke, S; Zeh, J; Corey, L				Brown, ZA; Wald, A; Morrow, RA; Selke, S; Zeh, J; Corey, L			Effect of serologic status and Cesarean delivery on transmission rates of herpes simplex virus from-mother to infant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL HERPES; PREGNANT-WOMEN; GLYCOPROTEIN-G; TYPE-2 INFECTION; ACYCLOVIR; ANTIBODIES; MANAGEMENT; ASSAY; EFFICACY; CULTURES	Context Neonatal herpes most commonly results from fetal exposure to infected maternal genital secretions at the time of delivery. The risk of transmission from mother to infant as it relates to maternal herpes simplex virus (HSV) serologic status and exposure to HSV in the maternal genital tract at the time of labor has not been quantified. Furthermore, no data exist on whether cesarean delivery, the standard of care for women with genital herpes lesions at the time of delivery, reduces HSV transmission, Objective To determine the effects of viral shedding, maternal HSV serologic status, and delivery route-on the risk of transmission of HSV from mother to infant. Design Prospective cohort of pregnant women enrolled between January 1982 and December 1999. Settings A university medical center, a US Army medical center, and 5 community hospitals in Washington State. Patients A total of 58362 pregnant women, of whom 40023 had HSV cultures obtained from the cervix and external genitalia and 31663 had serum samples tested for HSV. Main Outcome Measure Rates of neonatal HSV infection. Results Among the 202 women from whom HSV was isolated at the time of labor, 10 (5%) had neonates with HSV infection (odds ratio [OR], 346; 95% confidence interval [CI], 125-956 for neonatal herpes when HSV was isolated vs not isolated). Cesarean delivery significantly reduced the HSV transmission rate among women from whom HSV was isolated (1 [1.2%] of 85 cesarean vs 9 [7.7%] of 117 vaginal; OR, 0.14; 95% CI, 0.02-1.08; P=.047). Other risk factors for neonatal HSV included first-episode infection (OR, 33.1; 95% CI, 6.5-168), HSV isolation from the cervix (OR, 32.6; 95% CI, 4.1-260), HSV-1 vs HSV-2 isolation at the time of labor(OR, 16.5; 95% CI, 4.1-65), invasive monitoring (OR, 6.8; 95% CI, 1.4-32), delivery before 38 weeks (OR, 4.4;,95% CI, 1.216), and maternal age less than 21 years (OR, 4.1; 95% CI, 1.1-15). Neonatal HSV infection rates per 100000 live births were 54 (95% CI, 19.8-118) among HSV-seronegative women, 26 (95% CI, 9.3-56) among women who were HSV-1-seropositive only, and 22 (95% CI, 4.4-64) among all HSV-2-seropositive women. Conclusion Neonatal HSV infection rates can be reduced by preventing maternal acquisition of genital HSV-1 and HSV-2 infection near term. It can also be reduced by cesarean delivery and limiting the use of invasive monitors among women shedding HSV at the time of labor.	Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Fred Hutchinson Canc Res Ctr, Program Infect Dis, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Brown, ZA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Box 356460, Seattle, WA 98195 USA.	zbrown@u.washington.edu	Wald, Anna/B-6272-2012; Corey, Lawrence/AAE-1796-2020	Wald, Anna/0000-0003-3486-6438; Corey, Lawrence/0000-0002-2179-2436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI030731] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30731] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AM AC PED COMM IN, 1977, 1997 RED BOOK, V266, P276; *AM COLL OBST GYN, 2000, INT J GYNECOL OBSTET, V68, P165; Armstrong GL, 2001, AM J EPIDEMIOL, V153, P912, DOI 10.1093/aje/153.9.912; ASHLEY RL, 1988, J CLIN MICROBIOL, V26, P662, DOI 10.1128/JCM.26.4.662-667.1988; Ashley RL, 2001, SEX TRANSM INFECT, V77, P232, DOI 10.1136/sti.77.4.232; Austin H, 1999, SEX TRANSM DIS, V26, P329, DOI 10.1097/00007435-199907000-00004; Bergeron MG, 2000, NEW ENGL J MED, V343, P175, DOI 10.1056/NEJM200007203430303; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P275, DOI 10.1111/j.1471-0528.1998.tb10086.x; Brown ZA, 2000, REV MED VIROL, V10, P141, DOI 10.1002/(SICI)1099-1654(200005/06)10:3&lt;141::AID-RMV280&gt;3.0.CO;2-2; BROWN ZA, 1991, NEW ENGL J MED, V324, P1247, DOI 10.1056/NEJM199105023241804; Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801; COREY L, 1988, LANCET, V1, P1; Fleming DT, 1997, NEW ENGL J MED, V337, P1105, DOI 10.1056/NEJM199710163371601; Fonnest G, 1997, ACTA OBSTET GYN SCAN, V76, P355, DOI 10.1111/j.1600-0412.1997.tb07992.x; Forsgren M, 1996, SCAND J INFECT DIS, P14; FRENKEL LM, 1993, ANN INTERN MED, V118, P414, DOI 10.7326/0003-4819-118-6-199303150-00003; Gaytant M A, 2000, Ned Tijdschr Geneeskd, V144, P1832; GIBBS RS, 1988, OBSTET GYNECOL, V71, P779; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Kinghorn George R, 2002, Herpes, V9, P46; KULHANJIAN JA, 1992, NEW ENGL J MED, V326, P916, DOI 10.1056/NEJM199204023261403; LANGENBERG A, 1988, J CLIN MICROBIOL, V26, P1772, DOI 10.1128/JCM.26.9.1772-1774.1988; LIBMAN MD, 1991, REV INFECT DIS, V13, P1093; NAHMIAS AJ, 1971, AM J OBSTET GYNECOL, V110, P825, DOI 10.1016/0002-9378(71)90580-1; PROBER CG, 1992, CLIN INFECT DIS, V15, P1031, DOI 10.1093/clind/15.6.1031; PROBER CG, 1988, NEW ENGL J MED, V318, P887, DOI 10.1056/NEJM198804073181404; RANDOLPH AG, 1993, JAMA-J AM MED ASSOC, V270, P77, DOI 10.1001/jama.270.1.77; Ryncarz AJ, 1999, J CLIN MICROBIOL, V37, P1941, DOI 10.1128/JCM.37.6.1941-1947.1999; Scott LL, 1996, OBSTET GYNECOL, V87, P69, DOI 10.1016/0029-7844(95)00357-6; STONE KM, 1989, SEX TRANSM DIS, V16, P152, DOI 10.1097/00007435-198907000-00007; SULLENDER WM, 1988, J INFECT DIS, V157, P164, DOI 10.1093/infdis/157.1.164; Tookey P, 1996, PAEDIATR PERINAT EP, V10, P432, DOI 10.1111/j.1365-3016.1996.tb00070.x; VANEVERDINGEN JJE, 1993, J PERINAT MED, V21, P371, DOI 10.1515/jpme.1993.21.5.371; WALD A, 1995, NEW ENGL J MED, V333, P770, DOI 10.1056/NEJM199509213331205; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Whittington WLH, 2001, SEX TRANSM DIS, V28, P99, DOI 10.1097/00007435-200102000-00007; YEAGER AS, 1980, INFECT IMMUN, V29, P532	40	397	412	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					203	209		10.1001/jama.289.2.203	http://dx.doi.org/10.1001/jama.289.2.203			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517231	Bronze			2022-12-28	WOS:000180226400031
J	Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS				Woodman, CBJ; Collins, S; Rollason, TP; Winter, H; Bailey, A; Yates, M; Young, LS			Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia	LANCET			English	Article							NATURAL-HISTORY; RISK-FACTORS; CANCER; ADENOCARCINOMA; GRADE; PREVALENCE; EXPRESSION; INFECTION; CARCINOMA; HPV-18	Background Human papillomavirus type 18 (HPV-18) is the second most frequent of the HPV types detected when squamous-cell cancer is diagnosed and the type most strongly associated with adenocarcinoma of the cervix. However, in cross-sectional studies, HPV-18 is rarely detected at the time of diagnosis of high-grade cervical intraepithelial neoplasia (CIN). We used a longitudinal study design to describe the occurrence of cytological abnormality after incident HPV-18 and HPV-16 infections. Methods The analysis was based on 1075 women aged 15-19 years, who had normal cytology and were negative for HPV at recruitment from a single family-planning clinic, and who had further follow-up. The women reattended every 6 months, and samples were taken for cytological and virological examination. Findings The relative risk of a cytological diagnosis of borderline nuclear abnormality after exposure to HPV-18 was 2.06 (95% CI 1.24-3.43) and that after exposure to HPV-16 was 1.99 (1.32-3.01). The relative risks of mild dyskaryosis were 3.11 (1.86-5.18) and 4.76 (3.15-7.18), and the relative risks of moderate or severe dyskaryosis were 0.80 (0.24-2.65) and 2.85 (1.36-5.97). Time to acquisition of cytological abnormality was unrelated to the infecting type (p=0.88). Interpretation Our findings do not support the long-held view that the reason why HPV-18 infection is under-represented at the time of diagnosis of high-grade CIN is because HPV-18-associated disease rapidly progresses through the preinvasive stages of neoplasia. We suggest that the cytological changes detected after HPV-18 infection might understate the severity of underlying disease. This feature could compromise the effectiveness of screening programmes in reducing the frequency of HPV-18-associated cancers.	Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England; Birmingham Womens Hosp, Acad Dept Obstet & Gynaecol, Birmingham, W Midlands, England; Univ Birmingham, Dept Publ Hlth, Birmingham B15 2TT, W Midlands, England; Univ Birmingham, Canc Res UK Inst Canc Studies, Birmingham B15 2TT, W Midlands, England; Cent Manchester Healthcare Trust, Dept Clin Virol, Manchester, Lancs, England	University of Manchester; Birmingham Women's Hospital; University of Birmingham; Cancer Research UK; University of Birmingham	Woodman, CBJ (corresponding author), Univ Manchester, Ctr Canc Epidemiol, Manchester M20 4QL, Lancs, England.	ciaran.woodman@cce.man.ac.uk	Young, Lawrence S/B-7213-2009	Young, Lawrence S/0000-0003-3919-4298				BARNES W, 1990, GYNECOL ONCOL, V38, P343, DOI 10.1016/0090-8258(90)90070-2; BERGERON C, 1992, AM J SURG PATHOL, V16, P641, DOI 10.1097/00000478-199207000-00002; BJERSING L, 1991, ANTICANCER RES, V11, P123; BOSCH FX, 1995, JNCI-J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; BOSHART M, 1984, EMBO J, V3, P1151, DOI 10.1002/j.1460-2075.1984.tb01944.x; Chichareon S, 1998, J NATL CANCER I, V90, P50, DOI 10.1093/jnci/90.1.50; Collett D, 1994, MODELLING SURVIVAL D; CULLEN AP, 1991, J VIROL, V65, P606, DOI 10.1128/JVI.65.2.606-612.1991; GENEST DR, 1993, HUM PATHOL, V24, P730, DOI 10.1016/0046-8177(93)90009-6; HECHT JL, 1995, INT J CANCER, V60, P369, DOI 10.1002/ijc.2910600317; Hildesheim A, 1999, AM J OBSTET GYNECOL, V180, P571, DOI 10.1016/S0002-9378(99)70256-5; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; JARMULOWICZ MR, 1989, BRIT J OBSTET GYNAEC, V96, P1061, DOI 10.1111/j.1471-0528.1989.tb03381.x; Kalantari M, 1997, HUM PATHOL, V28, P899, DOI 10.1016/S0046-8177(97)90004-6; KURMAN RJ, 1988, AM J OBSTET GYNECOL, V159, P293, DOI 10.1016/S0002-9378(88)80070-X; McLachlin CM, 1997, HUM PATHOL, V28, P1226, DOI 10.1016/S0046-8177(97)90194-5; MCLACHLIN CM, 1994, AM J PATHOL, V144, P141; MITCHELL H, 1995, BRIT J CANCER, V71, P894, DOI 10.1038/bjc.1995.172; Nindl I, 1999, J CLIN PATHOL, V52, P17, DOI 10.1136/jcp.52.1.17; Pirog EC, 2000, AM J PATHOL, V157, P1055, DOI 10.1016/S0002-9440(10)64619-6; Riethdorf S, 2000, VIRCHOWS ARCH, V437, P491, DOI 10.1007/s004280000277; Sasieni P, 2001, LANCET, V357, P1490, DOI 10.1016/S0140-6736(00)04646-8; Schwartz SM, 2001, J CLIN ONCOL, V19, P1906, DOI 10.1200/JCO.2001.19.7.1906; Steenbergen RDM, 1998, J VIROL, V72, P749, DOI 10.1128/JVI.72.1.749-757.1998; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; Thomas KK, 2000, J INFECT DIS, V182, P1097, DOI 10.1086/315805; UNGER ER, 1995, J INFECT DIS, V172, P1184, DOI 10.1093/infdis/172.5.1184; Vizcaino AP, 1998, INT J CANCER, V75, P536, DOI 10.1002/(SICI)1097-0215(19980209)75:4<536::AID-IJC8>3.0.CO;2-U; WALKER J, 1989, OBSTET GYNECOL, V74, P781; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4	30	56	57	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					40	43		10.1016/S0140-6736(03)12120-4	http://dx.doi.org/10.1016/S0140-6736(03)12120-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517465				2022-12-28	WOS:000180191600019
J	Branch, D				Branch, D			When a white dwarf explodes	SCIENCE			English	Editorial Material							IA SUPERNOVA; MODELS		Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Branch, D (corresponding author), Univ Oklahoma, Dept Phys & Astron, Norman, OK 73019 USA.							Gamezo VN, 2003, SCIENCE, V299, P77, DOI 10.1126/science.1078129; Howell DA, 2001, ASTROPHYS J, V556, P302, DOI 10.1086/321584; Leibundgut B, 2001, ANNU REV ASTRON ASTR, V39, P67, DOI 10.1146/annurev.astro.39.1.67; Lentz EJ, 2001, ASTROPHYS J, V557, P266, DOI 10.1086/322239; Livne E, 1999, ASTROPHYS J, V527, pL97, DOI 10.1086/312405; MAZZALI FA, 1993, ASTRON ASTROPHYS, V269, P423; Nomoto K, 1997, SCIENCE, V276, P1378, DOI 10.1126/science.276.5317.1378; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; RUIZLAPUENTE P, 1995, ASTROPHYS J, V439, P60, DOI 10.1086/175151; THOMAS RC, IN PRESS ASTROPHYS J	11	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					53	54		10.1126/science.1080084	http://dx.doi.org/10.1126/science.1080084			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511633				2022-12-28	WOS:000180165800024
J	Okajima, T; Irvine, KD				Okajima, T; Irvine, KD			Regulation of notch signaling by O-linked fucose	CELL			English	Article							WING FORMATION; DROSOPHILA; FRINGE; DORSAL; MODULES; DELTA; CELLS; GLYCOSYLTRANSFERASE; TRANSDUCTION; FUCOSYLATION	Notch and its ligands are modified by a protein O-fucosyltransferase (OFUT1) that attaches fucose to a Serine or Threonine within EGF domains. By using RNAi to decrease Ofut1 expression in Drosophila, we demonstrate that O-linked fucose is positively required for Notch signaling, including both Fringe-dependent and Fringe-independent processes. The requirement for Ofut1 is cell autonomous, in the signal-receiving cell, and upstream of Notch activation. The transcription of Ofut1 is developmentally regulated, and surprisingly, overexpression of Ofut1 inhibits Notch signaling. Together, these results indicate that OFUT1 is a core component of the Notch pathway, which is required for the activation of Notch by its ligands, and whose regulation may contribute to the pattern of Notch activation during development.	Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA; Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Howard Hughes Medical Institute; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Irvine, KD (corresponding author), Rutgers State Univ, Howard Hughes Med Inst, Waksman Inst, Piscataway, NJ 08854 USA.		Okajima, Tetsuya/I-7332-2014	Okajima, Tetsuya/0000-0002-3677-648X	NIGMS NIH HHS [R01-GM54594] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054594] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Chen JH, 2001, P NATL ACAD SCI USA, V98, P13716, DOI 10.1073/pnas.241398098; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cooper MTD, 2000, DEV BIOL, V221, P390, DOI 10.1006/dbio.2000.9691; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; FEHON RG, 1991, J CELL BIOL, V113, P657, DOI 10.1083/jcb.113.3.657; Haltiwanger RS, 2002, CURR OPIN STRUC BIOL, V12, P593, DOI 10.1016/S0959-440X(02)00371-8; HARRIS RJ, 1993, GLYCOBIOLOGY, V3, P219, DOI 10.1093/glycob/3.3.219; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7; Justice NJ, 2002, CURR OPIN NEUROBIOL, V12, P64, DOI 10.1016/S0959-4388(02)00291-X; Kao YH, 1999, BIOCHEMISTRY-US, V38, P7097, DOI 10.1021/bi990234z; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Lopez-Schier H, 2001, GENE DEV, V15, P1393, DOI 10.1101/gad.200901; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Panin VM, 2002, J BIOL CHEM, V277, P29945, DOI 10.1074/jbc.M204445200; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; RABBANI SA, 1992, J BIOL CHEM, V267, P14151; Sacchettini JC, 2001, BIOCHEMISTRY-US, V40, P3009, DOI 10.1021/bi002544j; Schiffer SG, 2001, J BIOL CHEM, V276, P37769; Stenflo J, 2000, BBA-PROTEIN STRUCT M, V1477, P51, DOI 10.1016/S0167-4838(99)00262-9; Wang Y, 1998, J BIOL CHEM, V273, P8112, DOI 10.1074/jbc.273.14.8112; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002	34	307	315	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					893	904		10.1016/S0092-8674(02)01114-5	http://dx.doi.org/10.1016/S0092-8674(02)01114-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526814	Bronze			2022-12-28	WOS:000179862600014
J	Zheng, XL; Pallera, AM; Goodnough, LT; Sadler, JE; Blinder, MA				Zheng, XL; Pallera, AM; Goodnough, LT; Sadler, JE; Blinder, MA			Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab	ANNALS OF INTERNAL MEDICINE			English	Article							FACTOR-CLEAVING PROTEASE; HEMOLYTIC-UREMIC SYNDROME; PLASMA-EXCHANGE; THERAPY; MEMBER; FAMILY; TTP	Background: Thrombotic thrombocytopenic purpura (TTP) in adults is usually caused by autoantibody inhibitors of ADAMTS13. Treatment with plasma exchange is often effective but does not address the underlying autoimmune process. Objective: To report the efficacy of intensive immunosuppressive therapy in refractory TTP. Design: case report. Setting: University medical center. Patient: 42-year-old woman with chronic relapsing TTP. Intervention: Immunosuppression therapy with rituximab and cyclophosphamide. Measurements: ADAMTS13 activity and inhibitors and hematologic variables for TTP. Results: For 19 months, the patient had relapsing thrombotic microangiopathy despite plasma exchange; splenectomy; and therapy with vincristine, prednisone, and cyclosporine. ADAMTS13 activity was low, and tests detected an IgG inhibitor that recognized the metalloprotease domain of recombinant ADAMTS13. After treatment with rituximab and cyclophosphamide, the disease remitted, ADAMTS13 levels normalized, and the inhibitor was undetectable. The patient has required no treatment for 13 months. Conclusion: intensive immunosuppressive therapy can lead to sustained clinical remission in patients with refractory autoimmune TTP.	Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Blinder, MA (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave,Box 8125, St Louis, MO 63110 USA.	blinder@labmed.wustl.edu	Sadler, Evan/D-8556-2011; Zheng, X. Long/ABD-7362-2021	Zheng, X. Long/0000-0003-1680-5295; Sadler, J. Evan/0000-0001-5705-469X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL07088] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Allan DS, 2001, HAEMATOLOGICA, V86, P844; Bandarenko N, 1998, J CLIN APHERESIS, V13, P133, DOI 10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Chemnitz J, 2002, AM J HEMATOL, V71, P105, DOI 10.1002/ajh.10204; Crowther MA, 1996, ANN INTERN MED, V125, P294, DOI 10.7326/0003-4819-125-4-199608150-00006; Ferrara F, 1999, ANN HEMATOL, V78, P521, DOI 10.1007/s002770050549; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Gerritsen HE, 1999, THROMB HAEMOSTASIS, V82, P1386; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; Gutterman LA, 2002, BLOOD CELL MOL DIS, V28, P385, DOI 10.1006/bcmd.2002.0522; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Pasquale D, 1998, AM J HEMATOL, V57, P57, DOI 10.1002/(SICI)1096-8652(199801)57:1<57::AID-AJH10>3.0.CO;2-6; Quartier P, 2001, LANCET, V358, P1511, DOI 10.1016/S0140-6736(01)06573-4; ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604; Soejima K, 2001, J BIOCHEM-TOKYO, V130, P475, DOI 10.1093/oxfordjournals.jbchem.a003009; Stasi R, 2001, BLOOD, V98, P952, DOI 10.1182/blood.V98.4.952; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Veyradier A, 2001, BLOOD, V98, P1765, DOI 10.1182/blood.V98.6.1765; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	20	109	112	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					105	108		10.7326/0003-4819-138-2-200301210-00011	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00011			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529092				2022-12-28	WOS:000181018300004
J	Feurer, T; Vaughan, JC; Nelson, KA				Feurer, T; Vaughan, JC; Nelson, KA			Spatiotemporal coherent control of lattice vibrational waves	SCIENCE			English	Article							TERAHERTZ RADIATION; OPTICAL CONTROL; LASER-PULSES; FEMTOSECOND; SPECTROSCOPY; SCATTERING; CRYSTALS	We achieved automated optical control over coherent lattice responses that were both time- and position-dependent across macroscopic length scales. In our experiments, spatiotemporal femtosecond pulse shaping was used to generate excitation light fields that were directed toward distinct regions of crystalline samples, producing terahertz-frequency lattice vibrational waves that emanated outward from their multiple origins at lightlike speeds. Interferences among the waves resulted in fully specified far-field responses, including tilted, focusing, or amplified wavefronts. Generation and coherent amplification of terahertz traveling waves and terahertz phased-array generation also were demonstrated.	MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Nelson, KA (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.		Vaughan, Joshua/T-4324-2019					Assion A, 1998, SCIENCE, V282, P919, DOI 10.1126/science.282.5390.919; BARKER AS, 1972, REV MOD PHYS, V44, P18, DOI 10.1103/RevModPhys.44.18; BRENER I, 1994, J OPT SOC AM B, V11, P2457, DOI 10.1364/JOSAB.11.002457; Crimmins TF, 2002, J CHEM PHYS, V117, P2882, DOI 10.1063/1.1491948; Feurer T, 2002, OPT LETT, V27, P652, DOI 10.1364/OL.27.000652; FROBERG NM, 1992, IEEE J QUANTUM ELECT, V28, P2291, DOI 10.1109/3.159536; KAWASHIMA H, 1995, ANNU REV PHYS CHEM, V46, P627, DOI 10.1146/annurev.pc.46.100195.003211; Koehl RM, 2001, J CHEM PHYS, V114, P1443, DOI 10.1063/1.1340579; Koehl RM, 2001, CHEM PHYS, V267, P151, DOI 10.1016/S0301-0104(01)00263-4; Koehl RM, 1999, J PHYS CHEM A, V103, P10260, DOI 10.1021/jp9922007; Levis RJ, 2001, SCIENCE, V292, P709, DOI 10.1126/science.1059133; Liu YQ, 1996, OPT LETT, V21, P1762, DOI 10.1364/OL.21.001762; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Nakamura Y, 1999, NATURE, V398, P786, DOI 10.1038/19718; Schall M, 1999, INT J INFRARED MILLI, V20, P595, DOI 10.1023/A:1022636421426; Skolnik M.I., 1980, INTRO RADAR SYSTEMS; Stoyanov NS, 2002, NAT MATER, V1, P95, DOI 10.1038/nmat725; Vaughan JC, 2002, J OPT SOC AM B, V19, P2489, DOI 10.1364/JOSAB.19.002489; WEFERS MM, 1995, J CHEM PHYS, V102, P9133, DOI 10.1063/1.468862; Weinacht TC, 1999, NATURE, V397, P233, DOI 10.1038/16654; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; WEINER AM, 1990, SCIENCE, V247, P1317, DOI 10.1126/science.247.4948.1317; XU L, 1992, PHYS REV A, V45, P3184, DOI 10.1103/PhysRevA.45.3184; YAN YX, 1987, J CHEM PHYS, V87, P6240, DOI 10.1063/1.453733	24	195	202	4	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					374	377		10.1126/science.1078726	http://dx.doi.org/10.1126/science.1078726			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532012				2022-12-28	WOS:000180426800039
J	Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G				Ashrafi, K; Chang, FY; Watts, JL; Fraser, AG; Kamath, RS; Ahringer, J; Ruvkun, G			Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes	NATURE			English	Article							LIFE-SPAN; LONGEVITY; GENETICS; MUTATION; DAF-16; FOOD	Regulation of body fat storage involves signalling between centres that regulate feeding in the brain and sites of fat storage and use in the body(1,2). Here we describe an assay for analysing fat storage and mobilization in living Caenorhabditis elegans. By using RNA-mediated interference (RNAi)(3,4) to disrupt the expression of each of the 16,757 worm genes, we have systematically screened the C. elegans genome for genes necessary for normal fat storage. We identify 305 gene inactivations that cause reduced body fat and 112 gene inactivations that cause increased fat storage. Analysis of the fat-reducing gene inactivations in insulin, serotonin and tubby signalling mutants of C. elegans, which have increased body fat, identifies a core set of fat regulatory genes as well as pathway-specific fat regulators. Many of the newly identified worm fat regulatory genes have mammalian homologues, some of which are known to function in fat regulation. Other C. elegans fat regulatory genes that are conserved across animal phylogeny, but have not previously been implicated in fat storage, may point to ancient and universal features of fat storage regulation, and identify targets for treating obesity and its associated diseases.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; Univ Cambridge, Wellcome Canc Res UK Inst, Cambridge CB2 1QR, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Washington State University; University of Cambridge	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Watts, Jennifer/AAC-7425-2020	Ahringer, Julie/0000-0002-7074-4051; Watts, Jennifer/0000-0003-4349-0639; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; BRENNER S, 1974, GENETICS, V77, P71; Brockmann GA, 2002, TRENDS GENET, V18, P367, DOI 10.1016/S0168-9525(02)02703-8; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GOODMAN R, 1997, CHILD PSYCHOL PSYCHI, V2, P15; GREENSPAN P, 1985, J LIPID RES, V26, P781; Johnstone I.J., 1999, C ELEGANS PRACTICAL, P201; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; NobenTrauth K, 1996, NATURE, V380, P534, DOI 10.1038/380534a0; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogg S, 1998, MOL CELL, V2, P887, DOI 10.1016/S1097-2765(00)80303-2; Olswang Y, 2002, P NATL ACAD SCI USA, V99, P625, DOI 10.1073/pnas.022616299; Riddle DL, 1997, C ELEGANS, P739; ROLLAND V, 1995, J BIOL CHEM, V270, P1102, DOI 10.1074/jbc.270.3.1102; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; WADSWORTH WG, 1989, DEV BIOL, V132, P167, DOI 10.1016/0012-1606(89)90214-5; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; YAMASAKI H, 1984, MECHANISMS TUMOR PRO, V4, P1	29	762	835	5	113	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					268	272		10.1038/nature01279	http://dx.doi.org/10.1038/nature01279			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529643				2022-12-28	WOS:000180397600047
J	Duan, XF; Huang, Y; Agarwal, R; Lieber, CM				Duan, XF; Huang, Y; Agarwal, R; Lieber, CM			Single-nanowire electrically driven lasers	NATURE			English	Article							CDS THIN-FILMS; OPTICAL-PROPERTIES; SEMICONDUCTOR	Electrically driven semiconductor lasers are used in technologies ranging from telecommunications and information storage to medical diagnostics and therapeutics(1). The success of this class of lasers is due in part to well-developed planar semiconductor growth and processing, which enables reproducible fabrication of integrated, electrically driven devices(2,3). Yet this approach to device fabrication is also costly and difficult to integrate directly with other technologies such as silicon microelectronics. To overcome these issues for future applications, there has been considerable interest in using organic molecules(4,5), polymers(6,7), and inorganic nanostructures(8-10) for lasers, because these materials can be fashioned into devices by chemical processing. Indeed, amplified stimulated emission and lasing have been reported for optically pumped organic systems(4-7) and, more recently, inorganic nanocrystals(8,9) and nanowires(10). However, electrically driven lasing, which is required in most applications, has met with several difficulties in organic systems(11), and has not been addressed for assembled nanocrystals or nanowires. Here we investigate the feasibility of achieving electrically driven lasing from individual nanowires. Optical and electrical measurements made on single-crystal cadmium sulphide nanowires show that these structures can function as Fabry-Perot optical cavities with mode spacing inversely related to the nanowire length. Investigations of optical and electrical pumping further indicate a threshold for lasing as characterized by optical modes with instrument-limited linewidths. Electrically driven nanowire lasers, which might be assembled in arrays capable of emitting a wide range of colours, could improve existing applications and suggest new opportunities.	Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Lieber, CM (corresponding author), Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA.	cml@cmliris.harvard.edu	Duan, Xiangfeng/E-7522-2011; Huang, Yu/AAZ-9747-2020; Duan, Xiangfeng/AAQ-9674-2020	Duan, Xiangfeng/0000-0002-4321-6288; Huang, Yu/0000-0003-1793-0741; Duan, Xiangfeng/0000-0002-4321-6288; Agarwal, Ritesh/0000-0002-1289-4334				Bagnall DM, 2000, J CRYST GROWTH, V214, P1015, DOI 10.1016/S0022-0248(00)00253-0; Bagnall DM, 1999, OPT LETT, V24, P1278, DOI 10.1364/OL.24.001278; Berggren M, 1997, NATURE, V389, P466; Chen C.L., 1996, ELEMENTS OPTOELECTRO, V1st ed.; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Duan XF, 2000, ADV MATER, V12, P298, DOI 10.1002/(SICI)1521-4095(200002)12:4<298::AID-ADMA298>3.0.CO;2-Y; Duan XF, 2001, NATURE, V409, P66, DOI 10.1038/35051047; El Assali K, 2000, PHYS STATUS SOLIDI A, V178, P701, DOI 10.1002/1521-396X(200004)178:2<701::AID-PSSA701>3.0.CO;2-3; GRAY GR, 1995, SEMICONDUCTOR LASER, P284; Gudiksen MS, 2002, NATURE, V415, P617, DOI 10.1038/415617a; Gudiksen MS, 2000, J AM CHEM SOC, V122, P8801, DOI 10.1021/ja002008e; Hide F, 1996, SCIENCE, V273, P1833, DOI 10.1126/science.273.5283.1833; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Huang Y, 2002, NANO LETT, V2, P101, DOI 10.1021/nl015667d; KAPON E, 1999, SEMICONDUCTOR LASERS, V2; Kapon E, 1999, SEMICONDUCTOR LASERS, V1; Kazes M, 2002, ADV MATER, V14, P317, DOI 10.1002/1521-4095(20020219)14:4<317::AID-ADMA317>3.0.CO;2-U; Klimov VI, 2000, SCIENCE, V290, P314, DOI 10.1126/science.290.5490.314; Kozlov VG, 1997, NATURE, V389, P362, DOI 10.1038/38693; Kozlov VG, 2000, IEEE J QUANTUM ELECT, V36, P18, DOI 10.1109/3.817634; Lauhon LJ, 2002, NATURE, V420, P57, DOI 10.1038/nature01141; Morales AM, 1998, SCIENCE, V279, P208, DOI 10.1126/science.279.5348.208; Tessler N, 1996, NATURE, V382, P695, DOI 10.1038/382695a0; Wang JF, 2001, SCIENCE, V293, P1455, DOI 10.1126/science.1062340	25	2241	2330	21	1030	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					241	245		10.1038/nature01353	http://dx.doi.org/10.1038/nature01353			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529637				2022-12-28	WOS:000180397600040
J	Hoberman, A; Charron, M; Hickey, RW; Baskin, M; Kearney, DH; Wald, ER				Hoberman, A; Charron, M; Hickey, RW; Baskin, M; Kearney, DH; Wald, ER			Imaging studies after a first febrile urinary tract infection in young children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIMERCAPTOSUCCINIC ACID SCINTIGRAPHY; RENAL CORTICAL SCINTIGRAPHY; ACUTE PYELONEPHRITIS; TC-99M-DMSA SCINTIGRAPHY; VESICOURETERAL REFLUX; RADIOLOGICAL FINDINGS; DMSA SCAN; ULTRASONOGRAPHY; DIAGNOSIS; CHILDHOOD	Background: Guidelines from the American Academy of Pediatrics recommend obtaining a voiding cystourethrogram and a renal ultrasonogram for young children after a first urinary tract infection; renal scanning with technetium-99m-labeled dimercaptosuccinic acid has also been endorsed by other authorities. We investigated whether imaging studies altered management or improved outcomes in young children with a first febrile urinary tract infection. Methods: In a prospective trial involving 309 children (1 to 24 months old), an ultrasonogram and an initial renal scan were obtained within 72 hours after diagnosis, contrast voiding cystourethrography was performed one month later, and renal scanning was repeated six months later. Results: The ultrasonographic results were normal in 88 percent of the children (272 of 309); the identified abnormalities did not modify management. Acute pyelonephritis was diagnosed in 61 percent of the children (190 of 309). Thirty-nine percent of the children who underwent cystourethrography (117 of 302) had vesicoureteral reflux; 96 percent of these children (112 of 117) had grade I, II, or III vesicoureteral reflux. Repeated scans were obtained for 89 percent of the children (275 of 309); renal scarring was noted in 9.5 percent of these children (26 of 275). Conclusions: An ultrasonogram performed at the time of acute illness is of limited value. A voiding cystourethrogram for the identification of reflux is useful only if antimicrobial prophylaxis is effective in reducing reinfections and renal scarring. Renal scans obtained at presentation identify children with acute pyelonephritis, and scans obtained six months later identify those with renal scarring. The routine performance of urinalysis, urine culture, or both during subsequent febrile illnesses in all children with a previous febrile urinary tract infection will probably obviate the need to obtain either early or late scans.	Childrens Hosp Pittsburgh, Div Gen Acad Pediat, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Radiol, Pittsburgh, PA 15261 USA; Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; Columbus Childrens Hosp, Columbus, OH USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Hoberman, A (corresponding author), Childrens Hosp Pittsburgh, Div Gen Acad Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.							Alon US, 1999, CLIN PEDIATR, V38, P21, DOI 10.1177/000992289903800103; *AM AC PED COMM QU, 2000, PEDIATRICS, V105, P141; American Academy of Pediatrics, 1999, PEDIATRICS, V103, P1052; BENADOR D, 1994, J PEDIATR-US, V124, P17, DOI 10.1016/S0022-3476(94)70248-9; Bergman DA, 1999, PEDIATRICS, V103, P843; Biggi A, 2001, PEDIATR NEPHROL, V16, P733, DOI 10.1007/s004670100657; BJORGVINSSON E, 1991, AM J ROENTGENOL, V157, P539; BLACK WC, 1993, NEW ENGL J MED, V328, P1237, DOI 10.1056/NEJM199304293281706; Dick PT, 1996, J PEDIATR-US, V128, P15, DOI 10.1016/S0022-3476(96)70422-5; DOWNS SM, 1999, PEDIATRICS, V103, P810; FINE RN, 1992, J PEDIATR-US, V121, P333, DOI 10.1016/S0022-3476(05)81784-6; Foresman WH, 2001, J UROLOGY, V165, P2232, DOI 10.1016/S0022-5347(05)66172-1; GOLDRAICH NP, 1989, PEDIATR NEPHROL, V3, P1, DOI 10.1007/BF00859614; HANLEY JA, 1983, JAMA-J AM MED ASSOC, V249, P1743, DOI 10.1001/jama.249.13.1743; Hoberman A, 1998, AM FAM PHYSICIAN, V57, P2337; HOBERMAN A, 1994, J PEDIATR-US, V124, P513, DOI 10.1016/S0022-3476(05)83127-0; HOBERMAN A, 1993, PEDIATRICS, V91, P1196; Hoberman A, 1999, PEDIATRICS, V104, P79, DOI 10.1542/peds.104.1.79; JACOBSON SH, 1989, BMJ-BRIT MED J, V299, P703, DOI 10.1136/bmj.299.6701.703; JACOBSON SH, 1992, PEDIATR NEPHROL, V6, P19, DOI 10.1007/BF00856822; Jakobsson B, 1997, ACTA PAEDIATR, V86, P803; JAKOBSSON B, 1994, ARCH DIS CHILD, V70, P111, DOI 10.1136/adc.70.2.111; JAKOBSSON B, 1992, PEDIATR NEPHROL, V6, P328, DOI 10.1007/BF00869725; JAKOBSSON B, 1992, ARCH DIS CHILD, V67, P1338, DOI 10.1136/adc.67.11.1338; KASS EJ, 1992, J UROLOGY, V148, P606, DOI 10.1016/S0022-5347(17)36667-3; Lavocat MP, 1997, PEDIATR RADIOL, V27, P159, DOI 10.1007/s002470050091; LEVITT SB, 1981, PEDIATRICS, V67, P392; Martinell J, 1996, PEDIATR NEPHROL, V10, P139; MASTIN ST, 1995, CLIN NUCL MED, V20, P407, DOI 10.1097/00003072-199505000-00006; MELIS K, 1992, EUR J PEDIATR, V151, P536, DOI 10.1007/BF01957763; Morin L, 1996, J UROLOGY, V155, P2047, DOI 10.1016/S0022-5347(01)66102-0; Nguyen HT, 2000, J UROLOGY, V164, P1674, DOI 10.1016/S0022-5347(05)67081-4; PATEL K, 1993, PEDIATR RADIOL, V23, P506, DOI 10.1007/BF02012131; ROSENBERG AR, 1992, J UROLOGY, V148, P1746, DOI 10.1016/S0022-5347(17)37019-2; RUSHTON HG, 1992, J UROLOGY, V147, P1327, DOI 10.1016/S0022-5347(17)37555-9; RUSHTON HG, 1992, J UROLOGY, V148, P898; SREENARASIMHAIAH V, 1995, J PEDIATR-US, V127, P373, DOI 10.1016/S0022-3476(95)70066-8; Stokland E, 1996, J PEDIATR-US, V129, P815, DOI 10.1016/S0022-3476(96)70024-0; VERBER IG, 1988, ARCH DIS CHILD, V63, P1320, DOI 10.1136/adc.63.11.1320; VERBOVEN M, 1990, PEDIATR RADIOL, V20, P540, DOI 10.1007/BF02011385; Williams G, 2001, J PEDIATR-US, V138, P868, DOI 10.1067/mpd.2001.113785	41	401	434	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					195	202		10.1056/NEJMoa021698	http://dx.doi.org/10.1056/NEJMoa021698			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529459				2022-12-28	WOS:000180390600003
J	Jencks, SF; Huff, ED; Cuerdon, T				Jencks, SF; Huff, ED; Cuerdon, T			Change in the quality of care delivered to Medicare beneficiaries, 1998-1999 to 2000-2001	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSPECTIVE PAYMENT SYSTEM; IMPLEMENTATION	Context Despite widespread concern regarding the quality and safety of healthcare, and a Medicare Quality Improvement Organization (QIO) program intended to improve that care in the United States, there is only limited information on whether quality is improving. Objective To track national and state-level changes in performance on 22 quality indicators for care of Medicare beneficiaries. Design, Patients, and Setting National observational cross-sectional studies of national and state-level fee-for-service data for Medicare beneficiaries during 19981999 (baseline) and 2000-2001 (follow-up). Main Outcome Measures Twenty-two QIO quality indicators abstracted from statewide random samples of medical records for inpatient fee-for-service care and from Medicare beneficiary, surveys or Medicare claims for outpatient care. Absolute improvement is defined as the change in performance from baseline to follow-up (measured in percentage points for all indicators except those measured in minutes); relative improvement is defined as the absolute improvement divided by the difference between the baseline performance and perfect performance (100%). Results The median state's performance improved from baseline to follow-up on 20 of the 22 indicators. In the median state, the percentage of patients receiving appropriate care on the median indicator increased from 69.5% to 73.4%, a 12.8% relative improvement. The average relative improvement was 19.9% for outpatient indicators combined and 11.9% for inpatient indicators combined (P<.001). For all but one indicator, absolute improvement was greater in states in which performance was low at baseline than those in which it was high at baseline (median r=-0.43; range: 0.12 to -0.93). When states were ranked on each indicator, the state's average rank was highly stable over time (r=0.93 for 1998-1999 vs 2000-2001). Conclusions Care for Medicare fee-for-service plan beneficiaries improved substantially between 1998-1999 and 2000-2001, but a much larger opportunity remains for further improvement. Relative rankings among states changed little. The improved care is consistent with QIO activities over this period, but these cross-sectional data do not provide conclusive information about the degree to which the improvement can be attributed to the QIOs' quality improvement efforts.	Ctr Medicare Serv, Off Clin Stand & Qual, Baltimore, MD 21244 USA; Ctr Medicaid Serv, Off Clin Stand & Qual, Baltimore, MD 21244 USA; Ctr Medicare Serv, Div Clin Stand & Qual, Boston, MA USA; Ctr Medicaid Serv, Div Clin Stand & Qual, Boston, MA USA; NIMH, Hlth & Behav Sci Res Branch, Bethesda, MD 20892 USA	Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Jencks, SF (corresponding author), Ctr Medicare Serv, Off Clin Stand & Qual, 7500 Secur Blvd,Mail Stop S3-02-01, Baltimore, MD 21244 USA.							BROWN D, 2002, WASHINGTON POST 1114, pA1; Burke JP, 2001, CLIN INFECT DIS, V33, pS78, DOI 10.1086/321861; Committee on Quality of Health Care in America loM, 2001, CROSS QUAL CHASM; Huff ED, 1997, J CLIN EPIDEMIOL, V50, P1395, DOI 10.1016/S0895-4356(97)00218-7; Jencks SF, 2000, JAMA-J AM MED ASSOC, V284, P1670, DOI 10.1001/jama.284.13.1670; KAHN KL, 1990, JAMA-J AM MED ASSOC, V264, P1984, DOI 10.1001/jama.264.15.1984; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Leape LL, 2002, JAMA-J AM MED ASSOC, V288, P501, DOI 10.1001/jama.288.4.501; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; *NAT COMM QUAL ASS, STAT MAN CAR QUAL 20; *NAT FOR HEALTHC Q, 2002, HOSP CAR NAT PERF ME; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; SPRAGUE L, 2002, CONTRACTING QUALITY; US Department of Health and Human Services, 2010, HLTH PEOPL 2010, V2	15	399	399	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					305	312		10.1001/jama.289.3.305	http://dx.doi.org/10.1001/jama.289.3.305			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525231	Bronze			2022-12-28	WOS:000180345100025
J	van Mierlo, TD; van den Berg, HM; Nievelstein, RAJ; Braun, KPJ				van Mierlo, TD; van den Berg, HM; Nievelstein, RAJ; Braun, KPJ			An unconscious girl with sickle-cell disease	LANCET			English	Editorial Material							THROMBOSIS; CHILDREN; ANEMIA		Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Neurol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Haematol, NL-3508 AB Utrecht, Netherlands; Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Radiol, NL-3508 AB Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis	Braun, KPJ (corresponding author), Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Paediat Neurol, POB 85090, NL-3508 AB Utrecht, Netherlands.							Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; deVeber G, 2001, NEW ENGL J MED, V345, P417, DOI 10.1056/NEJM200108093450604; HOOVER R, 1979, BLOOD, V54, P872; OGUZ M, 1994, NEURORADIOLOGY, V36, P155, DOI 10.1007/BF00588087; Westerman MP, 1999, J LAB CLIN MED, V134, P352, DOI 10.1016/S0022-2143(99)90149-X	5	21	21	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					136	136		10.1016/S0140-6736(03)12232-5	http://dx.doi.org/10.1016/S0140-6736(03)12232-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531581				2022-12-28	WOS:000180428000013
J	Conradt, L; Roper, TJ				Conradt, L; Roper, TJ			Group decision-making in animals	NATURE			English	Article							VOCALIZATIONS; SYNCHRONY; COHESION	Groups of animals often need to make communal decisions, for example about which activities to perform(1), when to perform them(2-9) and which direction to travel in(1,6,7); however, little is known about how they do so(10-12). Here, we model the fitness consequences of two possible decision-making mechanisms: 'despotism'(6,7,10) and 'democracy'(1,6,7,10). We show that under most conditions, the costs to subordinate group members, and to the group as a whole, are considerably higher for despotic than for democratic decisions. Even when the despot is the most experienced group member, it only pays other members to accept its decision when group size is small and the difference in information is large. Democratic decisions are more beneficial primarily because they tend to produce less extreme decisions, rather than because each individual has an influence on the decision per se. Our model suggests that democracy should be widespread and makes quantitative, testable predictions about group decision-making in non-humans.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Conradt, L (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.	l.conradt@sussex.ac.uk	Conradt, Larissa/H-6309-2011					BLACK JM, 1988, ETHOLOGY, V79, P143, DOI 10.1111/j.1439-0310.1988.tb00707.x; BOINSKI S, 1995, BEHAVIOUR, V132, P875, DOI 10.1163/156853995X00054; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P2213, DOI 10.1098/rspb.2000.1271; Conradt L, 1998, P ROY SOC B-BIOL SCI, V265, P1359, DOI 10.1098/rspb.1998.0442; Cote SD, 1997, CAN J ZOOL, V75, P1628, DOI 10.1139/z97-789; Cuthill Innes C., 1997, P97; DECASTRO JM, 1989, AM J CLIN NUTR, V50, P237, DOI 10.1093/ajcn/50.2.237; Gompper ME, 1996, BEHAV ECOL, V7, P254, DOI 10.1093/beheco/7.3.254; Krebs J.R., 1991, P105; Norton G.W., 1986, P145; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Ruckstuhl KE, 1999, BEHAVIOUR, V136, P805, DOI 10.1163/156853999501577; Seeley TD, 1999, BEHAV ECOL SOCIOBIOL, V45, P19, DOI 10.1007/s002650050536; STEWART KJ, 1994, BEHAVIOUR, V130, P29, DOI 10.1163/156853994X00127; [No title captured]; [No title captured]; [No title captured]; [No title captured]	18	334	344	4	140	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					155	158		10.1038/nature01294	http://dx.doi.org/10.1038/nature01294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520299				2022-12-28	WOS:000180267200037
J	Zeff, BW; Lanterman, DD; McAllister, R; Roy, R; Kostelich, EJ; Lathrop, DP				Zeff, BW; Lanterman, DD; McAllister, R; Roy, R; Kostelich, EJ; Lathrop, DP			Measuring intense rotation and dissipation in turbulent flows	NATURE			English	Article							FLUID; GEOMETRY	Turbulent flows are highly intermittent- for example, they exhibit intense bursts of vorticity and strain. Kolmogorov theory(1,2) describes such behaviour in the form of energy cascades from large to small spatial and temporal scales, where energy is dissipated as heat. But the causes of high intermittency in turbulence, which show non-gaussian statistics(3-5), are not well understood. Such intermittency can be important, for example, for enhancing the mixing of chemicals(6,7), by producing sharp drops in local pressure that can induce cavitation (damaging mechanical components and biological organisms)(8), and by causing intense vortices in atmospheric flows. Here we present observations of the three components of velocity and all nine velocity gradients within a small volume, which allow us to determine simultaneously the dissipation (a measure of strain) and enstrophy (a measure of rotational energy) of a turbulent flow. Combining the statistics of all measurements and the evolution of individual bursts, we find that a typical sequence for intense events begins with rapid strain growth, followed by rising vorticity and a final sudden decline in stretching. We suggest two mechanisms which can produce these characteristics, depending whether they are due to the advection of coherent structures through our observed volume or caused locally.	Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Maryland, IPST, College Pk, MD 20742 USA; Univ Maryland, IREAP, College Pk, MD 20742 USA; Arizona State Univ, Dept Math, Tempe, AZ 85287 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Arizona State University; Arizona State University-Tempe	Lathrop, DP (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	dpl@complex.umd.edu	Roy, Rajarshi/F-1898-2017	Roy, Rajarshi/0000-0002-2381-829X; Lathrop, Daniel/0000-0001-9282-3247				CHATE H, 1999, MIXING CHAOS TURBULE; Chen SY, 1997, PHYS REV LETT, V79, P1253, DOI 10.1103/PhysRevLett.79.1253; FRISCH U, 1995, TURBULENCE LEGACY AN, P120, DOI DOI 10.1017/CBO9781139170666.009; GOLLUB JP, 1991, PHYS REV LETT, V67, P3507, DOI 10.1103/PhysRevLett.67.3507; KEANE RD, 1992, APPL SCI RES, V49, P191, DOI 10.1007/BF00384623; KIDA S, 1992, PHYS FLUIDS A-FLUID, V4, P1018, DOI 10.1063/1.858252; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301, DOI 10.1098/rspa.1991.0075; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V31, P538; Kostelich EJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016213; KUNAS KT, 1990, BIOTECHNOL BIOENG, V36, P476, DOI 10.1002/bit.260360507; La Porta A, 2001, NATURE, V409, P1017, DOI 10.1038/35059027; Majda A., 2002, CAM T APP M; MENEVEAU C, 1987, PHYS REV LETT, V59, P1424, DOI 10.1103/PhysRevLett.59.1424; Mordant N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.214501; SREENIVASAN KR, 1991, ANNU REV FLUID MECH, V23, P539; Tao B, 2000, PHYS FLUIDS, V12, P941, DOI 10.1063/1.870348; Tao B, 2002, J FLUID MECH, V457, P35, DOI 10.1017/S0022112001007443; VUKOSLAVCEVIC P, 1991, J FLUID MECH, V228, P25, DOI 10.1017/S0022112091002628	18	114	114	2	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					146	149		10.1038/nature01334	http://dx.doi.org/10.1038/nature01334			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520296				2022-12-28	WOS:000180267200034
J	Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K				Thompson, WW; Shay, DK; Weintraub, E; Brammer, L; Cox, N; Anderson, LJ; Fukuda, K			Mortality associated with influenza and respiratory syncytial virus in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ELDERLY PERSONS; PROTECTIVE EFFICACY; US CHILDREN; VACCINE; INFECTION; YOUNG; OLDER; DISEASE; DEATHS; IMPACT	Context Influenza and respiratory syncytial virus (RSV) cause substantial morbidity and mortality. Statistical methods used to estimate deaths in the United States attributable to influenza have not accounted for RSV circulation. Objective To develop a statistical model using national mortality and viral surveillance data to estimate annual influenza- and RSV-associated deaths in the United States, by age group, virus, and influenza type and subtype. Design, Setting, and Population Age-specific Poisson regression models using national viral surveillance data for the 1976-1977 through 1998-1999 seasons were used to estimate influenza-associated deaths. Influenza- and RSV-associated deaths were simultaneously estimated for the 1990-1991 through 1998-1999 seasons. Main Outcome Measures Attributable deaths for 3 categories: underlying pneumonia and influenza, underlying respiratory and circulatory, and all causes. Results Annual estimates of influenza-associated deaths increased significantly between the 1976-1977 and 1998-1999 seasons for all 3 death categories (P<.001 for each category). For the 1990-1991 through 1998-1999 seasons, the greatest mean numbers of deaths were associated with influenza A(H3N2) viruses, followed by RSV, influenza B, and influenza A(H1N1). Influenza viruses and RSV, respectively, were associated with annual means (SD) of 8097 (3084) and 2707 (196) underlying pneumonia and influenza deaths, 36155 (11055) and 11321 (668) underlying respiratory and circulatory deaths, and 51203 (15081) and 17358 (1086) all-cause deaths. For underlying respiratory and circulatory deaths, 90% of influenza- and 78% of RSV-associated deaths occurred among persons aged 65 years or older, Influenza was associated with more deaths than RSV in all age groups except for children younger than 1 year. On average, influenza was associated with 3 times as many deaths as RSV. Conclusions Mortality associated with both influenza and RSV circulation disproportionately affects elderly persons. Influenza deaths have increased substantially in the last 2 decades, in part because of aging of the population, underscoring the need for better prevention measures, including more effective vaccines and vaccination programs for elderly persons.	Ctr Dis Control & Prevent, Influenza Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA; Ctr Dis Control & Prevent, Resp & Enter Viruses Branch, Div Viral & Rickettsial Dis, Natl Ctr Infect Dis, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Thompson, WW (corresponding author), Ctr Dis Control & Prevent, Immunizat Safety Branch, Epidemiol & Surveillance Div, Natl Immunizat Program, 1600 Clifton Rd NE,MS E61, Atlanta, GA 30333 USA.	wct2@cdc.gov	Markofski, Melissa M/Q-6372-2016	Markofski, Melissa M/0000-0003-0214-4246; Shay, David/0000-0001-9619-4820; Fukuda, Keiji/0000-0002-9598-9565				ANDERSON LJ, 1990, J INFECT DIS, V161, P640, DOI 10.1093/infdis/161.4.640; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; [Anonymous], 1992, MAN INT STAT CLASS D; Barker WH, 1998, ARCH INTERN MED, V158, P645, DOI 10.1001/archinte.158.6.645; BISNO AL, 1971, AM J MED SCI, V261, P251, DOI 10.1097/00000441-197105000-00004; Brammer T L, 2000, MMWR CDC Surveill Summ, V49, P13; Bridges Carolyn B, 2002, MMWR Recomm Rep, V51, P1; *CDCP, 1999, DHHS PUBL; Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P1091; Christenson B, 2001, LANCET, V357, P1008, DOI 10.1016/S0140-6736(00)04237-9; Douglas R G Jr, 1976, Hosp Pract, V11, P43; Dowell SF, 1996, J INFECT DIS, V174, P456, DOI 10.1093/infdis/174.3.456; Falsey AR, 1996, VACCINE, V14, P1214, DOI 10.1016/S0264-410X(96)00030-8; FALSEY AR, 1995, J AM GERIATR SOC, V43, P30, DOI 10.1111/j.1532-5415.1995.tb06238.x; Falsey AR, 1999, J MED VIROL, V59, P221, DOI 10.1002/(SICI)1096-9071(199910)59:2&lt;221::AID-JMV16&gt;3.0.CO;2-H; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Farr W, 1985, VITAL STAT MEMORIAL; FLEMING DM, 1993, LANCET, V342, P1507, DOI 10.1016/S0140-6736(05)80082-0; Glaser CA, 2002, EMERG INFECT DIS, V8, P569, DOI 10.3201/eid0806.010370; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Griffin MR, 2002, ARCH INTERN MED, V162, P1229, DOI 10.1001/archinte.162.11.1229; GROSS PA, 1995, ANN INTERN MED, V123, P518, DOI 10.7326/0003-4819-123-7-199510010-00008; Han LL, 1999, J INFECT DIS, V179, P25, DOI 10.1086/314567; HETZEL AM, 1997, HIST ORG VITAL SAT S; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; Katz JM, 2000, VACCINE, V18, P2177, DOI 10.1016/S0264-410X(00)00022-0; Longini IM, 2000, VACCINE, V18, P1902, DOI 10.1016/S0264-410X(99)00419-3; *NAT CTR HLTH STAT, 1999, VIT STAT MORT DAT MU; Nichol KL, 1996, GERONTOLOGY, V42, P274, DOI 10.1159/000213803; Nichol KL, 1999, ANN INTERN MED, V130, P397, DOI 10.7326/0003-4819-130-5-199903020-00003; Nichol KL, 1998, ARCH INTERN MED, V158, P1769, DOI 10.1001/archinte.158.16.1769; NICHOL KL, 1994, NEW ENGL J MED, V331, P778, DOI 10.1056/NEJM199409223311206; Nicholson KG, 1996, EPIDEMIOL INFECT, V116, P51, DOI 10.1017/S0950268800058957; Nordin J, 2001, J INFECT DIS, V184, P665, DOI 10.1086/323085; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; Shay DK, 2001, J INFECT DIS, V183, P16, DOI 10.1086/317655; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Teng MN, 2000, J VIROL, V74, P9317, DOI 10.1128/JVI.74.19.9317-9321.2000; TREANOR JJ, 1992, ANN INTERN MED, V117, P625, DOI 10.7326/0003-4819-117-8-625; *US BUR CENS, 1990, INT EST POP AG SEX R; Walsh EE, 1999, AM J RESP CRIT CARE, V160, P791, DOI 10.1164/ajrccm.160.3.9901004; WHO (World Health Organization), 1977, MAN INT STAT CLASS D; Wright PF, 2000, J INFECT DIS, V182, P1331, DOI 10.1086/315859; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	46	2749	2914	7	457	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					179	186		10.1001/jama.289.2.179	http://dx.doi.org/10.1001/jama.289.2.179			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517228	Bronze			2022-12-28	WOS:000180226400028
J	Hardon, A				Hardon, A			New WHO leader should aim for equity and confront undue commercial influences	LANCET			English	Article									Univ Amsterdam, Hlth Act Int Fdn, NL-1012 WX Amsterdam, Netherlands	University of Amsterdam	Hardon, A (corresponding author), Univ Amsterdam, Hlth Act Int Fdn, NL-1012 WX Amsterdam, Netherlands.								0	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					6	6		10.1016/S0140-6736(03)12177-0	http://dx.doi.org/10.1016/S0140-6736(03)12177-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521037				2022-12-28	WOS:000180191600006
J	Keeley, EC; Boura, JA; Grines, CL				Keeley, EC; Boura, JA; Grines, CL			Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials	LANCET			English	Article							PRIMARY CORONARY ANGIOPLASTY; EARLY REVASCULARIZATION; IMMEDIATE ANGIOPLASTY; STREPTOKINASE; FIBRINOLYSIS; MORTALITY; SURVIVAL; VOLUME; PTCA	Background Many trials have been done to compare primary percutaneous transluminal coronary angioplasty (PTCA) with thrombolytic therapy for acute ST-segment elevation myocardial infarction (AMI). Our aim was to look at the combined results of these trials and to ascertain which reperfusion therapy is most effective. Methods We did a search of published work and identified 23 trials, which together randomly assigned 7739 thrombolytic-eligible patients with ST-segment elevation AMI to primary PTCA (n=3872) or thrombolytic therapy (n=3867). Streptokinase was used in eight trials (n=1837), and fibrin-specific agents in 15 (n=5902). Most patients who received thrombolytic therapy (76%, n=2939) received a fibrin-specific agent. Stents were used in 12 trials, and platelet glycoprotein IIb/IIIa inhibitors were used in eight. We identified short-term and long-term clinical outcomes of death, non-fatal reinfarction, and stroke, and did subgroup analyses to assess the effect of type of thrombolytic agent used and the strategy of emergent hospital transfer for primary PTCA. All analyses were done with and without inclusion of the SHOCK trial data. Findings Primary PTCA was better than thrombolytic therapy at reducing overall short-term death (7% [n=270] vs 9% [360]; p=0.0002), death excluding the SHOCK trial data (5% [199] vs 7% [276]; p=0.0003), non-fatal reinfarction (3% [80] vs 7% [222]; p<0.0001), stroke (1% [30] vs 2% [64]; p=0.0004), and the combined endpoint of death, non-fatal reinfarction, and stroke (8% [253] vs 14% [442]; p<0.0001). The results seen with primary PTCA remained better than those seen with thrombolytic therapy during long-term follow-up, and were independent of both the type of thrombolytic agent used, and whether or not the patient was transferred for primary PTCA. Interpretation Primary PTCA is more effective than thrombolytic therapy for the treatment of ST-segment elevation AMI.	Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, Dallas, TX 75390 USA; William Beaumont Hosp, Royal Oak, MI 48072 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Beaumont Health	Keeley, EC (corresponding author), Univ Texas, SW Med Ctr, Div Cardiol, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Ellen.Keeley@UTSouthwestern.edu						Akhras F., 1997, Journal of the American College of Cardiology, V29, p235A; Andersen H., 2002, CLIN CARDIOL, V25, P301; Aversano T, 2002, JAMA-J AM MED ASSOC, V287, P1943, DOI 10.1001/jama.287.15.1943; Betriu A, 1997, NEW ENGL J MED, V336, P1621; Bonnefoy E, 2002, LANCET, V360, P825, DOI 10.1016/S0140-6736(02)09963-4; Canto JG, 2000, NEW ENGL J MED, V342, P1573, DOI 10.1056/NEJM200005253422106; DAVIES MJ, 1976, BRIT HEART J, V38, P659; de Boer MJ, 2002, J AM COLL CARDIOL, V39, P1723, DOI 10.1016/S0735-1097(02)01878-8; DeWood MA, 1990, THROMB INT THER AC M; Garcia E., 1997, Journal of the American College of Cardiology, V29, p389A; Garcia E, 1999, J AM COLL CARDIOL, V33, P605, DOI 10.1016/S0735-1097(98)00644-5; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Grines CL, 2002, J AM COLL CARDIOL, V39, P1713, DOI 10.1016/S0735-1097(02)01870-3; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Grinfeld Liliana, 1996, Journal of the American College of Cardiology, V27, p222A; Hasdai D, 2002, EUR HEART J, V23, P1190, DOI 10.1053/euhj.2002.3193; Hochman JS, 1999, NEW ENGL J MED, V341, P625, DOI 10.1056/NEJM199908263410901; Hochman JS, 2001, JAMA-J AM MED ASSOC, V285, P190, DOI 10.1001/jama.285.2.190; Kastrati A, 2002, LANCET, V359, P920, DOI 10.1016/S0140-6736(02)08022-4; Le May MR, 2001, J AM COLL CARDIOL, V37, P985, DOI 10.1016/S0735-1097(00)01213-4; Magid DJ, 2000, JAMA-J AM MED ASSOC, V284, P3131, DOI 10.1001/jama.284.24.3131; MICHELS KB, 1995, CIRCULATION, V91, P476, DOI 10.1161/01.CIR.91.2.476; Nunn CM, 1999, J AM COLL CARDIOL, V33, P640, DOI 10.1016/S0735-1097(98)00622-6; ONEILL W, 1986, NEW ENGL J MED, V314, P812, DOI 10.1056/NEJM198603273141303; RENTROP K P, 1979, Clinical Cardiology, V2, P354; Ribeiro EE, 1993, J AM COLL CARDIOL, V22, P376, DOI 10.1016/0735-1097(93)90040-8; Ribichini F, 1998, J AM COLL CARDIOL, V32, P1687, DOI 10.1016/S0735-1097(98)00446-X; Ribichini Flavio, 1996, Journal of the American College of Cardiology, V27, p221A; Schomig A, 2000, NEW ENGL J MED, V343, P385, DOI 10.1056/NEJM200008103430602; SIMES J, IN PRESS AM HEART J; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VanderWerf F, 1997, EUR HEART J, V18, P1371; Vermeer F, 1999, HEART, V82, P426, DOI 10.1136/hrt.82.4.426; Weaver WD, 1997, JAMA-J AM MED ASSOC, V278, P2093, DOI 10.1001/jama.278.23.2093; Widimsky P, 2000, EUR HEART J, V21, P823, DOI 10.1053/euhj.1999.1993; WIDIMSKY P, 2002, PRAGUE 2 TRIAL C EUR; Zijistra F, 2002, EUR HEART J, V23, P550, DOI 10.1053/euhj.2001.2901; Zijlstra F, 1997, J AM COLL CARDIOL, V29, P908, DOI 10.1016/S0735-1097(97)00018-1; Zijlstra F, 1999, NEW ENGL J MED, V341, P1413, DOI 10.1056/NEJM199911043411901; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002; ZIJLSTRA F, 1994, CORONARY ARTERY DIS, V5, P707, DOI 10.1097/00019501-199408000-00009	41	3006	3264	0	99	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					13	20		10.1016/S0140-6736(03)12113-7	http://dx.doi.org/10.1016/S0140-6736(03)12113-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517460				2022-12-28	WOS:000180191600014
J	Smith, MK				Smith, MK			New WHO leader should keep health of the poor at the heart of the political agenda	LANCET			English	Article																			0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					5	5		10.1016/S0140-6736(03)12174-5	http://dx.doi.org/10.1016/S0140-6736(03)12174-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521036				2022-12-28	WOS:000180191600005
J	van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M				van Schaik, CP; Ancrenaz, M; Borgen, G; Galdikas, B; Knott, CD; Singleton, I; Suzuki, A; Utami, SS; Merrill, M			Orangutan cultures and the evolution of material culture	SCIENCE			English	Article							TOOL USE; CHIMPANZEES; PRIMATES; BEHAVIOR	Geographic variation in some aspects of chimpanzee behavior has been interpreted as evidence for culture. Here we document similar geographic variation in orangutan behaviors. Moreover, as expected under a cultural interpretation, we find a correlation between geographic distance and cultural difference, a correlation between the abundance of opportunities for social learning and the size of the local cultural repertoire, and no effect of habitat on the content of culture. Hence, great-ape cultures exist, and may have done so for at least 14 million years.	Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA; Kinabatangan Orang Utan Conservat Project, Sandakan 90734, Sabah, Malaysia; Simon Fraser Univ, Dept Archaeol, Burnaby, BC V5A 1S6, Canada; Orangutan Fdn Int, Los Angeles, CA 90049 USA; Harvard Univ, Dept Anthropol, Peabody Museum, Cambridge, MA 02138 USA; Sumatran Orangutan Conservat Programme, Medan 20000, Indonesia; Kyoto Univ, Primate Inst, Inuyama, Aichi 484, Japan; Univ Nas, Fak Biol, Jakarta 12520, Indonesia; Univ Utrecht, Dept Behav Biol, NL-3508 TB Utrecht, Netherlands	Duke University; Simon Fraser University; Harvard University; Kyoto University; Universitas Nasional Pionir Perubahan; Utrecht University	van Schaik, CP (corresponding author), Duke Univ, Dept Biol Anthropol & Anat, POB 90383, Durham, NC 27708 USA.		Merrill, Michelle Yvonne/D-7807-2014	Merrill, Michelle Yvonne/0000-0002-7337-7533; utami, sri/0000-0002-5138-242X				BOESCH C, 1994, J HUM EVOL, V26, P325, DOI 10.1006/jhev.1994.1020; Boesch Christophe, 1996, P101, DOI 10.1017/CBO9780511752414.010; Boyd Robert, 1996, Proceedings of the British Academy, V88, P77; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; Curio E., 1988, P75; de Waal FBM, 1999, NATURE, V399, P635, DOI 10.1038/21310; FOX EA, IN PRESS AM J PHYS A; Galef B G, 1992, Hum Nat, V3, P157, DOI 10.1007/BF02692251; GALEF BG, IN PRESS BIOL ANIMAL; Goodman M, 1998, MOL PHYLOGENET EVOL, V9, P585, DOI 10.1006/mpev.1998.0495; Hudson J. C., 1972, NW U STUDIES GEOGRAP; Keesing F. M, 1958, CULTURAL ANTHR SCI C; KUMMER H, 1985, PHILOS T ROY SOC B, V308, P203, DOI 10.1098/rstb.1985.0020; MANTEL N, 1967, CANCER RES, V27, P209; McGrew WC, 1997, INT J PRIMATOL, V18, P353, DOI 10.1023/A:1026382316131; Myowa-Yamakoshi M, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P349; Nishida T., 1987, P462; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; STOINSKI T, IN PRESS COMP PSYCHO; SUGIYAMA Y, 1981, Primates, V22, P435, DOI 10.1007/BF02381236; Sugiyama Y., 1968, Primates, V9, P225, DOI 10.1007/BF01730972; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Tuttle RH, 2001, CURR ANTHROPOL, V42, P407, DOI 10.1086/320476; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; Van Schaik CP, 2001, AM J PHYS ANTHROPOL, V114, P331, DOI 10.1002/ajpa.1045; VANSCHAIK CP, IN PRESS BIOL ANIMAL; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2000, COGNITIVE SCI, V24, P477	29	615	633	6	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					102	105		10.1126/science.1078004	http://dx.doi.org/10.1126/science.1078004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511649				2022-12-28	WOS:000180165800042
J	Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH				Gu, ZL; Steinmetz, LM; Gu, X; Scharfe, C; Davis, RW; Li, WH			Role of duplicate genes in genetic robustness against null mutations	NATURE			English	Article							REDUNDANCY; GENOME; YEAST; EVOLUTION	Deleting a gene in an organism often has little phenotypic effect(1-5), owing to two mechanisms of compensation(4-10). The first is the existence of duplicate genes: that is, the loss of function in one copy can be compensated by the other copy or copies. The second mechanism of compensation stems from alternative metabolic pathways, regulatory networks, and so on. The relative importance of the two mechanisms has not been investigated except for a limited study, which suggested that the role of duplicate genes in compensation is negligible(10). The availability of fitness data for a nearly complete set of single-gene-deletion mutants of the Saccharomyces cerevisiae genome(11) has enabled us to carry out a genome-wide evaluation of the role of duplicate genes in genetic robustness against null mutations. Here we show that there is a significantly higher probability of functional compensation for a duplicate gene than for a singleton, a high correlation between the frequency of compensation and the sequence similarity of two duplicates, and a higher probability of a severe fitness effect when the duplicate copy that is more highly expressed is deleted. We estimate that in S. cerevisiae at least a quarter of those gene deletions that have no phenotype are compensated by duplicate genes.	Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; Iowa State Univ, Dept Zool, Ames, IA 50011 USA; Iowa State Univ, Dept Genet, Ames, IA 50011 USA	University of Chicago; Stanford University; Stanford University; Iowa State University; Iowa State University	Li, WH (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57th St, Chicago, IL 60637 USA.			Li, Wen-Hsiung/0000-0003-1086-1456; Steinmetz, Lars/0000-0002-3962-2865				Brookfield John, 1992, Current Biology, V2, P553, DOI 10.1016/0960-9822(92)90036-A; CADIGAN KM, 1994, P NATL ACAD SCI USA, V91, P6324, DOI 10.1073/pnas.91.14.6324; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gibson TJ, 1998, TRENDS GENET, V14, P46, DOI 10.1016/S0168-9525(97)01367-X; Gu ZL, 2002, MOL BIOL EVOL, V19, P256, DOI 10.1093/oxfordjournals.molbev.a004079; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Kitami T, 2002, NAT GENET, V32, P191, DOI 10.1038/ng945; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Normanly J, 1999, CURR OPIN PLANT BIOL, V2, P207, DOI 10.1016/S1369-5266(99)80037-5; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; SAGA Y, 1992, GENE DEV, V6, P1821, DOI 10.1101/gad.6.10.1821; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yang CQ, 2000, TEXT CHEM COLOR AM D, V32, P43	22	645	661	0	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					63	66		10.1038/nature01198	http://dx.doi.org/10.1038/nature01198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511954				2022-12-28	WOS:000180165500037
J	Yano, JI; Talagrand, O; Drossart, P				Yano, JI; Talagrand, O; Drossart, P			Outer plants: Origins of atmospheric zonal winds	NATURE			English	Article							POTENTIAL VORTICITY; STABILITY; PLANETS; JUPITER		Ecole Polytech, Meteorol Dynam Lab, F-91128 Palaiseau, France; Ecole Normale Super, LMD, F-75231 Paris, France; Observ Paris, LESIA, CNRS, FRE 2461, F-92125 Meudon, France	Institut Polytechnique de Paris; UDICE-French Research Universities; Sorbonne Universite; Ecole des Ponts ParisTech; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite Paris Cite	Yano, JI (corresponding author), Ecole Polytech, Meteorol Dynam Lab, F-91128 Palaiseau, France.		Drossart, Pierre/H-8670-2013					BUSSE FH, 1976, ICARUS, V29, P255, DOI 10.1016/0019-1035(76)90053-1; Cho JYK, 1996, SCIENCE, V273, P335, DOI 10.1126/science.273.5273.335; INGERSOLL AP, 1982, ICARUS, V52, P62, DOI 10.1016/0019-1035(82)90169-5; INGERSOLL AP, 1990, SCIENCE, V248, P308, DOI 10.1126/science.248.4953.308; Pedlosky J., 1987, GEOPHYS FLUID DYN; RHINES PB, 1982, J FLUID MECH, V122, P347, DOI 10.1017/S0022112082002250; YANO J, 1994, ANN GEOPHYS, V12, P1, DOI 10.1007/s00585-994-0001-z; YANO JI, 1992, DYNAM ATMOS OCEANS, V16, P439, DOI 10.1016/0377-0265(92)90001-A; Yano JI, 1994, CHAOS, V4, P287, DOI 10.1063/1.166008	10	27	28	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					36	36		10.1038/421036a	http://dx.doi.org/10.1038/421036a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511945				2022-12-28	WOS:000180165500028
J	Schibler, U; Sassone-Corsi, P				Schibler, U; Sassone-Corsi, P			A web of circadian pacemakers	CELL			English	Review							GENE-EXPRESSION; CLOCK	The mammalian circadian timing system is composed of almost as many individual clocks as there are cells. These countless oscillators have to be synchronized by a central pacemaker to coordinate temporal physiology and behavior. Recently, there has been some progress in understanding the relationship and communication, mechanisms between central and peripheral clocks.	Univ Geneva, NCCR Frontiers Genet Sci 2, Dept Mol Biol, CH-1211 Geneva 4, Switzerland; Inst Genet & Biol Mol & Cellulaire, F-67404 Strasbourg, France	University of Geneva; Institut National de la Sante et de la Recherche Medicale (Inserm)	Schibler, U (corresponding author), Univ Geneva, NCCR Frontiers Genet Sci 2, Dept Mol Biol, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	ueli.schibler@molbio.unige.ch; paolosc@igbmc.u-strasbg.fr	Jansen, Heiko T./A-5770-2008; Sassone-Corsi, Paolo/H-6182-2011	Jansen, Heiko T./0000-0003-0178-396X; 				Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Giebultowicz JM, 2001, PHILOS T R SOC B, V356, P1791, DOI 10.1098/rstb.2001.0960; Golden SS, 2001, PLANT PHYSIOL, V125, P98, DOI 10.1104/pp.125.1.98; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Kondo T, 2000, BIOESSAYS, V22, P10, DOI 10.1002/(SICI)1521-1878(200001)22:1<10::AID-BIES4>3.0.CO;2-A; Kramer A, 2001, SCIENCE, V294, P2511, DOI 10.1126/science.1067716; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; MOHABIR G, 1998, P NATL ACAD SCI USA, V98, P10178; Pando MP, 2002, CELL, V110, P107, DOI 10.1016/S0092-8674(02)00803-6; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589	19	573	580	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 27	2002	111	7					919	922		10.1016/S0092-8674(02)01225-4	http://dx.doi.org/10.1016/S0092-8674(02)01225-4			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507418	Bronze			2022-12-28	WOS:000180086000001
J	Parrish, AG				Parrish, AG			Country gardens	LANCET			English	Editorial Material											Parrish, AG (corresponding author), POB 244, ZA-5256 Gonuble, South Africa.								0	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2059	2060		10.1016/S0140-6736(02)11996-9	http://dx.doi.org/10.1016/S0140-6736(02)11996-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504416				2022-12-28	WOS:000179974200027
J	Spechler, SJ				Spechler, SJ			A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HELICOBACTER-PYLORI INFECTION; GASTRIC-ACID BREAKTHROUGH; FOLLOW-UP; ANTIREFLUX SURGERY; OMEPRAZOLE THERAPY; UPDATED GUIDELINES; GRADE DYSPLASIA; PREVALENCE; DIAGNOSIS; RISK		Dallas Vet Affairs Med Ctr, Div Gastroenterol, Dallas, TX USA; Univ Texas, SW Med Ctr Dallas, Berta M & Cecil O Patterson Chair Gastroenterol, Dallas, TX 75235 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Spechler, SJ (corresponding author), Dallas VA Med Ctr, Div Gastroenterol 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.							Armstrong D, 1999, YALE J BIOL MED, V72, P93; BARON TH, 1992, GASTROENTEROL CLIN N, V21, P777; Cameron AJ, 1997, GASTROENTEROL CLIN N, V26, P487, DOI 10.1016/S0889-8553(05)70308-3; Castell DO, 2002, AM J GASTROENTEROL, V97, P575; Chiba N, 1997, GASTROENTEROLOGY, V112, P1798, DOI 10.1053/gast.1997.v112.pm9178669; Chow WH, 1998, CANCER RES, V58, P588; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; DAVILA ML, 2002, SLEISENGER FORDTRANS, P539; DENT J, 1994, GUT, V35, P590, DOI 10.1136/gut.35.5.590; DEVAULT KR, 1995, ARCH INTERN MED, V155, P2165, DOI 10.1001/archinte.155.20.2165; DeVault KR, 1999, AM J GASTROENTEROL, V94, P1434; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dulai GS, 2002, GASTROENTEROLOGY, V122, P26, DOI 10.1053/gast.2002.30297; DUNNINGTON GL, 1993, AM J SURG, V166, P654, DOI 10.1016/S0002-9610(05)80673-7; Eggleston A, 1998, GUT, V42, P13, DOI 10.1136/gut.42.1.13; Fackler WK, 2002, GASTROENTEROLOGY, V122, P625, DOI 10.1053/gast.2002.31876; Farup C, 2001, ARCH INTERN MED, V161, P45, DOI 10.1001/archinte.161.1.45; Fennerty MB, 2001, AM J GASTROENTEROL, V96, P2302; Filipi CJ, 2001, GASTROINTEST ENDOSC, V53, P416, DOI 10.1067/mge.2001.113502; Fitzgerald RC, 1996, J CLIN INVEST, V98, P2120, DOI 10.1172/JCI119018; Gerson LB, 2002, GASTROENTEROLOGY, V123, P461, DOI 10.1053/gast.2002.34748; GOY JA, 1986, MED J AUSTRALIA, V20, P71; Graham DY, 1998, HELICOBACTER, V3, P145, DOI 10.1046/j.1523-5378.1998.08031.x; GRAHAM DY, 1983, DIGEST DIS SCI, V28, P559, DOI 10.1007/BF01308159; HANSTEN PD, 1991, ALIMENT PHARM THERAP, V5, P121; Harding SM, 1997, CHEST, V111, P1389, DOI 10.1378/chest.111.5.1389; HETZEL DJ, 1988, GASTROENTEROLOGY, V95, P903, DOI 10.1016/0016-5085(88)90162-X; Hinder RA, 1999, GASTROENTEROL CLIN N, V28, P987, DOI 10.1016/S0889-8553(05)70101-1; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; Ho KY, 1998, AM J GASTROENTEROL, V93, P1816, DOI 10.1111/j.1572-0241.1998.00526.x; Inadomi JM, 2001, GASTROENTEROLOGY, V121, P1095, DOI 10.1053/gast.2001.28649; Jailwala JA, 2000, J CLIN GASTROENTEROL, V30, pS35; JAROFF L, 1995, TIME            1106; Kahrilas PJ, 1996, JAMA-J AM MED ASSOC, V276, P983, DOI 10.1001/jama.276.12.983; Katz PO, 1998, ALIMENT PHARM THER, V12, P1231; Klinkenberg-Knol EC, 2000, GASTROENTEROLOGY, V118, P661, DOI 10.1016/S0016-5085(00)70135-1; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Lagergren J, 1999, ANN INTERN MED, V130, P883, DOI 10.7326/0003-4819-130-11-199906010-00003; LAMBERTS R, 1993, GASTROENTEROLOGY, V104, P1356, DOI 10.1016/0016-5085(93)90344-C; Locke GR, 1997, GASTROENTEROLOGY, V112, P1448, DOI 10.1016/S0016-5085(97)70025-8; Lundell L, 2001, J AM COLL SURGEONS, V192, P172, DOI 10.1016/S1072-7515(00)00797-3; Lundell L, 2000, EUR J GASTROEN HEPAT, V12, P879, DOI 10.1097/00042737-200012080-00007; Malfertheiner P, 2002, ALIMENT PHARM THER, V16, P1, DOI 10.1046/j.1365-2036.16.s3.1.x; Mandel KG, 2000, ALIMENT PHARM THER, V14, P669; MARCUARD SP, 1994, ANN INTERN MED, V120, P211, DOI 10.7326/0003-4819-120-3-199402010-00006; MCCALLUM RW, 1984, AM J GASTROENTEROL, V79, P165; Ofman JJ, 2002, ALIMENT PHARM THER, V16, P261, DOI 10.1046/j.1365-2036.2002.01167.x; ORLANDO RC, 1991, AM J MED, V91, pS123, DOI 10.1016/0002-9343(91)90463-8; Ormseth EJ, 1999, AM J GASTROENTEROL, V94, P2812, DOI 10.1016/S0002-9270(99)00477-3; OTT DJ, 1994, RADIOL CLIN N AM, V32, P1147; Ouatu-Lascar R, 1999, GASTROENTEROLOGY, V117, P327, DOI 10.1053/gast.1999.0029900327; Ouatu-Lascar R, 1998, AM J GASTROENTEROL, V93, P711; Overholt BF, 1999, GASTROINTEST ENDOSC, V49, P1, DOI 10.1016/S0016-5107(99)70437-2; Peghini PL, 1998, GASTROENTEROLOGY, V115, P1335, DOI 10.1016/S0016-5085(98)70010-1; Peghini PL, 1998, AM J GASTROENTEROL, V93, P763; Richter JE, 1998, AM J GASTROENTEROL, V93, P1800, DOI 10.1111/j.1572-0241.1998.00523.x; Richter JE, 2001, AM J GASTROENTEROL, V96, P656; RICHTER JE, 1982, ANN INTERN MED, V97, P93, DOI 10.7326/0003-4819-97-1-93; Richter JE, 2000, J CLIN GASTROENTEROL, V30, pS39; Richter JE, 2000, ARCH INTERN MED, V160, P1810, DOI 10.1001/archinte.160.12.1810; Rodriguez LAG, 1997, EPIDEMIOLOGY, V8, P571; Rudolph RE, 2000, ANN INTERN MED, V132, P612, DOI 10.7326/0003-4819-132-8-200004180-00003; Sampliner RE, 2002, AM J GASTROENTEROL, V97, P1888; Shaheen N, 2002, JAMA-J AM MED ASSOC, V287, P1972, DOI 10.1001/jama.287.15.1972; Shaheen NJ, 2000, GASTROENTEROLOGY, V119, P333, DOI 10.1053/gast.2000.9302; Shaker R, 2001, GASTROENTEROLOGY, V120, pA420; Sharma P, 1998, AM J GASTROENTEROL, V93, P1033; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; SMITH PM, 1994, GASTROENTEROLOGY, V107, P1312, DOI 10.1016/0016-5085(94)90532-0; SONNENBERG A, 1994, DIGEST DIS SCI, V39, P183, DOI 10.1007/BF02090080; Souza RF, 2002, GASTROENTEROLOGY, V122, P299, DOI 10.1053/gast.2002.30993; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; SPECHLER SJ, 1992, NEW ENGL J MED, V326, P786, DOI 10.1056/NEJM199203193261202; SPECHLER SJ, 1992, DIGESTION, V51, P24, DOI 10.1159/000200911; Spechler SJ, 2002, ALIMENT PHARM THER, V16, P1795, DOI 10.1046/j.1365-2036.2002.01351.x; Spechler SJ, 2001, EUR J SURG, V167, P78; Spechler SJ, 2001, GASTROENTEROLOGY, V120, P1864, DOI 10.1053/gast.2001.25291; Spechler SJ, 2001, JAMA-J AM MED ASSOC, V285, P2331, DOI 10.1001/jama.285.18.2331; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; Spechler SJ, 2002, SLEISENGER FORDTRANS, P747; Ter RB, 1997, GASTROENTEROL CLIN N, V26, P549, DOI 10.1016/S0889-8553(05)70313-7; Theisen J, 2000, J GASTROINTEST SURG, V4, P50, DOI 10.1016/S1091-255X(00)80032-3; Triadafilopoulos G, 2002, GASTROINTEST ENDOSC, V55, P149, DOI 10.1067/mge.2002.121227; Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x; van den Boogert J, 1999, AM J GASTROENTEROL, V94, P1153, DOI 10.1016/S0002-9270(99)00114-8; VERDU E, 1994, GUT, V35, P455, DOI 10.1136/gut.35.4.455; WILDERSMITH CH, 1990, DIGEST DIS SCI, V35, P976, DOI 10.1007/BF01537246; Ye WM, 2001, GASTROENTEROLOGY, V121, P1286, DOI 10.1053/gast.2001.29569	89	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					466	475		10.1001/jama.289.4.466	http://dx.doi.org/10.1001/jama.289.4.466			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TD	12533126				2022-12-28	WOS:000180472300028
J	Blann, AD; Fitzmaurice, DA; Lip, GYH				Blann, AD; Fitzmaurice, DA; Lip, GYH			ABC of antithrombotic therapy - Anticoagulation in hospitals and general practice	BRITISH MEDICAL JOURNAL			English	Review							COMPUTERIZED DECISION-SUPPORT; PRIMARY-CARE; MANAGEMENT; PHARMACIST; INR		City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England	University of Birmingham	Blann, AD (corresponding author), City Hosp, Univ Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Birmingham, W Midlands, England.							Baglin T, 1997, BRIT J HAEMATOL, V96, P431, DOI 10.1046/j.1365-2141.1997.d01-2079.x; Blann A, 1999, BRIT J HAEMATOL, V107, P207, DOI 10.1046/j.1365-2141.1999.01672.x; *BRIT COMM STAND H, 1998, BRIT J HAEMATOL, V101, P374; Fitzmaurice DA, 1998, BRIT J HAEMATOL, V102, P907; Fitzmaurice DA, 2000, ARCH INTERN MED, V160, P2343, DOI 10.1001/archinte.160.15.2343; Fitzmaurice DA, 2002, J CLIN PATHOL, V55, P845, DOI 10.1136/jcp.55.11.845; Macgregor SH, 1996, BRIT MED J, V312, P560, DOI 10.1136/bmj.312.7030.560; PELL JP, 1993, BRIT J GEN PRACT, V43, P152; RADLEY AS, 1995, J CLIN PATHOL, V48, P545, DOI 10.1136/jcp.48.6.545	9	20	21	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					153	156		10.1136/bmj.326.7381.153	http://dx.doi.org/10.1136/bmj.326.7381.153			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531851	Green Published			2022-12-28	WOS:000180575900030
J	Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L				Zhuo, Y; Zhou, TG; Rao, HY; Wang, JJ; Meng, M; Chen, M; Zhou, C; Chen, L			Contributions of the visual ventral pathway to long-range apparent motion	SCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; TOPOLOGICAL-STRUCTURE; PERCEPTION; BRAIN; RECOGNITION; ACTIVATION; VARIABLES; VISION; COLOR; NAME	Objects displaced intermittently across the visual field will nonetheless give an illusion of continuous motion [called apparent motion (AM)] under many common conditions. It is believed that form perception is of minor importance in determining AM, and that AM is mediated by motion-sensitive areas in the where pathway of the cortex. However, form and motion typically interact in specific ways when natural objects move through the environment. We used functional magnetic resonance imaging to measure cortical activation to long-range AM, compared to short-range AM and flicker, while we varied stability of structural differences between forms. Long-range AM activated the anterior-temporal lobe in the visual ventral pathway, and the response varied according to the form stability. The results suggest that long-range AM is associated with neural systems for form perception.	Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, Beijing 100101, Peoples R China; Beijing Hosp, Beijing 100730, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; University of Chinese Academy of Sciences, CAS; Beijing Hospital	Chen, L (corresponding author), Chinese Acad Sci, Inst Biophys, Grad Sch, Key Lab Cognit Sci, 15 Datun Rd, Beijing 100101, Peoples R China.		Meng, Ming/A-5829-2008; Wang, Danny JJ/O-2482-2018; Rao, Hengyi/A-7064-2009; Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020	Wang, Danny JJ/0000-0002-0840-7062; Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500				ANSTIS S, 1986, SENSORY PROCESS PERC, V1, P16; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; CHEN L, 1985, PERCEPTION, V14, P197, DOI 10.1068/p140197; CHEN L, 1982, SCIENCE, V218, P699, DOI 10.1126/science.7134969; CHEN L, 1990, PERCEPT PSYCHOPHYS, V47, P47, DOI 10.3758/BF03208163; Chen L, 2001, VIS COGN, V8, P287, DOI 10.1080/13506280143000016; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Damasio H, 1996, NATURE, V380, P499, DOI 10.1038/380499a0; Gauthier I, 1997, CURR BIOL, V7, P645, DOI 10.1016/S0960-9822(06)00291-0; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; KOLERS PA, 1971, J EXP PSYCHOL, V87, P99, DOI 10.1037/h0030156; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; Moore CJ, 1999, BRAIN, V122, P943, DOI 10.1093/brain/122.5.943; Mummery CJ, 1996, P ROY SOC B-BIOL SCI, V263, P989, DOI 10.1098/rspb.1996.0146; PALMER P, 1999, VISION SCI; PETERSIK JT, 1989, PSYCHOL BULL, V106, P107, DOI 10.1037/0033-2909.106.1.107; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; PRAZDNY K, 1986, PERCEPTION, V15, P37, DOI 10.1068/p150037; Price CJ, 1996, P ROY SOC B-BIOL SCI, V263, P1501, DOI 10.1098/rspb.1996.0219; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Todd JT, 1998, PERCEPTION, V27, P273, DOI 10.1068/p270273; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Ullman S., 1979, PROC R SOC SER B-BIO, DOI 10.7551/mitpress/3877.003.0009; Ungerleider LG, 1982, ANAL VISUAL BEHAV, P263; Wang JJ, 1999, HUM BRAIN MAPP, V8, P170, DOI 10.1002/(SICI)1097-0193(1999)8:4<170::AID-HBM2>3.3.CO;2-N; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068	33	84	92	1	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					417	420		10.1126/science.1077091	http://dx.doi.org/10.1126/science.1077091			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	635YB	12532023				2022-12-28	WOS:000180426800053
J	Madeley, CR				Madeley, CR			Diagnosing smallpox in possible bioterrorist attack	LANCET			English	Editorial Material							VIRUS					dickmadeley@aol.com						ANDERSON T, 1951, LANCET, V260, P1248; Biel SS, 2001, J CLIN VIROL, V22, P1, DOI 10.1016/S1386-6532(01)00151-2; Breman JG, 2002, NEW ENGL J MED, V346, P1300, DOI 10.1056/NEJMra020025; Calisher CH, 2000, VIRAL IMMUNOL, V13, P411, DOI 10.1089/vim.2000.13.411; *CDCP, 2002, EV PAT SMALLP VERS 1; Elliott RM, 2001, SYMP SOC GEN MICROBI, V60, P53, DOI 10.1017/CBO9780511754883.004; GELDERBLOM HR, 2001, BIOFORUM INT, V5, P64; Nakano JH, 1989, DIAGNOSTIC PROCEDURE, P453; Yuen KY, 1998, LANCET, V351, P467, DOI 10.1016/S0140-6736(98)01182-9; 2002, TIMES           1203, P21	10	23	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					97	98		10.1016/S0140-6736(03)12241-6	http://dx.doi.org/10.1016/S0140-6736(03)12241-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531572				2022-12-28	WOS:000180428000004
J	Nakao, N; Yoshimura, A; Morita, H; Takada, M; Kayano, T; Ideura, T				Nakao, N; Yoshimura, A; Morita, H; Takada, M; Kayano, T; Ideura, T			RETRACTED: Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial (Retracted article. See vol. 374, pg. 1226, 2009)	LANCET			English	Article; Proceedings Paper; Retracted Publication	38th European-Renal-Association/European-Dialysis-and-Transplant-Association Congress	JUN 24-27, 2001	VIENNA, AUSTRIA	European Renal Assoc, European Dialysis & Transplant Assoc			GLOMERULAR-FILTRATION-RATE; ACE-INHIBITORS; PROGRESSION; NEPHROPATHY; INSUFFICIENCY; METAANALYSIS; HYPERTENSION; PROTEINURIA; BENAZEPRIL; EFFICACY	Background Present angiotensin-converting-enzyme inhibitor treatment fails to prevent progression of non-diabetic renal disease. We aimed to assess the efficacy and safety of combined treatment of angiotensin-converting-enzyme inhibitor and angiotensin-II receptor blocker, and monotherapy of each drug at its maximum dose, in patients with non-diabetic renal disease. Methods 336 patients with non-diabetic renal disease were enrolled from one renal outpatient department in Japan. After screening and an 18-week run-in period, 263 patients were randomly assigned angiotensin-II receptor blocker (losartan, 100 mg daily), angiotensin-converting-enzyme inhibitor (trandolapril, 3 mg daily), or a combination of both drugs at equivalent doses. Survival analysis was done to compare the effects of each regimen on the combined primary endpoint of time to doubling of serum creatinine concentration or endstage renal disease. Analysis was by intention to treat. Findings Seven patients discontinued or were otherwise lost to follow-up. Ten (11%) of 85 patients on combination treatment reached the combined primary endpoint compared with 20 (23%) of 85 on trandolapril alone (hazard ratio 0.38, 95% Cl 0.18-0.63, p=0.018) and 20 (23%) of 86 on losartan alone (0.40, 0.17-0.69, p=0.016). Covariates affecting renal survival were combination treatment (hazard ratio 0.38, 95% Cl 0.18-0.63, p=0.011), age (1.30, 1.03-2.29, p=0.009), baseline renal function (1.80, 1.02-2.99, p=0.021), change in daily urinary protein excretion rate (0.58, 0.24-0.88, p=0.022), use of diuretics (0.80, 0.30-0.94, p=0.043), and antiproteinuric response to trandolapril (0.81, 0.21-0.91, p=0.039). Frequency of side-effects with combination treatment was the same as with trandolapril alone. Interpretation Combination treatment safely retards progression of non-diabetic renal disease compared with monotherapy. However, since some patients reached the combined primary endpoint on combined treatment, further strategies for complete management of progressive nondiabetic renal disease need to be researched.	Showa Univ, Fujigaoka Hosp, Div Nephrol, Aoba Ku, Yokohama, Kanagawa 2278501, Japan; Gen Gen Do Kimitsu Hosp, Div Nephrol, Kimitsu, Japan	Showa University	Nakao, N (corresponding author), Showa Univ, Fujigaoka Hosp, Div Nephrol, Aoba Ku, 1-30 Fujigaoka, Yokohama, Kanagawa 2278501, Japan.	nakao@ce.catv.ne.jp						Agarwal R, 2001, KIDNEY INT, V59, P2282, DOI 10.1046/j.1523-1755.2001.00745.x; ANDERSON S, 1986, J CLIN INVEST, V77, P1993, DOI 10.1172/JCI112528; COLES GA, 2000, MECH CLIN MANAGMENT, P401; GARDMAN AH, 1995, HYPERTENSION, V25, P1345; Gehan EA, 1975, CANCER THERAPY PROGN, P7; Giatras I, 1997, ANN INTERN MED, V127, P337, DOI 10.7326/0003-4819-127-5-199709010-00001; Hemmelder MH, 1999, NEPHROL DIAL TRANSPL, V14, P98, DOI 10.1093/ndt/14.1.98; HERBERT LA, 1999, AM J NEPHROL, V19, P1; Jafar TH, 2001, ANN INTERN MED, V135, P73, DOI 10.7326/0003-4819-135-2-200107170-00007; Kshirsagar AV, 2000, AM J KIDNEY DIS, V35, P695, DOI 10.1016/S0272-6386(00)70018-7; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Locatelli F, 1996, NEPHROL DIAL TRANSPL, V11, P461; LOCATELLI F, 1997, KIDNEY INT S, V63, P63; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Maschio G, 1999, J CARDIOVASC PHARM, V33, pS16, DOI 10.1097/00005344-199900001-00004; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; *PAT REG COMM JAP, 2000, OV REG DIAL TREATM J; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Ruggenenti P, 1998, LANCET, V352, P1252, DOI 10.1016/S0140-6736(98)04433-X; Ruggenenti P, 2001, LANCET, V357, P1601, DOI 10.1016/S0140-6736(00)04728-0; Ruilope LM, 2000, J HYPERTENS, V18, P89, DOI 10.1097/00004872-200018010-00013; Russo D, 1999, AM J KIDNEY DIS, V33, P851, DOI 10.1016/S0272-6386(99)70416-6; Shiigai T, 2001, AM J KIDNEY DIS, V37, P477, DOI 10.1053/ajkd.2001.22069; Toto R, 1998, HYPERTENSION, V31, P684, DOI 10.1161/01.HYP.31.2.684; ZUCCHELLI P, 1992, KIDNEY INT, V42, P452, DOI 10.1038/ki.1992.309	27	741	791	0	61	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					117	124		10.1016/S0140-6736(03)12229-5	http://dx.doi.org/10.1016/S0140-6736(03)12229-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	635YP	12531578				2022-12-28	WOS:000180428000010
J	Tanoue, LT; Mark, EJ				Tanoue, LT; Mark, EJ			A 43-year-old man with fever and night sweats. Mycobacterium tuberculosis infection.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MILIARY TUBERCULOSIS; PULMONARY TUBERCULOSIS; RAPID DIAGNOSIS; UNITED-STATES; VITAMIN-D; EPIDEMIOLOGY; HYPOPITUITARISM; BRUCELLOSIS; MENINGITIS; DISEASE		Yale Univ, Sch Med, Pulm & Crit Care Med Sect, New Haven, CT 06510 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Yale University; Harvard University; Massachusetts General Hospital	Tanoue, LT (corresponding author), Yale Univ, Sch Med, Pulm & Crit Care Med Sect, 333 Cedar St, New Haven, CT 06510 USA.							ARIZA J, 1995, CLIN INFECT DIS, V20, P1241, DOI 10.1093/clinids/20.5.1241; Bellamy R, 2000, LANCET, V355, P588, DOI 10.1016/S0140-6736(99)00426-2; BERGER SA, 1986, REV INFECT DIS, V8, P747; BRISSONNOEL A, 1991, LANCET, V338, P364, DOI 10.1016/0140-6736(91)90492-8; BROOKS MH, 1973, AM J MED, V54, P777, DOI 10.1016/0002-9343(73)90065-X; Camarca MM, 2001, MIL MED, V166, P452, DOI 10.1093/milmed/166.5.452; *CDC, 1977, DHEW PUBL CDC; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Colmenero JD, 1997, MEDICINE, V76, P139; DAVIES PDO, 1995, J ROY COLL PHYS LOND, V29, P113; DAVIES PDO, 1984, J BONE JOINT SURG BR, V66, P326, DOI 10.1302/0301-620X.66B3.6427232; DOLBERG OT, 1991, REV INFECT DIS, V13, P177; GELB AF, 1973, AM REV RESPIR DIS, V108, P1327; GRUDEN JF, 1994, AM J ROENTGENOL, V162, P569, DOI 10.2214/ajr.162.3.8109498; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Indira B, 1996, SURG NEUROL, V45, P347, DOI 10.1016/0090-3019(95)00431-9; JEREN T, 1982, ACTA CYTOL, V26, P678; KANTOR HS, 1988, AM J MED, V84, P833, DOI 10.1016/0002-9343(88)90060-5; KIM JH, 1990, REV INFECT DIS, V12, P583; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; MCMURRAY DN, 1990, ANN NY ACAD SCI, V587, P59, DOI 10.1111/j.1749-6632.1990.tb00134.x; MEDLAR EM, 1955, AM REV TUBERC PULM, V71, pR3; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; MILLER WT, 1978, AM J ROENTGENOL, V130, P865; MUNT PW, 1972, MEDICINE, V51, P139, DOI 10.1097/00005792-197203000-00004; OGAWA SK, 1987, MEDICINE, V66, P317, DOI 10.1097/00005792-198707000-00004; Petrossians P, 1998, J CLIN ENDOCR METAB, V83, P3454, DOI 10.1210/jc.83.10.3454; RIEDER HL, 1991, CHEST, V100, P678, DOI 10.1378/chest.100.3.678; ROOK GAW, 1988, AM REV RESPIR DIS, V138, P768, DOI 10.1164/ajrccm/138.4.768; SHANKAR P, 1991, LANCET, V337, P5, DOI 10.1016/0140-6736(91)93328-7; SHERMAN BM, 1971, ARCH INTERN MED, V128, P600, DOI 10.1001/archinte.128.4.600; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; Takemura T, 2000, PATHOL INT, V50, P672, DOI 10.1046/j.1440-1827.2000.01086.x; Talavera W, 2001, TUBERCULOSIS CURRENT, P139; TRAUB M, 1984, Q J MED, V53, P81; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497; *WORK GROUP ANT TH, 1998, MMWR-MORBID MORTAL W, V47, P1; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283	40	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					151	161		10.1056/NEJMcpc020026	http://dx.doi.org/10.1056/NEJMcpc020026			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519926				2022-12-28	WOS:000180263900008
J	Bisley, JW; Goldberg, ME				Bisley, JW; Goldberg, ME			Neuronal activity in the lateral intraparietal area and spatial attention	SCIENCE			English	Article							POSTERIOR PARIETAL CORTEX; SELECTIVE VISUAL-ATTENTION; MOTOR INTENTION ACTIVITY; SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; MONKEY; MACAQUES; ENHANCEMENT; RESPONSES; PLAN	Although the parietal cortex has been implicated in the neural processes underlying visual attention, the nature of its contribution is not well understood. We tracked attention in the monkey and correlated the activity of neurons in the lateral intraparietal area (LIP) with the monkey's attentional performance. The ensemble activity in LIP across the entire visual field describes the spatial and temporal dynamics of a monkey's attention. Activity subtending a single location in the visual. field describes the attentional priority at that area but does not predict that the monkey will actually attend to or make an eye movement to that location.	New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, New York, NY 10032 USA; NEI, Sensorimotor Res Lab, Bethesda, MD 20892 USA; Georgetown Univ, Sch Med, Dept Neurol, Washington, DC 20007 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Neurol, Mahoney Ctr Mind & Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Keck Ctr Cognit & Plast,Dept Psychiat, Mahoney Ctr Mind & Brain, New York, NY 10032 USA	New York State Psychiatry Institute; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Georgetown University; Columbia University; Columbia University	Bisley, JW (corresponding author), New York State Psychiat Inst & Hosp, Ctr Neurobiol & Behav, Mahoney Keck Ctr Mind & Brain, Unit 87, Room 5-06,1051 Riverside Dr, New York, NY 10032 USA.			Bisley, James/0000-0002-2841-0306				Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BASHINSKI HS, 1980, PERCEPT PSYCHOPHYS, V28, P241, DOI 10.3758/BF03204380; Basso MA, 1998, J NEUROSCI, V18, P7519; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; Bracewell RM, 1996, J NEUROPHYSIOL, V76, P1457, DOI 10.1152/jn.1996.76.3.1457; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Egeth HE, 1997, ANNU REV PSYCHOL, V48, P269, DOI 10.1146/annurev.psych.48.1.269; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Joseph JS, 1996, PERCEPT PSYCHOPHYS, V58, P651, DOI 10.3758/BF03213098; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LaBerge D, 1997, J EXP PSYCHOL HUMAN, V23, P1380, DOI 10.1037/0096-1523.23.5.1380; Mazzoni P, 1996, J NEUROPHYSIOL, V76, P1439, DOI 10.1152/jn.1996.76.3.1439; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Murthy A, 2001, J NEUROPHYSIOL, V86, P2634, DOI 10.1152/jn.2001.86.5.2634; NAKAYAMA K, 1989, VISION RES, V29, P1631, DOI 10.1016/0042-6989(89)90144-2; Pare M, 2001, J NEUROPHYSIOL, V85, P2545, DOI 10.1152/jn.2001.85.6.2545; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; PLATT ML, 1997, J NEUROPHYSIOL, V78, P157; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Rensink RA, 2000, VISION RES, V40, P1469, DOI 10.1016/S0042-6989(00)00003-1; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Sato T, 2001, NEURON, V30, P583, DOI 10.1016/S0896-6273(01)00304-X; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1994, J NEUROPHYSIOL, V72, P1020, DOI 10.1152/jn.1994.72.2.1020; Witte EA, 1996, BEHAV BRAIN RES, V82, P103, DOI 10.1016/S0166-4328(97)81113-8; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yantis S, 1996, J EXP PSYCHOL HUMAN, V22, P1505, DOI 10.1037/0096-1523.22.6.1505; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	43	617	624	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					81	86		10.1126/science.1077395	http://dx.doi.org/10.1126/science.1077395			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	631JZ	12511644				2022-12-28	WOS:000180165800036
J	Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M				Walther, DJ; Peter, JU; Bashammakh, S; Hortnagl, H; Voits, M; Fink, H; Bader, M			Synthesis of serotonin by a second tryptophan hydroxylase isoform	SCIENCE			English	Article									Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; Humboldt Univ, Charite, Fac Med, Inst Pharmacol & Toxicol, D-10117 Berlin, Germany; Free Univ Berlin, Sch Vet Med, Inst Pharmacol & Toxicol, D-14195 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Walther, DJ (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13092 Berlin, Germany.		Bader, Michael/K-2124-2013	Bader, Michael/0000-0003-4780-4164				Chen JJ, 2001, J NEUROSCI, V21, P6348, DOI 10.1523/JNEUROSCI.21-16-06348.2001; Fitzpatrick PF, 1999, ANNU REV BIOCHEM, V68, P355, DOI 10.1146/annurev.biochem.68.1.355; Humble M, 2001, BIOL PSYCHIAT, V49, P360, DOI 10.1016/S0006-3223(00)00956-2; KUHN DM, 1980, ARCH BIOCHEM BIOPHYS, V199, P355, DOI 10.1016/0003-9861(80)90291-X; Veenstra-VanderWeele J, 2000, EUR J PHARMACOL, V410, P165, DOI 10.1016/S0014-2999(00)00814-1	5	1129	1206	5	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 3	2003	299	5603					76	76		10.1126/science.1078197	http://dx.doi.org/10.1126/science.1078197			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511643				2022-12-28	WOS:000180165800034
J	Cherwek, H; Amundson, S				Cherwek, H; Amundson, S			Pulmonary-artery aneurysm.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									Scripps Mercy Hosp, San Diego, CA 92103 USA		Cherwek, H (corresponding author), Scripps Mercy Hosp, San Diego, CA 92103 USA.								0	2	3	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					E1	E1		10.1056/ENEJMicm020014	http://dx.doi.org/10.1056/ENEJMicm020014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510057				2022-12-28	WOS:000180134400006
J	Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G				Blagoveshchenskaya, AD; Thomas, L; Feliciangeli, SF; Hung, CH; Thomas, G			HIV-1 Nef downregulates MHC-I by a PACS-1-and PI3K-regulated ARF6 endocytic pathway	CELL			English	Article							RIBOSYLATION FACTOR 6; PLASMA-MEMBRANE; CELL-SURFACE; COMPLEX; TRAFFICKING; MOLECULES; PROTEINS; BINDING; PHOSPHORYLATION; ACTIVATION	The HIV-1 Nef-mediated downregulation of cell surface MHC-I molecules to the trans-Golgi network (TGN) enables HIV-1 to escape immune surveillance. However, the cellular pathway used by Nef to downregulate MHC-I is unknown. Here, we show that Nef and PACS-1 combine to usurp the ARF6 endocytic pathway by a PI3K-dependent process and downregulate cell surface MHC-I to the TGN. This mechanism requires the hierarchical actions of three Nef motifs-the acidic cluster (EEEE65)-E-62, the SH3 domain binding site (PXXP75)-P-72, and M-20-in controlling PACS-1-dependent sorting to the TGN, ARF6 activation, and sequestering internalized MHC-I to the TGN, respectively. These data provide new insights into the cellular basis of HIV-1 immunoevasion.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Thomas, G (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	thomasg@ohsu.edu	Feliciangeli, Sylvain/Q-1292-2016	Feliciangeli, Sylvain/0000-0003-3358-3719	NIAID NIH HHS [R01 AI049793, AI49793, AI8585] Funding Source: Medline; NIDDK NIH HHS [DK37274] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037274] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baur AS, 1997, IMMUNITY, V6, P283, DOI 10.1016/S1074-7613(00)80331-3; Beraud-Dufour S, 1998, EMBO J, V17, P3651, DOI 10.1093/emboj/17.13.3651; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Blagoveshchenskaya AD, 1998, J BIOL CHEM, V273, P27896, DOI 10.1074/jbc.273.43.27896; Capps GG, 2000, MOL IMMUNOL, V37, P59, DOI 10.1016/S0161-5890(00)00019-5; Carl S, 2001, J VIROL, V75, P3657, DOI 10.1128/JVI.75.8.3657-3665.2001; Carreno S, 2000, J BIOL CHEM, V275, P36223, DOI 10.1074/jbc.M003901200; Chang AH, 2001, EUR J IMMUNOL, V31, P2382, DOI 10.1002/1521-4141(200108)31:8<2382::AID-IMMU2382>3.0.CO;2-K; Chavrier P, 1999, CURR OPIN CELL BIOL, V11, P466, DOI 10.1016/S0955-0674(99)80067-2; Claing A, 2001, J BIOL CHEM, V276, P42509, DOI 10.1074/jbc.M108399200; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Crump CM, 2001, EMBO J, V20, P2191, DOI 10.1093/emboj/20.9.2191; Doms RW, 2000, GENE DEV, V14, P2677, DOI 10.1101/gad.833300; Dyer WB, 1999, J VIROL, V73, P436, DOI 10.1128/JVI.73.1.436-443.1999; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Geyer M, 2001, EMBO REP, V2, P580, DOI 10.1093/embo-reports/kve141; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; Hitt M M, 1997, Adv Pharmacol, V40, P137, DOI 10.1016/S1054-3589(08)60140-4; Jondal M, 1996, IMMUNITY, V5, P295, DOI 10.1016/S1074-7613(00)80255-1; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Langille SE, 1999, J BIOL CHEM, V274, P27099, DOI 10.1074/jbc.274.38.27099; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Lerner EC, 2002, NAT STRUCT BIOL, V9, P365, DOI 10.1038/nsb782; Linnemann T, 2002, VIROLOGY, V294, P246, DOI 10.1006/viro.2002.1365; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Marsh M, 2000, TRAFFIC, V1, P525, DOI 10.1034/j.1600-0854.2000.010701.x; Matafora V, 2001, J CELL SCI, V114, P4509; Munch J, 2001, J VIROL, V75, P10532, DOI 10.1128/JVI.75.21.10532-10536.2001; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Peters PJ, 2001, TRAFFIC, V2, P885, DOI 10.1034/j.1600-0854.2001.21204.x; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Ploegh HL, 1998, SCIENCE, V280, P248, DOI 10.1126/science.280.5361.248; Radhakrishna H, 1996, J CELL BIOL, V134, P935, DOI 10.1083/jcb.134.4.935; Radhakrishna H, 1997, J CELL BIOL, V139, P49, DOI 10.1083/jcb.139.1.49; REID PA, 1990, NATURE, V346, P655, DOI 10.1038/346655a0; Schibeci SD, 2000, AIDS, V14, P1701, DOI 10.1097/00002030-200008180-00003; Swann SA, 2001, VIROLOGY, V282, P267, DOI 10.1006/viro.2000.0816; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Venkateswarlu K, 2000, BIOCHEM J, V345, P719, DOI 10.1042/0264-6021:3450719; Venkateswarlu K, 1998, CURR BIOL, V8, P463, DOI 10.1016/S0960-9822(98)70181-2; Wan L, 1998, CELL, V94, P205, DOI 10.1016/S0092-8674(00)81420-8; Xu XN, 1999, J EXP MED, V189, P1489, DOI 10.1084/jem.189.9.1489; Zhang Q, 1998, J BIOL CHEM, V273, P19977, DOI 10.1074/jbc.273.32.19977	49	231	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					853	866		10.1016/S0092-8674(02)01162-5	http://dx.doi.org/10.1016/S0092-8674(02)01162-5			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526811	Bronze			2022-12-28	WOS:000179862600011
J	Chen, LC; Thurston, G				Chen, LC; Thurston, G			World Trade Center cough	LANCET			English	Article									NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA	New York University	Chen, LC (corresponding author), NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY 10987 USA.		Cjem, Lung-Chi/H-5030-2012	Chen, Lung Chi/0000-0003-1154-2107	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES00260] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))			0	35	36	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S37	S38		10.1016/S0140-6736(02)11814-9	http://dx.doi.org/10.1016/S0140-6736(02)11814-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504497				2022-12-28	WOS:000180064500018
J	Murray, VSG; Bailey, MR; Spratt, BG				Murray, VSG; Bailey, MR; Spratt, BG			Depleted uranium: a new battlefield hazard	LANCET			English	Article									Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England; Natl Radiol Protect Board, Dose Assessments Dept, Chilton, England; St Marys Hosp, Imperial Coll, Dept Infect Dis Epidemiol, London, England	Imperial College London	Murray, VSG (corresponding author), Guys & St Thomas Hosp NHS Trust, Chem Incident Response Serv, London SE14 5ER, England.		Spratt, Brian G/A-1676-2009					*ROYAL SOC, 2001, HLTH HAZ DEPL UR M 1; Royal Society, 2002, HLTH HAZ DEPL UR M 2; World Health Organization, 2001, DEPL UR SOURC EXP HL, P273	3	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S31	S32		10.1016/S0140-6736(02)11811-3	http://dx.doi.org/10.1016/S0140-6736(02)11811-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504494				2022-12-28	WOS:000180064500015
J	Volans, GN; Karalliedde, L				Volans, GN; Karalliedde, L			Long-term effects of chemical weapons	LANCET			English	Article									Guys & St Thomas Hosp Trust, Med Toxicol Unit, London SE14 5ER, England	Guy's & St Thomas' NHS Foundation Trust	Volans, GN (corresponding author), Guys & St Thomas Hosp Trust, Med Toxicol Unit, London SE14 5ER, England.							IVARSSON U, 1992, CHEM WARFARE AGENTS, V16; Karalliedde Lakshman, 2001, ORGANOPHOSPHATES HLT; MARS TC, 1996, CHEM WARFARE AGENTS; Somani S.M., 2000, CHEM WARFARE AGENTS; ZAJTCHUK R, 1997, TXB MILITARY MED MED	5	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S35	S36		10.1016/S0140-6736(02)11813-7	http://dx.doi.org/10.1016/S0140-6736(02)11813-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504496	Bronze			2022-12-28	WOS:000180064500017
J	Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS				Du, XLL; Key, CR; Osborne, C; Mahnken, JD; Goodwin, JS			Discrepancy between consensus recommendations and actual community use of adjuvant chemotherapy in women with breast cancer	ANNALS OF INTERNAL MEDICINE			English	Article							OLDER WOMEN; CLINICAL GUIDELINES; CONSERVING SURGERY; RADIATION-THERAPY; LINKED MEDICARE; NATIONAL SURVEY; AGE; CARCINOMA; CARE; DETERMINANTS	Background: Although the efficacy of adjuvant chemotherapy in prolonging survival for women with breast cancer has been well documented, limited population-based information is available on the actual use of chemotherapy. Objective: To examine the relationship between age and chemotherapy use. Design: Cohort study. Setting: New Mexico. Patients: 5101 women 20 years of age or older receiving a diagnosis of stage 1, stage 11, or stage IIIA breast cancer from 1991 through 1997. Measurements: Pattern of chemotherapy use by age; logistic regression analysis to generate the odds and probabilities of receiving chemotherapy; and sensitivity analysis to estimate potential effects of unmeasured confounders. Results: Overall, 29% of women received chemotherapy. The rate of chemotherapy use for women with stage I, stage II, or stage IIIA breast cancer was 11%, 47%, and 68%, respectively. Across all tumor stages, the use of chemotherapy decreased substantially with increasing age (P < 0.001). overall, 66% of women younger than 45 years of age received chemotherapy compared with 44% of women between 50 and 54 years of age, 31% of women between 55 and 59 years of age, and 18% of women between 60 and 64 years of age. The decreasing pattern of chemotherapy use with age continued after adjustment for prognostic factors and was relatively insensitive to changes in unmeasured factors. Conclusions: There is considerable discrepancy between the 1990 National Institutes of Health Consensus Conference recommendations for chemotherapy administration in women with breast cancer and the actual use of chemotherapy in the community. The decrease in use with age may relate to the decreasing efficacy of chemotherapy with age, as reported in clinical trials. Outcomes studies should address whether the recommendations are overly aggressive or whether practicing oncologists are too conservative in their use of chemotherapy.	Univ Texas, Dept Internal Med, Med Branch, Galveston, TX 77555 USA; Univ New Mexico, Albuquerque, NM 87131 USA	University of Texas System; University of Texas Medical Branch Galveston; University of New Mexico	Du, XLL (corresponding author), Univ Texas, Dept Internal Med, Med Branch, 3-134 Jennie Sealy Hosp, Galveston, TX 77555 USA.	xdu@utmb.edu			NATIONAL CANCER INSTITUTE [R01CA090626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024832] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090626-02S1, R01 CA090626, R01 CA090626-03, R01 CA090626-04, R01-CA90626, R01-CA871773, R01 CA090626-02, R01 CA090626-01, R01 CA090626-03S1] Funding Source: Medline; NIA NIH HHS [P30 AG024832] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 1985, JAMA-J AM MED ASSOC, V254, P3461; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; [Anonymous], 1992, Lancet, V339, P1; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Carlson RW, 2000, ONCOLOGY-NY, V14, P33; CHRISTMAN K, 1992, JAMA-J AM MED ASSOC, V268, P57, DOI 10.1001/jama.268.1.57; CHU J, 1987, J GERONTOL, V42, P185, DOI 10.1093/geronj/42.2.185; Du XL, 1999, J CLIN EPIDEMIOL, V52, P463, DOI 10.1016/S0895-4356(99)00011-6; Du XL, 2001, CANCER-AM CANCER SOC, V92, P730, DOI 10.1002/1097-0142(20010815)92:4<730::AID-CNCR1376>3.0.CO;2-P; Du XL, 2001, J CLIN ONCOL, V19, P1455, DOI 10.1200/JCO.2001.19.5.1455; Du XL, 1999, J GERONTOL A-BIOL, V54, pM474, DOI 10.1093/gerona/54.9.M474; Du XLL, 2002, J CLIN ONCOL, V20, P4636, DOI 10.1200/JCO.2002.05.088; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Field MJ., 1992, GUIDELINES CLIN PRAC; Fisher B, 2001, J Natl Cancer Inst Monogr, P62; Fisher B, 1999, CA-CANCER J CLIN, V49, P159, DOI 10.3322/canjclin.49.3.159; FISHER B, 1998, LANCET, V352, P930; GOODWIN JS, 1993, CANCER-AM CANCER SOC, V72, P594, DOI 10.1002/1097-0142(19930715)72:2<594::AID-CNCR2820720243>3.0.CO;2-#; Goodwin JS, 1996, JNCI-J NATL CANCER I, V88, P1031, DOI 10.1093/jnci/88.15.1031; GOODWIN JS, 1988, ARCH INTERN MED, V148, P2258, DOI 10.1001/archinte.148.10.2258; GREENFIELD S, 1987, JAMA-J AM MED ASSOC, V257, P2766, DOI 10.1001/jama.257.20.2766; GREENLAND S, 1998, EPIDEMIOLOGY, P343; HALL WH, 1991, JAMA-J AM MED ASSOC, V265, P391; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974, DOI 10.1056/NEJM199810013391407; HOSMER DW, 2000, WILEY PS TX, P1; Hutchins LF, 1999, NEW ENGL J MED, V341, P2061, DOI 10.1056/NEJM199912303412706; LAZOVICH D, 1991, JAMA-J AM MED ASSOC, V266, P3433, DOI 10.1001/jama.266.24.3433; MANN BA, 1988, JAMA-J AM MED ASSOC, V259, P3413; MUSS HB, 1994, CANCER, V74, P2165, DOI 10.1002/1097-0142(19941001)74:7+<2165::AID-CNCR2820741727>3.0.CO;2-6; MUSS HB, 1995, SEMIN ONCOL, V22, P14; National Cancer Institute, 1994, NIH PUBLICATION; NERENZ DR, 1986, HEALTH SERV RES, V20, P961; *NEW MEX TUM REG, 2002, NEW MEX TUM REG; OSTEEN RT, 1994, J AM COLL SURGEONS, V178, P213; POTOSKY AL, 1993, MED CARE, V31, P732; RIES LA, 1997, NIH PUBLICAITON; RIES LAG, 1997, NIH PUBLICATION; SAMET J, 1986, JAMA-J AM MED ASSOC, V255, P3385, DOI 10.1001/jama.255.24.3385; Shekelle P, 2001, BMJ-BRIT MED J, V323, P155, DOI 10.1136/bmj.323.7305.155; Shekelle PG, 2001, JAMA-J AM MED ASSOC, V286, P1461, DOI 10.1001/jama.286.12.1461; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS52; *STEER COMM CLIN P, 1998, CAN MED ASSOC J S, V158, pS43; WETLE T, 1987, JAMA-J AM MED ASSOC, V258, P516, DOI 10.1001/jama.1987.03400040114035; WILSON RE, 1984, SURG GYNECOL OBSTET, V159, P309; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; [No title captured]	46	81	82	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					90	97		10.7326/0003-4819-138-2-200301210-00009	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00009			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529090	Green Accepted			2022-12-28	WOS:000181018300002
J	Pell, JP; Simpson, E; Rodger, JC; Finlayson, A; Clark, D; Anderson, J; Pell, ACH				Pell, JP; Simpson, E; Rodger, JC; Finlayson, A; Clark, D; Anderson, J; Pell, ACH			Impact of changing diagnostic criteria on incidence, management and outcome of acute myocardial infarction: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article									Monklands Hosp, Dept Med, Airdrie ML6 0JS, Lanark, Scotland; Monklands Hosp, Dept Biochem, Airdrie ML6 0JS, Lanark, Scotland; Greater Glasgow NHS Board, Dept Publ Hlth, Glasgow, Lanark, Scotland; Common Serv Agcy, Record Linkage Dept, Informat & Stat Div, Edinburgh, Midlothian, Scotland	Monklands Hospital; Monklands Hospital	Pell, ACH (corresponding author), Monklands Hosp, Dept Med, Airdrie ML6 0JS, Lanark, Scotland.			Pell, Jill/0000-0002-8898-7035				Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; HAMM CW, 1992, NEW ENGL J MED, V327, P146, DOI 10.1056/NEJM199207163270302; Pell ACH, 2002, BRIT MED J, V324, P1216; *WHO EXP COMM, 1959, TECHN REP SER WHO, V168	5	62	63	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					134	135		10.1136/bmj.326.7381.134	http://dx.doi.org/10.1136/bmj.326.7381.134			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531844	Green Published, Bronze			2022-12-28	WOS:000180575900023
J	Chavez, FP; Ryan, J; Lluch-Cota, SE; Niquen, M				Chavez, FP; Ryan, J; Lluch-Cota, SE; Niquen, M			From anchovies to sardines and back: Multidecadal change in the Pacific Ocean	SCIENCE			English	Review							EL-NINO; CALIFORNIA CURRENT; VARIABILITY; FLUCTUATIONS; POPULATIONS; OSCILLATION; SYSTEM; MODEL		Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; NW Biol Res Ctr, Fisheries Program, La Paz, Baja California, Mexico; Inst Mar Peru, Callao, Peru	Monterey Bay Aquarium Research Institute; CIBNOR - Centro de Investigaciones Biologicas del Noroeste; Instituto del Mar del Peru	Chavez, FP (corresponding author), Monterey Bay Aquarium Res Inst, 7700 Sandholdt Rd, Moss Landing, CA 95039 USA.		Lluch-Cota, Salvador E/D-7693-2013; Lluch-Cota, Salvador E./P-5203-2019	Lluch-Cota, Salvador E/0000-0003-1832-1200; Ryan, John Phillip/0000-0001-7954-5369				Bakun A, 2001, PROG OCEANOGR, V49, P485, DOI 10.1016/S0079-6611(01)00037-4; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; BARBER RT, 1988, CONCEPTS ECOSYSTEM E, P166; BATCHELDER H, 2002, PICES PRESS, V10, P22; Benson AJ, 2002, FISH FISH, V3, P95, DOI 10.1046/j.1467-2979.2002.00078.x; Carter A., 1989, GEOPHYS MONOGR SER, V55, P165, DOI DOI 10.1029/GM055P0165; Castro CG, 2001, GLOBAL BIOGEOCHEM CY, V15, P819, DOI 10.1029/2000GB001324; Cayan D.R., 1990, P 7 ANN PAC CLIM PAC, P115; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Chavez FP, 2002, PROG OCEANOGR, V54, P205, DOI 10.1016/S0079-6611(02)00050-2; CHAVEZ FP, 1995, WORLD CLIMATE RES PU, V4, P23; Deser C, 1999, J CLIMATE, V12, P1697, DOI 10.1175/1520-0442(1999)012<1697:EFAWDI>2.0.CO;2; EMMETT R, 2002, EOS T AGU, V83; Francis Robert C., 1994, Fisheries Oceanography, V3, P279, DOI 10.1111/j.1365-2419.1994.tb00105.x; Greene Katie, 2002, Science, V295, P1823, DOI 10.1126/science.295.5561.1823; Hampton J, 2001, MAR FRESHWATER RES, V52, P937, DOI 10.1071/MF01049; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; JONES PD, 2001, TRENDS COMPENDIUM DA; JORDAN FTW, 1966, AVIAN DIS, V10, P1, DOI 10.2307/1588203; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1449, DOI 10.1016/S0967-0645(00)00149-1; Kawasaki T, 1983, FAO FISH REP, V291, P1065; KEELING CD, 1985, METEORITICS, V20, P437; Kleeman R, 1999, GEOPHYS RES LETT, V26, P1743, DOI 10.1029/1999GL900352; Klyashtorin L. B., 2001, 410 FAO; Le Borgne R, 2002, DEEP-SEA RES PT II, V49, P2425, DOI 10.1016/S0967-0645(02)00043-7; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Lluch-Belda D., 1992, Fisheries Oceanography, V1, P339, DOI 10.1111/j.1365-2419.1992.tb00006.x; Lluch-Cota D.B.H.-V., 1997, 934 FAO; LLUCHBELDA D, 1989, S AFR J MARINE SCI, V8, P195, DOI 10.2989/02577618909504561; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Maunder Mark N., 2001, Inter-American Tropical Tuna Commission Stock Assessment Report, V1, P5; McFarlane GA, 2002, AM FISH S S, V32, P195; McGowan JA, 1998, SCIENCE, V281, P210, DOI 10.1126/science.281.5374.210; McPhaden MJ, 2002, NATURE, V415, P603, DOI 10.1038/415603a; MILLER AJ, 1994, CLIM DYNAM, V9, P287, DOI 10.1007/BF00204744; NIQUEN M, 2002, INVEST MAR, V30, P196; Pacala SW, 2001, SCIENCE, V292, P2316, DOI 10.1126/science.1057320; Pearcy WG, 2002, PROG OCEANOGR, V54, P399, DOI 10.1016/S0079-6611(02)00060-5; PETERSON WT, 2001, PICES PRESS, V9, P28; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; ROEMMICH D, 1995, SCIENCE, V267, P1324, DOI 10.1126/science.267.5202.1324; Schwartzlose RA, 1999, S AFR J MARINE SCI, V21, P289; SCHWING FB, 2000, T AM GEOPHYS UNION, V81, P301; Steinbeck J, 2000, CANNERY ROW; Taylor AH, 2002, NATURE, V416, P629, DOI 10.1038/416629a; VALDIVIA J, 1978, RAPP P V REUN CONS I, V173, P196; Veit RR, 1996, MAR ECOL PROG SER, V139, P11, DOI 10.3354/meps139011; Wada T., 1991, P181; 2002, S WORKSH IMP EL NIN; 2000, INT WORKSH INT CLIM; 2002, GLOB OC EC DYN SUPP	51	1222	1284	9	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					217	221		10.1126/science.1075880	http://dx.doi.org/10.1126/science.1075880			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522241				2022-12-28	WOS:000180284000028
J	Menaker, M				Menaker, M			Circadian photoreception	SCIENCE			English	Editorial Material							MELANOPSIN; OPSIN		Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA	University of Virginia	Menaker, M (corresponding author), Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA.							Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-01-j0002.2002; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MENAKER M, 1972, SCI AM, V226, P22, DOI 10.1038/scientificamerican0372-22; Menaker M., 1996, 6 SAPP S BIOL RHYTH, P37; MENAKER M, 1989, SCI PHOTOBIOLOGY, pCH8; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536	15	44	46	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					213	214		10.1126/science.1081112	http://dx.doi.org/10.1126/science.1081112			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522238				2022-12-28	WOS:000180284000025
J	Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR				Jiang, N; Bao, ZR; Zhang, XY; Hirochika, H; Eddy, SR; McCouch, SR; Wessler, SR			An active DNA transposon family in rice	NATURE			English	Article							ELEMENTS; MAIZE; INSERTION; HEARTBREAKER; SEQUENCES; REVEALS	The publication of draft sequences for the two subspecies of Oryza sativa (rice), japonica (cv. Nipponbare) and indica (cv. 93-11)(1,2), provides a unique opportunity to study the dynamics of transposable elements in this important crop plant. Here we report the use of these sequences in a computational approach to identify the first active DNA transposons from rice and the first active miniature inverted-repeat transposable element (MITE) from any organism. A sequence classified as a Tourist-like MITE of 430 base pairs, called miniature Ping (mPing), was present in about 70 copies in Nipponbare and in about 14 copies in 93-11. These mPing elements, which are all nearly identical, transpose actively in an indica cell-culture line. Database searches identified a family of related transposase-encoding elements (called Pong), which also transpose actively in the same cells. Virtually all new insertions of mPing and Pong elements were into low-copy regions of the rice genome. Since the domestication of rice mPing MITEs have been amplified preferentially in cultivars adapted to environmental extremes-a situation that is reminiscent of the genomic shock theory for transposon activation(3).	Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA; Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Natl Inst Agrobiol Resources, Tsukuba, Ibaraki 305, Japan; Cornell Univ, Dept Plant Breeding, Ithaca, NY 14853 USA	University System of Georgia; University of Georgia; Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL); National Institute of Agrobiological Sciences - Japan; Cornell University	Wessler, SR (corresponding author), Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA.		Jiang, Ning/G-6546-2012	Eddy, Sean/0000-0001-6676-4706				Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Bureau TE, 1996, P NATL ACAD SCI USA, V93, P8524, DOI 10.1073/pnas.93.16.8524; Burr B, 2002, PLANT CELL, V14, P521, DOI 10.1105/tpc.140310; Casa AM, 2000, P NATL ACAD SCI USA, V97, P10083, DOI 10.1073/pnas.97.18.10083; Feschotte C, 2002, P NATL ACAD SCI USA, V99, P280, DOI 10.1073/pnas.022626699; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Gautam R. K., 2014, RICE GENET NEWSL, V19, P136; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Jiang N, 2001, PLANT CELL, V13, P2553, DOI 10.1105/tpc.13.11.2553; Kawakami K, 2000, P NATL ACAD SCI USA, V97, P11403, DOI 10.1073/pnas.97.21.11403; Kushibuchi K., 1997, SCI RICE PLANT, V3, P837; Mao L, 2000, GENOME RES, V10, P982, DOI 10.1101/gr.10.7.982; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCOUCH SR, 1988, THEOR APPL GENET, V76, P815, DOI 10.1007/BF00273666; MORISHIMA H, 1981, JPN J BREED, V31, P402; REZSOHAZY R, 1993, MOL MICROBIOL, V9, P1283, DOI 10.1111/j.1365-2958.1993.tb01258.x; Tarchini R, 2000, PLANT CELL, V12, P381, DOI 10.1105/tpc.12.3.381; Ting Y., 1957, ACTA AGRON SIN, V8, P243; Turcotte K, 2001, PLANT J, V25, P169, DOI 10.1046/j.1365-313x.2001.00945.x; UENO K, 1988, Bulletin of the Institute for Agricultural Research Tohoku University, V39, P43; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; WANG ZY, 1992, THEOR APPL GENET, V83, P565, DOI 10.1007/BF00226900; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	30	333	365	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					163	167		10.1038/nature01214	http://dx.doi.org/10.1038/nature01214			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520302				2022-12-28	WOS:000180267200040
J	Schiermeier, Q				Schiermeier, Q			Insurers left reeling by disaster year	NATURE			English	News Item																		2000, NATURE, V418, P905	1	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					99	99		10.1038/421099b	http://dx.doi.org/10.1038/421099b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520264	Bronze			2022-12-28	WOS:000180267200003
J	Fletcher, RH				Fletcher, RH			Adverts in medical journals: caveat lector	LANCET			English	Editorial Material							PHARMACEUTICAL ADVERTISEMENTS		Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Pilgrim Hlth Care, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Fletcher, RH (corresponding author), Harvard Univ, Sch Med, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA.							AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; FLETCHER RH, 1992, ANN INTERN MED, V116, P951, DOI 10.7326/0003-4819-116-11-951; *INT COMM MED J ED, 2001, UNPUB UN REQ MAN; Lock S., 1985, DIFFICULT BALANCE ED; Psaty BM, 2000, J GEN INTERN MED, V15, P755, DOI 10.1046/j.1525-1497.2000.00814.x; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912	7	16	16	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					10	11		10.1016/S0140-6736(03)12185-X	http://dx.doi.org/10.1016/S0140-6736(03)12185-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517455				2022-12-28	WOS:000180191600009
J	Sibbald, B; Bojke, C; Gravelle, H				Sibbald, B; Bojke, C; Gravelle, H			National survey of job satisfaction and retirement intentions among general practitioners in England	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DOCTORS	Objectives To measure general practitioners' intentions to quit direct patient care, to assess changes between 1998 and 2000, and to investigate associated factors, notably job satisfaction. Design Analysis of national postal surveys conducted in 1998 and 2001. Setting England. Participants 1949 general practitioner principals, of whom 790 were surveyed in 1998 and 1159 in 2001. Main outcome measures Overall job satisfaction and likelihood of leaving direct patient care in the next five years. Results The proportion of doctors intending to quit direct patient care in the next five years rose from 14% in 1998 to 22% in 2001. In both years, the main factors associated with an increased likelihood of quitting were older age and ethnic minority status. Higher job satisfaction and having children younger than 18 years were associated with a reduced likelihood of quitting. There were no significant differences in regression coefficients between 1998 and 2001, suggesting that the effect of factors influencing intentions to quit remained stable over time. The rise in intentions to quit was due mainly to a reduction in job satisfaction (1998 mean 4.64, 2001 mean 3.96) together with a slight increase in the proportion of doctors from ethnic minorities and in the mean age of doctors. Doctors' personal and practice characteristics explained little of the variation in job satisfaction within or between years. Conclusions Job satisfaction is an important factor underlying intention to quit, and attention to this aspect of doctors' working lives may help to increase the supply of general practitioners.	Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England; Univ York, Ctr Hlth Econ, Natl Primary Care Res & Dev Ctr, York YO10 5DD, N Yorkshire, England	University of Manchester; University of York - UK	Sibbald, B (corresponding author), Univ Manchester, Natl Primary Care Res & Dev Ctr, Manchester M13 9PL, Lancs, England.	Bonnie.Sibbald@man.ac.uk		Gravelle, Hugh/0000-0002-7753-4233				Davidson JM, 2001, J PUBLIC HEALTH MED, V23, P323, DOI 10.1093/pubmed/23.4.323; *DEP HLTH, 2000, IMPR WORK LIV; *DEP HLTH, 2000, NHS PLAN; Edwards N, 2002, BMJ-BRIT MED J, V324, P835, DOI 10.1136/bmj.324.7341.835; *HLTH POL EC RES U, 2000, WORK REL STRESS SEN; JACOBS K, 1991, TIME RETIREMENT COMP; Lichtenstein R L, 1984, Med Care Rev, V41, P139, DOI 10.1177/107755878404100301; Mein G, 2000, AGE AGEING, V29, P529, DOI 10.1093/ageing/29.6.529; Sibbald B, 2000, FAM PRACT, V17, P364, DOI 10.1093/fampra/17.5.364; STEEL RP, 1984, J APPL PSYCHOL, V69, P673, DOI 10.1037/0021-9010.69.4.673; Taylor DH, 1997, BRIT MED J, V314, P1806, DOI 10.1136/bmj.314.7097.1806; WARR P, 1979, J OCCUP PSYCHOL, V52, P129, DOI 10.1111/j.2044-8325.1979.tb00448.x; Young R, 2001, WORK EMPLOY SOC, V15, P699, DOI 10.1177/095001701400438161	13	160	163	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					22	24		10.1136/bmj.326.7379.22	http://dx.doi.org/10.1136/bmj.326.7379.22			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633UP	12511457	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000180302000021
J	Kramer, KL; Barnette, JE; Yost, HJ				Kramer, KL; Barnette, JE; Yost, HJ			PKC gamma regulates syndecan-2 inside-out signaling during Xenopus left-right development	CELL			English	Article							PROTEIN-KINASE-C; LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; MUTANT MICE; IN-VIVO; PHOSPHORYLATION; DOMAIN; EXPRESSION; GENE; PROTEOGLYCAN	The transmembrane proteoglycan syndecan-2 cell nonautonomously regulates left-right (LR) development in migrating mesoderm by an unknown mechanism, leading to LR asymmetric gene expression and LR orientation of the heart and gut. Here, we demonstrate that protein kinase C gamma (PKCgamma) mediates phosphorylation of the cytoplasmic domain of syndecan-2 in right, but not left, animal cap ectodermal cells. Notably, both phosphorylation states of syndecan-2 are obligatory for normal LR development, with PKCgamma-dependent phosphorylated syndecan-2 in right ectodermal cells and nonphosphorylated syndecan-2 in left cells. The ectodermal cells contact migrating mesodermal cells during early gastrulation, concurrent with the transmission of LR information. This precedes the appearance of monocilia and is one of the earliest steps of LR development. These results demonstrate that PKCgamma regulates the cytoplasmic phosphorylation of syndecan-2 and, consequently, syndecan-2-mediated inside-out signaling to adjacent cells.	Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pediat, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Yost, HJ (corresponding author), Univ Utah, Huntsman Canc Inst, Ctr Children, Dept Oncol Sci, 2000 Circle Hope, Salt Lake City, UT 84112 USA.							ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Bamford RN, 2000, NAT GENET, V26, P365, DOI 10.1038/81695; BAUER DV, 1994, DEVELOPMENT, V120, P1179; BERRA E, 1993, CELL, V74, P555, DOI 10.1016/0092-8674(93)80056-K; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; DANOS MC, 1995, DEVELOPMENT, V121, P1467; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; FREISEWINKEL I, 1991, FEBS LETT, V280, P262, DOI 10.1016/0014-5793(91)80307-O; Gaio U, 1999, CURR BIOL, V9, P1339, DOI 10.1016/S0960-9822(00)80059-7; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Horowitz A, 1998, J BIOL CHEM, V273, P10914, DOI 10.1074/jbc.273.18.10914; Horowitz A, 2002, J CELL BIOL, V157, P715, DOI 10.1083/jcb.200112145; Hyatt BA, 1996, NATURE, V384, P62, DOI 10.1038/384062a0; Itano N, 1996, BIOCHEM J, V315, P925, DOI 10.1042/bj3150925; Kramer KL, 2002, DEV CELL, V2, P115, DOI 10.1016/S1534-5807(01)00107-1; Levin M, 2002, CELL, V111, P77, DOI 10.1016/S0092-8674(02)00939-X; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; MARYNEN P, 1989, J BIOL CHEM, V264, P7017; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; OTTE AP, 1991, SCIENCE, V251, P570, DOI 10.1126/science.1990433; Pauken CM, 2000, DEV BIOL, V223, P411, DOI 10.1006/dbio.2000.9763; Prasthofer T, 1995, BIOCHEM MOL BIOL INT, V36, P793; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Spitaler M, 2000, J BIOL CHEM, V275, P33289, DOI 10.1074/jbc.M002742200; Teel AL, 1996, MECH DEVELOP, V59, P115, DOI 10.1016/0925-4773(96)00584-9; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; Ward KW, 1998, REPROD TOXICOL, V12, P525, DOI 10.1016/S0890-6238(98)00032-X; Wright C V, 2001, Dev Cell, V1, P179, DOI 10.1016/S1534-5807(01)00036-3; Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527; YOST HJ, 1995, CELL, V82, P689, DOI 10.1016/0092-8674(95)90464-6; YOST HJ, 1992, NATURE, V357, P158, DOI 10.1038/357158a0; YOST HJ, 1991, CIBA F SYMP, V162, P165	41	86	87	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					981	990		10.1016/S0092-8674(02)01200-X	http://dx.doi.org/10.1016/S0092-8674(02)01200-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507425	Bronze			2022-12-28	WOS:000180086000008
J	Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J				Picard, F; Gehin, M; Annicotte, JS; Rocchi, S; Champy, MF; O'Malley, BW; Chambon, P; Auwerx, J			SRC-1 and TIF2 control energy balance between white and brown adipose tissues	CELL			English	Article							ACTIVATED RECEPTOR-GAMMA; PEROXISOME PROLIFERATOR; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; TRANSCRIPTION FACTOR; NUCLEAR RECEPTORS; MESSENGER-RNA; LIGAND; MOUSE; ALPHA	We have explored the effects of two members of the p160 coregulator family on energy homeostasis. TIF2-/- mice are protected against obesity and display enhanced adaptive thermogenesis, whereas SRC-1-/- mice are prone to obesity due to reduced energy expenditure. In white adipose tissue, lack of TIF2 decreases PPARgamma activity and reduces fat accumulation, whereas in brown adipose tissue it facilitates the interaction between SRC-1 and PGC-1alpha, which induces PGC-1alpha's thermogenic activity. Interestingly, a high-fat diet increases the TIF2/SRC-1 expression ratio, which may contribute to weight gain. These results reveal that the relative level of TIF2/SRC-1 can modulate energy metabolism.	ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Inst Clin Souris Genopole Strasbourg, F-67404 Illkirch Graffenstaden, France; Baylor Coll Med, Houston, TX 77030 USA	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Baylor College of Medicine	Auwerx, J (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France.		Auwerx, Johan/ABE-9307-2021; Rocchi, Stephane/O-4152-2016; Annicotte, Jean-Sébastien/H-4641-2018	Rocchi, Stephane/0000-0002-0943-1304; Annicotte, Jean-Sébastien/0000-0002-2109-4849; Auwerx, Johan/0000-0002-5065-5393	NIDDK NIH HHS [1-P01-DK59820-01] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Arvaniti K, 1998, ENDOCRINOLOGY, V139, P4000, DOI 10.1210/en.139.9.4000; BLANCHETTEMACKIE EJ, 1995, J LIPID RES, V36, P1211; CHAWLA A, 1994, P NATL ACAD SCI USA, V91, P1786, DOI 10.1073/pnas.91.5.1786; Choi DS, 1997, DEVELOPMENT, V124, P1745; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; Fajas L, 1999, MOL CELL BIOL, V19, P5495; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Gehin M, 2002, MOL CELL BIOL, V22, P5923, DOI 10.1128/MCB.22.16.5923-5937.2002; Gelman L, 1999, J BIOL CHEM, V274, P7681, DOI 10.1074/jbc.274.12.7681; Glass CK, 2000, GENE DEV, V14, P121; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; GUEZENNEC CY, 1988, EUR J APPL PHYSIOL O, V57, P114, DOI 10.1007/BF00691249; Hansen JB, 1999, J BIOL CHEM, V274, P2386, DOI 10.1074/jbc.274.4.2386; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Kodera Y, 2000, J BIOL CHEM, V275, P33201, DOI 10.1074/jbc.C000517200; LABORDA J, 1991, NUCLEIC ACIDS RES, V19, P3998, DOI 10.1093/nar/19.14.3998; LARSEN ML, 1993, CURR OPIN LIPIDOL, V4, P34, DOI 10.1097/00041433-199302000-00007; Lefebvre AM, 1997, ARTERIOSCL THROM VAS, V17, P1756, DOI 10.1161/01.ATV.17.9.1756; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; MARETTE A, 1991, AM J PHYSIOL, V261, pE204, DOI 10.1152/ajpendo.1991.261.2.E204; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; McInerney EM, 1998, GENE DEV, V12, P3357, DOI 10.1101/gad.12.21.3357; MIYAZAWA S, 1989, MOL CELL BIOL, V9, P83, DOI 10.1128/MCB.9.1.83; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; OLNEY JW, 1969, SCIENCE, V164, P719, DOI 10.1126/science.164.3880.719; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Qi C, 1999, P NATL ACAD SCI USA, V96, P1585, DOI 10.1073/pnas.96.4.1585; Reginato MJ, 1998, J BIOL CHEM, V273, P32679, DOI 10.1074/jbc.273.49.32679; Richard D, 2002, INT J OBESITY, V26, P344, DOI 10.1038/sj.ijo.0801873; RICHARD D, 1992, AM J PHYSIOL, V262, pR921, DOI 10.1152/ajpregu.1992.262.5.R921; RICQUIER D, 1979, FEBS LETT, V101, P35, DOI 10.1016/0014-5793(79)81289-2; Rocchi S, 2001, MOL CELL, V8, P737, DOI 10.1016/S1097-2765(01)00353-7; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Shao G, 2000, MOL ENDOCRINOL, V14, P1198, DOI 10.1210/me.14.8.1198; Spencer TE, 1997, NATURE, V389, P194, DOI 10.1038/38304; Takahashi N, 2002, J BIOL CHEM, V277, P16906, DOI 10.1074/jbc.M200585200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Trayhurn P, 1996, BIOCHEM SOC T, V24, P565, DOI 10.1042/bst0240565; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Voegel JJ, 1998, EMBO J, V17, P507, DOI 10.1093/emboj/17.2.507; Voegel JJ, 1996, EMBO J, V15, P3667, DOI 10.1002/j.1460-2075.1996.tb00736.x; Wang ZY, 2000, P NATL ACAD SCI USA, V97, P13549, DOI 10.1073/pnas.260463097; Wasylyk C, 1997, ONCOGENE, V14, P899, DOI 10.1038/sj.onc.1200914; Weiss RE, 2002, ENDOCRINOLOGY, V143, P1554, DOI 10.1210/en.143.4.1554; Xu JJ, 1998, ELECTROCHEM SOLID ST, V1, P1, DOI 10.1149/1.1390615; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yamauchi T, 2002, NAT GENET, V30, P221, DOI 10.1038/ng829	50	351	367	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 27	2002	111	7					931	941		10.1016/S0092-8674(02)01169-8	http://dx.doi.org/10.1016/S0092-8674(02)01169-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	630AU	12507421	Bronze			2022-12-28	WOS:000180086000004
J	Myat, MM; Andrew, DJ				Myat, MM; Andrew, DJ			Epithelial tube morphology is determined by the polarized growth and delivery of apical membrane	CELL			English	Article							DROSOPHILA SALIVARY-GLAND; GENE-EXPRESSION; NUCLEAR MIGRATION; HAIRY; PROTEIN; CELL; MORPHOGENESIS; SEGMENTATION; CRUMBS; MELANOGASTER	Formation of tubes of the correct size and shape is essential for viability of most organisms, yet little is understood of the mechanisms controlling tube morphology. We identified a new allele of hairy in a mutagenesis screen and showed that hairy mutations cause branching and bulging of the normally unbranched salivary tube, in part through prolonged expression of huckebein (hkb). HKB controls polarized cell shape change and apical membrane growth during salivary cell invagination via two downstream target genes, crumbs (crb), a determinant of the apical membrane, and klarsicht (klar), which mediates microtubule-dependent organelle transport. In invaginating salivary cells, crb and klar mediate growth and delivery of apical membrane, respectively, thus regulating the size and shape of the salivary tube.	Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Andrew, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.				NIDCR NIH HHS [R01DE13899] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013899] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5; Andrew DJ, 1997, DEVELOPMENT, V124, P181; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Bowes RC, 1999, J CELL PHYSIOL, V180, P81, DOI 10.1002/(SICI)1097-4652(199907)180:1<81::AID-JCP9>3.0.CO;2-J; Bradley PL, 2001, BIOESSAYS, V23, P901, DOI 10.1002/bies.1131; Bradley PL, 2001, DEVELOPMENT, V128, P3001; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; CARROLL SB, 1988, GENE DEV, V2, P883, DOI 10.1101/gad.2.7.883; CARROLL SB, 1986, NATURE, V323, P278, DOI 10.1038/323278a0; Clark IE, 1997, DEVELOPMENT, V124, P461; FISCHERVIZE JA, 1994, DEVELOPMENT, V120, P2609; GINIGER E, 1993, DEVELOPMENT, V117, P431; Hagios C, 1998, PHILOS T R SOC B, V353, P857, DOI 10.1098/rstb.1998.0250; Henderson KD, 2000, DEV BIOL, V217, P362, DOI 10.1006/dbio.1999.9560; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOOPER KL, 1989, DEVELOPMENT, V107, P489; HOWARD K, 1986, CELL, V44, P949, DOI 10.1016/0092-8674(86)90018-8; INGHAM PW, 1985, GENETICS, V111, P463; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; LEHMANN R, 1994, DROSOPHILA MELANOGAS, P755; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Myat MM, 2000, DEVELOPMENT, V127, P679; Myat MM, 2000, DEVELOPMENT, V127, P4217; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; ORENIC TV, 1993, DEVELOPMENT, V118, P9; PARKHURST SM, 1990, CELL, V63, P1179, DOI 10.1016/0092-8674(90)90414-A; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; REUTER R, 1990, DEVELOPMENT, V110, P1031; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Walpita D, 2002, NAT REV MOL CELL BIO, V3, P137, DOI 10.1038/nrm727; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5	41	101	101	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					879	891		10.1016/S0092-8674(02)01140-6	http://dx.doi.org/10.1016/S0092-8674(02)01140-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526813	Bronze			2022-12-28	WOS:000179862600013
J	D'Antonio, P				D'Antonio, P			Nurses in war	LANCET			English	Article									Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA	University of Pennsylvania	D'Antonio, P (corresponding author), Univ Penn, Sch Nursing, 420 Guardian Dr 307, Philadelphia, PA 19104 USA.							Brittain Vera, 1978, TESTAMENT YOUTH; DONNER H, 1997, J SOC HIST, V3, P667; Norman Elizabeth M., 1999, WE BAND ANGELS UNTOL; Sarnecky Mary, 1999, HIST US ARMY NURSE C; Summers Anne, 1988, ANGELS CITIZENS BRIT	5	5	5	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S7	S8		10.1016/S0140-6736(02)11798-3	http://dx.doi.org/10.1016/S0140-6736(02)11798-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504482				2022-12-28	WOS:000180064500003
J	van de Put, W				van de Put, W			Addressing mental health in Afghanistan	LANCET			English	Article									HealthNet Int, NL-1062 GL Amsterdam, Netherlands		van de Put, W (corresponding author), HealthNet Int, Maassluisstr 258, NL-1062 GL Amsterdam, Netherlands.								0	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S41	S42		10.1016/S0140-6736(02)11816-2	http://dx.doi.org/10.1016/S0140-6736(02)11816-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	629TG	12504499				2022-12-28	WOS:000180064500020
J	Freund, KM; Dolan, NC; Nelson, HD				Freund, KM; Dolan, NC; Nelson, HD			Update in women's health	ANNALS OF INTERNAL MEDICINE			English	Review							URINARY-TRACT INFECTIONS; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; BREAST-CANCER; ESTROGEN-REPLACEMENT; RANDOMIZED-TRIAL; DOUBLE-BLIND; RISK; OSTEOPOROSIS; FRACTURE		Boston Univ, Med Ctr, Evans Dept Med, Womens Hlth Unit, Boston, MA 02118 USA; Boston Univ, Med Ctr, Ctr Excellence Womens Hlth, Boston, MA 02118 USA; Northwestern Univ, Feinberg Sch Med, Sch Med, Chicago, IL 60611 USA; Oregon Hlth & Sci Univ, Portland, OR USA	Boston University; Boston University; Northwestern University; Feinberg School of Medicine; Oregon Health & Science University	Freund, KM (corresponding author), Boston Univ, Med Ctr, Evans Dept Med, Womens Hlth Unit, 720 Harrison Ave,Suite 1108, Boston, MA 02118 USA.	karen.freund@bmc.org		Freund, Karen/0000-0002-9049-5574				Alexandersen P, 2001, JAMA-J AM MED ASSOC, V285, P1482, DOI 10.1001/jama.285.11.1482; Arafah BM, 2001, NEW ENGL J MED, V344, P1743, DOI 10.1056/NEJM200106073442302; Bernstein SJ, 2001, AM J OBSTET GYNECOL, V185, P308, DOI 10.1067/mob.2001.116736; Blanck HM, 2001, JAMA-J AM MED ASSOC, V286, P930, DOI 10.1001/jama.286.8.930; Dube SR, 2001, JAMA-J AM MED ASSOC, V286, P3089, DOI 10.1001/jama.286.24.3089; Ferrara A, 2001, DIABETES CARE, V24, P1144, DOI 10.2337/diacare.24.7.1144; Gupta K, 2001, ANN INTERN MED, V135, P9, DOI 10.7326/0003-4819-135-1-200107030-00004; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hubacher D, 2001, NEW ENGL J MED, V345, P561, DOI 10.1056/NEJMoa010438; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Humphrey LL, 2002, ANN INTERN MED, V137, P347, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00012; Israel E, 2001, NEW ENGL J MED, V345, P941, DOI 10.1056/NEJMoa002304; Khan SA, 2001, ARCH INTERN MED, V161, P1309, DOI 10.1001/archinte.161.10.1309; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; NYSTROM L, 1993, LANCET, V341, P973, DOI 10.1016/0140-6736(93)91067-V; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Silverman JG, 2001, JAMA-J AM MED ASSOC, V286, P572, DOI 10.1001/jama.286.5.572; Simons-Morton DG, 2001, JAMA-J AM MED ASSOC, V286, P677; Siris ES, 2001, JAMA-J AM MED ASSOC, V286, P2815, DOI 10.1001/jama.286.22.2815; Soares CD, 2001, ARCH GEN PSYCHIAT, V58, P529; Solomon D, 2001, J NATL CANCER I, V93, P293, DOI 10.1093/jnci/93.4.293; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534	27	3	9	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					119	127		10.7326/0003-4819-138-2-200301210-00013	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00013			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529094				2022-12-28	WOS:000181018300006
J	Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R				Lahann, J; Mitragotri, S; Tran, TN; Kaido, H; Sundaram, J; Choi, IS; Hoffer, S; Somorjai, GA; Langer, R			A reversibly switching surface	SCIENCE			English	Article							SELF-ASSEMBLED MONOLAYERS; SUM-FREQUENCY GENERATION; IN-SITU STRUCTURE; GOLD ELECTRODES; ACTIVE CONTROL; NUCLEIC-ACIDS; FORCE-FIELD; CONTACT; SPECTROSCOPY; INTERFACE		MIT, Dept Chem Engn, Cambridge, MA 02139 USA; Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; Univ Calif Berkeley, Dept Chem, Div Mat Sci, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Santa Barbara; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Langer, R (corresponding author), MIT, Dept Chem Engn, 45 Carleton St, Cambridge, MA 02139 USA.	rlanger@mit.edu	Lahann, Joerg/J-7663-2013; CHOI, INSUNG S./C-1592-2011					ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005; Abbott S, 1999, LANGMUIR, V15, P8923, DOI 10.1021/la990558o; ABRAHAM MH, 1984, J CHEM SOC FARAD T 1, V80, P153, DOI 10.1039/f19848000153; ANDERSON MR, 1994, LANGMUIR, V10, P1638, DOI 10.1021/la00018a002; Aydogan N, 1999, LANGMUIR, V15, P722, DOI 10.1021/la9807208; Baldelli S, 1999, J PHYS CHEM B, V103, P8920, DOI 10.1021/jp991649x; Byloos M, 2001, J PHYS CHEM B, V105, P5900, DOI 10.1021/jp003066p; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; CHEN YL, 1991, J PHYS CHEM-US, V95, P10736, DOI 10.1021/j100179a041; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crevoisier GB, 1999, SCIENCE, V285, P1246, DOI 10.1126/science.285.5431.1246; DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827; EVERETT WR, 1995, ANAL CHIM ACTA, V307, P253, DOI 10.1016/0003-2670(95)00004-J; FINKLEA HO, 1987, LANGMUIR, V3, P409, DOI 10.1021/la00075a024; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; HAUTMAN J, 1989, J CHEM PHYS, V91, P4994, DOI 10.1063/1.457621; HINES MA, 1995, LANGMUIR, V11, P493, DOI 10.1021/la00002a022; IANNELLI A, 1994, J ELECTROANAL CHEM, V376, P49, DOI 10.1016/0022-0728(94)03463-X; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; LAIBINIS PE, 1995, J PHYS CHEM-US, V99, P7663, DOI 10.1021/j100019a054; Li TW, 1998, J PHYS CHEM B, V102, P2935, DOI 10.1021/jp980049f; NEUMANN AW, 1972, J COLLOID INTERF SCI, V38, P341, DOI 10.1016/0021-9797(72)90251-2; ONG TH, 1993, LANGMUIR, V9, P1836, DOI 10.1021/la00031a035; Russell TP, 2002, SCIENCE, V297, P964, DOI 10.1126/science.1075997; Schoenfisch MH, 1999, LANGMUIR, V15, P509, DOI 10.1021/la9811618; SHEN YR, 1989, NATURE, V337, P519, DOI 10.1038/337519a0; Shimazu K, 2002, J AM CHEM SOC, V124, P652, DOI 10.1021/ja004091b; STOLE SM, 1990, LANGMUIR, V6, P1199, DOI 10.1021/la00096a029; TAKEI YG, 1994, MACROMOLECULES, V27, P6163, DOI 10.1021/ma00099a035; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; WHITESIDES GM, 1990, LANGMUIR, V6, P87, DOI 10.1021/la00091a013; WILSON MD, 1988, J AM CHEM SOC, V110, P8718, DOI 10.1021/ja00234a035; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Zamborini FP, 1998, LANGMUIR, V14, P3279, DOI 10.1021/la971121o	34	969	1011	13	575	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					371	374		10.1126/science.1078933	http://dx.doi.org/10.1126/science.1078933			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532011				2022-12-28	WOS:000180426800038
J	Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ				Lee, JY; Yoo, BC; Rojas, MR; Gomez-Ospina, N; Staehelin, LA; Lucas, WJ			Selective trafficking of non-cell-autonomous proteins mediated by NtNCAPP1	SCIENCE			English	Article							TOBACCO MOSAIC-VIRUS; TO-CELL; MOVEMENT PROTEIN; MESSENGER-RNA; PLASMODESMATA; TRANSPORT; IDENTIFICATION; NUCLEAR; PHLOEM; LEAFY	In plants, cell-to-cell communication is mediated by plasmodesmata and involves the trafficking of non cell-autonomous proteins (NCAPs). A component in this pathway, Nicotiana tabacum NON-CELL-AUTONOMOUS PATHWAY PROTEIN1 (NtNCAPP1), was affinity purified and cloned. Protein overlay assays and in vivo studies showed that NtNCAPP1 is located on the endoplasmic reticulum at the cell periphery and displays specificity in its interaction with NCAPs. Deletion of the NtNCAPP1 amino-terminal transmembrane domain produced a dominant-negative mutant that blocked the trafficking of specific NCAPs. Transgenic tobacco plants expressing this mutant form of NtNCAPP1 and plants in which the NtNCAPP1 gene was silenced were compromised in their ability to regulate leaf and oral development. These results support a model in which NCAP delivery to plasmodesmata is both selective and regulated.	Univ Calif Davis, Div Biol Sci, Plant Biol Sect, Davis, CA 95616 USA; Univ Colorado, Boulder, CO 80309 USA	University of California System; University of California Davis; University of Colorado System; University of Colorado Boulder	Lucas, WJ (corresponding author), Univ Calif Davis, Div Biol Sci, Plant Biol Sect, 1 Shields Ave, Davis, CA 95616 USA.			Lee, Jinkee/0000-0001-5590-0549; Staehelin, Andrew/0000-0002-0611-4346; Lee, Jung-Youn/0000-0003-4604-7974; Gomez-Ospina, Natalia/0000-0002-6740-1154	NIGMS NIH HHS [GM18639] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahearn KP, 2001, PLANT CELL PHYSIOL, V42, P1130, DOI 10.1093/pcp/pce143; Balachandran S, 1997, P NATL ACAD SCI USA, V94, P14150, DOI 10.1073/pnas.94.25.14150; Citovsky V, 1999, PHILOS T ROY SOC B, V354, P637, DOI 10.1098/rstb.1999.0415; DING BA, 1995, VIROLOGY, V207, P345, DOI 10.1006/viro.1995.1093; FUJIWARA T, 1993, PLANT CELL, V5, P1783, DOI 10.1105/tpc.5.12.1783; Haywood V, 2002, PLANT CELL, V14, pS303, DOI 10.1105/tpc.000778; Kragler F, 2000, EMBO J, V19, P2856, DOI 10.1093/emboj/19.12.2856; Kragler F, 1998, PLANT J, V15, P367, DOI 10.1046/j.1365-313X.1998.00219.x; Li QB, 2001, MOL PLANT MICROBE IN, V14, P378, DOI 10.1094/MPMI.2001.14.3.378; LUCAS WJ, 1995, SCIENCE, V270, P1980, DOI 10.1126/science.270.5244.1980; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; NOUEIRY AO, 1994, CELL, V76, P925, DOI 10.1016/0092-8674(94)90366-2; ROBARDS AW, 1990, ANNU REV PLANT PHYS, V41, P369, DOI 10.1146/annurev.pp.41.060190.002101; Rojas MR, 1997, VIROLOGY, V237, P283, DOI 10.1006/viro.1997.8777; Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635; Sessions A, 2000, SCIENCE, V289, P779, DOI 10.1126/science.289.5480.779; TURNER A, 1994, J CELL SCI, V107, P3351; WAIGMANN E, 1994, P NATL ACAD SCI USA, V91, P1433, DOI 10.1073/pnas.91.4.1433; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; WU X, 2002, GENE DEV, V6, P151; Xoconostle-Cazares B, 1999, SCIENCE, V283, P94, DOI 10.1126/science.283.5398.94	21	128	137	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					392	396		10.1126/science.1077813	http://dx.doi.org/10.1126/science.1077813			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532017				2022-12-28	WOS:000180426800045
J	Goodnough, LT; Shander, A; Brecher, ME				Goodnough, LT; Shander, A; Brecher, ME			Transfusion medicine: looking to the future	LANCET			English	Review							FACTOR-CLEAVING PROTEASE; THROMBOTIC THROMBOCYTOPENIC PURPURA; UNITED-STATES; PHOTOCHEMICAL INACTIVATION; BACTERIAL-CONTAMINATION; PATIENT IDENTIFICATION; RETROSPECTIVE ANALYSIS; TRYPANOSOMA-CRUZI; BOVINE HEMOGLOBIN; HEMATOCRIT VALUES	The evolution of transfusion medicine into a clinically oriented discipline emphasising patient care has been accompanied by challenges that need to be faced as specialists look to the future. Emerging issues that affect blood safety and blood supply, such as pathogen inactivation and more stringent donor screening questions, bring new pressures on the availability of an affordable blood supply. Imminent alternatives for management of anaemia, such as oxygen carriers, hold great promise but, if available, will require close oversight. With current estimates of HIV or hepatitis C viral (HCV) transmission approaching one in 2 000 000 units transfused, keeping to a minimum bacterial contamination of platelet products (one in 2000) and errors in transfusion, with its estimated one in 800 000 mortality rate, assume great urgency. Finally, serious difficulties in blood safety and availability for poor, developing countries require innovative strategies and commitment of resources.	Washington Univ, Sch Med, Div Lab Med, Dept Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; Mt Sinai Sch Med, Dept Anesthesiol, New York, NY USA; Englewood Med Ctr, Dept Anesthesiol Crit Care & Hyperbar Med, Englewood, NJ USA; Univ N Carolina, Sch Med, Dept Pathol & Lab Med, Chapel Hill, NC USA	Washington University (WUSTL); Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Englewood Hospital & Medical Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Goodnough, LT (corresponding author), Washington Univ, Sch Med, Div Lab Med, Dept Med, Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	goodnough@labmed.wustl.edu						*AM ASS BLOOD BANK, 1996, ASS B AM ASS BLOOD B, V966; [Anonymous], 2001, ASS B AM ASS BLOOD B; AuBuchon JP, 1997, ANN INTERN MED, V127, P904, DOI 10.7326/0003-4819-127-10-199711150-00009; AuBuchon JP, 2001, TRANSFUSION, V41, p1S; AuBuchon JP, 2001, TRANSFUSION, V41, P964, DOI 10.1046/j.1537-2995.2001.41070964.x; Bandarenko N, 1998, J CLIN APHERESIS, V13, P133, DOI 10.1002/(SICI)1098-1101(1998)13:3<133::AID-JCA7>3.0.CO;2-Z; Battles JB, 1998, ARCH PATHOL LAB MED, V122, P231; BELL WR, 1991, NEW ENGL J MED, V325, P398, DOI 10.1056/NEJM199108083250605; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Brecher ME, 2000, TRANSFUSION, V40, P1308, DOI 10.1046/j.1537-2995.2000.40111308.x; Brecher ME, 1999, TRANSFUSION, V39, P396, DOI 10.1046/j.1537-2995.1999.39499235673.x; Brecher ME, 2001, TRANSFUSION, V41, P477, DOI 10.1046/j.1537-2995.2001.41040477.x; BROWN P, 1992, LANCET, V340, P24, DOI 10.1016/0140-6736(92)92431-E; *C HLTH, MILL NEED ACC SAF BL; Callum JL, 2001, TRANSFUSION, V41, P1204, DOI 10.1046/j.1537-2995.2001.41101204.x; CANNELLA G, 1991, NEPHROL DIAL TRANSPL, V6, P31, DOI 10.1093/ndt/6.1.31; Cardoso MD, 2000, TRANSFUSION, V40, P1422, DOI 10.1046/j.1537-2995.2000.40111422.x; Carson JL, 1996, LANCET, V348, P1055, DOI 10.1016/S0140-6736(96)04330-9; CHAPMAN J, 2001, 16 M JAN 31 202, V1; Cimo P L, 1993, Tex Med, V89, P48; Clark WF, 1999, ANN INTERN MED, V131, P453, DOI 10.7326/0003-4819-131-6-199909210-00011; Collins A., 1998, Journal of the American Society of Nephrology, V9, p204A; Collins AJ, 2000, SEMIN NEPHROL, V20, P345; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; Consulting Pathologists Group Committee, 1953, BRIT MED J, V2, P390; Corash L, 1997, BLOOD, V90, P1171; Cothren C, 2002, NEW ENGL J MED, V346, P1097, DOI 10.1056/NEJM200204043461420; Dodd RY, 1998, TRANSFUSION, V38, P221, DOI 10.1046/j.1537-2995.1998.38398222863.x; DYSKSTRA A, 1998, TRANSFUSION S, V38, pS104; Eschbach J, 1997, AM J KIDNEY DIS, V30, pS192; *FDA, REV PREV MEAS RED PO; Foley RN, 1996, AM J KIDNEY DIS, V28, P53, DOI 10.1016/S0272-6386(96)90130-4; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1998, NEW ENGL J MED, V339, P1578, DOI 10.1056/NEJM199811263392202; Gerritsen HE, 2001, BLOOD, V98, P1654, DOI 10.1182/blood.V98.6.1654; GILCHER R, 2002, 16 M JAN 31 2002, V1; GOLDMAN M, 1991, Transfusion Medicine Reviews, V5, P73, DOI 10.1016/S0887-7963(91)70194-6; Goldman M, 1997, TRANSFUSION, V37, P523, DOI 10.1046/j.1537-2995.1997.37597293885.x; Goodnough LT, 1999, NEW ENGL J MED, V340, P525, DOI 10.1056/NEJM199902183400706; Goodnough LT, 2001, NEW ENGL J MED, V345, P1272, DOI 10.1056/NEJM200110253451711; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Goodnough LT, 1999, TRANSFUSION, V39, P1031, DOI 10.1046/j.1537-2995.1999.39091031.x; GUERRERO IC, 1983, ANN INTERN MED, V99, P221, DOI 10.7326/0003-4819-99-2-221; Hebert PC, 1997, AM J RESP CRIT CARE, V155, P1618, DOI 10.1164/ajrccm.155.5.9154866; Hedner U, 2002, TRANSFUSION, V42, P114, DOI 10.1046/j.1537-2995.2002.00017.x; Jacobs MR, 2001, TRANSFUSION, V41, P1331, DOI 10.1046/j.1537-2995.2001.41111331.x; Jensen NJ, 1996, TRANSFUSION, V36, P216, DOI 10.1046/j.1537-2995.1996.36396182138.x; JONES JA, 1995, BRIT J ANAESTH, V74, P697, DOI 10.1093/bja/74.6.697; Kasper SM, 1998, ANESTH ANALG, V87, P284, DOI 10.1097/00000539-199808000-00009; KEIPERT PE, 1995, ARTIF CELL BLOOD SUB, V23, P381, DOI 10.3109/10731199509117954; Klein HG, 2001, TRANSFUSION, V41, P1179, DOI 10.1046/j.1537-2995.2001.41101179.x; Kleinman S. H., 2002, Vox Sanguinis, V83, P106; Knutson F, 2000, VOX SANG, V78, P209, DOI 10.1159/000031183; Laan E, 1999, TRANSFUSION, V39, p5S; Leiby DA, 1997, TRANSFUSION, V37, P259, DOI 10.1046/j.1537-2995.1997.37397240206.x; LENFANT C, 1992, TRANSFUSION, V32, P873, DOI 10.1046/j.1537-2995.1992.32993110764.x; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; Lin L, 1997, TRANSFUSION, V37, P423, DOI 10.1046/j.1537-2995.1997.37497265344.x; Linden JV, 2000, TRANSFUSION, V40, P1207, DOI 10.1046/j.1537-2995.2000.40101207.x; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; Ma ZM, 1997, CLIN CHEM, V43, P1732; Maguire PJ, 2000, CRIT CARE CLIN, V16, P681, DOI 10.1016/S0749-0704(05)70140-8; McCullough J, 2001, BLOOD, V98, p450A; McDonald C. P., 2000, Vox Sanguinis, V78, pP375; McQuiston JH, 2000, TRANSFUSION, V40, P274, DOI 10.1046/j.1537-2995.2000.40030274.x; Mullon J, 2000, NEW ENGL J MED, V342, P1638, DOI 10.1056/NEJM200006013422204; Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603; NAHLEN BL, 1991, TRANSFUSION, V31, P798, DOI 10.1046/j.1537-2995.1991.31992094665.x; Ness P, 2001, TRANSFUSION, V41, P857, DOI 10.1046/j.1537-2995.2001.41070857.x; NIGHTINGALE S, 2002, 16 M JAN 31 2002, V1; NOEL L, 2000, SAFE BLOOD STARTS ME; Ollgaard M., 1998, Vox Sanguinis, V74, P1126; OUELLETTE G, 2002, 16 M JAN 31 2002, V1; RIOUX F, 1995, J CARDIOVASC PHARM, V25, P587, DOI 10.1097/00005344-199504000-00012; SAZAMA K, 1990, TRANSFUSION, V30, P583, DOI 10.1046/j.1537-2995.1990.30790385515.x; Sazama K, 2001, TRANSFUSION, V41, P577, DOI 10.1046/j.1537-2995.2001.41050577.x; Schmidt PJ, 2002, NEW ENGL J MED, V346, P617, DOI 10.1056/NEJM200202213460813; SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x; Schmunis GA, 2001, AM J TROP MED HYG, V65, P924, DOI 10.4269/ajtmh.2001.65.924; Scott MG, 1997, CLIN CHEM, V43, P1724; Shulman IA, 1997, TRANSFUSION, V37, P727, DOI 10.1046/j.1537-2995.1997.37797369449.x; Silverberg DS, 2001, J AM COLL CARDIOL, V37, P1775, DOI 10.1016/S0735-1097(01)01248-7; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; SNYDER E, 2001, 16 M JAN 31 2002; SPAHN DR, 1994, ANESTH ANALG, V78, P1000; Spahn DR, 1999, ANESTHESIOLOGY, V91, P1195, DOI 10.1097/00000542-199911000-00009; Stowell CP, 2001, TRANSFUSION, V41, P287, DOI 10.1046/j.1537-2995.2001.41020287.x; Tsai HM, 1998, NEW ENGL J MED, V339, P1585, DOI 10.1056/NEJM199811263392203; Valeri CR, 2001, TRANSFUSION, V41, P933, DOI 10.1046/j.1537-2995.2001.41070933.x; VUETIC D, 2000, VOX SANG S, V78, pP371; WENZ B, 1991, TRANSFUSION, V31, P401, DOI 10.1046/j.1537-2995.1991.31591263193.x; Williamson LM, 1999, BRIT MED J, V319, P16, DOI 10.1136/bmj.319.7201.16; WINSLOW RM, 1995, NAT MED, V1, P1212, DOI 10.1038/nm1195-1212; Winslow RM, 2002, CURR OPIN HEMATOL, V9, P146, DOI 10.1097/00062752-200203000-00011; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; YOMTOVIAN R, 1993, TRANSFUSION, V33, P902, DOI 10.1046/j.1537-2995.1993.331194082380.x; Zayas CF, 2002, JAMA-J AM MED ASSOC, V287, P1795; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200	98	182	199	1	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					161	169		10.1016/S0140-6736(03)12195-2	http://dx.doi.org/10.1016/S0140-6736(03)12195-2			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531595				2022-12-28	WOS:000180428000026
J	Ogilvie, CM				Ogilvie, CM			Laboratory diagnosis	LANCET			English	Editorial Material									Guys & St Thomas Hosp, Genet Ctr, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Ogilvie, CM (corresponding author), Guys & St Thomas Hosp, Genet Ctr, London SE1 9RT, England.		MIZUTANI, Tetsuya/G-1086-2013; Ogilve, Caroline/AAW-3793-2021; Lo, Yuk Ming Dennis/D-4468-2011	MIZUTANI, Tetsuya/0000-0003-2570-0452; Lo, Yuk Ming Dennis/0000-0001-8746-0293					0	4	4	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					160	160		10.1016/S0140-6736(03)12194-0	http://dx.doi.org/10.1016/S0140-6736(03)12194-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531594				2022-12-28	WOS:000180428000025
J	Adam, D				Adam, D			British chemists warned of impending stagnation	NATURE			English	News Item																		2002, NATURE, V416, P777	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					100	100		10.1038/421100b	http://dx.doi.org/10.1038/421100b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520266	Bronze			2022-12-28	WOS:000180267200004
J	Visser, K; Thunell, R; Stott, L				Visser, K; Thunell, R; Stott, L			Magnitude and timing of temperature change in the Indo-Pacific warm pool during deglaciation	NATURE			English	Article							CLIMATE-CHANGE; TROPICAL PACIFIC; NORTH-ATLANTIC; OCEAN; ANTARCTICA; WATERS; CO2	Ocean-atmosphere interactions in the tropical Pacific region have a strong influence on global heat and water vapour transport and thus constitute an important component of the climate system(1,2). Changes in sea surface temperatures and convection in the tropical Indo-Pacific region are thought to be responsible for the interannual to decadal climate variability observed in extratropical regions(1,3), but the role of the tropics in climate changes on millennial and orbital timescales is less clear. Here we analyse oxygen isotopes and Mg/Ca ratios of foraminiferal shells from the Makassar strait in the heart of the Indo-Pacific warm pool, to obtain synchronous estimates of sea surface temperatures and ice volume. We find that sea surface temperatures increased by 3.5-4.0 degreesC during the last two glacial-interglacial transitions, synchronous with the global increase in atmospheric CO2 and Antarctic warming, but the temperature increase occurred 2,000-3,000 years before the Northern Hemisphere ice sheets melted. Our observations suggest that the tropical Pacific region plays an important role in driving glacial-interglacial cycles, possibly through a system similar to how El Nino/Southern Oscillation regulates the poleward flux of heat and water vapour.	Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA; Univ So Calif, Dept Earth Sci, Los Angeles, CA 90089 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of Southern California	Thunell, R (corresponding author), Univ S Carolina, Dept Geol Sci, Columbia, SC 29205 USA.			Ackerman, Kate/0000-0003-3925-721X				Bacastow RB, 1996, GLOBAL BIOGEOCHEM CY, V10, P319, DOI 10.1029/96GB00039; Bard E, 1988, PALEOCEANOGRAPHY, V3, P635, DOI 10.1029/PA003i006p00635; BOYLE EA, 1995, PALEOCEANOGRAPHY, V10, P881, DOI 10.1029/95PA01625; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P352, DOI 10.1029/98PA00920; Broecker WS, 1997, GLOBAL BIOGEOCHEM CY, V11, P589, DOI 10.1029/97GB02267; Cane M, 1999, GEOPH MONOG SERIES, V112, P373; Cane MA, 1998, SCIENCE, V282, P59, DOI 10.1126/science.282.5386.59; CLIMAP Climate: Long-Range Investigation Mapping and Prediction Project Members, 1981, GEOL SOC AM MAP CHAR, V36, P1; DEKENS PS, 2002, GEOCHEM GEOPHYS GEOS, V3; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; EPSTEIN S, 1953, GEOL SOC AM BULL, V64, P1315, DOI 10.1130/0016-7606(1953)64[1315:RCITS]2.0.CO;2; Farrell JW, 1989, PALEOCEANOGRAPHY, V4, P447, DOI 10.1029/PA004i004p00447; GUILDERSON T, 2000, GEOCHEM GEOPHYS GEOS, V1; Guilderson TP, 2001, MAR GEOL, V172, P75, DOI 10.1016/S0025-3227(00)00115-8; HASTENRATH S, 1982, J PHYS OCEANOGR, V12, P922, DOI 10.1175/1520-0485(1982)012<0922:OMHTIT>2.0.CO;2; HASTINGS D, 2001, EOS, V82; Hoerling MP, 2001, SCIENCE, V292, P90, DOI 10.1126/science.1058582; Koutavas A, 2002, SCIENCE, V297, P226, DOI 10.1126/science.1072376; Lea DW, 2000, SCIENCE, V289, P1719, DOI 10.1126/science.289.5485.1719; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; MARTENS R., 1987, SPORT PSYCHOL, V1, P29, DOI [10.1123/tsp.1.1.29, DOI 10.1123/TSP.1.1.29]; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pierrehumbert RT, 2000, P NATL ACAD SCI USA, V97, P1355, DOI 10.1073/pnas.97.4.1355; Rosenthal Y, 2000, PALEOCEANOGRAPHY, V15, P135, DOI 10.1029/1999PA000415; Schrag DP, 1996, SCIENCE, V272, P1930, DOI 10.1126/science.272.5270.1930; Shackleton NJ, 2000, SCIENCE, V289, P1897, DOI 10.1126/science.289.5486.1897; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Stott L, 2002, SCIENCE, V297, P222, DOI 10.1126/science.1071627; Stuiver M, 1998, RADIOCARBON, V40, P1041, DOI 10.1017/S0033822200019123; White WB, 1996, NATURE, V380, P699, DOI 10.1038/380699a0	31	281	333	2	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					152	155		10.1038/nature01297	http://dx.doi.org/10.1038/nature01297			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520298				2022-12-28	WOS:000180267200036
J	Trinh, NH; Hoblyn, J; Mohanty, SU; Yaffe, K				Trinh, NH; Hoblyn, J; Mohanty, SU; Yaffe, K			Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO-CONTROLLED TRIAL; CONTROLLED-RELEASE PHYSOSTIGMINE; QUALITY-OF-LIFE; LONG-TERM-CARE; DOUBLE-BLIND; PSYCHIATRIC-SYMPTOMS; DRUG TRIALS; DEMENTIA; METRIFONATE; MULTICENTER	Context Cholinesterase inhibitors are the primary treatment for the cognitive symptoms of Alzheimer disease (AD). Cholinergic dysfunction is also associated with neuropsychiatric and functional deficits, but results from randomized controlled trials of cholinesterase inhibitors are conflicting. Objective To conduct a systematic review and meta-analysis to quantify the efficacy of cholinesterase inhibitors for neuropsychiatric and functional outcomes in patients with mild to moderate AD. Data Sources We performed a literature search of trials using MEDLINE (January 1966-December 2001), Dissertations Abstracts On-line, PSYCHINFO, BIOSIS, PubMed, and the Cochrane Controlled Trials Register. We retrieved English- and non-English-language articles for review and collected references from bibliographies of reviews, original research articles, and other articles of interest. We searched for both published and unpublished trials, contacting researchers and pharmaceutical companies. Study Selection We included 29 parallel-group or crossover randomized, double-blind, placebo-controlled trials of outpatients who were diagnosed as having mild to moderate probable AD and were treated for at least 1 month with a cholinesterase inhibitor. Sixteen trials included neuropsychiatric and 18 included functional measures. Data Extraction Two investigators (N.H.T. and J.H.) independently extracted study methods, sources of bias, and outcomes. Neuropsychiatric outcomes were measured with the Neuropsychiatric Inventory (NPI, 0-120 points) and the Alzheimer Disease Assessment Scale, noncognitive (ADAS-noncog, 0-50 points) and were analyzed with the weighted mean difference method. Functional outcomes were measured with several activities of daily living (ADL) and instrumental activities of daily living (IADL) scales and analyzed with the standardized mean difference method. Data Synthesis For neuropsychiatric outcomes, 10 trials included the ADAS-noncog and 6 included the NPI. Compared with placebo, patients randomized to cholinesterase inhibitors improved 1.72 points on the NPI (95% confidence interval [CI], 0.87-2.57 points), and 0.03 points on the ADAS-noncog (95% CI, 0.00-0.05 points). For functional outcomes, 14 trials used ADL and 13 trials used IADL scales. Compared with placebo, patients randomized to cholinesterase inhibitors improved 0.1 SDs on ADL scales (95% CI, 0.00-0.19 SDs), and 0.09 SDs on IADL scales (95% CI, 0.01 to 0.17 SDs). There was no difference in efficacy among various cholinesterase inhibitors. Conclusions These results indicate that cholinesterase inhibitors have a modest beneficial impact on neuropsychiatric and functional outcomes for patients with AD. Future research should focus on how such improvements translate into long-term outcomes such as patient quality of life, institutionalization, and caregiver burden.	Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Psychiat, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94121 USA; Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA 94121 USA; Harvard Univ, Ctr Astrophys, Boston, MA 02115 USA; Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Palo Alto, CA 94304 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Harvard University; Massachusetts General Hospital	Yaffe, K (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Psychiat, Box 111G,4150 Clement St, San Francisco, CA 94121 USA.	kyaffe@itsa.ucsf.edu	Trinh, Nhi-Ha/AAH-7836-2019	Hoblyn MD, Jennifer/0000-0002-9393-4763	NIA NIH HHS [K23-AG00888] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K23AG000888] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agid Y, 1998, CURR THER RES CLIN E, V59, P837, DOI 10.1016/S0011-393X(98)85048-0; ANTUONO PG, 1995, ARCH INTERN MED, V155, P1766, DOI 10.1001/archinte.155.16.1766; Ballard C, 2001, INT PSYCHOGERIATR, V13, P93, DOI 10.1017/S1041610201007499; Becker RE, 1998, ALZ DIS ASSOC DIS, V12, P54, DOI 10.1097/00002093-199803000-00009; Becker RE, 1996, ALZ DIS ASSOC DIS, V10, P124, DOI 10.1097/00002093-199601030-00003; Begg C., 1994, HDB RES SYNTHESIS, P399; Birks JS, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001191.pub3; Coen RF, 1997, INT J GERIATR PSYCH, V12, P331, DOI 10.1002/(SICI)1099-1166(199703)12:3<331::AID-GPS495>3.3.CO;2-A; Cummings JL, 2000, AM J PSYCHIAT, V157, P4, DOI 10.1176/ajp.157.1.4; Cummings JL, 1998, NEUROLOGY, V50, P1214, DOI 10.1212/WNL.50.5.1214; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; Dubois B, 1999, INT J GERIATR PSYCH, V14, P973, DOI 10.1002/(SICI)1099-1166(199911)14:11<973::AID-GPS58>3.0.CO;2-U; EAGGER SA, 1991, LANCET, V337, P989, DOI 10.1016/0140-6736(91)92656-M; FARLOW M, 1992, JAMA-J AM MED ASSOC, V268, P2523, DOI 10.1001/jama.268.18.2523; Forette F, 1999, EUR J NEUROL, V6, P423, DOI 10.1046/j.1468-1331.1999.640423.x; FORETTE F, 1995, EUR J NEUROL, V2, P229, DOI 10.1111/j.1468-1331.1995.tb00124.x; Fratiglioni L, 2000, NEUROLOGY, V54, pS10; GAUTHIER L, 1990, NEUROEPIDEMIOLOGY, V9, P183, DOI 10.1159/000110771; Gonzalez-Salvador T, 2000, INT J GERIATR PSYCH, V15, P181, DOI 10.1002/(SICI)1099-1166(200002)15:2<181::AID-GPS96>3.0.CO;2-I; GREEN CR, 1993, J AM GERIATR SOC, V41, P654, DOI 10.1111/j.1532-5415.1993.tb06740.x; Heyman A, 1997, NEUROLOGY, V48, P1304, DOI 10.1212/WNL.48.5.1304; Imbimbo BP, 1999, NEUROLOGY, V52, P700, DOI 10.1212/WNL.52.4.700; Imbimbo BP, 1998, ALZ DIS ASSOC DIS, V12, P313, DOI 10.1097/00002093-199812000-00011; Imbimbo BP, 2000, DEMENT GERIATR COGN, V11, P17, DOI 10.1159/000017208; Jann MW, 1999, CLIN THER, V21, P88, DOI 10.1016/S0149-2918(00)88270-3; Katz IR, 1999, J CLIN PSYCHIAT, V60, P107, DOI 10.4088/JCP.v60n0207; KNAPP MJ, 1994, JAMA-J AM MED ASSOC, V271, P985, DOI 10.1001/jama.271.13.985; Lai MKP, 2001, NEUROLOGY, V57, P805; Lyketsos CG, 2002, JAMA-J AM MED ASSOC, V288, P1475, DOI 10.1001/jama.288.12.1475; Martinson I M, 1995, J Community Health Nurs, V12, P47, DOI 10.1207/s15327655jchn1201_5; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mega MS, 1999, ARCH NEUROL-CHICAGO, V56, P1388, DOI 10.1001/archneur.56.11.1388; Mega MS, 1996, NEUROLOGY, V46, P130, DOI 10.1212/WNL.46.1.130; Minger SL, 2000, NEUROLOGY, V55, P1460, DOI 10.1212/WNL.55.10.1460; Mohs RC, 2001, NEUROLOGY, V57, P481, DOI 10.1212/WNL.57.3.481; Moller HJ, 1999, PHARMACOPSYCHIATRY, V32, P99, DOI 10.1055/s-2007-979202; MOLLOY DW, 1991, CAN MED ASSOC J, V144, P29; Morris JC, 1998, NEUROLOGY, V50, P1222, DOI 10.1212/WNL.50.5.1222; Perrault A, 2000, J GERIATR PSYCH NEUR, V13, P181, DOI 10.1177/089198870001300403; PETITTI DB, 2000, METAANALYSIS DECISIO; Pigott T., 1994, HDB RES SYNTHESIS, P163; Porsteinsson AP, 2001, AM J GERIAT PSYCHIAT, V9, P58, DOI 10.1176/appi.ajgp.9.1.58; Qizilbash N, 1998, JAMA-J AM MED ASSOC, V280, P1777, DOI 10.1001/jama.280.20.1777; Raskind MA, 1999, J CLIN PSYCHIAT, V60, P318, DOI 10.4088/JCP.v60n0510; Rockwood K, 2001, NEUROEPIDEMIOLOGY, V20, P51, DOI 10.1159/000054761; Rockwood K, 2001, J NEUROL NEUROSUR PS, V71, P589, DOI 10.1136/jnnp.71.5.589; Rogers SL, 1996, DEMENTIA, V7, P293, DOI 10.1159/000106895; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Scott WK, 1997, GERONTOLOGIST, V37, P46, DOI 10.1093/geront/37.1.46; Shadish W., 1994, HDB RES SYNTHESIS, P265; STEELE C, 1990, AM J PSYCHIAT, V147, P1049; STERN Y, 1987, NEUROLOGY, V37, P1649, DOI 10.1212/WNL.37.10.1649; Tariot PN, 2000, NEUROLOGY, V54, P2269, DOI 10.1212/WNL.54.12.2269; Thal LJ, 1999, NEUROLOGY, V52, P1146, DOI 10.1212/WNL.52.6.1146; Thal LJ, 1996, NEUROLOGY, V47, P1389, DOI 10.1212/WNL.47.6.1389; THAL LJ, 1989, J AM GERIATR SOC, V37, P42, DOI 10.1111/j.1532-5415.1989.tb01567.x; van Dyck CH, 2000, ARCH GEN PSYCHIAT, V57, P157, DOI 10.1001/archpsyc.57.2.157; Weiner MF, 1996, ALZ DIS ASSOC DIS, V10, P20, DOI 10.1097/00002093-199601010-00005; Whitehouse PJ, 1998, J CLIN PSYCHIAT, V59, P19; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; Winblad B, 2001, NEUROLOGY, V57, P489, DOI 10.1212/WNL.57.3.489; WOOD PC, 1994, INT J GERIATR PSYCH, V9, P649, DOI 10.1002/gps.930090809; Zemlan FP, 1996, J NEURAL TRANSM, V103, P1105, DOI 10.1007/BF01291795	64	345	362	0	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					210	216		10.1001/jama.289.2.210	http://dx.doi.org/10.1001/jama.289.2.210			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517232				2022-12-28	WOS:000180226400032
J	Hypponen, E; Smith, GD; Power, C				Hypponen, E; Smith, GD; Power, C			Parental diabetes and birth weight of offspring: intergenerational cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ASSOCIATION		Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England; Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England	University of London; University College London; University of Bristol	Hypponen, E (corresponding author), Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, 30 Guilford St, London WC1N 1EH, England.	e.hypponen@ich.ucl.ac.uk	Hypponen, Elina/B-2596-2014; Davey Smith, George/A-7407-2013	Hypponen, Elina/0000-0003-3670-9399; Davey Smith, George/0000-0002-1407-8314	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Butler N.R., 1963, PERINATAL MORTALITY; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Lindsay RS, 2000, DIABETES, V49, P445, DOI 10.2337/diabetes.49.3.445; Pennison EH, 2001, AM J OBSTET GYNECOL, V184, P1118, DOI 10.1067/mob.2001.114918; Tynelius P, 2001, AM J EPIDEMIOL, V153, pS47	5	67	68	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 4	2003	326	7379					19	20		10.1136/bmj.326.7379.19	http://dx.doi.org/10.1136/bmj.326.7379.19			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511454	Bronze, Green Published, Green Submitted			2022-12-28	WOS:000180302000018
J	Rolla, G; Nebiolo, F; Guida, G; Marsico, P; Riva, G; Zanotta, S				Rolla, G; Nebiolo, F; Guida, G; Marsico, P; Riva, G; Zanotta, S			Cotton wool in pine trees	LANCET			English	Article							CATERPILLAR; PITYOCAMPA		Univ Turin, Osped Mauriziano Umberto I, Turin, Italy; Lab Lofarma SpA, Milan, Italy	A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; Mauritian Umberto I Hospital; University of Turin	Rolla, G (corresponding author), Allergol Osped Mauriziano Umberto I, Largo Turati 62, I-10128 Turin, Italy.		Guida, Giuseppe/B-9713-2008; Guida, Giuseppe/AAD-2118-2021; Rolla, Giovanni/C-9901-2009	Guida, Giuseppe/0000-0003-3876-8587; Rolla, Giovanni/0000-0001-5997-7172				DUCOMBS G, 1981, CONTACT DERMATITIS, V7, P287, DOI 10.1111/j.1600-0536.1981.tb04081.x; Vega JM, 1997, ALLERGY, V52, P1244, DOI 10.1111/j.1398-9995.1997.tb02532.x; Vega JM, 1999, CLIN EXP ALLERGY, V29, P1418, DOI 10.1046/j.1365-2222.1999.00626.x; WERNO J, 1993, LANCET, V342, P936, DOI 10.1016/0140-6736(93)91989-Y	4	3	4	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					44	44		10.1016/S0140-6736(03)12121-6	http://dx.doi.org/10.1016/S0140-6736(03)12121-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517466				2022-12-28	WOS:000180191600020
J	Sandham, JD; Hull, RD; Brant, RF; Knox, L; Pineo, GF; Doig, CJ; Laporta, DP; Viner, S; Passerini, L; Devitt, H; Kirby, A; Jacka, M				Sandham, JD; Hull, RD; Brant, RF; Knox, L; Pineo, GF; Doig, CJ; Laporta, DP; Viner, S; Passerini, L; Devitt, H; Kirby, A; Jacka, M		Canadian Critical Care Clin Trials	A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAXIMIZING OXYGEN DELIVERY; RIGHT HEART CATHETERIZATION; CRITICALLY-ILL PATIENTS; MYOCARDIAL-INFARCTION; SUPRANORMAL VALUES; MORTALITY; RESUSCITATION; EXPERIENCE; FREQUENCY; ELEVATION	Background: Some observational studies suggest that the use of pulmonary-artery catheters to guide therapy is associated with increased mortality. Methods: We performed a randomized trial comparing goal-directed therapy guided by a pulmonary-artery catheter with standard care without the use of a pulmonary-artery catheter. The subjects were high-risk patients 60 years of age or older, with American Society of Anesthesiologists (ASA) class III or IV risk, who were scheduled for urgent or elective major surgery, followed by a stay in an intensive care unit. Outcomes were adjudicated by observers who were unaware of the treatment-group assignments. The primary outcome was in-hospital mortality from any cause. Results: Of 3803 eligible patients, 1994 (52.4 percent) underwent randomization. The base-line characteristics of the two treatment groups were similar. A total of 77 of 997 patients who underwent surgery without the use of a pulmonary-artery catheter (7.7 percent) died in the hospital, as compared with 78 of 997 patients in whom a pulmonary-artery catheter was used (7.8 percent) -- a difference of 0.1 percentage point (95 percent confidence interval, -2.3 to 2.5). There was a higher rate of pulmonary embolism in the catheter group than in the standard-care group (8 events vs. 0 events, P=0.004).The survival rates at 6 months among patients in the standard-care and catheter groups were 88.1 and 87.4 percent, respectively (difference, -0.7 percentage point [95 percent confidence interval, -3.6 to 2.2]; negative survival differences favor standard care); at 12 months, the rates were 83.9 and 83.0 percent, respectively (difference, -0.9 percentage point [95 percent confidence interval, -4.3 to 2.4]). The median hospital stay was 10 days in each group. Conclusions: We found no benefit to therapy directed by pulmonary-artery catheter over standard care in elderly, high-risk surgical patients requiring intensive care.	Univ Calgary, Fac Med, Calgary, AB, Canada; Sir Mortimer B Davis Jewish Hosp, Montreal, PQ H3T 1E2, Canada; Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada; Dalhousie Univ, Fac Med, Halifax, NS, Canada; Univ Alberta, Edmonton, AB, Canada	University of Calgary; McGill University; Universite de Montreal; Dalhousie University; University of Alberta	Sandham, JD (corresponding author), Dept Crit Care Med, EG23 Foothills St NW, Calgary, AB T2N 2T9, Canada.	sandham@ucalgary.ca	Doig, Christopher/AAC-7949-2020	Doig, Christopher/0000-0002-8576-9139; Brant, Rollin/0000-0002-8026-2451				[Anonymous], 1989, AM REV RESPIR DIS, V139, P1058; BERLAUK JF, 1991, ANN SURG, V214, P289, DOI 10.1097/00000658-199109000-00011; Bernard GR, 2000, JAMA-J AM MED ASSOC, V283, P2568, DOI 10.1001/jama.283.19.2568; BISHOP M, 1992, CRIT CARE MED, V20, pS93; BOYD O, 1993, JAMA-J AM MED ASSOC, V270, P2699, DOI 10.1001/jama.270.22.2699; Connors AF, 1996, JAMA-J AM MED ASSOC, V276, P889, DOI 10.1001/jama.276.11.889; Cooper AB, 1996, CRIT CARE CLIN, V12, P777, DOI 10.1016/S0749-0704(05)70279-7; COWLEY G, 1996, NEWSWEEK        0930, P71; Dalen JE, 1996, JAMA-J AM MED ASSOC, V276, P916, DOI 10.1001/jama.276.11.916; DELGUERCIO LRM, 1980, JAMA-J AM MED ASSOC, V243, P1350, DOI 10.1001/jama.243.13.1350; Durham RM, 1996, J TRAUMA, V41, P32, DOI 10.1097/00005373-199607000-00007; Fisher J D, 1972, Arch Intern Med, V129, P836; FLEMING A, 1992, ARCH SURG-CHICAGO, V127, P1175; GATTINONI L, 1995, NEW ENGL J MED, V333, P1025, DOI 10.1056/NEJM199510193331601; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; GORE JM, 1987, CHEST, V92, P721, DOI 10.1378/chest.92.4.721; Guyatt G, 1991, J Intensive Care Med, V6, P91; HAYES MA, 1994, NEW ENGL J MED, V330, P1717, DOI 10.1056/NEJM199406163302404; Heyland DK, 1996, CRIT CARE MED, V24, P517, DOI 10.1097/00003246-199603000-00025; ISAACSON IJ, 1990, J VASC SURG, V12, P754, DOI 10.1067/mva.1990.24456; Ivanov R I, 1997, New Horiz, V5, P268; OLDER P, 1988, ANAESTH INTENS CARE, V16, P389, DOI 10.1177/0310057X8801600402; PEARSON KS, 1989, ANESTH ANALG, V69, P336; Polanczyk CA, 2001, JAMA-J AM MED ASSOC, V286, P309, DOI 10.1001/jama.286.3.309; RAO TLK, 1983, ANESTHESIOLOGY, V59, P499, DOI 10.1097/00000542-198312000-00003; Rapoport J, 2000, JAMA-J AM MED ASSOC, V283, P2559, DOI 10.1001/jama.283.19.2559; ROBIN ED, 1987, CHEST, V92, P727, DOI 10.1378/chest.92.4.727; SAVINO JA, 1985, SURG CLIN N AM, V65, P763; SCHULTZ RJ, 1985, J TRAUMA, V25, P309, DOI 10.1097/00005373-198504000-00005; SECHZER PH, 1963, ANESTHESIOLOGY, V24, P779, DOI 10.1097/00000542-196311000-00005; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; SWAN HJC, 1970, NEW ENGL J MED, V283, P447, DOI 10.1056/NEJM197008272830902; Taylor RW, 1997, CRIT CARE MED, V25, P910; TUCHSCHMIDT J, 1992, CHEST, V102, P216, DOI 10.1378/chest.102.1.216; TUMAN KJ, 1989, ANESTHESIOLOGY, V70, P199, DOI 10.1097/00000542-198902000-00004; WU AW, 1990, J AM GERIATR SOC, V38, P621, DOI 10.1111/j.1532-5415.1990.tb01419.x; YU M, 1994, CRIT CARE MED, V22, pA111; YU MH, 1995, CRIT CARE MED, V23, P1025, DOI 10.1097/00003246-199506000-00006; YU MH, 1993, CRIT CARE MED, V21, P830, DOI 10.1097/00003246-199306000-00009; ZION MM, 1990, CHEST, V98, P1331, DOI 10.1378/chest.98.6.1331	40	883	926	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					5	14		10.1056/NEJMoa021108	http://dx.doi.org/10.1056/NEJMoa021108			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510037				2022-12-28	WOS:000180134400002
J	Crowther, MA; Kelton, JG				Crowther, MA; Kelton, JG			Congenital thrombophilic states associated with venous thrombosis: A qualitative overview and proposed classification system	ANNALS OF INTERNAL MEDICINE			English	Review							PROTEIN-C DEFICIENCY; FACTOR-V-LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE GENE; NEONATAL PURPURA FULMINANS; BETA-SYNTHASE DEFICIENCY; INDUCED SKIN NECROSIS; DEEP-VEIN THROMBOSIS; S DEFICIENCY; RISK-FACTOR; ANTITHROMBIN DEFICIENCY	Congenital causes of venous thrombosis have gained increasing prominence with the description of the factor V Leiden mutation and the prothrombin gene mutation. More recently, the description of the association between increased levels of coagulation factors and venous thrombosis and the finding that patients with thrombophilia can harbor more than one prothrombotic state have further increased the clinical relevance of the congenital thrombophilic states. In this qualitative review, we summarize current knowledge of the congenital prothrombotic states and propose a simple classification system that divides the states into two broad groups: those associated with reduced levels of the inhibitors of the coagulation cascade and those associated with increased levels or function of the coagulation factors. The first group is less common than the second, but it is associated with a much higher risk for venous thrombosis. This review provides clinicians with an evidence-based, practical guide to the congenital prothrombotic states.	St Josephs Hosp, Hamilton, ON L8N 4A6, Canada	McGill University; McMaster University	Crowther, MA (corresponding author), St Josephs Hosp, Room L208,50 Charlton Ave E, Hamilton, ON L8N 4A6, Canada.							ALHENCGELAS M, 1995, BLOOD COAGUL FIBRIN, V6, P35, DOI 10.1097/00001721-199502000-00006; ANDERSON DR, 1992, HAEMOSTASIS, V22, P124; Bauters A, 1996, BLOOD COAGUL FIBRIN, V7, P705, DOI 10.1097/00001721-199610000-00008; BENTAL O, 1989, THROMB HAEMOSTASIS, V61, P50; BICK RL, 1992, HEMATOL ONCOL CLIN N, V6, P1421, DOI 10.1016/S0889-8588(18)30284-3; Borgel D, 1997, THROMB HAEMOSTASIS, V78, P351; Bucciarelli P, 1999, ARTERIOSCL THROM VAS, V19, P1026, DOI 10.1161/01.ATV.19.4.1026; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Cattaneo M, 1999, THROMB HAEMOSTASIS, V81, P165; COMP PC, 1984, NEW ENGL J MED, V311, P1525, DOI 10.1056/NEJM198412133112401; COMP PC, 1984, J CLIN INVEST, V74, P2082, DOI 10.1172/JCI111632; CONLAN MG, 1988, AM J HEMATOL, V29, P226, DOI 10.1002/ajh.2830290410; Crowther MA, 2001, THROMB HAEMOSTASIS, V85, P390; DAHLBACK B, 1994, P NATL ACAD SCI USA, V91, P1396, DOI 10.1073/pnas.91.4.1396; De Stefano V, 1999, NEW ENGL J MED, V341, P801, DOI 10.1056/NEJM199909093411104; De Stefano V, 2001, BRIT J HAEMATOL, V113, P630, DOI 10.1046/j.1365-2141.2001.02827.x; Dulicek P, 2000, CLIN APPL THROMB-HEM, V6, P87, DOI 10.1177/107602960000600207; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; Eichinger S, 1997, THROMB HAEMOSTASIS, V77, P624; Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578; GLADSON CL, 1988, THROMB HAEMOSTASIS, V59, P18; GOYETTE P, 1995, AM J HUM GENET, V56, P1052; GRIFFIN JH, 1981, J CLIN INVEST, V68, P1370, DOI 10.1172/JCI110385; Han X, 2000, BLOOD, V96, P3049; HOLMER E, 1981, BIOCHEM J, V193, P395, DOI 10.1042/bj1930395; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; KALAFATIS M, 1995, J BIOL CHEM, V270, P4053, DOI 10.1074/jbc.270.8.4053; Kluijtmans LAJ, 1998, BLOOD, V91, P2015, DOI 10.1182/blood.V91.6.2015.2015_2015_2018; Kluijtmans LAJ, 1996, AM J HUM GENET, V58, P35; Kraaijenhagen RA, 2000, THROMB HAEMOSTASIS, V83, P5; Lane DA, 1997, THROMB HAEMOSTASIS, V77, P197; Lee DH, 1996, CAN MED ASSOC J, V155, P285; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; LIND B, 1995, THROMB HAEMOSTASIS, V73, P186; Lowe GDO, 1999, THROMB HAEMOSTASIS, V81, P879; Ma J, 1996, CIRCULATION, V94, P2410, DOI 10.1161/01.CIR.94.10.2410; Madonna P, 2001, THROMB RES, V101, P317, DOI 10.1016/S0049-3848(00)00416-3; MAHASANDANA C, 1990, LANCET, V335, P61, DOI 10.1016/0140-6736(90)90201-F; MAHASANDANA C, 1990, J PEDIATR-US, V117, P750, DOI 10.1016/S0022-3476(05)83335-9; Manucci PM, 2000, VOX SANG, V78, P39; MARLAR RA, 1990, SEMIN THROMB HEMOST, V16, P299, DOI 10.1055/s-2007-1002683; Martinelli I, 1998, BLOOD, V92, P2353, DOI 10.1182/blood.V92.7.2353.2353_2353_2358; Mateo J, 1997, THROMB HAEMOSTASIS, V77, P444; McColl MD, 1999, BRIT J OBSTET GYNAEC, V106, P756, DOI 10.1111/j.1471-0528.1999.tb08395.x; Meijers JCM, 2000, NEW ENGL J MED, V342, P696, DOI 10.1056/NEJM200003093421004; Monagle P, 1998, THROMB HAEMOSTASIS, V79, P756, DOI 10.1055/s-0037-1615060; Morange PE, 2000, ARTERIOSCL THROM VAS, V20, P1387, DOI 10.1161/01.ATV.20.5.1387; MUDD SH, 1985, AM J HUM GENET, V37, P1; Nowak-Gottl U, 2002, BLOOD, V99, P3476, DOI 10.1182/blood-2002-01-0100; PABINGER I, 1992, BLOOD COAGUL FIBRIN, V3, P547, DOI 10.1097/00001721-199210000-00005; PESCATORE P, 1993, THROMB HAEMOSTASIS, V69, P311; Poort SR, 1996, BLOOD, V88, P3698, DOI 10.1182/blood.V88.10.3698.bloodjournal88103698; PRINS MH, 1991, ARCH INTERN MED, V151, P1721, DOI 10.1001/archinte.151.9.1721; Ray JG, 1998, ARCH INTERN MED, V158, P2101, DOI 10.1001/archinte.158.19.2101; REITSMA PH, 1995, THROMB HAEMOSTASIS, V73, P876; REITSMA PH, 2001, HEMOSTASIS THROMBOSI, P60; RIDKER PM, 1992, CIRCULATION, V85, P1822, DOI 10.1161/01.CIR.85.5.1822; RIDKER PM, 1995, NEW ENGL J MED, V332, P912, DOI 10.1056/NEJM199504063321403; Ridker PM, 1999, CIRCULATION, V99, P999, DOI 10.1161/01.CIR.99.8.999; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; Rodeghiero F, 1999, ANN INTERN MED, V130, P643, DOI 10.7326/0003-4819-130-8-199904200-00004; Rosenberg RD, 2001, THROMBOSIS HEMOSTASI, P711; Rosendaal FR, 1998, THROMB HAEMOSTASIS, V79, P706; Sakata T, 2000, SEMIN THROMB HEMOST, V26, P11, DOI 10.1055/s-2000-9796; Salomon O, 1999, ARTERIOSCL THROM VAS, V19, P511, DOI 10.1161/01.ATV.19.3.511; Schambeck CM, 2001, ARTERIOSCL THROM VAS, V21, P289, DOI 10.1161/01.ATV.21.2.289; TAIT RC, 1995, THROMB HAEMOSTASIS, V73, P87; TAIT RC, 1994, BRIT J HAEMATOL, V87, P106, DOI 10.1111/j.1365-2141.1994.tb04878.x; van Guldener C, 2000, SEMIN THROMB HEMOST, V26, P281, DOI 10.1055/s-2000-8472; van Tilburg NH, 2000, BLOOD, V95, P2855, DOI 10.1182/blood.V95.9.2855.009k02_2855_2859; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Villa P, 1999, THROMB HAEMOSTASIS, V82, P1011, DOI 10.1055/s-0037-1614320; VIRCHOW R, 1856, MED FRANKFURT GERMAN, P216; Vlieg AV, 2000, BLOOD, V95, P3678; WELLS PS, 1994, AM J HEMATOL, V45, P321, DOI 10.1002/ajh.2830450409; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596	76	187	196	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					128	134		10.7326/0003-4819-138-2-200301210-00014	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529095				2022-12-28	WOS:000181018300007
J	Buekens, P; Curtis, S; Alayon, S				Buekens, P; Curtis, S; Alayon, S			Demographic and Health Surveys: caesarean section rates in sub-Saharan Africa	BRITISH MEDICAL JOURNAL			English	Article									Univ N Carolina, Dept Maternal & Child Hlth, Sch Publ Hlth, Chapel Hill, NC 27599 USA; ORC Macro Int, Beltsville, MD 20705 USA	University of North Carolina; University of North Carolina Chapel Hill	Buekens, P (corresponding author), Univ N Carolina, Dept Maternal & Child Hlth, Sch Publ Hlth, Rosenau Hall,CB 7445, Chapel Hill, NC 27599 USA.							Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; BUEKENS P, 2001, SAFE MOTHERHOOD STRA, P195; De Brouwere V, 2002, LANCET, V359, P974, DOI 10.1016/S0140-6736(02)07993-X; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; *MEASURE DHS PLUS, DEM HLTH SURV PROV I	5	30	31	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					136	136		10.1136/bmj.326.7381.136	http://dx.doi.org/10.1136/bmj.326.7381.136			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531845	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000180575900024
J	Mann, D				Mann, D			On patterned ground	SCIENCE			English	Editorial Material									Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99708 USA	University of Alaska System; University of Alaska Fairbanks	Mann, D (corresponding author), Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99708 USA.							ANDERSON SP, 1988, GEOL SOC AM BULL, V100, P609, DOI 10.1130/0016-7606(1988)100<0609:TUPEWA>2.3.CO;2; BUDEL J, 1977, KLIMAGEOMORPHOLOGIE; HALLET B, 1990, CAN J PHYS, V68, P842, DOI 10.1139/p90-122; HALLET B, 1986, QUATERNARY RES, V26, P81, DOI 10.1016/0033-5894(86)90085-2; Kessler MA, 2003, SCIENCE, V299, P380, DOI 10.1126/science.1077309; NANSEN F, 1922, SPITZBERGEN; Nicolis G, 1977, SELF ORG NONEQUILIBR; Nordenskjold O., 1909, POLARWELT; Plug LJ, 2002, NATURE, V417, P929, DOI 10.1038/nature00796; Taber S, 1929, J GEOL, V37, P428, DOI 10.1086/623637; WASHBURN AL, 1956, GEOL SOC AM BULL, V67, P823, DOI 10.1130/0016-7606(1956)67[823:COPGAR]2.0.CO;2; WASHBURN AL, 1980, GEOCRYOLOGY; WASHBURN AL, 1997, PLUGS PLUG CIRCLES B; WERNER BT, 1993, SCIENCE, V260, P968, DOI 10.1126/science.260.5110.968; WERNER BT, 1995, GEOLOGY, V23, P1107, DOI 10.1130/0091-7613(1995)023<1107:EDCSAA>2.3.CO;2; WERNER BT, 1993, NATURE, V361, P142, DOI 10.1038/361142a0; WILCOCK PR, 2002, GEOPHYSICAL MONOGRAP, V135	17	12	12	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					354	355		10.1126/science.1080301	http://dx.doi.org/10.1126/science.1080301			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532004				2022-12-28	WOS:000180426800031
J	Leung, DYM; Bieber, T				Leung, DYM; Bieber, T			Atopic dermatitis	LANCET			English	Review							STAPHYLOCOCCAL-ENTEROTOXIN-B; RANDOMIZED CONTROLLED TRIAL; T-CELLS; CHEMOKINE PRODUCTION; ENHANCED EXPRESSION; TOPICAL TACROLIMUS; PERIPHERAL-BLOOD; ALLERGIC DISEASE; GENE-EXPRESSION; LESIONAL SKIN	Atopic dermatitis is a highly pruritic chronic inflammatory skin disorder affecting 10-20% of children worldwide. Symptoms can persist or begin in adulthood. It is also the most common cause of occupational skin disease in adults. This disease results from an interaction between susceptibility genes, the host's environment, pharmacological abnormalities, skin barrier defects, and immunological factors. New management approaches have evolved from advances in our understanding of the pathobiology of this common skin disorder.	Natl Jewish Med & Res Ctr, Div Pediat Allergy & Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pediat, Denver, CO 80262 USA; Univ Bonn, Dept Dermatol, D-5300 Bonn, Germany	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Bonn	Leung, DYM (corresponding author), Natl Jewish Med & Res Ctr, Div Pediat Allergy & Immunol, 1400 Jackson St,Room K926, Denver, CO 80206 USA.	leungd@njc.org						Allen A, 2001, ARCH DERMATOL, V137, P747; Ambach A, 2001, J ALLERGY CLIN IMMUN, V107, P878, DOI 10.1067/mai.2001.114240; Arkwright PD, 2001, J ALLERGY CLIN IMMUN, V108, P281, DOI 10.1067/mai.2001.117259; Beck Lisa A., 2000, Journal of Allergy and Clinical Immunology, V106, pS258; Bieber T, 2002, ATOPIC DERMATITIS; Boguniewicz M, 2001, J ALLERGY CLIN IMMUN, V108, P651, DOI 10.1067/mai.2001.118598; BRATTON DL, 1995, J CLIN INVEST, V95, P211, DOI 10.1172/JCI117642; Breuer K, 2000, ALLERGY, V55, P551, DOI 10.1034/j.1398-9995.2000.00432.x; Bunikowski R, 2000, J ALLERGY CLIN IMMUN, V105, P814, DOI 10.1067/mai.2000.105528; Cho SH, 2001, J ALLERGY CLIN IMMUN, V108, P269, DOI 10.1067/mai.2001.117455; Cho SH, 2001, J INVEST DERMATOL, V116, P658, DOI 10.1046/j.0022-202x.2001.01331.x; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Cox HE, 1998, BRIT J DERMATOL, V138, P182; Eichenfield LF, 2002, J AM ACAD DERMATOL, V46, P495, DOI 10.1067/mjd.2002.122187; Estelle F, 2001, J ALLERGY CLIN IMMUN, V107, P703, DOI 10.1067/mai.2001.113866; Forrest S, 1999, J ALLERGY CLIN IMMUN, V104, P1066, DOI 10.1016/S0091-6749(99)70090-4; Galli G, 2000, EUR J IMMUNOL, V30, P204, DOI 10.1002/1521-4141(200001)30:1<204::AID-IMMU204>3.0.CO;2-G; Giustizieri ML, 2001, J ALLERGY CLIN IMMUN, V107, P871, DOI 10.1067/mai.2001.114707; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Grundmann-Kollman M, 2001, ARCH DERMATOL, V137, P870; Hamid Q, 1996, J ALLERGY CLIN IMMUN, V98, P225, DOI 10.1016/S0091-6749(96)70246-4; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; Hanifin JM, 1996, J INVEST DERMATOL, V107, P51, DOI 10.1111/1523-1747.ep12297888; HANIFIN JM, 1993, J AM ACAD DERMATOL, V28, P189, DOI 10.1016/0190-9622(93)70026-P; Hauk PJ, 2000, J ALLERGY CLIN IMMUN, V105, P782, DOI 10.1067/mai.2000.105807; Higashi N, 2001, J ALLERGY CLIN IMMUN, V108, P607, DOI 10.1067/mai.2001.118601; Hoare C, 2000, Health Technol Assess, V4, P1; Hofer MF, 1999, J INVEST DERMATOL, V112, P171, DOI 10.1046/j.1523-1747.1999.00492.x; Holm L, 2001, ALLERGY, V56, P152, DOI 10.1034/j.1398-9995.2001.056002152.x; Imokawa G, 2001, J AM ACAD DERMATOL, V45, pS29, DOI 10.1067/mjd.2001.117020; Jirapongsananuruk O, 1998, J IMMUNOL, V160, P4622; Johansson SGO, 2001, ALLERGY, V56, P813, DOI 10.1034/j.1398-9995.2001.t01-1-00001.x; Jolles S, 2002, CLIN EXP DERMATOL, V27, P3, DOI 10.1046/j.0307-6938.2001.00955.x; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Kang S, 2001, J AM ACAD DERMATOL, V44, pS58, DOI 10.1067/mjd.2001.109812; Kapp A, 2002, J ALLERGY CLIN IMMUN, V110, P277, DOI 10.1067/mai.2002.126500; Kawashima T, 1998, J MED GENET, V35, P502, DOI 10.1136/jmg.35.6.502; Keane FM, 1999, BRIT MED J, V318, P563, DOI 10.1136/bmj.318.7183.563; Keller P, 1924, ARCH DERMATOL SYPH-G, V148, P82, DOI 10.1007/BF01827500; Kinaciyan T, 2002, J ALLERGY CLIN IMMUN, V109, P717, DOI 10.1067/mai.2002.123303; Koo J, 1998, ARCH DERMATOL, V134, P1388, DOI 10.1001/archderm.134.11.1388; Krutmann J, 1998, J AM ACAD DERMATOL, V38, P589, DOI 10.1016/S0190-9622(98)70123-9; Laberge S, 1998, J ALLERGY CLIN IMMUN, V102, P645, DOI 10.1016/S0091-6749(98)70282-9; Langeveld-Wildschut EG, 2000, J ALLERGY CLIN IMMUN, V105, P1008, DOI 10.1067/mai.2000.106544; Larsen FS, 2002, IMMUNOL ALLERGY CLIN, V22, P1, DOI 10.1016/S0889-8561(03)00066-3; Lee YA, 2000, NAT GENET, V26, P470, DOI 10.1038/82625; Leung DYM, 2000, J ALLERGY CLIN IMMUN, V105, P860, DOI 10.1067/mai.2000.106484; LEUNG DYM, 1983, J ALLERGY CLIN IMMUN, V71, P47, DOI 10.1016/0091-6749(83)90546-8; LEUNG DYM, 1993, J CLIN INVEST, V92, P1374, DOI 10.1172/JCI116711; Lever R, 1998, PEDIATR ALLERGY IMMU, V9, P13, DOI 10.1111/j.1399-3038.1998.tb00294.x; LEYDEN JJ, 1977, BRIT J DERMATOL, V96, P179, DOI 10.1111/j.1365-2133.1977.tb12541.x; Li XM, 2001, J ALLERGY CLIN IMMUN, V107, P693, DOI 10.1067/mai.2001.114110; Luger T, 2001, BRIT J DERMATOL, V144, P788, DOI 10.1046/j.1365-2133.2001.04134.x; MIHM MC, 1976, J INVEST DERMATOL, V67, P305, DOI 10.1111/1523-1747.ep12514346; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Nakatani T, 2001, J ALLERGY CLIN IMMUN, V107, P353, DOI 10.1067/mai.2001.112601; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; NILSSON EJ, 1992, J AM ACAD DERMATOL, V27, P29, DOI 10.1016/0190-9622(92)70151-5; Novak N, 2001, CURR OPIN IMMUNOL, V13, P721, DOI 10.1016/S0952-7915(01)00285-0; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Paller A, 2001, J AM ACAD DERMATOL, V44, pS47, DOI 10.1067/mjd.2001.109813; Reich K, 2002, J ALLERGY CLIN IMMUN, V109, P681, DOI 10.1067/mai.2002.122234; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P547, DOI 10.1067/mai.2002.121832; Reitamo S, 2002, J ALLERGY CLIN IMMUN, V109, P539, DOI 10.1067/mai.2002.121831; Remitz A, 2001, J ALLERGY CLIN IMMUN, V107, P196, DOI 10.1067/mai.2001.112131; Reynolds NJ, 2001, LANCET, V357, P2012, DOI 10.1016/S0140-6736(00)05114-X; Romagnani S, 2000, J ALLERGY CLIN IMMUN, V105, P399, DOI 10.1067/mai.2000.104575; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; SAURAT JH, 1985, ACTA DERM-VENEREOL, P125; Scalabrin DMF, 1999, J ALLERGY CLIN IMMUN, V104, P1273, DOI 10.1016/S0091-6749(99)70024-2; Schafer T, 2000, BRIT J DERMATOL, V143, P992, DOI 10.1046/j.1365-2133.2000.03832.x; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V107, P171, DOI 10.1067/mai.2001.111850; Schmid-Ott G, 2001, J ALLERGY CLIN IMMUN, V108, P455, DOI 10.1067/mai.2001.117800; Skov L, 2000, J ALLERGY CLIN IMMUN, V105, P820, DOI 10.1067/mai.2000.105524; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; SOWDEN JM, 1991, LANCET, V338, P137, DOI 10.1016/0140-6736(91)90134-B; Spergel JM, 1998, J CLIN INVEST, V101, P1614, DOI 10.1172/JCI1647; Strickland I, 1999, J INVEST DERMATOL, V112, P249, DOI 10.1046/j.1523-1747.1999.00502.x; Taha RA, 2000, J ALLERGY CLIN IMMUN, V105, P1002, DOI 10.1067/mai.2000.106483; Tan BB, 1996, LANCET, V347, P15, DOI 10.1016/S0140-6736(96)91556-1; TAYLOR B, 1984, LANCET, V2, P1255, DOI 10.1016/S0140-6736(84)92805-8; Trautmann A, 2001, J ALLERGY CLIN IMMUN, V108, P839, DOI 10.1067/mai.2001.118796; Tupker RA, 1996, J ALLERGY CLIN IMMUN, V97, P1064, DOI 10.1016/S0091-6749(96)70259-2; Valenta R, 2000, J ALLERGY CLIN IMMUN, V105, P432, DOI 10.1067/mai.2000.104783; Valenta R, 1998, J INVEST DERMATOL, V111, P1178, DOI 10.1046/j.1523-1747.1998.00413.x; Van der Meer JB, 1999, BRIT J DERMATOL, V140, P1114; van Reijsen FC, 1998, J ALLERGY CLIN IMMUN, V101, P207, DOI 10.1016/S0091-6749(98)70410-5; VANREIJSEN FC, 1992, J ALLERGY CLIN IMMUN, V90, P184, DOI 10.1016/0091-6749(92)90070-I; von Bubnoff D, 2001, J ALLERGY CLIN IMMUN, V108, P329, DOI 10.1067/mai.2001.117457; von Mutius E, 2000, J ALLERGY CLIN IMMUN, V105, P9, DOI 10.1016/S0091-6749(00)90171-4; WHEATLEY LM, 2000, ALLERGIC SKIN DIS MU, P423; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; Williams HC, 1999, ARCH DERMATOL, V135, P583, DOI 10.1001/archderm.135.5.583; Wollenberg A, 1996, J INVEST DERMATOL, V106, P446, DOI 10.1111/1523-1747.ep12343596; Wollenberg A, 2001, J ALLERGY CLIN IMMUN, V107, P519, DOI 10.1067/mai.2001.112942; Woodmansee DP, 2001, J ALLERGY CLIN IMMUN, V108, P309, DOI 10.1067/mai.2001.116986; Woodward AL, 2001, J ALLERGY CLIN IMMUN, V107, P359, DOI 10.1067/mai.2001.112695; Yawalkar N, 1999, J INVEST DERMATOL, V113, P43, DOI 10.1046/j.1523-1747.1999.00619.x; Zargari A, 2001, ACTA DERM-VENEREOL, V81, P418, DOI 10.1080/000155501317208363; Zuberbier T, 2001, J ALLERGY CLIN IMMUN, V108, P275, DOI 10.1067/mai.2001.116865	100	1037	1096	4	131	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					151	160		10.1016/S0140-6736(03)12193-9	http://dx.doi.org/10.1016/S0140-6736(03)12193-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531593				2022-12-28	WOS:000180428000024
J	Stewart, PS				Stewart, PS			New ways to stop biofilm infections	LANCET			English	Editorial Material							PSEUDOMONAS-AERUGINOSA; ACETYLATION		Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Stewart, PS (corresponding author), Montana State Univ, Ctr Biofilm Engn, Bozeman, MT 59717 USA.			Stewart, Philip/0000-0001-7773-8570				Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87; Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001; Recht J, 2001, J BACTERIOL, V183, P5718, DOI 10.1128/JB.183.19.5718-5724.2001; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; YASUDA H, 1993, ANTIMICROB AGENTS CH, V37, P1749, DOI 10.1128/AAC.37.9.1749	9	33	37	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					97	97		10.1016/S0140-6736(03)12245-3	http://dx.doi.org/10.1016/S0140-6736(03)12245-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531571	Green Submitted			2022-12-28	WOS:000180428000003
J	Jogl, G; Tong, L				Jogl, G; Tong, L			Crystal structure of carnitine acetyltransferase and implications for the catalytic mechanism and fatty acid transport	CELL			English	Article							TRANSITION-STATE STABILIZATION; SITE-DIRECTED MUTAGENESIS; CHLORAMPHENICOL ACETYLTRANSFERASE; ANOMALOUS DIFFRACTION; PALMITOYLTRANSFERASE; MACROMOLECULES; CLONING; BINDING; SYSTEM; MODELS	Carnitine acyltransferases have crucial roles in the transport of fatty acids for beta-oxidation. Dysregulation of these enzymes can lead to serious diseases in humans, and they are targets for therapeutic development against diabetes. We report the crystal structures of murine carnitine acetyltransferase (CRAT), alone and in complex with its substrate carnitine or CoA. The structure contains two domains. Surprisingly, these two domains share the same backbone fold, which is also similar to that of chloramphenicol acetyltransferase and dihydrolipoyl transacetylase. The active site is located at the interface between the two domains. Carnitine and CoA are bound in deep channels in the enzyme, on opposite sides of the catalytic His343 residue. The structural information provides a molecular basis for understanding the catalysis by carnitine acyltransferases and for designing their inhibitors. Specifically, our structural information suggests that the substrate carnitine may assist the catalysis by stabilizing the oxyanion in the reaction intermediate.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Tong, L (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.		Jogl, Gerwald/AAJ-5783-2021	Jogl, Gerwald/0000-0002-5465-5315; Tong, Liang/0000-0002-0563-6468				Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Anderson RC, 1998, CURR PHARM DESIGN, V4, P1; BIEBER LL, 1988, ANNU REV BIOCHEM, V57, P261, DOI 10.1146/annurev.bi.57.070188.001401; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunner S, 1997, BIOCHEM J, V322, P403, DOI 10.1042/bj3220403; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; COLUCCI WJ, 1986, J AM CHEM SOC, V108, P7141, DOI 10.1021/ja00283a001; Cronin CN, 1997, BIOCHEM BIOPH RES CO, V238, P784, DOI 10.1006/bbrc.1997.7390; Cronin CN, 1997, EUR J BIOCHEM, V247, P1029, DOI 10.1111/j.1432-1033.1997.01029.x; Dall'Acqua W, 2000, PROTEIN SCI, V9, P1; DIMAURO S, 1973, SCIENCE, V182, P929, DOI 10.1126/science.182.4115.929; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Giannessi F, 2001, J MED CHEM, V44, P2383, DOI 10.1021/jm010889+; HENDLE J, 1995, BIOCHEMISTRY-US, V34, P4287, DOI 10.1021/bi00013a018; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Jogl G, 2001, ACTA CRYSTALLOGR D, V57, P1127, DOI 10.1107/S0907444901006783; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kerner J, 2000, BBA-MOL CELL BIOL L, V1486, P1, DOI 10.1016/S1388-1981(00)00044-5; LESLIE AGW, 1988, P NATL ACAD SCI USA, V85, P4133, DOI 10.1073/pnas.85.12.4133; LEWENDON A, 1990, BIOCHEMISTRY-US, V29, P2075, DOI 10.1021/bi00460a016; Lian W, 2002, ACTA CRYSTALLOGR D, V58, P1193, DOI 10.1107/S0907444902005498; MATTEVI A, 1992, SCIENCE, V255, P1544, DOI 10.1126/science.1549782; MATTEVI A, 1993, BIOCHEMISTRY-US, V32, P3887, DOI 10.1021/bi00066a007; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramsay RR, 2001, BBA-PROTEIN STRUCT M, V1546, P21, DOI 10.1016/S0167-4838(01)00147-9; SAEED A, 1993, ARCH BIOCHEM BIOPHYS, V305, P307, DOI 10.1006/abbi.1993.1427; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wagman AS, 2001, CURR PHARM DESIGN, V7, P417, DOI 10.2174/1381612013397915; Weeks CM, 1999, J APPL CRYSTALLOGR, V32, P120, DOI 10.1107/S0021889898010504	34	105	110	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					113	122		10.1016/S0092-8674(02)01228-X	http://dx.doi.org/10.1016/S0092-8674(02)01228-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526798	Bronze			2022-12-28	WOS:000181191500011
J	Gerard, C				Gerard, C			Complement C5a in the sepsis syndrome - too much of a good thing?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp, Div Pulm, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Gerard, C (corresponding author), Childrens Hosp, Div Pulm, Enders Bldg,Rm 144,300 Longwood Ave, Boston, MA 02115 USA.							Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; STEVENS JH, 1986, J CLIN INVEST, V77, P1812, DOI 10.1172/JCI112506	5	66	74	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					167	169		10.1056/NEJMcibr022995	http://dx.doi.org/10.1056/NEJMcibr022995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519929				2022-12-28	WOS:000180263900011
J	Bluestone, K				Bluestone, K			Strengthening WHO's position should be a priority for the new Director-General	LANCET			English	Article																			0	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					2	2		10.1016/S0140-6736(03)12172-1	http://dx.doi.org/10.1016/S0140-6736(03)12172-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521031				2022-12-28	WOS:000180191600002
J	Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R				Martinez, LO; Jacquet, S; Esteve, JP; Rolland, C; Cabezon, E; Champagne, E; Pineau, T; Georgeaud, V; Walker, JE; Terce, F; Collet, X; Perret, B; Barbaras, R			Ectopic beta-chain of ATP synthase is an apolipoprotein A-I receptor in hepatic HDL endocytosis	NATURE			English	Article							DENSITY-LIPOPROTEIN HDL; HIGH-AFFINITY BINDING; SCAVENGER RECEPTOR; CHOLESTEROL EFFLUX; BOVINE F-1-ATPASE; INHIBITOR PROTEIN; SR-BI; SURFACE; SUBUNIT; SITES	The effect of high-density lipoprotein (HDL) in protecting against atherosclerosis is usually attributed to its role in 'reverse cholesterol transport'(1). In this process, HDL particles mediate the efflux and the transport of cholesterol from peripheral cells to the liver for further metabolism and bile excretion. Thus, cell-surface receptors for HDL on hepatocytes are chief partners in the regulation of cholesterol homeostasis(2). A high-affinity HDL receptor for apolipoprotein A-I (apoA-I) was previously identified on the surface of hepatocytes(3,4). Here we show that this receptor is identical to the beta-chain of ATP synthase, a principal protein complex of the mitochondrial inner membrane. Different experimental approaches confirm this ectopic localization of components of the ATP synthase complex and the presence of ATP hydrolase activity at the hepatocyte cell surface. Receptor stimulation by apoA-I triggers the endocytosis of holo-HDL particles (protein plus lipid) by a mechanism that depends strictly on the generation of ADP. We confirm this effect on endocytosis in perfused rat liver ex vivo by using a specific inhibitor of ATP synthase. Thus, membrane-bound ATP synthase has a previously unsuspected role in modulating the concentrations of extracellular ADP and is regulated by a principal plasma apolipoprotein.	Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France; Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Immunol Mol & Biol Lymphocyte T, F-31059 Toulouse, France; Hop Rangueil, IFR 31, INSERM,U531, Inst Federatif REch Louis Bugnard, F-31403 Toulouse, France; MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England; INRA, Lab Pharmacol & Toxicol, F-31931 Toulouse 9, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; INRAE	Barbaras, R (corresponding author), Inst Federatif Rech Claude de Preval, IFR 30, INSERM,U563, Dept Lipoprot & Med Lipid, F-31059 Toulouse, France.	Ronald.Barbaras@toulouse.inserm.fr	Cabezon, Elena/K-5874-2014; Martinez, Laurent O./ABD-6880-2020; Collet, Xavier/M-6938-2017; Tercé, François/M-5863-2018; Martinez, Laurent O/B-8343-2015; Eckhardt, Erik/G-1567-2010; Champagne, Eric/M-1543-2014	Martinez, Laurent O./0000-0002-0985-3152; Tercé, François/0000-0003-4488-2167; Martinez, Laurent O/0000-0002-0985-3152; Champagne, Eric/0000-0002-8852-0734; Cabezon, Elena/0000-0002-6177-5016; Walker, John/0000-0001-7929-2162; Bertrand, PERRET/0000-0001-7568-445X				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; BARBARAS R, 1994, BIOCHEMISTRY-US, V33, P2335, DOI 10.1021/bi00174a047; BARRANS A, 1994, J BIOL CHEM, V269, P11572; BEISIEGEL U, 1988, ARTERIOSCLEROSIS, V8, P288, DOI 10.1161/01.ATV.8.3.288; Bortnick AE, 2000, J BIOL CHEM, V275, P28634, DOI 10.1074/jbc.M003407200; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Burgess JW, 2002, J BIOL CHEM, V277, P31318, DOI 10.1074/jbc.M204200200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2001, EMBO J, V20, P6990, DOI 10.1093/emboj/20.24.6990; Chang SY, 2002, J BIOL CHEM, V277, P8388, DOI 10.1074/jbc.M108792200; DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273; Ferrini JB, 1997, CHEM-BIOL INTERACT, V107, P31, DOI 10.1016/S0009-2797(97)00072-0; Fidge NH, 1999, J LIPID RES, V40, P187; Fitzgerald ML, 2002, J BIOL CHEM, V277, P33178, DOI 10.1074/jbc.M204996200; Guendouzi K, 1998, BIOCHEMISTRY-US, V37, P14974, DOI 10.1021/bi9810508; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; MAHLEY RW, 1989, ARTERIOSCLEROSIS, V9, pI14; Martinez LO, 2000, BIOCHEMISTRY-US, V39, P1076, DOI 10.1021/bi991971y; Moser TL, 2001, P NATL ACAD SCI USA, V98, P6656, DOI 10.1073/pnas.131067798; Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811; Schippers IJ, 1997, CELL BIOL TOXICOL, V13, P375, DOI 10.1023/A:1007404028681; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; SULTAN C, 1990, BIOCHEM J, V269, P831, DOI 10.1042/bj2690831; Sviridov D, 2002, ATHEROSCLEROSIS, V161, P245, DOI 10.1016/S0021-9150(01)00677-3; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Wang N, 2001, J BIOL CHEM, V276, P23742, DOI 10.1074/jbc.M102348200; WILLIAMS N, 1984, ANAL BIOCHEM, V140, P581, DOI 10.1016/0003-2697(84)90210-0	29	370	400	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					75	79		10.1038/nature01250	http://dx.doi.org/10.1038/nature01250			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511957				2022-12-28	WOS:000180165500040
J	Gordon-Lubitz, RJ				Gordon-Lubitz, RJ			Risk communication: Problems of presentation and understanding	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Gordon-Lubitz, RJ (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.							Benichou J, 1996, J CLIN ONCOL, V14, P103, DOI 10.1200/JCO.1996.14.1.103; Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1037, DOI 10.1001/jama.281.11.1037; Edwards A, 2000, MED DECIS MAKING, V20, P290, DOI 10.1177/0272989X0002000305; Edwards A, 2001, QUAL HEALTH CARE, V10, pI9; Hallowell N, 1997, J Genet Couns, V6, P269, DOI 10.1023/A:1025624221369; Lipkus I M, 1999, J Natl Cancer Inst Monogr, P149; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; Rothman Alexander J., 1999, Journal of the National Cancer Institute Monographs, P44; Schwartz LM, 1997, ANN INTERN MED, V127, P966, DOI 10.7326/0003-4819-127-11-199712010-00003; SHILOH S, 1989, PSYCHOL HEALTH, V3, P45, DOI DOI 10.1080/08870448908400365	10	24	24	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 1	2003	289	1					95	95		10.1001/jama.289.1.95	http://dx.doi.org/10.1001/jama.289.1.95			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630XL	12503988	Bronze			2022-12-28	WOS:000180136600036
J	de Quadros, CA; Epstein, D				de Quadros, CA; Epstein, D			Health as a bridge for peace: PAHO's experience	LANCET			English	Article									Pan Amer Hlth Org, Div Vaccines & Immunizat, Washington, DC 20037 USA; Pan Amer Hlth Org, Off Publ Informat, Washington, DC 20037 USA	Pan American Health Organization; Pan American Health Organization	de Quadros, CA (corresponding author), Pan Amer Hlth Org, Div Vaccines & Immunizat, 525 23rd St NW, Washington, DC 20037 USA.								0	11	11	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S25	S26		10.1016/S0140-6736(02)11808-3	http://dx.doi.org/10.1016/S0140-6736(02)11808-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504491				2022-12-28	WOS:000180064500012
J	Greene, MF				Greene, MF			Magnesium sulfate for preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ECLAMPSIA		Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Greene, MF (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.							DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; HUTTON JD, 1992, BRIT J OBSTET GYNAEC, V99, P554, DOI 10.1111/j.1471-0528.1992.tb13819.x; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401	4	20	20	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					275	276		10.1056/NEJMp020166	http://dx.doi.org/10.1056/NEJMp020166			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540639				2022-12-28	WOS:000180507200001
J	Lynskey, MT; Heath, AC; Bucholz, KK; Slutske, WS; Madden, PAF; Nelson, EC; Statham, DJ; Martin, NG				Lynskey, MT; Heath, AC; Bucholz, KK; Slutske, WS; Madden, PAF; Nelson, EC; Statham, DJ; Martin, NG			Escalation of drug use in early-onset cannabis users vs co-twin controls	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBSTANCE USE; ADOLESCENCE; PATTERNS; DEPENDENCE; HEROIN; ABUSE; DELTA(9)-TETRAHYDROCANNABINOL; PROGRESSION; INVOLVEMENT; INITIATION	Context Previous studies have reported that early initiation of cannabis (marijuana) use is a significant risk factor for other drug use and drug-related problems. Objective To examine whether the association between early cannabis use and subsequent progression to use of other drugs and drug abuse/dependence persists after controlling for genetic and shared environmental influences. Design Cross-sectional survey conducted in 1996-2000 among an Australian national volunteer sample of 311 young adult (median age, 30 years) monozygotic and dizygotic same-sex twin pairs discordant for early cannabis use (before age 17 years). Main Outcome Measures Self-reported subsequent nonmedical use of prescription sedatives, hallucinogens, cocaine/other stimulants, and opioids; abuse or dependence on these drugs (including cannabis abuse/dependence); and alcohol dependence. Results Individuals who used cannabis by age 17 years had odds of other drug use, alcohol dependence, and drug abuse/dependence that were 2.1 to 5.2 times higher than those of their co-twin, who did not use cannabis before age 17 years. Controlling for known risk factors (early-onset alcohol or tobacco use, parental conflict/separation, childhood sexual abuse, conduct disorder, major depression, and social anxiety) had only negligible effects on these results. These associations did not differ significantly between monozygotic and dizygotic twins. Conclusions Associations between early cannabis use and later drug use and abuse/dependence cannot solely be explained by common predisposing genetic or shared environmental factors. The association may arise from the effects of the peer and social context within which cannabis is used and obtained. In particular, early access to and use of cannabis may reduce perceived barriers against the use of other illegal drugs and provide access to these drugs.	Washington Univ, Sch Med, Dept Psychiat, Missouri Alcoholism Res Ctr, St Louis, MO 63108 USA; Queensland Inst Med Res, Brisbane, Qld 4006, Australia; Washington Univ, Dept Psychol, St Louis, MO 63108 USA	Washington University (WUSTL); QIMR Berghofer Medical Research Institute; Washington University (WUSTL)	Lynskey, MT (corresponding author), Washington Univ, Sch Med, Dept Psychiat, Missouri Alcoholism Res Ctr, 40 N Kingshighway,Suite 1, St Louis, MO 63108 USA.	mlynskey@matlock.wustl.edu	Lynskey, Michael T/A-3181-2008; Lynskey, michael T/B-9179-2016	Martin, Nicholas/0000-0003-4069-8020; Statham, Dixie/0000-0002-8721-2369	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA007728, P50AA011998, R01AA007728, P60AA011998, R01AA010249, R01AA012640, R01AA009022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA014363, R01DA014632, K21DA000272, R01DA012854] Funding Source: NIH RePORTER; NIAAA NIH HHS [AA00277, AA 12640, AA07728, AA09022, AA11998, AA10249] Funding Source: Medline; NIDA NIH HHS [DA 14363, DA 14632, DA00272, DA12854] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; *AUSTR I HLTH WELF, 1999, 1998 NAT DRUG STRAT; Bachman JG, 1998, AM J PUBLIC HEALTH, V88, P887, DOI 10.2105/AJPH.88.6.887; BAUMRIND D, 1983, J PERS SOC PSYCHOL, V45, P1289, DOI 10.1037/0022-3514.45.6.1289; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; Cadoni C, 2001, PSYCHOPHARMACOLOGY, V158, P259, DOI 10.1007/s002130100875; CEDERLOEF R, 1961, ACTA GENET STAT MED, V11, P338; CHEN K, 1995, AM J PUBLIC HEALTH, V85, P41, DOI 10.2105/AJPH.85.1.41; COHEN H, 1972, INT J ADDICT, V7, P27, DOI 10.3109/10826087209026759; ELLICKSON PL, 1992, J ABNORM PSYCHOL, V101, P441, DOI 10.1037/0021-843X.101.3.441; FERGUSSON DM, 1993, NEW ZEAL MED J, V106, P247; Fergusson DM, 2000, ADDICTION, V95, P505, DOI 10.1046/j.1360-0443.2000.9545053.x; Fergusson DM, 1997, ADDICTION, V92, P279; GRAHAM JW, 1991, J CONSULT CLIN PSYCH, V59, P48, DOI 10.1037/0022-006X.59.1.48; Grant BF, 1998, J SUBST ABUSE, V10, P163, DOI 10.1016/S0899-3289(99)80131-X; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; Heath A C, 2001, Twin Res, V4, P73, DOI 10.1375/1369052012182; KANDEL D, 1975, ARCH GEN PSYCHIAT, V32, P923; KANDEL D, 1975, SCIENCE, V190, P912, DOI 10.1126/science.1188374; KANDEL DB, 1992, J STUD ALCOHOL, V53, P447, DOI 10.15288/jsa.1992.53.447; KASRIEL J, 1976, J BIOSOC SCI, V8, P263, DOI 10.1017/S0021932000010737; Kendler KS, 2000, ARCH GEN PSYCHIAT, V57, P261, DOI 10.1001/archpsyc.57.3.261; Kendler KS, 2002, PSYCHOL MED, V32, P551, DOI 10.1017/S0033291701004950; Kosterman R, 2000, AM J PUBLIC HEALTH, V90, P360, DOI 10.2105/AJPH.90.3.360; Lamarque S, 2001, NEUROPHARMACOLOGY, V41, P118, DOI 10.1016/S0028-3908(01)00039-9; Lynskey MT, 2002, PSYCHOL MED, V32, P195, DOI 10.1017/S0033291701005062; MacCoun R, 2001, BRIT J PSYCHIAT, V178, P123, DOI 10.1192/bjp.178.2.123; MACCOUN R, 1998, FAS DRUG POLICY ANAL; McLellan AT, 2000, JAMA-J AM MED ASSOC, V284, P1689, DOI 10.1001/jama.284.13.1689; NAHAS GG, 1990, KEEP OFF GRASS; Nelson EC, 2002, ARCH GEN PSYCHIAT, V59, P139, DOI 10.1001/archpsyc.59.2.139; NICHOLS RC, 1966, ACTA GENET STAT MED, V16, P265; Reid A, 2000, AUST NZ J PUBL HEAL, V24, P596, DOI 10.1111/j.1467-842X.2000.tb00523.x; SARNA S, 1978, HUM HERED, V28, P241, DOI 10.1159/000152964; SAS, 1996, SAS STAT SOFTW CHANG; SOLWIJ N, 2002, JAMA-J AM MED ASSOC, V287, P1123; *STAT, 1999, STAT STAT SOFTW REL; *SUBST AB MENT HLH, 2002, DASIS REP MAR TREATM; *SUBST AB MENT HLT, 2002, DASIS REP TREATM REF; Tanda G, 1997, SCIENCE, V276, P2048, DOI 10.1126/science.276.5321.2048; Tsuang MT, 1998, ARCH GEN PSYCHIAT, V55, P967, DOI 10.1001/archpsyc.55.11.967; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P673, DOI 10.2105/AJPH.74.7.673	42	450	460	0	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					427	433		10.1001/jama.289.4.427	http://dx.doi.org/10.1001/jama.289.4.427			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533121	Bronze			2022-12-28	WOS:000180472300023
J	Volkman, SK; Hartl, DL				Volkman, SK; Hartl, DL			A game of cat and mouth	SCIENCE			English	Editorial Material									Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Volkman, SK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.							Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035	2	9	9	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					353	354		10.1126/science.1081278	http://dx.doi.org/10.1126/science.1081278			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532003				2022-12-28	WOS:000180426800030
J	Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J				Kamath, RS; Fraser, AG; Dong, Y; Poulin, G; Durbin, R; Gotta, M; Kanapin, A; Le Bot, N; Moreno, S; Sohrmann, M; Welchman, DP; Zipperlen, P; Ahringer, J			Systematic functional analysis of the Caenorhabditis elegans genome using RNAi	NATURE			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; GENE-EXPRESSION; C-ELEGANS; INTERFERENCE; SEQUENCE; DATABASE; GERMLINE; DOMAINS; SIRNAS	A principal challenge currently facing biologists is how to connect the complete DNA sequence of an organism to its development and behaviour. Large-scale targeted-deletions have been successful in defining gene functions in the single-celled yeast Saccharomyces cerevisiae, but comparable analyses have yet to be performed in an animal. Here we describe the use of RNA interference to inhibit the function of similar to86% of the 19,427 predicted genes of C. elegans. We identified mutant phenotypes for 1,722 genes, about two-thirds of which were not previously associated with a phenotype. We find that genes of similar functions are clustered in distinct, multi-megabase regions of individual chromosomes; genes in these regions tend to share transcriptional profiles. Our resulting data set and reusable RNAi library of 16,757 bacterial clones will facilitate systematic analyses of the connections among gene sequence, chromosomal location and gene function in C. elegans.	Univ Cambridge, Wellcome Trust Canc Res UK Inst, Cambridge CB2 1QR, England; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; EMBL, European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Salamanca, CSIC, Ctr Invest Canc, Salamanca 37007, Spain	University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Ahringer, J (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	jaa@mole.bio.cam.ac.uk	Kanapin, Alexander/E-7632-2013; Durbin, Richard/AAE-7178-2019; Moreno, Sergio/K-3671-2014; Kanapin, Alexander A/Q-7590-2016	Durbin, Richard/0000-0002-9130-1006; Moreno, Sergio/0000-0002-8039-1413; Kanapin, Alexander A/0000-0001-9802-5297; Poulin, Gino/0000-0003-1016-348X; Fraser, Andrew/0000-0001-9939-6014; Le Bot, Nathalie/0000-0002-5258-2837; Ahringer, Julie/0000-0002-7074-4051	Wellcome Trust [054523] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Apweiler R, 2001, NUCLEIC ACIDS RES, V29, P37, DOI 10.1093/nar/29.1.37; BARNES TM, 1995, GENETICS, V141, P159; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46; Elbashir SM, 2002, METHODS, V26, P199, DOI 10.1016/S1046-2023(02)00023-3; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kruglyak S, 2000, TRENDS GENET, V16, P109, DOI 10.1016/S0168-9525(99)01941-1; Kuwabara PE, 1999, CURR TOP DEV BIOL, V41, P99; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Mewes HW, 2000, NUCLEIC ACIDS RES, V28, P37, DOI 10.1093/nar/28.1.37; Miyagishi M, 2002, NAT BIOTECHNOL, V20, P497, DOI 10.1038/nbt0502-497; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Piano F, 2000, CURR BIOL, V10, P1619, DOI 10.1016/S0960-9822(00)00869-1; PRYER NK, 1993, J CELL BIOL, V120, P865, DOI 10.1083/jcb.120.4.865; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Roy PJ, 2002, NATURE, V418, P975, DOI 10.1038/nature01012; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; SPELLMAN PT, 2002, J BIOL, V1; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	40	2551	3034	9	266	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					231	237		10.1038/nature01278	http://dx.doi.org/10.1038/nature01278			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529635				2022-12-28	WOS:000180397600038
J	Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK				Rosenstiel, TN; Potosnak, MJ; Griffin, KL; Fall, R; Monson, RK			Increased CO2 uncouples growth from isoprene emission in an agriforest ecosystem	NATURE			English	Article							BIOGENIC HYDROCARBONS; ATMOSPHERIC CO2; PLANTS; IMPACT; PATHWAY; LEAVES; OZONE; OAK	The emission of isoprene from the leaves of forest trees is a fundamental component of biosphere-atmosphere interactions, controlling many aspects of photochemistry in the lower atmosphere(1-3). As almost all commercial agriforest species emit high levels of isoprene(4), proliferation of agriforest plantations has significant potential to increase regional ozone pollution(5-7) and enhance the lifetime of methane(8), an important determinant of global climate. Here we show that growth of an intact Populus deltoides plantation under increased CO2 (800 mumol mol(-1) and 1,200 mumol mol(-1)) reduced ecosystem isoprene production by 21% and 41%, while above-ground biomass accumulation was enhanced by 60% and 82%, respectively. Exposure to increased CO2 significantly reduced the cellular content of dimethylallyl diphosphate, the substrate for isoprene synthesis, in both leaves and leaf protoplasts. We identify intracellular metabolic competition for phosphoenolpyruvate as a possible control point in explaining the suppression of isoprene emission under increased CO2. Our results highlight the potential for uncoupling isoprene emission from biomass accumulation in an agriforest species, and show that negative air-quality effects of proliferating agriforests may be offset by increases in CO2.	Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA; Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Columbia University	Rosenstiel, TN (corresponding author), Univ Colorado, Dept Environm Populat & Organism Biol, Boulder, CO 80309 USA.		Griffin, Kevin L./B-2629-2013; TATSUTA, HARUKI/F-2997-2010; Griffin, Kevin Lee/GWZ-4828-2022	Griffin, Kevin L./0000-0003-4124-3757; 				BROWN S, 1996, CLIMATE CHANGE 1995, P776; CHAMEIDES WL, 1988, SCIENCE, V241, P1473, DOI 10.1126/science.3420404; Chollet R, 1996, ANNU REV PLANT PHYS, V47, P273, DOI 10.1146/annurev.arplant.47.1.273; Crutzen PJ, 1999, TELLUS A, V51, P123, DOI 10.1034/j.1600-0870.1999.t01-1-00010.x; EDWARDS GE, 1978, ARCH BIOCHEM BIOPHYS, V190, P421, DOI 10.1016/0003-9861(78)90295-3; *FAO, 1995, FAO FOR SER, V30; Fehsenfeld F, 1992, GLOBAL BIOGEOCHEM CY, V6, P389, DOI 10.1029/92GB02125; Fenning TM, 2002, TRENDS BIOTECHNOL, V20, P291, DOI 10.1016/S0167-7799(02)01983-2; Fuentes JD, 2000, B AM METEOROL SOC, V81, P1537, DOI 10.1175/1520-0477(2000)081<1537:BHITAB>2.3.CO;2; Gielen B, 2001, ENVIRON POLLUT, V115, P335, DOI 10.1016/S0269-7491(01)00226-3; Griffin KL, 2002, GLOBAL CHANGE BIOL, V8, P479, DOI 10.1046/j.1365-2486.2002.00487.x; Griffin KL, 2001, P NATL ACAD SCI USA, V98, P2473, DOI 10.1073/pnas.041620898; Harley P, 1997, TREE PHYSIOL, V17, P705; Harley PC, 1999, OECOLOGIA, V118, P109, DOI 10.1007/s004420050709; JENKINS CLD, 1989, PLANT PHYSIOL, V91, P1356, DOI 10.1104/pp.91.4.1356; Karl T, 2002, PLANTA, V215, P894, DOI 10.1007/s00425-002-0825-2; Lerdau M, 2002, TRENDS ECOL EVOL, V17, P309, DOI 10.1016/S0169-5347(02)02535-1; Lichtenthaler HK, 1999, ANNU REV PLANT PHYS, V50, P47, DOI 10.1146/annurev.arplant.50.1.47; MAGIN NC, 1997, PLANT PHYSIOL, V115, P1681; MARINO BDV, 1999, BIOSPHERE 2 RES PRES; Monson RK, 2001, ANNU REV ECOL SYST, V32, P547, DOI 10.1146/annurev.ecolsys.32.081501.114136; MULLER JF, 1992, J GEOPHYS RES-ATMOS, V97, P3787, DOI 10.1029/91JD02757; Pierce T, 1998, J GEOPHYS RES-ATMOS, V103, P25611, DOI 10.1029/98JD01804; Poisson N, 2000, J ATMOS CHEM, V36, P157, DOI 10.1023/A:1006300616544; Rosenstiel TN, 2002, PLANT PHYSIOL, V129, P1276, DOI 10.1104/pp.002717; SANADZE GA, 1990, SOV PLANT PHYSIOL+, V37, P1; Sharkey TD, 2001, ANNU REV PLANT PHYS, V52, P407, DOI 10.1146/annurev.arplant.52.1.407; SHARKEY TD, 1991, PLANT CELL ENVIRON, V14, P333, DOI 10.1111/j.1365-3040.1991.tb01509.x; TRAINER M, 1987, NATURE, V329, P705, DOI 10.1038/329705a0; Wang XZ, 2001, P NATL ACAD SCI USA, V98, P2479, DOI 10.1073/pnas.051622998	30	245	250	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					256	259		10.1038/nature01312	http://dx.doi.org/10.1038/nature01312			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529640				2022-12-28	WOS:000180397600044
J	Bayat, A; McGrouther, DA; Ferguson, MWJ				Bayat, A; McGrouther, DA; Ferguson, MWJ			Skin scarring	BRITISH MEDICAL JOURNAL			English	Review							HYPERTROPHIC SCARS; KELOID SCARS; EXCISION; BETA; CARE		Wythenshawe Hosp, S Manchester Univ Hosp Trust, Dept Plast & Reconstruct Surg, Manchester M23 9LT, Lancs, England; Univ Manchester, Sch Biol Sci, Div Cells Immunol & Dev, Manchester M13 9PT, Lancs, England	Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester	Bayat, A (corresponding author), Wythenshawe Hosp, S Manchester Univ Hosp Trust, Dept Plast & Reconstruct Surg, Manchester M23 9LT, Lancs, England.			BAYAT, ARDESHIR/0000-0002-4116-6491	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adant JP, 1998, ACTA CHIR BELG, V98, P5; ALSTER TS, 1995, LANCET, V345, P1198, DOI 10.1016/S0140-6736(95)91989-9; Ashcroft GS, 1998, LAB INVEST, V78, P47; Beausang E, 1998, PLAST RECONSTR SURG, V102, P1954, DOI 10.1097/00006534-199811000-00022; Bell L, 1988, J Burn Care Rehabil, V9, P305; BORDER WA, 1995, NAT MED, V1, P1000, DOI 10.1038/nm1095-1000; Brockes JP, 2001, J ANAT, V199, P3; Broker BJ, 1996, LARYNGOSCOPE, V106, P1497, DOI 10.1097/00005537-199612000-00010; Clavere P, 1997, DERMATOLOGY, V195, P349, DOI 10.1159/000245986; DARZI MA, 1992, BRIT J PLAST SURG, V45, P374, DOI 10.1016/0007-1226(92)90008-L; DORFMULLER M, 1995, UNFALLCHIRURG, V98, P213; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Espana A, 2001, DERMATOL SURG, V27, P23; Ferguson M W J, 2002, Br Dent J, V192, P475, DOI 10.1038/sj.bdj.4801404a; Ferguson MWJ, 1996, PLAST RECONSTR SURG, V97, P854, DOI 10.1097/00006534-199604000-00029; Hirsch RJ, 2001, SEMIN CUTAN MED SURG, V20, P190, DOI 10.1053/sder.2001.27557; Jordan RB, 2000, CLIN PLAST SURG, V27, P71; MCGROUTHER DA, 1994, EYE, V8, P200, DOI 10.1038/eye.1994.46; MUIR IFK, 1990, BRIT J PLAST SURG, V43, P61, DOI 10.1016/0007-1226(90)90046-3; MURRAY JC, 1981, J AM ACAD DERMATOL, V4, P461, DOI 10.1016/S0190-9622(81)70048-3; Mustoe TA, 2002, PLAST RECONSTR SURG, V110, P560, DOI 10.1097/00006534-200208000-00031; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; OKane S, 1997, INT J BIOCHEM CELL B, V29, P63, DOI 10.1016/S1357-2725(96)00120-3; PEACOCK EE, 1970, SOUTHERN MED J, V63, P755, DOI 10.1097/00007611-197007000-00002; Powers PS, 1999, J BURN CARE REHABIL, V20, P54, DOI 10.1097/00004630-199901001-00011; Robert R, 1999, BURNS, V25, P581, DOI 10.1016/S0305-4179(99)00065-0; RUDOLPH R, 1987, CLIN PLAST SURG, V14, P253; SOMMERLAD BC, 1978, BRIT J PLAST SURG, V31, P34, DOI 10.1016/0007-1226(78)90012-7; Sund B, 2000, NEW DEV WOUND CARE, P1; Taal L, 1998, BURNS, V24, P399, DOI 10.1016/S0305-4179(98)00053-9; Tsao SS, 2002, SEMIN CUTAN MED SURG, V21, P46, DOI 10.1016/S1085-5629(02)80719-2; Uppal RS, 2001, PLAST RECONSTR SURG, V108, P1218, DOI 10.1097/00006534-200110000-00018; Urioste SS, 1999, SEMIN CUTAN MED SURG, V18, P159, DOI 10.1016/S1085-5629(99)80040-6; VANDENHELDER CJM, 1994, AESTHET PLAST SURG, V18, P307, DOI 10.1007/BF00449800; Woo SH, 2001, PLAST RECONSTR SURG, V107, P1, DOI 10.1097/00006534-200101000-00001; Zouboulis CC, 2002, WOUND REPAIR REGEN, V10, P98, DOI 10.1046/j.1524-475X.2002.02111.x	36	419	441	2	47	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2003	326	7380					88	92		10.1136/bmj.326.7380.88	http://dx.doi.org/10.1136/bmj.326.7380.88			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YC	12521975	Green Published			2022-12-28	WOS:000180426900019
J	Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T				Inoue, A; Saijo, Y; Maemondo, M; Gomi, K; Tokue, Y; Kimura, Y; Ebina, M; Kikuchi, T; Moriya, T; Nukiwa, T			Severe acute interstitial pneumonia and gefitinib	LANCET			English	Article								Gefitinib is an oral selective inhibitor of the epidermal growth factor receptor tyrosine kinase that is an effective treatment for patients with advanced non-small cell lung cancer who do not respond to platinum-based chemotherapy. We assessed four patients who had non-small cell lung cancer causing severe acute interstitial pneumonia in association with gefitinib. Although two patients recovered after treatment with steroids, the other two died from progressive respiratory dysfunction. On the basis of autopsies and bilateral distribution of diffuse ground-glass opacities In chest CTs, we diagnosed diffuse alveolar damage, which was consistent with acute interstitial pneumonia. Patients with interstitial pneumonia also had other pulmonary disorders such as previous thoracic irradiation and poor performance status. Physicians should be aware of the alveolar damage induced by gefitinib, especially for patients with these characteristic features.	Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Mol Med & Gene Transfer Res, Aoba Ku, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, Sendai, Miyagi 9808575, Japan	Tohoku University; Tohoku University; Tohoku University	Inoue, A (corresponding author), Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Aoba Ku, Sendai, Miyagi 9808575, Japan.	akinoue@idac.tohoku.ac.jp	Moriya, Takuya/AAM-6974-2020					FUKUOKA M, 2002, P AN M AM SOC CLIN, V22, pA298; Giaccone G, 2002, ANN ONCOL, V13, P217, DOI 10.1093/annonc/mdf663; Kris MG, 2002, P AN M AM SOC CLIN, V21, p292a; *PMDEC, 2002, REV GEF; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081	5	348	361	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					137	139		10.1016/S0140-6736(03)12190-3	http://dx.doi.org/10.1016/S0140-6736(03)12190-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531582				2022-12-28	WOS:000180428000014
J	Sanders, D; Chopra, M				Sanders, D; Chopra, M			Two key issues for the new WHO leadership	LANCET			English	Article							HEALTH		Univ Western Cape, Sch Publ Hlth, ZA-7535 Bellville, South Africa	University of the Western Cape	Sanders, D (corresponding author), Univ Western Cape, Sch Publ Hlth, Private Bag X17, ZA-7535 Bellville, South Africa.							Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; GILSON L, 1995, HEALTH POLICY, V32, P215, DOI 10.1016/0168-8510(95)00737-D; LABONTE R, IN PRESS HLTH GLOBAL; SANDERS D, IN PRESS GLOBAL PUBL; TARIMO E, 1994, 7 SHS WHO; *UN DEV PROGR, 2001, HUM DEV REP 2001; Unicef, PROGR WORLD SUMM CHI; Varkevisser CM, 2001, HEALTH POLICY PLANN, V16, P281, DOI 10.1093/heapol/16.3.281; Yach D, 1998, AM J PUBLIC HEALTH, V88, P735, DOI 10.2105/AJPH.88.5.735	9	2	2	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					172	173		10.1016/S0140-6736(03)12198-8	http://dx.doi.org/10.1016/S0140-6736(03)12198-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	635YP	12531598				2022-12-28	WOS:000180428000029
J	Pedersen, K; Zavialov, AV; Pavlov, MY; Elf, J; Gerdes, K; Ehrenberg, M				Pedersen, K; Zavialov, AV; Pavlov, MY; Elf, J; Gerdes, K; Ehrenberg, M			The bacterial toxin RelE displays codon-specific cleavage of rnRNAs in the ribosomal A site	CELL			English	Article							PROGRAMMED CELL-DEATH; ESCHERICHIA-COLI; FACTOR RF3; INACTIVATING PROTEINS; NUTRITIONAL STRESS; TRANSLATION; RNA; DEGRADATION; SYSTEM; RECOGNITION	The Escherichia coli reIBE operon encodes a toxin-antitoxin pair, ReIE-ReIB. ReIB can reverse inhibition of protein synthesis by ReIE in vivo. We have found that although ReIE does not degrade free RNA, it cleaves mRNA in the ribosomal A site with high codon specificity. Among stop codons UAG is cleaved with fast, UAA intermediate and UGA slow rate, while UCG and CAG are cleaved most rapidly among sense codons. We suggest that inhibition of protein synthesis by ReIE is reversed with the help of tmRNA, and that ReIE plays a regulatory role in bacteria during adaptation to poor growth conditions.	Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Univ So Denmark, OU, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	Uppsala University; University of Southern Denmark	Ehrenberg, M (corresponding author), Uppsala Univ, BMC, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.		Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Zavialov, Andrey/0000-0001-6420-0368; elf, johan/0000-0001-5522-1810				BECH FW, 1985, EMBO J, V4, P1059, DOI 10.1002/j.1460-2075.1985.tb03739.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLOCK R, 1975, J BIOL CHEM, V250, P1212; BRUNSCHEDE H, 1971, J MOL BIOL, V37, P35; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; DIDERICHSEN B, 1977, J BACTERIOL, V131, P30, DOI 10.1128/JB.131.1.30-33.1977; DIDERICHSEN B, 1980, MOL GEN GENET, V180, P429, DOI 10.1007/BF00425859; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FIIL NP, 1977, MOL GEN GENET, V150, P87, DOI 10.1007/BF02425329; Freistroffer DV, 2000, P NATL ACAD SCI USA, V97, P2046, DOI 10.1073/pnas.030541097; Freistroffer DV, 1997, EMBO J, V16, P4126, DOI 10.1093/emboj/16.13.4126; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gillet R, 2001, MOL MICROBIOL, V42, P879, DOI 10.1046/j.1365-2958.2001.02701.x; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Gottesman S, 2001, SCIENCE, V293, P614, DOI 10.1126/science.1063371; GUZMAN P, 1989, GENETICS, V121, P401; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Hazan R, 2001, J BACTERIOL, V183, P2046, DOI 10.1128/JB.183.6.2046-2050.2001; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JENSEN RB, 1995, MOL MICROBIOL, V17, P205, DOI 10.1111/j.1365-2958.1995.mmi_17020205.x; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; LAVALLE R, 1965, B SOC CHIM BIOL, V47, P1567; LAVALLE R, 1976, A BENZON S, P408; MONRO RE, 1969, COLD SPRING HARB SYM, V34, P357, DOI 10.1101/SQB.1969.034.01.042; MOSTELLER RD, 1978, J BACTERIOL, V133, P1034, DOI 10.1128/JB.133.2.1034-1037.1978; Nielsen K, 2001, ANNU REV PLANT PHYS, V52, P785, DOI 10.1146/annurev.arplant.52.1.785; OFARRELL PH, 1978, CELL, V14, P545, DOI 10.1016/0092-8674(78)90241-6; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Pavlov MY, 1997, EMBO J, V16, P4134, DOI 10.1093/emboj/16.13.4134; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Peumans WJ, 2001, FASEB J, V15, P1493, DOI 10.1096/fj.00-0751rev; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; Soelaiman S, 2001, MOL CELL, V8, P1053, DOI 10.1016/S1097-2765(01)00396-3; SOMERVILLE CR, 1979, MOL GEN GENET, V169, P315, DOI 10.1007/BF00382277; WOOL IG, 1992, TRENDS BIOCHEM SCI, V17, P266, DOI 10.1016/0968-0004(92)90407-Z; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	43	431	444	1	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					131	140		10.1016/S0092-8674(02)01248-5	http://dx.doi.org/10.1016/S0092-8674(02)01248-5			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526800	Bronze			2022-12-28	WOS:000181191500013
J	Fine, LG; Keogh, BE; Cretin, S; Orlando, M; Gould, MM				Fine, LG; Keogh, BE; Cretin, S; Orlando, M; Gould, MM		Nuffield-Rand Cardiac Surg Demonst	How to evaluate and improve the quality and credibility of an outcomes database: validation and feedback study on the UK Cardiac Surgery Experience	BRITISH MEDICAL JOURNAL			English	Article							RISK	Objectives To assess the quality and completeness of a database of clinical outcomes after cardiac surgery and to determine whether a process of validation, monitoring, and feedback could improve the quality of the database. Design Stratified sampling of retrospective data followed by prospective re-sampling of database after intervention of monitoring, validation, and feedback. Setting Ten tertiary care cardiac surgery centres in the United Kingdom. Intervention Validation of data derived from a stratified sample of case notes (recording of deaths cross checked with mortuary records), monitoring of completeness and accuracy of data entry, feedback to local data managers and lead surgeons. Main outcome measures Average percentage missing data, average kappa coefficient, and reliability score by centre for 17 variables required for assignment of risk scores. Actual minus risk adjusted mortality in each centre. Results The database was incomplete, with a mean (SE) of 24.96% (0.091%) of essential data elements missing, whereas only 1.18% (0.06%) were missing in the patient records (P < 0.0001). Intervention was associated with (a) significantly less missing data (9.33% (0.08%) P < 0.0001); (b) marginal improvement in reliability of data and mean (SE) overall centre reliability score (0.53.(0.15) v 0.44 (0.17)); and (c) improved accuracy of assigned Parsonnet risk scores (kappa 0.84 v 0.70). Mortality scores (actual minus risk adjusted mortality) for all participating centres fell within two standard deviations of the mean score. Conclusion A short period of independent validation, monitoring, and feedback improved the quality of an outcomes database and improved the process of risk adjustment, but with substantial room for further improvement. Wider application of this approach should increase the credibility of similar databases before their public release.	UCL, Royal Free & Univ Coll Med Sch, Dept Med, London WC1E 6JJ, England; Queen Elizabeth Hosp, Dept Cardiothorac Surg, Birmingham B15 2TH, W Midlands, England; RAND Hlth, Santa Monica, CA 90407 USA	University of London; University College London; University of Birmingham; RAND Corporation	Fine, LG (corresponding author), UCL, Royal Free & Univ Coll Med Sch, Dept Med, London WC1E 6JJ, England.	l.fine@ucl.ac.uk						*BRIST ROYAL INF I, INQ MAN CAR CHILDR R; Keogh B., 1999, NATL ADULT CARDIAC S; KEOGH B, 2002, TIMES           1119; Keogh B, 2002, NATL ADULT CARDIAC S; Keogh BE, 1998, BMJ-BRIT MED J, V316, P1759, DOI 10.1136/bmj.316.7147.1759; Marshall MN, 2000, DYING KNOW PUBLIC RE; PARSONNET V, 1989, CIRCULATION, V79, P3; Roques F, 1999, EUR J CARDIO-THORAC, V15, P816, DOI 10.1016/S1010-7940(99)00106-2; *SOC CARD SURG GRE, NAT CARD SURG DAT MI	9	48	50	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					25	28		10.1136/bmj.326.7379.25	http://dx.doi.org/10.1136/bmj.326.7379.25			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511458	Green Published, Bronze			2022-12-28	WOS:000180302000022
J	Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E				Sutcliffe, SJ; Fox, KF; Wood, DA; Sutcliffe, A; Stock, K; Wright, M; Akhras, F; Langford, E			Incidence of coronary heart disease in a health authority in London: review of a community register	BRITISH MEDICAL JOURNAL			English	Article							ANGINA-PECTORIS; PROGNOSIS		Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England; Bromley Hosp, Bromley Hosp NHS Trust, London BR2 9AQ, England	Imperial College London	Wood, DA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Charing Cross Hosp, Natl Heart & Lung Inst, Cardiovasc Res Grp, London W6 8RF, England.							*DEP HLTH, 1999, SAV LIV OUR HLTH NAT; *DEP HLTH, 2000, NAT SERV FRAM COR HE; GANDHI MM, 1995, BRIT HEART J, V73, P193; KANNEL WB, 1972, AM J CARDIOL, V29, P154, DOI 10.1016/0002-9149(72)90624-8; Wood D, 1998, HEART, V80, pS1	5	19	19	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					20	20		10.1136/bmj.326.7379.20	http://dx.doi.org/10.1136/bmj.326.7379.20			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633UP	12511455	Bronze, Green Published			2022-12-28	WOS:000180302000019
J	Wang, YY; Ono, S; Onose, Y; Gu, G; Ando, Y; Tokura, Y; Uchida, S; Ong, NP				Wang, YY; Ono, S; Onose, Y; Gu, G; Ando, Y; Tokura, Y; Uchida, S; Ong, NP			Dependence of upper critical field and pairing strength on doping in cuprates	SCIENCE			English	Article							TRANSPORT-PROPERTIES; MAGNETIC-FIELD; VORTEX CORES; TEMPERATURE; STATE; LINES; TC	We have determined the upper critical field H-c2 as a function of hole concentration in bismuth-based cuprates by measuring the voltage induced by vortex flow in a driving temperature gradient (the Nernst effect), in magnetic fields up to 45 tesla. We found that H-c2 decreased steeply as doping increased, in both single and bilayer cuprates. This relationship implies that the Cooper pairing potential displays a trend opposite to that of the superfluid density versus doping. The coherence length of the pairs xi(0) closely tracks the gap measured by photoemission. We discuss implications for understanding the doping dependence of the critical temperature T-c0.	Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Elect Power Ind, Cent Res Inst, Tokyo 2018511, Japan; Japan Sci & Technol, Spin Superstruct Project, Tsukuba, Ibaraki 3058562, Japan; Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Univ Tokyo, Sch Frontier Sci, Tokyo 1138656, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Princeton University; Central Research Institute of Electric Power Industry - Japan; Japan Science & Technology Agency (JST); United States Department of Energy (DOE); Brookhaven National Laboratory; University of Tokyo; University of Tokyo	Ong, NP (corresponding author), Princeton Univ, Dept Phys, Princeton, NJ 08544 USA.	npo@princeton.edu	Ong, N. Phuan/Z-1626-2019; Onose, Yoshinori/F-1977-2010; Tokura, Yoshinori/C-7352-2009; Ando, Yoichi/B-8163-2013; Ono, Shimpei/D-2918-2017	Onose, Yoshinori/0000-0002-8398-2956; Tokura, Yoshinori/0000-0002-2732-4983; Ando, Yoichi/0000-0002-3553-3355; Ando, Yukio/0000-0001-7115-9105; Ono, Shimpei/0000-0003-1514-8879; Ong, N. Phuan/0000-0001-7166-1058				Ando Y, 1999, PHYS REV B, V60, P12475, DOI 10.1103/PhysRevB.60.12475; Bonn DA, 1996, CZECH J PHYS, V46, P3195, DOI 10.1007/BF02548130; Capan C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.056601; Ding H, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.227001; Fournier P, 1997, PHYS REV B, V56, P14149, DOI 10.1103/PhysRevB.56.14149; Gollnik F, 1998, PHYS REV B, V58, P11734, DOI 10.1103/PhysRevB.58.11734; Hoffman JE, 2002, SCIENCE, V295, P466, DOI 10.1126/science.1066974; KOTLIAR G, 1988, PHYS REV B, V38, P5142, DOI 10.1103/PhysRevB.38.5142; MACKENZIE AP, 1993, PHYS REV LETT, V71, P1238, DOI 10.1103/PhysRevLett.71.1238; Nguyen AK, 1998, PHYS REV B, V57, P3123, DOI 10.1103/PhysRevB.57.3123; OSOFSKY MS, 1993, PHYS REV LETT, V71, P2315, DOI 10.1103/PhysRevLett.71.2315; Pan SH, 2000, PHYS REV LETT, V85, P1536, DOI 10.1103/PhysRevLett.85.1536; Shibauchi T, 2001, PHYS REV LETT, V86, P5763, DOI 10.1103/PhysRevLett.86.5763; TESANOVIC Z, 1995, PHYS REV B, V51, P16204, DOI 10.1103/PhysRevB.51.16204; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; VIDAL F, 1973, PHYS REV B, V8, P1982, DOI 10.1103/PhysRevB.8.1982; Wang YY, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.257003; Wang YY, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.224519; Xu ZA, 2000, NATURE, V406, P486, DOI 10.1038/35020016	22	167	171	2	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					86	89		10.1126/science.1078422	http://dx.doi.org/10.1126/science.1078422			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511645				2022-12-28	WOS:000180165800037
J	Gizon, L; Duvall, TL; Schou, J				Gizon, L; Duvall, TL; Schou, J			Wave-like properties of solar supergranulation	NATURE			English	Article							TIME-DISTANCE HELIOSEISMOLOGY; COMPRESSIBLE CONVECTION; MAGNETIC FEATURES; ROTATION; EVOLUTION; FIELDS; MODES; FLOWS	Supergranulation(1,2) on the surface of the Sun is a pattern of horizontal outflows, outlined by a network of small magnetic features, with a distinct scale of 30 million metres and an apparent lifetime of one day. It is generally believed that supergranulation corresponds to a preferred 'cellular' scale of thermal convection; rising magnetic fields are dragged by the outflows and concentrated into 'ropes' at the 'cell' boundaries(3). But as the convection zone is highly turbulent and stratified, numerical modelling has proved to be difficult and the dynamics remain poorly understood. Moreover, there is as yet no explanation for the observation that the pattern appears(4,5) to rotate faster around the Sun than the magnetic features. Here we report observations showing that supergranulation undergoes oscillations and supports waves with periods of 6-9 days. The waves are predominantly prograde, which explains the apparent super-rotation of the pattern. The rotation of the plasma through which the pattern propagates is consistent with the motion of the magnetic network.	Stanford Univ, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; NASA, Goddard Space Flight Ctr, Astron & Solar Phys Lab, Greenbelt, MD 20771 USA	Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Gizon, L (corresponding author), Stanford Univ, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.		Gizon, Laurent/B-9457-2008; Duvall, Thomas L/C-9998-2012	Gizon, Laurent/0000-0001-7696-8665; 				Beck JG, 2000, SOL PHYS, V193, P333, DOI 10.1023/A:1005258123855; BECK JG, 1997, LARGE SCALE SOLAR VE; Brummell NH, 1996, ASTROPHYS J, V473, P494, DOI 10.1086/178161; Duvall TL, 2000, SOL PHYS, V192, P177, DOI 10.1023/A:1005239503637; DUVALL TL, 1980, SOL PHYS, V66, P213, DOI 10.1007/BF00150578; DUVALL TL, 1993, NATURE, V362, P430, DOI 10.1038/362430a0; GALLOWAY DJ, 1981, ASTROPHYS J, V243, P945, DOI 10.1086/158659; Hurlburt NE, 1996, ASTROPHYS J, V457, P933, DOI 10.1086/176786; KOMM RW, 1993, SOL PHYS, V147, P207, DOI 10.1007/BF00690713; KOMM RW, 1993, SOL PHYS, V145, P1, DOI 10.1007/BF00627979; LEIGHTON RB, 1962, ASTROPHYS J, V135, P474, DOI 10.1086/147285; Miesch MS, 2000, ASTROPHYS J, V532, P593, DOI 10.1086/308555; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; Schou J, 1998, ASTROPHYS J, V504, pL131, DOI 10.1086/311575; SIMON GW, 1964, ASTROPHYS J, V140, P1120, DOI 10.1086/148010; SNODGRASS HB, 1990, ASTROPHYS J, V351, P309, DOI 10.1086/168467; WALDEN RW, 1985, PHYS REV LETT, V55, P496, DOI 10.1103/PhysRevLett.55.496; ZHONG F, 1991, PHYS REV LETT, V67, P2473, DOI 10.1103/PhysRevLett.67.2473	18	91	91	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					43	44		10.1038/nature01287	http://dx.doi.org/10.1038/nature01287			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511947				2022-12-28	WOS:000180165500030
J	Rojas-Marcos, I; Gorriz, M; Santafosta, E; Coll, S; de Miquel, MA; Serrallonga, M; Avila, J				Rojas-Marcos, I; Gorriz, M; Santafosta, E; Coll, S; de Miquel, MA; Serrallonga, M; Avila, J			Cerebellar oedema and sideroblastic anaemia	LANCET			English	Article									Bellvitge Hosp, Serv Neurol, Barcelona 08907, Spain; CSU Bellvitge, Hosp Duran & Reynals, Inst Diagnost Image, Neuroradiol Sect, Barcelona 08907, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Duran i Reynals	Rojas-Marcos, I (corresponding author), Bellvitge Hosp, Serv Neurol, Barcelona 08907, Spain.		Serrallonga-Mercader, Marta/W-9612-2018	Serrallonga-Mercader, Marta/0000-0002-3296-2912; Rojas-Marcos, Inigo/0000-0003-4142-4283				BIEMOND A, 1939, ACTA PAEDIATR SCAND, V27, P51; BRUIN GW, 1994, HDB CLIN NEUROLOGY 1, V20, P431; Mani J, 1998, J NEUROL NEUROSUR PS, V65, P797, DOI 10.1136/jnnp.65.5.797; PAPAS CL, 1986, SURG NEUROL, V26, P391; VIADER F, 1985, ANN MED INTERNE, V136, P401	5	2	2	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2046	2046		10.1016/S0140-6736(02)12026-5	http://dx.doi.org/10.1016/S0140-6736(02)12026-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504402				2022-12-28	WOS:000179974200014
J	Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J				Heilig, R; Eckenberg, R; Petit, JL; Fonknechten, NR; Da Silva, C; Cattolico, L; Levy, M; Barbe, V; de Berardinis, V; Ureta-Vidal, A; Pelletier, E; Vico, V; Anthouard, V; Rowen, L; Madan, A; Qin, SZ; Sun, H; Du, H; Pepin, K; Artiguenave, F; Robert, C; Cruaud, C; Bruls, T; Jaillon, O; Friedlander, L; Samson, G; Brottier, P; Cure, S; Segurens, B; Aniere, F; Samain, S; Crespeau, H; Abbasi, N; Alach, N; Boscus, D; Dickhoff, R; Dors, M; Dubois, I; Friedman, C; Gouyvenoux, M; James, R; Madan, A; Malrey-Estrada, B; Mangenot, S; Martins, N; Menard, M; Oztas, S; Ratcliffe, A; Shaffer, T; Trask, B; Vacherle, B; Bellemere, C; Belser, C; Besnard-Gonnet, M; Bartol-Mavel, D; Boutard, M; Briez-Silla, S; Combette, S; Dufosse-Laurent, V; Ferron, C; Lechaplais, C; Louesse, C; Muselet, D; Magdelenat, G; Pateau, E; Petit, E; Sirvain-Trukniewicz, P; Trybou, A; Vega-Czarny, N; Bataille, E; Bluet, E; Bordelais, I; Dubois, M; Dumont, C; Guerin, T; Haffray, S; Hammadi, R; Muanga, J; Pellouin, V; Robert, D; Wunderle, E; Gauguet, G; Roy, A; Sainte-Marthe, L; Verdier, J; Verdier-Discala, C; Hillier, L; Fulton, L; McPherson, J; Matsuda, F; Wilson, R; Scarpelli, C; Gyapay, G; Wincker, P; Saurin, W; Quetier, F; Waterston, R; Hood, L; Weissenbach, J			The DNA sequence and analysis of human chromosome 14	NATURE			English	Article							GENE; MAP; IDENTIFICATION; RECOMBINATION; LOCALIZATION; POLYMORPHISM; TRANSCRIPTS; MUTATIONS; FORM	Chromosome 14 is one of five acrocentric chromosomes in the human genome. These chromosomes are characterized by a heterochromatic short arm that contains essentially ribosomal RNA genes, and a euchromatic long arm in which most, if not all, of the protein-coding genes are located. The finished sequence of human chromosome 14 comprises 87,410,661 base pairs, representing 100% of its euchromatic portion, in a single continuous segment covering the entire long arm with no gaps. Two loci of crucial importance for the immune system, as well as more than 60 disease genes, have been localized so far on chromosome 14. We identified 1,050 genes and gene fragments, and 393 pseudogenes. On the basis of comparisons with other vertebrate genomes, we estimate that more than 96% of the chromosome 14 genes have been annotated. From an analysis of the CpG island occurrences, we estimate that 70% of these annotated genes are complete at their 5' end.	Genoscope Ctr Natl Sequencage, F-91000 Evry, France; CNRS, UMR 8030, F-91000 Evry, France; Univ Evry, F-91000 Evry, France; Ctr Natl Genotypage, F-91000 Evry, France; Inst Syst Biol, Seattle, WA 98103 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institute for Systems Biology (ISB); Washington University (WUSTL)	Heilig, R (corresponding author), Genoscope Ctr Natl Sequencage, F-91000 Evry, France.	heilig@genoscope.cns.fr	Belser, Caroline/X-5482-2019; Wilson, Richard K./AAF-4139-2019; Matsuda, Fumihiko/B-9893-2009; McPherson, John D/D-2633-2017; Jaillon, Olivier/GRY-6287-2022	Belser, Caroline/0000-0002-8108-9910; Wilson, Richard K./0000-0002-1992-1358; McPherson, John D/0000-0001-8049-9347; Petit, Jean-Louis/0000-0002-8566-0571; Vacherie, Benoit/0000-0002-1564-0575; Cruaud, Corinne/0000-0002-4752-7278; Pelletier, Eric/0000-0003-4228-1712; de Berardinis, Veronique/0000-0002-3273-4135; DA SILVA, Corinne/0000-0002-7618-7831				Antequera F, 1999, CURR BIOL, V9, pR661, DOI 10.1016/S0960-9822(99)80418-7; Araki O, 1999, CYTOGENET CELL GENET, V84, P73, DOI 10.1159/000015218; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bruls T, 2001, NATURE, V409, P947, DOI 10.1038/35057177; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Chen CQ, 1997, J IMMUNOL, V159, P1310; Chu FF, 1996, GENOMICS, V32, P272, DOI 10.1006/geno.1996.0115; Clay O, 2001, GENE, V276, P25, DOI 10.1016/S0378-1119(01)00668-0; Dear PH, 1998, GENOMICS, V48, P232, DOI 10.1006/geno.1997.5140; DEAR PH, 1993, NUCLEIC ACIDS RES, V21, P13, DOI 10.1093/nar/21.1.13; Deloukas P, 2001, NATURE, V414, P865, DOI 10.1038/414865a; Dib C, 1996, NATURE, V380, P152, DOI 10.1038/380152a0; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Dunham I, 1999, NATURE, V402, P489, DOI 10.1038/990031; Erdmann VA, 1999, NUCLEIC ACIDS RES, V27, P192, DOI 10.1093/nar/27.1.192; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hernandez A, 1998, GENOMICS, V53, P119, DOI 10.1006/geno.1998.5505; Kamnasaran D, 2002, J MED GENET, V39, P81, DOI 10.1136/jmg.39.2.81; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Modrek B, 2002, NAT GENET, V30, P13, DOI 10.1038/ng0102-13; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Percin EF, 2000, NAT GENET, V25, P397, DOI 10.1038/78071; Reiss J, 2001, AM J HUM GENET, V68, P208, DOI 10.1086/316941; Roest Crollius H, 2000, NAT GENET, V25, P235, DOI 10.1038/76118; Rowen L, 2002, GENOMICS, V79, P587, DOI 10.1006/geno.2002.6734; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Shoemaker DD, 2001, NATURE, V409, P922, DOI 10.1038/35057141; Stockton DW, 2000, NAT GENET, V24, P18, DOI 10.1038/71634; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wintle RF, 1997, GENOMICS, V40, P409, DOI 10.1006/geno.1996.4572; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zhen YY, 2002, J CELL SCI, V115, P3207	39	83	589	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 6	2003	421	6923					601	U1		10.1038/nature01348	http://dx.doi.org/10.1038/nature01348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642KH	12508121	Bronze			2022-12-28	WOS:000180803200034
J	Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC				Casalino, L; Gillies, RR; Shortell, SM; Schmittdiel, JA; Bodenheimer, T; Robinson, JC; Rundall, T; Oswald, N; Schauffler, H; Wang, MC			External incentives, information technology, and organized processes to improve health care quality for patients with chronic diseases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC ILLNESS CARE; MANAGEMENT PROGRAMS; SELF-MANAGEMENT; DEPRESSION; INTERVENTIONS; ASTHMA; MODEL; PERFORMANCE; OUTCOMES; IMPACT	Context Organized care management processes (CMPs) can Improve healthcare quality for patients with chronic diseases. The Institute of Medicine of the National Academy of Sciences has called for public and private purchasers of health care to create incentives for physician organizations (POs) to use CMPs and for the government to assist POs in implementing information technology (IT) to facilitate CMP use. Research is lacking about the extent to which POs use CMPs or about the degree to which incentives, IT, or other factors are associated with their use. Objectives To determine the extent to which POs with 20 or more physicians use CMPs and to identify key factors associated with CMP use for 4 chronic diseases (asthma, congestive heart failure, depression, and diabetes). Design, Setting, and Participants One thousand five hundred eighty-seven US POs (medical groups and independent practice associations) with 20 or more physicians were identified using 5 large databases. one thousand one hundred four of these POs (70%) agreed to participate in a telephone survey conducted between September 2000 and September 2001. Sixty-four responding POs were excluded because they did not treat any of the 4 diseases, leaving 1040 POs. Main Outcome Measures Extent of use of CMPs as calculated on the basis of a summary measure, a PO care management index (POCMI; range, 0-6) and factors associated with CMP use. Results Physician organizations' mean use of CMPs was 5.1 of a possible 16; 50% used 4 or fewer. External incentives and clinical IT were most strongly associated with CMP use, Controlling for other factors, use of the 2 most strongly associated incentives-public recognition and better contracts for health care quality-was associated with use of 1.3 and 0.7 additional CMPs, respectively (P<.001 and P=.007). Each additional IT capability was associated with 0.37 additional CMPs (P<.001). However, 33% of POs reported no external incentives and 50% reported no clinical IT capability. Conclusions The use of CMPs varies greatly among POs, but it is low on average. Government and private purchasers of health care may increase CMP use by providing external incentives for improvement of health care quality to POs and by assisting them in improving their clinical IT capability.	Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Univ Calif Berkeley, Sch Publ Hlth, Div Hlth Policy & Management, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; Healthcare Consulting, Berkeley, CA USA	University of Chicago; University of California System; University of California Berkeley; University of California System; University of California San Francisco	Casalino, L (corresponding author), Univ Chicago, Dept Hlth Studies, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	casalino@health.bsd.uchicago.edu	Casalino, Lawrence/ABE-1245-2020; Greiver, Michelle/N-8764-2015; Young, Alexander/A-1523-2009; Tao, Youyou/D-2367-2014	Casalino, Lawrence/0000-0002-7927-7859; Greiver, Michelle/0000-0001-8957-0285; Young, Alexander/0000-0002-9367-9213; 				*AG HEALTHC RES QU, PARTN QUAL; ANDERSON RM, 1995, DIABETES CARE, V18, P943, DOI 10.2337/diacare.18.7.943; Balas EA, 2000, ARCH INTERN MED, V160, P301, DOI 10.1001/archinte.160.3.301; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Becher EC, 2001, HEALTH AFFAIR, V20, P68, DOI 10.1377/hlthaff.20.3.68; Beckles GLA, 1998, DIABETES CARE, V21, P1432, DOI 10.2337/diacare.21.9.1432; Berwick DM, 1998, ANN INTERN MED, V128, P651, DOI 10.7326/0003-4819-128-8-199804150-00009; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P2469, DOI 10.1001/jama.288.19.2469; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bonomi AE, 2002, HEALTH SERV RES, V37, P791, DOI 10.1111/1475-6773.00049; BURNES B, 1995, LOGISTICS FOCUS, V3, P10; Burns LR, 2000, AD HEA CA M, V1, P273; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Chassin MR, 1998, JAMA-J AM MED ASSOC, V280, P1000, DOI 10.1001/jama.280.11.1000; Christianson JB, 2002, HEALTH AFFAIR, V21, P76, DOI 10.1377/hlthaff.21.1.76; Demakis JG, 2000, JAMA-J AM MED ASSOC, V284, P1411, DOI 10.1001/jama.284.11.1411; Dudley RA, 2000, MED CARE RES REV, V57, P116, DOI 10.1177/107755800773743754; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Enthoven AC, 2002, J HEALTH POLIT POLIC, V27, P37, DOI 10.1215/03616878-27-1-37; Ferguson JA, 1998, J GEN INTERN MED, V13, P123, DOI 10.1046/j.1525-1497.1998.00029.x; GRIFFIN S, 2000, COCHRANE REV; Griffin SJ, 2001, BRIT MED J, V323, P946, DOI 10.1136/bmj.323.7319.946; GRIMSHAW JM, 2001, MED CARE S2, V39, P2, DOI DOI 10.1097/00005650-200108002-00002; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Hersh WR, 2002, JAMA-J AM MED ASSOC, V288, P1955, DOI 10.1001/jama.288.16.1955; Holloway F, 2001, INT J SOC PSYCHIATR, V47, P21, DOI 10.1177/002076400104700303; Hoyert D L, 2001, Natl Vital Stat Rep, V49, P1; Institute of Medicine, 2001, CROSSING QUALITY CHA; Institute of Medicine, 2002, LEAD EX COORD GOV RO; Jessup M, 2001, NEW ENGL J MED, V345, P1490, DOI 10.1056/NEJMed010109; Jowers JR, 2000, AM J MANAG CARE, V6, P585; Kerr EA, 1996, JAMA-J AM MED ASSOC, V276, P1236, DOI 10.1001/jama.276.15.1236; Kilo C M, 1998, Qual Manag Health Care, V6, P1; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Landon BE, 1998, JAMA-J AM MED ASSOC, V279, P1377, DOI 10.1001/jama.279.17.1377; Lansky D, 2002, HEALTH AFFAIR, V21, P52, DOI 10.1377/hlthaff.21.4.52; Leatherman ST, 2002, QUALITY HLTH CARE US; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Maxwell J, 2002, J HEALTH POLIT POLIC, V27, P5, DOI 10.1215/03616878-27-1-5; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2001, HEALTH AFFAIR, V20, P82, DOI 10.1377/hlthaff.20.3.82; Miller RH, 2002, J HEALTH POLIT POLIC, V27, P401, DOI 10.1215/03616878-27-3-401; *NAT COMM QUAL ASS, HLTH PLAN EMPL DAT I; *NAT HEART LUNG BL, 1996, CONGESTIVE HEART FAI; Newhouse JP, 2002, HEALTH AFFAIR, V21, P13, DOI 10.1377/hlthaff.21.4.13; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; OBRIEN MAT, 2002, COCHRANE REV; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Philbin EF, 1999, J GEN INTERN MED, V14, P130, DOI 10.1046/j.1525-1497.1999.00291.x; *R WOOD JOHNS FDN, REW RES AL INC HIGH; Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rich MW, 2001, AM J MED, V110, P410, DOI 10.1016/S0002-9343(01)00632-5; ROBINSON JC, 1999, CALIF MILBANK S, P1; Rossiter LF, 2000, INQUIRY-J HEALTH CAR, V37, P188; Rundall TG, 2002, BMJ-BRIT MED J, V325, P958, DOI 10.1136/bmj.325.7370.958; Saaddine JB, 2002, ANN INTERN MED, V136, P565, DOI 10.7326/0003-4819-136-8-200204160-00005; Schoenbaum M, 2001, JAMA-J AM MED ASSOC, V286, P1325, DOI 10.1001/jama.286.11.1325; Schuster MA, 1998, MILBANK Q, V76, P517, DOI 10.1111/1468-0009.00105; Shortell SM, 2001, MED CARE, V39, pI62; Simon GE, 2000, BRIT MED J, V320, P550, DOI 10.1136/bmj.320.7234.550; Solberg L I, 2000, Jt Comm J Qual Improv, V26, P171; Songer TJ, 1998, STUDIES COST DIABETE; Thomson O'Brien MA, 2000, COCHRANE DB SYST REV, V2; Von Korff M, 2001, BRIT MED J, V323, P948, DOI 10.1136/bmj.323.7319.948; Wagner EH, 2001, HEALTH AFFAIR, V20, P64, DOI 10.1377/hlthaff.20.6.64; Wagner EH, 1996, MILBANK Q, V74, P511, DOI 10.2307/3350391; Wagner EH, 2001, DIABETES CARE, V24, P695, DOI 10.2337/diacare.24.4.695; WAGNER EH, 2001, IT COMM J QUAL IMPRO, V27, P63; WEINGARTEN S, 2002, BMJ-BRIT MED J, V325; Weiss KB, 2001, J ALLERGY CLIN IMMUN, V107, P3, DOI 10.1067/mai.2001.112262; Wells KB, 2000, JAMA-J AM MED ASSOC, V283, P212, DOI 10.1001/jama.283.2.212; Wholey DR, 1997, HEALTH AFFAIR, V16, P75, DOI 10.1377/hlthaff.16.6.75	74	358	359	0	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					434	441		10.1001/jama.289.4.434	http://dx.doi.org/10.1001/jama.289.4.434			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TD	12533122	Bronze, Green Published			2022-12-28	WOS:000180472300024
J	Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA				Rajagopal, J; Anderson, WJ; Kume, S; Martinez, OI; Melton, DA			Insulin staining of ES cell progeny from insulin uptake	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; PANCREATIC-ISLETS; IN-VITRO		Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.		Young, Richard A/F-6495-2012; Kume, Shoen/M-4356-2016	Young, Richard A/0000-0001-8855-8647; Kume, Shoen/0000-0002-4292-205X; Anderson, William/0000-0001-7823-8340				Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; BENVENISTY N, COMMUNICATION; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Ramiya VK, 2000, NAT MED, V6, P278; Shiroi A, 2002, STEM CELLS, V20, P284, DOI 10.1634/stemcells.20-4-284; Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157; Zulewski H, 2001, DIABETES, V50, P521, DOI 10.2337/diabetes.50.3.521	9	372	446	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 17	2003	299	5605					363	363						1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532008				2022-12-28	WOS:000180426800035
J	Check, E				Check, E			Report backs smithsonian research	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					198	198		10.1038/421198c	http://dx.doi.org/10.1038/421198c			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529600	Bronze			2022-12-28	WOS:000180397600006
J	Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W				Chen, YH; Xu, SJ; Bendahhou, S; Wang, XL; Wang, Y; Xu, WY; Jin, HW; Sun, H; Su, XY; Zhuang, QN; Yang, YQ; Li, YB; Liu, Y; Xu, HJ; Li, XF; Ma, N; Mou, CP; Chen, Z; Barhanin, J; Huang, W			KCNQ1 gain-of-function mutation in familial atrial fibrillation	SCIENCE			English	Article							LONG QT SYNDROME; CARDIAC-ARRHYTHMIAS; POTASSIUM CHANNEL; KVLQT1; INTERVAL	Atrial fibrillation (AF) is a common cardiac arrhythmia whose molecular etiology is poorly understood. We studied a family with hereditary persistent AF and identified the causative mutation (S140G) in the KCNQ1 (KvLQT1) gene on chromosome 11p15.5. The KCNQ1 gene encodes the pore-forming alpha subunit of the cardiac I-Ks channel (KCNQ1/KCNE1), the KCNQ1/KCNE2 and the KCNQ1/KCNE3 potassium channels. Functional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome. Thus, the S140G mutation is likely to initiate and maintain AF by reducing action potential duration and effective refractory period in atrial myocytes.	Tongji Hosp, Dept Cardiol, Shanghai 200065, Peoples R China; Tongji Univ, Inst Med Genet, Shanghai 200065, Peoples R China; Chinese Natl Human Genome Ctr Shanghai, Shanghai 201203, Peoples R China; Chinese Acad Sci, Hlth Sci Ctr, Inst Biol Sci, Shanghai 200025, Peoples R China; Shanghai Med Univ 2, Shanghai 200025, Peoples R China; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Sophia Antipolis, France; Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China; Shanghai Med Univ 2, Rui Jin Hosp, Shanghai Inst Hematol, State Key Lab Med Genom, Shanghai 200025, Peoples R China	Tongji University; Chinese Academy of Sciences; Shanghai Jiao Tong University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Sciences; Shanghai Jiao Tong University	Chen, YH (corresponding author), Tongji Hosp, Dept Cardiol, 399 Xin Cun Rd, Shanghai 200065, Peoples R China.	drchen@public7.sta.net.cn; xusj@chgc.sh.cn						Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Brugada R, 1997, NEW ENGL J MED, V336, P905, DOI 10.1056/NEJM199703273361302; Cannom DS, 2000, AM J CARDIOL, V85, p25D; Chen QY, 1998, NATURE, V392, P293, DOI 10.1038/32675; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Chugh SS, 2001, J AM COLL CARDIOL, V37, P371, DOI 10.1016/S0735-1097(00)01107-4; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Lai LP, 2002, AM HEART J, V144, P485, DOI 10.1067/mhj.2002.123573; Mazhari R, 2002, J CLIN INVEST, V109, P1083, DOI 10.1172/JCI200215062; Nattel S, 2002, NATURE, V415, P219, DOI 10.1038/415219a; PAI GR, 1989, BRIT HEART J, V61, P510; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; SEED WA, 1987, BRIT HEART J, V57, P32; Tan HL, 2001, NATURE, V409, P1043, DOI 10.1038/35059090; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Wang Z, 1999, J CARDIOVASC ELECTR, V10, P817, DOI 10.1111/j.1540-8167.1999.tb00262.x	21	718	772	5	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					251	254		10.1126/science.1077771	http://dx.doi.org/10.1126/science.1077771			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522251				2022-12-28	WOS:000180284000039
J	Young, JC; Hoogenraad, NJ; Hartl, FU				Young, JC; Hoogenraad, NJ; Hartl, FU			Molecular chaperones Hsp90 and Hsp70 deliver preproteins to the mitochondrial import receptor Tom70	CELL			English	Article							ADP ATP CARRIER; PROTEIN IMPORT; NUCLEOTIDE EXCHANGE; MAMMALIAN-CELLS; ADP/ATP CARRIER; CO-CHAPERONE; TRANSLOCATION; MEMBRANE; COMPLEX; PEPTIDE	The role of cytosolic factors in protein targeting to mitochondria is poorly understood. Here, we show that in mammals, the cytosolic chaperones Hsp90 and Hsp70 dock onto a specialized TPR domain in the import receptor Tom70 at the outer mitochondrial membrane. This interaction serves to deliver a set of preproteins to the receptor for subsequent membrane translocation dependent on the Hsp90 ATPase. Disruption of the chaperone/Tom70 recognition inhibits the import of these preproteins into mitochondria. In yeast, Hsp70 rather than Hsp90 is used in import, and Hsp70 docking is required for the formation of a productive preprotein/Tom70 complex. We outline a novel mechanism in which chaperones are recruited for a specific targeting event by a membrane-bound receptor.	La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia; Max Planck Inst Biochem, D-82152 Martinsried, Germany	La Trobe University; Max Planck Society	Hoogenraad, NJ (corresponding author), La Trobe Univ, Dept Biochem, Melbourne, Vic 3086, Australia.		Hartl, F. Ulrich/Y-8206-2019; Hoogenraad, Nicholas J/C-7505-2011					BOSE S, 1996, SCIENCE, V274, P1613; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Brinker A, 2002, J BIOL CHEM, V277, P19265, DOI 10.1074/jbc.M109002200; Brix J, 2000, J MOL BIOL, V303, P479, DOI 10.1006/jmbi.2000.4120; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; DAUM G, 1982, J BIOL CHEM, V257, P3075; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214; HACHIYA N, 1994, EMBO J, V13, P5146, DOI 10.1002/j.1460-2075.1994.tb06844.x; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hohfeld J, 1997, EMBO J, V16, P6209, DOI 10.1093/emboj/16.20.6209; Hoogenraad NJ, 2002, BBA-MOL CELL RES, V1592, P97, DOI 10.1016/S0167-4889(02)00268-9; LINGELBACH KR, 1986, EUR J BIOCHEM, V161, P19, DOI 10.1111/j.1432-1033.1986.tb10119.x; MURAKAMI H, 1988, J CELL BIOL, V107, P2051, DOI 10.1083/jcb.107.6.2051; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; PFANNER N, 1987, J BIOL CHEM, V262, P7528; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; Suzuki H, 2002, J CELL SCI, V115, P1895; Takayama S, 1997, EMBO J, V16, P4887, DOI 10.1093/emboj/16.16.4887; Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951; Young JC, 2000, EMBO J, V19, P5930, DOI 10.1093/emboj/19.21.5930; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Young L, 2001, SCIENCE, V291, P2135, DOI 10.1126/science.1056957; ZARA V, 1992, J BIOL CHEM, V267, P12077; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	37	618	635	2	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					41	50		10.1016/S0092-8674(02)01250-3	http://dx.doi.org/10.1016/S0092-8674(02)01250-3			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526792	hybrid			2022-12-28	WOS:000181191500005
J	Bawaskar, HS				Bawaskar, HS			Mistakes are lessons of the past	LANCET			English	Editorial Material									Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India		Bawaskar, HS (corresponding author), Bawaskar Hosp & Res Ctr, Mahad 402301, Maharashtra, India.								0	1	1	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					59	59		10.1016/S0140-6736(03)12163-0	http://dx.doi.org/10.1016/S0140-6736(03)12163-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517471				2022-12-28	WOS:000180191600025
J	Tse, HF; Kwong, YL; Chan, JKF; Lo, G; Ho, CL; Lau, CP				Tse, HF; Kwong, YL; Chan, JKF; Lo, G; Ho, CL; Lau, CP			Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation	LANCET			English	Article							GENE-TRANSFER	Results of experimental studies have shown that intramyocardial implantation of bone marrow cells induces neovascularisation and improves heart function after myocardial infarction. Our aim was to test this notion in people. We implanted autologous mononuclear bone marrow cells into the ischaemic myocardium of eight patients with severe ischaemic heart disease as guided by electromechanical mapping with a percutaneous catheter procedure. After 3 months of follow-up, there was improvement in symptoms, myocardial perfusion, and function at the ischaemic region on MRI. Future randomised, controlled studies are required to validate this initial encouraging result.	Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; Hong Kong Sanatorium & Hosp, Dept Radiol, Hong Kong, Hong Kong, Peoples R China; Hong Kong Sanatorium & Hosp, Dept Radiotherapy, Hong Kong, Hong Kong, Peoples R China; Hong Kong Sanatorium & Hosp, Dept Nucl Med, Hong Kong, Hong Kong, Peoples R China; Hong Kong Sanatorium & Hosp, Dept Positron Emiss Tomog, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Tse, HF (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China.		Kwong, Yok Lam/C-4296-2009; Tse, Hung-Fat/C-4426-2009	Tse, Hung-Fat/0000-0002-9578-7808				Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laham RJ, 2001, ANNU REV MED, V52, P485, DOI 10.1146/annurev.med.52.1.485; Laham RJ, 2002, J AM COLL CARDIOL, V39, P1, DOI 10.1016/S0735-1097(01)01691-6; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Vale PR, 2001, CIRCULATION, V103, P2138	5	633	755	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					47	49		10.1016/S0140-6736(03)12111-3	http://dx.doi.org/10.1016/S0140-6736(03)12111-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517468				2022-12-28	WOS:000180191600022
J	[Anonymous]				[Anonymous]			Health and dictatorship: effects of repression in Turkmenistan	LANCET			English	Editorial Material																		Human Rights Watch, 2002, WORLD REP 2002; United Nations, 2022, HUMAN DEV REPORTS; [No title captured]; [No title captured]; [No title captured]; [No title captured]	7	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					69	70						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517475				2022-12-28	WOS:000180191600029
J	Shevell, M				Shevell, M			Hallervorden and history.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Div Pediat Neurol, Montreal, PQ H3H 1P3, Canada	McGill University; McGill University; McGill University	Shevell, M (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.								0	40	43	0	3	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					3	4		10.1056/NEJMp020158	http://dx.doi.org/10.1056/NEJMp020158			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510036				2022-12-28	WOS:000180134400001
J	Cherry, N; Gilmour, K; Hannaford, P; Heagerty, A; Khan, MA; Kitchener, H; McNamee, R; Elstein, M; Kay, C; Seif, M; Buckley, H				Cherry, N; Gilmour, K; Hannaford, P; Heagerty, A; Khan, MA; Kitchener, H; McNamee, R; Elstein, M; Kay, C; Seif, M; Buckley, H		ESPIRIT Team	Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial	LANCET			English	Article							HORMONE REPLACEMENT THERAPY; HEART-DISEASE; CARDIOVASCULAR-DISEASE; SECONDARY PREVENTION; CORONARY EVENTS; PLUS PROGESTIN; ATHEROSCLEROSIS; PROGRESSION; INITIATION; HEALTH	Background Results of observational studies suggest that hormone replacement therapy (HRT) could reduce the risk of coronary heart disease (CHD), but those of randomised trials do not indicate a lower risk in women who use oestrogen plus progestagen. The aim of this study was to ascertain whether or not unopposed oestrogen reduces the risk of further cardiac events in postmenopausal women who survive a first myocardial infarction. Methods The study was a randomised, blinded, placebo controlled, secondary prevention trial of postmenopausal women, age 50-69 years (n=1017) who had survived a first myocardial infarction. Individuals were recruited from 35 hospitals in England and Wales. Women received either one tablet of oestradiol valerate (2 mg; n=513) or placebo (n=504), daily for 2 years. Primary outcomes were reinfarction or cardiac death, and all-cause mortality. Analyses were by intention-to-treat. Secondary outcomes were uterine bleeding, endometrial cancer, stroke or other embolic events, and fractures. Findings Frequency of reinfarction or cardiac death did not differ between treatment groups at 24 months (rate ratio 0.99, 95% Cl 0.70-1.41, p=0.97). Similarly, the reduction in all-cause mortality between those who took oestrogen and those on placebo was not significant (0.79, 0.50-1.27, p=0.34). The relative risk of any death (0.56, 0.23-1.33) and cardiac death (0.33, 0.11-1.01) was lowest at 3 months post-recruitment. Interpretation Oestradiol valerate does not reduce the overall risk of further cardiac events in postmenopausal women who have survived a myocardial infarction.	Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada	University of Alberta	Cherry, N (corresponding author), Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada.	nicola.cherry@ualberta.ca						Alexander KP, 2001, J AM COLL CARDIOL, V38, P1, DOI 10.1016/S0735-1097(01)01329-8; Angerer P, 2002, MATURITAS, V41, P51, DOI 10.1016/S0378-5122(01)00255-9; Angerer P, 2001, ARTERIOSCL THROM VAS, V21, P262, DOI 10.1161/01.ATV.21.2.262; Barrett-Connor E, 1998, ANNU REV PUBL HEALTH, V19, P55, DOI 10.1146/annurev.publhealth.19.1.55; Beral V, 2002, LANCET, V360, P942, DOI 10.1016/S0140-6736(02)11032-4; CAGNACCI A, 1992, J CLIN ENDOCR METAB, V74, P1396, DOI 10.1210/jc.74.6.1396; Clarke SC, 2002, BJOG-INT J OBSTET GY, V109, P1056, DOI 10.1111/j.1471-0528.2002.01544.x; DALY E, 1992, BRIT MED BULL, V48, P368, DOI 10.1093/oxfordjournals.bmb.a072552; Espeland MA, 1998, CIRCULATION, V97, P979; Fletcher SW, 2002, JAMA-J AM MED ASSOC, V288, P366, DOI 10.1001/jama.288.3.366; Gotto AM, 1998, CIRCULATION, V97, P1027, DOI 10.1161/01.CIR.97.11.1027; Grady D, 2002, JAMA-J AM MED ASSOC, V288, P49, DOI 10.1001/jama.288.1.49; Grodstein F, 2001, ANN INTERN MED, V135, P1, DOI 10.7326/0003-4819-135-1-200107030-00003; HAMSTEN A, 1991, CURR OPIN LIPIDOL, V2, P266; Heckbert SR, 2001, ARCH INTERN MED, V161, P1709, DOI 10.1001/archinte.161.14.1709; HENDERSON BE, 1988, FERTIL STERIL, V49, pS9; Herrington DM, 2000, NEW ENGL J MED, V343, P522, DOI 10.1056/NEJM200008243430801; Hodis HN, 2001, ANN INTERN MED, V135, P939, DOI 10.7326/0003-4819-135-11-200112040-00005; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; KAY CR, 1982, AM J OBSTET GYNECOL, V142, P762; MEADE TW, 1992, BRIT MED BULL, V48, P276, DOI 10.1093/oxfordjournals.bmb.a072548; Meilahn E N, 1992, Ann Epidemiol, V2, P445; Mendelsohn ME, 1999, NEW ENGL J MED, V340, P1801, DOI 10.1056/NEJM199906103402306; MILLER VT, 1995, JAMA-J AM MED ASSOC, V273, P199, DOI 10.1001/jama.1995.03520270033028; Mosca L, 2001, CIRCULATION, V104, P499, DOI 10.1161/hc2901.092200; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Schulman SP, 2002, J AM COLL CARDIOL, V39, P231, DOI 10.1016/S0735-1097(01)01724-7; SPORRONG T, 1990, BRIT J OBSTET GYNAEC, V97, P939, DOI 10.1111/j.1471-0528.1990.tb02451.x; SULLIVAN JM, 1990, ARCH INTERN MED, V150, P2557, DOI 10.1001/archinte.150.12.2557; Viscoli CM, 2001, NEW ENGL J MED, V345, P1243, DOI 10.1056/NEJMoa010534; Waters DD, 2002, JAMA-J AM MED ASSOC, V288, P2432, DOI 10.1001/jama.288.19.2432	31	223	226	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 21	2002	360	9350					2001	2008						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504395				2022-12-28	WOS:000179974200007
J	Santini, H				Santini, H			Rebirth of the health-care system in Cambodia	LANCET			English	Article									Univ Hlth Sci, Phnom Penh, Cambodia		Santini, H (corresponding author), 20 Rue Croix, F-34000 Montpellier, France.								0	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S57	S58		10.1016/S0140-6736(02)11824-1	http://dx.doi.org/10.1016/S0140-6736(02)11824-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504507				2022-12-28	WOS:000180064500028
J	Scully, MO; Zubairy, MS; Agarwal, GS; Walther, H				Scully, MO; Zubairy, MS; Agarwal, GS; Walther, H			Extracting work from a single heat bath via vanishing quantum coherence	SCIENCE			English	Article							CARNOT CYCLE; ONE-ATOM; 2ND LAW; LASER; THERMODYNAMICS; INVERSION; ENTROPY	We present here a quantum Carnot engine in which the atoms in the heat bath are given a small bit of quantum coherence. The induced quantum coherence becomes vanishingly small in the high-temperature limit at which we operate and the heat bath is essentially thermal. However, the phase phi associated with the atomic coherence, provides a new control parameter that can be varied to increase the temperature of the radiation field and to extract work from a single heat bath. The deep physics behind the second law of thermodynamics is not violated; nevertheless, the quantum Carnot engine has certain features that are not possible in a classical engine.	Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA; Texas A&M Univ, Inst Quantum Studies, College Stn, TX 77843 USA; Max Planck Inst Quantum Opt, D-85748 Garching, Germany; Quaid I Azam Univ, Dept Elect, Islamabad, Pakistan; Phys Res Lab, Ahmadabad 380009, Gujarat, India	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Max Planck Society; Quaid I Azam University; Department of Space (DoS), Government of India; Physical Research Laboratory - India	Scully, MO (corresponding author), Texas A&M Univ, Dept Phys, College Stn, TX 77843 USA.							AN K, 1994, PHYS REV LETT, V73, P3375, DOI 10.1103/PhysRevLett.73.3375; ANNAMALAI K, 2001, ADV THERMODYNAMIC EN; Arimondo E, 1996, PROG OPTICS, V35, P257, DOI 10.1016/S0079-6638(08)70531-6; Bender CM, 2002, P ROY SOC A-MATH PHY, V458, P1519, DOI 10.1098/rspa.2001.0928; BENNETT CH, 1987, SCI AM, V257, P108, DOI 10.1038/scientificamerican1187-108; BERMAN PR, 1994, CAVITY QUANTUM ELECT, P57; FILIPOWICZ P, 1986, J OPT SOC AM B, V3, P906, DOI 10.1364/JOSAB.3.000906; FREEDMANN T, 2000, PHYS REV E, V61, P4774; HAROCHE S, 1989, PHYS TODAY, V42, P24, DOI 10.1063/1.881201; Harris SE, 1997, PHYS TODAY, V50, P36, DOI 10.1063/1.881806; KIM M, 2002, SPECTROSCOPY SYSTEMS; KOCHAROVSKAYA O, 1992, PHYS REP, V219, P175, DOI 10.1016/0370-1573(92)90135-M; Kosloff R, 2000, J APPL PHYS, V87, P8093, DOI 10.1063/1.373503; Lee MH, 2001, AM J PHYS, V69, P874, DOI 10.1119/1.1371917; LEFF HS, 1990, MAXWELLS DEMON; Linke H, 1999, SCIENCE, V286, P2314, DOI 10.1126/science.286.5448.2314; Lloyd S, 1997, PHYS REV A, V56, P3374, DOI 10.1103/PhysRevA.56.3374; LLOYD S, 1989, PHYS REV A, V39, P5378, DOI 10.1103/PhysRevA.39.5378; MESCHEDE D, 1985, PHYS REV LETT, V54, P551, DOI 10.1103/PhysRevLett.54.551; Opatrny T, 2002, FORTSCHR PHYS, V50, P657, DOI 10.1002/1521-3978(200205)50:5/7<657::AID-PROP657>3.0.CO;2-#; RAMSEY NF, 1956, PHYS REV, V103, P20, DOI 10.1103/PhysRev.103.20; ROSTOVSTEV Y, UNPUB; Scully M.O., 1997, QUANTUM OPT; SCULLY MO, 1989, PHYS REV LETT, V62, P2813, DOI 10.1103/PhysRevLett.62.2813; Scully MO, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.050602; Scully MO, 2002, AIP CONF PROC, V643, P83, DOI 10.1063/1.1523786; Scully MO, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.220601; SKOVIL H, 1959, PHYS REV LETT, V2, P262; Von Baeyer H.C, 1999, WARMTH DISPERSES TIM; Zubairy MS, 2002, AIP CONF PROC, V643, P92; [No title captured]	31	507	513	3	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 7	2003	299	5608					862	864		10.1126/science.1078955	http://dx.doi.org/10.1126/science.1078955			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642XN	12511655				2022-12-28	WOS:000180830900043
J	Coulthard, MG; Haycock, GB				Coulthard, MG; Haycock, GB			Distinguishing between salt poisoning and hypernatraemic dehydration in children	BRITISH MEDICAL JOURNAL			English	Article							PLASMA CREATININE; VASOPRESSIN; DIARRHEA		Royal Victoria Infirm, Dept Paediat Nephrol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Guys Kings & St Thomass Sch Med, London SE1 9RT, England	Newcastle University - UK; University of London; King's College London	Coulthard, MG (corresponding author), Royal Victoria Infirm, Dept Paediat Nephrol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.							Boyd E, 1935, GROWTH SURFACE AREA; CHAMBERS TL, 1975, ARCH DIS CHILD, V50, P610, DOI 10.1136/adc.50.8.610; DERUBERTIS FR, 1971, J CLIN INVEST, V50, P97, DOI 10.1172/JCI106489; FINBERG L, 1963, JAMA-J AM MED ASSOC, V184, P187, DOI 10.1001/jama.1963.03700160063009; FINBERG L, 1964, AM J DIS CHILD, V107, P483, DOI 10.1001/archpedi.1964.02080060485008; HIRSCHHORN N, 1976, ARCH DIS CHILD, V51, P326, DOI 10.1136/adc.51.4.326-a; HIRSCHHORN N, 1980, AM J CLIN NUTR, V33, P637, DOI 10.1093/ajcn/33.3.637; HUNG CC, 2000, HONG KONG J PAEDIAT, V5, P31; LINDFORS A, 1992, ACTA PAEDIATR, V81, P73, DOI 10.1111/j.1651-2227.1992.tb12083.x; MEADOW R, 1993, ARCH DIS CHILD, V68, P448, DOI 10.1136/adc.68.4.448; Oddie S, 2001, ARCH DIS CHILD, V85, P318, DOI 10.1136/adc.85.4.318; SCHAFFBLASS E, 1983, J PEDIATR-US, V102, P703, DOI 10.1016/S0022-3476(83)80237-6; SCHWARTZ GJ, 1976, J PEDIATR-US, V88, P828, DOI 10.1016/S0022-3476(76)81125-0; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Watkins SJ, 2000, BRIT MED J, V320, P2, DOI 10.1136/bmj.320.7226.2; WEIL WB, 1956, PEDIATRICS, V17, P171	16	23	23	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2003	326	7381					157	160		10.1136/bmj.326.7381.157	http://dx.doi.org/10.1136/bmj.326.7381.157			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	638MY	12531853	Green Published			2022-12-28	WOS:000180575900031
J	Hyman, SE; Fenton, WS				Hyman, SE; Fenton, WS			Medicine: What are the right targets for psychopharmacology?	SCIENCE			English	Editorial Material							SCHIZOPHRENIA; DYSFUNCTION; DEFICITS		NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA; Harvard Univ, Cambridge, MA 02138 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University	Fenton, WS (corresponding author), NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA.	SEH@harvard.edu; wfenton@mail.nih.gov						American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Berrettini WH, 2000, BIOL PSYCHIAT, V48, P531, DOI 10.1016/S0006-3223(00)00883-0; Bilder RM, 2000, AM J PSYCHIAT, V157, P549, DOI 10.1176/appi.ajp.157.4.549; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Center for Mental Health Services and National Institute of Mental Health, 1999, MENT HLTH REP SURG G; Cowan WM, 2002, ANNU REV NEUROSCI, V25, P1, DOI 10.1146/annurev.neuro.25.112701.142853; Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO;2-Y; Friedman JI, 1999, BIOL PSYCHIAT, V45, P1, DOI 10.1016/S0006-3223(98)00287-X; Friedman JI, 2001, AM J PSYCHIAT, V158, P1441, DOI 10.1176/appi.ajp.158.9.1441; Gold JM, 1999, AM J PSYCHIAT, V156, P1944; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Hyman SE, 2002, PSYCHOPATHOLOGY, V35, P139, DOI 10.1159/000065134; KENDLER KS, 1995, AM J PSYCHIAT, V152, P749; KENDLER KS, 1992, ARCH GEN PSYCHIAT, V49, P716; Kindermann SS, 1997, SCHIZOPHR RES, V27, P143, DOI 10.1016/S0920-9964(97)00063-7; Merikangas K, 2002, ACTA PSYCHIAT SCAND, V105, P3, DOI 10.1034/j.1600-0447.2002.01001.x; Mitchell RLC, 2001, TRENDS COGN SCI, V5, P71, DOI 10.1016/S1364-6613(00)01599-0; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; Wilk CM, 2002, AM J PSYCHIAT, V159, P838, DOI 10.1176/appi.ajp.159.5.838; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	22	215	224	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					350	351		10.1126/science.1077141	http://dx.doi.org/10.1126/science.1077141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532001				2022-12-28	WOS:000180426800028
J	Lakhani, SR				Lakhani, SR			In-situ lobular neoplasia: time for an awakening	LANCET			English	Editorial Material							CARCINOMA INSITU; FOLLOW-UP; BREAST; HETEROZYGOSITY; HYPERPLASIA; LESIONS		Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England; Royal Marsden Hosp, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust	Lakhani, SR (corresponding author), Inst Canc Res, Breakthrough Toby Robins Breast Canc Res Ctr, London SW3 6JB, England.		Lakhani, Sunil R/I-1970-2018	Lakhani, Sunil R/0000-0003-4067-2760				Broders AC, 1932, J AMER MED ASSOC, V99, P1670, DOI 10.1001/jama.1932.02740720024007; Foote FW, 1941, AM J PATHOL, V17, P491; HAAGENSEN CD, 1978, CANCER, V42, P737, DOI 10.1002/1097-0142(197808)42:2<737::AID-CNCR2820420247>3.0.CO;2-T; Lakhani SR, 2001, NAT REV CANCER, V1, P151, DOI 10.1038/35101087; LAKHANI SR, 1995, J CLIN PATHOL-CL MOL, V48, pM74; Lu YJ, 1998, CANCER RES, V58, P4721; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; Nayar R, 1997, HUM PATHOL, V28, P277, DOI 10.1016/S0046-8177(97)90124-6; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; Vos CBJ, 1997, BRIT J CANCER, V76, P1131, DOI 10.1038/bjc.1997.523; WHEELER JE, 1974, CANCER-AM CANCER SOC, V34, P554, DOI 10.1002/1097-0142(197409)34:3<554::AID-CNCR2820340313>3.0.CO;2-7	12	23	25	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					96	96		10.1016/S0140-6736(03)12240-4	http://dx.doi.org/10.1016/S0140-6736(03)12240-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531570				2022-12-28	WOS:000180428000002
J	Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH				Lyte, M; Freestone, PPE; Neal, CP; Olson, BA; Haigh, RD; Bayston, R; Williams, PH			Stimulation of Staphylococcus epidermidis growth and biofilm formation by catecholamine inotropes	LANCET			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; INTENSIVE-CARE UNIT; BACTERIAL BIOFILMS; INFECTIONS; ADHERENCE; MORTALITY; ADHESION; RP62A; IRON	Background Bacterial colonisation of indwelling medical devices by coagulase-negative staphylococci is a prevalent risk in intensive-care units. Factors determining biofilm formation and progression to catheter related infection are incompletely understood. We postulated that administration of inotropic agents via indwelling intravenous catheters may stimulate growth and formation of biofilms by Staphylococcus epidermidis. Methods Inocula representing physiologically relevant infecting doses of S epidermidis were incubated in a minimum medium supplemented with fresh human plasma in the presence or absence of pharmacological concentrations of norepinephrine or dobutamine. Biofilm formation on polystyrene and medical-grade silicone was examined. After incubation, cultures were assessed for growth and formation of biofilms by colony counting and scanning electronmicroscopy. The production of exopolysaccharide, a major constituent of S epidermidis biofilms, was also assessed by use of immunofluorescence microscopy. Findings Incubation of S epidermidis with catecholamine inotropes in the presence of human plasma resulted in a significant increase in growth compared with control on both polystyrene and silicone surfaces, with pronounced increases in biofilm formation as visualised by scanning electronmicroscopy. Experiments with transferrin labelled with radioactive iron showed the ability of catecholamine inotropes to facilitate acquisition of iron by S epidermidis. Immunofluorescence microscopy revealed extensive exopolysaccharide production associated with S epidermidis biofilms. Interpretation The ability of catecholamine inotropic drugs to stimulate bacterial proliferation and biofilm formation may be an aetiological factor in the development of intravascular catheter colonisation and catheter-related infection. The removal of iron from transferrin for subsequent use by S epidermidis is a possible mechanism by which catecholamine inotropes stimulate bacterial growth as biofilms.	Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, Minneapolis, MN 55404 USA; Minnesota State Univ Mankato, Dept Biol Sci, Mankato, MN USA; Univ Leicester, Dept Microbiol & Immunol, Leicester, Leics, England; Univ Nottingham, Div Orthopaed & Accid Surg, Biomat Related Infect Grp, Nottingham NG7 2RD, England	Hennepin County Medical Center; Minneapolis Medical Research Foundation; Minnesota State Colleges & Universities; Minnesota State University Mankato; University of Leicester; University of Nottingham	Lyte, M (corresponding author), Minneapolis Med Res Fdn Inc, Hennepin Cty Med Ctr, Dept Surg, 914 S 8th St,D3, Minneapolis, MN 55404 USA.	lytex001@umn.edu	Lyte, Mark/AAI-7602-2020; Bayston, Roger/E-7699-2019; Bayston, Roger/AAD-5427-2019; Lyte, Mark/C-3865-2008	Lyte, Mark/0000-0001-8512-2581; Bayston, Roger/0000-0002-8312-3844; Haigh, Richard/0000-0001-8597-9980	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050431] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50431] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAYSTON R, 1972, DEV MED CHILD NEUROL, V14, P25; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; CLAWSON CC, 1971, AM J PATHOL, V65, P381; COOPER EV, 1946, LANCET, V250, P459; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; DEIGHTON MA, 1990, J CLIN MICROBIOL, V28, P2442, DOI 10.1128/JCM.28.11.2442-2447.1990; EVANS DG, 1948, BRIT J EXP PATHOL, V29, P20; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Galloway MT, 1998, AM HEART J, V135, P888, DOI 10.1016/S0002-8703(98)70051-1; GANDERTON L, 1992, EUR J CLIN MICROBIOL, V11, P789, DOI 10.1007/BF01960877; INMAN RD, 1984, AM J MED, V77, P47, DOI 10.1016/0002-9343(84)90434-0; Linton CJ, 1999, J APPL MICROBIOL, V86, P194, DOI 10.1046/j.1365-2672.1999.00650.x; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; LYTE M, 1992, LIFE SCI, V50, P203, DOI 10.1016/0024-3205(92)90273-R; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; Merritt K, 1998, J BIOMED MATER RES, V39, P415, DOI 10.1002/(SICI)1097-4636(19980305)39:3<415::AID-JBM10>3.0.CO;2-9; Neal CP, 2001, FEMS MICROBIOL LETT, V194, P163, DOI 10.1016/S0378-1097(00)00523-1; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; Polonio RE, 2001, ANTIMICROB AGENTS CH, V45, P3262, DOI 10.1128/AAC.45.11.3262-3266.2001; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; RELLO J, 1994, INTENS CARE MED, V20, P94, DOI 10.1007/BF01707661; Renaud M, 1930, CR SOC BIOL, V103, P1052; Roberts A, 2002, ORAL MICROBIOL IMMUN, V17, P296, DOI 10.1034/j.1399-302X.2002.170506.x; RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; SMYTHE MA, 1993, CRIT CARE MED, V21, P1319, DOI 10.1097/00003246-199309000-00014; Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000	30	145	158	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					130	135		10.1016/S0140-6736(03)12231-3	http://dx.doi.org/10.1016/S0140-6736(03)12231-3			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531580				2022-12-28	WOS:000180428000012
J	Rothwell, PM; Eliasziw, M; Gutnikov, SA; Fox, AJ; Taylor, DW; Mayberg, MR; Warlow, CP; Barnett, HJM				Rothwell, PM; Eliasziw, M; Gutnikov, SA; Fox, AJ; Taylor, DW; Mayberg, MR; Warlow, CP; Barnett, HJM		Carotid Endarterectomy Trialists C	Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis	LANCET			English	Article							STROKE; RISK; PREVENTION; OCCLUSION	Background Endarterectomy reduces risk of stroke in certain patients with recently symptomatic internal carotid stenosis. However, investigators have made different recommendations about the degree of stenosis above which surgery is effective, partly because of differences between trials in the methods of measurement of stenosis. To accurately assess the overall effect of surgery, and to increase power for secondary analyses, we pooled trial data and reassessed carotid angiograms. Methods We pooled data from the European Carotid Surgery Trial (ECST), North American Symptomatic Carotid Endarterectomy Trial, and Veterans Affairs trial 309 from the original electronic data files. Outcome events were re-defined, if necessary, to achieve comparability. Pre-randomisation carotid angiograms from ECST were re-measured by the method used in the other two trials. Results Risks of main outcomes in both treatment groups and effects of surgery did not differ between trials. Data for 6092 patients, with 35 000 patient-years of follow-up, were therefore pooled. Surgery increased the 5-year risk of ipsilateral ischaemic stroke in patients with less than 30% stenosis (n=1746, absolute risk reduction -2.2%, p=0.05), had no effect in patients with 30-49% stenosis (1429, 3.2%, p=0.6), was of marginal benefit in those with 50-69% stenosis (1549, 4.6%, p=0.04), and was highly beneficial in those with 70% stenosis or greater without near-occlusion (1095, 16.0%, p<0.001). There was a trend towards benefit from surgery in patients with near-occlusion at 2 years' follow-up (262, 5.6%, p=0.19), but no benefit at 5 years (-1.7%, p=0.9). Interpretation Re-analysis of the trials with the same measurements and definitions yielded highly consistent results. Surgery is of some benefit for patients with 50-69% symptomatic stenosis, and highly beneficial for those with 70% symptomatic stenosis or greater but without near-occlusion. Benefit in patients with carotid near-occlusion is marginal in the short-term and uncertain in the long-term.	Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Oxford OX2 6HE, England; Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; Sunnybrook & Womens Hlth Sci Ctr, Dept Radiol, Toronto, ON, Canada; McMaster Univ, Hamilton, ON, Canada; Cleveland Clin, Dept Neurosurg, Cleveland, OH USA; Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; John P Robarts Res Inst, London, ON N6A 5K8, Canada	Radcliffe Infirmary; University of Oxford; University of Calgary; University of Calgary; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; McMaster University; Cleveland Clinic Foundation; University of Edinburgh; Western University (University of Western Ontario)	Rothwell, PM (corresponding author), Univ Oxford, Radcliffe Infirm, Dept Clin Neurol, Stroke Prevent Res Unit, Woodstock Rd, Oxford OX2 6HE, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS-24456] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armitage P., 2001, STAT METHODS MED RES; BARNETT HJM, 1993, STROKE, V24, P1281, DOI 10.1161/01.STR.24.9.1281; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; BARNETT HJM, 1991, STROKE, V22, P711, DOI 10.1161/01.STR.22.6.711; Barnett HJM, 2002, CAN MED ASSOC J, V166, P1169; Biller J, 1998, CIRCULATION, V97, P501; CINA C, 1999, COCHRANE LIB; Collet D., 1994, MODELLING SURVIVAL D; ELIASZIW M, 1994, STROKE, V25, P2445, DOI 10.1161/01.STR.25.12.2445; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; FIELDS WS, 1970, J AMER MED ASSOC, V211, P1993, DOI 10.1001/jama.211.12.1993; FOX AJ, 1993, RADIOLOGY, V186, P316, DOI 10.1148/radiology.186.2.8421726; GOLDSTEIN LB, 1995, NEUROLOGY, V45, P1965, DOI 10.1212/WNL.45.11.1965; Gorelick PB, 1999, STROKE, V30, P1745, DOI 10.1161/01.STR.30.9.1745; Henderson RD, 2000, STROKE, V31, P128, DOI 10.1161/01.STR.31.1.128; HOWARD VJ, 1992, STROKE, V23, P583, DOI 10.1161/01.STR.23.4.583; Hsia DC, 1998, STROKE, V29, P346, DOI 10.1161/01.STR.29.2.346; Johnston DCC, 2001, NEUROLOGY, V56, P1009, DOI 10.1212/WNL.56.8.1009; Masuhr F, 1998, STROKE, V29, P339, DOI 10.1161/01.STR.29.2.339; MAYBERG MR, 1991, JAMA-J AM MED ASSOC, V266, P3289, DOI 10.1001/jama.266.23.3289; Morgenstern LB, 1997, NEUROLOGY, V48, P911, DOI 10.1212/WNL.48.4.911; ROTHWELL P, 1995, LANCET, V346, P1623, DOI 10.1016/S0140-6736(95)91953-8; Rothwell PM, 2000, STROKE, V31, P622, DOI 10.1161/01.STR.31.3.622; ROTHWELL PM, 1994, STROKE, V25, P2435, DOI 10.1161/01.STR.25.12.2435; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; Rothwell PM, 1996, STROKE, V27, P260, DOI 10.1161/01.STR.27.2.260; Rothwell PM, 2000, STROKE, V31, P1444, DOI 10.1161/01.STR.31.6.1444; Rothwell PM, 2000, J NEUROL, V247, P825, DOI 10.1007/s004150070068; ROTHWELL PM, 1993, SURGERY STROKE, P369; *ROYAL COLL PHYS, 2000, INT WORK PART STROK; SHAW DA, 1984, J NEUROL SCI, V64, P45, DOI 10.1016/0022-510X(84)90054-6; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tu JV, 1998, NEW ENGL J MED, V339, P1441, DOI 10.1056/NEJM199811123392006; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WARLOW C, 1991, LANCET, V337, P1235, DOI 10.1016/0140-6736(91)92916-P	36	1108	1146	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 11	2003	361	9352					107	116		10.1016/S0140-6736(03)12228-3	http://dx.doi.org/10.1016/S0140-6736(03)12228-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531577				2022-12-28	WOS:000180428000009
J	Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY				Kikuchi, K; Terauchi, K; Wada, M; Hirano, HY			The plant MITE mPing is mobilized in anther culture	NATURE			English	Article							REPEAT TRANSPOSABLE ELEMENTS; REPETITIVE-DNA ELEMENTS; ARABIDOPSIS-THALIANA; FAMILY; RICE; GENOME; MAIZE; TOURIST; GENE; AMPLIFICATION	Transposable elements constitute a large portion of eukaryotic genomes and contribute to their evolution and diversification. Miniature inverted-repeat transposable elements (MITEs) constitute one of the main groups of transposable elements and are distributed ubiquitously in the genomes of plants and animals 1 such as maize(2-5), rice(3), Arabidopsis(6,7), human(8), insect(9,10) and nematode(11). Because active MITEs have not been identified, the transposition mechanism of MITEs and their accumulation in eukaryotic genomes remain poorly understood. Here we describe a new class of MITE, called miniature Ping (mPing), in the genome of Oryza sativa (rice). mPing elements are activated in cells derived from anther culture, where they are excised efficiently from original sites and reinserted into new loci. An mPing-associated Ping element, which has a putative PIF family(5) transposase, is implicated in the recent proliferation of this MITE family in a subspecies of rice.	Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Natl Inst Basic Biol, Okazaki, Aichi 4448585, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Tokyo 1920397, Japan	University of Tokyo; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Tokyo Metropolitan University	Hirano, HY (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.		Hirano, Hiro-Yuki/G-4928-2014	Hirano, Hiro-Yuki/0000-0001-7364-8893				Barry GF, 2001, PLANT PHYSIOL, V125, P1164, DOI 10.1104/pp.125.3.1164; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; BUREAU TE, 1994, P NATL ACAD SCI USA, V91, P1411, DOI 10.1073/pnas.91.4.1411; Casacuberta E, 1998, PLANT J, V16, P79, DOI 10.1046/j.1365-313x.1998.00267.x; Feschotte C, 2000, MOL BIOL EVOL, V17, P730, DOI 10.1093/oxfordjournals.molbev.a026351; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Feschotte C, 2000, GENE, V250, P109, DOI 10.1016/S0378-1119(00)00187-6; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hirano HY, 1998, MOL BIOL EVOL, V15, P978, DOI 10.1093/oxfordjournals.molbev.a026013; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Kikuchi K, 2000, MOL GEN GENET, V262, P1047, DOI 10.1007/PL00008647; Morishima H., 1992, OXFORD SURV EVOL BIO, V8, P135; NEGISHI T, 1994, Patent No. 06036698; Raina SK, 1997, PL BRED RE, V15, P141; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Surzycki SA, 2000, P NATL ACAD SCI USA, V97, P245, DOI 10.1073/pnas.97.1.245; Surzycki SA, 1999, J MOL EVOL, V48, P684, DOI 10.1007/PL00006512; Tu ZJ, 2000, MOL BIOL EVOL, V17, P1313, DOI 10.1093/oxfordjournals.molbev.a026415; WESSLER S, 1990, P NATL ACAD SCI USA, V87, P8731, DOI 10.1073/pnas.87.22.8731; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Zhang Q, 2000, P NATL ACAD SCI USA, V97, P1160, DOI 10.1073/pnas.97.3.1160; Zhang XY, 2001, P NATL ACAD SCI USA, V98, P12572, DOI 10.1073/pnas.211442198	23	212	240	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					167	170		10.1038/nature01218	http://dx.doi.org/10.1038/nature01218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520303				2022-12-28	WOS:000180267200041
J	Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I				Nelson, C; Goto, S; Lund, K; Hung, W; Sadowski, I			Srb10/Cdk8 regulates yeast filamentous growth by phosphorylating the transcription factor Ste12	NATURE			English	Article							POLYMERASE-II HOLOENZYME; SACCHAROMYCES-CEREVISIAE; INVASIVE GROWTH; CELL-TYPE; KINASE; ACTIVATION	The budding yeast Saccharomyces cerevisiae differentiates into filamentous invasively growing forms under conditions of nutrient limitation(1,2). This response is dependent on the transcription factor Ste12 and on the mating pheromone-response mitogen-activated protein (MAP) kinase cascade 1, but a mechanism for regulation of Ste12 by nutrient limitation has not been defined. Here we show that Ste12 function in filamentous growth is regulated by the cyclin-dependent kinase Srb10 (also known as Cdk8), which is associated with the RNA polymerase II holoenzyme. Srb10 inhibits filamentous growth in cells growing in rich medium by phosphorylating Ste12 and decreasing its stability. Under conditions of limiting nitrogen, loss of Srb10 protein and kinase activity occurs, with a corresponding loss of Ste12 phosphorylation. Mutation of the Srb10-dependent phosphorylation sites increases pseudohyphal development but has no effect on the pheromone response of haploid yeast. Srb10 kinase activity is also regulated independently of the mating pheromone-response pathway. This indicates that Srb10 controls Ste12 activity for filamentous growth in response to nitrogen limitation and is consistent with the hypothesis that Srb10 regulates gene-specific activators in response to physiological signals to coordinate gene expression with growth potential.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Sadowski, I (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	sadowski@interchange.ubc.ca						BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Chang YW, 2001, GENETICS, V157, P17; Chi Y, 2001, GENE DEV, V15, P1078, DOI 10.1101/gad.867501; Cullen PJ, 2000, P NATL ACAD SCI USA, V97, P13619, DOI 10.1073/pnas.240345197; FIELDS S, 1987, MOL CELL BIOL, V7, P3818, DOI 10.1128/MCB.7.10.3818; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; Hirst M, 1999, MOL CELL, V3, P673, DOI 10.1016/S1097-2765(00)80360-3; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hung W, 1997, EUR J BIOCHEM, V245, P241, DOI 10.1111/j.1432-1033.1997.00241.x; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Morillon S, 2000, MOL CELL BIOL, V20, P5766, DOI 10.1128/MCB.20.15.5766-5776.2000; Olson KA, 2000, MOL CELL BIOL, V20, P4199, DOI 10.1128/MCB.20.12.4199-4209.2000; Pi HW, 1997, MOL CELL BIOL, V17, P6410, DOI 10.1128/MCB.17.11.6410; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rohde JR, 2000, MOL CELL BIOL, V20, P3880, DOI 10.1128/MCB.20.11.3880-3886.2000	15	120	125	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					187	190		10.1038/nature01243	http://dx.doi.org/10.1038/nature01243			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520306				2022-12-28	WOS:000180267200046
J	Boles, LC; Lohmann, KJ				Boles, LC; Lohmann, KJ			True navigation and magnetic maps in spiny lobsters	NATURE			English	Article							SEA-TURTLES; COIL SYSTEMS; ORIENTATION; INFORMATION; FIELDS; SENSE	Animals are capable of true navigation if, after displacement to a location where they have never been, they can determine their position relative to a goal without relying on familiar surroundings, cues that emanate from the destination, or information collected during the outward journey(1,2). So far, only a few animals, all vertebrates, have been shown to possess true navigation(3). Those few invertebrates that have been carefully studied return to target areas using path integration, landmark recognition, compass orientation and other mechanisms that cannot compensate for displacements into unfamiliar territory(4,5). Here we report, however, that the spiny lobster Panulirus argus oriented reliably towards a capture site when displaced 12-37 km to unfamiliar locations, even when deprived of all known orientation cues en route. Little is known about how lobsters and other animals determine position during true navigation. To test the hypothesis that lobsters derive positional information from the Earth's magnetic field, lobsters were exposed to fields replicating those that exist at specific locations in their environment. Lobsters tested in a field north of the capture site oriented themselves southwards, whereas those tested in a field south of the capture site oriented themselves northwards. These results imply that true navigation in spiny lobsters, and perhaps in other animals, is based on a magnetic map sense.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Boles, LC (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.							Able KP, 2001, J AVIAN BIOL, V32, P174, DOI 10.1034/j.1600-048X.2001.320211.x; ABLE KP, 1991, AM ZOOL, V31, P157; CREASER EP, 1950, SCIENCE, V112, P169, DOI 10.1126/science.112.2902.169; Fischer JH, 2001, ANIM BEHAV, V62, P1, DOI 10.1006/anbe.2000.1722; Gould JL, 1998, CURR BIOL, V8, pR731, DOI 10.1016/S0960-9822(98)70461-0; GOULD JL, 1982, NATURE, V296, P205, DOI 10.1038/296205a0; GREGORY DR, 1986, CAN J FISH AQUAT SCI, V43, P2228, DOI 10.1139/f86-273; GRIFFIN DR, 1952, BIOL REV, V27, P359, DOI 10.1111/j.1469-185X.1952.tb01509.x; Groeneveld JC, 2002, MAR ECOL PROG SER, V232, P225, DOI 10.3354/meps232225; Herrnkind W.F., 1980, P349; Herrnkind W.F., 1975, Science Bull nat Hist Mus Los Ang Cty, VNo. 20, P31; Kirschvink J. L., 1985, MAGNETITE BIOMINERAL, V1st; KIRSCHVINK JL, 1992, BIOELECTROMAGNETICS, V13, P401, DOI 10.1002/bem.2250130507; Kramer G., 1957, Ibis, V99, P196, DOI 10.1111/j.1474-919X.1957.tb01947.x; LOHMANN KJ, 1984, J EXP BIOL, V113, P29; Lohmann KJ, 1996, NATURE, V380, P59, DOI 10.1038/380059a0; Lohmann KJ, 2001, SCIENCE, V294, P364, DOI 10.1126/science.1064557; LOHMANN KJ, 1994, J EXP BIOL, V194, P23; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; Munro U, 1997, NATURWISSENSCHAFTEN, V84, P26, DOI 10.1007/s001140050343; Papi F, 2001, ITAL J ZOOL, V68, P171, DOI 10.1080/11250000109356405; Phillips JB, 1996, J THEOR BIOL, V180, P309, DOI 10.1006/jtbi.1996.0105; PHILLIPS JB, 1995, ANIM BEHAV, V50, P855, DOI 10.1016/0003-3472(95)80146-4; Walcott C, 1996, J EXP BIOL, V199, P21; Walcott C., 1991, ORIENTATION BIRDS, P38; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; WALKER MM, 1997, ORIENTATION COMMUNIC, P187; Wehner R, 1996, J EXP BIOL, V199, P129; Wiltschko R., 1995, TIEROSYCHOL; Zar J. H., 1996, BIOSTATISTICAL ANAL	30	251	261	2	106	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					60	63		10.1038/nature01226	http://dx.doi.org/10.1038/nature01226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511953				2022-12-28	WOS:000180165500036
J	Glass, L				Glass, L			Arthur T. Winfree (1942-2002) - Obituary	NATURE			English	Biographical-Item									McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Glass, L (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.		Glass, Leon/C-5732-2008					WINFREE AT, PUBLICATION LIST	1	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					34	34		10.1038/421034a	http://dx.doi.org/10.1038/421034a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511943	Bronze			2022-12-28	WOS:000180165500026
J	McDowell, N				McDowell, N			Joint European plan will tackle Africa's killer diseases	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					5	5		10.1038/421005b	http://dx.doi.org/10.1038/421005b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511923	Bronze			2022-12-28	WOS:000180165500008
J	Root, TL; Price, JT; Hall, KR; Schneider, SH; Rosenzweig, C; Pounds, JA				Root, TL; Price, JT; Hall, KR; Schneider, SH; Rosenzweig, C; Pounds, JA			Fingerprints of global warming on wild animals and plants	NATURE			English	Article								Over the past 100 years, the global average temperature has increased by approximately 0.6 degreesC and is projected to continue to rise at a rapid rate(1). Although species have responded to climatic changes throughout their evolutionary history(2), a primary concern for wild species and their ecosystems is this rapid rate of change(3). We gathered information on species and global warming from 143 studies for our meta-analyses. These analyses reveal a consistent temperature-related shift, or 'fingerprint', in species ranging from molluscs to mammals and from grasses to trees. Indeed, more than 80% of the species that show changes are shifting in the direction expected on the basis of known physiological constraints of species. Consequently, the balance of evidence from these studies strongly suggests that a significant impact of global warming is already discernible in animal and plant populations. The synergism of rapid temperature rise and other stresses, in particular habitat destruction, could easily disrupt the connectedness among species and lead to a reformulation of species communities, reflecting differential changes in species, and to numerous extirpations and possibly extinctions.	Stanford Univ, Inst Int Studies, Ctr Environm Sci & Policy, Stanford, CA 94305 USA; Amer Bird Conservancy, Boulder, CO 80301 USA; Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; NASA, Goddard Inst Space Studies, New York, NY 10025 USA; Monteverde Cloud Forest Preserve & Trop Sci Ctr, Golden Toad Lab Conservat, Santa Elena, Puntarenas, Costa Rica	Stanford University; Michigan State University; Stanford University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Root, TL (corresponding author), Stanford Univ, Inst Int Studies, Ctr Environm Sci & Policy, Stanford, CA 94305 USA.			Hall, Kimberly R./0000-0002-7802-3558				Darwin C., 1964, ORIGIN SPECIES FACSI; Fleming R. A., 1995, P505; HARRIS AH, 1993, QUATERNARY RES, V40, P127, DOI 10.1006/qres.1993.1063; Hedges LV, 2014, STAT METHODS META AN; Houghton J. T., 2001, CLIMATE CHANGE 2001; HUNTER JE, 1995, METHODS METAANAL COR; McCarthy J.J., 2001, CLIMATE CHANGE 2001; OVERPECK JT, 1992, GEOLOGY, V20, P1071, DOI 10.1130/0091-7613(1992)020<1071:MENAVC>2.3.CO;2; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; RAJU NS, 1986, APPL PSYCH MEAS, V10, P195, DOI 10.1177/014662168601000211; Root TL, 2002, WILDLIFE RESPONSES TO CLIMATE CHANGE: NORTH AMERICAN CASE STUDIES, P1; SCHNEIDER SH, 1998, STATUS TRENDS NATION, P89; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; [No title captured]	14	3195	3472	54	2988	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					57	60		10.1038/nature01333	http://dx.doi.org/10.1038/nature01333			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511952				2022-12-28	WOS:000180165500035
J	Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA				Li, F; Xiong, Y; Wang, JM; Cho, HD; Tomita, K; Weiner, AM; Steitz, TA			Crystal structures of the Bacillus stearothermophilus CCA-adding enzyme and its complexes with ATP or CTP	CELL			English	Article							TRANSFER-RNA NUCLEOTIDYLTRANSFERASE; MAMMALIAN POLY(A) POLYMERASE; DNA-POLYMERASE; BINDING; PRIMER; REGION; BETA; END	CCA-adding enzymes polymerize CCA onto the 3' terminus of immature tRNAs without using a nucleic acid template. The 3.0 Angstrom resolution crystal structures of the CCA-adding enzyme from Bacillus stearothermophilus and its complexes with ATP or CTP reveal a sea-horse-shaped subunit consisting of four domains: head, neck, body, and tail. The head is structurally homologous to the palm domain of DNA polymerase beta but has additional structural features and functions. The neck, body, and tail represent new protein folding motifs. The neck provides a specific template for the incoming ATP or CTP, whereas the body and tail may bind tRNA. Each subunit has one active site capable of switching its base specificity between ATP and CTP, an important component of the CCA-adding mechanism.	Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; Yale Univ, Dept Chem, New Haven, CT 06520 USA; Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Washington, Sch Med, Dept Biochem, Seattle, WA 98195 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Washington; University of Washington Seattle	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	eatherton@csb.yale.edu	Tomita, Kozo/J-5746-2013; Steitz, Thomas A./C-6559-2009; Tomita, Kozo/E-9390-2017	Tomita, Kozo/0000-0002-7374-3898	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057510, R01GM059804] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM57510, GM59804] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI M, 1990, J BIOL CHEM, V265, P16216; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346; Brautigam CA, 1998, CURR OPIN STRUC BIOL, V8, P54, DOI 10.1016/S0959-440X(98)80010-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427; DEUTSCHER MP, 1972, J BIOL CHEM, V247, P459; DEUTSCHER MP, 1982, ENZYMES, V15, P183, DOI DOI 10.1016/S1874-6047(08)60279-6; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EVANS JA, 1978, J BIOL CHEM, V253, P7276; Ferre-D'Amare AR, 1998, NATURE, V395, P567, DOI 10.1038/26912; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Ippolito JA, 1998, P NATL ACAD SCI USA, V95, P9819, DOI 10.1073/pnas.95.17.9819; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x; Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193; MILLER JP, 1971, J BIOL CHEM, V246, P1280; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SAKON J, 1993, BIOCHEMISTRY-US, V32, P11977, DOI 10.1021/bi00096a006; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9; SPRINZL M, 1977, EUR J BIOCHEM, V81, P579, DOI 10.1111/j.1432-1033.1977.tb11985.x; Tomari Y, 2000, GENES CELLS, V5, P689, DOI 10.1046/j.1365-2443.2000.00360.x; Tomita K, 2001, SCIENCE, V294, P1334, DOI 10.1126/science.1063816; ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x	38	97	98	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					815	824		10.1016/S0092-8674(02)01115-7	http://dx.doi.org/10.1016/S0092-8674(02)01115-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526808	Bronze			2022-12-28	WOS:000179862600008
J	Donovan, P				Donovan, P			Rape and HIV/AIDS in Rwanda	LANCET			English	Article											Donovan, P (corresponding author), POB 39773, Nairobi, Kenya.								0	41	42	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S17	S18		10.1016/S0140-6736(02)11804-6	http://dx.doi.org/10.1016/S0140-6736(02)11804-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504487				2022-12-28	WOS:000180064500008
J	Belfort, MA; Anthony, J; Saade, GR; Allen, JC				Belfort, MA; Anthony, J; Saade, GR; Allen, JC		Nimodipine Study Grp	A comparison of magnesium sulfate and nimodipine for the prevention of eclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEVERE PREECLAMPSIA; BLOOD-FLOW; MANAGEMENT; PREGNANCY; PLACEBO	OBJECTIVE Magnesium sulfate may prevent eclampsia by reducing cerebral vasoconstriction and ischemia. Nimodipine is a calcium-channel blocker with specific cerebral vasodilator activity. Our objective was to determine whether nimodipine is more effective than magnesium sulfate for seizure prophylaxis in women with severe preeclampsia. METHODS We conducted an unblinded, multicenter trial in which 1650 women with severe preeclampsia were randomly assigned to receive either nimodipine (60 mg orally every 4 hours) or intravenous magnesium sulfate (given according to the institutional protocol) from enrollment until 24 hours post partum. High blood pressure was controlled with intravenous hydralazine as needed. The primary outcome measure was the development of eclampsia, as defined by a witnessed tonic-clonic seizure. RESULTS Demographic and clinical characteristics were similar in the two groups. The women who received nimodipine were more likely to have a seizure than those who received magnesium sulfate (21 of 819 [2.6 percent] vs. 7 of 831 [0.8 percent], P=0.01). The adjusted risk ratio for eclampsia associated with nimodipine, as compared with magnesium sulfate, was 3.2 (95 percent confidence interval, 1.1 to 9.1). The antepartum seizure rates did not differ significantly between groups, but the nimodipine group had a higher rate of postpartum seizures (9 of 819 [1.1 percent] vs. 0 of 831, P=0.01). There were no significant differences in neonatal outcome between the two groups. More women in the magnesium sulfate group than in the nimodipine group needed hydralazine to control blood pressure (54.3 percent vs. 45.7 percent, P<0.001). CONCLUSIONS Magnesium sulfate is more effective than nimodipine for prophylaxis against seizures in women with severe preeclampsia.	Univ Utah, Hlth Sci Ctr, Dept Obstet & Gynecol, Salt Lake City, UT USA; Int Hlth Care Utah Valley Reg Med Ctr, Provo, UT USA; Univ Cape Town, ZA-7925 Cape Town, South Africa; Univ Texas, Med Branch, Galveston, TX 77550 USA; Univ Texas, Sch Publ Hlth, Houston, TX USA	Utah System of Higher Education; University of Utah; University of Cape Town; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health	Belfort, MA (corresponding author), 1034 N 500 W, Provo, UT 84604 USA.							[Anonymous], 1995, LANCET, V346, P258; [Anonymous], ACOG TECHN B; Belfort MA, 1999, AM J OBSTET GYNECOL, V181, P402, DOI 10.1016/S0002-9378(99)70569-7; BELFORT MA, 1992, AM J OBSTET GYNECOL, V167, P661, DOI 10.1016/S0002-9378(11)91567-1; Belfort MA, 2002, AM J OBSTET GYNECOL, V187, P626, DOI 10.1067/mob.2002.125241; BELFORT MA, 1994, AM J OBSTET GYNECOL, V171, P417, DOI 10.1016/0002-9378(94)90277-1; BOURA ALA, 1991, PLACENTA, V12, P453, DOI 10.1016/0143-4004(91)90023-9; Coetzee EJ, 1998, BRIT J OBSTET GYNAEC, V105, P300, DOI 10.1111/j.1471-0528.1998.tb10090.x; COTTON DB, 1984, AM J OBSTET GYNECOL, V148, P162, DOI 10.1016/S0002-9378(84)80169-6; DONALDSON JO, 1988, SEMIN NEUROL, V8, P230, DOI 10.1055/s-2008-1041383; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; FLEISS JL, 1981, STATISTICAL METHODS, P64; HORN EH, 1990, BRIT MED J, V301, P794, DOI 10.1136/bmj.301.6755.794; LUCAS MJ, 1995, NEW ENGL J MED, V333, P201, DOI 10.1056/NEJM199507273330401; Mahmoudi N, 1999, J WOMEN HEALTH GEN-B, V8, P495, DOI 10.1089/jwh.1.1999.8.495; Morriss MC, 1997, OBSTET GYNECOL, V89, P561; OVERGAARD J, 1975, STROKE, V6, P402, DOI 10.1161/01.STR.6.4.402; Panchal S, 2001, ANESTH ANALG, V93, P134; PRITCHARD JA, 1955, SURG GYNECOL OBSTET, V100, P131; RICHARDS A, 1988, J NEUROL NEUROSUR PS, V51, P416, DOI 10.1136/jnnp.51.3.416; Sawhney H, 2000, J Obstet Gynaecol Res, V26, P351; SCHWARTZ RB, 1992, AM J ROENTGENOL, V159, P379, DOI 10.2214/ajr.159.2.1632361; SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P1141, DOI 10.1016/0002-9378(90)90002-O; TROMMER BL, 1988, STROKE, V19, P326, DOI 10.1161/01.STR.19.3.326; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; VANDAMME H, 1994, CARDIOVASC PATHOL, V3, P9, DOI 10.1016/1054-8807(94)90003-5; WILL AD, 1987, NEUROLOGY, V37, P1555, DOI 10.1212/WNL.37.9.1555; Zeeman GG, 2001, AM J OBSTET GYNECOL, V185, pS168, DOI 10.1016/S0002-9378(01)80347-1	29	164	172	0	4	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					304	311		10.1056/NEJMoa021180	http://dx.doi.org/10.1056/NEJMoa021180			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540643				2022-12-28	WOS:000180507200005
J	Michaelsson, K; Lithell, H; Vessby, B; Melhus, H				Michaelsson, K; Lithell, H; Vessby, B; Melhus, H			Serum retinol levels and the risk of fracture	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; VITAMIN-A INTAKE; BONE-MINERAL DENSITY; HIP FRACTURE; ALPHA-TOCOPHEROL; BETA-CAROTENE; HYPERVITAMINOSIS-A; GENE-EXPRESSION; PLASMA RETINOL	BACKGROUND Although studies in animals and epidemiologic studies have indicated that a high vitamin A intake is associated with increased bone fragility, no biologic marker of vitamin A status has thus far been used to assess the risk of fractures in humans. METHODS We enrolled 2322 men, 49 to 51 years of age, in a population-based, longitudinal cohort study. Serum retinol and beta carotene were analyzed in samples obtained at enrollment. Fractures were documented in 266 men during 30 years of follow-up. Cox regression analysis was used to determine the risk of fracture according to the serum retinol level. RESULTS The risk of fracture was highest among men with the highest levels of serum retinol. Multivariate analysis of the risk of fracture in the highest quintile for serum retinol (>75.62 microg per deciliter [2.64 micromol per liter]) as compared with the middle quintile (62.16 to 67.60 microg per deciliter [2.17 to 2.36 micromol per liter]) showed that the rate ratio was 1.64 (95 percent confidence interval, 1.12 to 2.41) for any fracture and 2.47 (95 percent confidence interval, 1.15 to 5.28) for hip fracture. The risk of fracture was further increased within the highest quintile for serum retinol. Men with retinol levels in the 99th percentile (>103.12 microg per deciliter [3.60 micromol per liter]) had an overall risk of fracture that exceeded the risk among men with lower levels by a factor of seven (P<0.001). The level of serum beta carotene was not associated with the risk of fracture. CONCLUSIONS Our findings, which are consistent with the results of studies in animals, as well as in vitro and epidemiologic dietary studies, suggest that current levels of vitamin A supplementation and food fortification in many Western countries may need to be reassessed.	Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Geriatr, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Publ Hlth & Caring Sci, Sect Clin Nutr Res, S-75185 Uppsala, Sweden; Univ Uppsala Hosp, Dept Med Sci, Clin Pharmacol Sect, S-75185 Uppsala, Sweden	Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital; Uppsala University; Uppsala University Hospital	Michaelsson, K (corresponding author), Univ Uppsala Hosp, Dept Surg Sci, Sect Orthoped, S-75185 Uppsala, Sweden.	karl.michaelsson@surgsci.uu.se	Michaelsson, Karl/AAM-9094-2021	Michaelsson, Karl/0000-0003-2815-1217				Ballew C, 2001, J BONE MINER RES, V16, P2306, DOI 10.1359/jbmr.2001.16.12.2306; Ballew C, 2001, AM J CLIN NUTR, V73, P586; Baron JA, 2001, ARCH INTERN MED, V161, P983, DOI 10.1001/archinte.161.7.983; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; BERSHAD S, 1985, NEW ENGL J MED, V313, P981, DOI 10.1056/NEJM198510173131604; Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; BITZEN U, 1994, SCAND J CLIN LAB INV, V54, P611, DOI 10.3109/00365519409087540; COMSTOCK GW, 1993, CLIN CHEM, V39, P1075; CRUZ JAA, 1991, EUR J CLIN NUTR, V45, P121; Cumming RG, 1997, EPIDEMIOL REV, V19, P244, DOI 10.1093/oxfordjournals.epirev.a017956; CUMMINGS SR, 1995, NEW ENGL J MED, V332, P767, DOI 10.1056/NEJM199503233321202; Denke MA, 2002, JAMA-J AM MED ASSOC, V287, P102, DOI 10.1001/jama.287.1.102; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; FRAME B, 1974, ANN INTERN MED, V80, P44, DOI 10.7326/0003-4819-80-1-44; GARRY PJ, 1987, AM J CLIN NUTR, V46, P989, DOI 10.1093/ajcn/46.6.989; Grisso JA, 1997, AM J EPIDEMIOL, V145, P786, DOI 10.1093/oxfordjournals.aje.a009171; HALLFRISCH J, 1994, AM J CLIN NUTR, V60, P176, DOI 10.1093/ajcn/60.2.176; HARADA H, 1995, ENDOCRINOLOGY, V136, P5329, DOI 10.1210/en.136.12.5329; Heinzl H, 1997, COMPUT METH PROG BIO, V54, P201, DOI 10.1016/S0169-2607(97)00043-6; Johansson S, 2001, J BONE MINER RES, V16, P1899, DOI 10.1359/jbmr.2001.16.10.1899; JOHANSSON S, IN PRESS BONE; JOHNELL O, 1992, OSTEOPOROSIS INT, V2, P298, DOI 10.1007/BF01623186; JOHNSON EJ, 1992, J AM COLL NUTR, V11, P682; KATZ CM, 1972, METABOLISM, V21, P1171, DOI 10.1016/0026-0495(72)90112-6; KINDMARK A, 1995, CALCIFIED TISSUE INT, V57, P242, DOI 10.1007/BF00310266; KINDMARK A, 1993, BIOCHEM BIOPH RES CO, V192, P1367, DOI 10.1006/bbrc.1993.1567; KRASINSKI SD, 1990, METABOLISM, V39, P357, DOI 10.1016/0026-0495(90)90249-C; Leo MA, 1999, AM J CLIN NUTR, V69, P1071; Lofthus CM, 2001, BONE, V29, P413, DOI 10.1016/S8756-3282(01)00603-2; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; MEYER HE, 1993, AM J EPIDEMIOL, V137, P1203, DOI 10.1093/oxfordjournals.aje.a116622; MILNE DB, 1986, CLIN CHEM, V32, P874; MURRAY JC, 1983, ARCH DERMATOL, V119, P675, DOI 10.1001/archderm.119.8.675; NAESSEN T, 1989, AM J EPIDEMIOL, V130, P289, DOI 10.1093/oxfordjournals.aje.a115335; Neuhouser ML, 2001, J NUTR, V131, P2184, DOI 10.1093/jn/131.8.2184; Nierenberg DW, 1997, AM J CLIN NUTR, V66, P315, DOI 10.1093/ajcn/66.2.315; Promislow JHE, 2002, J BONE MINER RES, V17, P1349, DOI 10.1359/jbmr.2002.17.8.1349; ROIDT L, 1988, AM J EPIDEMIOL, V128, P645, DOI 10.1093/oxfordjournals.aje.a115012; ROTHMAN KJ, 1995, NEW ENGL J MED, V333, P1369, DOI 10.1056/NEJM199511233332101; SANESHIGE S, 1995, BIOCHEM J, V309, P721, DOI 10.1042/bj3090721; SCHEVEN BAA, 1990, BONE, V11, P53, DOI 10.1016/8756-3282(90)90072-7; SEELEY DG, 1991, ANN INTERN MED, V115, P837, DOI 10.7326/0003-4819-115-11-837; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; STAUBER PM, 1991, AM J CLIN NUTR, V54, P878, DOI 10.1093/ajcn/54.5.878; Stephensen CB, 2000, AM J CLIN NUTR, V72, P1170; Sundstrom J, 2001, CIRCULATION, V103, P836, DOI 10.1161/01.CIR.103.6.836; Underwood BA, 1984, RETINOIDS, P281; vonReinersdorff D, 1996, J LIPID RES, V37, P1875; WILLETT WC, 1983, AM J CLIN NUTR, V38, P631, DOI 10.1093/ajcn/38.4.631	51	234	246	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					287	294		10.1056/NEJMoa021171	http://dx.doi.org/10.1056/NEJMoa021171			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540641				2022-12-28	WOS:000180507200003
J	Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O				Dale, JK; Maroto, M; Dequeant, ML; Malapert, P; McGrew, M; Pourquie, O			Periodic Notch inhibition by lunatic fringe underlies the chick segmentation clock	NATURE			English	Article							SOMITE BOUNDARY FORMATION; INTRACELLULAR DOMAIN; DELTA-HOMOLOG; EXPRESSION; GENE; GLYCOSYLTRANSFERASE; REQUIRES; SOMITOGENESIS; OSCILLATOR; RELEASE	The segmented aspect of the vertebrate body plan first arises through the sequential formation of somites. The periodicity of somitogenesis is thought to be regulated by a molecular oscillator, the segmentation clock, which functions in presomitic mesoderm cells. This oscillator controls the periodic expression of 'cyclic genes', which are all related to the Notch pathway(1-7). The mechanism underlying this oscillator is not understood. Here we show that the protein product of the cyclic gene lunatic fringe (Lfng), which encodes a glycosyltransferase that can modify Notch activity, oscillates in the chick presomitic mesoderm. Overexpressing Lfng in the paraxial mesoderm abolishes the expression of cyclic genes including endogenous Lfng and leads to defects in segmentation. This effect on cyclic genes phenocopies inhibition of Notch signalling in the presomitic mesoderm. We therefore propose that Lfng establishes a negative feedback loop that implements periodic inhibition of Notch, which in turn controls the rhythmic expression of cyclic genes in the chick presomitic mesoderm. This feedback loop provides a molecular basis for the oscillator underlying the avian segmentation clock.	Univ Mediterranee AP Marseille, Lab Genet & Phys Dev, Inst Biol Dev Marseille, CNRS,INSERM, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Pourquie, O (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.		Pourquié, Olivier/CAJ-5443-2022; Dale, Kim/A-4480-2016	Pourquié, Olivier/0000-0001-5189-1227; Dale, Kim/0000-0002-9294-947X				Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Barrantes ID, 1999, CURR BIOL, V9, P470, DOI 10.1016/S0960-9822(99)80212-7; Bruckner K, 2000, NATURE, V406, P411, DOI 10.1038/35019075; Cole SE, 2002, DEV CELL, V3, P75, DOI 10.1016/S1534-5807(02)00212-5; CONLON RA, 1995, DEVELOPMENT, V121, P1533; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Evrard YA, 1998, NATURE, V394, P377, DOI 10.1038/28632; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Holley SA, 2000, GENE DEV, V14, P1678; Holley SA, 2002, DEVELOPMENT, V129, P1175; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Jouve C, 2000, DEVELOPMENT, V127, P1421; Mansouri A, 1997, DEV DYNAM, V210, P53, DOI 10.1002/(SICI)1097-0177(199709)210:1<53::AID-AJA6>3.0.CO;2-0; Maroto M, 2001, CURR TOP DEV BIOL, V51, P221, DOI 10.1016/S0070-2153(01)51007-8; McGrew MJ, 1998, CURR BIOL, V8, P979, DOI 10.1016/S0960-9822(98)70401-4; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Sato Y, 2002, DEVELOPMENT, V129, P3633; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Waltzer L, 1995, NUCLEIC ACIDS RES, V23, P4939, DOI 10.1093/nar/23.24.4939; Zhang NA, 1998, NATURE, V394, P374, DOI 10.1038/28625	29	252	259	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					275	278		10.1038/nature01244	http://dx.doi.org/10.1038/nature01244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529645				2022-12-28	WOS:000180397600049
J	Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM				Srinivasan, A; Wolfenden, LL; Song, XY; Mackie, K; Hartsell, TL; Jones, HD; Diette, GB; Orens, JB; Yung, RC; Ross, TL; Merz, W; Scheel, PJ; Haponik, EF; Perl, TM			An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; TRANSMISSION; CONTAMINATION; ENDOSCOPY	Background: Endoscopes, including bronchoscopes, are the medical devices most frequently associated with outbreaks of nosocomial infections. We investigated an outbreak of Pseudomonas aeruginosa infections after bronchoscopic procedures. Methods: Microbiologic results were reviewed to determine the rates of recovery of P. aeruginosa from bronchoalveolar-lavage specimens. Environmental samples from endoscopes and the endoscopy suite were cultured. Medical records were reviewed to identify infections in the 14 days after a bronchoscopy. Results: The rate of recovery of P. aeruginosa from bronchoalveolar-lavage specimens obtained with use of endoscopy-suite bronchoscopes increased from 10.4 percent at base line to 31.0 percent during the outbreak (relative risk, 2.97; 95 percent confidence interval, 2.28 to 3.90). Cultures of samples from three bronchoscopes grew P. aeruginosa, whereas cultures of samples from the environment, instrument-cleaning machines, and gastrointestinal endoscopes did not. The three bronchoscopes had been part of a nationwide recall. A total of 414 patients underwent bronchoscopy during the outbreak, and there were 48 respiratory tract and bloodstream infections among 39 of these patients (9.4 percent). In 32 infections (66.7 percent), P. aeruginosa was confirmed as a potentially causative organism. Exposure to a potentially contaminated bronchoscope may have had a role in the death of three patients. The rate of recovery of P. aeruginosa returned to base line after the instruments were removed from service. Conclusions: This large outbreak of P. aeruginosa infections related to bronchoscopy was apparently caused by a loose biopsy-port cap in the bronchoscopes. Instrument safety and surveillance methods for bronchoscopy must be improved, and better recall procedures are needed for medical devices.	Johns Hopkins Med Inst, Dept Hosp Epidemiol & Infect Control, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Infect Dis, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Div Nephrol, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Srinivasan, A (corresponding author), Johns Hopkins Univ Hosp, Off Antibiot Management, 600 N Wolfe St,Carnegie Bldg,Rm 284, Baltimore, MD 21287 USA.				ODCDC CDC HHS [UR8/CCU315092] Funding Source: Medline	ODCDC CDC HHS		Agerton T, 1997, JAMA-J AM MED ASSOC, V278, P1073, DOI 10.1001/jama.278.13.1073; [Anonymous], 1994, NNIS MAN NAT NOS INF; Colt HG, 2000, CHEST, V118, P183, DOI 10.1378/chest.118.1.183; Diette GB, 1999, CHEST, V115, P397, DOI 10.1378/chest.115.2.397; *FDA, 2002, FDA REC POL; GOERING RV, 1993, INFECT CONT HOSP EP, V14, P595; Kirkpatrick BD, 1999, CLIN INFECT DIS, V29, P1268, DOI 10.1086/313456; Kirschke DL, 2003, NEW ENGL J MED, V348, P214, DOI 10.1056/NEJMoa021791; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, DOI 10.17226/9728; MARKOVITZ A, 1979, WESTERN J MED, V131, P550; MARTIN MA, 1994, AM J INFECT CONTROL, V22, P19, DOI 10.1016/0196-6553(94)90087-6; Mehta AC, 1999, CLIN CHEST MED, V20, P19, DOI 10.1016/S0272-5231(05)70123-4; Michele TM, 1997, JAMA-J AM MED ASSOC, V278, P1093, DOI 10.1001/jama.278.13.1093; NELSON KE, 1983, AM REV RESPIR DIS, V127, P97, DOI 10.1164/arrd.1983.127.1.97; PAPPAS SA, 1983, AM REV RESPIR DIS, V127, P391; PEREIRA W, 1975, AM REV RESPIR DIS, V112, P59; SPACH DH, 1993, ANN INTERN MED, V118, P117, DOI 10.7326/0003-4819-118-2-199301150-00008; Walter V A, 2000, Gastrointest Endosc Clin N Am, V10, P265; WEBB SF, 1975, CHEST, V68, P703, DOI 10.1378/chest.68.5.703; WHEELER PW, 1989, J INFECT DIS, V159, P954, DOI 10.1093/infdis/159.5.954	20	126	137	0	5	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					221	227		10.1056/NEJMoa021808	http://dx.doi.org/10.1056/NEJMoa021808			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529462				2022-12-28	WOS:000180390600006
J	McNeil, BI; Matear, RJ; Key, RM; Bullister, JL; Sarmiento, JL				McNeil, BI; Matear, RJ; Key, RM; Bullister, JL; Sarmiento, JL			Anthropogenic CO2 uptake by the ocean based on the global chlorofluorocarbon data set	SCIENCE			English	Article							ATMOSPHERIC O-2; CARBON; WATER; VARIABILITY; INVENTORY; SINKS	We estimated the oceanic inventory of anthropogenic carbon dioxide (CO2) from 1980 to 1999 using a technique based on the global chlorofluorocarbon data set. Our analysis suggests that the ocean stored 14.8 petagrams of anthropogenic carbon from mid-1980 to mid-1989 and 17.9 petagrams of carbon from mid-1990 to mid-1999, indicating an oceanwide net uptake of 1.6 and 2.0 +/- 0.4 petagrams of carbon per year, respectively. Our results provide an upper limit on the solubility-driven anthropogenic CO2 flux into the ocean, and they suggest that most ocean general circulation models are overestimating oceanic anthropogenic CO2 uptake over the past two decades.	Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA; Commonwealth Sci & Ind Res Org, Marine Res, Hobart, Tas, Australia; Antarctic Cooperat Res Ctr, Hobart, Tas, Australia; NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA	McNeil, BI (corresponding author), Princeton Univ, Atmospher & Ocean Sci Program, Princeton, NJ 08544 USA.		matear, richard J/C-5133-2011	matear, richard J/0000-0002-3225-0800; McNeil, Ben/0000-0001-5765-7087				Battle M, 2000, SCIENCE, V287, P2467, DOI 10.1126/science.287.5462.2467; Bopp L, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001445; Doney SC, 1998, GEOPHYS RES LETT, V25, P1399, DOI 10.1029/98GL00844; England MH, 2001, REV GEOPHYS, V39, P29, DOI 10.1029/1998RG000043; GOYET C, 1989, DEEP-SEA RES, V36, P1635, DOI 10.1016/0198-0149(89)90064-2; Haine TWN, 2002, J PHYS OCEANOGR, V32, P1932, DOI 10.1175/1520-0485(2002)032<1932:AGTTWM>2.0.CO;2; Hall TM, 2002, J PHYS OCEANOGR, V32, P1987, DOI 10.1175/1520-0485(2002)032<1987:OOTDTI>2.0.CO;2; Houghton J. T., 2001, CLIMATE CHANGE 2001; Keeling CD., 2002, TRENDS COMPENDIUM DA; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; Keeling RF, 2002, P NATL ACAD SCI USA, V99, P7848, DOI 10.1073/pnas.122154899; Keller K, 2001, DEEP-SEA RES PT II, V49, P345; Levitus S, 2000, SCIENCE, V287, P2225, DOI 10.1126/science.287.5461.2225; Matear RJ, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/2000GC000086; Matear RJ, 1999, TELLUS B, V51, P722, DOI 10.1034/j.1600-0889.1999.t01-1-00012.x; MATEAR RJ, UNPUB; McNeil BI, 2001, J GEOPHYS RES-OCEANS, V106, P31431, DOI 10.1029/2000JC000331; Min DH, 2000, GEOPHYS RES LETT, V27, P3909, DOI 10.1029/1999GL011318; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; ORR JC, 2001, INT GEOSPH BIOSPH PR; Peng TH, 1998, NATURE, V396, P560, DOI 10.1038/25103; Plattner GK, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001746; Sabine CL, 1999, GLOBAL BIOGEOCHEM CY, V13, P179, DOI 10.1029/1998GB900022; SARMIENTO JL, 1982, OBJECTIVE ANAL TRITI; Sonnerup RE, 2001, GEOPHYS RES LETT, V28, P1739, DOI 10.1029/2000GL012569; SUNDQUIST ET, 1979, SCIENCE, V204, P1203, DOI 10.1126/science.204.4398.1203; Walker SJ, 2000, J GEOPHYS RES-OCEANS, V105, P14285, DOI 10.1029/1999JC900273; WALLACE DWR, 1995, 5 OOSDP TEX A M U; WARNER MJ, 1985, DEEP-SEA RES, V32, P1485, DOI 10.1016/0198-0149(85)90099-8; Watanabe YW, 2000, MAR CHEM, V72, P297, DOI 10.1016/S0304-4203(00)00087-6	30	130	135	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					235	239		10.1126/science.1077429	http://dx.doi.org/10.1126/science.1077429			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522246				2022-12-28	WOS:000180284000034
J	Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA				Druss, BG; Marcus, SC; Olfson, M; Tanielian, T; Pincus, HA			Trends in care by nonphysician clinicians in the United States.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSE PRACTITIONERS; PATIENT-CARE; PHYSICIAN ASSISTANTS; OUTCOMES	BACKGROUND: The 1990s saw rising numbers of graduates of training programs for nonphysician clinicians, passage of legislation expanding their scope of practice, and a proliferation of managed-care models that emphasized the use of these providers as a strategy for containing health care costs. METHODS: We used two nationally representative surveys to examine trends in outpatient care provided by physicians and nonphysician clinicians between 1987 and 1997, adjusting for the case mix. Analyses examined care provided by 10 categories of nonphysician clinicians: chiropractors, midwives, nurses or nurse practitioners, optometrists, podiatrists, physician assistants, physical or occupational therapists, psychologists, social workers, and others. RESULTS: Between 1987 and 1997, the proportion of patients who saw a nonphysician clinician rose from 30.6 percent to 36.1 percent (adjusted relative risk for 1997 as compared with 1987, 1.42 [95 percent confidence interval, 1.35 to 1.50]). The trend was driven by an increase in the proportion of persons who visited both a physician and a nonphysician clinician (from 23.5 percent to 30.9 percent; adjusted relative risk, 1.49 [95 percent confidence interval, 1.40 to 1.58]), rather than an increase in the proportion who saw only a nonphysician clinician (from 7.2 percent to 5.3 percent; adjusted relative risk, 0.81 [95 percent confidence interval, 0.70 to 0.93]). This pattern was consistent in analyses of specific medical conditions and specific types of nonphysician clinicians. There was an increase in the proportion of patients obtaining preventive services from nonphysician clinicians and a decline in the proportion receiving acute care services from such clinicians. CONCLUSIONS: From 1987 to 1997, there was a degree of differentiation between physicians and nonphysician clinicians with respect to the services they provided but not with respect to the patients they treated. The implications of these findings hinge on the degree to which the increase in conjoint service delivery represents growing coordination or fragmentation of care.	Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, Atlanta, GA 30322 USA; Univ Penn, Sch Social Work, Philadelphia, PA 19104 USA; Columbia Univ, Coll Phys & Surg, New York, NY USA; RAND, Washington, DC USA; RAND, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Pittsburgh, PA USA	Emory University; Rollins School Public Health; University of Pennsylvania; Columbia University; RAND Corporation; RAND Corporation; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Druss, BG (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Dept Hlth Policy & Management, 1518 Clifton Rd NE, Atlanta, GA 30322 USA.		Olfson, Mark/AAA-8547-2021		NIMH NIH HHS [K08-MH01556-01A] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001556] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		*AG HEALTHC RES QU, 2002, CLIN CLASS SOFTW ICD; COHEN SB, 2000, AHRQ PUBLICATION; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P788, DOI 10.1001/jama.280.9.788; Cooper RA, 1998, JAMA-J AM MED ASSOC, V280, P795, DOI 10.1001/jama.280.9.795; DIAL TH, 1995, HEALTH AFFAIR, V14, P168, DOI 10.1377/hlthaff.14.2.168; EDWARDS WS, 1989, DHHS PUBLICATION PHS; Glasgow RE, 2001, MILBANK Q, V79, P579, DOI 10.1111/1468-0009.00222; GOODE E, 2002, NY TIMES        0611, pF1; Grumbach K, 1998, JAMA-J AM MED ASSOC, V280, P825, DOI 10.1001/jama.280.9.825; *HLTH POL TRACK SE, 2002, NAT C STAT LEG JUN; HOFFMAN C, 1994, HEALTH AFFAIR, V13, P140, DOI 10.1377/hlthaff.13.4.140; Hooker RS, 2001, HEALTH AFFAIR, V20, P231, DOI 10.1377/hlthaff.20.4.231; HOSMER DW, 1989, APPL LOGISTIC REGRES; KIRBY JB, 2001, AHRQ PUBLICATION; MELFI C, 1995, J CLIN EPIDEMIOL, V48, P917, DOI 10.1016/0895-4356(94)00202-2; Mundinger, 2000, JAMA, V283, P2521; SEKSCENSKI ES, 1994, NEW ENGL J MED, V331, P1266, DOI 10.1056/NEJM199411103311905; Shah BV, 1997, SUDAAN USERS MANUAL; SOX HC, 1979, ANN INTERN MED, V91, P459, DOI 10.7326/0003-4819-91-3-459; STARFIELD B, 1998, PRIMARY CARE BALANCI, P94; STARFIELD BH, 1976, MED CARE, V14, P625, DOI 10.1097/00005650-197607000-00008; Wagner EH, 2000, BMJ-BRIT MED J, V320, P569, DOI 10.1136/bmj.320.7234.569; *WHO, 1977, 9 REV C 1975 GEN WHO; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zuvekas SH, 2002, INQUIRY-J HEALTH CAR, V39, P76, DOI 10.5034/inquiryjrnl_39.1.76	25	117	118	0	9	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 9	2003	348	2					130	137		10.1056/NEJMsa020993	http://dx.doi.org/10.1056/NEJMsa020993			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	633DL	12519924				2022-12-28	WOS:000180263900006
J	Dale, H				Dale, H			WHO should build partnerships with the pharmaceutical industry to improve public health	LANCET			English	Article									IFPMA, Geneva, Switzerland		Dale, H (corresponding author), IFPMA, Geneva, Switzerland.								0	1	1	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					4	4		10.1016/S0140-6736(03)12182-4	http://dx.doi.org/10.1016/S0140-6736(03)12182-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521034				2022-12-28	WOS:000180191600004
J	Ghosh, S; Goldin, E; Gordon, FH; Malchow, HA; Rask-Madsen, J; Rutgeerts, P; Vyhnalek, P; Zadorova, Z; Palmer, T; Donoghue, S				Ghosh, S; Goldin, E; Gordon, FH; Malchow, HA; Rask-Madsen, J; Rutgeerts, P; Vyhnalek, P; Zadorova, Z; Palmer, T; Donoghue, S		Natalizumab Pan-European Study Grp	Natalizumab for active Crohn's disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-ADHESION MOLECULE-1; COTTON-TOP TAMARIN; MONOCLONAL-ANTIBODY; INTEGRIN ALPHA-4-BETA-7; LYMPHOID-TISSUE; IN-VIVO; COLITIS; MODELS	Background: In chronic inflammatory conditions such as Crohn's disease, the migration of leukocytes from the circulation into the parenchyma and their activation within inflammatory sites are mediated in part by (alpha)(sub 4) integrins. Methods: We conducted a double-blind, placebo-controlled trial of the (alpha)(sub 4) integrin-specific humanized monoclonal antibody natalizumab in 248 patients with moderate-to-severe Crohn's disease. Patients were randomly assigned to receive one of four treatments: two infusions of placebo; one infusion of 3 mg of natalizumab per kilogram of body weight, followed by placebo; two infusions of 3 mg of natalizumab per kilogram; or two infusions of 6 mg of natalizumab per kilogram. Infusions were given four weeks apart. Outcomes included changes in scores for the Crohn's Disease Activity Index (higher scores indicate more severe disease), the health-related quality of life, and C-reactive protein levels. Results: The group given two infusions of 6 mg of natalizumab per kilogram did not have a significantly higher rate of clinical remission (defined by a score of less than 150 on the Crohn's Disease Activity Index) than the placebo group at week 6 (the prospectively defined primary end point in the efficacy analysis). However, both groups that received two infusions of natalizumab had higher remission rates than the placebo group at multiple time points. Natalizumab also produced a significant improvement in response rates (defined by a reduction of at least 70 points in the score on the Crohn's Disease Activity Index). The highest remission rate was 44 percent and the highest response rate was 71 percent (at week 6 in the group given two infusions of 3 mg per kilogram). Overall, the two infusions of 6 mg of natalizumab per kilogram and of 3 mg per kilogram had similar effects. The quality of life improved in all natalizumab groups; C-reactive protein levels improved in groups receiving two infusions of natalizumab. The rates of adverse events were similar in all four groups. Conclusions: Treatment with the selective adhesion-molecule inhibitor natalizumab increased the rates of clinical remission and response, improved the quality of life and C-reactive protein levels, and was well tolerated in patients with active Crohn's disease.	Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; Hadassah Univ Hosp, IL-91120 Jerusalem, Israel; Royal Free Hosp, London NW3 2QG, England; Klinikum Leverkusen, Leverkusen, Germany; Herlev Hosp, Copenhagen, Denmark; Univ Hosp, Louvain, Belgium; Nemocnice Pardubice, Pardubice, Czech Republic; Kralovske Vinohrady, Prague, Czech Republic; Elan Pharmaceut, Stevenage, Herts, England	University of Edinburgh; Hebrew University of Jerusalem; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of Copenhagen; Herlev & Gentofte Hospital	Ghosh, S (corresponding author), Hammersmith Hosp, Imperial Coll London, London W12 0NN, England.			Zadorova, Zdena/0000-0002-9187-2466				BEST WR, 1976, GASTROENTEROLOGY, V70, P439; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Briskin M, 1997, AM J PATHOL, V151, P97; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; DAMLE NK, 1993, J IMMUNOL, V151, P2368; Farstad IN, 1997, AM J PATHOL, V150, P187; Gordon FH, 2001, GASTROENTEROLOGY, V121, P268, DOI 10.1053/gast.2001.26260; Gordon FH, 2002, ALIMENT PHARM THER, V16, P699, DOI 10.1046/j.1365-2036.2002.01205.x; Hesterberg PE, 1996, GASTROENTEROLOGY, V111, P1373, DOI 10.1053/gast.1996.v111.pm8898653; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; ISSEKUTZ TB, 1991, J IMMUNOL, V147, P4178; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; Johnston B, 1997, J IMMUNOL, V159, P4514; KOOPMAN G, 1994, J IMMUNOL, V152, P3760; LANDIS RJ, 1978, INT STAT REV, V46, P237; Leussink VI, 2002, ACTA NEUROPATHOL, V103, P131; LOBB RR, 1994, J CLIN INVEST, V94, P1722, DOI 10.1172/JCI117519; PODOLSKY DK, 1993, J CLIN INVEST, V92, P372, DOI 10.1172/JCI116575; POSTIGO AA, 1993, RES IMMUNOL, V144, P723, DOI 10.1016/S0923-2494(93)80057-6; Sandborn WJ, 2001, INFLAMM BOWEL DIS, V7, pS9, DOI 10.1002/ibd.3780070504; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Stein RB, 2001, SURG CLIN N AM, V81, P71, DOI 10.1016/S0039-6109(05)70274-7; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847	24	631	698	1	23	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					24	32		10.1056/NEJMoa020732	http://dx.doi.org/10.1056/NEJMoa020732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510039				2022-12-28	WOS:000180134400004
J	Ager, A				Ager, A			Psychosocial needs in complex emergencies	LANCET			English	Article									Queen Margaret Univ Coll, Ctr Int Hlth Studies, Edinburgh, Midlothian, Scotland; Queen Margaret Univ Coll, Psychosocial Working Grp, Edinburgh, Midlothian, Scotland	Queen Margaret University; Queen Margaret University	Ager, A (corresponding author), Queen Margaret Univ Coll, Ctr Int Hlth Studies, Edinburgh, Midlothian, Scotland.			Ager, Alastair/0000-0002-9474-3563					0	29	31	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S43	S44		10.1016/S0140-6736(02)11817-4	http://dx.doi.org/10.1016/S0140-6736(02)11817-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504500				2022-12-28	WOS:000180064500021
J	Eltzschig, HK; Lieberman, ES; Camann, WR				Eltzschig, HK; Lieberman, ES; Camann, WR			Regional anesthesia and analgesia for labor and delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SPINAL-EPIDURAL ANALGESIA; CESAREAN-DELIVERY; RANDOMIZED-TRIAL; INTRAPARTUM FEVER; NULLIPAROUS WOMEN; PAIN RELIEF; INTRAVENOUS MEPERIDINE; INTRATHECAL INJECTION; TRACHEAL INTUBATION; UNITED-STATES		Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Obstet & Gynecol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Tubingen, Dept Anesthesiol & Intens Care Med, Tubingen, Germany	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Eberhard Karls University of Tubingen	Camann, WR (corresponding author), Brigham & Womens Hosp, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA.	wcamann@partners.org						ACOG, 2002, OBSTET GYNECOL, V99, P869; Albright GA, 1997, REGION ANESTH, V22, P400, DOI 10.1016/S1098-7339(97)80025-9; Alexander JM, 2001, ANESTH ANALG, V92, P1524; *AM COLL OBST GYN, 1992, 104 ACOG; Bailey PL, 2000, NEW ENGL J MED, V343, P1228, DOI 10.1056/NEJM200010263431705; BARAKA A, 1981, ANESTHESIOLOGY, V54, P136, DOI 10.1097/00000542-198102000-00007; Barnardo PD, 2000, ANAESTHESIA, V55, P690, DOI 10.1046/j.1365-2044.2000.01536.x; Bloom SL, 1998, NEW ENGL J MED, V339, P76, DOI 10.1056/NEJM199807093390203; Bofill JA, 1997, AM J OBSTET GYNECOL, V177, P1465, DOI 10.1016/S0002-9378(97)70092-9; Borum SE, 1997, ANESTHESIOLOGY, V86, P487, DOI 10.1097/00000542-199702000-00024; Bricker L, 2002, AM J OBSTET GYNECOL, V186, pS94, DOI 10.1067/mob.2002.121549; CAMANN WR, 1991, BRIT J ANAESTH, V67, P565, DOI 10.1093/bja/67.5.565; CHESTNUT DH, 1994, ANESTHESIOLOGY, V80, P1201, DOI 10.1097/00000542-199406000-00006; CHESTNUT DH, 1994, ANESTHESIOLOGY, V80, P1193, DOI 10.1097/00000542-199406000-00005; CLARKE VT, 1994, ANESTHESIOLOGY, V81, P1083, DOI 10.1097/00000542-199410000-00041; Cohen SE, 2000, ANESTHESIOLOGY, V92, P387, DOI 10.1097/00000542-200002000-00019; COLLIS RE, 1995, LANCET, V345, P1413, DOI 10.1016/S0140-6736(95)92602-X; Dahl JB, 1999, ANESTHESIOLOGY, V91, P1919, DOI 10.1097/00000542-199912000-00045; DAngelo R, 1997, ANESTHESIOLOGY, V87, P166, DOI 10.1097/00000542-199707000-00023; Dashe JS, 1999, OBSTET GYNECOL, V93, P341, DOI 10.1016/S0029-7844(98)00415-3; Ecker JL, 2001, AM J OBSTET GYNECOL, V185, P883, DOI 10.1067/mob.2001.117364; FLOBERG J, 1987, ACTA OBSTET GYN SCAN, V66, P127, DOI 10.3109/00016348709083033; Fogel ST, 1998, ANESTH ANALG, V87, P119, DOI 10.1097/00000539-199807000-00026; Gambling DR, 1998, ANESTHESIOLOGY, V89, P1336, DOI 10.1097/00000542-199812000-00010; Goetzl L, 2001, PEDIATRICS, V108, P1099, DOI 10.1542/peds.108.5.1099; Goldberg AB, 1999, BIRTH-ISS PERINAT C, V26, P139, DOI 10.1046/j.1523-536x.1999.00139.x; GOYERT GL, 1989, NEW ENGL J MED, V320, P706, DOI 10.1056/NEJM198903163201106; Halpern SH, 1998, JAMA-J AM MED ASSOC, V280, P2105, DOI 10.1001/jama.280.24.2105; Hawkins JL, 1999, ANESTHESIOLOGY, V90, P600; Hawkins JL, 1997, ANESTHESIOLOGY, V86, P277, DOI 10.1097/00000542-199702000-00002; Hawthorne L, 1996, BRIT J ANAESTH, V76, P680, DOI 10.1093/bja/76.5.680; Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141; Howell CJ, 2002, BMJ-BRIT MED J, V325, P580; Howell CJ, 2002, BMJ-BRIT MED J, V325, P357, DOI 10.1136/bmj.325.7360.357; Howell CJ, 2001, BRIT J OBSTET GYNAEC, V108, P27, DOI 10.1016/S0306-5456(00)00012-7; HYNSON JM, 1991, ANESTHESIOLOGY, V74, P680, DOI 10.1097/00000542-199104000-00011; Impey L, 2000, AM J OBSTET GYNECOL, V182, P358, DOI 10.1016/S0002-9378(00)70224-9; Kannan S, 2001, REGION ANESTH PAIN M, V26, P468, DOI 10.1053/rapm.2001.24260; Khor LJH, 2000, ANAESTHESIA, V55, P1168, DOI 10.1046/j.1365-2044.2000.01720.x; Kubli M, 2002, ANESTH ANALG, V94, P404, DOI 10.1097/00000539-200202000-00033; Lieberman E, 2000, PEDIATRICS, V106, P983, DOI 10.1542/peds.106.5.983; Lieberman E, 2000, PEDIATRICS, V105, P8, DOI 10.1542/peds.105.1.8; Lieberman E, 2002, AM J OBSTET GYNECOL, V186, pS31, DOI 10.1067/mob.2002.122522; Lieberman E, 1996, OBSTET GYNECOL, V88, P993, DOI 10.1016/S0029-7844(96)00359-6; Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415; Lucas MJ, 2001, AM J OBSTET GYNECOL, V185, P970, DOI 10.1067/mob.2001.117970; Luxman D, 1998, INT J OBSTET ANESTH, V7, P161, DOI 10.1016/S0959-289X(98)80004-6; Lyon DS, 1997, OBSTET GYNECOL, V90, P135, DOI 10.1016/S0029-7844(97)00214-7; Macarthur AJ, 1997, ANESTH ANALG, V85, P1066, DOI 10.1097/00000539-199711000-00019; MARTIN JA, 2000, NATL VITAL STAT REPO, V50; MARTIN JA, 2001, NATL VITAL STAT REPO, V50; MENDELSON CL, 1946, AM J OBSTET GYNECOL, V52, P191; Nageotte MP, 1997, NEW ENGL J MED, V337, P1715, DOI 10.1056/NEJM199712113372402; NORRIS MC, 1989, ANESTHESIOLOGY, V70, P729, DOI 10.1097/00000542-198905000-00002; Palmer CM, 1999, ANESTH ANALG, V88, P577, DOI 10.1097/00000539-199903000-00021; Palmer CM, 2000, ANESTH ANALG, V90, P887, DOI 10.1213/00000539-200004000-00021; Palmer CM, 1999, ANESTHESIOLOGY, V90, P1241; Philip J, 1999, ANESTHESIOLOGY, V90, P1271, DOI 10.1097/00000542-199905000-00008; Pickering AE, 1999, ANESTHESIOLOGY, V91, P436, DOI 10.1097/00000542-199908000-00018; Poen AC, 1998, BRIT J SURG, V85, P1433; RAMIN SM, 1995, OBSTET GYNECOL, V86, P783, DOI 10.1016/0029-7844(95)00269-W; Robinson JN, 1999, OBSTET GYNECOL, V94, P259, DOI 10.1016/S0029-7844(99)00259-8; Rogers R, 1999, OBSTET GYNECOL, V93, P995, DOI 10.1016/S0029-7844(98)00564-X; Russell R, 1996, BRIT MED J, V312, P1384; Sachs BP, 1999, NEW ENGL J MED, V340, P54, DOI 10.1056/NEJM199901073400112; Safa-Tisseront V, 2001, ANESTHESIOLOGY, V95, P334, DOI 10.1097/00000542-200108000-00012; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; Segal S, 2000, AM J OBSTET GYNECOL, V183, P974, DOI 10.1067/mob.2000.106677; Segal S, 1999, ANESTHESIOLOGY, V91, P90, DOI 10.1097/00000542-199907000-00016; Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4; Sharma SK, 2002, ANESTHESIOLOGY, V96, P546, DOI 10.1097/00000542-200203000-00007; Sharma SK, 1997, ANESTHESIOLOGY, V87, P487, DOI 10.1097/00000542-199709000-00006; Simkin PP, 2002, AM J OBSTET GYNECOL, V186, pS131, DOI 10.1016/S0002-9378(02)70188-9; SIMPSON W, 1871, WORKS JY SIMPSON; Swart M, 1997, ANAESTHESIA, V52, P373, DOI 10.1111/j.1365-2044.1997.az0083c.x; THORP JA, 1991, AM J PERINAT, V8, P402, DOI 10.1055/s-2007-999426; THORP JA, 1993, AM J OBSTET GYNECOL, V169, P851, DOI 10.1016/0002-9378(93)90015-B; Towner D, 1999, NEW ENGL J MED, V341, P1709, DOI 10.1056/NEJM199912023412301; Tsen LC, 1999, ANESTHESIOLOGY, V91, P920, DOI 10.1097/00000542-199910000-00010; WANG JK, 1979, ANESTHESIOLOGY, V50, P149, DOI 10.1097/00000542-197902000-00013; WILLDECKLUND G, 1979, ACTA ANAESTH SCAND, V23, P519, DOI 10.1111/j.1399-6576.1979.tb01482.x; YAKSH TL, 1976, SCIENCE, V192, P1357, DOI 10.1126/science.1273597; Yancey MK, 1999, AM J OBSTET GYNECOL, V180, P353, DOI 10.1016/S0002-9378(99)70213-9; Zhang J, 2001, AM J OBSTET GYNECOL, V185, P128, DOI 10.1067/mob.2001.113874	85	128	145	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					319	332		10.1056/NEJMra021276	http://dx.doi.org/10.1056/NEJMra021276			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540646				2022-12-28	WOS:000180507200008
J	Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA				Xie, DY; Sharma, SB; Paiva, NL; Ferreira, D; Dixon, RA			Role of anthocyanidin reductase, encoded by BANYULS in plant flavonoid biosynthesis	SCIENCE			English	Article							CONDENSED TANNINS; GENE ENCODES; FLAVAN-3-OL BIOSYNTHESIS; FORAGE LEGUMES; DOMAIN PROTEIN; PROANTHOCYANIDINS; CONVERSION; LEUCOCYANIDIN; ACCUMULATION; EXPRESSION	Condensed tannins (CTs) are flavonoid oligomers, many of which have beneficial effects on animal and human health. The flavanol (-)-epicatechin is a component of many CTs and contributes to flavor and astringency in tea and wine. We show that the BANYULS ( BAN) genes from Arabidopsis thaliana and Medicago truncatula encode anthocyanidin reductase, which converts anthocyanidins to their corresponding 2,3-cis-avan-3-ols. Ectopic expression of BAN in tobacco flower petals and Arabidopsis leaves results in loss of anthocyanins and accumulation of CTs.	Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res, University, MS 38677 USA	Noble Research Institute; University of Mississippi	Dixon, RA (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	radixon@noble.org		XIE, DE-YU/0000-0002-3054-1188				Aerts RJ, 1999, AGR ECOSYST ENVIRON, V75, P1, DOI 10.1016/S0167-8809(99)00062-6; ALBRECHT KA, 1991, CROP SCI, V31, P464, DOI 10.2135/cropsci1991.0011183X003100020048x; Bagchi D, 2000, TOXICOLOGY, V148, P187, DOI 10.1016/S0300-483X(00)00210-9; Barry TN, 1999, BRIT J NUTR, V81, P263, DOI 10.1017/S0007114599000501; BRODERICK GA, 1995, J ANIM SCI, V73, P2760; Dalzell SA, 1998, J SCI FOOD AGR, V78, P405, DOI [10.1002/(SICI)1097-0010(199811)78:3<405::AID-JSFA133>3.0.CO;2-G, 10.1002/(SICI)1097-0010(199811)78:3&lt;405::AID-JSFA133&gt;3.0.CO;2-G]; Debeaujon I, 2001, PLANT CELL, V13, P853, DOI 10.1105/tpc.13.4.853; Devic M, 1999, PLANT J, V19, P387, DOI 10.1046/j.1365-313X.1999.00529.x; Douglas GB, 1999, NEW ZEAL J AGR RES, V42, P55, DOI 10.1080/00288233.1999.9513353; Foo LY, 2000, PHYTOCHEMISTRY, V54, P173, DOI 10.1016/S0031-9422(99)00573-7; FOO LY, 1983, J CHEM SOC PERK T 1, P1535, DOI 10.1039/p19830001535; KORVER O, 1971, TETRAHEDRON, V27, P5459, DOI 10.1016/S0040-4020(01)91712-0; KRISTIANSEN KN, 1986, CARLSBERG RES COMMUN, V51, P51, DOI 10.1007/BF02907995; Lin LC, 2002, J NAT PROD, V65, P505, DOI 10.1021/np010414l; McMahon LR, 2000, CAN J PLANT SCI, V80, P469, DOI 10.4141/P99-050; NEL RJJ, 1999, J CHEM RES S, P606; Nesi N, 2000, PLANT CELL, V12, P1863, DOI 10.1105/tpc.12.10.1863; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Pataki T, 2002, AM J CLIN NUTR, V75, P894, DOI 10.1093/ajcn/75.5.894; Porter L.J., 1989, TANNINS METHODS PLAN, V1, P389; Sagasser M, 2002, GENE DEV, V16, P138, DOI 10.1101/gad.212702; Saito K, 1999, PLANT J, V17, P181, DOI 10.1046/j.1365-313X.1999.00365.x; Singh S, 1997, PHYTOCHEMISTRY, V44, P425, DOI 10.1016/S0031-9422(96)00415-3; Skadhauge B, 1997, AM J BOT, V84, P494, DOI 10.2307/2446026; STAFFORD HA, 1985, PLANT PHYSIOL, V78, P791, DOI 10.1104/pp.78.4.791; STAFFORD HA, 1983, PHYTOCHEMISTRY, V22, P2643, DOI 10.1016/S0031-9422(00)97664-7; STAFFORD HA, 1984, PLANT PHYSIOL, V76, P184, DOI 10.1104/pp.76.1.184; Stafford HA, 1990, FLAVONOID METABOLISM, P63; TANNER GJ, 1993, ANAL BIOCHEM, V209, P274, DOI 10.1006/abio.1993.1119; van Rensburg H, 1999, J CHEM RES-S, P450, DOI 10.1039/a901599j; Walker AR, 1999, PLANT CELL, V11, P1337, DOI 10.1105/tpc.11.7.1337; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485	33	526	619	15	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 17	2003	299	5605					396	399		10.1126/science.1078540	http://dx.doi.org/10.1126/science.1078540			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635YB	12532018	Green Submitted			2022-12-28	WOS:000180426800046
J	Butler, D				Butler, D			Safety doubts force rethink of embattled comet mission	NATURE			English	News Item																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					198	198		10.1038/421198b	http://dx.doi.org/10.1038/421198b			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529599	Bronze			2022-12-28	WOS:000180397600005
J	Noguchi, P				Noguchi, P			Risks and benefits of gene therapy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									US FDA, Rockville, MD 20857 USA	US Food & Drug Administration (FDA)	Noguchi, P (corresponding author), US FDA, Rockville, MD 20857 USA.								0	52	57	5	13	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					193	194		10.1056/NEJMp020184	http://dx.doi.org/10.1056/NEJMp020184			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529458				2022-12-28	WOS:000180390600002
J	Yurchak, PM; Deshpande, V; Holmvang, G; Playford, D; Mark, EJ; Rubenstein, MH; Hourigan, L; Hilgenberg, AD; Deshpande, V				Yurchak, PM; Deshpande, V; Holmvang, G; Playford, D; Mark, EJ; Rubenstein, MH; Hourigan, L; Hilgenberg, AD; Deshpande, V			Case 2-2003: A 60-year-old man with mild congestive heart failure of uncertain cause - Rheumatoid arthritis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EVIDENT CARDIOVASCULAR-DISEASE; DIASTOLIC FUNCTION; CONSTRICTIVE PERICARDITIS; ABNORMALITIES; DURATION		Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yurchak, PM (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.		Deshpande, Vikram/O-3100-2019; Deshpande, Vikram/C-6750-2013	Deshpande, Vikram/0000-0003-3899-3573; Deshpande, Vikram/0000-0003-3899-3573				CAMERON J, 1987, AM HEART J, V113, P354, DOI 10.1016/0002-8703(87)90278-X; CHARCOT JM, 1881, CLINICAL LECTURES SE, V95, P172; Corrao S, 1996, EUR J CLIN INVEST, V26, P293, DOI 10.1046/j.1365-2362.1996.133284.x; Di Franco M, 2000, ANN RHEUM DIS, V59, P227, DOI 10.1136/ard.59.3.227; FRANCO AE, 1972, ANN INTERN MED, V77, P837, DOI 10.7326/0003-4819-77-6-837; GROSSMAN W, 1991, NEW ENGL J MED, V325, P1557; Grossman W, 2000, CIRCULATION, V101, P2020, DOI 10.1161/01.CIR.101.17.2020; MASUI T, 1992, RADIOLOGY, V182, P369, DOI 10.1148/radiology.182.2.1732952; Montecucco C, 1999, CLIN EXP RHEUMATOL, V17, P407; MUSTONEN J, 1993, EUR J CLIN INVEST, V23, P246, DOI 10.1111/j.1365-2362.1993.tb00769.x	10	5	5	0	0	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 16	2003	348	3					243	249		10.1056/NEJMcpc020025	http://dx.doi.org/10.1056/NEJMcpc020025			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635GJ	12529466				2022-12-28	WOS:000180390600010
J	Hayes, CS				Hayes, CS			Toxin-antitoxin pairs in bacteria: Killers or stress regulators?	CELL			English	Editorial Material							NUTRITIONAL STRESS	Plasmid toxin-antitoxin systems, which kill daughter cells that fail to inherit the plasmid genome, have chromosomal homologs in eubacteria and archaea. In this issue of Cell, Pederson et al. show that E. coli ReIE toxin cleaves mRNA in the ribosomal A site, potentially allowing it to function as a stress regulator during amino acid starvation.	MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hayes, CS (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.		Hayes, Christopher/A-5505-2009	Sauer, Robert/0000-0002-1719-5399				Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Gerdes K, 2000, J BACTERIOL, V182, P561, DOI 10.1128/JB.182.3.561-572.2000; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; HUTTENHOFER A, 1994, EMBO J, V13, P3892, DOI 10.1002/j.1460-2075.1994.tb06700.x; Karzai AW, 2000, NAT STRUCT BIOL, V7, P449; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003	10	37	38	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					2	4		10.1016/S0092-8674(02)01282-5	http://dx.doi.org/10.1016/S0092-8674(02)01282-5			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526786	Bronze			2022-12-28	WOS:000181191500015
J	Kastan, MB; Zambetti, GP				Kastan, MB; Zambetti, GP			Parc-ing p53 in the cytoplasm	CELL			English	Editorial Material							NUCLEAR EXCLUSION; NEUROBLASTOMA; LOCALIZATION; PROTEIN; SIGNAL; CELLS	Nikolaev et al. (this issue of Cell) report the identification of a parkin-like protein, Parc, and its role in anchoring the tumor suppressor protein p53 in the cytoplasm reveals yet another level of control of p53 function. Regulation of the subcellular localization of p53 by Parc may serve as a novel target in treatment of certain types of tumors.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Zambetti, Gerard/N-8093-2018	Zambetti, Gerard/0000-0002-0929-5007				Aladjem MI, 1998, CURR BIOL, V8, P145, DOI 10.1016/S0960-9822(98)70061-2; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Goldman SC, 1996, AM J PATHOL, V148, P1381; Klotzsche O, 1998, ONCOGENE, V16, P3423, DOI 10.1038/sj.onc.1202155; Lu WG, 2000, ONCOGENE, V19, P232, DOI 10.1038/sj.onc.1203262; MOLL UM, 1992, P NATL ACAD SCI USA, V89, P7262, DOI 10.1073/pnas.89.15.7262; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Ostermeyer AG, 1996, P NATL ACAD SCI USA, V93, P15190, DOI 10.1073/pnas.93.26.15190; Sengupta S, 2000, EMBO J, V19, P6051, DOI 10.1093/emboj/19.22.6051; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660	10	24	27	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 10	2003	112	1					1	2		10.1016/S0092-8674(02)01281-3	http://dx.doi.org/10.1016/S0092-8674(02)01281-3			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526785	Bronze			2022-12-28	WOS:000181191500014
J	Katan, MB; de Roos, NM				Katan, MB; de Roos, NM			Public health - Toward evidence-based health claims for foods	SCIENCE			English	Editorial Material							TRENDS		Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands; Univ Med Ctr, Utrecht, Netherlands	Wageningen University & Research; Utrecht University; Utrecht University Medical Center	Katan, MB (corresponding author), Wageningen Univ, Div Human Nutr & Epidemiol, Wageningen, Netherlands.	wcfs1@wur.nl						Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Blendon RJ, 2001, ARCH INTERN MED, V161, P805, DOI 10.1001/archinte.161.6.805; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; *EUR COMM, SANCO18322002 EUR CO; GUTHRIE JF, 1999, AM EATING HABITS CHA, P269; HELLER IR, 1999, FUNCTIONAL FOODS PUB, P9; Hu FB, 2000, NEW ENGL J MED, V343, P530, DOI 10.1056/NEJM200008243430802; *I MED, 2002, PROP FRAM EV SAF DIE; Jacobson MF, 1999, BMJ-BRIT MED J, V319, P205, DOI 10.1136/bmj.319.7204.205; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; NESTLE M, 2002, FOOD POLITICS FOOD I, P316; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sloan AE, 2002, FOOD TECHNOL-CHICAGO, V56, P32; Southon S, 2000, ROY SOC CH, P3; Truswell AS, 2001, LANCET, V357, P1061, DOI 10.1016/S0140-6736(00)04308-7; *US GEN ACC OFF, 2000, GAORCED00156; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5	17	26	26	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 10	2003	299	5604					206	207		10.1126/science.1078638	http://dx.doi.org/10.1126/science.1078638			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522235				2022-12-28	WOS:000180284000022
J	Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M				Hove, JR; Koster, RW; Forouhar, AS; Acevedo-Bolton, G; Fraser, SE; Gharib, M			Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis	NATURE			English	Article							SHEAR-STRESS; BLOOD-FLOW; CARDIAC DEVELOPMENT; ENDOTHELIAL-CELLS; ZEBRAFISH; MECHANOTRANSDUCTION; EXPRESSION; SYSTEM; HEART; GENE	The pattern of blood flow in the developing heart has long been proposed to play a significant role in cardiac morphogenesis. In response to flow-induced forces, cultured cardiac endothelial cells rearrange their cytoskeletal structure and change their gene expression profiles(1,2). To link such in vitro data to the intact heart, we performed quantitative in vivo analyses of intracardiac flow forces in zebrafish embryos. Using in vivo imaging, here we show the presence of high-shear, vortical flow at two key stages in the developing heart, and predict flow-induced forces much greater than might have been expected for micro-scale structures at low Reynolds numbers. To test the relevance of these shear forces in vivo, flow was occluded at either the cardiac inflow or outflow tracts, resulting in hearts with an abnormal third chamber, diminished looping and impaired valve formation. The similarity of these defects to those observed in some congenital heart diseases argues for the importance of intracardiac haemodynamics as a key epigenetic factor in embryonic cardiogenesis.	CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Biol Imaging Ctr, Pasadena, CA 91125 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology	Hove, JR (corresponding author), CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA.	jhove@caltech.edu; rkoeste1@gg.caltech.edu	Fraser, Scott/Y-3406-2019	Fraser, Scott/0000-0002-5377-0223; Koster, Reinhard/0000-0001-6593-8196; Gharib, Mohammed/0000-0001-9611-1693				Chen JN, 2000, TRENDS GENET, V16, P383, DOI 10.1016/S0168-9525(00)02075-8; DAVIES PF, 1995, PHYSIOL REV, V75, P519, DOI 10.1152/physrev.1995.75.3.519; DAVIES PF, 1986, P NATL ACAD SCI USA, V83, P2114, DOI 10.1073/pnas.83.7.2114; Di Stefano I, 1998, J VASC RES, V35, P1, DOI 10.1159/000025559; HELMLINGER G, 1991, J BIOMECH ENG-T ASME, V113, P123, DOI 10.1115/1.2891226; Hogers B, 1997, CIRC RES, V80, P473, DOI 10.1161/01.RES.80.4.473; HOU PCL, 1995, AM J PHYSIOL-REG I, V269, pR1126, DOI 10.1152/ajpregu.1995.269.5.R1126; Icardo JM, 1996, J EXP ZOOL, V275, P144, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<144::AID-JEZ7>3.3.CO;2-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Langille BL, 1995, FLOW DEPENDENT REGUL, P277; Liao EC, 2002, DEVELOPMENT, V129, P649; Long QM, 1997, DEVELOPMENT, V124, P4105; MANASEK FJ, 1972, DEV BIOL, V27, P584, DOI 10.1016/0012-1606(72)90196-0; Mankad R, 2001, J CARDIOVASC MAGN R, V3, P257, DOI 10.1081/JCMR-100107474; Meinhart CD, 1999, EXP FLUIDS, V27, P414, DOI 10.1007/s003480050366; NEREM RM, 1993, J CARDIOVASC PHARM, V21, pS6, DOI 10.1097/00005344-199321001-00002; OBRIEN SPM, 1999, FETAL PROGRAMMING IN; OLESEN SP, 1988, NATURE, V331, P168, DOI 10.1038/331168a0; Pelster B, 1996, CIRC RES, V79, P358, DOI 10.1161/01.RES.79.2.358; Sehnert AJ, 2002, NAT GENET, V31, P106, DOI 10.1038/ng875; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; STAINIER DYR, 1994, TRENDS CARDIOVAS MED, V4, P207, DOI 10.1016/1050-1738(94)90036-1; Stainier DYR, 1996, DEVELOPMENT, V123, P285; Taber LA, 1998, PROG BIOPHYS MOL BIO, V69, P237, DOI 10.1016/S0079-6107(98)00010-8; Takahashi M, 1997, J VASC RES, V34, P212, DOI 10.1159/000159225; Topper JN, 1999, MOL MED TODAY, V5, P40, DOI 10.1016/S1357-4310(98)01372-0; Walsh EC, 2001, SCIENCE, V293, P1670, DOI 10.1126/science.293.5535.1670; WESTERFIELD M, 1995, ZEBRAFISH BOOK; WILLERT CE, 1991, EXP FLUIDS, V10, P181	29	771	786	3	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					172	177		10.1038/nature01282	http://dx.doi.org/10.1038/nature01282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520305				2022-12-28	WOS:000180267200043
J	Menikoff, J				Menikoff, J			The hidden alternative: getting investigational treatments off-study	LANCET			English	Article							METASTATIC BREAST-CANCER; INFORMED CONSENT; TRANSPLANTATION; TRIALS	Research studies commonly randomise patients between standard care and some new form of treatment. In a substantial number of studies, the new treatment could have been obtained by the patient directly from their doctor, without participating in a study. Yet it is a common practice, endorsed and encouraged by the US government, not to advise potential research participants about their ability to get the new treatment outside of the study. This policy is even occurring in one of the largest studies ever funded by the US government, the 22 000 patient, 5-year comparison of tamoxifen and raloxifene in the prevention of breast cancer. This practice has the effect, of encouraging more individuals to participate in research studies, but the result is that their consent to participate is not fully voluntary. Many ongoing studies may therefore be of questionable ethical soundness.	Univ Kansas, Med Ctr, Dept Hist & Philosophy Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center	Menikoff, J (corresponding author), Univ Kansas, Med Ctr, Dept Hist & Philosophy Med, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.							[Anonymous], INT C HARM TECHN REQ; Beck JM, 1998, FOOD DRUG LAW J, V53, P71; BRODY JE, 1999, NY TIMES        0511; *COMPR WORK GROUP, 1998, REC DEV INF CONS DOC, P2; *COUNC INT ORG MED, 1993, INT ETH GUID BIOM RE; Cummings SR, 1999, JAMA-J AM MED ASSOC, V281, P2189, DOI 10.1001/jama.281.23.2189; Daugherty C K, 2000, IRB, V22, P6, DOI 10.2307/3564113; Freedman B, 1992, J Clin Ethics, V3, P231; GRADY D, 1999, NY TIMES        0105; GRADY D, 1999, NY TIMES        0416; KOLATA G, 1999, NY TIMES        1003; Lippman ME, 2000, NEW ENGL J MED, V342, P1119, DOI 10.1056/NEJM200004133421508; MCCULLOUGH M, 1999, PHILADELPHIA IN 1214; *NAT CANC I, STUD TAM RAL STAR TR; *NIH, 1998, COMPR WORK GROUP INF, P9; Olson-Garewal JK, 2001, HASTINGS CENT REP, V31, P22, DOI 10.2307/3527552; SALBU SR, 1999, FLA L REV, V51, P181, DOI DOI 10.1377/HLTHAFF.2010.1032; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; 1949, US VERSUS BRANDT MED, V2, P181	20	15	15	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					63	67		10.1016/S0140-6736(03)12165-4	http://dx.doi.org/10.1016/S0140-6736(03)12165-4			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517473				2022-12-28	WOS:000180191600027
J	Sobngwi, E; Gautier, J; Mbanya, J				Sobngwi, E; Gautier, J; Mbanya, J			Exercise and the prevention of cardiovascular events in women.	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									St Louis Univ Hosp, F-75010 Paris, France; Univ Yaounde 1, Yaounde, Cameroon	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Yaounde I	Sobngwi, E (corresponding author), St Louis Univ Hosp, F-75010 Paris, France.		Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653				Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Sobngwi E, 2002, INT J OBESITY, V26, P1009, DOI 10.1038/sj.ijo.0802008; Sobngwi E, 2001, INT J EPIDEMIOL, V30, P1361, DOI 10.1093/ije/30.6.1361; Unwin N, 1999, PUBLIC HEALTH, V113, P141, DOI 10.1016/S0033-3506(99)00139-0	5	4	4	0	1	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					77	78						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510049				2022-12-28	WOS:000180134400016
J	Chan, D; Rossor, MN				Chan, D; Rossor, MN			"-but who is that on the other side of you?" - Extracampine hallucinations revisited	LANCET			English	Editorial Material							PARKINSONS-DISEASE; LEWY BODIES; DEMENTIA; AREA; BODY		Inst Neurol, Dept Clin Neurol, Dementia Res Grp, London WC1N 3BG, England; Univ London Imperial Coll Sci & Technol, Fac Med, Div Neurosci, London, England	University of London; University College London; Imperial College London	Chan, D (corresponding author), Natl Hosp Neurol & Neurosurg, Dementia Res Grp, Queen Sq, London WC1N 3BG, England.		Rossor, Martin/C-1598-2008	Rossor, Martin/0000-0001-8215-3120				Aarsland D, 2001, INT J GERIATR PSYCH, V16, P528, DOI 10.1002/gps.389; Barnes J, 2001, J NEUROL NEUROSUR PS, V70, P727, DOI 10.1136/jnnp.70.6.727; CELESIA GG, 1970, ARCH NEUROL-CHICAGO, V23, P193, DOI 10.1001/archneur.1970.00480270003001; Critchley M, 1943, SHIPWRECK SURVIVORS; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Fenelon G, 2000, BRAIN, V123, P733, DOI 10.1093/brain/123.4.733; Harding AJ, 2002, BRAIN, V125, P391, DOI 10.1093/brain/awf033; Kanwisher N, 1997, J NEUROSCI, V17, P4302; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Melzack R, 1997, BRAIN, V120, P1603, DOI 10.1093/brain/120.9.1603; PERRY EK, 1993, J NEURAL TRANSM-PARK, V6, P167, DOI 10.1007/BF02260919; Shackleton E, 1919, SOUTH; Ungerleider L.G., 1982, ANAL VISUAL BEHAV	13	19	20	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					2064	2066		10.1016/S0140-6736(02)11998-2	http://dx.doi.org/10.1016/S0140-6736(02)11998-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628CH	12504418				2022-12-28	WOS:000179974200029
J	Taylor, CW				Taylor, CW			Controlling calcium entry	CELL			English	Review							RECEPTOR; CHANNEL; RELEASE	Ca2+ enters cells through an assortment of Ca2+-permeable channels that respond to different stimuli and couple to different cellular responses. Several different Ca2+ entry pathways can be activated by receptors that stimulate phospholipase C (PLC). Both limbs of this signaling pathway (IP3 and diacylglycerol), PLC itself, and its substrate (PIP2) contribute to the coordinate regulation of these Ca2+ entry pathways.	Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Taylor, CW (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.		Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044				Barritt GJ, 1999, BIOCHEM J, V337, P153, DOI 10.1042/0264-6021:3370153; Carroll RC, 1998, EMBO J, V17, P3036, DOI 10.1093/emboj/17.11.3036; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Delmas P, 2002, NEURON, V34, P209, DOI 10.1016/S0896-6273(02)00641-4; Glitsch MD, 2002, J PHYSIOL-LONDON, V539, P93, DOI 10.1113/jphysiol.2001.012826; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; Mignen O, 2000, J BIOL CHEM, V275, P9114, DOI 10.1074/jbc.275.13.9114; Moneer Z, 2002, BIOCHEM J, V362, P13, DOI 10.1042/0264-6021:3620013; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Patterson RL, 2002, CELL, V111, P529, DOI 10.1016/S0092-8674(02)01045-0; Putney JW, 2001, J CELL SCI, V114, P2223; Rosado JA, 2000, J PHYSIOL-LONDON, V529, P159, DOI 10.1111/j.1469-7793.2000.00159.x; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Venkatachalam K, 2002, NAT CELL BIOL, V4, pE263, DOI 10.1038/ncb1102-e263	18	73	76	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					767	769		10.1016/S0092-8674(02)01197-2	http://dx.doi.org/10.1016/S0092-8674(02)01197-2			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526803	Bronze			2022-12-28	WOS:000179862600003
J	Burton, A; Breen, C				Burton, A; Breen, C			Older refugees in humanitarian emergencies	LANCET			English	Article									Int Rescue Comm, Bangkok, Thailand		Burton, A (corresponding author), Int Rescue Comm, 2106 New Petchburi Rd, Bangkok, Thailand.							EADE D, 1995, OXFAM HDB DEV RELIEF, V1; Eade Deborah., 1995, OXFAM HDB DEV RELIEF, V2; *HELP INT, 2002, STAT WORLDS OLD PEOP; *HELP INT, 2000, OLD PEOPL DIS HUM CR; *UNHCR, 2001, OLD REF RES REF COMM; VESPA J, 1995, BRIT MED J, V311, P652, DOI 10.1136/bmj.311.7006.652	6	18	18	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S47	S48		10.1016/S0140-6736(02)11819-8	http://dx.doi.org/10.1016/S0140-6736(02)11819-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504502				2022-12-28	WOS:000180064500023
J	Maron, MS; Olivotto, I; Betocchi, S; Casey, SA; Lesser, JR; Losi, MA; Cecchi, F; Maron, BJ				Maron, MS; Olivotto, I; Betocchi, S; Casey, SA; Lesser, JR; Losi, MA; Cecchi, F; Maron, BJ			Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUDDEN-DEATH; DOPPLER ECHOCARDIOGRAPHY; MITRAL REGURGITATION; PATHO-PHYSIOLOGY; GRADIENT; INTERRELATIONS; MANIFESTATIONS; POPULATION; SPECTRUM; MYECTOMY	BACKGROUND The influence of left ventricular outflow tract obstruction on the clinical outcome of hypertrophic cardiomyopathy remains unresolved. METHODS We assessed the effect of outflow tract obstruction on morbidity and mortality in a large cohort of patients with hypertrophic cardiomyopathy who were followed for a mean (+/-SD) of 6.3+/-6.2 years. RESULTS Of the 1101 consecutive patients, 273 (25 percent) had obstruction of left ventricular outflow under basal (resting) conditions with a peak instantaneous gradient of at least 30 mm Hg. A total of 127 patients (12 percent) died of hypertrophic cardiomyopathy, and 216 surviving patients (20 percent) had severe, disabling symptoms of progressive heart failure (New York Heart Association [NYHA] functional class III or IV). The overall probability of death related to hypertrophic cardiomyopathy was significantly greater among patients with outflow tract obstruction than among those without obstruction (relative risk, 2.0; P=0.001). The risk of progression to NYHA class III or IV or death specifically from heart failure or stroke was also greater among patients with obstruction (relative risk, 4.4; P<0.001), particularly among patients 40 years of age or older (P<0.001). Age-adjusted multivariate analysis confirmed that outflow tract obstruction was independently associated with an increased risk of both death related to hypertrophic cardiomyopathy (relative risk, 1.6; P=0.02) and progression to NYHA class III or IV or death from heart failure or stroke (relative risk, 2.7; P<0.001). The likelihood of severe symptoms and death related to outflow tract obstruction did not increase as the gradient increased above the threshold of 30 mm Hg. CONCLUSIONS In patients with hypertrophic cardiomyopathy, left ventricular outflow tract obstruction at rest is a strong, independent predictor of progression to severe symptoms of heart failure and of death.	Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, Minneapolis, MN 55407 USA; Tufts New England med Ctr, Div Cardiol, Boston, MA USA; Azienda Osped Careggi, Reg Referral Ctr Myocardial Dis, Florence, Italy; Univ Naples Federico II, Dept Clin Med Cardiovasc & Immunol Sci, Naples, Italy	Minneapolis Heart Institute Foundation; Tufts Medical Center; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Naples Federico II	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Hypertroph Cardiomyopathy Ctr, 920 E 28th St,Suite 60, Minneapolis, MN 55407 USA.		Olivotto, Iacopo/AAC-5950-2022; Betocchi, Sandro/N-9647-2013	Olivotto, Iacopo/0000-0003-1751-9266; LOSI, Maria Angela/0000-0001-9819-0401; Canciello, Grazia/0000-0002-1546-1737; Cecchi, Franco/0000-0002-2035-5621; Betocchi, Sandro/0000-0002-8701-2463				BRAUNWALD E, 1964, CIRCULATION, V30, P3; CANNON RO, 1985, CIRCULATION, V71, P234, DOI 10.1161/01.CIR.71.2.234; CECCHI F, 1995, J AM COLL CARDIOL, V26, P1529, DOI 10.1016/0735-1097(95)00353-3; CRILEY JM, 1985, CIRCULATION, V72, P1148, DOI 10.1161/01.CIR.72.6.1148; Elliott PM, 2000, J AM COLL CARDIOL, V36, P2212, DOI 10.1016/S0735-1097(00)01003-2; FACTOR SM, 1991, J AM COLL CARDIOL, V17, P1343, DOI 10.1016/S0735-1097(10)80145-7; FRANK S, 1968, CIRCULATION, V37, P759, DOI 10.1161/01.CIR.37.5.759; GILLIGAN DM, 1991, J AM COLL CARDIOL, V18, P429, DOI 10.1016/0735-1097(91)90596-2; HELMCKE F, 1987, CIRCULATION, V75, P175, DOI 10.1161/01.CIR.75.1.175; HENRY WL, 1980, CIRCULATION, V62, P1054, DOI 10.1161/01.CIR.62.5.1054; Kizilbash AM, 1998, CIRCULATION, V97, P461; KLUES HG, 1992, J AM COLL CARDIOL, V19, P527, DOI 10.1016/S0735-1097(10)80266-9; KLUES HG, 1995, J AM COLL CARDIOL, V26, P1699, DOI 10.1016/0735-1097(95)00390-8; Maki S, 1998, AM J CARDIOL, V82, P774, DOI 10.1016/S0002-9149(98)00455-X; Maron BJ, 2000, CIRCULATION, V102, P858; Maron BJ, 1999, JAMA-J AM MED ASSOC, V281, P650, DOI 10.1001/jama.281.7.650; MARON BJ, 1985, J AM COLL CARDIOL, V6, P1, DOI 10.1016/S0735-1097(85)80244-8; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; Maron BJ, 2000, NEW ENGL J MED, V342, P365, DOI 10.1056/NEJM200002103420601; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MARON BJ, 1986, J AM COLL CARDIOL, V8, P545, DOI 10.1016/S0735-1097(86)80181-4; MARON BJ, 1999, JAMA-J AM MED ASSOC, V281, P2288; MARON BJ, 2002, JAMA-J AM MED ASSOC, V287, P1307; McCully RB, 1996, CIRCULATION, V94, P467, DOI 10.1161/01.CIR.94.3.467; MURGO JP, 1980, J CLIN INVEST, V66, P1369, DOI 10.1172/JCI109990; Olivotto I, 2001, CIRCULATION, V104, P2517, DOI 10.1161/hc4601.097997; PANZA JA, 1992, J AM COLL CARDIOL, V19, P91, DOI 10.1016/0735-1097(92)90057-T; PANZA JA, 1992, CIRCULATION, V85, P1398, DOI 10.1161/01.CIR.85.4.1398; Paz R, 1996, NEW ENGL J MED, V335, P938, DOI 10.1056/NEJM199609263351305; Qin JX, 2001, J AM COLL CARDIOL, V38, P1994; ROMEO F, 1990, EUR HEART J, V11, P233, DOI 10.1093/oxfordjournals.eurheartj.a059689; ROSS J, 1966, CIRCULATION, V34, P558, DOI 10.1161/01.CIR.34.4.558; SHAH PM, 1981, AM J CARDIOL, V48, P258, DOI 10.1016/0002-9149(81)90605-6; SHAH PM, 1974, CIRC RES, V35, P179; Sherrid MV, 1998, CIRCULATION, V97, P1026; SIGWART U, 1995, LANCET, V346, P211, DOI 10.1016/S0140-6736(95)91267-3; Spirito P, 2000, NEW ENGL J MED, V342, P1778, DOI 10.1056/NEJM200006153422403; Spirito P, 1997, NEW ENGL J MED, V336, P775, DOI 10.1056/NEJM199703133361107; WIGLE ED, 1967, CIRCULATION, V35, P1100, DOI 10.1161/01.CIR.35.6.1100; WIGLE ED, 1995, CIRCULATION, V92, P1680, DOI 10.1161/01.CIR.92.7.1680; WIGLE ED, 1985, PROG CARDIOVASC DIS, V28, P1, DOI 10.1016/0033-0620(85)90024-6; Yu EHC, 2000, J AM COLL CARDIOL, V36, P2219, DOI 10.1016/S0735-1097(00)01019-6	42	904	969	0	21	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					295	303		10.1056/NEJMoa021332	http://dx.doi.org/10.1056/NEJMoa021332			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540642				2022-12-28	WOS:000180507200004
J	Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF				Page, DL; Schuyler, PA; Dupont, WD; Jensen, RA; Plummer, WD; Simpson, JF			Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study	LANCET			English	Article							TOTAL GLANDULAR MASTECTOMY; FOLLOW-UP; PROPHYLACTIC MASTECTOMY; CARCINOMA INSITU; DISEASE; WOMEN; NEOPLASIA	Background Clinical decisions about atypical lobular hyperplasia are based on the belief that later invasive breast-cancer risk is equal in both breasts. We aimed to show laterality and subsequent risk implications of invasive breast cancer in women with atypical lobular hyperplasia. Methods We did a retrospective cohort study of 252 women who had undergone 261 benign surgical biopsies that showed atypical lobular hyperplasia from 1950 to 1985, as part of the Nashville Breast Studies. Primary outcomes were development of invasive breast cancer and laterality of cancer compared with side of the biopsied breast. Findings 50 (20%) of 252 women treated by biopsy only developed invasive breast cancer. Relative risk of breast cancer in women with atypical lobular hyperplasia was 3.1 (95% Cl 2.3-4.3, p<0.0001). Of these 50 women, the breast with invasive cancer was the same breast diagnosed with atypical lobular hyperplasia (ipsilateral) in 34 (68%) and the contralateral breast in 12 (24%). The ratio of ipsilateral/ contralateral cancers for atypical lobular hyperplasia without other atypical lesions was 17/5. For six women with atypical lobular hyperplasia plus atypical ductal hyperplasia, the ratio was 1/1. Interpretation Invasive carcinoma after atypical lobular hyperplasia is about three times more likely to arise in the breast diagnosed with atypical lobular hyperplasia than in the opposite breast without these initial findings. Our findings suggest a model of premalignancy for atypical lobular hyperplasia intermediate between a local precursor and a generalised risk for both breasts.	Vanderbilt Univ, Med Ctr, Dept Anat Pathol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN USA; Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Page, DL (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, MCN, C-3311, Nashville, TN 37232 USA.		Dupont, William D./I-4430-2012; Jensen, Roy A/B-9739-2011	Jensen, Roy A/0000-0003-4430-2281	NATIONAL CANCER INSTITUTE [R01CA062212, R01CA050468] Funding Source: NIH RePORTER; NCI NIH HHS [CA-62212, CA-50468, CA-31698] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acs G, 2001, AM J CLIN PATHOL, V115, P85; BARTON FE, 1991, PLAST RECONSTR SURG, V88, P389, DOI 10.1097/00006534-199109000-00001; Beller F K, 1988, Recent Results Cancer Res, V106, P73; Bodian CA, 1996, CANCER, V78, P1024, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4; Brinton LA, 2001, CANCER, V91, P478, DOI 10.1002/1097-0142(20010201)91:3<478::AID-CNCR1025>3.3.CO;2-X; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; Fitzgibbons PL, 1998, ARCH PATHOL LAB MED, V122, P1053; Fleiss J.L., 1981, STAT METHODS RATES P, V2nd ed., P321; FREEMAN BS, 1978, PLAST RECONSTR SURG, V62, P167, DOI 10.1097/00006534-197808000-00003; Gobbi H, 1999, J NATL CANCER I, V91, P2096, DOI 10.1093/jnci/91.24.2096; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; HUTTER RVP, 1969, CANCER, V24, P1081, DOI 10.1002/1097-0142(196911)24:5<1081::AID-CNCR2820240534>3.0.CO;2-D; LAMBIRD PA, 1969, J AMER MED ASSOC, V210, P689; Lawless J.F, 1982, STAT MODELS METHODS; Lishman SC, 1999, HISTOPATHOLOGY, V35, P195; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; Marshall LM, 1997, CANCER EPIDEM BIOMAR, V6, P297; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MCDIVITT RW, 1967, J AMER MED ASSOC, V201, P82, DOI 10.1001/jama.201.2.82; Meijers-Heijboer H, 2001, NEW ENGL J MED, V345, P159, DOI 10.1056/NEJM200107193450301; Newman LA, 2000, J AM COLL SURGEONS, V191, P322, DOI 10.1016/S1072-7515(00)00361-6; PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A; PAGE DL, 1988, HUM PATHOL, V19, P201, DOI 10.1016/S0046-8177(88)80350-2; PAGE DL, 1991, HUM PATHOL, V22, P1232, DOI 10.1016/0046-8177(91)90105-X; ROSEN PP, 1978, AM J SURG PATHOL, V2, P225, DOI 10.1097/00000478-197809000-00001; ROSEN PP, 1981, CANCER, V47, P813, DOI 10.1002/1097-0142(19810215)47:4<813::AID-CNCR2820470431>3.0.CO;2-J; Rothman K., 1998, MODERN EPIDEMIOLOGY; SIMPSON JF, 1998, BREAST, P91; SLOANE JP, 1995, PATHOLOGY REPORTING, P21	29	218	226	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 11	2003	361	9352					125	129		10.1016/S0140-6736(03)12230-1	http://dx.doi.org/10.1016/S0140-6736(03)12230-1			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	635YP	12531579				2022-12-28	WOS:000180428000011
J	Shindell, D				Shindell, D			Whither Arctic climate?	SCIENCE			English	Editorial Material							GENERAL-CIRCULATION MODEL; STRATOSPHERIC OZONE; TEMPERATURE; SIMULATIONS; CHEMISTRY; TRENDS; IMPACT; LAYER		NASA, Goddard Inst Space Studies, New York, NY 10025 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center	Shindell, D (corresponding author), NASA, Goddard Inst Space Studies, New York, NY 10025 USA.	dshindell@giss.nasa.gov	Shindell, Drew/D-4636-2012	Shindell, Drew/0000-0003-1552-4715				Austin J, 2001, Q J ROY METEOR SOC, V127, P959, DOI 10.1002/qj.49712757313; ELCHELBERGER SJ, 2002, J GEOPHYS RES, V107, P4388; Gillett NP, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014444; Hartmann DL, 2000, P NATL ACAD SCI USA, V97, P1412, DOI 10.1073/pnas.97.4.1412; Johannessen OM, 1999, SCIENCE, V286, P1937, DOI 10.1126/science.286.5446.1937; Lanzante JR, 2003, J CLIMATE, V16, P241, DOI 10.1175/1520-0442(2003)016<0241:THOMRT>2.0.CO;2; Nagashima T, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014026; Newman PA, 2001, J GEOPHYS RES-ATMOS, V106, P19999, DOI 10.1029/2000JD000061; Pitari G, 2002, J ATMOS SCI, V59, P414, DOI 10.1175/1520-0469(2002)059<0414:IOFCAE>2.0.CO;2; Polvani LM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014284; Ramaswamy V, 2001, REV GEOPHYS, V39, P71, DOI 10.1029/1999RG000065; Schnadt C, 2002, CLIM DYNAM, V18, P501, DOI 10.1007/s00382-001-0190-z; Shindell DT, 1998, NATURE, V392, P589, DOI 10.1038/33385; Thompson DWJ, 1998, GEOPHYS RES LETT, V25, P1297, DOI 10.1029/98GL00950; *UNEP WMO, 2002, UNEP WMO SCI ASS OZ; Waugh DW, 1999, J GEOPHYS RES-ATMOS, V104, P27191, DOI 10.1029/1999JD900795; Zhou ST, 2000, GEOPHYS RES LETT, V27, P1123, DOI 10.1029/1999GL011018	17	11	12	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					215	216		10.1126/science.1080855	http://dx.doi.org/10.1126/science.1080855			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522240				2022-12-28	WOS:000180284000027
J	Van Gelder, RN; Wee, R; Lee, JA; Tu, DC				Van Gelder, RN; Wee, R; Lee, JA; Tu, DC			Reduced pupillary light responses in mice lacking cryptochromes	SCIENCE			English	Article							OCULAR PHOTORECEPTORS; NON-CONE; NON-ROD		Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63131 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63131 USA	Washington University (WUSTL); Washington University (WUSTL)	Van Gelder, RN (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63131 USA.		Van Gelder, Russell/ABB-4225-2021	Van Gelder, Russell/0000-0001-5368-3659	NATIONAL EYE INSTITUTE [K08EY000403] Funding Source: NIH RePORTER; NEI NIH HHS [K08EY00403] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Thompson CL, 2001, P NATL ACAD SCI USA, V98, P11708, DOI 10.1073/pnas.201301498; Van Gelder RN, 2002, J BIOL RHYTHM, V17, P110, DOI 10.1177/074873002129002401; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301	13	82	83	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					222	222		10.1126/science.1079536	http://dx.doi.org/10.1126/science.1079536			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522242				2022-12-28	WOS:000180284000029
J	Duft, D; Achtzehn, T; Muller, R; Huber, BA; Leisner, T				Duft, D; Achtzehn, T; Muller, R; Huber, BA; Leisner, T			Coulomb fission - Rayleigh jets from levitated microdroplets	NATURE			English	Article							DYNAMICS		Tech Univ Ilmenau, Inst Phys, D-98684 Ilmenau, Germany; Ctr Interdisciplinaire Rech Ions Lourds, F-14070 Caen 5, France	Technische Universitat Ilmenau; Universite de Caen Normandie	Huber, BA (corresponding author), Tech Univ Ilmenau, Inst Phys, Postfach 100565, D-98684 Ilmenau, Germany.	thomas.leisner@TU-Ilmenau.de	Leisner, Thomas K/A-2391-2013	Leisner, Thomas K/0000-0001-9693-7671				Davis E.J., 2002, AIRBORNE MICROPARTIC; Duft D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.084503; Kramer B, 1999, J CHEM PHYS, V111, P6521, DOI 10.1063/1.479946; Pashkevich VV, 1997, Z PHYS D ATOM MOL CL, V40, P338, DOI 10.1007/s004600050222; Rayleigh L., 1882, LONDON, V14, P184, DOI [10.1080/14786448208628425, DOI 10.1080/14786448208628425]; Schwell M, 2000, J PHYS CHEM A, V104, P6726, DOI 10.1021/jp994200c; Smith JN, 2002, J PHYS CHEM A, V106, P9957, DOI 10.1021/jp025723e; TAYLOR G, 1964, PROC R SOC LON SER-A, V280, P383, DOI 10.1098/rspa.1964.0151; TSAMOPOULOS JA, 1985, P ROY SOC LOND A MAT, V401, P67, DOI 10.1098/rspa.1985.0088	9	297	298	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 9	2003	421	6919					128	128		10.1038/421128a	http://dx.doi.org/10.1038/421128a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520291	Bronze			2022-12-28	WOS:000180267200028
J	Deane, J				Deane, J			Communication, cooperation, leadership - priorities for the new WHO Director-General	LANCET			English	Article									Panos London, London, England		Deane, J (corresponding author), Panos London, London, England.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					7	7		10.1016/S0140-6736(03)12180-0	http://dx.doi.org/10.1016/S0140-6736(03)12180-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12521040				2022-12-28	WOS:000180191600007
J	Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL				Wentz, KU; Frohlich, JM; von Weymarn, C; Patak, MA; Jenelten, R; Zollikofer, CL			High-resolution magnetic resonance angiography of hands with timed arterial compression (tac-MRA)	LANCET			English	Article								Timed arterial compression (tac) of blood flow can be achieved by inflation of a blood-pressure cuff. We postulated that this technique might improve contrast-enhanced magnetic resonance angiography (MRA) of the arteries of the hands. We studied eight volunteers and six patients with occlusive arterial disease of the hands with standard MRA and tac-MRA. Compared with standard MRA, acquisition time was extended with the blood-pressure cuff by a factor of four, leading to quadrupled image resolution (512x1024). Furthermore, flow-related artifacts were not seen. Tac-MRA permits visualisation of the peripheral arterial system in finer detail than that achieved with standard MRA.	Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland; Cantonal Hosp, Dept Internal Med, Div Angiol, CH-8401 Winterthur, Switzerland; Univ Witten Herdecke, Dept Radiol & MicroTherapy, Witten, Germany	Witten Herdecke University	Wentz, KU (corresponding author), Cantonal Hosp, Dept Radiol, Inst Radiol, MR Res Grp, CH-8401 Winterthur, Switzerland.							Earls JP, 1996, RADIOLOGY, V201, P705, DOI 10.1148/radiology.201.3.8939219; Goldfarb JW, 2001, AM J ROENTGENOL, V177, P1177, DOI 10.2214/ajr.177.5.1771177; Rofsky N M, 1995, Magn Reson Imaging Clin N Am, V3, P345; Winterer JT, 2000, J COMPUT ASSIST TOMO, V24, P903, DOI 10.1097/00004728-200011000-00017	4	20	20	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					49	50		10.1016/S0140-6736(03)12112-5	http://dx.doi.org/10.1016/S0140-6736(03)12112-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517469				2022-12-28	WOS:000180191600023
J	[Anonymous]				[Anonymous]			Nature in 2003	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					1	1		10.1038/421001a	http://dx.doi.org/10.1038/421001a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511916	Bronze			2022-12-28	WOS:000180165500001
J	Kremsner, PG; Krishna, S				Kremsner, PG; Krishna, S			Antimalarial cocktails - tropical flavours of the month	LANCET			English	Editorial Material							PLASMODIUM-FALCIPARUM; MALARIA; ARTESUNATE; CHILDREN; EFFICACY; DRUG		Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany; Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; St Georges Med Sch, Dept Infect Dis, London, England	Eberhard Karls University of Tubingen; St Georges University London	Kremsner, PG (corresponding author), Univ Tubingen, Inst Trop Med, Dept Parasitol, Tubingen, Germany.			Krishna, Sanjeev/0000-0003-0066-0634				Adjuik M, 2002, LANCET, V359, P1365, DOI 10.1016/S0140-6736(02)08348-4; HATTON CSR, 1986, LANCET, V1, P411; Krishna S, 2001, ANTIMICROB AGENTS CH, V45, P509, DOI 10.1128/AAC.45.2.509-516.2001; Radloff PD, 1996, LANCET, V347, P1511, DOI 10.1016/S0140-6736(96)90671-6; STEFFEN R, 1993, LANCET, V341, P1299, DOI 10.1016/0140-6736(93)90814-W; STURCHLER D, 1993, DRUG SAFETY, V8, P160; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; von Seidlein L, 2000, LANCET, V355, P352, DOI 10.1016/S0140-6736(99)10237-X; vonSeidlein L, 1997, J INFECT DIS, V176, P1113, DOI 10.1086/516524; White N, 1999, PHILOS T R SOC B, V354, P739, DOI 10.1098/rstb.1999.0426	10	6	6	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC 21	2002	360	9350					1998	1999		10.1016/S0140-6736(02)12032-0	http://dx.doi.org/10.1016/S0140-6736(02)12032-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628CH	12504391				2022-12-28	WOS:000179974200004
J	Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK				Gong, ZH; Morales-Ruiz, T; Ariza, RR; Roldan-Arjona, T; David, L; Zhu, JK			ROS1, a repressor of transcriptional gene silencing in Arabidopsis, encodes a DNA glycosylase/lyase	CELL			English	Article							BASE EXCISION-REPAIR; DE-NOVO METHYLATION; ESCHERICHIA-COLI; RNA; MAINTENANCE; MECHANISMS; DEMETHYLATION; DISRUPTION; INITIATION; MUTATIONS	Mutations in the Arabidopsis ROS1 locus cause transcriptional silencing of a transgene and a homologous endogenous gene. In the ros1 mutants, the promoter of the silenced loci is hypermethylated, which may be triggered by small RNAs produced from the transgene repeats. The transcriptional silencing in ros1 mutants can be released by the ddm1 mutation or the application of the DNA methylation inhibitor 5-aza-2'-deoxycytidine. ROS1 encodes an endonuclease III domain nuclear protein with bifunctional DNA glycosylase/lyase activity against methylated but not unmethylated DNA. The ros1 mutant shows enhanced sensitivity to genotoxic agents methyl methanesulfonate and hydrogen peroxide. We suggest that ROS1 is a DNA repair protein that represses homology-dependent transcriptional gene silencing by demethylating the target promoter DNA.	Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA; Univ Cordoba, Dept Genet, E-14071 Cordoba, Spain	University of Arizona; Universidad de Cordoba	Zhu, JK (corresponding author), Univ Arizona, Dept Plant Sci, Tucson, AZ 85721 USA.		Zhu, Jian-Kang/F-7658-2011; Gong, Zhizhong/AAS-4796-2021; Roldan-Arjona, Teresa/H-5976-2015; Morales-Ruiz, Teresa/L-4842-2014	Zhu, Jian-Kang/0000-0001-5134-731X; Roldan-Arjona, Teresa/0000-0003-2842-3956; Morales-Ruiz, Teresa/0000-0002-6357-6977; Rodriguez Ariza, Rafael/0000-0002-0338-7306				Adams S, 2000, DEVELOPMENT, V127, P2493; Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Bartee L, 2001, GENE DEV, V15, P1753, DOI 10.1101/gad.905701; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen ZJ, 1997, GENE DEV, V11, P2124, DOI 10.1101/gad.11.16.2124; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; Garcia-Ortiz MV, 2001, PLANT MOL BIOL, V47, P795, DOI 10.1023/A:1013644026132; Habu Y, 2001, CURR OPIN GENET DEV, V11, P215, DOI 10.1016/S0959-437X(00)00182-9; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1999, DEVELOPMENT, V126, P5231; Jeddeloh JA, 1998, GENE DEV, V12, P1714, DOI 10.1101/gad.12.11.1714; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; JOST JP, 1995, J BIOL CHEM, V270, P9734, DOI 10.1074/jbc.270.17.9734; Kakutani T, 1996, P NATL ACAD SCI USA, V93, P12406, DOI 10.1073/pnas.93.22.12406; Krokan HE, 1997, BIOCHEM J, V325, P1; Lindahl T, 1999, SCIENCE, V286, P1897, DOI 10.1126/science.286.5446.1897; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Luff B, 1999, MOL CELL, V3, P505, DOI 10.1016/S1097-2765(00)80478-5; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; Mette MF, 2001, CURR BIOL, V11, P1119, DOI 10.1016/S0960-9822(01)00315-3; Mette MF, 2000, EMBO J, V19, P5194, DOI 10.1093/emboj/19.19.5194; Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9; Richards EJ, 2002, CELL, V108, P489, DOI 10.1016/S0092-8674(02)00644-X; Rine J, 1999, P NATL ACAD SCI USA, V96, P8309, DOI 10.1073/pnas.96.15.8309; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; Ronemus MJ, 1996, SCIENCE, V273, P654, DOI 10.1126/science.273.5275.654; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Tyler JK, 1999, NATURE, V402, P555, DOI 10.1038/990147; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wood Richard D., 1995, Methods (Orlando), V7, P163, DOI 10.1006/meth.1995.1022; Zamore PD, 2002, SCIENCE, V296, P1265, DOI 10.1126/science.1072457	39	499	551	14	176	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					803	814		10.1016/S0092-8674(02)01133-9	http://dx.doi.org/10.1016/S0092-8674(02)01133-9			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526807	Green Published, Bronze			2022-12-28	WOS:000179862600007
J	Schreiber, SL; Bernstein, BE				Schreiber, SL; Bernstein, BE			Signaling network model of chromatin	CELL			English	Review							GROWTH-FACTOR RECEPTOR; HISTONE H3; CHROMOSOME CONDENSATION; LYSINE 9; YEAST; ACETYLATION; PHOSPHORYLATION; METHYLATION; HETEROCHROMATIN; TRANSCRIPTION	We suggest that common principles underlie both cellular signaling networks and chromatin. To exemplify similarities, we focus on signaling complexes that form at membrane receptors and on nucleosomes. Multiple signal-transducing modifications on side chain residues of receptor tyrosine kinases (RTKs) and histone proteins are used to create docking sites that facilitate proximal relations of enzymes and their substrates. We argue that multiple histone modifications, like RTK modifications, promote switch-like behavior and ensure robustness of the signal, and we compare this interpretation with the histone code hypothesis. This view provides insight into chromatin function and epigenetic inheritance.	Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Schreiber, SL (corresponding author), Harvard Univ, Dept Chem & Chem Biol, 12 Oxford St, Cambridge, MA 02138 USA.	sls@slsiris.harvard.edu						Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Ahmad K, 2002, CELL, V111, P281, DOI 10.1016/S0092-8674(02)01081-4; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Braunstein M, 1996, MOL CELL BIOL, V16, P4349; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; CHAN CSM, 1993, GENETICS, V135, P677; Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de la Barre AE, 2001, EMBO J, V20, P6383, DOI 10.1093/emboj/20.22.6383; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hassan AH, 2002, CELL, V111, P369, DOI 10.1016/S0092-8674(02)01005-X; Henry KW, 2002, NAT STRUCT BIOL, V9, P565, DOI 10.1038/nsb0802-565; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hudson BP, 2000, J MOL BIOL, V304, P355, DOI 10.1006/jmbi.2000.4207; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kaczanowski S, 2001, J MOL EVOL, V53, P19, DOI 10.1007/s002390000000; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; KORNBERG RD, 1974, SCIENCE, V184, P865, DOI 10.1126/science.184.4139.865; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Luger K, 2002, NAT GENET, V32, P221, DOI 10.1038/ng1000; Lyko F, 1999, BIOESSAYS, V21, P824; Madhani HD, 2001, CELL, V106, P9, DOI 10.1016/S0092-8674(01)00422-6; Maina F, 2001, MOL CELL, V7, P1293, DOI 10.1016/S1097-2765(01)00261-1; Mohammadi M, 1996, MOL CELL BIOL, V16, P977; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nishioka K, 2002, GENE DEV, V16, P479, DOI 10.1101/gad.967202; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Taunton J, 1996, SCIENCE, V272, P408, DOI 10.1126/science.272.5260.408; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Wang HB, 2001, MOL CELL, V8, P1207, DOI 10.1016/S1097-2765(01)00405-1; Wei Y, 1999, CELL, V97, P99, DOI 10.1016/S0092-8674(00)80718-7; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481; Zegerman P, 2002, J BIOL CHEM, V277, P11621, DOI 10.1074/jbc.C200045200; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	74	309	335	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					771	778		10.1016/S0092-8674(02)01196-0	http://dx.doi.org/10.1016/S0092-8674(02)01196-0			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526804	Bronze			2022-12-28	WOS:000179862600004
J	Zilberman, D; Cao, XF; Jacobsen, SE				Zilberman, D; Cao, XF; Jacobsen, SE			ARGONAUTE4 control of locus-specific siRNA accumulation and DNA and histone methylation	SCIENCE			English	Article							EPIGENETIC ALLELES; GENE; ARABIDOPSIS; PROTEINS; RNA	Proteins of the ARGONAUTE family are important in diverse posttranscriptional RNA-mediated gene-silencing systems as well as in transcriptional gene silencing in Drosophila and fission yeast and in programmed DNA elimination in Tetrahymena. We cloned ARGONAUTE4 (AGO4) from a screen for mutants that suppress silencing of the Arabidopsis SUPERMAN (SUP) gene. The ago4-1 mutant reactivated silent SUP alleles and decreased CpNpG and asymmetric DNA methylation as well as histone H3 lysine-9 methylation. In addition, ago4-1 blocked histone and DNA methylation and the accumulation of 25-nucleotide small interfering RNAs (siRNAs) that correspond to the retroelement AtSN1. These results suggest that AGO4 and long siRNAs direct chromatin modifications, including histone methylation and non-CpG DNA methylation.	Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.			Zilberman, Daniel/0000-0002-0123-8649	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398, R01GM060398, T32GM007185] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07185, GM60398] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAULCOMBE D, COMMUNICATION; CAO X, 2002, P NATL ACAD SCI US; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cerutti L, 2000, TRENDS BIOCHEM SCI, V25, P481, DOI 10.1016/S0968-0004(00)01641-8; Fagard M, 2000, P NATL ACAD SCI USA, V97, P11650, DOI 10.1073/pnas.200217597; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hamilton A, 2002, EMBO J, V21, P4671, DOI 10.1093/emboj/cdf464; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacobsen SE, 1997, SCIENCE, V277, P1100, DOI 10.1126/science.277.5329.1100; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Lindroth AM, 2001, SCIENCE, V292, P2077, DOI 10.1126/science.1059745; Matzke M, 2001, SCIENCE, V293, P1080, DOI 10.1126/science.1063051; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Morel JB, 2000, CURR BIOL, V10, P1591, DOI 10.1016/S0960-9822(00)00862-9; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Schauer SE, 2002, TRENDS PLANT SCI, V7, P487, DOI 10.1016/S1360-1385(02)02355-5; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973	22	799	876	8	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 31	2003	299	5607					716	719		10.1126/science.1079695	http://dx.doi.org/10.1126/science.1079695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640KH	12522258				2022-12-28	WOS:000180687700050
J	Lin, JL; Lin-Tan, DT; Hsu, KH; Yu, CC				Lin, JL; Lin-Tan, DT; Hsu, KH; Yu, CC			Environmental lead exposure and progression of chronic renal diseases in patients without diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHELATION-THERAPY; INDUCED HYPERTENSION; SERUM CREATININE; URATE EXCRETION; NEPHROPATHY; INSUFFICIENCY; IMPAIRMENT; GOUT; PLAY	BACKGROUND Previous research suggests that environmental lead exposure correlates with age-related decreases in renal function. METHODS Two hundred two patients with chronic renal insufficiency (indicated by a serum creatinine level between 1.5 mg per deciliter and 3.9 mg per deciliter) who had a normal total-body lead burden and no history of exposure to lead were observed for 24 months. After the observation period, 64 subjects with an elevated body lead burden were randomly assigned to the chelation control groups. For three months, the patients in the chelation group received lead-chelation therapy with calcium disodium EDTA, and the control group received placebo. During the ensuing 24 months, repeated chelation therapy was administered weekly to 32 patients with high-normal body lead burdens (at least 80 microg but less than 600 microg) unless on repeated testing the body lead burden fell below 60 microg; the other 32 patients served as controls and received weekly placebo infusions for 5 weeks every 6 months. The primary end point was an increase in the serum creatinine level to 1.5 times the base-line value during the observation period. A secondary end point was the change in renal function during the intervention period. RESULTS The primary end point occurred in 24 patients during the observation period; the serum creatinine levels and body lead burden at base line were the most important risk factors. The glomerular filtration rate improved significantly by the end of the 27-month intervention period in patients receiving chelation therapy: the mean (+/-SD) change in the glomerular filtration rate in the patients in the chelation group was 2.1+/-5.7 ml per minute per 1.73 m(sup 2) of body-surface area, as compared with -6.0+/-5.8 ml per minute per 1.73 m(sup 2) of body-surface area in the controls (P<0.001). The rate of decline in the glomerular filtration rate in the chelation group was also lower than that in the controls during the 24-month period of repeated chelation therapy or placebo. CONCLUSIONS Low-level environmental lead exposure may accelerate progressive renal insufficiency in patients without diabetes who have chronic renal disease. Repeated chelation therapy may improve renal function and slow the progression of renal insufficiency.	Chang Gung Univ, Coll Med, Lin Kou Med Ctr,Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; Chang Gung Univ, Coll Med, Lin Kou Med Ctr,Chang Gung Mem Hosp, Div Clin Toxicol, Taipei 10591, Taiwan; Chang Gung Univ, Dept Hlth Care Management, Lab Epidemiol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Lin, JL (corresponding author), Chang Gung Mem Hosp, Poison Ctr, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.			Hsu, Kuang-Hung/0000-0003-2642-7689				BATUMAN V, 1993, AM J MED SCI, V305, P241, DOI 10.1097/00000441-199304000-00008; BEHRINGER D, 1986, NEPHRON, V42, P323, DOI 10.1159/000183696; BRENNER BM, 1982, NEW ENGL J MED, V307, P652, DOI 10.1056/NEJM198209093071104; Ding YX, 1998, ENVIRON RES, V76, P107, DOI 10.1006/enrs.1997.3796; HENDERSON DA, 1958, MED J AUSTRALIA, V1, P377; Henrich W L, 1998, J Am Soc Nephrol, V9, pS63; HOSTETTER T, 1981, AM J PHYSIOL, V241, P85; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; ISAKSSON B, 1980, AM J CLIN NUTR, V33, P4, DOI 10.1093/ajcn/33.1.4; KHALILMANESH F, 1992, ENVIRON RES, V58, P35, DOI 10.1016/S0013-9351(05)80203-8; Kim R, 1996, JAMA-J AM MED ASSOC, V275, P1177, DOI 10.1001/jama.275.15.1177; LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.me.39.020188.002341; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lin JL, 1999, ANN INTERN MED, V130, P7, DOI 10.7326/0003-4819-130-1-199901050-00003; LIN JL, 1993, AM J NEPHROL, V13, P442, DOI 10.1159/000168661; Lin JL, 2001, ARCH INTERN MED, V161, P264, DOI 10.1001/archinte.161.2.264; LIN JL, 1992, AM J NEPHROL, V12, P457, DOI 10.1159/000168498; LIN JL, 1994, J HUM HYPERTENS, V8, P495; LIN JL, 1994, J RHEUMATOL, V21, P705; Lin JL, 2001, KIDNEY INT, V60, P266, DOI 10.1046/j.1523-1755.2001.00795.x; Liou SH, 1996, INT ARCH OCC ENV HEA, V68, P80, DOI 10.1007/s004200050032; Mitch WE, 2000, KIDNEY INT, V57, pS38, DOI 10.1046/j.1523-1755.2000.07510.x; NUYTS GD, 1991, NEPHROL DIAL TRANSPL, V6, P307, DOI 10.1093/ndt/6.5.307; Obrador G T, 1998, J Am Soc Nephrol, V9, pS44; PAYTON M, 1994, AM J EPIDEMIOL, V140, P821, DOI 10.1093/oxfordjournals.aje.a117330; PIRKLE JL, 1994, JAMA-J AM MED ASSOC, V272, P284, DOI 10.1001/jama.272.4.284; POLLOCK CA, 1988, INT J ARTIF ORGANS, V11, P75, DOI 10.1177/039139888801100204; STAESSEN JA, 1992, NEW ENGL J MED, V327, P151, DOI 10.1056/NEJM199207163270303; Vaziri ND, 1999, KIDNEY INT, V56, P1492, DOI 10.1046/j.1523-1755.1999.00670.x; WEDEEN RP, 1979, ARCH INTERN MED, V139, P53, DOI 10.1001/archinte.139.1.53; WEDEEN RP, 1983, ENVIRON RES, V30, P58, DOI 10.1016/0013-9351(83)90166-4; WEDEEN RP, 1975, AM J MED, V59, P630, DOI 10.1016/0002-9343(75)90224-7	32	204	207	0	15	MASSACHUSETTS MEDICAL SOC/NEJM	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 23	2003	348	4					277	286		10.1056/NEJMoa021672	http://dx.doi.org/10.1056/NEJMoa021672			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	637JD	12540640				2022-12-28	WOS:000180507200002
J	Gabow, P; Eisert, S; Wright, R				Gabow, P; Eisert, S; Wright, R			Denver health: A model for the integration of a public hospital and community health centers	ANNALS OF INTERNAL MEDICINE			English	Article								Two major pillars of the United States' safety net system are urban public hospitals and community health centers. Their common mission is to care for the uninsured and other vulnerable populations. However, in most communities these important components of the safety net remain organizationally and functionally separate, which inhibits the continuum of care and creates substantial inefficiencies. Denver Health is a long-standing vertically and horizontally integrated system for vulnerable populations. The integration benefits the patient and the system and serves as a model for the U.S. safety net. This paper outlines the benefits of integration to the patient, provider, and health system, using data from the National Association of Public Hospitals and Health Systems, the Bureau of Primary Health Care, and Denver Health.	Denver Hlth, Denver, CO 80204 USA	Denver Health Medical Center	Gabow, P (corresponding author), Denver Hlth, 660 Bannock St,MC 0278, Denver, CO 80204 USA.	PGabow@dhha.org						*BBC RES CONS DENV, 1999, AN PAT COMM SERV; BLAISDELL FW, 1994, ARCH SURG-CHICAGO, V129, P760; *COL COMM HLTH NET, 1999, SAL BEN SURV COL HLT; GEIGER HJ, 1993, AM J PUBLIC HEALTH, V83, P946, DOI 10.2105/AJPH.83.7.946; HOLLISTER RM, 1974, DEMONSTRATION PROJEC; *NAT ASS PUBL HOSP, 1997, NAT ASS PUBL HOSP HL; *NAT ASS PUBL HOSP, 1996, SAF NET TRANS INCR R; *NAT ASS PUBL HOSP, 1999, SIT END MILL AM THIN; *OFF DAT EV AN RES, 1998, UN DAT SYST BETH MED; Sardell A, 1988, US EXPT SOCIAL MED C; Singer JD, 1998, MED CARE, V36, P1198, DOI 10.1097/00005650-199808000-00008	11	89	90	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2003	138	2					143	149		10.7326/0003-4819-138-2-200301210-00016	http://dx.doi.org/10.7326/0003-4819-138-2-200301210-00016			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646CY	12529097				2022-12-28	WOS:000181018300009
J	Whiting, MF; Bradler, S; Maxwell, T				Whiting, MF; Bradler, S; Maxwell, T			Loss and recovery of wings in stick insects	NATURE			English	Article							CHARACTER STATES; DNA-SEQUENCES; PHYLOGENY; FLIGHTLESSNESS	The evolution of wings was the central adaptation allowing insects to escape predators, exploit scattered resources, and disperse into new niches, resulting in radiations into vast numbers of species(1). Despite the presumed evolutionary advantages associated with full-sized wings (macroptery), nearly all pterygote (winged) orders have many partially winged (brachypterous) or wingless (apterous) lineages, and some entire orders are secondarily wingless (for example, fleas, lice, grylloblattids and mantophasmatids), with about 5% of extant pterygote species being flightless(2,3). Thousands of independent transitions from a winged form to winglessness have occurred during the course of insect evolution; however, an evolutionary reversal from a flightless to a volant form has never been demonstrated clearly for any pterygote lineage. Such a reversal is considered highly unlikely because complex interactions between nerves, muscles, sclerites and wing foils are required to accommodate flight(4). Here we show that stick insects (order Phasmatodea) diversified as wingless insects and that wings were derived secondarily, perhaps on many occasions. These results suggest that wing developmental pathways are conserved in wingless phasmids, and that 're-evolution' of wings has had an unrecognized role in insect diversification.	Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA; Univ Gottingen, Inst Zool & Anthropol, D-3400 Gottingen, Germany; Washington Univ, Dept Biol, St Louis, MO 63130 USA	Brigham Young University; University of Gottingen; Washington University (WUSTL)	Whiting, MF (corresponding author), Brigham Young Univ, Dept Integrat Biol, Provo, UT 84602 USA.	Michael_Whiting@byu.edu	Bradler, Sven/D-8655-2015	Bradler, Sven/0000-0001-9307-1032				Andersen Nils Moller, 1997, Memoires du Museum National d'Histoire Naturelle, V173, P91; Beutel RG, 2001, J ZOOL SYST EVOL RES, V39, P177, DOI 10.1046/j.1439-0469.2001.00155.x; Bradler S., 2001, ZOOLOGY S3, V104, P69, DOI DOI 10.1016/J.CRVI.2011.01.006; COHEN B, 1993, DEVELOPMENT, V117, P597; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Dudley R., 2000, BIOMECHANICS INSECT; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; Gunther K., 1953, Beitraege zur Entomologie Berlin, V3, P541; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Hennig W., 1981, INSECT PHYLOGENY; Hennig W., 1969, STAMMESGESCHICHTE IN; KAMP JW, 1973, CAN ENTOMOL, V105, P1235, DOI 10.4039/Ent1051235-9; Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0; Kristensen N.P., 1991, P125; KUTSCH W, 1991, J COMP PHYSIOL A, V168, P483, DOI 10.1007/BF00199608; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Maddison D. R., 2000, MACCLADE 4 ANAL PHYL; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; PAGEL M, 1999, DISCRETE; ROFF DA, 1994, EVOL ECOL, V8, P639, DOI 10.1007/BF01237847; SORENSON MD, 1999, TREEROT VERSION 2; SWOFFORD DL, 2000, PAUP STAR PHYLOGENET; Tilgner EH, 1999, DEUT ENTOMOL Z, V46, P149, DOI 10.1002/mmnd.19990460203; WAGNER DL, 1992, TRENDS ECOL EVOL, V7, P216, DOI 10.1016/0169-5347(92)90047-F; Wheeler W, 1999, CLADISTICS, V15, P379, DOI 10.1111/j.1096-0031.1999.tb00274.x; Wheeler WC, 2001, CLADISTICS, V17, P113, DOI [10.1111/j.1096-0031.2001.tb00115.x, 10.1006/clad.2000.0147]; Whiting MF, 2002, MOLECULAR SYSTEMATICS AND EVOLUTION: THEORY AND PRACTICE, P69; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1	29	322	336	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 16	2003	421	6920					264	267		10.1038/nature01313	http://dx.doi.org/10.1038/nature01313			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529642				2022-12-28	WOS:000180397600046
J	Jain, RK; Padera, TP				Jain, RK; Padera, TP			Lymphatics make the break	SCIENCE			English	Editorial Material							MICE LACKING; SYK		Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Jain, RK (corresponding author), Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Boston, MA 02114 USA.		Padera, Timothy/R-2982-2019; Jain, Rakesh K/I-1384-2017	Padera, Timothy/0000-0002-3453-9384; Jain, Rakesh K/0000-0001-7571-3548				Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Alitalo K, 2002, CANCER CELL, V1, P219, DOI 10.1016/S1535-6108(02)00051-X; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Pivniouk V, 1998, CELL, V94, P229, DOI 10.1016/S0092-8674(00)81422-1; Salven P, 2003, BLOOD, V101, P168, DOI 10.1182/blood-2002-03-0755; Toyama T, 2003, CANCER LETT, V189, P97, DOI 10.1016/S0304-3835(02)00463-9; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0	10	37	38	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					209	210		10.1126/science.1081345	http://dx.doi.org/10.1126/science.1081345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522236				2022-12-28	WOS:000180284000023
J	Lubarsky, B; Krasnow, MA				Lubarsky, B; Krasnow, MA			Tube morphogenesis: Making and shaping biological tubes	CELL			English	Review							POLYCYSTIC KIDNEY-DISEASE; CELL-CELL CONTACT; CAENORHABDITIS-ELEGANS; PLASMA-MEMBRANE; CAPILLARY LUMEN; GENETIC-CONTROL; MOLECULAR-BASIS; PDGF-B; MECHANISMS; GROWTH	Many organs are composed of epithelial tubes that transport vital fluids. Such tubular organs develop in many different ways and generate tubes of widely varying sizes and structures, but always with the apical epithelial surface lining the lumen. We describe recent progress in several diverse cell culture and genetic models of tube morphogenesis, which suggest apical membrane biogenesis, vesicle fusion, and secretion play central roles in tube formation and growth. We propose a unifying mechanism of tube morphogenesis that has been modified to create tube diversity and describe how defects in the tube size-sensing step can lead to polycystic kidney disease.	Stanford Univ, Sch Med, Dept Biochem, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Krasnow, MA (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Howard Hughes Med Inst, Stanford, CA 94305 USA.	krasnow@cmgm.stanford.edu						ALCORN D, 1977, J ANAT, V123, P649; Arias A.M., 1993, DEV DROSOPHILA, P609; Bard J. B. L., 1990, MORPHOGENESIS CELLUL; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Bayless KJ, 2002, J CELL SCI, V115, P1123; Bedore M. P., 1982, ELEPHANT, V2, P3, DOI DOI 10.22237/ELEPHANT/1521731887; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; BORGHESE E, 1950, J ANAT, V84, P287; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Calvet JP, 2002, J AM SOC NEPHROL, V13, P2614, DOI 10.1681/ASN.V13102614; Clark ER, 1939, AM J ANAT, V64, P251, DOI 10.1002/aja.1000640203; Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144; COUCOUVANIS E, 1995, CELL, V83, P279, DOI 10.1016/0092-8674(95)90169-8; CRILEY BB, 1969, J MORPHOL, V128, P465, DOI 10.1002/jmor.1051280406; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DYSON SE, 1976, CELL TISSUE RES, V173, P529; EVAN AP, 1990, CYSTIC KIDNEY, P21; FANKHAUSER G, 1945, J EXP ZOOL, V100, P445, DOI 10.1002/jez.1401000310; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; GABOW PA, 1993, NEW ENGL J MED, V329, P332, DOI 10.1056/NEJM199307293290508; Gallagher AR, 2000, CELL TISSUE RES, V300, P361, DOI 10.1007/s004410000215; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; GLUCKSMANNKUIS MA, 1995, CELL, V81, P289; GRANTHAM JJ, 1993, J AM SOC NEPHROL, V3, P1843; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218; Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840; HOOPER SB, 1995, CLIN EXP PHARMACOL P, V22, P235, DOI 10.1111/j.1440-1681.1995.tb01988.x; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Hou XY, 2002, J CLIN INVEST, V109, P533, DOI 10.1172/JC1200214099; HOUSER JW, 1961, ANAT REC, V140, P29, DOI 10.1002/ar.1091400105; JONES SJM, 1995, MOL GEN GENET, V248, P719, DOI 10.1007/BF02191712; Jost PA, 1948, ARCH ANAT MICR MORPH, V37, P323; KEISTER ML, 1948, J MORPHOL, V83, P373, DOI 10.1002/jmor.1050830304; Kim K, 2000, P NATL ACAD SCI USA, V97, P1731, DOI 10.1073/pnas.040550097; LANE MC, 1993, DEVELOPMENT, V117, P1049; Lange K, 1999, J CELL PHYSIOL, V180, P19, DOI 10.1002/(SICI)1097-4652(199907)180:1<19::AID-JCP3>3.0.CO;2-K; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lin HH, 1999, KIDNEY INT, V55, P168, DOI 10.1046/j.1523-1755.1999.00249.x; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Lipschutz JH, 2000, MOL BIOL CELL, V11, P4259, DOI 10.1091/mbc.11.12.4259; Lu WN, 1997, NAT GENET, V17, P179, DOI 10.1038/ng1097-179; McKeown C, 1998, DEVELOPMENT, V125, P2087; Melnick M, 2000, CRIT REV ORAL BIOL M, V11, P199, DOI 10.1177/10454411000110020401; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F; MONTESANO R, 1991, CELL, V67, P901, DOI 10.1016/0092-8674(91)90363-4; Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; OLVER RE, 1974, J PHYSIOL-LONDON, V241, P327, DOI 10.1113/jphysiol.1974.sp010659; Onuchic LF, 2002, AM J HUM GENET, V70, P1305, DOI 10.1086/340448; Pollack AL, 1998, DEV BIOL, V204, P64, DOI 10.1006/dbio.1998.9091; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Qian F, 1996, CELL, V87, P979, DOI 10.1016/S0092-8674(00)81793-6; Qin HM, 2001, CURR BIOL, V11, P457, DOI 10.1016/S0960-9822(01)00122-1; REMY L, 1977, J ULTRA MOL STRUCT R, V61, P243, DOI 10.1016/S0022-5320(77)80049-X; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; Samakovlis C, 1996, DEVELOPMENT, V122, P1395; Saxen L., 1987, ORGANOGENESIS KIDNEY; SCHOENWOLF GC, 1990, DEVELOPMENT, V109, P243; Schwartz EA, 1997, AM J PHYSIOL-RENAL, V272, pF132, DOI 10.1152/ajprenal.1997.272.1.F132; Somlo S, 2001, CURR BIOL, V11, pR356, DOI 10.1016/S0960-9822(01)00193-2; Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; van Adelsberg JS, 1999, PEDIATR NEPHROL, V13, P454, DOI 10.1007/s004670050639; VEGASALAS DE, 1987, J CELL BIOL, V104, P1249, DOI 10.1083/jcb.104.5.1249; VEGASALAS DE, 1988, J CELL BIOL, V107, P1717, DOI 10.1083/jcb.107.5.1717; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; WARD CJ, 1994, CELL, V77, P881; Watnick T, 1999, SEMIN NEPHROL, V19, P327; WHEATLEY DN, 1982, CENTRIOLE CENTRAL EN; WOLFF JR, 1972, BRAIN RES, V41, P17, DOI 10.1016/0006-8993(72)90613-0; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Wu GQ, 1998, CELL, V93, P177, DOI 10.1016/S0092-8674(00)81570-6; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Yoder BK, 2002, J AM SOC NEPHROL, V13, P2508, DOI 10.1097/01.ASN.0000029587.47950.25; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001; Zimmerman K., 1898, ARCH MIKROSK ANAT, V52, P552, DOI [10.1007/BF02975837, DOI 10.1007/BF02975837]	87	517	544	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 10	2003	112	1					19	28		10.1016/S0092-8674(02)01283-7	http://dx.doi.org/10.1016/S0092-8674(02)01283-7			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	649DK	12526790	Bronze			2022-12-28	WOS:000181191500003
J	Bedinghaus, JM				Bedinghaus, JM			Family history	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		POSKANZER DC, 1977, HARRISONS PRINCIPLES, P1903	1	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					142	142		10.1001/jama.289.2.142	http://dx.doi.org/10.1001/jama.289.2.142			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517205				2022-12-28	WOS:000180226400001
J	Villanueva, P; Peiro, S; Librero, J; Pereiro, I				Villanueva, P; Peiro, S; Librero, J; Pereiro, I			Accuracy of pharmaceutical advertisements in medical journals	LANCET			English	Article							SELF-REGULATION; PROMOTION; INDUSTRY; EDITORS; CODES	Background Because of the effect of the ever-growing evidence-based medicine movement on prescribing behaviour of doctors, the pharmaceutical industry incorporates bibliographical references to clinical trials that endorse their products in their advertisements. We aimed to assess whether the references about efficacy, safety, convenience, or cost of anti hypertensive and lipid-lowering drugs included in advertisements supported the promotional claims. Methods We assessed all advertisements for anti hypertensive and lipid-lowering drugs published in six Spanish medical journals in 1997 that had at least one bibliographical reference. Two pairs of investigators independently reviewed the advertisements to see whether the studies quoted to endorse the advertising messages supported the corresponding claims. Findings We identified 264 different advertisements for anti hypertensive drugs and 23 different advertisements for lipid-lowering drugs. We recorded at least one reference in 31 advertisements in the anti hypertensive group and at least one reference in every seven advertisements in the lipid-lowering group, providing a total of 125 promotional claims with references. We could not retrieve 23 (18%) references from monographic works and non-published data on file. 79 (63%) of the 125 references were from journals with a high impact factor; 84 (82%) of the 102 references retrieved were from randomised clinical trials. In 45 claims (44.1%; 95% CI 34.3-54.3) the promotional statement was not supported by the reference, most frequently because the slogan recommended the drug in a patient group other than that assessed in the study. Interpretation Doctors should be cautious in assessment of advertisements that claim a drug has greater efficacy, safety, or convenience, even though these claims are accompanied by bibliographical references to randomised clinical trials published in reputable medical journals and seem to be evidence-based.	Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Valencia 46017, Spain; Inst Social Marina, Valencia, Spain		Peiro, S (corresponding author), Escuela Valenciana Estudios Salud, Conselleria Sanitat, Generalitat Valenciana, Fdn Inst Invest Serv Salud, Juan de Garay 21, Valencia 46017, Spain.		Peiro, Salvador/H-5778-2017; Librero, Julian/F-4947-2017	Peiro, Salvador/0000-0002-3902-569X; Librero, Julian/0000-0002-4859-9054				Angell M, 2000, NEW ENGL J MED, V342, P1516, DOI 10.1056/NEJM200005183422009; AVORN J, 1982, AM J MED, V73, P4, DOI 10.1016/0002-9343(82)90911-1; BERO LA, 1992, NEW ENGL J MED, V327, P1135, DOI 10.1056/NEJM199210153271606; CARANDANG ED, 1994, MED J AUSTRALIA, V161, P671, DOI 10.5694/j.1326-5377.1994.tb126915.x; CAUDILL TS, 1992, J DRUG ISSUES, V22, P331, DOI 10.1177/002204269202200212; Greenhalgh T, 1997, BRIT MED J, V315, P1623, DOI 10.1136/bmj.315.7122.1623; HEALING E, 1994, BRIT MED J, V308, P474, DOI 10.1136/bmj.308.6926.474a; HERXHEIMER A, 1990, BRIT MED J, V300, P307, DOI 10.1136/bmj.300.6720.307; KESSLER DA, 1990, JAMA-J AM MED ASSOC, V264, P2409, DOI 10.1001/jama.264.18.2409; KESSLER DA, 1994, NEW ENGL J MED, V331, P1350, DOI 10.1056/NEJM199411173312007; LEXCHIN J, 1994, INT J HEALTH SERV, V24, P91, DOI 10.2190/EKEP-D9JE-31A4-KTE5; Lexchin J, 1997, CAN FAM PHYSICIAN, V43, P1997; LEXCHIN J, 1994, CAN MED ASSOC J, V151, P47; Mansfield PR, 1997, MED J AUSTRALIA, V167, P590, DOI 10.5694/j.1326-5377.1997.tb138906.x; Mindell J, 1997, BRIT MED J, V315, P1622; PERMAN E, 1990, NEW ENGL J MED, V323, P616, DOI 10.1056/NEJM199008303230921; RENNIE D, 1991, JAMA-J AM MED ASSOC, V265, P2394, DOI 10.1001/jama.265.18.2394; Roughead EE, 1998, INT J HEALTH SERV, V28, P269, DOI 10.2190/B81X-4A53-TY5M-C2HR; Sackett D. L., 1997, EVIDENCE BASED MED P; Smart S, 1997, BRIT MED J, V315, P1622; SMITH MC, 1977, AM J HOSP PHARM, V34, P1208, DOI 10.1093/ajhp/34.11.1208; Wang TJ, 1999, CIRCULATION, V99, P2055, DOI 10.1161/01.CIR.99.15.2055; WILKES MS, 1992, ANN INTERN MED, V116, P912, DOI 10.7326/0003-4819-116-11-912; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916; 1894, JAMA, V22, P958; 1982, LANCET, V2, P1257; 1994, B OFICIAL ESTADO	27	105	111	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					27	32		10.1016/S0140-6736(03)12118-6	http://dx.doi.org/10.1016/S0140-6736(03)12118-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517463				2022-12-28	WOS:000180191600017
J	Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ				Cook, DL; Schwindt, PC; Grande, LA; Spain, WJ			Synaptic depression in the localization of sound	NATURE			English	Article							INTERAURAL TIME DIFFERENCES; STEM AUDITORY NUCLEI; COINCIDENCE DETECTION; BRAIN-STEM; PHASE-LOCKING; LAMINARIS; NEURONS; MAGNOCELLULARIS; LATERALIZATION; ORGANIZATION	Short-term synaptic plasticity, which is common in the central nervous system, may contribute to the signal processing functions of both temporal integration and coincidence detection(1-3). For temporal integrators, whose output firng rate depends on a running average of recent synaptic inputs, plasticity modulates input synaptic strength and thus may directly control signalling gain(2) and the function of neural networks(1-4). But the firing probability of an ideal coincidence detector would depend on the temporal coincidence of events rather than on the average frequency of synaptic events. Here we have examined a specific case of how synaptic plasticity can affect temporal coincidence detection, by experimentally characterizing synaptic depression at the synapse between neurons in the nucleus magnocellularis and coincidence detection neurons in the nucleus laminaris in the chick auditory brainstem(5). We combine an empirical description of this depression with a biophysical model of signalling in the nucleus laminaris. The resulting model predicts that synaptic depression provides an adaptive mechanism for preserving interaural time-delay information (a proxy for the location of sound in space) despite the confounding effects of sound-intensity-related information. This mechanism may help nucleus laminaris neurons to pass specific sound localization information to higher processing centres.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA; Univ Washington, Dept Neurol, Seattle, WA 98105 USA; Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98105 USA; VA Puget Sound Hlth Care Syst, Seattle, WA 98108 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Spain, WJ (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98105 USA.	spain@u.washington.edu			BLRD VA [I01 BX000386] Funding Source: Medline; Veterans Affairs [I01BX000386] Funding Source: NIH RePORTER	BLRD VA; Veterans Affairs(US Department of Veterans Affairs)		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Agmon-Snir H, 1998, NATURE, V393, P268, DOI 10.1038/30505; Brenowitz S, 2001, J NEUROSCI, V21, P9487, DOI 10.1523/JNEUROSCI.21-23-09487.2001; Bruckner S, 1998, EUR J NEUROSCI, V10, P3438, DOI 10.1046/j.1460-9568.1998.00353.x; CARR CE, 1990, J NEUROSCI, V10, P3227; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Funabiki K, 1998, J PHYSIOL-LONDON, V508, P851, DOI 10.1111/j.1469-7793.1998.851bp.x; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; JACKSON H, 1978, J COMP PHYSIOL PSYCH, V92, P682, DOI 10.1037/h0077496; JEFFRESS LA, 1968, J ACOUST SOC AM, V44, P187, DOI 10.1121/1.1911053; Koppl C, 1997, J NEUROSCI, V17, P3312; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; Nadim F, 1999, P NATL ACAD SCI USA, V96, P8206, DOI 10.1073/pnas.96.14.8206; PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404; Pena JL, 1996, J NEUROSCI, V16, P7046; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; SMITH DJ, 1979, J COMP NEUROL, V186, P213, DOI 10.1002/cne.901860207; TOBIAS JV, 1959, J ACOUST SOC AM, V31, P1591, DOI 10.1121/1.1907664; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; WAGNER H, 1991, J COMP PHYSIOL A, V169, P281; WARCHOL ME, 1990, J COMP PHYSIOL A, V166, P721; Yang LC, 1999, J NEUROSCI, V19, P2313; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; ZHOU N, 1991, HEARING RES, V52, P195, DOI 10.1016/0378-5955(91)90199-J	30	139	139	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 2	2003	421	6918					66	70		10.1038/nature01248	http://dx.doi.org/10.1038/nature01248			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511955				2022-12-28	WOS:000180165500038
J	Khoury, MJ; McCabe, LL; McCabe, ERB				Khoury, MJ; McCabe, LL; McCabe, ERB			Genomic medicine - Population screening in the age of genomic medicine.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FACTOR-V-LEIDEN; ORAL-CONTRACEPTIVE USERS; DRIED BLOOD SPECIMENS; CYSTIC-FIBROSIS; HEREDITARY HEMOCHROMATOSIS; VENOUS THROMBOEMBOLISM; PUBLIC-HEALTH; UNITED-STATES; TAY-SACHS; DIAGNOSIS		Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Ctr Dis Control & Prevent, Off Genom & Dis Prevent, Atlanta, GA USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA USA; Univ Calif Los Angeles, Ctr Soc Individual & Genet, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centers for Disease Control & Prevention - USA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	McCabe, ERB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.	emccabe@mednet.ucla.edu						*AM AC PED COMM GE, 1989, PEDIATRICS, V83, P449; Andresen BS, 2001, AM J HUM GENET, V68, P1408, DOI 10.1086/320602; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Brown AS, 2001, GENET MED, V3, P109, DOI 10.1097/00125817-200103000-00004; Burke W, 1998, JAMA-J AM MED ASSOC, V280, P172, DOI 10.1001/jama.280.2.172; Burke W, 2001, GENET TEST, V5, P201, DOI 10.1089/10906570152742245; Burke W, 2000, GENET MED, V2, P271, DOI 10.1097/00125817-200009000-00001; BURROW GN, 1980, NEONATAL THYROID SCR, P155; Chace DH, 1997, CLIN CHEM, V43, P2106; Cogswell ME, 1999, AM J PREV MED, V16, P134, DOI 10.1016/S0749-3797(98)00141-X; Cohn ES, 1999, AM J MED GENET, V89, P130, DOI 10.1002/(SICI)1096-8628(19990924)89:3<130::AID-AJMG3>3.0.CO;2-M; COLLINS FS, 2000, 2 NAT C GEN PUBL HLT; *COMM STUD INB ERR, 1975, GEN SCREEN PROGR PRI; *CONS DEV C, 1987, NATL I HLTH CONSENSU, V6, P1; Cunniff C, 2000, PEDIATRICS, V106, P1494; Dequeker E, 2001, AM J HUM GENET, V69, P438; DESCARTES M, 1992, PEDIATR RES, V31, P217, DOI 10.1203/00006450-199203000-00005; *EASL, 2000, J HEPATOL, V33, P496; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P1598; Emmerich J, 2001, THROMB HAEMOSTASIS, V86, P809; ESMON CT, 2001, METABOLIC MOL BASES, V3, P4327; Farrell PM, 2001, PEDIATRICS, V107, P1, DOI 10.1542/peds.107.1.1; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; Goel V, 2001, BMJ-BRIT MED J, V322, P1174, DOI 10.1136/bmj.322.7295.1174; GREENBERG DL, 2001, METABOLIC MOL BASES, V3, P4293; GREGG RG, 1993, AM J HUM GENET, V52, P616; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; GUTHRIE R, 1963, PEDIATRICS, V32, P338; HASSEMER DJ, 2001, PEDIATR PULM, V7, P76; HOLTZMAN C, 1986, PEDIATRICS, V78, P553; Howell RR, 1999, ARCH INTERN MED, V159, P1529; IMPERATORE G, IN PRESS HUMAN GENOM; JINKS DC, 1989, HUM GENET, V81, P363, DOI 10.1007/BF00283692; Juengst ET, 1995, HUM GENE THER, V6, P1595, DOI 10.1089/hum.1995.6.12-1595; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Kant JA, 1995, CLIN LAB MED, V15, P877, DOI 10.1016/S0272-2712(18)30305-6; KHOURY MJ, 2000, OX MG MED G, P3; Mak V, 1999, JAMA-J AM MED ASSOC, V281, P2217, DOI 10.1001/jama.281.23.2217; MATSUBARA Y, 1991, LANCET, V338, P552, DOI 10.1016/0140-6736(91)91110-G; MCCABE ERB, 1983, PEDIATRICS, V72, P390; MCCABE ERB, 1987, HUM GENET, V75, P213, DOI 10.1007/BF00281061; McCabe ERB, 2001, GENET MED, V3, P426, DOI 10.1097/00125817-200111000-00009; McCabe ERB, 1999, ACTA PAEDIATR, V88, P58, DOI 10.1080/080352599750029402; McCabe L, 1996, AM J HUM GENET, V59, P762; MCCABE LL, IN PRESS MOL GENET M; Mehl AL, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e7; Mitchell JJ, 1996, AM J HUM GENET, V59, P793; Morell RJ, 1998, NEW ENGL J MED, V339, P1500, DOI 10.1056/NEJM199811193392103; Naylor EW, 1999, J CHILD NEUROL, V14, pS4, DOI 10.1177/0883073899014001021; Nelson RM, 2001, PEDIATRICS, V107, P1451; Raman V, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.1.e13; Ransohoff DF, 2002, NEW ENGL J MED, V346, P40, DOI 10.1056/NEJMcp010886; REARDON MC, 1984, J PEDIATR-US, V105, P271, DOI 10.1016/S0022-3476(84)80128-6; REES DC, 1995, LANCET, V346, P1133, DOI 10.1016/S0140-6736(95)91803-5; Ridker PM, 1997, JAMA-J AM MED ASSOC, V277, P1305, DOI 10.1001/jama.277.16.1305; ROE CR, 2001, METABOLIC MOL BASIS, V2, P2297; ROSENDAAL FR, 1995, BLOOD, V85, P1504, DOI 10.1182/blood.V85.6.1504.bloodjournal8561504; SELTZER WK, 1991, BIOCHEM MED METAB B, V46, P105, DOI 10.1016/0885-4505(91)90055-P; Steinberg KK, 2001, JAMA-J AM MED ASSOC, V285, P2216, DOI 10.1001/jama.285.17.2216; Strass E, 1996, AM J HUM GENET, V59, P471; Tonniges TF, 2000, PEDIATRICS, V106, P389; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; VANDENBROUCKE JP, 1994, LANCET, V344, P1453, DOI 10.1016/S0140-6736(94)90286-0; Wald NJ, 1999, BMJ-BRIT MED J, V319, P1562, DOI 10.1136/bmj.319.7224.1562; Wald NJ, 2001, J MED SCREEN, V8, P1, DOI 10.1136/jms.8.1.1; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; Wilcken B, 1999, ACTA PAEDIATR, V88, P33, DOI 10.1080/080352599750029330; WILFOND BS, 2000, OX MG MED G, P61; Wilson JM, 1968, PUBLIC HLTH PAPERS W, V34; Yang QH, 1998, ANN INTERN MED, V129, P946, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00005; ZHANG YH, 1994, BIOCHEM MED METAB B, V52, P27, DOI 10.1006/bmmb.1994.1030; 2002, PHYSICIANS DESK REFE	72	264	269	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 2	2003	348	1					50	58		10.1056/NEJMra013182	http://dx.doi.org/10.1056/NEJMra013182			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630WY	12510043	Bronze			2022-12-28	WOS:000180134400008
J	Parmesan, C; Yohe, G				Parmesan, C; Yohe, G			A globally coherent fingerprint of climate change impacts across natural systems	NATURE			English	Article							EGG-LAYING TRENDS; BRITISH BUTTERFLIES; PHENOLOGY; PLANTS; RESPONSES; BIRDS; TIME; TEMPERATURE; ABUNDANCE; MOUNTAIN	Causal attribution of recent biological trends to climate change is complicated because non-climatic influences dominate local, short-term biological changes. Any underlying signal from climate change is likely to be revealed by analyses that seek systematic trends across diverse species and geographic regions; however, debates within the Intergovernmental Panel on Climate Change (IPCC) reveal several definitions of a 'systematic trend'. Here, we explore these differences, apply diverse analyses to more than 1,700 species, and show that recent biological trends match climate change predictions. Global meta-analyses documented significant range shifts averaging 6.1 km per decade towards the poles ( or metres per decade upward), and significant mean advancement of spring events by 2.3 days per decade. We define a diagnostic fingerprint of temporal and spatial 'sign-switching' responses uniquely predicted by twentieth century climate trends. Among appropriate long-term/large-scale/multi-species data sets, this diagnostic fingerprint was found for 279 species. This suite of analyses generates 'very high confidence' (as laid down by the IPCC) that climate change is already affecting living systems.	Univ Texas, Patterson Labs 141, Austin, TX 78712 USA; Wesleyan Univ, Publ Affairs Ctr 238, Middletown, CT 06459 USA	University of Texas System; University of Texas Austin; Wesleyan University	Parmesan, C (corresponding author), Univ Texas, Patterson Labs 141, Austin, TX 78712 USA.	parmesan@mail.utexas.edu	Parmesan, Camille/GVT-5674-2022	Parmesan, Camille/0000-0002-1515-274X				Ahas R, 1999, INT J BIOMETEOROL, V42, P119, DOI 10.1007/s004840050094; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; BEEBEE TJC, 1995, NATURE, V374, P219, DOI 10.1038/374219a0; Bradley NL, 1999, P NATL ACAD SCI USA, V96, P9701, DOI 10.1073/pnas.96.17.9701; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; de Jong PW, 1998, P ROY SOC B-BIOL SCI, V265, P39, DOI 10.1098/rspb.1998.0261; Dunn PO, 1999, P ROY SOC B-BIOL SCI, V266, P2487, DOI 10.1098/rspb.1999.0950; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; GATTER W, 1992, J ORNITHOL, V133, P427, DOI 10.1007/BF01640470; Gibbs JP, 2001, CONSERV BIOL, V15, P1175, DOI 10.1046/j.1523-1739.2001.0150041175.x; GRABHERR G, 1995, ECOL STU AN, V113, P167; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Gurevitch J., 2001, DESIGNS ANAL ECOLOGI, P347; HERSTEINSSON P, 1992, OIKOS, V64, P505, DOI 10.2307/3545168; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Holbrook SJ, 1997, ECOL APPL, V7, P1299; Kullman L, 2001, AMBIO, V30, P72, DOI 10.1639/0044-7447(2001)030[0072:CCWATL]2.0.CO;2; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Menzel A, 1999, NATURE, V397, P659, DOI 10.1038/17709; Menzel A, 2001, GLOBAL CHANGE BIOL, V7, P657, DOI 10.1046/j.1365-2486.2001.00430.x; Menzel A, 2000, INT J BIOMETEOROL, V44, P76, DOI 10.1007/s004840000054; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 1996, NATURE, V382, P765, DOI 10.1038/382765a0; Parmesan C, 2000, B AM METEOROL SOC, V81, P443, DOI 10.1175/1520-0477(2000)081<0443:IOEWAC>2.3.CO;2; PAYETTE S, 1989, NATURE, V341, P429, DOI 10.1038/341429a0; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 2001, NATURE, V410, P639, DOI 10.1038/35070683; Rodriguez-Trelles F, 1998, EVOL ECOL, V12, P829, DOI 10.1023/A:1006546616462; ROSS MS, 1994, ECOL APPL, V4, P144, DOI 10.2307/1942124; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Rusterholz HP, 1998, OECOLOGIA, V113, P341, DOI 10.1007/s004420050385; Sagarin RD, 1999, ECOL MONOGR, V69, P465, DOI 10.1890/0012-9615(1999)069[0465:CRCIAI]2.0.CO;2; Smith RC, 1999, BIOSCIENCE, V49, P393, DOI 10.2307/1313632; SMITH RIL, 1994, OECOLOGIA, V99, P322, DOI 10.1007/BF00627745; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Sturm M, 2001, NATURE, V411, P546, DOI 10.1038/35079180; Thomas CD, 1999, NATURE, V399, P213, DOI 10.1038/20335; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; van Herk CM, 2002, LICHENOLOGIST, V34, P141, DOI 10.1006/lich.2002.0378; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; WILLIAMSON K, 1975, BIRD STUDY, V22, P143, DOI 10.1080/00063657509476459	46	6842	7309	163	6771	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					37	42		10.1038/nature01286	http://dx.doi.org/10.1038/nature01286			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511946				2022-12-28	WOS:000180165500029
J	Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG				Speck, O; Hughes, SC; Noren, NK; Kulikauskas, RM; Fehon, RG			Moesin functions antagonistically to the Rho pathway to maintain epithelial integrity	NATURE			English	Article							EZRIN/RADIXIN/MOESIN ERM PROTEINS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; CELL POLARITY; DROSOPHILA; PHOSPHORYLATION; LOCALIZATION; ASSOCIATION; FIBROBLASTS; EXPRESSION	Two prominent characteristics of epithelial cells, apical-basal polarity and a highly ordered cytoskeleton, depend on the existence of precisely localized protein complexes associated with the apical plasma membrane(1,2), and on a separate machinery that regulates the spatial order of actin assembly(3). ERM (ezrin, radixin, moesin) proteins have been proposed to link transmembrane proteins to the actin cytoskeleton(4) in the apical domain, suggesting a structural role in epithelial cells, and they have been implicated in signalling pathways(5). Here, we show that the sole Drosophila ERM protein Moesin functions to promote cortical actin assembly and apical-basal polarity. As a result, cells lacking Moesin lose epithelial characteristics and adopt invasive migratory behaviour. Our data demonstrate that Moesin facilitates epithelial morphology not by providing an essential structural function, but rather by antagonizing activity of the small GTPase Rho. Thus, Moesin functions in maintaining epithelial integrity by regulating cell-signalling events that affect actin organization and polarity. Furthermore, our results show that there is negative feedback between ERM activation and activity of the Rho pathway.	Duke Univ, Dept Biol, DCMB Grp, Durham, NC 27708 USA; Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Fehon, RG (corresponding author), Duke Univ, Dept Biol, DCMB Grp, Box 91000, Durham, NC 27708 USA.		Noren Hooten, Nicole/J-5498-2019; Hughes, Sarah/D-3677-2009	Noren Hooten, Nicole/0000-0002-1683-3838; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034783] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Baum B, 2001, NAT CELL BIOL, V3, P883, DOI 10.1038/ncb1001-883; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Bretscher A, 1997, J CELL SCI, V110, P3011; Edwards KA, 1997, DEV BIOL, V191, P103, DOI 10.1006/dbio.1997.8707; FEHON RG, 1994, DEVELOPMENT, V120, P545; Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193; Halsell SR, 2000, GENETICS, V156, P469; Hayashi K, 1999, J CELL SCI, V112, P1149; Hirao M, 1996, J CELL BIOL, V135, P37, DOI 10.1083/jcb.135.1.37; LaJeunesse DR, 1998, J CELL BIOL, V141, P1589, DOI 10.1083/jcb.141.7.1589; Mackay DJG, 1997, J CELL BIOL, V138, P927, DOI 10.1083/jcb.138.4.927; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; McCartney BM, 1996, J CELL BIOL, V133, P843, DOI 10.1083/jcb.133.4.843; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Polesello C, 2002, NAT CELL BIOL, V4, P782, DOI 10.1038/ncb856; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; REBAY I, 1993, CELL, V74, P319, DOI 10.1016/0092-8674(93)90423-N; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Schmitz AAP, 2000, EXP CELL RES, V261, P1, DOI 10.1006/excr.2000.5049; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shaw RJ, 1998, MOL BIOL CELL, V9, P403, DOI 10.1091/mbc.9.2.403; Simons PC, 1998, BIOCHEM BIOPH RES CO, V253, P561, DOI 10.1006/bbrc.1998.9823; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Takahashi K, 1998, ONCOGENE, V16, P3279, DOI 10.1038/sj.onc.1201874; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7	30	200	210	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					83	87		10.1038/nature01295	http://dx.doi.org/10.1038/nature01295			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511959				2022-12-28	WOS:000180165500042
J	Blat, Y; Protacio, RU; Hunter, N; Kleckner, N				Blat, Y; Protacio, RU; Hunter, N; Kleckner, N			Physical and functional interactions among basic chromosome organizational features govern early steps of meiotic chiasma formation	CELL			English	Article							SISTER-CHROMATID COHESION; YEAST SACCHAROMYCES-CEREVISIAE; DOUBLE-STRAND BREAKS; RECOMBINATION INITIATION; CROSSOVER INTERFERENCE; SYNAPTONEMAL COMPLEXES; AXIAL ELEMENT; MEIOSIS; PROTEIN; SITES	Analysis of meiotic recombination by functional genomic approaches reveals prominent spatial and functional interactions among diverse organizational determinants. Recombination occurs between chromatin loop sequences; however, these sequences are spatially tethered to underlying chromosome axes via their recombinosomes. Meiotic chromosomal protein, Red1, localizes to chromosome axes; however, Red1 loading is modulated by R/G-bands isochores and thus by bulk chromatin state. Recombination is also modulated by isochore determinants: R-bands differentially favor double-strand break (DSB) formation but disfavor subsequent loading of meiotic RecA homolog, Dmc1. Red1 promotes DSB formation in both R- and G-bands and then promotes Dmc1 loading, specifically counteracting disfavoring R-band effects. These complexities are discussed in the context of chiasma formation as a series of coordinated local changes at the DNA and chromosome-axis levels.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Kleckner, N (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NIGMS NIH HHS [R01-GM44794] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044794] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1990, CELL, V61, P419, DOI 10.1016/0092-8674(90)90524-I; ALBINI SM, 1987, CHROMOSOMA, V95, P324, DOI 10.1007/BF00293179; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Anderson LK, 1997, P NATL ACAD SCI USA, V94, P6868, DOI 10.1073/pnas.94.13.6868; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Blumental-Perry A, 2000, EMBO REP, V1, P232, DOI 10.1093/embo-reports/kvd047; Borde V, 2000, SCIENCE, V290, P806, DOI 10.1126/science.290.5492.806; Debrauwere H, 1999, NAT GENET, V23, P367, DOI 10.1038/15557; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DRESSER ME, 1988, J CELL BIOL, V106, P567, DOI 10.1083/jcb.106.3.567; Dujon B, 1996, TRENDS GENET, V12, P263, DOI 10.1016/0168-9525(96)10027-5; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Franklin AE, 1999, PLANT CELL, V11, P809, DOI 10.1105/tpc.11.5.809; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; GIMENEZABIAN JF, 1995, J CELL BIOL, V131, P7, DOI 10.1083/jcb.131.1.7; Guacci V, 1997, CELL, V91, P47, DOI 10.1016/S0092-8674(01)80008-8; Hollingsworth NM, 1997, GENETICS, V147, P33; HOLMQUIST GP, 1992, AM J HUM GENET, V51, P17; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; John B., 1990, MEIOSIS; Kaback DB, 1999, GENETICS, V152, P1475; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; KING JS, 1990, GENETICS, V126, P1127; Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1; Laloraya S, 2000, J CELL BIOL, V151, P1047, DOI 10.1083/jcb.151.5.1047; MaoDraayer Y, 1996, GENETICS, V144, P71; MOENS PB, 1988, BIOESSAYS, V9, P151, DOI 10.1002/bies.950090503; Pelttari J, 2001, MOL CELL BIOL, V21, P5667, DOI 10.1128/MCB.21.16.5667-5677.2001; Petes TD, 2001, NAT REV GENET, V2, P360, DOI 10.1038/35072078; ROCKMILL B, 1988, P NATL ACAD SCI USA, V85, P6057, DOI 10.1073/pnas.85.16.6057; ROCKMILL B, 1990, GENETICS, V126, P563; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; STACK SM, 1986, AM J BOT, V73, P264, DOI 10.2307/2444181; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; Tarsounas M, 1999, J CELL BIOL, V147, P207, DOI 10.1083/jcb.147.2.207; TEASE C, 1978, NATURE, V272, P823, DOI 10.1038/272823a0; Thompson DA, 1999, GENETICS, V153, P621; van Heemst D, 2000, CHROMOSOMA, V109, P10, DOI 10.1007/s004120050408; VONWETTS.D, 1971, P NATL ACAD SCI USA, V68, P851, DOI 10.1073/pnas.68.4.851; WU TC, 1994, SCIENCE, V263, P515, DOI 10.1126/science.8290959; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; Yokota H, 1997, CHROMOSOME RES, V5, P157, DOI 10.1023/A:1018438729203; ZENVIRTH D, 1992, EMBO J, V11, P3441, DOI 10.1002/j.1460-2075.1992.tb05423.x; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603; Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619	53	246	252	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					791	802		10.1016/S0092-8674(02)01167-4	http://dx.doi.org/10.1016/S0092-8674(02)01167-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526806	Bronze			2022-12-28	WOS:000179862600006
J	Casper, AM; Nghiem, P; Arlt, MF; Glover, TW				Casper, AM; Nghiem, P; Arlt, MF; Glover, TW			ATR regulates fragile site stability	CELL			English	Article							DNA-REPLICATION; ATAXIA-TELANGIECTASIA; FHIT GENE; MOLECULAR CHARACTERIZATION; FREQUENT DELETIONS; INTEGRATION SITE; CANCER-CELLS; CHECKPOINT; FRA3B; EXPRESSION	Conditions that partially inhibit DNA replication induce expression of common fragile sites. These sites form gaps and breaks on metaphase chromosomes and are deleted and rearranged in many tumors. Yet, the mechanism of fragile site expression has been elusive. We demonstrate that the replication checkpoint kinase ATR, but not ATM, is critical for maintenance of fragile site stability. ATR deficiency results in fragile site expression with and without addition of replication inhibitors. Thus, we propose that fragile sites are unreplicated chromosomal regions resulting from stalled forks that escape the ATR replication checkpoint. These findings have important implications for understanding both the mechanism of fragile site instability and the consequences of stalled replication in mammalian cells.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Harvard Univ, Howard Hughes Med Inst, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; Dana Farber Canc Inst, Cutaneous Oncol Unit, Boston, MA 02115 USA	University of Michigan System; University of Michigan; Harvard University; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute	Glover, TW (corresponding author), Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA.		Nghiem, Paul T/A-9210-2011	Nghiem, Paul T/0000-0003-2784-963X; Casper, Anne/0000-0003-4975-5749	NCI NIH HHS [CA43222] Funding Source: Medline; NIAMS NIH HHS [K08-AR02087] Funding Source: Medline; NIGMS NIH HHS [GM38627] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038627, R01GM038627] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; ANTON M, 1995, J VIROL, V69, P4600, DOI 10.1128/JVI.69.8.4600-4606.1995; Arlt MF, 2002, GENE CHROMOSOME CANC, V33, P82, DOI 10.1002/gcc.10000; Bednarek AK, 2001, CANCER RES, V61, P8068; Bentley NJ, 1996, EMBO J, V15, P6641, DOI 10.1002/j.1460-2075.1996.tb01054.x; Brown EJ, 2000, GENE DEV, V14, P397; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cliby WA, 1998, EMBO J, V17, P159, DOI 10.1093/emboj/17.1.159; Coquelle A, 1997, CELL, V89, P215, DOI 10.1016/S0092-8674(00)80201-9; Corbin S, 2002, CANCER RES, V62, P3477; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; Druck T, 1997, CANCER RES, V57, P504; Dumon KR, 2001, P NATL ACAD SCI USA, V98, P3346, DOI 10.1073/pnas.061020098; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Glover TW, 1998, RECENT RES CANCER, V154, P185; GLOVER TW, 1987, AM J HUM GENET, V41, P882; Glover TW, 1998, CANCER RES, V58, P3409; GLOVER TW, 1986, CANCER GENET CYTOGEN, V19, P141, DOI 10.1016/0165-4608(86)90381-X; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hansen RS, 1997, P NATL ACAD SCI USA, V94, P4587, DOI 10.1073/pnas.94.9.4587; Harborth J, 2001, J CELL SCI, V114, P4557; Hellman A, 2000, MOL CELL BIOL, V20, P4420, DOI 10.1128/MCB.20.12.4420-4427.2000; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Kondo T, 2001, SCIENCE, V294, P867, DOI 10.1126/science.1063827; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Liu QH, 2000, GENE DEV, V14, P1448; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Marchetti MA, 2002, P NATL ACAD SCI USA, V99, P7472, DOI 10.1073/pnas.112702399; Masramon L, 2000, CANCER GENET CYTOGEN, V121, P17, DOI 10.1016/S0165-4608(00)00219-3; Michael D, 1997, ONCOGENE, V15, P1653; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Nghiem P, 2002, J BIOL CHEM, V277, P4428, DOI 10.1074/jbc.M106113200; Paige AJW, 2001, P NATL ACAD SCI USA, V98, P11417, DOI 10.1073/pnas.191175898; Paige AJW, 2000, CANCER RES, V60, P1690; Pincheira J, 2001, MUTAGENESIS, V16, P419, DOI 10.1093/mutage/16.5.419; RASSOOL FV, 1991, P NATL ACAD SCI USA, V88, P6657, DOI 10.1073/pnas.88.15.6657; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Santocanale C, 1998, NATURE, V395, P615, DOI 10.1038/27001; Sarkaria JN, 1999, CANCER RES, V59, P4375; Shiraishi T, 2001, P NATL ACAD SCI USA, V98, P5722, DOI 10.1073/pnas.091095898; SMEETS DFCM, 1990, CYTOGENET CELL GENET, V53, P8, DOI 10.1159/000132885; Sutherland GR, 1998, TRENDS GENET, V14, P501, DOI 10.1016/S0168-9525(98)01628-X; Telatar M, 1996, AM J HUM GENET, V59, P40; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Thorland EC, 2000, CANCER RES, V60, P5916; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang L, 1997, GENOMICS, V41, P485, DOI 10.1006/geno.1997.4690; Wang L, 1999, HUM MOL GENET, V8, P431, DOI 10.1093/hmg/8.3.431; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; Wilke CM, 1996, HUM MOL GENET, V5, P187, DOI 10.1093/hmg/5.2.187; Wright J, 1996, AM J HUM GENET, V59, P839; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; YUNIS JJ, 1984, SCIENCE, V226, P1199, DOI 10.1126/science.6239375; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	62	450	459	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	DEC 13	2002	111	6					779	789		10.1016/S0092-8674(02)01113-3	http://dx.doi.org/10.1016/S0092-8674(02)01113-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526805	Bronze			2022-12-28	WOS:000179862600005
J	Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY				Shumyatsky, GP; Tsvetkov, E; Malleret, G; Vronskaya, S; Hatton, M; Hampton, L; Battey, JF; Dulac, C; Kandel, ER; Bolshakov, VY			Identification of a signaling network in lateral nucleus of amygdala important for inhibiting memory specifically related to learned fear	CELL			English	Article							LONG-TERM POTENTIATION; BOMBESIN-LIKE PEPTIDES; BASOLATERAL AMYGDALA; SYNAPTIC PLASTICITY; CA3-CA1 SYNAPSES; KINASE PATHWAYS; DEFICIENT MICE; MESSENGER-RNA; RECEPTOR; PROTEIN	We identified the Grp gene, encoding gastrin-releasing peptide, as being highly expressed both in the lateral nucleus of the amygdala, the nucleus where associations for Pavlovian learned fear are formed, and in the regions that convey fearful auditory information to the lateral nucleus. Moreover, we found that GRP receptor (GRPR) is expressed in GABAergic interneurons of the lateral nucleus. GRP excites these interneurons and increases their inhibition of principal neurons. GRPR-deficient mice showed decreased inhibition of principal neurons by the interneurons, enhanced long-term potentiation (LTP), and greater and more persistent long-term fear memory. By contrast, these mice performed normally in hippocampus-dependent Morris maze. These experiments provide genetic evidence that GRP and its neural circuitry operate as a negative feedback regulating fear and establish a causal relationship between Grpr gene expression, LTP, and amygdala-dependent memory for fear.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; NINDS, NIH, Bethesda, MD 20892 USA; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, McLean Hosp, Dept Psychiat, Belmont, MA 02478 USA	Columbia University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Harvard University; Howard Hughes Medical Institute; Harvard University; McLean Hospital	Kandel, ER (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907; Dulac, Catherine/0000-0001-5024-5418	NIDA NIH HHS [DA15098] Funding Source: Medline; NINDS NIH HHS [NS44185] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Bachevalier J, 2001, BEHAV NEUROSCI, V115, P545, DOI 10.1037//0735-7044.115.3.545; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Bast T, 2001, EXP BRAIN RES, V139, P39, DOI 10.1007/s002210100746; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Brauer AU, 2001, NEUROSCIENCE, V102, P515, DOI 10.1016/S0306-4522(00)00471-1; Cook EH, 1998, AM J HUM GENET, V62, P1077, DOI 10.1086/301832; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Frederickson CJ, 2000, J NUTR, V130, p1471S, DOI 10.1093/jn/130.5.1471S; Goddard AW, 2001, ARCH GEN PSYCHIAT, V58, P556, DOI 10.1001/archpsyc.58.6.556; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; HARRELL AV, 2001, 31 ANN M SAN DIEG CA; Hellmich MR, 1999, J BIOL CHEM, V274, P23901, DOI 10.1074/jbc.274.34.23901; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; IshikawaBrush Y, 1997, HUM MOL GENET, V6, P1241, DOI 10.1093/hmg/6.8.1241; Johansson B, 2001, P NATL ACAD SCI USA, V98, P9407, DOI 10.1073/pnas.161292398; KAPP B S, 1992, P229; Krezel W, 2001, P NATL ACAD SCI USA, V98, P12278, DOI 10.1073/pnas.221451898; KROOG GS, 1995, MED RES REV, V15, P389, DOI 10.1002/med.2610150502; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee K, 1999, J PHYSIOL-LONDON, V518, P791, DOI 10.1111/j.1469-7793.1999.0791p.x; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; Merali Z, 1998, J NEUROSCI, V18, P4758; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Parent MB, 2002, BIOCHEM PHARMACOL, V63, P57, DOI 10.1016/S0006-2952(01)00856-5; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; Rammes G, 2000, EUR J NEUROSCI, V12, P2534, DOI 10.1046/j.1460-9568.2000.00108.x; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sharif TR, 1997, MOL CELL ENDOCRINOL, V130, P119, DOI 10.1016/S0303-7207(97)00080-4; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Wada E, 1997, BIOCHEM BIOPH RES CO, V239, P28, DOI 10.1006/bbrc.1997.7418; Wang C, 2001, J NEUROPHYSIOL, V86, P1422, DOI 10.1152/jn.2001.86.3.1422; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Weisskopf MG, 1999, J NEUROPHYSIOL, V81, P930, DOI 10.1152/jn.1999.81.2.930; Woodson W, 2000, SYNAPSE, V38, P124, DOI 10.1002/1098-2396(200011)38:2<124::AID-SYN3>3.0.CO;2-N; Yu BJ, 1997, J NEUROPHYSIOL, V77, P690, DOI 10.1152/jn.1997.77.2.690	49	243	257	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 13	2002	111	6					905	918		10.1016/S0092-8674(02)01116-9	http://dx.doi.org/10.1016/S0092-8674(02)01116-9			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	626GC	12526815	Bronze			2022-12-28	WOS:000179862600015
J	Pinn, VW				Pinn, VW			Sex and gender factors in medical studies - Implications for health and clinical practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMENS HEALTH; MYOCARDIAL-INFARCTION; TRIALS; HEART; CARE; REPRESENTATION; PROLONGATION; DELIVERY; TRENDS		NIH, Off Res Womens Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Pinn, VW (corresponding author), NIH, Off Res Womens Hlth, 9000 Rockville Pike,Bldg 1,Room 201, Bethesda, MD 20892 USA.	orwh-research@od.nih.gov						*AM PSYCH ASS, 2002, SUMM WOM DEPR P REC; Anthony Marietta, 2002, J Womens Health Gend Based Med, V11, P601, DOI 10.1089/152460902760360559; Arnold K, 2000, J NATL CANCER I, V92, P1561, DOI 10.1093/jnci/92.19.1561; Benton RE, 2000, CLIN PHARMACOL THER, V67, P413, DOI 10.1067/mcp.2000.105761; BERG MJ, 1999, NIH PUBLICATION, V2; BLEHAR MC, 2001, TEN, V3, P42; Brandt E N Jr, 1998, J Gend Specif Med, V1, P48; Buring JE, 2000, NEW ENGL J MED, V343, P505, DOI 10.1056/NEJM200008173430711; Campaigne B N, 2000, J Gend Specif Med, V3, P51; CARLSON KJ, 1997, TXB WOMENS HLTH, P33; *CDCP, HIV AIDS SURV WOM; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V285, P1508, DOI 10.1001/jama.285.11.1508; Desai H D, 2000, J Am Pharm Assoc (Wash), V40, P525; Doyal L, 2001, BRIT MED J, V323, P1061, DOI 10.1136/bmj.323.7320.1061; FISHMAN JR, 1999, NIH PUBLICATION, V2; Gear RW, 1996, NAT MED, V2, P1248, DOI 10.1038/nm1196-1248; Gesensway D, 2001, ANN INTERN MED, V135, P935, DOI 10.7326/0003-4819-135-10-200111200-00032; Gwinn DE, 2000, AM J SPORT MED, V28, P98, DOI 10.1177/03635465000280012901; Harris DJ, 2000, NEW ENGL J MED, V343, P475, DOI 10.1056/NEJM200008173430706; HEALY B, 1991, NEW ENGL J MED, V325, P274, DOI 10.1056/NEJM199107253250408; Hobbs F. B., ELDERLY POPULATION; Hoffman E, 1995, J Am Med Womens Assoc (1972), V50, P17; Hoffman E, 1997, WOMEN HEALTH ISS, V7, P362, DOI 10.1016/S1049-3867(97)00074-1; Hoffmann DE, 2001, J LAW MED ETHICS, V29, P13, DOI 10.1111/j.1748-720X.2001.tb00037.x; Horwitz BJ, 2001, NEW ENGL J MED, V344, P1846, DOI 10.1056/NEJM200106143442407; KASPER AS, 1997, TXB WOMENS HLTH, P3; Kendler K S, 1998, J Gend Specif Med, V1, P28; Krummel DA, 2001, J WOMEN HEALTH GEN-B, V10, P117, DOI 10.1089/152460901300039467; LaRosa J H, 1993, J Am Med Womens Assoc (1972), V48, P145; Lawlor DA, 2001, BRIT MED J, V323, P541, DOI 10.1136/bmj.323.7312.541; Lee PY, 2001, JAMA-J AM MED ASSOC, V286, P708, DOI 10.1001/jama.286.6.708; Legato M J, 2000, J Gend Specif Med, V3, P15; LEGATO MJ, 2000, J GEND SPECIF MED, V3, P12; LENFANT C, 1999, NIH PUBLICATION, V2; Mastroianni AC, 1994, WOMEN HLTH RES ETHIC; Mehilli J, 2002, JAMA-J AM MED ASSOC, V287, P210, DOI 10.1001/jama.287.2.210; Meinert CL, 2000, CONTROL CLIN TRIALS, V21, P462, DOI 10.1016/S0197-2456(00)00086-6; Natelson BH, 2001, JAMA-J AM MED ASSOC, V285, P2557, DOI 10.1001/jama.285.20.2557; *NIH OFF RES WOM H, 1999, NIH PUBL, V2; Perkins KA, 2001, CNS DRUGS, V15, P391, DOI 10.2165/00023210-200115050-00005; Phelan EA, 2000, J GEN INTERN MED, V15, P8, DOI 10.1046/j.1525-1497.2000.12178.x; Pinn V W, 1998, J Gend Specif Med, V1, P50; Pinn VW, 1999, ACAD MED, V74, P1104, DOI 10.1097/00001888-199910000-00013; PINN VW, 1997, TXB WOMENS HLTH, P971; PINN VW, 2002, MONITORING ADHERENCE; Prout M N, 2001, Medscape Womens Health, V6, P1; Rodriguez I, 2001, JAMA-J AM MED ASSOC, V285, P1322, DOI 10.1001/jama.285.10.1322; Romanzi L J, 2001, J Gend Specif Med, V4, P14; Shlipak MG, 2001, ANN INTERN MED, V134, P1043, DOI 10.7326/0003-4819-134-11-200106050-00010; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; *US GEN ACC OFF, 2001, WOM HLTH WOM CLIN DR; *US GEN ACC OFF, 2000, WOMENS HLTH NIH INCR; Walsh SJ, 2000, AM J PUBLIC HEALTH, V90, P1463, DOI 10.2105/AJPH.90.9.1463; Weisman C S, 2000, J Gend Specif Med, V3, P22; Weisman CS, 1997, HEALTH AFFAIR, V16, P276, DOI 10.1377/hlthaff.16.3.276-a; Weisman CS, 2000, ACAD MED, V75, P1107, DOI 10.1097/00001888-200011000-00016; Wizemann T. M., 2001, EXPLORING BIOL CONTR; 2000, HARV WOMENS HLTH WAT, V7, P4; [No title captured]	59	118	123	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 22	2003	289	4					397	400		10.1001/jama.289.4.397	http://dx.doi.org/10.1001/jama.289.4.397			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TD	12533102				2022-12-28	WOS:000180472300001
J	Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ				Gomez-Roman, N; Grandori, C; Eisenman, RN; White, RJ			Direct activation of RNA polymerase III transcription by c-Myc	NATURE			English	Article							TATA-BINDING-PROTEIN; CELL-GROWTH; RIBOSOME BIOGENESIS; GENES; EXPRESSION; TARGET; CYCLE; P107; TRANSACTIVATION; FIBROBLASTS	The proto-oncogene product c-Myc has a direct role in both metazoan cell growth and division(1-4). RNA polymerase III (pol III) is involved in the generation of transfer RNA and 5S ribosomal RNA, and these molecules must be produced in bulk to meet the need for protein synthesis in growing cells(5). We demonstrate here that c-Myc binds to TFIIIB, a pol III-specific general transcription factor, and directly activates pol III transcription. Chromatin immunoprecipitation reveals that endogenous c-Myc is present at tRNA and 5S rRNA genes in cultured mammalian cells. These results suggest that activation of pol III may have a role in the ability of c-Myc to stimulate cell growth.	Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; Univ Glasgow, Inst Biomed & Life Sci, Div Biochem & Mol Biol, Glasgow G12 8QQ, Lanark, Scotland	Fred Hutchinson Cancer Center; University of Glasgow	Eisenman, RN (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA.			Gomez-Roman, Natividad/0000-0002-2325-7517				Beier R, 2000, EMBO J, V19, P5813, DOI 10.1093/emboj/19.21.5813; Boon K, 2001, EMBO J, V20, P1383, DOI 10.1093/emboj/20.6.1383; Brown TRP, 2000, GENE EXPRESSION, V9, P15; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Coller HA, 2000, P NATL ACAD SCI USA, V97, P3260, DOI 10.1073/pnas.97.7.3260; Dang CV, 1999, MOL CELL BIOL, V19, P1; EILERS M, 1991, EMBO J, V10, P133, DOI 10.1002/j.1460-2075.1991.tb07929.x; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Elend M, 1999, CURR BIOL, V9, pR936, DOI 10.1016/S0960-9822(00)80109-8; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; GU W, 1994, SCIENCE, V264, P251, DOI 10.1126/science.8146655; HATEBOER G, 1993, P NATL ACAD SCI USA, V90, P8489, DOI 10.1073/pnas.90.18.8489; Hirst SK, 2000, ONCOGENE, V19, P5189, DOI 10.1038/sj.onc.1203904; HOANG AT, 1995, MOL CELL BIOL, V15, P4031; Iritani BM, 1999, P NATL ACAD SCI USA, V96, P13180, DOI 10.1073/pnas.96.23.13180; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kim S, 2000, P NATL ACAD SCI USA, V97, P11198, DOI 10.1073/pnas.200372597; Mateyak MK, 1997, CELL GROWTH DIFFER, V8, P1039; Rosenwald IB, 1996, CANCER LETT, V102, P113, DOI 10.1016/0304-3835(96)04171-7; Schmidt EV, 1999, ONCOGENE, V18, P2988, DOI 10.1038/sj.onc.1202751; Schubeler D, 2000, GENE DEV, V14, P940; Schuhmacher M, 1999, CURR BIOL, V9, P1255, DOI 10.1016/S0960-9822(99)80507-7; Scott PH, 2001, J BIOL CHEM, V276, P1005, DOI 10.1074/jbc.M005417200; STEINER P, 1995, EMBO J, V14, P4814, DOI 10.1002/j.1460-2075.1995.tb00163.x; Sutcliffe JE, 1999, MOL CELL BIOL, V19, P4255; White RJ, 1996, NATURE, V382, P88, DOI 10.1038/382088a0; WHITE RJ, 1995, MOL CELL BIOL, V15, P1983; Winter AG, 2000, P NATL ACAD SCI USA, V97, P12619, DOI 10.1073/pnas.230224097	30	313	320	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 16	2003	421	6920					290	294		10.1038/nature01327	http://dx.doi.org/10.1038/nature01327			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	635KG	12529648				2022-12-28	WOS:000180397600053
J	Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP				Schneider, AT; Pancioli, AM; Khoury, JC; Rademacher, E; Tuchfarber, A; Miller, R; Woo, D; Kissela, B; Broderick, JP			Trends in community knowledge of the warning signs and risk factors for stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NORTHERN MANHATTAN STROKE; HEALTH-CARE DASH; ALCOHOL-CONSUMPTION; ISCHEMIC STROKE; SYMPTOMS; EMERGENCY; DELAYS; DETERMINANTS; INFARCTION; POPULATION	Context Poor public knowledge of stroke warning signs and risk factors limits effective stroke intervention and prevention. Objective To examine temporal trends in public knowledge of stroke warning signs and risk factors. Design and Setting Population-based random-digit telephone survey conducted in July-November 2000 among individuals in the greater Cincinnati, Ohio, region. Participants A total of 2173 survey respondents (69% response rate) were randomly identified based on their demographic similarities to the ischemic stroke population with regard to age, race, and sex. Main Outcome Measures Spontaneous recall of at least 1 important stroke warning sign and 1 established stroke risk factor in comparison with findings from the same survey in 1995. Results In 2000, 70% of respondents correctly named at least 1 established stroke warning sign vs 57% in 1995 (P<.001), and 72% correctly named at least 1 established stroke risk factor vs 68% in 1995. Groups of individuals with the highest risk and incidence of stroke, such as persons at least 75 years old, blacks, and men, were the least knowledgeable about warning signs and risk factors. Television was the most frequently cited source of knowledge, 32% in 2000 vs 24% in 1995 (P<.001). Conclusions Public knowledge of stroke warning signs within the greater Cincinnati region has significantly improved from 1995 to 2000, although knowledge of stroke risk factors did not improve significantly during the same time period. Public education efforts must continue and should focus on groups at the highest risk of stroke.	Univ Cincinnati, Dept Neurol, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; Univ Cincinnati, Inst Policy Res, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Schneider, AT (corresponding author), Univ Cincinnati, Dept Neurol, Med Sci Bldg 0525,231 Albert Sabin Way, Cincinnati, OH 45267 USA.		Khoury, Jane/O-2068-2015	Kissela, Brett/0000-0002-9773-4013	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030678, U10NS077311] Funding Source: NIH RePORTER; NINDS NIH HHS [R01-NS30678-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		*AM STROK ASS, KNOW WARN SIGNS STRO; Amarenco P, 2001, NEUROLOGY, V57, pS35, DOI 10.1212/WNL.57.suppl_2.S35; BARSAN WG, 1993, ARCH INTERN MED, V153, P2558, DOI 10.1001/archinte.153.22.2558; BARSAN WG, 1994, STROKE, V25, P2132, DOI 10.1161/01.STR.25.11.2132; Broderick J, 1998, STROKE, V29, P415, DOI 10.1161/01.STR.29.2.415; Caicoya M, 1999, J CLIN EPIDEMIOL, V52, P677, DOI 10.1016/S0895-4356(98)00074-2; Di Mascio R, 2000, CEREBROVASC DIS, V10, P85, DOI 10.1159/000016035; Evenson KR, 2001, NEUROEPIDEMIOLOGY, V20, P65, DOI 10.1159/000054763; Ezzati TM, 1992, VITAL HLTH STAT 2, V2, P1; FELDMANN E, 1993, STROKE, V24, P1805, DOI 10.1161/01.STR.24.12.1805; GILL JS, 1986, NEW ENGL J MED, V315, P1041, DOI 10.1056/NEJM198610233151701; ISO H, 1989, NEW ENGL J MED, V320, P904, DOI 10.1056/NEJM198904063201405; Kothari R, 1997, STROKE, V28, P1871, DOI 10.1161/01.STR.28.10.1871; Kothari R, 1999, ANN EMERG MED, V33, P3, DOI 10.1016/S0196-0644(99)70431-2; Morris DL, 2000, STROKE, V31, P2585, DOI 10.1161/01.STR.31.11.2585; *NAT STROK ASS, REC STROK SYMPT; Pancioli AM, 1998, JAMA-J AM MED ASSOC, V279, P1288, DOI 10.1001/jama.279.16.1288; Rosamond WD, 1999, STROKE, V30, P736, DOI 10.1161/01.STR.30.4.736; Rosamond WD, 1998, ACAD EMERG MED, V5, P45, DOI 10.1111/j.1553-2712.1998.tb02574.x; Rowe AE, 2001, SOUTHERN MED J, V94, P613, DOI 10.1097/00007611-200194060-00014; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Sacco RL, 1999, JAMA-J AM MED ASSOC, V281, P53, DOI 10.1001/jama.281.1.53; Sacco RL, 1998, AM J EPIDEMIOL, V147, P259, DOI 10.1093/oxfordjournals.aje.a009445; Samsa GP, 1997, STROKE, V28, P916, DOI 10.1161/01.STR.28.5.916; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; *US CENS BUR, 1990 CENS QUICK TABL; Whisnant JP, 1997, STROKE, V28, P1840, DOI 10.1161/01.STR.28.9.1840; Williams LS, 1997, STROKE, V28, P912, DOI 10.1161/01.STR.28.5.912; Yoon SS, 2001, STROKE, V32, P1926, DOI 10.1161/01.STR.32.8.1926	29	253	261	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 15	2003	289	3					343	346		10.1001/jama.289.3.343	http://dx.doi.org/10.1001/jama.289.3.343			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	634MV	12525235	Bronze			2022-12-28	WOS:000180345100029
J	Adams, MD; McVey, M; Sekelsky, JJ				Adams, MD; McVey, M; Sekelsky, JJ			Drosophila BLM in double-strand break repair by synthesis-dependent strand annealing	SCIENCE			English	Article							SYNDROME GENE-PRODUCT; INDUCED GAP REPAIR; BLOOM-SYNDROME; IN-VIVO; RECOMBINATION; MELANOGASTER; JUNCTIONS; MECHANISM; HELICASE; PROTEIN	Bloom syndrome, characterized by a predisposition to cancer, is caused by mutation of the RecQ DNA helicase gene BLM. The precise function of BLM remains unclear. Previous research suggested that Drosophila BLM functions in the repair of DNA double-strand breaks. Most double-strand breaks in flies are repaired by homologous recombination through the synthesis-dependent strand-annealing pathway. Here, we demonstrate that Drosophila BLM mutants are severely impaired in their ability to carry out repair DNA synthesis during synthesis-dependent strand annealing. Consequently, repair in the mutants is completed by error-prone pathways that create large deletions. These results suggest a model in which BLM maintains genomic stability by promoting efficient repair DNA synthesis and thereby prevents double-strand break repair by less precise pathways.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, SPIRE Program, Chapel Hill, NC 27599 USA; Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sekelsky, JJ (corresponding author), Univ N Carolina, Dept Biol, CB 3280, Chapel Hill, NC 27599 USA.		Sekelsky, Jeff J/F-9892-2010		NIGMS NIH HHS [GM000678] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beall EL, 1996, GENE DEV, V10, P921, DOI 10.1101/gad.10.8.921; Beall EL, 1997, GENE DEV, V11, P2137, DOI 10.1101/gad.11.16.2137; BOYD JB, 1981, GENETICS, V97, P607; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; ENGELS WR, 1990, CELL, V62, P515, DOI 10.1016/0092-8674(90)90016-8; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; GERMAN J, 1993, MEDICINE, V72, P393, DOI 10.1097/00005792-199311000-00003; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Harmon FG, 1998, GENE DEV, V12, P1134, DOI 10.1101/gad.12.8.1134; Jager U, 2000, BLOOD, V95, P3520, DOI 10.1182/blood.V95.11.3520.011k12_3520_3529; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; KAUFMAN PD, 1992, CELL, V69, P27, DOI 10.1016/0092-8674(92)90116-T; KURKULOS M, 1994, GENETICS, V136, P1001; Kusano K, 2001, SCIENCE, V291, P2600, DOI 10.1126/science.291.5513.2600; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; OHARE K, 1983, CELL, V34, P25, DOI 10.1016/0092-8674(83)90133-2; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2001, NUCLEIC ACIDS RES, V29, P4378, DOI 10.1093/nar/29.21.4378; Richardson C, 2000, MOL CELL BIOL, V20, P9068, DOI 10.1128/MCB.20.23.9068-9075.2000; STAVELEY BE, 1995, GENETICS, V139, P1321; Welzel N, 2001, CANCER RES, V61, P1629; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200	24	194	200	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					265	267		10.1126/science.1077198	http://dx.doi.org/10.1126/science.1077198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522255				2022-12-28	WOS:000180284000044
J	Tyler, RH; Maus, S; Luhr, H				Tyler, RH; Maus, S; Luhr, H			Satellite observations of magnetic fields due to ocean tidal flow	SCIENCE			English	Article							INDUCED ELECTROMAGNETIC-FIELDS; DAILY GEOMAGNETIC-VARIATIONS; SEPARATION	The ocean is an electrically conducting fluid that generates secondary magnetic fields as it flows through Earth's main magnetic field. Extracting ocean flow signals from remote observations has become possible with the current generation of satellites measuring Earth's magnetic field. Here, we consider the magnetic fields generated by the ocean lunar semidiurnal (M-2) tide and demonstrate that magnetic fields of oceanic origin can be clearly identified in satellite observations.	Univ Washington, Ocean Phys Dept, Appl Phys Lab, Seattle, WA 98103 USA; Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	University of Washington; University of Washington Seattle; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Tyler, RH (corresponding author), Univ Washington, Ocean Phys Dept, Appl Phys Lab, 1013 NE 40th St, Seattle, WA 98103 USA.							BINDOFF NL, 1988, J GEOMAGN GEOELECTR, V40, P1445, DOI 10.5636/jgg.40.1445; CHAVE AD, 1990, J GEOPHYS RES-OCEANS, V95, P7185, DOI 10.1029/JC095iC05p07185; EGBERT GD, 1994, J GEOPHYS RES-OCEANS, V99, P24821, DOI 10.1029/94JC01894; HOLME R, IN PRESS 1 CHAMP MIS; LARSEN JC, 1968, GEOPHYS J ROY ASTR S, V16, P47, DOI 10.1111/j.1365-246X.1968.tb07135.x; LILLEY FEM, 1993, J GEOMAGN GEOELECTR, V45, P403, DOI 10.5636/jgg.45.403; MALIN SRC, 1970, GEOPHYS J ROY ASTR S, V21, P447, DOI 10.1111/j.1365-246X.1970.tb01781.x; MAUS S, 2002, GEOPHYS RES LETT, V29; MCKNIGHT JD, 1995, GEOPHYS J INT, V122, P889, DOI 10.1111/j.1365-246X.1995.tb06844.x; PRICE AT, 1949, Q J MECH APPL MATH, V2, P283, DOI 10.1093/qjmam/2.3.283; SANFORD TB, 1971, J GEOPHYS RES, V76, P3476, DOI 10.1029/JC076i015p03476; Tyler RH, 1995, GEOPHYS ASTRO FLUID, V80, P167, DOI 10.1080/03091929508228954; Tyler RH, 1997, J GEOMAGN GEOELECTR, V49, P1351, DOI 10.5636/jgg.49.1351; Tyler RH, 1997, J GEOPHYS RES-OCEANS, V102, P5531, DOI 10.1029/96JC03545; TYLER RH, 1995, THESIS MCGILL U; TYLER RH, 2001, 3 INT C MAR EL STOCK	16	118	122	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 10	2003	299	5604					239	241		10.1126/science.1078074	http://dx.doi.org/10.1126/science.1078074			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633LD	12522247				2022-12-28	WOS:000180284000035
J	Brumfiel, G				Brumfiel, G			US societies unite in plea for boost to research budgets	NATURE			English	News Item																		2002, NATURE, V419, P3; 2002, NATURE, V419, P657	2	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 9	2003	421	6919					100	100		10.1038/421100a	http://dx.doi.org/10.1038/421100a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633DR	12520265	Bronze			2022-12-28	WOS:000180267200005
J	Lyder, CH				Lyder, CH			Pressure ulcer prevention and management	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COST-EFFECTIVENESS; RISK		Univ Virginia, Sch Nursing, Charlottesville, VA 22908 USA; Yale Univ, Sch Nursing, Program Advancement Chron Wound Care, New Haven, CT 06536 USA	University of Virginia; Yale University	Lyder, CH (corresponding author), Univ Virginia, Sch Nursing, McLeod Hall,POB 800782, Charlottesville, VA 22908 USA.							*AG HEALTHC RES QU, 2002, CLIN PRACT GUID ONL; ALLMAN RM, 1999, PRINCIPLES GERIATRIC, P1577; [Anonymous], 1975, INVESTIGATION GERIAT; Baker Lucinda L., 1996, Wound Repair and Regeneration, V4, P21, DOI 10.1046/j.1524-475X.1996.40106.x; Bates-Jensen B M, 1997, Adv Wound Care, V10, P65; Bello YM, 2000, JAMA-J AM MED ASSOC, V283, P716, DOI 10.1001/jama.283.6.716; Bennett RG, 2000, J AM GERIATR SOC, V48, P73, DOI 10.1111/j.1532-5415.2000.tb03033.x; BERGSTROM N, 1994, AHCPR PUBL; Bergstrom N, 1992, CLIN PRACTICE GUIDEL; Bliss M R, 1998, J Tissue Viability, V8, P4; COLWELL S, 1993, NEW STATESMAN SOC, V6, P28; CUDDIGAN J, 2001, PRESSURE ULCERS AM P; INMAN KJ, 1993, JAMA-J AM MED ASSOC, V269, P1139; Kloth L C, 1996, Adv Wound Care, V9, P42; Kloth L C, 2000, Adv Skin Wound Care, V13, P69; Knox D M, 1994, Adv Wound Care, V7, P48; Knox DM, 1994, ADV WOUND CARE, V7, P54; Lyder C H, 1998, Ostomy Wound Manage, V44, p42S; Lyder CH, 2001, ARCH INTERN MED, V161, P1549, DOI 10.1001/archinte.161.12.1549; Lyder Courtney H, 2002, Ostomy Wound Manage, V48, P52; *NAT PRESS ULC ADV, 1989, S N PUBL, P3; Philippidis TP, 1999, COMPOS STRUCT, V45, P41, DOI 10.1016/S0263-8223(99)00012-4; RACKETT SC, 1993, J AM ACAD DERMATOL, V29, P447, DOI 10.1016/0190-9622(93)70210-K; Stotts NA, 2001, J GERONTOL A-BIOL, V56, pM795, DOI 10.1093/gerona/56.12.M795; Strauss E A, 1996, Adv Wound Care, V9, P37; Thomas DR, 1996, J AM GERIATR SOC, V44, P1435, DOI 10.1111/j.1532-5415.1996.tb04067.x; Thomas DR, 2001, NUTRITION, V17, P121, DOI 10.1016/S0899-9007(00)00514-1; Xakellis G C Jr, 1998, Adv Wound Care, V11, P22; XAKELLIS GC, 1992, ARCH PHYS MED REHAB, V73, P463; Xia ZD, 2000, WOUND REPAIR REGEN, V8, P138, DOI 10.1046/j.1524-475x.2000.00138.x	30	262	273	1	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 8	2003	289	2					223	226		10.1001/jama.289.2.223	http://dx.doi.org/10.1001/jama.289.2.223			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632ME	12517234				2022-12-28	WOS:000180226400034
J	Cleary, PD				Cleary, PD			A hospitalization from hell: A patient's perspective on quality	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; INTENSIVE-CARE UNITS; POSTOPERATIVE PAIN; SURGICAL SERVICES; 5 COUNTRIES; OF-CARE; MANAGEMENT; OUTCOMES; COORDINATION; PHYSICIANS	Patients usually cannot assess the technical quality of their care; however, examining a hospitalization through the patients' eyes can reveal important information about the quality of care. Patients are the best source of information about a hospital system's communication, education, and pain-management processes, and they are the only source of information about whether they were treated with dignity and respect. Their experiences often reveal how well a hospital system is operating and can stimulate important insights into the kinds of changes that are needed to close the chasm between the care provided and the care that should be provided. This article examines the case of a patient admitted for ankle arthrodesis due to severe hemophilia-related arthritis. The surgery was successful, but the hospital stay was marked by inefficiency and inconveniences, as well as events that reveal fundamental problems with the hospital's organization and teamwork. These problems could seriously compromise the quality of clinical care. Unfortunately, most of these events occur regularly in U.S. hospitals. Relatively easy and inexpensive ways to avoid many of these problems are discussed, such as reducing variability in non-urgent procedures and routinely asking patients about their experiences and suggestions for improvement.	Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Cleary, PD (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	cleary@hcp.med.harvard.edu	Cleary, Paul/AAF-7048-2019	Cleary, Paul/0000-0001-7527-4354				Aiken LH, 2001, HEALTH AFFAIR, V20, P43, DOI 10.1377/hlthaff.20.3.43; *AM NURS ASS NETW, 2000, NURSE STAFF PAT OUTC; *AM NURS ASS NETW, 1997, IMPL NURS REP CARD S; ANGELL M, 1982, NEW ENGL J MED, V306, P98, DOI 10.1056/NEJM198201143060210; Ayanian JZ, 1997, ARCH INTERN MED, V157, P2570, DOI 10.1001/archinte.157.22.2570; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Chassin MR, 1998, MILBANK Q, V76, P565, DOI 10.1111/1468-0009.00106; Chassin MR, 2002, ANN INTERN MED, V136, P826, DOI 10.7326/0003-4819-136-11-200206040-00012; Cleary P D, 1989, QRB Qual Rev Bull, V15, P172; Cleary P D, 1992, QRB Qual Rev Bull, V18, P53; Cleary P D, 1993, Qual Manag Health Care, V2, P31; CLEARY PD, 1991, HEALTH AFFAIR, V10, P254, DOI 10.1377/hlthaff.10.4.254; Cleary PD, 1999, BRIT MED J, V319, P720, DOI 10.1136/bmj.319.7212.720; Cleary PD, 1997, JAMA-J AM MED ASSOC, V278, P1608, DOI 10.1001/jama.278.19.1608; COHEN FL, 1980, PAIN, V9, P265, DOI 10.1016/0304-3959(80)90013-5; Coulter A, 2001, HEALTH AFFAIR, V20, P244, DOI 10.1377/hlthaff.20.3.244; dAmours RH, 1996, J ORTHOP SPORT PHYS, V24, P227, DOI 10.2519/jospt.1996.24.4.227; DONOVAN BD, 1983, ANAESTH INTENS CARE, V11, P125, DOI 10.1177/0310057X8301100206; DONOVAN M, 1987, PAIN, V30, P69, DOI 10.1016/0304-3959(87)90084-4; Fuss M A, 1998, Nurs Adm Q, V23, P1; GERTEIS M, 1993, THROUGH PATIENTS EYE, P45; Gittell JH, 2000, MED CARE, V38, P807, DOI 10.1097/00005650-200008000-00005; Hillier FS., 1995, INTRO OPERATIONS RES; Hruby M, 2001, AM J MED, V111, P21, DOI 10.1016/S0002-9343(01)00965-2; Johnson J E, 1973, Gastrointest Endosc, V19, P180, DOI 10.1016/S0016-5107(73)73995-X; JOHNSON JE, 1974, J PERS SOC PSYCHOL, V29, P710, DOI 10.1037/h0036555; Kaluzny A D, 1992, QRB Qual Rev Bull, V18, P380; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; KEERISZA.M, 1972, SURG GYNECOL OBSTETR, V134, P647; Kehlet H, 1999, SURG CLIN N AM, V79, P431, DOI 10.1016/S0039-6109(05)70390-X; Kitahata MM, 1996, NEW ENGL J MED, V334, P701, DOI 10.1056/NEJM199603143341106; KNAUS WA, 1986, ANN INTERN MED, V104, P410, DOI 10.7326/0003-4819-104-3-410; Kovner C, 1998, Image J Nurs Sch, V30, P315, DOI 10.1111/j.1547-5069.1998.tb01326.x; Landon BE, 2002, J GEN INTERN MED, V17, P12, DOI 10.1046/j.1525-1497.2002.10401.x; LANDRO L, 2002, WALL STREET J   0610; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEHMANN KA, 1995, ANN MED, V27, P271, DOI 10.3109/07853899509031970; Lichtig LK, 1999, J NURS ADMIN, V29, P25, DOI 10.1097/00005110-199902000-00008; Litvak E, 2000, AM J MANAG CARE, V6, P305; Litvak E, 2001, ACAD EMERG MED, V8, P1108; MARKS RM, 1973, ANN INTERN MED, V78, P173, DOI 10.7326/0003-4819-78-2-173; McManus ML, 2000, CRIT CARE MED, V28, pA79; MCMANUS ML, 2002, ANESTHESIOLOGY, V96, pA1144; Needleman J, 2002, NEW ENGL J MED, V346, P1715, DOI 10.1056/NEJMsa012247; Nelson JR, 2001, AM J MED, V111, P43, DOI 10.1016/S0002-9343(01)00970-6; Norrish BR, 2001, MILBANK Q, V79, P55, DOI 10.1111/1468-0009.00196; Panush R S, 1995, J Clin Rheumatol, V1, P74, DOI 10.1097/00124743-199504000-00003; Pfeffer J., 1998, HUMAN EQUATION BUILD; Rankin M A, 1984, Cancer Nurs, V7, P149; SCHREIBER TL, 1995, J AM COLL CARDIOL, V26, P577, DOI 10.1016/0735-1097(95)00214-O; Seago J. A., 2001, MAKING HLTH CARE SAF, V40, P423; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Solomon DH, 1997, ANN INTERN MED, V127, P52, DOI 10.7326/0003-4819-127-1-199707010-00009; Steinbrook R, 2002, NEW ENGL J MED, V346, P1757, DOI 10.1056/NEJM200205303462225; vom Eigen KA, 1999, MED CARE, V37, P33, DOI 10.1097/00005650-199901000-00006; Wachter RM, 2001, AM J MED, V111, P40, DOI 10.1016/S0002-9343(01)00969-X; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Willison DJ, 1998, ARCH INTERN MED, V158, P1778, DOI 10.1001/archinte.158.16.1778; Young GJ, 1997, HEALTH CARE MANAGE R, V22, P72, DOI 10.1097/00004010-199710000-00010; Young GJ, 1998, HEALTH SERV RES, V33, P1211; ZIMMERMAN JE, 1993, CRIT CARE MED, V21, P1443, DOI 10.1097/00003246-199310000-00010	62	56	56	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					33	39		10.7326/0003-4819-138-1-200301070-00009	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513042				2022-12-28	WOS:000180996200005
J	Moynihan, R				Moynihan, R			The making of a disease: female sexual dysfunction	BRITISH MEDICAL JOURNAL			English	Article									Australian Financial Review, Sydney, NSW 2201, Australia		Moynihan, R (corresponding author), 4-1312 21st St NW, Washington, DC 20036 USA.		Moynihan, Ray/ABC-3010-2020					Bancroft J, 2002, ARCH SEX BEHAV, V31, P451, DOI 10.1023/A:1019800426980; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Berman J., 2002, ANN M INT SOC STUD W, P49; Berman JR, 1999, UROLOGY, V54, P385, DOI 10.1016/S0090-4295(99)00230-7; Berman JR, 2001, J SEX MARITAL THER, V27, P411, DOI 10.1080/713846815; COOKE R, 2002, OBSERVER        1227; KASCHAK E, 2001, NEW VIEW WOMENS SEXU, P70; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Park K, 1997, INT J IMPOT RES, V9, P27, DOI 10.1038/sj.ijir.3900258; *PFIZ, ANN REP 2001; Segraves RT, 2001, J SEX MARITAL THER, V27, P81, DOI 10.1080/00926230152051699; Tiefer L, 2000, J SEX RES, V37, P273, DOI 10.1080/00224490009552048; 2003, 2 INT CONS ER SEX DY; 1998, INT J IMPOTENCE R S2, V10, pS1; [No title captured]	16	224	244	0	23	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 4	2003	326	7379					45	47		10.1136/bmj.326.7379.45	http://dx.doi.org/10.1136/bmj.326.7379.45			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	633UP	12511464	Green Published			2022-12-28	WOS:000180302000029
J	Patel, V; Chisholm, D; Rabe-Hesketh, S; Dias-Saxena, F; Andrew, G; Mann, A				Patel, V; Chisholm, D; Rabe-Hesketh, S; Dias-Saxena, F; Andrew, G; Mann, A			Efficacy and cost-effectiveness of drug and psychological treatments for common mental disorders in general health care in Goa, India: a randomised, controlled trial	LANCET			English	Article							DEPRESSION; MANAGEMENT; DISABILITY; PLACEBO; MODELS	Background Common mental disorders are associated with substantial morbidity and disability in developing countries, but there are no data for efficacy of treatment. We aimed to assess the efficacy and cost-effectiveness of antidepressant and psychological treatment for common mental disorders in general health-care settings. Method We did a randomised, placebo-controlled trial (double-blind for the antidepressant group) in general outpatient clinics in two district hospitals in Goa, India. Consecutive eligible adults who scored more than 15 on the Revised Clinical Interview Schedule (n=450) were randomly assigned to antidepressant (fluoxetine), placebo, or psychological treatment. Antidepressant or placebo was provided for up to 6 months. Up to six sessions of psychological treatment were provided by trained therapists. The primary outcome was psychiatric morbidity; secondary outcomes were disability and costs. Outcome measurements were done at 2, 6, and 12 months. Intention-to-treat analyses were done with linear regression. Findings 80% of patients were reviewed; the number of dropouts was similar in all three groups. Psychiatric outcome was significantly better with antidepressant than with placebo at 2 months (p=0.02; standardised effect size 0.3), but not over the 2-12 month period (p=0.10); antidepressants were significantly more cost effective than placebo in the short term and long term (p<0.05). Psychological treatment was not more effective than placebo for any outcome during either period. Interpretation Affordable antidepressants such as fluoxetine should. be the treatment of choice for common mental disorders in general health-care settings in India, since they are associated with improved clinical and economic outcomes, especially in the short term.	Inst Psychiat, Epidemiol Sect, London, England; Sangath Soc, Porvorim, Goa, India; Inst Psychiat, Dept Hlth Serv Res, London, England; Inst Psychiat, Dept Biostat & Comp, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Patel, V (corresponding author), Sangath Ctr, 841-1 Alto, Porvorim 403521, Goa, India.	vikpat@goatelecom.com	mann, anthony/A-8911-2011; Rabe-Hesketh, Sophia/B-1643-2008	Rabe-Hesketh, Sophia/0000-0002-5257-4837; Patel, Vikram/0000-0003-1066-8584				Andrew G, 2000, INDIAN J CLIN PSYCHO, V27, P72; Bech P, 2000, BRIT J PSYCHIAT, V176, P421, DOI 10.1192/bjp.176.5.421; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Chisholm D, 2000, BRIT J PSYCHIAT, V177, pS28, DOI 10.1192/bjp.177.39.s28; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Efron B., 1994, MONOGRAPHS STAT APPL; Everitt BS, 1998, BRIT J PSYCHIAT, V172, P7, DOI 10.1192/bjp.172.1.7; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Linden M, 1999, J CLIN PSYCHOPHARM, V19, P132, DOI 10.1097/00004714-199904000-00007; MOULTON LH, 1989, BIOMETRICS, V45, P381, DOI 10.2307/2531484; Murray C. J. L., 1996, GLOBAL BURDEN DIS; MYNORSWALLIS LM, 1995, BMJ-BRIT MED J, V310, P441, DOI 10.1136/bmj.310.6977.441; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Patel V, 1998, BRIT J PSYCHIAT, V172, P533, DOI 10.1192/bjp.172.6.533; Patel V, 2000, PSYCHOL MED, V30, P743, DOI 10.1017/S0033291799002147; Patel V, 2001, BRIT MED J, V322, P482, DOI 10.1136/bmj.322.7284.482; Patel V, 1998, PSYCHOL MED, V28, P135, DOI 10.1017/S0033291797005941; Patel V, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/bjp.172.1.53; PAYKEL ES, 1992, BRIT MED J, V305, P1198, DOI 10.1136/bmj.305.6863.1198; Pereira J, 1999, Indian J Psychiatry, V41, P358; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Shah A, 1999, ACTA PSYCHIAT SCAND, V100, P1; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9	25	145	146	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 4	2003	361	9351					33	39		10.1016/S0140-6736(03)12119-8	http://dx.doi.org/10.1016/S0140-6736(03)12119-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517464				2022-12-28	WOS:000180191600018
J	Stamm, C; Westphal, B; Kleine, HD; Petzsch, M; Kittner, C; Klinge, H; Schumichen, C; Nienaber, CA; Freund, M; Steinhoff, G				Stamm, C; Westphal, B; Kleine, HD; Petzsch, M; Kittner, C; Klinge, H; Schumichen, C; Nienaber, CA; Freund, M; Steinhoff, G			Autologous bone-marrow stem-cell transplantation for myocardial regeneration	LANCET			English	Article							HEART	Implantation of bone-marrow stem cells in the heart might be a new method to restore tissue viability after myocardial infarction. We injected up to 1.5x10(8) autologous AC133+ bone-marrow cells into the infarct border zone in six patients who had had a myocardial infarction and undergone coronary artery bypass grafting. 3-9 months after surgery, all patients were alive and well, global left-ventricular function was enhanced in four patients, and infarct tissue perfusion had improved strikingly in five patients. We believe that implantation of AC133+ stem cells to the heart is safe and might induce angiogenesis, thus improving perfusion of the Infarcted myocardium..	Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany; Univ Rostock, Dept Haematol & Oncol, D-18057 Rostock, Germany; Univ Rostock, Dept Cardiol, D-18057 Rostock, Germany; Univ Rostock, Dept Radiol, D-18057 Rostock, Germany	University of Rostock; University of Rostock; University of Rostock; University of Rostock	Steinhoff, G (corresponding author), Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany.		Stamm, Christof/J-5719-2014; Steinhoff, Gustav/AAB-1848-2020					Hamano K, 2002, ANN THORAC SURG, V73, P1210, DOI 10.1016/S0003-4975(02)03373-8; Li RK, 1996, ANN THORAC SURG, V62, P654; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327	5	1010	1173	0	35	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	JAN 4	2003	361	9351					45	46		10.1016/S0140-6736(03)12110-1	http://dx.doi.org/10.1016/S0140-6736(03)12110-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631WX	12517467				2022-12-28	WOS:000180191600021
J	Catlos, EJ; Sorensen, SS				Catlos, EJ; Sorensen, SS			Phengite-based chronology of K- and Ba-rich fluid flow in two paleosubduction zones	SCIENCE			English	Article							HIGH-GRADE BLUESCHISTS; FRANCISCAN COMPLEX; SUBDUCTION ZONES; ECLOGITES; AMPHIBOLITES; METAMORPHISM; CALIFORNIA; SERPENTINITE; ENRICHMENT; PENINSULA	Subduction recycles aqueous fluids from slab and sediment to the mantle. Subduction zones are long-lived, but time scales for fluid-rock interaction within subduction complexes are uncertain. Large-ion lithophile elements (potassium and barium) were added to eclogite (subducted basalt) during high pressure/temperature metamorphism via phengite crystallization from subduction zone fluids. Phengite grains from eclogite blocks and their metasomatic selvages yielded 40Ar/39Ar ages across grains and between samples that indicate 25 and 60 million years of fluid-rock interaction in the Samana Complex, Dominican Republic, and the Franciscan Complex, California, respectively.	Oklahoma State Univ, Sch Geol, Noble Res Ctr 105, Stillwater, OK 74078 USA; Smithsonian Inst, Natl Museum Nat Hist, Dept Mineral Sci, Washington, DC 20560 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Smithsonian Institution; Smithsonian National Museum of Natural History	Catlos, EJ (corresponding author), Oklahoma State Univ, Sch Geol, Noble Res Ctr 105, Stillwater, OK 74078 USA.	catlos@okstate.edu	Catlos, Elizabeth J./B-7943-2011; Catlos, Elizabeth/AAA-7884-2021	Catlos, Elizabeth/0000-0001-6043-3498				BALDWIN SL, 1992, GEOL SOC AM BULL, V104, P18, DOI 10.1130/0016-7606(1992)104<0018:TPTTHO>2.3.CO;2; Becker H, 2000, CHEM GEOL, V163, P65, DOI 10.1016/S0009-2541(99)00071-6; CLOOS M, 1986, GEOLOGICAL SOC AM ME, V164, P77, DOI DOI 10.1130/MEM164-P77; COLEMAN RG, 1971, GEOL SOC AM BULL, V82, P2397, DOI 10.1130/0016-7606(1971)82[2397:DAAOHB]2.0.CO;2; Dalla Torre M., 1996, GEOL SOC AM BULL, V108, P578, DOI DOI 10.1130/0016-7606(1996)108<0578:VLTMOS>2.3.CO;2; Domanik KJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4133, DOI 10.1016/S0016-7037(96)00241-4; DUDLEY PP, 1972, GEOL SOC AM BULL, V83, P3497, DOI 10.1130/0016-7606(1972)83[3497:COTDAA]2.0.CO;2; Fox L. K., 1990, GEOLOGICAL SOC AM ME, V174, P111, DOI 10.1130/MEM174-p111; GIARAMITA MJ, 1994, CONTRIB MINERAL PETR, V117, P279, DOI 10.1007/BF00310869; Goncalves P, 2000, GEODIN ACTA, V13, P119, DOI 10.1016/S0985-3111(00)00116-9; HARLOW GE, 1995, EUR J MINERAL, V7, P775; Joyce J., 1991, GEOLOGIC TECTONIC ST, V262, P47; JOYCE J, 1987, P 10 CARB GEOL C ING, V53, P454; Melzer S, 2000, GEOLOGY, V28, P583, DOI 10.1130/0091-7613(2000)028<0583:IABARC>2.3.CO;2; MOORE DE, 1989, J METAMORPH GEOL, V7, P211, DOI 10.1111/j.1525-1314.1989.tb00585.x; NELSON BK, 1991, GEOLOGY, V19, P1033, DOI 10.1130/0091-7613(1991)019<1033:SDFISZ>2.3.CO;2; PERFIT MR, 1982, TERRA COGNITA, V2, P325; ROSS JA, 1988, CONTRIB MINERAL PETR, V100, P213, DOI 10.1007/BF00373587; Smith CA, 1999, GEOL SOC AM BULL, V111, P831, DOI 10.1130/0016-7606(1999)111<0831:TCPTTP>2.3.CO;2; Sorensen SS, 1997, J PETROL, V38, P3, DOI 10.1093/petrology/38.1.3; SUPPE J, 1969, GEOL SOC AM BULL, V80, P135, DOI 10.1130/0016-7606(1969)80[135:TOMITF]2.0.CO;2; Terabayashi M, 1998, TECTONOPHYSICS, V285, P87, DOI 10.1016/S0040-1951(97)00194-7; WAKABAYASHI J, 1992, J GEOL, V100, P19, DOI 10.1086/629569; WAKABAYASHI J, 1990, J GEOL, V98, P657, DOI 10.1086/629432; WYLD SJ, 2000, GEOL SOC AM ABSTR, V32, P46	25	50	51	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 3	2003	299	5603					92	95		10.1126/science.1076977	http://dx.doi.org/10.1126/science.1076977			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JZ	12511647				2022-12-28	WOS:000180165800039
J	Gulde, S; Riebe, M; Lancaster, GPT; Becher, C; Eschner, J; Haffner, H; Schmidt-Kaler, F; Chuang, IL; Blatt, R				Gulde, S; Riebe, M; Lancaster, GPT; Becher, C; Eschner, J; Haffner, H; Schmidt-Kaler, F; Chuang, IL; Blatt, R			Implementation of the Deutsch-Jozsa algorithm on an ion-trap quantum computer	NATURE			English	Article							ENTANGLEMENT; STATE; ATOM	Determining classically whether a coin is fair (head on one side, tail on the other) or fake (heads or tails on both sides) requires an examination of each side. However, the analogous quantum procedure (the Deutsch-Jozsa algorithm(1,2)) requires just one examination step. The Deutsch-Jozsa algorithm has been realized experimentally using bulk nuclear magnetic resonance techniques(3,4), employing nuclear spins as quantum bits (qubits). In contrast, the ion trap processor utilises(5) motional and electronic quantum states of individual atoms as qubits, and in principle is easier to scale to many qubits. Experimental advances in the latter area include the realization of a two-qubit quantum gate(6), the entanglement of four ions(7), quantum state engineering(8) and entanglement-enhanced phase estimation(9). Here we exploit techniques(10,11) developed for nuclear magnetic resonance to implement the Deutsch-Jozsa algorithm on an ion-trap quantum processor, using as qubits the electronic and motional states of a single calcium ion. Our ion-based implementation of a full quantum algorithm serves to demonstrate experimental procedures with the quality and precision required for complex computations, confirming the potential of trapped ions for quantum computation.	Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; MIT, Media Lab, Cambridge, MA 02139 USA	University of Innsbruck; Massachusetts Institute of Technology (MIT)	Schmidt-Kaler, F (corresponding author), Univ Innsbruck, Inst Expt Phys, Technikerstr 25, A-6020 Innsbruck, Austria.	Ferdinand.Schmidt-Kaler@uibk.ac.at	Eschner, Jürgen/N-1073-2013; Haeffner, Hartmut/D-8046-2012; Blatt, Rainer/H-9527-2014; Schmidt-Kaler, Ferdinand/E-2151-2017; Becker, Jonas/GZG-4234-2022; Becher, Christoph/AAE-8756-2020	Eschner, Jürgen/0000-0002-8393-7258; Haeffner, Hartmut/0000-0002-5113-9622; Becher, Christoph/0000-0003-4645-6882; Schmidt-Kaler, Ferdinand/0000-0002-5697-2568				Childs AM, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.012306; Chuang IL, 1998, NATURE, V393, P143, DOI 10.1038/30181; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; DEHMELT H, 1975, B AM PHYS SOC, V20, P60; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; DEUTSCH D, 1985, P ROY SOC LOND A MAT, V400, P97, DOI 10.1098/rspa.1985.0070; Eschner J, 2001, NATURE, V413, P495, DOI 10.1038/35097017; Guthohrlein GR, 2001, NATURE, V414, P49, DOI 10.1038/35102129; HAFFNER H, 2002, PRECISION MEASUREMEN; Jones JA, 1998, J CHEM PHYS, V109, P1648, DOI 10.1063/1.476739; LEVITT MH, 1986, PROG NUCL MAG RES SP, V18, P61, DOI 10.1016/0079-6565(86)80005-X; Meekhof DM, 1996, PHYS REV LETT, V76, P1796, DOI 10.1103/PhysRevLett.76.1796; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Monroe C, 1996, SCIENCE, V272, P1131, DOI 10.1126/science.272.5265.1131; Mundt AB, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.103001; Nagerl HC, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.023405; Nielsen Michael A., 2002, QUANTUM COMPUTATION; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Sackett CA, 2000, NATURE, V404, P256, DOI 10.1038/35005011; Sasura M, 2002, J MOD OPTIC, V49, P1593, DOI 10.1080/09500340110115497; SCHMIDTKALER F, 2002, COHERENCE QUBITS BAS	22	364	373	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					48	50		10.1038/nature01336	http://dx.doi.org/10.1038/nature01336			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511949				2022-12-28	WOS:000180165500032
J	Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J				Rawat, UBS; Zavialov, AV; Sengupta, J; Valle, M; Grassucci, RA; Linde, J; Vestergaard, B; Ehrenberg, M; Frank, J			A cryo-electron microscopic study of ribosome-bound termination factor RF2	NATURE			English	Article							MESSENGER-RNA; TRANSLATION TERMINATION; CHAIN TERMINATION; CODON RECOGNITION; FACTOR-II; RELEASE; RESOLUTION; PROTEINS; LOCATION; BINDING	Protein synthesis takes place on the ribosome, where genetic information carried by messenger RNA is translated into a sequence of amino acids. This process is terminated when a stop codon moves into the ribosomal decoding centre (DC) and is recognized by a class-1 release factor (RF). RFs have a conserved GGQ amino-acid motif, which is crucial for peptide release and is believed to interact directly with the peptidyl-transferase centre (PTC) of the 50S ribosomal subunit(1),(2). Another conserved motif of RFs (SPF in RF2) has been proposed to interact directly with stop codons in the DC of the 30S subunit(3). The distance between the DC and PTC is, 73 Angstrom. However, in the X-ray structure of RF2, SPF and GGQ are only 23 Angstrom apart(4), indicating that they cannot be at DC and PTC simultaneously. Here we show that RF2 is in an open conformation when bound to the ribosome, allowing GGQ to reach the PTC while still allowing SPF-stop-codon interaction. The results indicate new interpretations of accuracy in termination, and have implications for how the presence of a stop codon in the DC is signalled to PTC.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr, Albany, NY 12201 USA; Uppsala Univ, BMC, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; Aarhus Univ, Inst Mol & Struct Biol, DK-8000 Aarhus, Denmark; SUNY Albany, Dept Biomed Sci, Albany, NY 12222 USA	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; Uppsala University; Aarhus University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.		Valle, Mikel/F-7598-2011	Valle, Mikel/0000-0001-8268-6912; Zavialov, Andrey/0000-0001-6420-0368; Vestergaard, Bente/0000-0001-8011-6414				Arkov AL, 1999, BIOCHEMISTRY-MOSCOW+, V64, P1354; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BROT N, 1974, P NATL ACAD SCI USA, V71, P89, DOI 10.1073/pnas.71.1.89; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P103; Drugeon G, 1997, NUCLEIC ACIDS RES, V25, P2254, DOI 10.1093/nar/25.12.2254; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gabashvili IS, 2000, CELL, V100, P537, DOI 10.1016/S0092-8674(00)80690-X; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Ito K, 2000, NATURE, V403, P680, DOI 10.1038/35001115; Ito K, 1996, P NATL ACAD SCI USA, V93, P5443, DOI 10.1073/pnas.93.11.5443; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisselev LL, 2000, TRENDS BIOCHEM SCI, V25, P561, DOI 10.1016/S0968-0004(00)01669-8; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Seit-Nebi A, 2001, NUCLEIC ACIDS RES, V29, P3982, DOI 10.1093/nar/29.19.3982; Song HW, 2000, CELL, V100, P311, DOI 10.1016/S0092-8674(00)80667-4; TATE W, 1990, NUCLEIC ACIDS RES, V18, P6537, DOI 10.1093/nar/18.22.6537; TATE WP, 1984, J BIOL CHEM, V259, P7317; Vestergaard B, 2001, MOL CELL, V8, P1375, DOI 10.1016/S1097-2765(01)00415-4; Wilson KS, 2000, NAT STRUCT BIOL, V7, P866, DOI 10.1038/82818; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; YUSUPOV MM, 2001, SCIENCE, V4, P897; Yusupova GZ, 2001, CELL, V106, P233, DOI 10.1016/S0092-8674(01)00435-4; Zavialov AV, 2002, MOL CELL, V10, P789, DOI 10.1016/S1097-2765(02)00691-3; Zavialov AV, 2001, CELL, V107, P115, DOI 10.1016/S0092-8674(01)00508-6	28	199	202	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					87	90		10.1038/nature01224	http://dx.doi.org/10.1038/nature01224			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12511960				2022-12-28	WOS:000180165500043
J	Ashby, P				Ashby, P			Child combatants: a soldier's perspective	LANCET			English	Article																			0	7	7	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S11	S12		10.1016/S0140-6736(02)11800-9	http://dx.doi.org/10.1016/S0140-6736(02)11800-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504484				2022-12-28	WOS:000180064500005
J	Marusic, A; Marsic, M				Marusic, A; Marsic, M			What can medical journal editors do in war?	LANCET			English	Article									Univ Zagreb, Sch Med, Croat Med Journal, Zagreb 41001, Croatia	University of Zagreb	Marusic, A (corresponding author), Univ Zagreb, Sch Med, Croat Med Journal, Zagreb 41001, Croatia.		Marusic, Ana/E-7683-2013; Marusic, Matko/E-1834-2017	Marusic, Ana/0000-0001-6272-0917; Marusic, Matko/0000-0001-5562-1777				Marusic A, 1999, CROAT MED J, V40, P508; Marusic A, 2002, CROAT MED J, V43, P1; Marusic M, 2001, CROAT MED J, V42, P113	3	15	15	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S59	S60		10.1016/S0140-6736(02)11825-3	http://dx.doi.org/10.1016/S0140-6736(02)11825-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504508				2022-12-28	WOS:000180064500029
J	Peyton, R				Peyton, R			Punishment beatings and the rule of law	LANCET			English	Article									S Tyrone Hosp, Dungannon BT71 6AU, North Ireland; Royal Coll Surgeons England, London, England	Royal College of Surgeons of England	Peyton, R (corresponding author), S Tyrone Hosp, Carland Rd, Dungannon BT71 6AU, North Ireland.								0	0	0	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	DEC	2002	360			S			S53	S54		10.1016/S0140-6736(02)11822-8	http://dx.doi.org/10.1016/S0140-6736(02)11822-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	629TG	12504505	Bronze			2022-12-28	WOS:000180064500026
J	Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M				Seibert, C; Barbouche, E; Fagan, J; Myint, E; Wetterneck, T; Wittemyer, M			Prescribing oral contraceptives for women older than 35 years of age	ANNALS OF INTERNAL MEDICINE			English	Review							HORMONE REPLACEMENT THERAPY; VENOUS THROMBOEMBOLIC DISEASE; METABOLIC RISK MARKERS; BONE-MINERAL DENSITY; G ETHINYL ESTRADIOL; BREAST-CANCER RISK; FACTOR-V-LEIDEN; YOUNG-WOMEN; UNITED-STATES; MYOCARDIAL-INFARCTION	This paper addresses the use of combined oral contraceptives in women older than 35 years of age, including the potential risks and benefits, pretreatment assessment, common side effects and their management, appropriate follow-up, and diagnosis of menopause. The case-based discussion also focuses on issues that pertain to women who smoke, have hypertension, or have dyslipidemia.	Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, Madison, WI 53706 USA; Virginia Mason Med Ctr, Lynnwood, WA USA	University of Wisconsin System; University of Wisconsin Madison; University Wisconsin Health; Virginia Mason Medical Center	Seibert, C (corresponding author), Univ Wisconsin, Sch Med, UW Hlth Clin E, Dept Med, 5249 E Terrace Dr, Madison, WI 53706 USA.	cseibert@facstaff.wisc.edu						ABMA J, 1997, VITAL HLTH STAT, V23; Adesanya OO, 1996, J REPROD MED, V41, P431; AKERLUND M, 1993, BRIT J OBSTET GYNAEC, V100, P832, DOI 10.1111/j.1471-0528.1993.tb14309.x; *AM COLL OBST GYN, 1996, GUID WOM HLTH CAR; [Anonymous], 1983, JAMA, V249, P1596; [Anonymous], 1986, NEW ENGL J MED, V315, P405; Barrett D H, 1994, Arch Fam Med, V3, P438, DOI 10.1001/archfami.3.5.438; Berg AO, 2001, AM J PREV MED, V20, P73, DOI 10.1016/S0749-3797(01)00266-5; Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; BLOEMENKAMP KWM, 1995, LANCET, V346, P1593, DOI 10.1016/S0140-6736(95)91929-5; Bousser MG, 2000, CEPHALALGIA, V20, P147, DOI 10.1046/j.1468-2982.2000.00050.x; Brinton LA, 1998, MENOPAUSE, V5, P145; Brinton LA, 1997, CONTRACEPTION, V55, P197, DOI 10.1016/S0010-7824(97)00012-7; Burkman RT, 1998, CONTRACEPTION, V58, p35S, DOI 10.1016/S0010-7824(98)00081-X; BURKMAN RT, 2000, INT J FERTIL S2, V45, P134; Burt VK, 1998, HARVARD REV PSYCHIAT, V6, P121, DOI 10.3109/10673229809000320; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; Cardoso F, 1997, INT J GYNECOL OBSTET, V59, P237, DOI 10.1016/S0020-7292(97)00239-7; CASPER RF, 1991, FERTIL STERIL, V55, P292; Castracane VD, 1995, CONTRACEPTION, V52, P371; CAUFIELD KA, 1998, WOMENS HLTH PRIMARY, P161; Chang CL, 1999, BMJ-BRIT MED J, V318, P13; ChasanTaber L, 1996, CIRCULATION, V94, P483, DOI 10.1161/01.CIR.94.3.483; Coney P, 2001, CONTRACEPTION, V63, P297, DOI 10.1016/S0010-7824(01)00208-6; CONNELL EB, 1993, J REPROD MED, V38, P1036; Connelly PW, 1999, CAN J CARDIOL, V15, P419; COOPER C, 1993, BONE, V14, P41, DOI 10.1016/8756-3282(93)90254-8; Corson SL, 1996, INT J FERTIL MENOP S, V41, P77; Crook D, 1997, CONTRACEPTION, V55, P219, DOI 10.1016/S0010-7824(97)00010-3; Crosignani PG, 2000, HUM REPROD, V15, P1865; CULLBERG G, 1985, ACTA OBSTET GYN SCAN, V64, P195, DOI 10.3109/00016348509155112; DEWIS P, 1985, CLIN ENDOCRINOL, V22, P29, DOI 10.1111/j.1365-2265.1985.tb01061.x; DICKEY RP, 1994, MANAGING CONTRACEPTI, P60; DIEHL AK, 1991, GASTROENTEROL CLIN N, V20, P1; Dong W, 1997, J HYPERTENS, V15, P1063, DOI 10.1097/00004872-199715100-00003; Douketis JD, 1997, ARCH INTERN MED, V157, P1522, DOI 10.1001/archinte.157.14.1522; Dunn N, 1999, BRIT MED J, V318, P1579, DOI 10.1136/bmj.318.7198.1579; Eck LH, 1997, AM J CLIN NUTR, V65, P419, DOI 10.1093/ajcn/65.2.419; EDGREN RA, 1989, CONTRACEPTION, V40, P285, DOI 10.1016/0010-7824(89)90093-0; FARLEY TMM, 1995, LANCET, V346, P1582; Farley TMM, 1998, CONTRACEPTION, V57, P211, DOI 10.1016/S0010-7824(98)00019-5; Farmer RDT, 2000, BRIT J CLIN PHARMACO, V49, P580, DOI 10.1046/j.1365-2125.2000.00198.x; Farmer RDT, 1998, AM J OBSTET GYNECOL, V179, pS78, DOI 10.1053/ob.1998.v179.a92634; Franceschi S, 1998, CONTRACEPTION, V58, P335, DOI 10.1016/S0010-7824(98)00128-0; Fruzzetti F, 1999, AM J OBSTET GYNECOL, V180, pS369, DOI 10.1016/S0002-9378(99)70698-8; Gabrick DM, 2000, JAMA-J AM MED ASSOC, V284, P1791, DOI 10.1001/jama.284.14.1791; GAMBACCIANI M, 1994, MATURITAS, V19, P125, DOI 10.1016/0378-5122(94)90062-0; GERSTMAN BB, 1991, AM J EPIDEMIOL, V133, P32, DOI 10.1093/oxfordjournals.aje.a115799; Gillum LA, 2000, JAMA-J AM MED ASSOC, V284, P72, DOI 10.1001/jama.284.1.72; GODSLAND IF, 1995, CONTRACEPTION, V52, P143, DOI 10.1016/0010-7824(95)00153-2; Godsland IF, 1996, CONTRACEPTION, V53, P9, DOI 10.1016/0010-7824(95)00260-X; Goldhaber SZ, 1997, JAMA-J AM MED ASSOC, V277, P642, DOI 10.1001/jama.277.8.642; Hankinson SE, 1997, CANCER CAUSE CONTROL, V8, P65, DOI 10.1023/A:1018435205695; HANKINSON SE, 1992, OBSTET GYNECOL, V80, P708; HANNAFORD PC, 1994, STROKE, V25, P935, DOI 10.1161/01.STR.25.5.935; Hannaford PC, 1996, CONTRACEPTION, V54, P125, DOI 10.1016/S0010-7824(96)00167-9; HATCHER RA, 1999, MANAGING CONTRACEPTI, P97; Hatcher RA, 1998, CONTRACEPTIVE TECHNO, P405; Heinemann LAJ, 1998, CONTRACEPTION, V57, P29, DOI 10.1016/S0010-7824(97)00204-7; Helmerhorst FM, 1998, HUM REPROD, V13, P2981, DOI 10.1093/humrep/13.11.2981; Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Kaunitz AM, 2001, AM J OBSTET GYNECOL, V185, pS32, DOI 10.1067/mob.2001.116525; KAUNITZ AM, 2001, DIALOGUES CONTRACEPT, V6, P4; Kemmeren JM, 2001, BRIT MED J, V323, P131, DOI 10.1136/bmj.323.7305.131; Klein NA, 1998, CLIN OBSTET GYNECOL, V41, P912, DOI 10.1097/00003081-199812000-00017; KNOPP RH, 1993, AM J OBSTET GYNECOL, V168, P1994, DOI 10.1016/S0002-9378(12)90941-2; KRETTEK JE, 1993, OBSTET GYNECOL, V81, P728; Kuohung W, 2000, CONTRACEPTION, V61, P77, DOI 10.1016/S0010-7824(00)00086-X; Lewis MA, 1997, CONTRACEPTION, V56, P129, DOI 10.1016/S0010-7824(97)00118-2; Lewis MA, 1998, AM J OBSTET GYNECOL, V179, pS68, DOI 10.1053/ob.1998.v179.a93122; Lewis MA, 1996, CONTRACEPTION, V54, P5, DOI 10.1016/0010-7824(96)00112-6; LIDEGAARD O, 1995, BRIT J OBSTET GYNAEC, V102, P153, DOI 10.1111/j.1471-0528.1995.tb09070.x; LIDEGAARD O, 1993, BRIT MED J, V306, P956, DOI 10.1136/bmj.306.6883.956; Lidegaard O, 1998, AM J OBSTET GYNECOL, V179, pS62, DOI 10.1053/ob.1998.v179.a91674; Lidegaard O, 1999, AM J OBSTET GYNECOL, V180, pS357, DOI 10.1016/S0002-9378(99)70696-4; Lidegaard O, 1998, CONTRACEPTION, V57, P303, DOI 10.1016/S0010-7824(98)00032-8; Lidegaard O, 1997, ACTA OBSTET GYN SCAN, V76, P252; Lobo RA, 1996, FERTIL STERIL, V65, P1100, DOI 10.1016/S0015-0282(16)58321-6; Lobo RA, 1998, CLIN OBSTET GYNECOL, V41, P895, DOI 10.1097/00003081-199812000-00015; Lucky AW, 1997, J AM ACAD DERMATOL, V37, P746, DOI 10.1016/S0190-9622(97)70112-9; Magnusson CM, 1999, INT J CANCER, V80, P231, DOI 10.1002/(SICI)1097-0215(19990118)80:2<231::AID-IJC11>3.3.CO;2-I; MALONE KE, 1993, EPIDEMIOL REV, V15, P80, DOI 10.1093/oxfordjournals.epirev.a036119; Marchbanks PA, 2002, NEW ENGL J MED, V346, P2025, DOI 10.1056/NEJMoa013202; Martinelli I, 1998, NEW ENGL J MED, V338, P1793, DOI 10.1056/NEJM199806183382502; MCKINLAY SM, 1992, MATURITAS, V14, P103, DOI 10.1016/0378-5122(92)90003-M; MEADE TW, 1977, LANCET, V2, P948; *MED EC, 2000, RED BOOK 2000 DRUG T, P313; Michaelsson K, 1999, LANCET, V353, P1481, DOI 10.1016/S0140-6736(98)09044-8; Newcomb PA, 1996, CANCER CAUSE CONTROL, V7, P525, DOI 10.1007/BF00051885; Oddens BJ, 1999, CONTRACEPTION, V59, P277, DOI 10.1016/S0010-7824(99)00034-7; Petitti DB, 1996, NEW ENGL J MED, V335, P8, DOI 10.1056/NEJM199607043350102; PORTER JB, 1985, OBSTET GYNECOL, V66, P1; Poulter NR, 1996, LANCET, V348, P505; POULTER NR, 1995, LANCET, V346, P1575; Poulter NR, 1996, LANCET, V348, P498; Poulter NR, 1997, LANCET, V349, P1202, DOI 10.1016/S0140-6736(97)02358-1; RAMCHARAN S, 1981, NIH PUBLICATION, V3; Redmond GP, 1997, OBSTET GYNECOL, V89, P615, DOI 10.1016/S0029-7844(97)00059-8; REUBINOFF BE, 1995, FERTIL STERIL, V63, P516, DOI 10.1016/S0015-0282(16)57419-6; Rosenberg L, 1996, AM J EPIDEMIOL, V143, P25; Rosenberg M, 1998, CONTRACEPTION, V58, P345, DOI 10.1016/S0010-7824(98)00127-9; Rosenberg MJ, 1996, CONTRACEPTION, V53, P85, DOI 10.1016/0010-7824(95)00270-7; Rosenberg MJ, 1998, AM J OBSTET GYNECOL, V179, P577, DOI 10.1016/S0002-9378(98)70047-X; Rosenberg MJ, 1996, AM J OBSTET GYNECOL, V174, P628, DOI 10.1016/S0002-9378(96)70440-4; Rosing J, 1999, AM J OBSTET GYNECOL, V180, pS375, DOI 10.1016/S0002-9378(99)70699-X; Rossing MA, 1996, AM J EPIDEMIOL, V144, P161, DOI 10.1093/oxfordjournals.aje.a008903; SALEH WA, 1993, AM J OBSTET GYNECOL, V168, P1740, DOI 10.1016/0002-9378(93)90685-C; Schiff I, 1999, AM J OBSTET GYNECOL, V180, pS383, DOI 10.1016/S0002-9378(99)70700-3; Schlesselman JJ, 1997, HUM REPROD, V12, P1851, DOI 10.1093/humrep/12.9.1851; SCHLESSELMAN JJ, 1995, OBSTET GYNECOL, V85, P793, DOI 10.1016/0029-7844(95)00022-J; Schmidt PJ, 2000, AM J OBSTET GYNECOL, V183, P414, DOI 10.1067/mob.2000.106004; Schwartz SM, 1998, STROKE, V29, P2277, DOI 10.1161/01.STR.29.11.2277; Schwartz SM, 1997, ANN INTERN MED, V127, P596, DOI 10.7326/0003-4819-127-8_Part_1-199710150-00003; Schwingl PJ, 1999, AM J OBSTET GYNECOL, V180, P241, DOI 10.1016/S0002-9378(99)70182-1; SCRAGG RKR, 1984, BRIT MED J, V288, P1795, DOI 10.1136/bmj.288.6433.1795; Seifer DB, 1998, FERTIL STERIL, V69, P387; SHARGIL AA, 1985, INT J FERTIL, V30, P15; Sherif K, 1999, AM J OBSTET GYNECOL, V180, pS343, DOI 10.1016/S0002-9378(99)70694-0; Shulman LP, 2000, OBSTET GYN CLIN N AM, V27, P695, DOI 10.1016/S0889-8545(05)70168-6; Shulman LP, 1999, INT J FERTIL WOMEN M, V44, P78; Sidney S, 1996, OBSTET GYNECOL, V88, P939, DOI 10.1016/S0029-7844(96)00351-1; SPEROFF L, 1993, OBSTET GYNECOL, V81, P1034; SPEROFF L, 1994, CLIN GYNECOLOGIC END, P722; Spitzer WO, 1998, AM J OBSTET GYNECOL, V179, pS43, DOI 10.1053/ob.1998.v179.a93059; Spitzer WO, 1996, BRIT MED J, V312, P83; Stahl SM, 1998, PSYCHOPHARMACOL BULL, V34, P319; STERGACHIS A, 1992, AM J OBSTET GYNECOL, V167, P1165, DOI 10.1016/S0002-9378(12)90406-8; Stern RS, 2000, J AM ACAD DERMATOL, V43, P1042, DOI 10.1067/mjd.2000.110901; Stewart FH, 2001, JAMA-J AM MED ASSOC, V285, P2232, DOI 10.1001/jama.285.17.2232; STROM BL, 1986, CLIN PHARMACOL THER, V39, P335, DOI 10.1038/clpt.1986.49; Sulak P, 1999, CONTRACEPTION, V59, P161, DOI 10.1016/S0010-7824(99)00026-8; Tanis BC, 2001, NEW ENGL J MED, V345, P1787, DOI 10.1056/NEJMoa003216; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS280, DOI 10.1016/S0002-9378(99)70719-2; Thorneycroft IH, 1999, AM J OBSTET GYNECOL, V180, pS288, DOI 10.1016/S0002-9378(99)70720-9; THORVALDSEN P, 1995, STROKE, V26, P361, DOI 10.1161/01.STR.26.3.361; Tomasson H, 1996, ACTA OBSTET GYN SCAN, V75, P157, DOI 10.3109/00016349609033309; Tryggvadottir L, 1997, BRIT J CANCER, V75, P139, DOI 10.1038/bjc.1997.23; Tyden T, 1999, ADV CONTRACEPT, V15, P133, DOI 10.1023/A:1006749709993; TZOURIO C, 1995, BMJ-BRIT MED J, V310, P830, DOI 10.1136/bmj.310.6983.830; Ursin G, 1999, AM J EPIDEMIOL, V150, P561; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P73; Van Winter JT, 1998, AM FAM PHYSICIAN, V58, P1373; Vandenbroucke JP, 1996, BRIT MED J, V313, P1127, DOI 10.1136/bmj.313.7065.1127; Vessey M, 1998, CONTRACEPTION, V57, P231, DOI 10.1016/S0010-7824(98)00026-2; VESSEY MP, 1984, BRIT MED J, V289, P530, DOI 10.1136/bmj.289.6444.530-a; VOLPE A, 1993, CONTRACEPTION, V47, P229, DOI 10.1016/0010-7824(93)90040-E; Warren MP, 1998, CLIN OBSTET GYNECOL, V41, P976, DOI 10.1097/00003081-199812000-00024; Weiss G, 1999, AM J OBSTET GYNECOL, V180, pS295, DOI 10.1016/S0002-9378(99)70721-0; Westhoff CL, 1998, AM J OBSTET GYNECOL, V179, pS38, DOI 10.1053/ob.1998.v179.a91673; *WHO, 2000, IMPR ACC QUAL CAR FA, P1; *WHO US AG INT DEV, 1994, REC UPD SEL PRACT CO, V1; WINGO PA, 1991, OBSTET GYNECOL, V78, P161; 1999, FERTIL STERIL S3, V71, pS1; 1998, HUM REPROD, V13, P2325; 2000, AM COLL OBSTERTRICIA, V18, P1071; 1996, CONTRACEPTION, V54, pS1	157	24	26	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2003	138	1					54	64		10.7326/0003-4819-138-1-200301070-00013	http://dx.doi.org/10.7326/0003-4819-138-1-200301070-00013			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	645TV	12513046				2022-12-28	WOS:000180996200008
J	Wilson, AM; Watson, JC; Lichtwark, GA				Wilson, AM; Watson, JC; Lichtwark, GA			Biomechanics: A catapult action for rapid limb protraction	NATURE			English	Article							HORSE; MUSCLE		Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; UCL, Inst Human Performance, Stanmore HA7 4LP, Middx, England	University of London; University of London Royal Veterinary College; University of London; University College London	Wilson, AM (corresponding author), Univ London Royal Vet Coll, Dept Vet Basic Sci, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk	Lichtwark, Glen A/B-6002-2008	Lichtwark, Glen A/0000-0001-7366-3348; Wilson, Alan/0000-0001-9914-3455				Alexander RM., 1988, ELASTIC MECH ANIMAL; BENNETCLARK HC, 1975, J EXP BIOL, V63, P53; Biewener A A, 2000, Exerc Sport Sci Rev, V28, P99; Biewener AA, 1998, COMP BIOCHEM PHYS B, V120, P73, DOI 10.1016/S0305-0491(98)00024-8; DYCE KM, 1987, TXB VET ANATOMY, P542; HERMANSON JW, 1990, ACTA ANAT, V137, P146, DOI 10.1159/000146875; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; Peplowski MM, 1997, J EXP BIOL, V200, P2861; PRATT GW, 1978, AM J VET RES, V39, P249; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Weyand PG, 2000, J APPL PHYSIOL, V89, P1991, DOI 10.1152/jappl.2000.89.5.1991; WOLEDGE R, 1985, MONOGR PHYSL SOC, V41	13	107	111	4	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 2	2003	421	6918					35	36		10.1038/421035a	http://dx.doi.org/10.1038/421035a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	631JY	12569935				2022-12-28	WOS:000180165500027
